Citrus Sinensis ID: 036051
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | 2.2.26 [Sep-21-2011] | |||||||
| O80939 | 675 | L-type lectin-domain cont | yes | no | 1.0 | 0.622 | 0.698 | 1e-171 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 1.0 | 0.620 | 0.658 | 1e-168 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.988 | 0.615 | 0.620 | 1e-152 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.978 | 0.614 | 0.631 | 1e-150 | |
| O04533 | 656 | Putative L-type lectin-do | no | no | 0.988 | 0.632 | 0.548 | 1e-136 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.890 | 0.546 | 0.578 | 1e-129 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.961 | 0.603 | 0.536 | 1e-127 | |
| O04534 | 666 | Putative L-type lectin-do | no | no | 0.990 | 0.624 | 0.510 | 1e-124 | |
| Q9FIF1 | 674 | Probable L-type lectin-do | no | no | 0.959 | 0.597 | 0.524 | 1e-120 | |
| Q9M1G4 | 674 | Probable L-type lectin-do | no | no | 0.904 | 0.563 | 0.550 | 1e-119 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 600 bits (1548), Expect = e-171, Method: Compositional matrix adjust.
Identities = 297/425 (69%), Positives = 354/425 (83%), Gaps = 5/425 (1%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L HYILGWSF +N +A L LS+LPKLPR PK+ S+F IG+P+I + LI + + V
Sbjct: 251 LSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVC 310
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y++RR+RKFAEELE+WE ++G +RFR+KDLY ATKGF+EK LLG+GGFG VY+G +P +K
Sbjct: 311 YIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTK 370
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+EIAVK++SHESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLD
Sbjct: 371 LEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN P+VTLNW+QR VI GVA GL YLHEEWEQVVIHRDVKASNVLLDGELNGRLGD
Sbjct: 431 KYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 490
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE- 299
FGLARLYDHG+DPQTTHVVGTLGYLAPEHTRTG+AT + DVF+FGAFLLEVACGRRPIE
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEF 550
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
+Q +E +LVDWVF WN+G++L A+DPN+G+E +E+E++LKLGLLCSHSDP ARPS
Sbjct: 551 QQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPS 610
Query: 360 MRQVVQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSM--GFTRPSSLAESL 415
MRQV+ L D LP +S L LS G+ + +GF + +SYSSS+ GFT SS+A+S
Sbjct: 611 MRQVLHYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSSIADSQ 670
Query: 416 LSGGR 420
LSGGR
Sbjct: 671 LSGGR 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1527), Expect = e-168, Method: Compositional matrix adjust.
Identities = 281/427 (65%), Positives = 353/427 (82%), Gaps = 7/427 (1%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L H+++GWSF++NG+A L+LS+LPKLPR P++ S+F IG+P+I +SLI + +
Sbjct: 251 LSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAF 310
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y++RRK+K+ EEL+DWE ++G +RFR+K+LY ATKGF+EK+LLGSGGFGRVYRG LP +K
Sbjct: 311 YIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTK 370
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+E+AVK++SH+S+QGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLD
Sbjct: 371 LEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN P+ TL+W+QR +IKGVA GL YLHEEWEQVVIHRDVKASNVLLD + NGRLGD
Sbjct: 431 KYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGD 490
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE- 299
FGLARLYDHG+DPQTTHVVGTLGYLAPEH+RTG+ATT+ DV++FGAFLLEV GRRPIE
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEF 550
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTE-YVAEELELILKLGLLCSHSDPTARP 358
++ +LV+WVF W RG ++EA+DP LG+ Y EE+E++LKLGLLCSHSDP ARP
Sbjct: 551 HSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARP 610
Query: 359 SMRQVVQILERDVALPAISALGLSARGITY---QEGFDDFAVSYSSSM--GFTRPSSLAE 413
SMRQV+Q L D+ALP ++ L LSA + ++GF A++ S++ GFT SS+A+
Sbjct: 611 SMRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGSSIAD 670
Query: 414 SLLSGGR 420
SLLSGGR
Sbjct: 671 SLLSGGR 677
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 539 bits (1389), Expect = e-152, Method: Compositional matrix adjust.
Identities = 265/427 (62%), Positives = 327/427 (76%), Gaps = 12/427 (2%)
Query: 1 LVSHYILGWSFKINGQ-AQELNLSQLPKLPRVGPKKRSKFLTIGLPV-----ICVSLILA 54
L H++ GWSF + G+ A L LS++PK PRVGP +F +P+ I V +++
Sbjct: 253 LSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVS 312
Query: 55 AVSGVVYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRG 114
+ V +++RR+RKFAEE EDWE ++G +R R+KDLY ATKGF++K+LLGSGGFGRVYRG
Sbjct: 313 LIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRG 372
Query: 115 TLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174
+P +K EIAVK++S+ESRQG+KEFVAEIVSIGR+ HRNLV LLGYCRR+ ELLLVYDYM
Sbjct: 373 VMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYM 432
Query: 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234
PNGSLDKYLY+ P+VTL+W+QR+ VI GVA GL YLHEEWEQVVIHRD+KASNVLLD E
Sbjct: 433 PNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEY 492
Query: 235 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 294
NGRLGDFGLARL DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG LLEVACG
Sbjct: 493 NGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACG 552
Query: 295 RRPIERQ-GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSD 353
RRPIE + +E+++LVD VF FW G +L+A DPNLG+ Y E+E +LKLGLLCSHSD
Sbjct: 553 RRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSD 612
Query: 354 PTARPSMRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAE 413
P RP+MRQV+Q L D LP +S L RG G + +S S F+ SS+A
Sbjct: 613 PQVRPTMRQVLQYLRGDATLPDLSPLDF--RGSGKMLGMNH---RFSESCTFSSGSSIAY 667
Query: 414 SLLSGGR 420
S++SGGR
Sbjct: 668 SIVSGGR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1371), Expect = e-150, Method: Compositional matrix adjust.
Identities = 266/421 (63%), Positives = 327/421 (77%), Gaps = 10/421 (2%)
Query: 5 YILGWSFKINGQAQELNLSQLPKLP--RVGPKKRSKFLTIGLPVICVSLILAAVSG--VV 60
++LGWSF +NG+AQ L LS+LP+LP + P + +F +P+I + LI + V
Sbjct: 254 FVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVR 313
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
++++R+RKFAEE+EDWE ++G +R R+KDLY ATKGF++K +LGSGGFG VY+G +PK+K
Sbjct: 314 FIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTK 373
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
EIAVK++S+ESRQG+KEFVAEIVSIG++ HRNLV L+GYCRR+ ELLLVYDYMPNGSLD
Sbjct: 374 KEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLD 433
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN P+VTL+W+QR+ VI GVA L YLHEEWEQVVIHRDVKASNVLLD ELNGRLGD
Sbjct: 434 KYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGD 493
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLA+L DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG LLEVACGRRPIE
Sbjct: 494 FGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEI 553
Query: 301 QGPE-ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
E ++LVDWVF FW +L+A+DPNLG+EY +E+E++LKLGLLCSHSDP ARP+
Sbjct: 554 NNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPT 613
Query: 360 MRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAESLLSGG 419
MRQV+Q L D LP +S L L GI S S M FT SS+A SLLS G
Sbjct: 614 MRQVLQYLRGDAMLPDLSPLDLRGSGIM----LGTHNGSNESGM-FTSGSSVAYSLLSSG 668
Query: 420 R 420
R
Sbjct: 669 R 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 231/421 (54%), Positives = 305/421 (72%), Gaps = 6/421 (1%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKR--SKFLTIGLPVICVSLILAAVSGVV 60
SHYILGWSF G ++NLS+LPK+P ++ SK L I L + V+L++ + GV+
Sbjct: 239 SHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVIVLILGVM 298
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
++RK KF E +EDWE+ +GPH+F YKDL+IATKGF+ E+LG GGFG+V++G LP S
Sbjct: 299 LFLKRK-KFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFGKVFKGILPLSS 357
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
I IAVKKISH+SRQGM+EF+AEI +IGRLRH +LV+LLGYCRRKGEL LVYD+MP GSLD
Sbjct: 358 IPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSLD 417
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
K+LYNQP L+W QR+ +IK VA GL YLH++W QV+IHRD+K +N+LLD +N +LGD
Sbjct: 418 KFLYNQPNQILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAKLGD 477
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLA+L DHG D QT++V GT GY++PE +RTGK++TS+DVF+FG F+LE+ CGRRPI
Sbjct: 478 FGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRPIGP 537
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
+G ++L DWV D W+ G++L+ D LG Y+AE++ L+LKLGLLCSH RPSM
Sbjct: 538 RGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATRPSM 597
Query: 361 RQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPS-SLAESLLSGG 419
V+Q L+ LP +++R I EGFD V+ S + S + ES LS G
Sbjct: 598 SSVIQFLDGVATLPHNLLDLVNSRII--NEGFDTLGVTTESMEASSNVSLVMTESFLSSG 655
Query: 420 R 420
R
Sbjct: 656 R 656
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-129, Method: Compositional matrix adjust.
Identities = 218/377 (57%), Positives = 287/377 (76%), Gaps = 3/377 (0%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPR--VGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
SHYILGW+F ++G+A L+L LP++P KK+ + L +G+ ++C LI A +
Sbjct: 250 SHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAAS 309
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
+ RK K + +E+WELD+GPHRF Y++L AT GF +KELLGSGGFG+VY+G LP S
Sbjct: 310 LFVVRKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSD 369
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+AVK+ISHESRQG++EF++E+ SIG LRHRNLVQLLG+CRR+ +LLLVYD+MPNGSLD
Sbjct: 370 EFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLD 429
Query: 181 KYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239
YL+++ P+V L W+QR+ +IKGVA GLLYLHE WEQ VIHRD+KA+NVLLD E+NGR+G
Sbjct: 430 MYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVG 489
Query: 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299
DFGLA+LY+HG+DP T VVGT GYLAPE T++GK TTS DV++FGA LLEVACGRRPIE
Sbjct: 490 DFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIE 549
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
E L++VDWV+ W G++ + D L E+ EE+ +++KLGLLCS++ P RP+
Sbjct: 550 TSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPT 609
Query: 360 MRQVVQILERDVALPAI 376
MRQVV LE+ P +
Sbjct: 610 MRQVVMYLEKQFPSPEV 626
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 223/416 (53%), Positives = 295/416 (70%), Gaps = 12/416 (2%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVG-PKKRSKFLTIGLPVICVSLILAAVSGVVY 61
SHYILGW+FK+NG A +++S+LPKLPR K L I L + +++++ +
Sbjct: 250 SHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYML 309
Query: 62 VIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKI 121
++RK K E LEDWE+ +GPHRF YKDLYIATKGFR ELLG GGFG+VY+GTL S +
Sbjct: 310 FLKRK-KLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNM 368
Query: 122 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
+IAVKK+SH+SRQGM+EFVAEI +IGRLRH NLV+LLGYCRRKGEL LVYD MP GSLDK
Sbjct: 369 DIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDK 428
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
+LY+QP+ +L+W QR+ +IK VA GL YLH +W QV+IHRD+K +NVLLD +NG+LGDF
Sbjct: 429 FLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDF 488
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI-ER 300
GLA+L +HG DPQT++V GT GY++PE +RTGKA+TS+DVF+FG +LE+ CGRRP+ R
Sbjct: 489 GLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPR 548
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTE--YVAEELELILKLGLLCSHSDPTARP 358
++L DWV D W ++L+ D + + Y+ E++ L+LKLGL CSH RP
Sbjct: 549 ASSPSEMVLTDWVLDCW-EDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRP 607
Query: 359 SMRQVVQILERDVALPAISALGLSAR-GITYQEGFDDFAVSYS-----SSMGFTRP 408
SM V+Q L+ LP + AR + EGF + A S + +++ FT P
Sbjct: 608 SMSSVIQFLDGVAQLPNNLFDIVKARENVGAIEGFGEAAESLAEPCSVATLTFTEP 663
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 215/421 (51%), Positives = 290/421 (68%), Gaps = 5/421 (1%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGP---KKRSKFLTIGLPVICVSLILAAVSGV 59
SHYILGW+FK+NG +++ S+LPK+PR + + LTI L V V +++ +
Sbjct: 248 SHYILGWTFKMNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSL 307
Query: 60 VYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKS 119
++RK K E LEDWE+ +GPHRF +KDL+IATKGF++ E+LG GGFG+VY+GTLP S
Sbjct: 308 WLFLKRK-KLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVS 366
Query: 120 KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179
+EIAVK +SH+SRQGM+EF+AEI +IGRLRH NLV+L GYCR KGEL LVYD M GSL
Sbjct: 367 NVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSL 426
Query: 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239
DK+LY+Q L+W QR+ +IK VA GL YLH++W QV+IHRD+K +N+LLD +N +LG
Sbjct: 427 DKFLYHQQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLG 486
Query: 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299
DFGLA+L DHGTDPQT+HV GTLGY++PE +RTGKA+T +DVF+FG +LE+ACGR+PI
Sbjct: 487 DFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPIL 546
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
+ + ++L DWV + W ++++ D +G EYV E+ L+LKLGL CSH RP+
Sbjct: 547 PRASQREMVLTDWVLECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPN 606
Query: 360 MRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAESLLSGG 419
M V+Q+L+ LP + R + A S P + ES +S G
Sbjct: 607 MSSVIQLLDSVAQLPHNLLDIVQTREVHRGTEISGEAADSPESCSIA-PLTFTESFVSHG 665
Query: 420 R 420
R
Sbjct: 666 R 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1112), Expect = e-120, Method: Compositional matrix adjust.
Identities = 223/425 (52%), Positives = 296/425 (69%), Gaps = 22/425 (5%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYV 62
+ YILGWSFK G+A+ L++S+L P PK+ +G + ++ + + G+VY
Sbjct: 265 NQYILGWSFKQGGKAESLDISRLSN-PPPSPKRFPLKEVLGATISTIAFL--TLGGIVY- 320
Query: 63 IRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIE 122
+ +K+K+AE LE WE +Y P R+ ++ LY ATKGFRE +LLG+GGFG+VY+G LP S +
Sbjct: 321 LYKKKKYAEVLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILP-SGTQ 379
Query: 123 IAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKY 182
IAVK++ H++ QGMK++VAEI S+GRLRH+NLV LLGYCRRKGELLLVYDYMPNGSLD Y
Sbjct: 380 IAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDY 439
Query: 183 LYNQPKVT-LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
L+++ K+ L W QR +IKGVA LLYLHEEWEQVV+HRD+KASN+LLD +LNG+LGDF
Sbjct: 440 LFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDF 499
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQ 301
GLAR +D G + + T VVGT+GY+APE T G TT DV++FGAF+LEV CGRRP++
Sbjct: 500 GLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPD 559
Query: 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMR 361
P E +ILV WV R L + D L ++ EE +L+LKLG+LCS +P RPSMR
Sbjct: 560 APREQVILVKWVASCGKRDALTDTVDSKL-IDFKVEEAKLLLKLGMLCSQINPENRPSMR 618
Query: 362 QVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAE------SL 415
Q++Q LE +V++PAIS G A GI +S+ + T SS A ++
Sbjct: 619 QILQYLEGNVSVPAIS-FGTVALGIP--------NISHETVTQMTTTSSSANFSFEDVTV 669
Query: 416 LSGGR 420
L GGR
Sbjct: 670 LFGGR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 213/387 (55%), Positives = 277/387 (71%), Gaps = 7/387 (1%)
Query: 4 HYILGWSFKINGQ-AQELNLSQLPKLPRV-GPKKRSKF-LTIGLPVICVSLILAAVSGVV 60
HY+LGWSF N + +Q L+ S+LP++PR K+ +F L I LPVI +++A ++GV
Sbjct: 250 HYLLGWSFSTNRELSQLLDFSKLPQVPRPRAEHKKVQFALIIALPVILAIVVMAVLAGVY 309
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y RK+K+AE E WE YG HRF YK LYIATKGF + LG GGFG VYRG LP +K
Sbjct: 310 Y--HRKKKYAEVSEPWEKKYGTHRFSYKSLYIATKGFHKDRFLGRGGFGEVYRGDLPLNK 367
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+AVK++SH+ QGMK+FVAE+VS+ L+HRNLV LLGYCRRKGELLLV +YMPNGSLD
Sbjct: 368 T-VAVKRVSHDGEQGMKQFVAEVVSMKSLKHRNLVPLLGYCRRKGELLLVSEYMPNGSLD 426
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
++L++ L+W QR+ ++KG+A L YLH E EQVV+HRD+KASNV+LD ELNGRLGD
Sbjct: 427 QHLFDDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRDIKASNVMLDAELNGRLGD 486
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FG+AR +DHG + TT VGT+GY+APE G A+T DV++FG FLLEVACGR+P+E
Sbjct: 487 FGMARFHDHGGNAATTAAVGTVGYMAPELITMG-ASTITDVYAFGVFLLEVACGRKPVEF 545
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
E L+ WV + W + LL+A+DP LG E+V EE+EL++KLGLLC++ P +RP+M
Sbjct: 546 GVQVEKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEVELVMKLGLLCTNIVPESRPAM 605
Query: 361 RQVVQILERDVALPAISALGLSARGIT 387
QVV L ++ LP S L T
Sbjct: 606 GQVVLYLSGNLPLPDFSPYTLGIGSFT 632
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | ||||||
| 359481749 | 1258 | PREDICTED: L-type lectin-domain containi | 0.992 | 0.331 | 0.792 | 0.0 | |
| 255588220 | 669 | kinase, putative [Ricinus communis] gi|2 | 1.0 | 0.627 | 0.785 | 0.0 | |
| 38112427 | 669 | lectin-like receptor kinase 7;2 [Medicag | 1.0 | 0.627 | 0.738 | 0.0 | |
| 147808029 | 616 | hypothetical protein VITISV_019444 [Viti | 0.854 | 0.582 | 0.825 | 1e-179 | |
| 449440319 | 706 | PREDICTED: L-type lectin-domain containi | 0.983 | 0.584 | 0.706 | 1e-175 | |
| 356567974 | 667 | PREDICTED: L-type lectin-domain containi | 0.990 | 0.623 | 0.724 | 1e-175 | |
| 356520929 | 667 | PREDICTED: L-type lectin-domain containi | 0.997 | 0.628 | 0.726 | 1e-174 | |
| 449483657 | 703 | PREDICTED: L-type lectin-domain containi | 0.976 | 0.583 | 0.704 | 1e-172 | |
| 224110964 | 623 | predicted protein [Populus trichocarpa] | 0.904 | 0.609 | 0.728 | 1e-172 | |
| 224090779 | 534 | predicted protein [Populus trichocarpa] | 0.871 | 0.685 | 0.793 | 1e-171 |
| >gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/424 (79%), Positives = 375/424 (88%), Gaps = 7/424 (1%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L SHY+LGWSFK+NGQAQ L +SQLPKLPR+G +K+S FLT GLPVICV ILA +SG V
Sbjct: 838 LTSHYLLGWSFKMNGQAQPLAISQLPKLPRIGGQKKSAFLTSGLPVICVVSILAVMSGAV 897
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y+IRRK+KFAEELEDWELDYGPHRF+YKDLY ATKGF++KELLGSGGFGRVYRG LP SK
Sbjct: 898 YLIRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGVLPTSK 957
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+EIAVKKISHESRQGMKEFVAEIVSIGRLRHRN+V LLGYCRRKGELLLVYDYMPNGSLD
Sbjct: 958 LEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMPNGSLD 1017
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLY+QPKVTLNW QR+ V+KGVA GL YLH EWEQVV+HRDVKASNVLLDGELNGRLGD
Sbjct: 1018 KYLYDQPKVTLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGELNGRLGD 1077
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT DV++FGAFLLEVACGRRPI
Sbjct: 1078 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACGRRPI-- 1135
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
P E+LILVDWVF FWNRGE+L+A DP LG +Y AEE+EL+LKLGL+CSHS+P ARPSM
Sbjct: 1136 -APMEDLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEPNARPSM 1194
Query: 361 RQVVQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSMG--FTRPSSLAESLL 416
QVVQ LER V LP ++LGLSA G+++ +EGFDDFA+SY S+ F+ S++ ESLL
Sbjct: 1195 PQVVQYLERTVPLPEFTSLGLSANGLSFAHREGFDDFALSYPFSLDKTFSHASTVPESLL 1254
Query: 417 SGGR 420
SGGR
Sbjct: 1255 SGGR 1258
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255588220|ref|XP_002534539.1| kinase, putative [Ricinus communis] gi|223525084|gb|EEF27843.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/424 (78%), Positives = 377/424 (88%), Gaps = 4/424 (0%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L SHY+LGWS+K+NGQAQ L+LS LPKLPR+GPKKRSKF+TIG+P I +S IL A+SG V
Sbjct: 246 LTSHYVLGWSYKMNGQAQPLDLSALPKLPRIGPKKRSKFVTIGVPAISISSILIAISGSV 305
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y IRRKRKFAEELEDWELDY PHRF+YKDLYIATKGF++KELLGSGGFGRVY+G LP K
Sbjct: 306 YFIRRKRKFAEELEDWELDYWPHRFKYKDLYIATKGFKDKELLGSGGFGRVYKGVLPIPK 365
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+EIAVK++SHE+RQGMK F+AEIVSIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLD
Sbjct: 366 LEIAVKRVSHETRQGMKVFIAEIVSIGRLRHRNLVTLLGYCRRKGELLLVYDYMPNGSLD 425
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLY+QP+VTLNW QR+ VIKGVA GL YLHEEWEQVVIHRDVKASNVLLDGE+N RLGD
Sbjct: 426 KYLYDQPEVTLNWSQRFKVIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEMNARLGD 485
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLARLYDHGTDPQTTHVVGT GYLAPEHTRTGKATT DVFSFGAFLLEVA GRRPIER
Sbjct: 486 FGLARLYDHGTDPQTTHVVGTFGYLAPEHTRTGKATTKTDVFSFGAFLLEVASGRRPIER 545
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
E++I VDWVF W RGE++EA+DPNLGT+++AEE+EL+LKLGLLCSH++P ARPSM
Sbjct: 546 STTPEDIISVDWVFSCWIRGEIVEAKDPNLGTDFIAEEVELVLKLGLLCSHAEPEARPSM 605
Query: 361 RQVVQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSM--GFTRPSSLAESLL 416
RQV+QILERD+ LP +S+LGLSA G+ + EGFDDFA+S SSM F+ S++AESLL
Sbjct: 606 RQVMQILERDIPLPELSSLGLSASGLVFARHEGFDDFAMSCPSSMDKAFSHTSTIAESLL 665
Query: 417 SGGR 420
SGGR
Sbjct: 666 SGGR 669
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|38112427|gb|AAR11299.1| lectin-like receptor kinase 7;2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/425 (73%), Positives = 362/425 (85%), Gaps = 5/425 (1%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
SHYILGWSFK+NGQA+ L +S+LPKLPR G KK S FLT+GLP++ +SL+ GV+
Sbjct: 245 FTSHYILGWSFKVNGQAENLVISELPKLPRFGEKKESMFLTVGLPLVLLSLVFMITLGVI 304
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y I+R++KFAE LEDWE +YGPHRF++KDLY ATKGF+EK LLG GGFGRVY+G +P SK
Sbjct: 305 YYIKRRKKFAELLEDWEHEYGPHRFKFKDLYFATKGFKEKGLLGVGGFGRVYKGVMPGSK 364
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+E+AVK++SHESRQGM+EFV+EIVSIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLD
Sbjct: 365 LEVAVKRVSHESRQGMREFVSEIVSIGRLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLD 424
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
YLYNQP+VTLNW QR+ +IKGVALGL YLHEEWEQVVIHRD+KASNVLLDGELNGRLGD
Sbjct: 425 NYLYNQPRVTLNWSQRFRIIKGVALGLFYLHEEWEQVVIHRDIKASNVLLDGELNGRLGD 484
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLARLYDHG DP TTH+VGT+GYLAPEHTRTGKAT +DVFSFGAFLLEVACGRRPIE
Sbjct: 485 FGLARLYDHGADPHTTHLVGTVGYLAPEHTRTGKATKFSDVFSFGAFLLEVACGRRPIEN 544
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
E +ILVD VF+ W RG +LEA+D NLGT YV+EE+EL+LKLGLLCSHS+P ARP M
Sbjct: 545 VAENECVILVDCVFECWKRGNILEAKDVNLGTNYVSEEVELVLKLGLLCSHSEPLARPGM 604
Query: 361 RQVVQILERDVALPAISALGLSARGIT--YQEGFDDFAVSYSSSMGFTRPS---SLAESL 415
RQVVQ LERD+ LP +S L LS+ G+T YQE F+DF +SY SSMG T S+A+SL
Sbjct: 605 RQVVQYLERDIPLPDLSLLSLSSSGLTFGYQEFFEDFPLSYPSSMGNTMSHTSVSIADSL 664
Query: 416 LSGGR 420
LSGGR
Sbjct: 665 LSGGR 669
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147808029|emb|CAN77672.1| hypothetical protein VITISV_019444 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 299/362 (82%), Positives = 328/362 (90%), Gaps = 3/362 (0%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L SHY+LGWSFK+NGQAQ L +SQLPKLPR+G +K+S FLT GLPVICV +LA +SG V
Sbjct: 247 LTSHYLLGWSFKMNGQAQPLAISQLPKLPRIGGQKKSAFLTSGLPVICVVSVLAVMSGAV 306
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y+IRRK+KFAEELEDWELDYGPHRF+YKDLY ATKGF++KELLGSGGFGRVYRG LP SK
Sbjct: 307 YLIRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGVLPTSK 366
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+EIAVKKISHESRQGMKEFVAEIVSIGRLRHRN+V LLGYCRRKGELLLVYDYMPNGSLD
Sbjct: 367 LEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMPNGSLD 426
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLY+QPKV LNW QR+ V+KGVA GL YLH EWEQVV+HRDVKASNVLLDGELNGRLGD
Sbjct: 427 KYLYDQPKVXLNWXQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGELNGRLGD 486
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT DV++FGAFLLEVACGRRPI
Sbjct: 487 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACGRRPI-- 544
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
P E+LILVDWVF FWNRGE+L+A DP LG +Y AEE+EL+LKLGL+CSHS+P ARPSM
Sbjct: 545 -APMEDLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEPNARPSM 603
Query: 361 RQ 362
Q
Sbjct: 604 PQ 605
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440319|ref|XP_004137932.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1598), Expect = e-175, Method: Compositional matrix adjust.
Identities = 304/430 (70%), Positives = 353/430 (82%), Gaps = 17/430 (3%)
Query: 4 HYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYVI 63
HYILGWSF++NGQAQ L++S+LPKLP+ K RSK LTIGLP+I + L + +V+VI
Sbjct: 281 HYILGWSFRLNGQAQSLDISRLPKLPQ--KKHRSKVLTIGLPLISGGIALLVILSIVHVI 338
Query: 64 RRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEI 123
RRKRKFAE LEDWELDYGPHRF+YKDLY AT GF+EKE+LGSGGFGRVY+G LPKSK+EI
Sbjct: 339 RRKRKFAELLEDWELDYGPHRFKYKDLYTATNGFKEKEILGSGGFGRVYKGALPKSKLEI 398
Query: 124 AVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL 183
AVK++SHESRQGMKEFVAEIVS+GRLRHRNLVQLLGYCRRKGELLLVYDYM NGSLDKYL
Sbjct: 399 AVKRVSHESRQGMKEFVAEIVSLGRLRHRNLVQLLGYCRRKGELLLVYDYMQNGSLDKYL 458
Query: 184 YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243
+N+ +LNW QR+ +IKGVA GLLYLHEEWEQ VIHRDVKASNVLLD ELNGRLGDFGL
Sbjct: 459 FNETNPSLNWSQRFRIIKGVASGLLYLHEEWEQTVIHRDVKASNVLLDNELNGRLGDFGL 518
Query: 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
ARLYDHGTDPQTTH+VGTLGYLAPEHTR+G+ TT DVF+FGAFLLEVA G+RPIE +G
Sbjct: 519 ARLYDHGTDPQTTHIVGTLGYLAPEHTRSGRPTTQMDVFAFGAFLLEVATGKRPIEIRGM 578
Query: 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
E++IL+DWV W RG ++EA+DP LGTEYV EE+E++LKLGLLCS S+P ARPSMRQ+
Sbjct: 579 MEDVILLDWVLLCWMRGAIVEAKDPKLGTEYVTEEMEMVLKLGLLCSQSNPMARPSMRQI 638
Query: 364 VQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSM-------------GFTRPSS 410
VQ LE D +P + ++ G Y EGFDD +SY+S + GF SS
Sbjct: 639 VQYLEGDAVMPEMGSIETLGGGGGY-EGFDDLGMSYNSFLDKAIAYSTSSLERGFAH-SS 696
Query: 411 LAESLLSGGR 420
A+SLLSGGR
Sbjct: 697 DAQSLLSGGR 706
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567974|ref|XP_003552189.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1597), Expect = e-175, Method: Compositional matrix adjust.
Identities = 305/421 (72%), Positives = 355/421 (84%), Gaps = 5/421 (1%)
Query: 4 HYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYVI 63
HY+LGWSFK+NG+AQ+L +S+LP LPR+G K+ SK L +GLP+I +SLIL VV+VI
Sbjct: 248 HYVLGWSFKVNGKAQQLAISELPMLPRLGGKEESKVLIVGLPLILLSLILMVALAVVHVI 307
Query: 64 RRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEI 123
+RK KF E LEDWE DYGPHRF+YKDL +ATKGFREKELLGSGGFGRVY+G +P SKIE+
Sbjct: 308 KRK-KFTELLEDWEQDYGPHRFKYKDLSLATKGFREKELLGSGGFGRVYKGVMPISKIEV 366
Query: 124 AVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL 183
AVKK+S ESRQGM+EFVAEIVSIG LRHRNLV LLGYCRRKGELLLVYDYMPNGSLDKYL
Sbjct: 367 AVKKVSRESRQGMREFVAEIVSIGCLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLDKYL 426
Query: 184 YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243
YN+P+VTLNW QR+ + KGVA GL YLHEEWEQVV+HRD+KASNVLLD ELNGRLGDFGL
Sbjct: 427 YNKPRVTLNWSQRFKITKGVASGLFYLHEEWEQVVVHRDIKASNVLLDAELNGRLGDFGL 486
Query: 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
+RLY+HGTDP TTHVVGTLGYLAPEHTRTGKATTS+DVF+FGAF+LEV CGRRPIE+ G
Sbjct: 487 SRLYEHGTDPHTTHVVGTLGYLAPEHTRTGKATTSSDVFAFGAFMLEVVCGRRPIEKGGE 546
Query: 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
+ ILVDWV++ W +GE+LE+ DPNLG Y +E+EL+LKL LLCSHS+P ARPSMRQV
Sbjct: 547 SGSEILVDWVYNCWKKGEILESMDPNLGANYRPDEVELVLKLALLCSHSEPLARPSMRQV 606
Query: 364 VQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSMG--FTRPSSLAESLLSGG 419
VQ LE+DV LP + L LS+ G+T+ E F D +SY SSM + SS+ ESLLSGG
Sbjct: 607 VQYLEKDVPLPDLCMLSLSSNGLTFGLHEDFQDCPMSYPSSMNRPISHTSSIVESLLSGG 666
Query: 420 R 420
R
Sbjct: 667 R 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520929|ref|XP_003529112.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 308/424 (72%), Positives = 357/424 (84%), Gaps = 5/424 (1%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L SHY+LGWSFK+NG+AQ+L +S+LP LPR+ K+ SK L +GLP+I + LIL VV
Sbjct: 245 LSSHYVLGWSFKVNGKAQQLAISELPMLPRLVGKQESKVLIVGLPLILLILILMVALAVV 304
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
+ I+RK KF E LEDWE DYGPHRF+YKDL +ATKGFREKELLGSGGFGRVY+G +P SK
Sbjct: 305 HAIKRK-KFVELLEDWEQDYGPHRFKYKDLSLATKGFREKELLGSGGFGRVYKGVMPISK 363
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
IE+AVKK+SHESRQGM+EFVAEI SIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLD
Sbjct: 364 IEVAVKKVSHESRQGMREFVAEIASIGRLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLD 423
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN+P+VTLNW QR+ + KGVA GL YLHEEWEQVV+HRD+KASNVLLD ELNGRLGD
Sbjct: 424 KYLYNKPRVTLNWSQRFRITKGVASGLFYLHEEWEQVVLHRDIKASNVLLDAELNGRLGD 483
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGL+RLY+HGTDP TTHVVGTLGYLAPEHTRTGKATTS+DVF+FGAF+LEV CGRRPIE+
Sbjct: 484 FGLSRLYEHGTDPHTTHVVGTLGYLAPEHTRTGKATTSSDVFAFGAFMLEVVCGRRPIEQ 543
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
+ ILVDWV++ W +GE+LEARDPNLG Y +E+EL+LKL LLCSHS+P ARPSM
Sbjct: 544 GRESGSEILVDWVYNCWKKGEILEARDPNLGANYRPDEVELVLKLALLCSHSEPLARPSM 603
Query: 361 RQVVQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSMG--FTRPSSLAESLL 416
RQVVQ LE+DV LP +S L LS+ G+T+ E F D +SY SSM + SS+AESLL
Sbjct: 604 RQVVQYLEKDVPLPDLSMLSLSSIGLTFGLHEDFQDCPMSYPSSMDRPISHTSSIAESLL 663
Query: 417 SGGR 420
SGGR
Sbjct: 664 SGGR 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483657|ref|XP_004156651.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1574), Expect = e-172, Method: Compositional matrix adjust.
Identities = 303/430 (70%), Positives = 350/430 (81%), Gaps = 20/430 (4%)
Query: 4 HYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYVI 63
HYILGWSF++NGQAQ L++S+LPKLP+ K RSK LTIGLP+I + L + +V+VI
Sbjct: 281 HYILGWSFRLNGQAQSLDISRLPKLPQ--KKHRSKVLTIGLPLISGGIALLVILSIVHVI 338
Query: 64 RRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEI 123
RRKRKFAE LEDWELDYGPHRF+YKDLY AT GF+EKE+LGSGGFGRVY+G LPKSK+EI
Sbjct: 339 RRKRKFAELLEDWELDYGPHRFKYKDLYTATNGFKEKEILGSGGFGRVYKGALPKSKLEI 398
Query: 124 AVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL 183
AVK++SHESRQGMKEFVAEIVS+GRLRHRNLVQLLGYCRRKGELLLVYDYM NGSLDKYL
Sbjct: 399 AVKRVSHESRQGMKEFVAEIVSLGRLRHRNLVQLLGYCRRKGELLLVYDYMQNGSLDKYL 458
Query: 184 YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243
+N+ +LNW QR+ +IKGVA GLLYLHEEWEQ VIHRDVKASNVLLD ELNGRLGDFGL
Sbjct: 459 FNETNPSLNWSQRFRIIKGVASGLLYLHEEWEQTVIHRDVKASNVLLDNELNGRLGDFGL 518
Query: 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
ARLYDHGTDPQTTH+VGTLGYLAPEHTR+G+ TT DVF+FGAFLLEVA G+RPIE +G
Sbjct: 519 ARLYDHGTDPQTTHIVGTLGYLAPEHTRSGRPTTQMDVFAFGAFLLEVATGKRPIEIRGM 578
Query: 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
E++IL+DWV W RG ++EA+DP LGTEYV EE+ LKLGLLCS S+P ARPSMRQ+
Sbjct: 579 MEDVILLDWVLLCWMRGAIVEAKDPKLGTEYVTEEM---LKLGLLCSQSNPMARPSMRQI 635
Query: 364 VQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSM-------------GFTRPSS 410
VQ LE D +P + ++ G Y EGFDD +SY+S + GF SS
Sbjct: 636 VQYLEGDAVMPEMGSIETLGGGGGY-EGFDDLGMSYNSFLDKAIAYSTSSLERGFAH-SS 693
Query: 411 LAESLLSGGR 420
A+SLLSGGR
Sbjct: 694 DAQSLLSGGR 703
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110964|ref|XP_002333003.1| predicted protein [Populus trichocarpa] gi|222834498|gb|EEE72975.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1574), Expect = e-172, Method: Compositional matrix adjust.
Identities = 312/428 (72%), Positives = 340/428 (79%), Gaps = 48/428 (11%)
Query: 2 VSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVY 61
S Y+LGWSFK+NG A+ LN+S+LPKLPRVGPKK SKFLTIGLPV+C+SL+L AVS + Y
Sbjct: 235 TSQYVLGWSFKMNGLAKGLNISRLPKLPRVGPKKTSKFLTIGLPVLCLSLVLVAVSSISY 294
Query: 62 VIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKI 121
IRR RKFAE LEDWELDYGPHRF+ KDLY ATKGFR++E LGSGGFGRVY+G LP SKI
Sbjct: 295 AIRRARKFAEVLEDWELDYGPHRFKLKDLYTATKGFRDEEQLGSGGFGRVYKGVLPTSKI 354
Query: 122 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
+IAVK++SHESRQGM+EFVAEIVSIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLDK
Sbjct: 355 QIAVKRVSHESRQGMREFVAEIVSIGRLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLDK 414
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
YLY+QP V LNW QR+ VIKGVA GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF
Sbjct: 415 YLYDQPTVALNWSQRFRVIKGVASGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 474
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQ 301
GLARLYDHGTDPQTTHVVGTLGYLAPEH RTGKATTS DVF+FGAFLLEVA GRRPI+
Sbjct: 475 GLARLYDHGTDPQTTHVVGTLGYLAPEHARTGKATTSTDVFAFGAFLLEVASGRRPIQ-- 532
Query: 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMR 361
P E++ILVDWVF W LG ARPSMR
Sbjct: 533 -PTEDIILVDWVFSRW------------LG------------------------ARPSMR 555
Query: 362 QVVQILERDVALPAISALGLSARGITY--QEGFDDFAV-----SYSSSM--GFTRPSSLA 412
QVVQ LE DV LP IS L LSA G+T+ +EGFDDFA+ SY SSM F SS+A
Sbjct: 556 QVVQFLEGDVPLPDISPLRLSASGLTFSHREGFDDFAIDDFANSYPSSMDKAFAHSSSVA 615
Query: 413 ESLLSGGR 420
ESLLSGGR
Sbjct: 616 ESLLSGGR 623
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090779|ref|XP_002309078.1| predicted protein [Populus trichocarpa] gi|222855054|gb|EEE92601.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1570), Expect = e-171, Method: Compositional matrix adjust.
Identities = 300/378 (79%), Positives = 328/378 (86%), Gaps = 12/378 (3%)
Query: 52 ILAAVSGVVYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRV 111
I AVS + Y IRR RKFAE LEDWELDYGPHRF++KDLY ATKGFR++ELLGSGGFGRV
Sbjct: 160 INVAVSSISYSIRRTRKFAEVLEDWELDYGPHRFKFKDLYTATKGFRDEELLGSGGFGRV 219
Query: 112 YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171
Y+G LP SKI+IAVK++SHESRQGM+EFVAEIVSIGRLRHRNLV LLGYCRRKGELLLVY
Sbjct: 220 YKGVLPTSKIQIAVKRVSHESRQGMREFVAEIVSIGRLRHRNLVPLLGYCRRKGELLLVY 279
Query: 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231
DYMPNGSLDKYLY+QP V LNW QR+ VIKGVA GLLYLHEEWEQVV+HRDVKASNVLLD
Sbjct: 280 DYMPNGSLDKYLYDQPTVALNWSQRFRVIKGVASGLLYLHEEWEQVVVHRDVKASNVLLD 339
Query: 232 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291
GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH RTGKATTS DVF+FGAFLLEV
Sbjct: 340 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHARTGKATTSTDVFAFGAFLLEV 399
Query: 292 ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSH 351
A GRRPI+ P E++ILVDWVF W GE+LEARDPNLGTEY+AEE+EL+LKLGL+CSH
Sbjct: 400 ASGRRPIQ---PTEDIILVDWVFSRWLGGEILEARDPNLGTEYIAEEMELVLKLGLMCSH 456
Query: 352 SDPTARPSMRQVVQILERDVALPAISALGLSARGITY--QEGFDDFAV-----SYSSSM- 403
S+P ARPSMRQVVQ LE DV LP IS L LS G+T+ +EGFDDFA+ SY SSM
Sbjct: 457 SEPAARPSMRQVVQFLEGDVRLPDISPLRLSTSGLTFSHREGFDDFAIDDFANSYPSSMD 516
Query: 404 -GFTRPSSLAESLLSGGR 420
F SS+AESLLSGGR
Sbjct: 517 KAFAHSSSVAESLLSGGR 534
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | ||||||
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 1.0 | 0.622 | 0.68 | 5.6e-155 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 1.0 | 0.620 | 0.637 | 2.7e-148 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.988 | 0.620 | 0.615 | 6.9e-134 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.988 | 0.615 | 0.606 | 8.8e-134 | |
| TAIR|locus:2020593 | 656 | AT1G70130 [Arabidopsis thalian | 0.988 | 0.632 | 0.532 | 4.7e-119 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.888 | 0.545 | 0.563 | 2.2e-114 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.988 | 0.620 | 0.513 | 1.2e-111 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.990 | 0.624 | 0.501 | 2.6e-111 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.897 | 0.559 | 0.535 | 1.9e-106 | |
| TAIR|locus:2085587 | 669 | AT3G45440 [Arabidopsis thalian | 0.890 | 0.559 | 0.530 | 1.3e-102 |
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1511 (537.0 bits), Expect = 5.6e-155, P = 5.6e-155
Identities = 289/425 (68%), Positives = 342/425 (80%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L HYILGWSF +N +A L LS+LPKLPR PK+ S+F IG+P+I + LI + + V
Sbjct: 251 LSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVC 310
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y++RR+RKFAEELE+WE ++G +RFR+KDLY ATKGF+EK LLG+GGFG VY+G +P +K
Sbjct: 311 YIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTK 370
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+EIAVK++SHESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLD
Sbjct: 371 LEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN P+VTLNW+QR VI GVA GL YLHEEWEQVVIHRDVKASNVLLDGELNGRLGD
Sbjct: 431 KYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 490
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE- 299
FGLARLYDHG+DPQTTHVVGTLGYLAPEHTRTG+AT + DVF+FGAFLLEVACGRRPIE
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEF 550
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPS 359
+Q +E +LVDWVF WN+G++L A+DPN+G+E CSHSDP ARPS
Sbjct: 551 QQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPS 610
Query: 360 MRQVVQILERDVALPAISALGLSARGITY--QEGFDDFAVSYSSSM--GFTRPSSLAESL 415
MRQV+ L D LP +S L LS G+ + +GF + +SYSSS+ GFT SS+A+S
Sbjct: 611 MRQVLHYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSSIADSQ 670
Query: 416 LSGGR 420
LSGGR
Sbjct: 671 LSGGR 675
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 272/427 (63%), Positives = 341/427 (79%)
Query: 1 LVSHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVV 60
L H+++GWSF++NG+A L+LS+LPKLPR P++ S+F IG+P+I +SLI + +
Sbjct: 251 LSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAF 310
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
Y++RRK+K+ EEL+DWE ++G +RFR+K+LY ATKGF+EK+LLGSGGFGRVYRG LP +K
Sbjct: 311 YIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTK 370
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
+E+AVK++SH+S+QGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLD
Sbjct: 371 LEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
KYLYN P+ TL+W+QR +IKGVA GL YLHEEWEQVVIHRDVKASNVLLD + NGRLGD
Sbjct: 431 KYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGD 490
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE- 299
FGLARLYDHG+DPQTTHVVGTLGYLAPEH+RTG+ATT+ DV++FGAFLLEV GRRPIE
Sbjct: 491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEF 550
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTE-YVAXXXXXXXXXXXXCSHSDPTARP 358
++ +LV+WVF W RG ++EA+DP LG+ Y CSHSDP ARP
Sbjct: 551 HSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARP 610
Query: 359 SMRQVVQILERDVALPAISALGLSARGITY---QEGFDDFAVSYSSSM--GFTRPSSLAE 413
SMRQV+Q L D+ALP ++ L LSA + ++GF A++ S++ GFT SS+A+
Sbjct: 611 SMRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGSSIAD 670
Query: 414 SLLSGGR 420
SLLSGGR
Sbjct: 671 SLLSGGR 677
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 6.9e-134, P = 6.9e-134
Identities = 262/426 (61%), Positives = 321/426 (75%)
Query: 1 LVSH-YILGWSFKINGQAQELNLSQLPKLP--RVGPKKRSKFLTIGLPVICVSLI--LAA 55
+VS ++LGWSF +NG+AQ L LS+LP+LP + P + +F +P+I + LI L
Sbjct: 249 IVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLI 308
Query: 56 VSGVVYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGT 115
+ V ++++R+RKFAEE+EDWE ++G +R R+KDLY ATKGF++K +LGSGGFG VY+G
Sbjct: 309 IFLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGI 368
Query: 116 LPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175
+PK+K EIAVK++S+ESRQG+KEFVAEIVSIG++ HRNLV L+GYCRR+ ELLLVYDYMP
Sbjct: 369 MPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMP 428
Query: 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235
NGSLDKYLYN P+VTL+W+QR+ VI GVA L YLHEEWEQVVIHRDVKASNVLLD ELN
Sbjct: 429 NGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELN 488
Query: 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 295
GRLGDFGLA+L DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG LLEVACGR
Sbjct: 489 GRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGR 548
Query: 296 RPIERQGPE-ENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDP 354
RPIE E ++LVDWVF FW +L+A+DPNLG+EY CSHSDP
Sbjct: 549 RPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDP 608
Query: 355 TARPSMRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAES 414
ARP+MRQV+Q L D LP +S L L GI G + S S M FT SS+A S
Sbjct: 609 LARPTMRQVLQYLRGDAMLPDLSPLDLRGSGIML--GTHNG--SNESGM-FTSGSSVAYS 663
Query: 415 LLSGGR 420
LLS GR
Sbjct: 664 LLSSGR 669
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.8e-134, P = 8.8e-134
Identities = 259/427 (60%), Positives = 317/427 (74%)
Query: 1 LVSHYILGWSFKINGQ-AQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLI--LAAVS 57
L H++ GWSF + G+ A L LS++PK PRVGP +F +P+ + LI L VS
Sbjct: 253 LSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVS 312
Query: 58 GVV---YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRG 114
+ +++RR+RKFAEE EDWE ++G +R R+KDLY ATKGF++K+LLGSGGFGRVYRG
Sbjct: 313 LIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRG 372
Query: 115 TLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174
+P +K EIAVK++S+ESRQG+KEFVAEIVSIGR+ HRNLV LLGYCRR+ ELLLVYDYM
Sbjct: 373 VMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYM 432
Query: 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234
PNGSLDKYLY+ P+VTL+W+QR+ VI GVA GL YLHEEWEQVVIHRD+KASNVLLD E
Sbjct: 433 PNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEY 492
Query: 235 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 294
NGRLGDFGLARL DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG LLEVACG
Sbjct: 493 NGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACG 552
Query: 295 RRPIERQ-GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSD 353
RRPIE + +E+++LVD VF FW G +L+A DPNLG+ Y CSHSD
Sbjct: 553 RRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSD 612
Query: 354 PTARPSMRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAE 413
P RP+MRQV+Q L D LP +S L RG G + +S S F+ SS+A
Sbjct: 613 PQVRPTMRQVLQYLRGDATLPDLSPLDF--RGSGKMLGMNH---RFSESCTFSSGSSIAY 667
Query: 414 SLLSGGR 420
S++SGGR
Sbjct: 668 SIVSGGR 674
|
|
| TAIR|locus:2020593 AT1G70130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
Identities = 224/421 (53%), Positives = 293/421 (69%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKR--SKFLTIGLPVICVSLILAAVSGVV 60
SHYILGWSF G ++NLS+LPK+P ++ SK L I L + V+L++ + GV+
Sbjct: 239 SHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVIVLILGVM 298
Query: 61 YVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK 120
++RK KF E +EDWE+ +GPH+F YKDL+IATKGF+ E+LG GGFG+V++G LP S
Sbjct: 299 LFLKRK-KFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFGKVFKGILPLSS 357
Query: 121 IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
I IAVKKISH+SRQGM+EF+AEI +IGRLRH +LV+LLGYCRRKGEL LVYD+MP GSLD
Sbjct: 358 IPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSLD 417
Query: 181 KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
K+LYNQP L+W QR+ +IK VA GL YLH++W QV+IHRD+K +N+LLD +N +LGD
Sbjct: 418 KFLYNQPNQILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAKLGD 477
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
FGLA+L DHG D QT++V GT GY++PE +RTGK++TS+DVF+FG F+LE+ CGRRPI
Sbjct: 478 FGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRPIGP 537
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSM 360
+G ++L DWV D W+ G++L+ D LG Y+A CSH RPSM
Sbjct: 538 RGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATRPSM 597
Query: 361 RQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSS-LAESLLSGG 419
V+Q L+ LP + L L I EGFD V+ S + S + ES LS G
Sbjct: 598 SSVIQFLDGVATLPH-NLLDLVNSRII-NEGFDTLGVTTESMEASSNVSLVMTESFLSSG 655
Query: 420 R 420
R
Sbjct: 656 R 656
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 2.2e-114, P = 2.2e-114
Identities = 213/378 (56%), Positives = 280/378 (74%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSK--FLTIGLPVICVSLILAA-VSGV 59
SHYILGW+F ++G+A L+L LP++P K++ K L +G+ ++C LI A V+
Sbjct: 250 SHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAAS 309
Query: 60 VYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKS 119
++V+R K K + +E+WELD+GPHRF Y++L AT GF +KELLGSGGFG+VY+G LP S
Sbjct: 310 LFVVR-KVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGS 368
Query: 120 KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179
+AVK+ISHESRQG++EF++E+ SIG LRHRNLVQLLG+CRR+ +LLLVYD+MPNGSL
Sbjct: 369 DEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSL 428
Query: 180 DKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238
D YL+++ P+V L W+QR+ +IKGVA GLLYLHE WEQ VIHRD+KA+NVLLD E+NGR+
Sbjct: 429 DMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRV 488
Query: 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
GDFGLA+LY+HG+DP T VVGT GYLAPE T++GK TTS DV++FGA LLEVACGRRPI
Sbjct: 489 GDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPI 548
Query: 299 ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARP 358
E E L++VDWV+ W G++ + D L E+ CS++ P RP
Sbjct: 549 ETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRP 608
Query: 359 SMRQVVQILERDVALPAI 376
+MRQVV LE+ P +
Sbjct: 609 TMRQVVMYLEKQFPSPEV 626
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1102 (393.0 bits), Expect = 1.2e-111, P = 1.2e-111
Identities = 217/423 (51%), Positives = 285/423 (67%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKR-SKFLTIGLPVICVSLILAAVSGVVY 61
SHYILGW+FK+NG A +++S+LPKLPR K L I L + +++++ +
Sbjct: 250 SHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYML 309
Query: 62 VIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKI 121
++RK K E LEDWE+ +GPHRF YKDLYIATKGFR ELLG GGFG+VY+GTL S +
Sbjct: 310 FLKRK-KLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNM 368
Query: 122 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
+IAVKK+SH+SRQGM+EFVAEI +IGRLRH NLV+LLGYCRRKGEL LVYD MP GSLDK
Sbjct: 369 DIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDK 428
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
+LY+QP+ +L+W QR+ +IK VA GL YLH +W QV+IHRD+K +NVLLD +NG+LGDF
Sbjct: 429 FLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDF 488
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI-ER 300
GLA+L +HG DPQT++V GT GY++PE +RTGKA+TS+DVF+FG +LE+ CGRRP+ R
Sbjct: 489 GLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPR 548
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTE--YVAXXXXXXXXXXXXCSHSDPTARP 358
++L DWV D W ++L+ D + + Y+ CSH RP
Sbjct: 549 ASSPSEMVLTDWVLDCWE-DDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRP 607
Query: 359 SMRQVVQILERDVALPAISALGLSAR-GITYQEGFDDFAVSYSSSMGFTRPSSLAESLLS 417
SM V+Q L+ LP + AR + EGF + A S + + E +S
Sbjct: 608 SMSSVIQFLDGVAQLPNNLFDIVKARENVGAIEGFGEAAESLAEPCSVAT-LTFTEPFVS 666
Query: 418 GGR 420
GR
Sbjct: 667 HGR 669
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 211/421 (50%), Positives = 285/421 (67%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVG-PKKRSK--FLTIGLPVICVSLILAAVSGV 59
SHYILGW+FK+NG +++ S+LPK+PR P +S LTI L V V +IL +S
Sbjct: 248 SHYILGWTFKMNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLTVSGV-IILIILSLS 306
Query: 60 VYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKS 119
+++ +++K E LEDWE+ +GPHRF +KDL+IATKGF++ E+LG GGFG+VY+GTLP S
Sbjct: 307 LWLFLKRKKLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVS 366
Query: 120 KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179
+EIAVK +SH+SRQGM+EF+AEI +IGRLRH NLV+L GYCR KGEL LVYD M GSL
Sbjct: 367 NVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSL 426
Query: 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239
DK+LY+Q L+W QR+ +IK VA GL YLH++W QV+IHRD+K +N+LLD +N +LG
Sbjct: 427 DKFLYHQQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLG 486
Query: 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299
DFGLA+L DHGTDPQT+HV GTLGY++PE +RTGKA+T +DVF+FG +LE+ACGR+PI
Sbjct: 487 DFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPIL 546
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPS 359
+ + ++L DWV + W ++++ D +G EYV CSH RP+
Sbjct: 547 PRASQREMVLTDWVLECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPN 606
Query: 360 MRQVVQILERDVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAESLLSGG 419
M V+Q+L+ LP + R + A S P + ES +S G
Sbjct: 607 MSSVIQLLDSVAQLPHNLLDIVQTREVHRGTEISGEAADSPESCSIA-PLTFTESFVSHG 665
Query: 420 R 420
R
Sbjct: 666 R 666
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 1.9e-106, P = 1.9e-106
Identities = 206/385 (53%), Positives = 271/385 (70%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYV 62
+ YILGWSFK G+A+ L++S+L P PK+ +G + ++ + + G+VY+
Sbjct: 265 NQYILGWSFKQGGKAESLDISRLSN-PPPSPKRFPLKEVLGATISTIAFL--TLGGIVYL 321
Query: 63 IRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIE 122
++K K+AE LE WE +Y P R+ ++ LY ATKGFRE +LLG+GGFG+VY+G LP S +
Sbjct: 322 YKKK-KYAEVLEQWEKEYSPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILP-SGTQ 379
Query: 123 IAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKY 182
IAVK++ H++ QGMK++VAEI S+GRLRH+NLV LLGYCRRKGELLLVYDYMPNGSLD Y
Sbjct: 380 IAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDY 439
Query: 183 LYNQPKVT-LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
L+++ K+ L W QR +IKGVA LLYLHEEWEQVV+HRD+KASN+LLD +LNG+LGDF
Sbjct: 440 LFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDF 499
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQ 301
GLAR +D G + + T VVGT+GY+APE T G TT DV++FGAF+LEV CGRRP++
Sbjct: 500 GLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPD 559
Query: 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMR 361
P E +ILV WV R L + D L ++ CS +P RPSMR
Sbjct: 560 APREQVILVKWVASCGKRDALTDTVDSKL-IDFKVEEAKLLLKLGMLCSQINPENRPSMR 618
Query: 362 QVVQILERDVALPAISALGLSARGI 386
Q++Q LE +V++PAIS G A GI
Sbjct: 619 QILQYLEGNVSVPAIS-FGTVALGI 642
|
|
| TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1017 (363.1 bits), Expect = 1.3e-102, P = 1.3e-102
Identities = 201/379 (53%), Positives = 261/379 (68%)
Query: 1 LVSH-YILGWSFKINGQA-QELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSG 58
L+S+ YILGWS N + Q L++++LP++PR K + + + + +I +++I+ G
Sbjct: 245 LISYQYILGWSLSRNKVSLQTLDVTKLPRVPRHRAKNKGPSVVLIVLLILLAIIVFLALG 304
Query: 59 VVYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPK 118
YV RR RK+AE E+WE +YGPHRF YKDLYIAT GF + LLG GGFG+VY+GTLP
Sbjct: 305 AAYVYRR-RKYAEIREEWEKEYGPHRFSYKDLYIATNGFNKDGLLGKGGFGKVYKGTLP- 362
Query: 119 SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178
SK +IAVK++SH++ +GMK+FVAEIVS+G L+H+N+V LLGYCRRKGELLLV +YMPNGS
Sbjct: 363 SKGQIAVKRVSHDAEEGMKQFVAEIVSMGNLKHKNMVPLLGYCRRKGELLLVSEYMPNGS 422
Query: 179 LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238
LD+YL+N K +WR+R +IK +A L Y+H QVV+HRD+KASNV+LD E NGRL
Sbjct: 423 LDQYLFNDEKPPFSWRRRLLIIKDIATALNYMHTGAPQVVLHRDIKASNVMLDTEFNGRL 482
Query: 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
GDFG+AR +DHG DP TT VGT+GY+APE G A T+ DV+ FGAFLLEV CGRRP+
Sbjct: 483 GDFGMARFHDHGKDPATTAAVGTIGYMAPELATVG-ACTATDVYGFGAFLLEVTCGRRPV 541
Query: 299 ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARP 358
E E +V WV + W LL ARDP + E A C++ P RP
Sbjct: 542 EPGLSAERWYIVKWVCECWKMASLLGARDPRMRGEISAEEVEMVLKLGLLCTNGVPDLRP 601
Query: 359 SMRQVVQILERDVALPAIS 377
SM +VQ L + LP IS
Sbjct: 602 SMEDIVQYLNGSLELPDIS 620
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80939 | LRK41_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6988 | 1.0 | 0.6222 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 420 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-51
Identities = 81/273 (29%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE--FVAEIVSIGRLRHRNL 154
+ LGSG FG VY+ + +AVK + S + K+ EI + RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+L+ K L LV +Y G L YL L+ + + + GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+IHRD+K N+LLD ++ DFGLA+ + T VGT Y+APE G
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 275 -ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
DV+S G L E+ G+ P + + L L+ R
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------RILGPPLEFDEPKWS 227
Query: 334 YVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
+EE +LI K C + DP+ RP+ +++Q
Sbjct: 228 SGSEEAKDLIKK----CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 7e-49
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 155
+ E LG G FG+VY K+ +A+K I + + +E + EI + +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L + +L LV +Y G L L + +++ + + Y ++ + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
++HRD+K N+LLD + + +L DFGLAR D G + T VGT Y+APE
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGY 173
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEENL--ILVDWVFDFWNRGELL--EARDPNLG 331
+ D++S G L E+ G+ P L + F + EA+D
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD---- 229
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
LI K LL DP R + + +Q
Sbjct: 230 ---------LIRK--LLV--KDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 29/276 (10%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNL 154
+ LG G FG VY+GTL ++E+AVK + + S Q ++EF+ E + +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+LLG C + L++V +YMP G L YL L+ +A G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRT 272
+ IHRD+ A N L+ L ++ DFGL+R D D G L +APE +
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 273 GKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
GK T+ +DV+SFG L E+ G P E V ++ +G L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGYRLPKP----- 226
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
EL ++ C DP RP+ ++V+IL
Sbjct: 227 -PNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 3e-48
Identities = 82/274 (29%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 101 ELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 155
+ LG G FG VY+GTL ++ ++AVK + S + +EF+ E + +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+LLG C + L +V +YMP G L +L + L + + +A G+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE---S 120
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ +HRD+ A N L+ L ++ DFGL+R +Y+ + + ++APE + GK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 275 ATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
T+ +DV+SFG L E+ G +P EE V + G L P E
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPR--P----E 227
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+EL ++ C DP RP+ ++V+ L
Sbjct: 228 NCPDELYELML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-48
Identities = 66/192 (34%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLLGYC 161
LG GGFG VY K+ ++A+K I E + E + EI + +L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
+ L LV +Y GSL L L+ + ++ + GL YLH +IHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 222 DVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGKATTS 278
D+K N+LLD NG+ L DFGL++L +VGT Y+APE G +
Sbjct: 117 DLKPENILLD-SDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 279 ADVFSFGAFLLE 290
+D++S G L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 7e-48
Identities = 89/278 (32%), Positives = 131/278 (47%), Gaps = 30/278 (10%)
Query: 98 REKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHR 152
+ LG G FG VY+G L K K+E+AVK + + S Q ++EF+ E + +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N+V+LLG C + L +V +YM G L YL + + L+ +A G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHT 270
+ IHRD+ A N L+ L ++ DFGL+R D D G L +APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 271 RTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
+ GK T+ +DV+SFG L E+ G +P EE V ++ G L P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGYRLPQ--P- 225
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
EL ++ C DP RP+ ++V+IL
Sbjct: 226 ---PNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 90/286 (31%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG G FG VY+G L E+AVK + + S + K+F+ E + +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYL-------YNQPKVTLNWRQRYGVIKGVALGLLY 209
LLG C + L LV +YM G L YL + K TL+ + +A G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG-----Y 264
L + +HRD+ A N L+ +L ++ DFGL+R + T G +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELL 323
+APE + G T+ +DV+SFG L E+ G P EE V ++ +G L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL 226
Query: 324 EARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILE 368
P EY +EL EL+L C DP RP+ ++V+ LE
Sbjct: 227 PK--P----EYCPDELYELMLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
ELLG G FG VY + +AVK + S +S + ++ EI + L+H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 159 GYCR--RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G R K L + +Y+ GSL L K+ ++Y + + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLHS---N 120
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
++HRD+K +N+L+D + +L DFG A+ L D T T V GT ++APE R +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
+AD++S G ++E+A G+ P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 73/216 (33%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F E +G GGFG VY+ ++ E+A+K I ES++ ++ + EI + + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G +K EL +V ++ GSL L TL Q V K + GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117
Query: 217 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+IHRD+KA+N+LL DGE+ +L DFGL+ T VGT ++APE
Sbjct: 118 GIIHRDIKAANILLTSDGEV--KLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKP 173
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
AD++S G +E+A G+ P P + L +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 86/273 (31%), Positives = 128/273 (46%), Gaps = 31/273 (11%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+G G FG V G K+ AVK + +S + F+AE + LRH NLVQLLG
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKV--AVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
+ L +V +YM GSL YL ++ + + Q+ G V G+ YL E+ +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTGKATT 277
HRD+ A NVL+ +L ++ DFGLA+ + G L + APE R K +T
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 278 SADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336
+DV+SFG L E+ + GR P R ++ +V V +G +EA + Y
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGYRMEAPEGCPPEVY-- 229
Query: 337 EELELILKLGLLCSHSDPTARPSMRQVVQILER 369
K+ C DP RP+ +Q+ + L
Sbjct: 230 -------KVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 157
+L+G G FG VY+G ++ +A+K+IS E + +K + EI + L+H N+V+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
+G L ++ +Y NGSL + + + Y + V GL YLHE Q
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--VYQVLQGLAYLHE---QG 119
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
VIHRD+KA+N+L + +L DFG+A + VVGT ++APE A+T
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 278 SADVFSFGAFLLEVACGRRP 297
++D++S G ++E+ G P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 24/284 (8%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH- 151
+R LG G FG VY + + +A+K ++ + + ++ F+ EI + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYL 210
N+V+L + + +G L LV +Y+ GSL+ L K L+ + ++ + L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 211 HEEWEQVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQ-----TTHVVGTLGY 264
H + +IHRD+K N+LLD + +L DFGLA+L + VGT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 265 LAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321
+APE A++S+D++S G L E+ G P E + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
L P+ +L+ K DP R S +
Sbjct: 235 LASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 84/283 (29%), Positives = 137/283 (48%), Gaps = 42/283 (14%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 156
+++G G FG V RG L K +I++A+K + S + +F+ E +G+ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L G + ++++ +YM NGSLDK+L N K T Q G+++G+A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLS---E 124
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG--TLGYLAPEHTRTG 273
+HRD+ A N+L++ L ++ DFGL+R ++ T G + + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 274 KATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDW----VFDFWNRGELLEA-RD 327
K T+++DV+SFG + EV + G RP D V G L D
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQDVIKAVEDGYRLPPPMD 232
Query: 328 -PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
P+ + +L L C D RP+ Q+V L++
Sbjct: 233 CPS-----------ALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 38/274 (13%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 161
LG G G VY+ + A+KKI + K+ + E+ ++ +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA----LGLLYLHEEWEQV 217
++GE+ +V +YM GSL L K+ V+ +A GL YLH +
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEP------VLAYIARQILKGLDYLHTKRHI- 121
Query: 218 VIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
IHRD+K SN+L+ GE+ ++ DFG++++ ++ D T VGT+ Y++PE +
Sbjct: 122 -IHRDIKPSNLLINSKGEV--KIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESY 177
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA----RDPNLG 331
+ +AD++S G LLE A G+ P G F+ EL++A P+L
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPG----------QPSFF---ELMQAICDGPPPSLP 224
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E + E + C DP RPS +++Q
Sbjct: 225 AEEFSPEFRDFIS---ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 44/288 (15%)
Query: 97 FREKELLGSGGFGRVYRGT----LPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 151
+ ++LGSG FG VY+G K KI +A+K + E+ + KE + E + + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ-----PKVTLNW-RQRYGVIKGVAL 205
++V+LLG C ++ L+ MP G L Y+ N + LNW Q +A
Sbjct: 69 PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-------IAK 120
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TL 262
G+ YL E + ++HRD+ A NVL+ + ++ DFGLA+L D D + H G +
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGE 321
++A E T +DV+S+G + E+ G +P E + V+ + D +GE
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY------EGIPAVE-IPDLLEKGE 228
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L P + T + +++K C D +RP+ ++++ +
Sbjct: 229 RLP--QPPICT---IDVYMVLVK----CWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 46/285 (16%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
+ + +G G FG+VY +K+I S+ S + ++ + E+ + +L H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT--------LNW-RQRYGVIKGVAL 205
++ KG+L +V +Y G L + + Q K L+W Q + L
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LCL 114
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
L YLH + ++HRD+K N+ L +LGDFG++++ D T VVGT YL
Sbjct: 115 ALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYL 170
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL--- 322
+PE + +D++S G L E+ + P F+ N EL
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----------------FEGENLLELALK 214
Query: 323 -LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
L+ + P + ++Y +E L+ L L DP RPS+ Q++Q
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVSSL-L---QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 70/209 (33%), Positives = 122/209 (58%), Gaps = 17/209 (8%)
Query: 100 KELLGSGGFGRVYRGTLP---KSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 154
+E++G+G FG V RG L K +I +A+K K + +Q ++F++E +G+ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ L G + ++++ ++M NG+LD +L N + T+ Q G+++G+A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLS-- 123
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEH 269
E +HRD+ A N+L++ L ++ DFGL+R L D +DP T +G + + APE
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 270 TRTGKATTSADVFSFGAFLLEV-ACGRRP 297
K T+++DV+S+G + EV + G RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LGSG FG V+ G + KI++A+K I E +F+ E + +L H NLVQL G C
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
++ + +V +YM NG L YL + L + V + YL IHRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 279
+ A N L+ + ++ DFGLAR D Q T GT + + PE + ++ +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 280 DVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 338
DV+SFG + EV + G+ P ER N +V+ V + G L P L V
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERF---SNSEVVESV----SAGYRLY--RPKLAPTEVYT- 232
Query: 339 LELILKLGLLCSHSDPTARPSMRQVVQIL 367
I+ C H P RP+ ++++ L
Sbjct: 233 ---IMY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 6/216 (2%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F + LGSG FG V+ G L K+++ +A+K + + ++F E+ ++ RLRH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L C + ++ + M GSL +L + L + VA G+ YL EQ
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
IHRD+ A N+L+ +L ++ DFGLARL + + + APE G +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHGTFS 182
Query: 277 TSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVD 311
T +DV+SFG L E+ G+ P E +
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-----HESRQGMKEFVAEIVSIGRLRHR 152
R+ ELLGSG FG VY G AVK++S ++ +K+ EI + +L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRYGVIKGVALGL 207
N+VQ LG R + L + + +P GSL K L + +P + L RQ + LGL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-------ILLGL 115
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
YLH ++ +HRD+K +N+L+D +L DFG+A+ G+ ++AP
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAP 170
Query: 268 E-HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326
E + G +AD++S G +LE+A G+ P + V VF EL
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP-- 222
Query: 327 DPNLGTEYVAEELELILKLG-LLCSHSDPTARPSMRQVVQ 365
+ + L K L C DP+ RP+ ++++
Sbjct: 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 76/283 (26%), Positives = 146/283 (51%), Gaps = 37/283 (13%)
Query: 99 EKELLGSGGFGRVYRGTLP---KSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRN 153
+++++G+G FG V+RG L + ++ +A+K K + +Q ++F++E +G+ H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHN 67
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+++L G + +++ +YM NG+LDKYL + + Q G+++G+A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLS-- 124
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEH 269
+ +HRD+ A N+L++ L ++ DFGL+R+ + DP+ T+ + + APE
Sbjct: 125 -DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSGGKIPIRWTAPEA 181
Query: 270 TRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRG--ELLEAR 326
K T+++DV+SFG + EV + G RP +W+ E+++A
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP------------------YWDMSNHEVMKAI 223
Query: 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + + +L L C D RP +V +L++
Sbjct: 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 89/281 (31%), Positives = 130/281 (46%), Gaps = 41/281 (14%)
Query: 103 LGSGGFGRVYRGT-LPKS--KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLL 158
LG G FG V +G L KS ++E+AVK + E G KEF+ E + +L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 159 GYCRRKGE-LLLVYDYMPNGSLDKYLYNQPKVT----LNWRQRYGVIKGVALGLLYLHEE 213
G C KGE L+LV + P G L KYL + ++ + VA+G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES- 113
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTHVVGTLGYLAPEHTR 271
+ +HRD+ A NVLL ++ DFG++R G+D TT L + APE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 272 TGKATTSADVFSFGAFLLEV-ACGRRPI-ERQGPEENLILVDWVFDFWNRGELLEARDPN 329
GK ++ +DV+S+G L E + G +P E +G E V GE L P
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGERLPR--PE 221
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370
+ I + L C P RP+ ++ RD
Sbjct: 222 ECPQE-------IYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 44/282 (15%)
Query: 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
E+ +LG G +G VY +++ IA+K+I + ++ EI L+HRN+VQ L
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYL--------YNQPKVTLNWRQRYGVIKGVALGLLYL 210
G G + + +P GSL L N+ + +Q + GL YL
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-------ILEGLKYL 124
Query: 211 HEEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLA 266
H + ++HRD+K NVL++ G + ++ DFG + RL G +P T GTL Y+A
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVV--KISDFGTSKRL--AGINPCTETFTGTLQYMA 177
Query: 267 PEHTRTGKA--TTSADVFSFGAFLLEVACGRRP-IERQGPEENLILVDWVFDFWNRGELL 323
PE G AD++S G ++E+A G+ P IE P+ + V
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI-------- 229
Query: 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
P + AE IL+ C DP R S ++Q
Sbjct: 230 ---HPEIPESLSAEAKNFILR----CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 32/285 (11%)
Query: 103 LGSGGFGRVYRGTLP----KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 157
LG G FG+V + ++AVK ++H Q +F EI + L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 158 LGYCRRKGE--LLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
G C + G L L+ +Y+P+GSL YL ++ ++ L + + G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS--QICKGMDYLGS-- 127
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRT 272
Q IHRD+ A N+L++ E ++ DFGLA++ D G + APE RT
Sbjct: 128 -QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 273 GKATTSADVFSFGAFLLEVACGRRP--------IERQGPEENLILVDWVFDFWNRGELLE 324
K ++++DV+SFG L E+ P + G + ++V + + GE L
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL- 245
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
R P+ E + L LC ++P RPS ++ I++R
Sbjct: 246 PRPPSCPDE--------VYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 6/196 (3%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG+G FG V+ G L + +AVK + + K+F+AE + +LRH L+QL C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
+ + +V + M GSL +YL L Q + VA G+ YL Q IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 282
+ A NVL+ ++ DFGLAR+ + + APE + + +DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 283 SFGAFLLE-VACGRRP 297
SFG L E V GR P
Sbjct: 189 SFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
++ E +G G G VY+ T + E+A+KK+ Q + + EI+ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
EL +V +YM GSL + Q V +N Q V + V GL YLH Q
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 217 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
VIHRD+K+ N+LL DG + +L DFG A + + VVGT ++APE +
Sbjct: 136 NVIHRDIKSDNILLSKDGSV--KLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKD 192
Query: 275 ATTSADVFSFGAFLLEVACGRRP 297
D++S G +E+A G P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 19/207 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGM-KEFVAEIVSIGRLRHRNL 154
+ + E LG G +G VY+ K+ +A+KKI + +G+ + EI + L+H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP-KVTLNWRQRYG--VIKGVALGLLYLH 211
V+LL + +L LV++Y L KYL +P ++ N + +++G+A Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCH 115
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 268
++HRD+K N+L++ + +L DFGLAR + TH V TL Y APE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLWYRAPEILL 171
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGR 295
++ +T+ D++S G E+ G+
Sbjct: 172 GSK--HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F E LG G +G VY+ ++ +A+K + E ++E + EI + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 157 LLGYCRRKGELLLVYDYMPNGS-LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
G + +L +V +Y GS D + TL + ++ GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
IHRD+KA N+LL+ E +L DFG++ + T V+GT ++APE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGY 176
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
AD++S G +E+A G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MK--EFVAEIVSIGRLRHRN 153
+ + LG+G FG V+ GT + ++AVK + + G M F+ E + +LRH
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LVQL C + + +V +YM GSL +L + L Q + +A G+ YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-- 120
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHT 270
+ IHRD+ A N+L+ L ++ DFGLARL + D + T G + + APE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIE---DDEYTAREGAKFPIKWTAPEAA 176
Query: 271 RTGKATTSADVFSFGAFLLE-VACGRRP 297
G+ T +DV+SFG L E V GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 95/359 (26%), Positives = 162/359 (45%), Gaps = 36/359 (10%)
Query: 23 SQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYVIRRKRKFAE----ELED--W 76
S LP RV K S + I + ++ A+ +V R R E E ED W
Sbjct: 614 SGLPPCKRV-RKTPSWWFYIT--CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW 670
Query: 77 ELDYGPHRFRYKDLYIAT--KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESR 133
EL + + K + I +E+ ++ G G Y+G K+ ++ VK+I+ S
Sbjct: 671 ELQFFDSKVS-KSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI 729
Query: 134 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNW 193
EI +G+L+H N+V+L+G CR + L+++Y+ +L + L N L+W
Sbjct: 730 PSS-----EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSW 779
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
+R + G+A L +LH V+ ++ +++DG+ L RL G
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLC 833
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP--IERQGPEENLILVD 311
T + Y+APE T T +D++ FG L+E+ G+ P E +V+
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVE 890
Query: 312 WVFDFWNRGELLEARDPNLGTEYVAEELELI--LKLGLLCSHSDPTARPSMRQVVQILE 368
W ++ L DP++ + + E++ + L L C+ +DPTARP V++ LE
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFV-AE--IVSIGRLRHRNLVQL 157
LG G FG+V + A+K + ++ E E I+S R+ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS--RINHPFIVKL 58
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
+ + +L LV +Y P G L +L + + + + Y + L L YLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA--EIVLALEYLHS---LG 113
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
+I+RD+K N+LLD + + +L DFGLA+ +T GT YLAPE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 278 SADVFSFGAFLLEVACGRRP 297
+ D +S G L E+ G+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 25/272 (9%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
K LG G +G VY G K + +AVK + ++ + ++EF+ E + ++H NLVQLLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C R+ ++ ++M G+L YL + +N + ++ + YL ++ I
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTGKATT 277
HRD+ A N L+ ++ DFGL+RL D T H + + APE K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 278 SADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336
+DV++FG L E+A G P P +L V++ +G +E R +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY----PGIDL---SQVYELLEKGYRME-RPEGCPPK--- 233
Query: 337 EELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ +L C +P+ RPS ++ Q E
Sbjct: 234 -----VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLLG 159
E +G G FG VY+G L K E+AVK +K F+ E + + H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C +K + +V + +P GSL +L + K L ++ + A G+ YL + I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG-----YLAPEHTRTGK 274
HRD+ A N L+ ++ DFG++R + G V L + APE G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGG----IYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 275 ATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
T+ +DV+S+G L E + G P ++ ++ G + A P L E
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGYRMPA--PQLCPE 222
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
I +L L C DP RPS ++ L+
Sbjct: 223 E-------IYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH------ESRQGMKEFVAEIVSIG 147
KG + LG+G F Y+ K+ +AVK++++ E + ++ EI +
Sbjct: 3 LKG----QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
RL H +++++LG L ++M GS+ L Y + + GL
Sbjct: 59 RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGL 116
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLA-RLYDHGT--DPQTTHVVGT 261
YLHE +IHRDVK +N+L+D G R+ DFG A RL GT ++GT
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321
+ ++APE R + S DV+S G ++E+A + P + +L L+ +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---------FK 222
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ A E+++ L + L C P RP R++++
Sbjct: 223 IASATTAPSIPEHLSPGLRDVT---LRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 6e-24
Identities = 74/271 (27%), Positives = 122/271 (45%), Gaps = 22/271 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
F +G G FG V++ K A+K+I S +R+ +E + E + +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
++ KG+L +V +Y NG L K L Q L Q + + LGL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ ++HRD+K+ N+ LD N ++GD G+A+L T+ T +VGT YL+PE
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
+DV++ G L E G+ P + + LIL +++ P + Y
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANN-QGALIL-----------KIIRGVFPPVSQMY 225
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ +LI C D RP Q+++
Sbjct: 226 SQQLAQLI----DQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVA-EIVSIGRLRHRNL 154
+ + +G G +G+VY+ K+ +A+KKI ++G EI + +LRH N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 155 VQLLGYC--RRKGELLLVYDYMP---NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
V+L + KG + +V++YM G LD P+V Q +K + GL Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-----SPEVKFTESQIKCYMKQLLEGLQY 115
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE- 268
LH ++HRD+K SN+L++ + +L DFGLAR Y T+ V TL Y PE
Sbjct: 116 LHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 269 ---HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
TR G D++S G L E+ G +PI
Sbjct: 173 LLGATRYG---PEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 88/280 (31%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 95 KGFREKELLGSGGFGRV----YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR 150
K + + +G G FG V YRG ++AVK I +++ + F+AE + +LR
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 151 HRNLVQLLGY-CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
H NLVQLLG KG L +V +YM GSL YL ++ + L V + Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
L +HRD+ A NVL+ + ++ DFGL + D V T APE
Sbjct: 118 LE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 170
Query: 270 TRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328
R K +T +DV+SFG L E+ + GR P R ++ + V+ +G ++A D
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD- 222
Query: 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
G V + ++K C H D RPS Q+ + LE
Sbjct: 223 --GCPPVVYD---VMK---QCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-23
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+GSG FG V+ G K ++A+K I E ++F+ E + +L H LVQL G C
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
+ + LV+++M +G L YL Q + + G+ V G+ YL VIHRD
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 279
+ A N L+ ++ DFG+ R D Q T GT + + +PE K ++ +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 280 DVFSFGAFLLEV-ACGRRPIERQGPEE 305
DV+SFG + EV + G+ P E + E
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 71/267 (26%), Positives = 120/267 (44%), Gaps = 29/267 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
LG+G G V + + +AVK I +Q ++E +I+ + +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILREL--DILH--KCNSPYIVGF 64
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
G G++ + +YM GSLDK + + + R + V GL YLHE+ +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKI-LKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
+IHRDVK SN+L++ +L DFG++ + VGT Y+APE + +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 278 SADVFSFGAFLLEVACGRRPI--ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+D++S G L+E+A GR P E P+ L+ ++ + P L +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------VNEPPPRLPSGKF 229
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQ 362
+ + + + LC DP RPS ++
Sbjct: 230 SPDFQDFVN---LCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-23
Identities = 65/207 (31%), Positives = 118/207 (57%), Gaps = 15/207 (7%)
Query: 100 KELLGSGGFGRVYRGTLP---KSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 154
++++G+G FG V G L K +I +A+K K + +Q ++F++E +G+ H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ L G + +++V +YM NGSLD +L + + T+ Q G+++G+A G+ YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLS-- 123
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTR 271
+ +HRD+ A N+L++ L ++ DFGL+R+ + + T G + + APE
Sbjct: 124 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 272 TGKATTSADVFSFGAFLLEV-ACGRRP 297
K T+++DV+S+G + EV + G RP
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-23
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 100 KELLGSGGFGRVYRGTLPK-----SKIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRN 153
K LG G FG+V+ G K +AVK + S K+F E + +H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL------------YNQPKVTLNWRQRYGVIK 201
+V+ G C ++V++YM +G L+K+L + P L Q +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT----- 256
+A G++YL Q +HRD+ N L+ +L ++GDFG++R D TT
Sbjct: 130 QIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRV 180
Query: 257 --HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 297
H + + ++ PE K TT +DV+SFG L E+ G++P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-23
Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 48/291 (16%)
Query: 103 LGSGGFGRV----YRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQL 157
LG G FG+V Y + +AVK + E Q + EI + L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 158 LGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
G C +G L L+ +Y+P GSL YL PK LN Q + + G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS--- 125
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA----------RLYDHGTDPQTTHVVGTLGYL 265
Q IHRD+ A NVLLD + ++GDFGLA R+ + G P + +
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--------VFWY 177
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRP--------IERQGPEENLILVDWVFDFW 317
A E + K + ++DV+SFG L E+ E GP++ + V + +
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
RG L +E+ +++K C ++ RP+ R ++ IL+
Sbjct: 238 ERGMRLPCPKN------CPQEVYILMK---NCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
E++G G FG V +G K+ AVK I + + F+ E + +L H+NLV+LLG
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKV--AVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
G L +V + M G+L +L + + ++ Q VA G+ YL + ++H
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
RD+ A N+L+ + ++ DFGLAR+ G D V T APE + K ++ +D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 281 VFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339
V+S+G L EV + GR P + +E V + +G +E + YV
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCPADVYV---- 228
Query: 340 ELILKLGLLCSHSDPTARPSMRQVVQILERD 370
L C ++P RPS ++ + LE++
Sbjct: 229 -----LMTSCWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 47/278 (16%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LGSG FG V+ G +++I++A+K I +E ++F+ E + +L H LVQL G C
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI---------KGVALGLLYLHEE 213
++ L +V ++M NG L YL RQR G + + V G+ YL
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----------RQRQGKLSKDMLLSMCQDVCEGMEYLE-- 117
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHT 270
IHRD+ A N L+ ++ DFG+ R + D + T G + + PE
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR---YVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 271 RTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
K ++ +DV+SFG + EV G+ P E+ + N +V+ + +RG L P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEVVEMI----SRGFRL--YRPK 224
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
L + V E + C H P RP+ ++++ +
Sbjct: 225 LASMTVYEVM-------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQG-MKEFVAEIVSIGRL-RHR 152
F+ +++G G F V ++ E A+K + ++ +K E + RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+++L + + L V +Y PNG L +Y+ + + Y + L L YLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY--AAEILLALEYLHS 120
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ------------------ 254
+ +IHRD+K N+LLD +++ ++ DFG A++ D + P+
Sbjct: 121 ---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 255 -TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL 309
VGT Y++PE A S+D+++ G + ++ G+ P +G E L
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF--RGSNEYLTF 231
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 101 ELLGSGGFGRVYRGTL-----PKSKIEIAVKKI-SHESRQGMKEFVAEIV---SIGRLRH 151
+ LG G FG+V + P +AVK + + + + + V+E+ IG+ H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKG-------- 202
+N++ LLG C ++G L +V +Y +G+L +L +P +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 203 -----VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD-HGTDPQTT 256
VA G+ +L + IHRD+ A NVL+ + ++ DFGLAR D H D
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRK 190
Query: 257 HVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIERQGPEENLILVDWV 313
G L +APE T +DV+SFG L E G P I V+ +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-------IPVEEL 243
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
F G +E + N E + L C H P+ RP+ +Q+V+ L+R
Sbjct: 244 FKLLKEGYRME-KPQNCTQE--------LYHLMRDCWHEVPSQRPTFKQLVEDLDR 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 82/277 (29%), Positives = 125/277 (45%), Gaps = 44/277 (15%)
Query: 101 ELLGSGGFGRVYRG-TLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLL 158
E++G G VY LP ++ ++A+K+I E Q + E E+ ++ + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNE-KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 159 GYCRRKGELLLVYDYMPNGS-LD--KYLYNQ---PKVTLNWRQRYGVIKGVALGLLYLHE 212
EL LV Y+ GS LD K Y + + + V+K V GL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLHS 120
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTH--VVGTLGYLAPE- 268
IHRD+KA N+LL + + ++ DFG+ A L D G + VGT ++APE
Sbjct: 121 ---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 269 -HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
G AD++SFG +E+A G P + P + L+L L+
Sbjct: 178 MEQVHG-YDFKADIWSFGITAIELATGAAPYSKYPPMKVLML------------TLQNDP 224
Query: 328 PNLGTE-----YVAEELELILKLGLLCSHSDPTARPS 359
P+L T Y ++I C DP+ RP+
Sbjct: 225 PSLETGADYKKYSKSFRKMISL----CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 6e-22
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGM-KEFVAEIVSIGRLRHRNLVQLLGY 160
+G G FG+VY + +AVK+I ++ KE E+ + L+H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
+ ++ + +Y G+L++ L + + + + Y + GL YLH ++H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHS---HGIVH 122
Query: 221 RDVKASNVLLDGELNG--RLGDFGLA-RLYDHGTDPQTT--HVVGTLGYLAPEHTRTGKA 275
RD+K +N+ LD NG +LGDFG A +L ++ T + GT Y+APE GK
Sbjct: 123 RDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 276 T---TSADVFSFGAFLLEVACGRRPIERQ 301
+AD++S G +LE+A G+RP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ + +GSG +G VY+ + +A+K I E + EI + RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G R+ +L +V +Y GSL +Y + L+ Q V + GL YLH E
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH---ET 120
Query: 217 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTR 271
IHRD+K +N+LL DG++ +L DFG++ + + +GT ++APE R
Sbjct: 121 GKIHRDIKGANILLTEDGDV--KLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVER 177
Query: 272 TGKATTSADVFSFGAFLLEVACGRRP 297
G D+++ G +E+A + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 80/299 (26%), Positives = 120/299 (40%), Gaps = 62/299 (20%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+G G +G VY+ + +A+KKI ES K + EI + L H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGV----IKGVAL----GLLYLHE 212
R KG+L LV+++M D LY K ++ G+ IK GL + H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIK-----DRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE-HT 270
++HRD+K N+L++ E +L DFGLAR + G+ + TH V T Y APE
Sbjct: 117 HG---ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLL 171
Query: 271 RTGKATTSADVFSFGAFLLEVACGR--------------------RPIERQGPEENLILV 310
+T D++S G E+ R P P+ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 311 DWVFDF--WNRGELLEARDPNLGTEYVAEELELILKLGLL--CSHSDPTARPSMRQVVQ 365
++ F F L PN + L LL H DP R + Q +
Sbjct: 232 NYKFSFPKKAGMP-LPKLFPNASPQ----------ALDLLSQMLHYDPHKRITAEQALA 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 69/215 (32%), Positives = 113/215 (52%), Gaps = 28/215 (13%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKIS--------HESRQ-GM-KEFVAEIVSIGRLR 150
EL+G G +GRVY + +AVK++ H+SRQ M K +EI ++ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRYGVIKGVAL 205
H N+VQ LG+ + L + +Y+P GS+ L + + V Q V++G+A
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ---VLEGLA- 122
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGY 264
YLH + ++HRD+KA N+L+D + ++ DFG+++ D D Q + G++ +
Sbjct: 123 ---YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 265 LAPEHTRTGKATTSA--DVFSFGAFLLEVACGRRP 297
+APE + SA D++S G +LE+ GRRP
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 63/192 (32%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 159
ELLG G FG V++GTL K K +AVK + Q +K +F++E + + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C ++ + +V + +P G +L + K L +Q A G+ YL + I
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 220 HRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
HRD+ A N L+ GE N ++ DFG++R D G + + + APE G+ ++
Sbjct: 116 HRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 279 ADVFSFGAFLLE 290
+DV+S+G L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 71/225 (31%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMK-EFVAEIVSIGRLRHRNL 154
+ LG G FG VY+ K+ +A+KKI H + G + EI + +L+H N+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 155 VQLL--------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
V L+ R++G + +V YM + L L N P V L Q + + G
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLEN-PSVKLTESQIKCYMLQLLEG 127
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD----------HGTDPQTT 256
+ YLHE ++HRD+KA+N+L+D + ++ DFGLAR YD G + T
Sbjct: 128 INYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 257 HVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
++V T Y PE R + TT+ D++ G E+ RRPI
Sbjct: 185 NLVVTRWYRPPELLLGER--RYTTAVDIWGIGCVFAEMF-TRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRH 151
+R +LLG G FGRVY + E+AVK++ S E+++ + EI + L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
+VQ G R L + +YMP GS+ L +T ++Y + + G+ YLH
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY--TRQILEGVEYLH 121
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFG----LARLYDHGTDPQTTHVVGTLGYLAP 267
+++HRD+K +N+L D N +LGDFG L + GT ++ V GT +++P
Sbjct: 122 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSP 176
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACGRRP 297
E ADV+S G ++E+ + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 66/193 (34%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMK-EFVAEIVSIGRLRHRNLVQLLGY 160
+G G +G VYR S +A+KK+ + R G+ + EI + LRH N+V+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 161 C--RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
+ + LV +Y L L N P + Q ++ + GL YLHE + +
Sbjct: 75 VVGKHLDSIFLVMEYCEQ-DLASLLDNMPT-PFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT-RTGKATT 277
IHRD+K SN+LL + ++ DFGLAR Y P T VV TL Y APE TT
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTT 188
Query: 278 SADVFSFGAFLLE 290
+ D+++ G L E
Sbjct: 189 AIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 103 LGSGGFGRVYRGTL-----PKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQ 156
LG G FG VY G + + +A+K ++ + S + EF+ E + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYL-------YNQPKVTLNWRQR-YGVIKGVALGLL 208
LLG L+V + M G L YL N P + Q+ + +A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 267
YL + +HRD+ A N ++ +L ++GDFG+ R +Y+ + + + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 268 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326
E + G TT +DV+SFG L E+A +P + EE V F G L+
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDLP 243
Query: 327 D--PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ P+ +L+L +C +P RP+ ++V L+
Sbjct: 244 ENCPD-----------KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 40/289 (13%)
Query: 100 KELLGSGGFGRV-----YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K LG G FG+V Y + K K+ +AVK + + K+F E + L+H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYN--------------QPKVTLNWRQRYGVI 200
V+ G C L++V++YM +G L+K+L Q K L Q +
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVV 259
+A G++YL Q +HRD+ N L+ L ++GDFG++R +Y H +
Sbjct: 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWN 318
+ ++ PE K TT +DV+SFG L E+ G++P + E V +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECIT 239
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+G +LE P + + V + + LG C +P R +++++ +IL
Sbjct: 240 QGRVLER--PRVCPKEVYD-----IMLG--CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 35/279 (12%)
Query: 103 LGSGGFGRVYRGT---LPKSK--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 155
LG+G FG+V T L KS +++AVK + + +E ++E+ + L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
LLG C G +L++ +Y G L +L + + L VA G+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TLGYLAPEHT 270
+ IHRD+ A NVLL ++ DFGLAR + ++ +VV + ++APE
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPESI 215
Query: 271 RTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
T +DV+S+G L E+ + G P P + VD F +L++
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPY----PG---MPVDSKF-----YKLIKEGYRM 263
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
E+ E+ I+K C +DP RP+ +Q+VQ++
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 101 ELLGSGGFGRVYRGTL-----PKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRN 153
E LG G FG+VY+G L S +A+K K + E + +EF E + L+H N
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV-QQEFRQEAELMSDLQHPN 69
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKG---------- 202
+V LLG C ++ ++++Y+ +G L ++L N P + +K
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 203 ---VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL-YDHGTDPQTTHV 258
+A G+ YL +HRD+ A N L+ L ++ DFGL+R Y +
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291
+ + ++ PE GK TT +D++SFG L E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 100 KELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K LG G FG+V+ + KI +AVK + S K+F E + L+H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY-----------NQPKVTLNWRQRYGVIKGV 203
V+ G C L++V++YM +G L+K+L L Q + + +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL 262
A G++YL Q +HRD+ N L+ L ++GDFG++R +Y H + +
Sbjct: 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 297
++ PE K TT +DV+S G L E+ G++P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG G FG+VY+ ++ + A K I ES + +++F+ EI + +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
+ +L ++ ++ G+LD + + L Q V + + L +LH VIHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKAT---T 277
+KA N+LL + + +L DFG++ T + +GT ++APE T K
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 278 SADVFSFGAFLLEVACGRRP 297
AD++S G L+E+A P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG+G FG V G + + ++A+K I E EF+ E + +L H LVQL G C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
++ + +V +YM NG L YL K Q + K V G+ YL E +Q IHRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRD 125
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 279
+ A N L+D + ++ DFGL+R + D + T VG+ + + PE K ++ +
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 280 DVFSFGAFLLEV-ACGRRPIER 300
DV++FG + EV + G+ P ER
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 50/291 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-----FVAEIVSIGR-LR 150
+ E +G G FG V + + K+I + + M E V+E V+I R L+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSE-VNILRELK 57
Query: 151 HRNLVQLLGYCRR-----KGELLLVYDYMPNGSLDKYLYNQPKVTLN------WRQRYGV 199
H N+V+ Y R L +V +Y G L + + K WR +
Sbjct: 58 HPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----I 110
Query: 200 IKGVALGLLYLH--EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257
+ + L L H + V+HRD+K +N+ LD N +LGDFGLA++ H + T+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317
VGT Y++PE +D++S G + E+ P + + L
Sbjct: 171 -VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LA--------- 219
Query: 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
++ E + + Y + EL ++K + DP RPS ++L+
Sbjct: 220 --SKIKEGKFRRIPYRY-SSELNEVIK---SMLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 10/207 (4%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHR 152
F ++G G FG+V +K A+K ++ + ++ + E + L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
LV L + + + LV D + G L +L + K + + + I + L L YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW--ICEIVLALEYLHS 118
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
+ +IHRD+K N+LLD + + + DF +A D TT GT GY+APE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCR 173
Query: 273 GKATTSADVFSFGAFLLEVACGRRPIE 299
+ + D +S G E G+RP
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 75/244 (30%), Positives = 116/244 (47%), Gaps = 34/244 (13%)
Query: 97 FREKEL-----LGSGGFGRVYRGT-LPKS---KIEIAVKKISHES-RQGMKEFVAEIVSI 146
+E EL LGSG FG V++G +P+ KI +A+K I S RQ +E ++++
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ-----PKVTLNWRQRYGVIK 201
G L H +V+LLG C L LV P GSL ++ P+ LNW +
Sbjct: 64 GSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ----- 117
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG 260
+A G+ YL E ++HR++ A N+LL + ++ DFG+A LY +
Sbjct: 118 -IAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNR 319
+ ++A E G+ T +DV+S+G + E+ + G P P E V D +
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEK 226
Query: 320 GELL 323
GE L
Sbjct: 227 GERL 230
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIE---IAVKKISHESRQGMKEFVA---EIVSIGRLRHRNL 154
+ +G G FG++Y L K+K + +K+I + +KE A E++ + +++H N+
Sbjct: 6 KKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLT-KMPVKEKEASKKEVILLAKMKHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V + G L +V +Y G L K + Q V + Q ++LGL ++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118
Query: 215 EQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
++ ++HRD+K+ N+ L NG +LGDFG+AR + + T VGT YL+PE +
Sbjct: 119 DRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIE 299
D++S G L E+ + P E
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 88/281 (31%), Positives = 133/281 (47%), Gaps = 37/281 (13%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 156
++G G FG VY GTL KI AVK ++ + +++F+ E + + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 157 LLGYC-RRKGELLLVYDYMPNGSLDKYLYNQ---PKVTLNWRQRYGVIKGVALGLLYLHE 212
LLG C +G L+V YM +G L ++ ++ P V + G VA G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEYLAS 116
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEH 269
+ +HRD+ A N +LD ++ DFGLAR +YD H L ++A E
Sbjct: 117 ---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 270 TRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328
+T K TT +DV+SFG L E+ G P P+ + FD LL+ R
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVD------SFDITVY--LLQGRRL 221
Query: 329 NLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILE 368
L EY + L E++L C H P RP+ ++V +E
Sbjct: 222 -LQPEYCPDPLYEVMLS----CWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRH---R 152
++ EL+G G +G VYRG + +A+K I+ ++ + + E+ + +LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 153 NLVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG--VIKGVALGLLY 209
N+ + G KG L ++ +Y GS+ + P ++Y +I+ V + L Y
Sbjct: 63 NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGP-----IAEKYISVIIREVLVALKY 116
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+H+ VIHRD+KA+N+L+ N +L DFG+A L + + ++T VGT ++APE
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACGRRP 297
GK T AD++S G + E+A G P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 51/297 (17%)
Query: 103 LGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156
+G G FGRV++ P + +AVK + E S +F E + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYL--------------------YNQPKVTLNWRQR 196
LLG C + L+++YM G L+++L + L+ ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR---LYDHGTDP 253
+ K VA G+ YL E+ +HRD+ N L+ + ++ DFGL+R D+
Sbjct: 133 LCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDW 312
+ + + ++ PE + TT +DV+++G L E+ + G +P EE ++ +
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VIYY 244
Query: 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
V D G +L D N E + L LC P+ RPS + +IL+R
Sbjct: 245 VRD----GNVLSCPD-NCPLE--------LYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 78/276 (28%), Positives = 116/276 (42%), Gaps = 30/276 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSK---IEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 156
+ LG G FG V RG S I +AVK + + M +F+ E + L H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEW 214
L G L++V + P GSL L ++ Y V +A G+ YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYLES-- 115
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT--HVVGTLGYLAPEHTRT 272
+ IHRD+ A N+LL + ++GDFGL R D H+ + APE RT
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 273 GKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
+ ++DV+ FG L E+ G P + L +D GE LE
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID------KEGERLER------ 222
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
E ++ I + L C +P RP+ + + L
Sbjct: 223 PEACPQD---IYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE---FVA--EIVSIGRLRHRNLV 155
+ LG G + VY+ ++ +A+KKI R+ K+ F A EI + L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLH 211
LL K + LV+++M L+K + + L IK L GL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVL----TPADIKSYMLMTLRGLEYLH 119
Query: 212 EEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
W ++HRD+K +N+L+ DG L +L DFGLAR + T VV T Y APE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVL--KLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
+ D++S G E+ R P
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAEL-LLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVA---EIVSIGRLRH 151
+R +LLG G FGRVY + E+AVK++ ES + KE A EI + L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 152 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+VQ G R E L + ++MP GS+ L + +T N ++Y + + G+ Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSY 121
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD----HGTDPQTTHVVGTLGYL 265
LH +++HRD+K +N+L D N +LGDFG ++ GT ++ V GT ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWM 176
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
+PE AD++S G ++E+ + P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 72/288 (25%), Positives = 136/288 (47%), Gaps = 47/288 (16%)
Query: 100 KELLGSGGFGRVYRGTLP---KSKIEIAVKKI----SHESRQGMKEFVAEIVSIGRLRHR 152
+ +LG+G FG + RG L K ++ +A+ + S + R+G F+AE +++G+ H
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHS 66
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N+V+L G R +++V +YM NG+LD +L + + L Q G++ G+A G+ YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLS- 124
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG------YLA 266
E +H+ + A VL++ +L ++ F + ++ + T+ + A
Sbjct: 125 --EMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 267 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRG--ELL 323
PE + ++++DV+SFG + EV + G RP +W+ +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERP------------------YWDMSGQDVI 218
Query: 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371
+A + L+ +L L C + RP Q+ IL + V
Sbjct: 219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVA---EIVSIGRLRH 151
+R +LLG G FGRVY + E+A K++ ES + KE A EI + L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 152 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+VQ G R + E L + +YMP GS+ L +T + ++Y + + G+ Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSY 121
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD----HGTDPQTTHVVGTLGYL 265
LH +++HRD+K +N+L D N +LGDFG ++ GT ++ V GT ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
+PE ADV+S G ++E+ + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 155
F E +G G FG VY+ ++ +A+K I E+ +++ EI + + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G + +L ++ +Y GS L L+ +++ V LGL YLHE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHE--- 116
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ IHRD+KA+N+LL E + +L DFG++ +L + T VGT ++APE +
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQSG 174
Query: 275 ATTSADVFSFGAFLLEVACGRRP 297
AD++S G +E+A G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 100 KELLGSGGFGRVYRGTLPKS--KIEIAVKKIS-HESRQGMKEFVAEIVSIGRL-RHRNLV 155
++++G G FG+V + + K +++ A+K++ + S+ ++F E+ + +L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLY--------------NQPKVTLNWRQRYGVIK 201
LLG C +G L L +Y P+G+L +L N TL+ +Q
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
VA G+ YL ++ IHRD+ A N+L+ ++ DFGL+R Q +V T
Sbjct: 132 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181
Query: 262 LG-----YLAPEHTRTGKATTSADVFSFGAFLLEV 291
+G ++A E TT++DV+S+G L E+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+ LG+G FG V+ G ++A+K + + + F+AE + +L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMG-YYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
++ + ++ +YM NGSL +L + L + + +A G+ ++ + IH
Sbjct: 70 VTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATT 277
RD++A+N+L+ L ++ DFGLARL + D + T G + + APE G T
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 278 SADVFSFGAFLLE-VACGRRP 297
+DV+SFG L E V GR P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRH 151
+R +LLG G FG VY + E+AVK++ S E+ + + EI + LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 152 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+VQ G R E L + +YMP GS+ L +T N +RY + + G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVSY 121
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTTHVVGTLGYL 265
LH +++HRD+K +N+L D N +LGDFG ++ + GT ++ V GT ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYWM 176
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
+PE ADV+S ++E+ + P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 70/287 (24%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI------SHESRQGMKEFVAEIVSIG 147
F+ ++ +G G F VY+ +A+KK+ ++RQ + + EI +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVAL 205
+L H N+++ L EL +V + G L + + + + K + R + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT---HVVGTL 262
L ++H + ++HRD+K +NV + +LGD GL R + +TT +VGT
Sbjct: 118 ALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS----KTTAAHSLVGTP 170
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322
Y++PE +D++S G L E+A + P G + NL + + E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNL------YSLCKKIEK 222
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ P L ++ +EEL L C + DP RP + V+Q+ +
Sbjct: 223 CDY--PPLPADHYSEELR---DLVSRCINPDPEKRPDISYVLQVAKE 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-19
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 7/207 (3%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 151
I + R + LG G FG V+ GT +A+K + + F+ E + +LRH
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRH 60
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
LVQL + + +V +YM GSL +L + L Q + +A G+ Y+
Sbjct: 61 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
+HRD++A+N+L+ L ++ DFGLARL + + + APE
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 272 TGKATTSADVFSFGAFLLEVAC-GRRP 297
G+ T +DV+SFG L E+ GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 83/296 (28%), Positives = 141/296 (47%), Gaps = 44/296 (14%)
Query: 103 LGSGGFGRVYRGTL-------PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 153
LG G FG+V P ++AVK + S + + + + ++E+ + + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YN---QPKVTLNWRQRYGV 199
++ LLG C + G L ++ +Y G+L +YL YN P+ L+++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 258
VA G+ YL + IHRD+ A NVL+ + ++ DFGLAR H +TT+
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFW 317
+ ++APE T +DV+SFG L E+ G P EE +F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLL 255
Query: 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373
G ++ P+ T EL ++++ C H+ P+ RP+ +Q+V+ L+R +AL
Sbjct: 256 KEGHRMDK--PSNCT----NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 24/280 (8%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRN 153
+ E LG G G V + L + + A+K I+ + K+ + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 154 LVQLLGYC--RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG------VIKGVAL 205
+V+ G + + +Y GSLD +Y K R G + + V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IY---KKVKKRGGRIGEKVLGKIAESVLK 116
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
GL YLH + +IHRD+K SN+LL + +L DFG++ + GT Y+
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYM 170
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325
APE + + ++DV+S G LLEVA R P +G E L ++ + N
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG-EPPLGPIELLSYIVNMPNPELK 229
Query: 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+P G ++ +EE + +K C DPT RP+ +++
Sbjct: 230 DEPGNGIKW-SEEFKDFIK---QCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
LG GGFG V + + A KK+ + R+G + + E + ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
K +L LV M G L ++YN + + + GL +LH+ ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 279
+RD+K NVLLD N R+ D GLA G + GT GY+APE + S
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 280 DVFSFGAFLLEVACGRRPIERQG 302
D F+ G L E+ GR P ++
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 89/326 (27%), Positives = 147/326 (45%), Gaps = 47/326 (14%)
Query: 103 LGSGGFGRVYRGTL-------PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 153
LG G FG+V P + +AVK + + + + + + V+E+ + + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ--------------PKVTLNWRQRYGV 199
++ LLG C + G L ++ +Y G+L +YL + P+ L ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTH 257
VA G+ YL Q IHRD+ A NVL+ + ++ DFGLAR H D +TT+
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195
Query: 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDF 316
+ ++APE T +DV+SFG L E+ G P I V+ +F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-------IPVEELFKL 248
Query: 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPAI 376
G ++ EL +I++ C H+ P+ RP+ +Q+V+ L+R + + +
Sbjct: 249 LKEGHRMDK------PANCTHELYMIMR---ECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 377 SA-LGLSARGITYQEGFDDFAVSYSS 401
L LS Y G D S SS
Sbjct: 300 DEYLDLSVPFEQYSPGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 155
F + E +G G FG V++G +++ +A+K I E+ +++ EI + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G + +L ++ +Y+ GS L P L+ Q +++ + GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
IHRD+KA+NVLL +L DFG+A +L D T + VGT ++APE +
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
+ AD++S G +E+A G P P + L L+ + P L Y
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------KNNPPTLEGNY 225
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E + C + +P+ RP+ +++++
Sbjct: 226 SKPLKEFVEA----CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEF-VAEIVSIGRLR---H 151
+ E +G G +G VY+ + +A+KK+ S +G+ + EI + +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 152 RNLVQLLGYC---RRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
N+V+LL C R E L LV++++ + L YL PK L +++ + G
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
+ +LH ++HRD+K N+L+ + ++ DFGLAR+Y + T VV TL Y A
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVTLWYRA 174
Query: 267 PEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
PE T D++S G E+ RRP+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELF-RRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 26/271 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 155
F + E +G G FG VY+G ++K +A+K I E+ +++ EI + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G + +L ++ +Y+ GS L P L +++ + GL YLH E +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERK 122
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
IHRD+KA+NVLL + + +L DFG+A +L D T + VGT ++APE +
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
AD++S G +E+A G P P L L+ + P L +Y
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------------KNSPPTLEGQY 225
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E + C + DP RP+ +++++
Sbjct: 226 SKPFKEFVEA----CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 155
F + E +G G FG V++G +++ +A+K I E+ +++ EI + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G + +L ++ +Y+ GS L P + Q ++K + GL YLH E +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKK 122
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
IHRD+KA+NVLL + + +L DFG+A +L D T + VGT ++APE +
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
+ AD++S G +E+A G P P L L+ + P L E+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------KNNPPTLTGEF 225
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E I C + DP+ RP+ +++++
Sbjct: 226 SKPFKEFIDA----CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG+G FG V+ GT ++AVK + + F+ E + +LRH LVQL
Sbjct: 14 LGNGQFGEVWMGTW-NGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
+ + +V +YM GSL +L + L + VA G+ Y+ IHRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 279
++++N+L+ L ++ DFGLARL + D + T G + + APE G+ T +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 280 DVFSFGAFLLE-VACGRRP 297
DV+SFG L E V GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 82/297 (27%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 90 LYIATKGFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKIS-HESRQGMKEFVAEIV 144
+ I+ +LL G FGR++ G L P + E+ VK + H S + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLV-YDYMPNGSLDKYLYN------QPKVTLNWRQRY 197
+ L H+N++ +L C GE V Y YM G+L +L L+ +Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 256
+ +A G+ YLH+ + VIH+D+ A N ++D EL ++ D L+R L+ P
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLF-----PMDY 172
Query: 257 HVVGT-----LGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIERQGPEENLILV 310
H +G + ++A E + ++++DV+SFG L E + G+ P P E
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----- 227
Query: 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+ + G L A+ N E A + C DP RPS Q+VQ L
Sbjct: 228 --MAAYLKDGYRL-AQPINCPDELFA--------VMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 79/297 (26%), Positives = 138/297 (46%), Gaps = 46/297 (15%)
Query: 103 LGSGGFGRVYRGTL-------PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 153
LG G FG+V PK + +AVK + + + + + + V+E+ + + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ--------------PKVTLNWRQRYGV 199
++ LLG C + G L ++ +Y G+L +YL + P + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTH 257
VA G+ YL Q IHRD+ A NVL+ ++ DFGLAR + D +TT+
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198
Query: 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDF 316
+ ++APE T +DV+SFG + E+ G P I V+ +F
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-------IPVEELFKL 251
Query: 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373
G ++ + N EL ++++ C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 252 LKEGHRMD-KPAN-----CTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRH-RNLVQ 156
+ +G G FG V + S +AVK+I + K + ++ + R +V+
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 157 LLGYCRRKGELLLVYDYMPNGSLD---KYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
G R+G+ + + M + SLD KY+Y K + + L YL EE
Sbjct: 68 FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGL--------ARLYDHGTDPQTTHVVGTLGYL 265
+ +IHRDVK SN+LLD N +L DFG+ A+ D G P Y+
Sbjct: 127 LK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP----------YM 174
Query: 266 APE----HTRTGKATTSADVFSFGAFLLEVACGRRP 297
APE R G S DV+S G L EVA G+ P
Sbjct: 175 APERIDPSARDGYDVRS-DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-18
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 101 ELLGSGGFGRVYRGTLPKS--KIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLVQ 156
+++G G FG+V + + K +++ A+K++ + S+ ++F E+ + +L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSL------DKYLYNQPKV--------TLNWRQRYGVIKG 202
LLG C +G L L +Y P+G+L + L P TL+ +Q
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 262
VA G+ YL + + IHRD+ A N+L+ ++ DFGL+R G + +G L
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 173
Query: 263 G--YLAPEHTRTGKATTSADVFSFGAFLLEV 291
++A E TT++DV+S+G L E+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 83/287 (28%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 102 LLGSGGFGRVYRGTLP------KSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNL 154
LGSG FG VY GT I +AVK + + Q KEF+ E + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT-----LNWRQRYGVIKGVALGLLY 209
V+LLG C ++ + M G L YL + L ++ + VA G +Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 210 LHEEWEQV-VIHRDVKASNVLLDGELNGR-----LGDFGLAR-LYDHGTDPQTTHVVGTL 262
L EQ+ IHRD+ A N L+ + +GDFGLAR +Y + + +
Sbjct: 122 L----EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGE 321
++APE GK TT +DV+SFG + E+ G++P +E V G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG 230
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
L+ P + I +L C DP+ RP+ ++ +IL+
Sbjct: 231 RLQK--PENCPDK-------IYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 100 KELLGSGGFGRVYRGTLPKS--KIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 155
++++G G FG+V R + K K+ A+K + S ++F E+ + +L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 156 QLLGYCRRKGELLLVYDYMPNGSL------DKYLYNQPKV--------TLNWRQRYGVIK 201
LLG C +G L + +Y P G+L + L P TL +Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
VA G+ YL E + IHRD+ A NVL+ L ++ DFGL+R G + +G
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179
Query: 262 LG--YLAPEHTRTGKATTSADVFSFGAFLLEV 291
L ++A E TT +DV+SFG L E+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 79/304 (25%), Positives = 147/304 (48%), Gaps = 42/304 (13%)
Query: 103 LGSGGFGRVYRG-------TLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 153
LG G FG+V R + P + +AVK + + + + + ++E+ + + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YNQPKVT---LNWRQRYGV 199
++ LLG C ++G L ++ +Y G+L ++L ++ KV L+++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 258
VA G+ YL + IHRD+ A NVL+ + ++ DFGLAR ++D +T++
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318
+ ++APE T +DV+SFG + E+ G I V+ +F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI------FTLGGSPYPGIPVEELFKLLR 250
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPAISA 378
G ++ + N EL ++++ C H+ PT RP+ +Q+V+ L++ +A +
Sbjct: 251 EGHRMD-KPSN-----CTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301
Query: 379 LGLS 382
L LS
Sbjct: 302 LDLS 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 101 ELLGSGGFGRV----YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG G FG V Y + +AVKK+ H + + +++F EI + L+H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 157 LLGYCRRKG--ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
G C G L LV +Y+P GSL YL + L+ R+ + G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS-- 126
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRT 272
+ +HRD+ N+L++ E ++GDFGL ++ + G + + APE
Sbjct: 127 -KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 273 GKATTSADVFSFGAFLLEV 291
K + ++DV+SFG L E+
Sbjct: 186 SKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 71/288 (24%), Positives = 133/288 (46%), Gaps = 40/288 (13%)
Query: 101 ELLGSGGFGRVYRGTLPK---SKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 155
++LG G FG V G L + S++++AVK K+ + ++EF++E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 156 QLLGYCRRKGEL------LLVYDYMPNGSLDKYLY------NQPKVTLNWRQRYGVIKGV 203
+L+G C L +++ +M +G L +L K+ L ++ V +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-L 262
ALG+ YL + IHRD+ A N +L ++ + DFGL++ G + + +
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGE 321
++A E T+ +DV++FG + E+A G+ P E ++D+ G
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRHGN 232
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L + P + L+ + L C +DP RP+ ++ ++LE
Sbjct: 233 RL--KQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 103 LGSGGFGRVYRGTL-----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156
LG G FG VY G ++++AVK + S Q +F+ E + + + H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKV----TLNWRQRYGVIKGVALGLLYLH 211
L+G + ++ + M G L +L N+P+ +L + + VA G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 267
E IHRD+ A N LL + GR + DFG+AR +Y + + + ++ P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 268 EHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILV 310
E G T+ DV+SFG L E+ + G P + +E + V
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 92 IATKGFREKE---LLGSGGFGRVYRGTLPKSKIEIAVKKI--SHES---RQGMKEFVAEI 143
A K E E +GSG G VY+ + A+K I +HE RQ +E
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE----- 122
Query: 144 VSIGR-LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYNQPKVTLNWRQRYGVIK 201
+ I R + H N+V+ GE+ ++ ++M GSL+ ++ ++ + RQ ++
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ---ILS 179
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
G+A YLH + ++HRD+K SN+L++ N ++ DFG++R+ DP + VGT
Sbjct: 180 GIA----YLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGT 231
Query: 262 LGYLAPEHTRT----GKATTSA-DVFSFGAFLLEVACGRRP--IERQGPEENLILVDWVF 314
+ Y++PE T G A D++S G +LE GR P + RQG DW
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------DW-- 281
Query: 315 DFWNRGELLEA---RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
L+ A P + E + C +P R S Q++Q
Sbjct: 282 -----ASLMCAICMSQPPEAPATASREFRHFIS---CCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 24/210 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF-VAEIVSIGRLRHRNLV 155
F++ E LG G + VY+G + +A+K+I ++ +G + EI + L+H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL---YNQPKVTLNWRQR--YGVIKGVALGLLYL 210
+L + +L+LV++YM + L KY+ + + N + Y ++KG+A +
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FC 116
Query: 211 HEEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
HE V+HRD+K N+L+ GEL +L DFGLAR + + + VV TL Y AP+
Sbjct: 117 HE---NRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170
Query: 269 ---HTRTGKATTSADVFSFGAFLLEVACGR 295
+RT +TS D++S G + E+ GR
Sbjct: 171 VLLGSRT--YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKI--------SHESRQGMKEFVA-EIVSIGRLRHR 152
L+GSG FG VY G S +AVK++ S + ++ M + +A EI + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGS----LDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
N+VQ LG L + +Y+P GS L+ Y + + N+ ++ + GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF------VRQILKGLN 120
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-----ARLYDHGTDPQTTHVVGTLG 263
YLH + +IHRD+K +N+L+D + ++ DFG+ A T+ + G++
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 264 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
++APE + T AD++S G ++E+ G+ P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
++G G +G V + + +A+K K S + K + E+ + +LRH N+V L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPK---VTLNWRQRYGVIKGVALGLLYLHEEWE 215
RRKG L LV++Y+ L+ L P + +++ +A Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIA----YCHS--- 118
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTR 271
+IHRD+K N+L+ +L DFG AR T V T Y APE T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 272 TGKATTSADVFSFGAFLLEVACGR 295
GK DV++ G + E+ G
Sbjct: 179 YGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 155
F + LG+G G V + S + +A K I E + ++ + + E+ + +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
G GE+ + ++M GSLD+ L ++ N + + V GL YL E+ +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK 120
Query: 216 QVVIHRDVKASNVLL--DGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
++HRDVK SN+L+ GE+ +L DFG++ +L D VGT Y++PE +
Sbjct: 121 --IMHRDVKPSNILVNSRGEI--KLCDFGVSGQLID----SMANSFVGTRSYMSPERLQG 172
Query: 273 GKATTSADVFSFGAFLLEVACGRRPI 298
T +D++S G L+E+A GR PI
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 7e-17
Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 23/207 (11%)
Query: 97 FREKELLGSGGFGRVYRGT-LPKS---KIEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 151
+ ++LGSG FG VY+G +P+ KI +A+K ++ + + EF+ E + + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ-----PKVTLNWRQRYGVIKGVALG 206
+LV+LLG C + LV MP+G L Y++ ++ LNW + +A G
Sbjct: 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKG 121
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GY 264
++YL E + ++HRD+ A NVL+ + ++ DFGLARL + G + + G + +
Sbjct: 122 MMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKW 177
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEV 291
+A E K T +DV+S+G + E+
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
F++ E +G G +G VY+ + +A+KKI E+ + EI + L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+LL + +L LV++++ + L K++ P + + + GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-- 118
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHTRTG 273
V+HRD+K N+L++ E +L DFGLAR + G +T TH V TL Y APE
Sbjct: 119 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 274 K-ATTSADVFSFGAFLLEV 291
K +T+ D++S G E+
Sbjct: 176 KYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 31/215 (14%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMK-EFVAEIVSIGRLRHRNLVQL--- 157
+G G +G+VY+ + +A+KK+ ++ ++G + EI + +L HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 158 -------LGYCRRKGELLLVYDYMPN---GSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
L + + KG LV++YM + G L+ L V + +K + GL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGL 129
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
Y H+ + +HRD+K SN+LL+ + +L DFGLARLY+ T+ V TL Y P
Sbjct: 130 NYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 268 E----HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
E R G A DV+S G L E+ ++PI
Sbjct: 187 ELLLGEERYGPAI---DVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-17
Identities = 57/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG+G FG V+ G S ++AVK + + ++ F+ E + L+H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNST-KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
++ + ++ +YM GSL +L + + + +A G+ Y+ + IHRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 128
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 279
++A+NVL+ L ++ DFGLAR+ + D + T G + + APE G T +
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 280 DVFSFGAFLLEV 291
DV+SFG L E+
Sbjct: 186 DVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS------HESRQGMKEFVAEIVSIGRLR 150
F+ ++ +G G F VYR T + +A+KK+ ++RQ + V EI + +L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVALGLL 208
H N+++ L EL +V + G L + + + + K + R + + +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
++H + V+HRD+K +NV + +LGD GL R + T + +VGT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328
+D++S G L E+A + P G + NL F + E + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL------FSLCQKIEQCDY--P 226
Query: 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
L TE+ +E+L ++ +C + DP RP + V QI
Sbjct: 227 PLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
LG GGFG V + + A KK++ + R+G + + E + ++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYN---------QPKVTLNWRQRYGVIKGVALGLLYL 210
+ K +L LV M G L ++YN +P+ Q + GL +L
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-------IISGLEHL 113
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
H+ + +I+RD+K NVLLD + N R+ D GLA G +T GT G++APE
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELL 169
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQG 302
+ + S D F+ G L E+ R P +G
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 64/265 (24%), Positives = 120/265 (45%), Gaps = 16/265 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM-KEFVAEIVSIGRLRHRNLVQLLGYC 161
LG+G G V + + +A K + ++ + K+ + E+ + R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
+ + + ++M GSLD+ + + + + V GL YL+ ++HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128
Query: 222 DVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
D+K SN+L++ +L DFG++ L + D VGT Y++PE + GK T +D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQGGKYTVKSD 184
Query: 281 VFSFGAFLLEVACGRRPI-ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339
V+S G ++E+A G+ P ++ + D + +++ P L + E+L
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ--IVQEPPPRLPSSDFPEDL 242
Query: 340 ELILKLGLLCSHSDPTARPSMRQVV 364
+ C DPT RP+ +Q+
Sbjct: 243 RDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 97 FREKELLGSGGFGRV----YRGT--------LPKSKIEIAVKKISHESRQGMKEFVAEIV 144
F + LG+G FGRV ++G+ L K+KI + +K++ H + E
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEH--------VLNEKR 53
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA 204
+ +RH LV L G + L LV +Y+P G L +L + + Y V
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA--QVV 111
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
L L YLH +++RD+K N+LLD + ++ DFG A+ T T + GT Y
Sbjct: 112 LALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT--LCGTPEY 164
Query: 265 LAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 297
LAPE GKA D ++ G + E+ G P
Sbjct: 165 LAPEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 71/282 (25%), Positives = 130/282 (46%), Gaps = 30/282 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS------HESRQGMKEFVAEIVSIGRLR 150
FR ++ +G G F VYR T + +A+KK+ ++R + + EI + +L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLN 60
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVALGLL 208
H N+++ EL +V + G L + + + + K + + + + L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
++H + V+HRD+K +NV + +LGD GL R + T + +VGT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD- 327
+D++S G L E+A + P G + NL ++ + +E D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL---------YSLCKKIEQCDY 225
Query: 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
P L +++ +EEL +L +C + DP RP + V + +R
Sbjct: 226 PPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 155
E +G G +G VY+ + +A+KKI E+ E V EI + L H N+V
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIV 61
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQ----RYGVIKGVALGLLYLH 211
+LL + +L LV++++ + L KY+ + P L+ Y +++G+A Y H
Sbjct: 62 RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YCH 116
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHT 270
V+HRD+K N+L+D E +L DFGLAR + G +T TH V TL Y APE
Sbjct: 117 S---HRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL 171
Query: 271 RTGKA-TTSADVFSFGAFLLEVACGRRPI 298
+ +T D++S G E+ RRP+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEM-VNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 11/170 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNLVQLLGY 160
+G G G V++ ++ +A+KK++ +G + + EI ++ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
+LV +YMP L + L ++ + L Q ++ + G+ Y+H ++H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 221 RDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
RD+K +N+L+ DG L ++ DFGLARL+ +H V T Y APE
Sbjct: 123 RDLKPANLLISADGVL--KIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 100 KELLGSGGFGRVYRGT--LPKS-KIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 155
+G G FG VY+G P++ KI +AVK + + ++E F+ E + + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L+G + +V + P G L YL K +L+ ++ L YL
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+ +HRD+ A NVL+ +LGDFGL+R + + + + + ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 276 TTSADVFSFGAFLLEV 291
T+++DV+ FG + E+
Sbjct: 186 TSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 10/209 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
FR+ +LG GGFG V + + A KK+ + R+G + E + ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L K L LV M G L ++Y+ + + + GL LH+E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRT 272
+++RD+K N+LLD + R+ D GLA H + QT VGT+GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 273 GKATTSADVFSFGAFLLEVACGRRPIERQ 301
+ T S D ++ G L E+ G+ P +++
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 52/305 (17%)
Query: 97 FREKELLGSGGFGRV----------YRGTLPKSK----IEIAVKKI-SHESRQGMKEFVA 141
R KE LG G FG V + G + +AVK + + ++ +F+
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 142 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY------------NQPKV 189
EI + RL++ N+++LLG C L ++ +YM NG L+++L N P V
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 190 TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD 248
++ V +A G+ YL +HRD+ N L+ ++ DFG++R LY
Sbjct: 127 SIANLLYMAV--QIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV--ACGRRPIERQGPEEN 306
V + ++A E GK TT++DV++FG L E+ C +P E+
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELEL----ILKLGLLCSHSDPTARPSMRQ 362
+ N GE N G + + L + KL + C D RP+ +
Sbjct: 242 I---------ENTGEFFR----NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288
Query: 363 VVQIL 367
+ L
Sbjct: 289 IHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKE-----FVAEIVSIG 147
TKG E+LG G +G VY G + ++ IAVK++ S E E+ +
Sbjct: 3 TKG----EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYN-QPKVTLNWRQRYGVIKGVALG 206
L+H N+VQ LG C + + +++P GS+ L P + +Y K + G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KY--TKQILDG 114
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTTHVV-GT 261
+ YLH V+HRD+K +NV+L +L DFG AR + HGT + GT
Sbjct: 115 VAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
++APE +D++S G + E+A G+ P+
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG G FG+VY+ ++ A K I +S + +++++ EI + H +V+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 163 RKGELLLVYDYMPNGSLDKYL------YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G+L ++ ++ P G++D + +P++ + RQ + L YLH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ-------MLEALQYLH---SM 129
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGK 274
+IHRD+KA NVLL + + +L DFG++ + T + +GT ++APE T K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 275 ATT---SADVFSFGAFLLEVA 292
T AD++S G L+E+A
Sbjct: 189 DTPYDYKADIWSLGITLIEMA 209
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 29/218 (13%)
Query: 103 LGSGGFGRVY----RGTLPKS-KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
LG G FG+V+ LP+ K+ +AVK + S ++F E + L+H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYN-------------QPKVTLNWRQRYGVIKGVA 204
G C LL+V++YM +G L+++L + L Q + +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 205 LGLLY---LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG 260
G++Y LH +HRD+ N L+ L ++GDFG++R +Y +
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 297
+ ++ PE K TT +D++SFG L E+ G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 45/283 (15%)
Query: 103 LGSGGFGRVYRGTL-------PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 155
LG G FG VY G P++++ I + R+ + EF+ E + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYN-QPKVTLNWRQRYGVIKG-------VALGL 207
+LLG + L++ + M G L YL + +P++ N Q +K +A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLG--Y 264
YL+ +HRD+ A N ++ + ++GDFG+ R +Y+ TD G L +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRW 187
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELL 323
++PE + G TT +DV+SFG L E+A +P + E+ V F G LL
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVMEGGLL 240
Query: 324 EARD--PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364
+ D P +++ +L +C +P RPS +++
Sbjct: 241 DKPDNCP-----------DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
L+G G +G V + ++ +A+KK S + + K + EI + +LRH NLV L+
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWEQ 216
RRK L LV++++ + LD + + ++Y +++G+ + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FCH---SH 119
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRT 272
+IHRD+K N+L+ +L DFG AR + T + V T Y APE T+
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY-VATRWYRAPELLVGDTKY 178
Query: 273 GKATTSADVFSFGAFLLEVACG 294
G+A D+++ G + E+ G
Sbjct: 179 GRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 63/229 (27%), Positives = 119/229 (51%), Gaps = 20/229 (8%)
Query: 103 LGSGGFGRVYRGT--LPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 159
LGSG FG V +G + K +I++A+K + +E+ + ++ E + E + +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C + L+LV + G L+K+L + K + ++ V++G+ YL + +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTGKATT 277
HRD+ A NVLL + ++ DFGL++ G L + APE K ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 278 SADVFSFGAFLLEV-ACGRRPIER-QGPEENLILVDWVFDFWNRGELLE 324
+DV+S+G + E + G++P ++ +GPE V F +G+ L+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 37/284 (13%)
Query: 103 LGSGGFGRVYRGTLPK--SKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
LG G FG V G L + S +++AVK KI+ +R M++F++E V + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 159 GYCRRKGEL------LLVYDYMPNGSLDKYLY-----NQPKVTLNWRQRYGVIKGVALGL 207
G C + E +++ +M +G L +L + P L + + +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP-QYLPTQMLVKFMTDIASGM 125
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLA 266
YL + IHRD+ A N +L+ +N + DFGL+ ++Y+ Q + ++A
Sbjct: 126 EYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 267 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325
E TT +DV+SFG + E+A G+ P G E + I +D+ +G L
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP--GVENSEI-----YDYLRQGNRL-- 233
Query: 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ P + L+ + L C +P RPS + LE+
Sbjct: 234 KQP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 24/182 (13%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 160
+G G FG V++ K+K +A+KK+ E+ + A EI + L+H N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 161 CRR--------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
CR KG LV+++ + L L + V + V+K + GL Y+H
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHR 137
Query: 213 EWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQ----TTHVVGTLGYLA 266
++HRD+KA+N+L+ DG L +L DFGLAR + + + T VV TL Y
Sbjct: 138 ---NKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRP 191
Query: 267 PE 268
PE
Sbjct: 192 PE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG G FG+VY+ ++ + A K I +S + +++++ EI + H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
+ L ++ ++ G++D + + L Q V K L YLH E +IHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128
Query: 223 VKASNVL--LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP-----EHTRTGKA 275
+KA N+L LDG++ +L DFG++ + T + +GT ++AP E ++
Sbjct: 129 LKAGNILFTLDGDI--KLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 276 TTSADVFSFGAFLLEVA 292
ADV+S G L+E+A
Sbjct: 186 DYKADVWSLGITLIEMA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKI--------EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
+G G FG+ L KSK EI + K+S + R+ E E+ + ++H N+
Sbjct: 8 IGEGSFGKAI---LVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
VQ G L +V DY G L K + Q V Q + L L ++H+
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-- 119
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ ++HRD+K+ N+ L + +LGDFG+AR+ + + T +GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRP 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL 309
+D+++ G L E+ + E G +NL+L
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFE-AGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 78/310 (25%), Positives = 125/310 (40%), Gaps = 47/310 (15%)
Query: 92 IATKGFREKELLGSGGFGRVY-------RGTLPKSKIE---------IAVKKI-SHESRQ 134
+ E LG G FG V+ + K+ E +AVK + S
Sbjct: 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61
Query: 135 GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLN 192
++F+ E+ + RL N+ +LLG C L ++ +YM NG L+++L + L
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 193 WRQR---YGVIKGVAL----GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245
+ + + +A G+ YL +HRD+ N L+ ++ DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 246 -LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA--CGRRPIERQG 302
LY + ++A E GK TT +DV++FG L E+ C +P E
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 303 PE---ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
+ EN F R L R PN + I +L L C D RP+
Sbjct: 239 DQQVIENAGH---FFRDDGRQIYL-PRPPNCPKD--------IYELMLECWRRDEEDRPT 286
Query: 360 MRQVVQILER 369
R++ L+R
Sbjct: 287 FREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 36/280 (12%)
Query: 101 ELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 153
E LG G F ++++G + K E+ +K + R + F + +L H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
LV G C E ++V +Y+ GSLD YL N+ + ++W+ V K +A L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLE- 117
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH---VVGTLGYLAPEH 269
++ + H +V A NVLL E + + G+ +L D G ++ + ++ PE
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACG-RRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
+ + +AD +SFG L E+ G +P+ ++ L F+ L A
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYEDRHQLPA-- 226
Query: 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
P EL ++ C +P RPS R +++ L
Sbjct: 227 PKW------TELANLIN---QCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-15
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 7/216 (3%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K + E +G G G V+ + E+A+K+I+ + + + + EI+ + L++ N+
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V L EL +V +Y+ GSL + + ++ Q V + L +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLH--- 132
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
VIHRD+K+ NVLL + + +L DFG ++T +VGT ++APE
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D++S G +E+ G P + P L L+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 8/198 (4%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
LG GGFG V + + A KK+ + + G K + E + ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
K L LV M G L ++YN + L + + G+L+LH ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 279
+RD+K NVLLD + N RL D GLA G T GT GY+APE + +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 280 DVFSFGAFLLEVACGRRP 297
D F+ G + E+ GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHR 152
RE +G G FG VY ++ +A+KK+S+ +Q +++ + E+ + +LRH
Sbjct: 19 DLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N ++ G R+ LV +Y + D + K L + + G GL YLH
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---H 269
IHRD+KA N+LL +L DFG A L P + VGT ++APE
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS-FVGTPYWMAPEVILA 185
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRP 297
G+ DV+S G +E+A R+P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELA-ERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 78/278 (28%), Positives = 119/278 (42%), Gaps = 23/278 (8%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 151
I + R LG G FG V+ GT ++A+K + + + F+ E + +LRH
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRH 60
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
LV L + + +V ++M GSL +L L Q + +A G+ Y+
Sbjct: 61 DKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
IHRD++A+N+L+ L ++ DFGLARL + + + APE
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 272 TGKATTSADVFSFGAFLLE-VACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
G+ T +DV+SFG L E V GR P E L V+ RG + P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------RGYRMPC--PQG 227
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
E + E ++ LC DP RP+ + LE
Sbjct: 228 CPESLHELMK-------LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 154
+ + E +G G +G VY+G K+ +A+KKI ES +G+ + EI + L+H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKV-TLNWRQRYGVIKGVALGLLYLHEE 213
V L ++ L L+++++ + L KYL + PK ++ + + G+L+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS- 119
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHTRT 272
+ V+HRD+K N+L+D + +L DFGLAR + G + TH V TL Y APE
Sbjct: 120 --RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 273 G-KATTSADVFSFGAFLLEVACGRRPI 298
+ +T D++S G E+A ++P+
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 154
+ + E +G G +G VY+ + IA+KKI E +G+ + EI + ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQ----RYGVIKGVALGLLYL 210
V+L + L LV++Y+ + L K++ + P N R Y +++G+A Y
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YC 118
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE 268
H V+HRD+K N+L+D N +L DFGLAR + G +T TH V TL Y APE
Sbjct: 119 HS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173
Query: 269 HTRTGKA-TTSADVFSFGAFLLEV 291
+ +T D++S G E+
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 49/285 (17%)
Query: 103 LGSGGFGRVYRGTL-PKSKIEIA--------VKKISHESRQGMKEFVAEIVSIGRLRHRN 153
LG G F +Y+G L +S ++I V K+ + F + +L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHE 212
LV+L G C R E ++V +Y+ G LD +L+ + V+L+W + V K +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY-------L 265
++ ++H +V N+L+ R G + +DP V + +
Sbjct: 119 --DKKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171
Query: 266 APEHTRTGKA--TTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGEL 322
APE R G+A T +AD +SFG LLE+ G P+ E F+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHR 224
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
L D AE LI + C DPT RPS R +++ L
Sbjct: 225 LPMPD-------CAELANLINQ----CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRN 153
K + E +G G G VY + E+A+K+++ +Q KE + EI+ + +H N
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPN 77
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L EL +V +Y+ GSL + + ++ Q V + L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS- 133
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
VIHRD+K+ N+LL + + +L DFG ++T +VGT ++APE
Sbjct: 134 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D++S G +E+ G P + P L L+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAE--IVSIGRLRHRNLVQ 156
+LG G FG+V L + AVK + + ++ + E ++++ +H L Q
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L + K L V +Y+ G L ++ + + Y + LGL +LHE +
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--EIVLGLQFLHE---R 115
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+I+RD+K NVLLD E + ++ DFG+ + T+ GT Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVDWVF 314
+ D ++ G L E+ G+ P E +E IL D V
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 8/197 (4%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 161
LG+G G V + S + +A K I E + ++ + + E+ + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
GE+ + ++M GSLD+ L ++ + + V GL YL E+ + ++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLREKHQ--IMHR 128
Query: 222 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 281
DVK SN+L++ +L DFG++ D VGT Y++PE + + +D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 282 FSFGAFLLEVACGRRPI 298
+S G L+E+A GR PI
Sbjct: 186 WSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
++G G FGR S + A+K+I +S +++ E V + +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQ-----PKVT-LNWRQRYGVIKGVALGLLYLHEEW 214
G L +V +Y G L + + Q P+ T L W + + LG+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHE-- 118
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ V+HRD+K+ N+ L +LGDFG ARL T+ VGT Y+ PE
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMP 176
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL 309
+D++S G L E+ + P + +NLIL
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQ-ANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 4e-15
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+ +GSG +G V ++ ++A+KKIS+ + K + EI + LRH N++ L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 158 L-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR--YGVIKGVALGLLYL 210
L ++ +V + M L K + + +T + Q Y +++G L YL
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG----LKYL 119
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH---GTDPQTTHVVGTLGYLAP 267
H VIHRD+K SN+L++ + ++ DFGLAR D T +VV T Y AP
Sbjct: 120 HS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAP 175
Query: 268 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
E + T + D++S G E+ R+P+
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 103 LGSGGFGRV----YRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQL 157
LG G FG+V Y + ++AVK + ES + + EI + L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 158 LGYCRRKGE--LLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
G C G + L+ +++P+GSL +YL N+ K+ L + +Y V + G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGS-- 127
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG----YLAPEHT 270
+ +HRD+ A NVL++ E ++GDFGL + + TD + V L + APE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEYYTVKDDLDSPVFWYAPECL 184
Query: 271 RTGKATTSADVFSFGAFLLEV 291
K ++DV+SFG L E+
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 155
F + LG+G G V++ + S + +A K I E + ++ + + E+ + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIK-GVALGLLYLHEEW 214
G GE+ + ++M GSLD+ L ++ Q G + V GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLTYLREKH 123
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ ++HRDVK SN+L++ +L DFG++ D VGT Y++PE +
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 275 ATTSADVFSFGAFLLEVACGRRPI 298
+ +D++S G L+E+A GR PI
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 25/271 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 159
E +G G FG V+ G L +AVK +K +F+ E + + H N+V+L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
C +K + +V + + G +L + P+ L ++ +++ A G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLE---SKHC 115
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-LGYLAPEHTRTGKATT 277
IHRD+ A N L+ + ++ DFG++R + G T + + + APE G+ ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 278 SADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336
+DV+SFG L E + G P ++ + +G L P L + V
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQGVRLPC--PELCPDAV- 225
Query: 337 EELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+L C DP RPS V Q L
Sbjct: 226 ------YRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 29/268 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIE--IAVKKISHESR-QGMK-EFVAEIVSIGRLRHRNLVQLL 158
LGSG FG V +G K E +AVK + +++ +K E + E + +L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
G C + +LV + G L+K+L VT + ++ V++G+ YL E
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLEE---TNF 116
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+HRD+ A NVLL + ++ DFGL++ D TH + + APE K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 277 TSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+ +DV+SFG + E + G++P + E V GE +E +
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERMEC------PQRC 223
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQV 363
E+ ++K LC RP V
Sbjct: 224 PPEMYDLMK---LCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 71/267 (26%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
LG+G FG V+ T K ++AVK + S ++ F+AE + L+H LV+L
Sbjct: 14 LGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
++ + ++ ++M GSL +L + + +A G+ ++ + + IHRD
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 282
++A+N+L+ L ++ DFGLAR+ + + + APE G T +DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 283 SFGAFLLE-VACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELEL 341
SFG L+E V GR P E V RG + E EEL
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPR------PENCPEELYN 234
Query: 342 ILKLGLLCSHSDPTARPSMRQVVQILE 368
I+ + C + P RP+ + +L+
Sbjct: 235 IM---MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 22/264 (8%)
Query: 103 LGSGGFGR--VYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
LG G FG +YR T S + ++ S + ++ + EIV + L+H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
LL+ +Y G+L + Q + + + Y+H+ ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
RD+K N+ L +LGDFG++++ T VVGT Y++PE + K +D
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSD 183
Query: 281 VFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELE 340
+++ G L E+ +R + P ++V V + + Y +E +
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLN--LVVKIVQGNYTPVV----------SVYSSELIS 231
Query: 341 LILKLGLLCSHSDPTARPSMRQVV 364
L+ DP RP+ +V+
Sbjct: 232 LVHS----LLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG---MKEFVAEIVSIGRLRH 151
K F + +G G FG VY ++ +A+KK+S+ +Q ++ + E+ + +LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
N +Q G R+ LV +Y + D L K L + V G GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 268
+IHRDVKA N+LL +LGDFG A + P VGT ++APE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVIL 184
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307
G+ DV+S G +E+A ER+ P N+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELA------ERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-------EFVA--EIVSIG 147
++ + LG G FG VY ++ +A+KK MK E + E+ S+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLR 52
Query: 148 RL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
+L H N+V+L R EL V++YM G+L + + ++ + +I + G
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
L ++H+ HRD+K N+L+ G ++ DFGLAR P T + V T Y A
Sbjct: 112 LAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDY-VSTRWYRA 166
Query: 267 PE-HTRTGKATTSADVFSFGAFLLEVACGR 295
PE R+ ++ D+++ G + E+ R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 45/282 (15%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHESRQGMKEFVAEI-VSIGRLRHRNLVQLL 158
E LG G +G V + + +AVK+I + + Q K + ++ +S+ + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIK-GVALGLLYLHEEWE 215
G R+G++ + + M + SLDK+ +T+ G I + L YLH +
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIP-EDILGKIAVSIVKALEYLHSKLS 124
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFG--------LARLYDHGTDPQTTHVVGTLGYLAP 267
VIHRDVK SNVL++ +L DFG +A+ D G P Y+AP
Sbjct: 125 --VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------YMAP 172
Query: 268 EH----TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323
E +DV+S G ++E+A GR P + W F +++
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQVV 221
Query: 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E P L E + E + + C + RP+ +++Q
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVN---KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAE------------IVSIGRL 149
+LG G FG+V L + A+K + K+ V E ++++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-------KDVVLEDDDVECTMVERRVLALA-W 53
Query: 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
H L L + K L V +Y+ G L ++ + + + Y + GL +
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAA--EIICGLQF 111
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
LH++ +I+RD+K NVLLD + + ++ DFG+ + +G + + + GT Y+APE
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCGTPDYIAPEI 167
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
+ K S D +SFG L E+ G+ P + +E
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 97 FREKELLGSGGFGRVYRGT-LP---KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 151
F++ ++LGSG FG VY+G +P K KI +A+K++ S + KE + E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYL 210
++ +LLG C + L+ MP G L Y+ ++ + + + V +A G+ YL
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYL 125
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLGYLAP 267
E + ++HRD+ A NVL+ + ++ DFGLA+L G D + H G + ++A
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIKWMAL 180
Query: 268 EHTRTGKATTSADVFSFGAFLLEVAC-GRRP 297
E T +DV+S+G + E+ G +P
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 103 LGSGGFGRVYRGTLPKSK-----IEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 156
LG G FG+V + T + K +AVK + + +++ ++E + ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----------- 205
L G C + G LLL+ +Y GSL +L KV ++ G L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 206 -----------GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 253
G+ YL E ++HRD+ A NVL+ ++ DFGL+R +Y+ +
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIERQGPEENLILVDW 312
+ + + ++A E TT +DV+SFG L E V G P PE
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER------- 237
Query: 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+F+ G +E R N E + L L C +P RP+ + + LE+
Sbjct: 238 LFNLLKTGYRME-RPENCSEE--------MYNLMLTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 69/216 (31%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEI---VSIGRLRHR--NLV 155
+GSG G+VY+ K+ +AVK++ R G KE I + + H +V
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQP-------KVTLNWRQRYGVIKGVALG 206
+ GY ++ + + M LDK L P K+T ++K
Sbjct: 78 KCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMT------VAIVKA---- 126
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYL 265
L YL E+ VIHRDVK SN+LLD N +L DFG++ RL D T G Y+
Sbjct: 127 LHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYM 181
Query: 266 APEH----TRTGKATTSADVFSFGAFLLEVACGRRP 297
APE K ADV+S G L+E+A G+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIE-----IAVKKISHESRQGMK-EFVAEIVSIGRL 149
+E LG G FG V+ + E + VK + + ++ EF E+ +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVT------LNWRQRYGVIKG 202
H+N+V+LLG CR ++ +Y G L ++L + K L+ +Q+ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGT 261
+ALG+ +L +HRD+ A N L+ + ++ L++ +Y+ ++
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRG 320
L +LAPE + +T +DV+SFG + EV G P EE L
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL------------- 228
Query: 321 ELLEARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILE 368
L+A L V E + KL C +P RPS ++V L
Sbjct: 229 NRLQAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 26/184 (14%)
Query: 104 GSGGFGRVYRGTL--PKSKIEIAVKKISHESRQGM---KEFVAEIVSIGRLRHRNLVQLL 158
G G +GRVY+ K E A+KK + Q + EI + L+H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 159 GYC--RRKGELLLVYDYMPN--GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+ L++DY + + K+ +V++ ++ + G+ YLH W
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 215 EQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYD------HGTDPQTTHVVGTLGY 264
V+HRD+K +N+L+ GE R +GD GLARL++ DP VV T+ Y
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----VVVTIWY 181
Query: 265 LAPE 268
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ +E+LG G G VY+ ++ +AVK I + + + K+ ++E+ + + ++
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G + + + ++M GSLD Y P+ L R V+KG L YL W
Sbjct: 64 FYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLG-RIAVAVVKG----LTYL---WSL 114
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
++HRDVK SN+L++ +L DFG++ + VGT Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 277 TSADVFSFGAFLLEVACGRRP 297
+DV+S G +E+A GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 64/283 (22%), Positives = 118/283 (41%), Gaps = 44/283 (15%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKK--ISHESRQGMKEFVAEIVSIGRLRHRN 153
F+ + LG G +G VY+ A+K+ + S++ ++ V EI + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 154 LVQ-----LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT------LNWRQRYGVIKG 202
++ L G + L +V +Y P G L K + + K WR +
Sbjct: 61 IISYKEAFLDG-NK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQ 111
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 262
+ GL LHE Q ++HRD+K++N+LL ++GD G++++ +GT
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTP 165
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322
Y+APE + + +D++S G L E+A P E + ++ R ++
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------------LRYKV 213
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ P + Y + I P RP+ +++
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRS----MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 98 REKELLGSGGFGRVYRG----TLPKSKIE-IAVKKISHESRQGMKE-FVAEIVSIGRLRH 151
R E LG FG+VY+G T P + + +A+K + ++ ++E F E + RL+H
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRY 197
N+V LLG ++ L +++ Y + L ++L + K TL
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 256
++ +A G+ +L V+H+D+ NVL+ +LN ++ D GL R +Y
Sbjct: 128 HIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291
+ + + +++PE GK + +D++S+G L EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 103 LGSGGFGRVY----RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
L G G V+ G + K+ VK ++ G K EI + + HR ++ L+
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKV--IVKAVT-----GGKTPGREIDILKTISHRAIINLI 152
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
R K + +V MP D + Y L Q + + + L YLH + +
Sbjct: 153 HAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGI 206
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
IHRDVK N+ LD N LGDFG A +L H PQ GTL +PE
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266
Query: 278 SADVFSFGAFLLEVACGRRPI 298
D++S G L E++ +
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 10/231 (4%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL----RHRNLVQ 156
++LG G FG+V+ L + A+K + + + +V L H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L + K L V +Y+ G L ++ + K L Y + GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA--EIICGLQFLHSKG-- 116
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+++RD+K N+LLD + + ++ DFG+ + G D +T GT Y+APE K
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
TS D +SFG L E+ G+ P EE + + R EA+D
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 100 KELLGSGGFGRVY----RGTL------------PKSKIEIAVKKISHESRQGMK-EFVAE 142
KE LG G FG V+ G + +AVK + ++ + + +F+ E
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 143 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL---------YNQPKVTLNW 193
I + RL+ N+++LL C L ++ +YM NG L+++L VT+++
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD 252
+ +A G+ YL +HRD+ N L+ ++ DFG++R LY
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA--CGRRPIERQGPEENLILV 310
V + +++ E GK TT++DV++FG L E+ C +P Q +E +I
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS-QLSDEQVI-- 243
Query: 311 DWVFDFWNRGELLEARDPNLGTEYVAEEL--ELILKLGLLCSHSDPTARPSMRQV-VQIL 367
N GE RD L + + KL L C + RPS +++ +L
Sbjct: 244 ------ENTGEFF--RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295
Query: 368 E 368
E
Sbjct: 296 E 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFV---AEIVSIGRLRHRNLVQL 157
LG GGFGRV + A+K + H G +E + EI+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE--CNHPFIVKL 58
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
+ K + ++ +Y G L L ++ + R+ I V L YLH +
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARF-YIACVVLAFEYLH---NRG 113
Query: 218 VIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRTGK 274
+I+RD+K N+LLD NG L DFG A+ G Q T GT Y+APE
Sbjct: 114 IIYRDLKPENLLLD--SNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPEIILNKG 168
Query: 275 ATTSADVFSFGAFLLEVACGRRP 297
S D +S G L E+ GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+G G +G V++ ++ +A+KK S + K + EI + +L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
RRK +L LV++Y + L++ L P+ + +I + + H+ IH
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNE-LEKNPR-GVPEHLIKKIIWQTLQAVNFCHK---HNCIH 123
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTGKAT 276
RDVK N+L+ + +L DFG AR+ G T V T Y APE T+ G
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQYG--- 179
Query: 277 TSADVFSFGAFLLEVACG 294
DV++ G E+ G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM---KEFVAEIVSIGRLRH 151
K F + +G G FG VY ++ +A+KK+S+ +Q ++ + E+ + R++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
N ++ G R+ LV +Y + D L K L + + G GL YLH
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 268
+IHRD+KA N+LL +L DFG A + P + VGT ++APE
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS-FVGTPYWMAPEVIL 194
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
G+ DV+S G +E+A + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLL 158
E +GSG +G V +S ++A+KKI H K + E+ + +H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 159 GYCRRKGELL----LVYDYMPNGSLDKYLY-NQPKVTLNWRQ-RYGVIKGVALGLLYLHE 212
R G +V D M + L ++ +QP + R Y +++G L Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHS 125
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLAPEH 269
VIHRD+K SN+L++ + R+GDFG+AR + V T Y APE
Sbjct: 126 ---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 270 TRT-GKATTSADVFSFGAFLLEVACGRRPI 298
+ + TT+ D++S G E+ GRR +
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR----HR 152
F E++G G +G+VY+ K+ +A+K + + + +E + E +I LR H
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNI--LRKYSNHP 63
Query: 153 NLVQLLGYCRRKG------ELLLVYDYMPNGS---LDKYLYNQPK-VTLNWRQRYGVIKG 202
N+ G +K +L LV + GS L K L + K + W Y +++
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-ILRE 121
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 262
GL YLHE VIHRD+K N+LL +L DFG++ D T + +GT
Sbjct: 122 TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTFIGTP 177
Query: 263 GYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
++APE +DV+S G +E+A G+ P+ P L +
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYC 161
LG G +G VY+ + + +A+K+I E + + + E+ + + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLN------WRQRYGVIKGVALGLLYLHEEWE 215
+G + + +YM GSLDK LY T R Y V+KG L +L EE
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG----LKFLKEEHN 123
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+IHRDVK +NVL++G +L DFG++ +G Y+APE ++G
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPERIKSGGP 178
Query: 276 ------TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
T +DV+S G +LE+A GR P P E + F +++ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANI-----FAQLSAIVDGDPPT 229
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
L + Y + + + K C + P RP+ Q+++
Sbjct: 230 LPSGYSDDAQDFVAK----CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 103 LGSGGFGRVYRGTLPK--SKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLG 159
+G+G FG+V G + SK + VK++ + F+ E+ L H N++Q LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYN---------QPKVTLNWRQRYGVIKGVALGLLYL 210
C LLV ++ P G L YL + Q V QR VA GLL+L
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMAC--EVASGLLWL 116
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT---HVVGTLGYLAP 267
H + IH D+ N L +L+ ++GD+GLA L + D T H V L +LAP
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAV-PLRWLAP 171
Query: 268 E-----HTR--TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNR 319
E T ++++S G + E+ +P E+ V R
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVR 224
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+ ++ P L +Y E++ L DP RP+ +V ++L
Sbjct: 225 EQDIKLPKPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+G G G V S ++AVK + +Q + E+V + +H+N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
EL ++ +++ G+L + + LN Q V + V L YLH Q VIHRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRD 142
Query: 223 VKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
+K+ ++LL L+GR L DFG P+ +VGT ++APE T D
Sbjct: 143 IKSDSILL--TLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 281 VFSFGAFLLEVACGRRPIERQGP 303
++S G ++E+ G P P
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 42/287 (14%)
Query: 97 FREKELLGSGGFGRVYRGT-LPKS---KIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRH 151
++ ++LGSG FG VY+G +P KI +A+K + + S + KE + E + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKV----TLNWRQRYGVIKGVALG 206
+ +LLG C + LV MP G L Y+ N+ ++ LNW + +A G
Sbjct: 69 PYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKG 121
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 263
+ YL E ++HRD+ A NVL+ + ++ DFGLARL D D H G +
Sbjct: 122 MSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIK 176
Query: 264 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGEL 322
++A E + T +DV+S+G + E+ G +P + E + D +GE
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGER 229
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L + P + + + + C D RP R++V R
Sbjct: 230 L-PQPPICTID--------VYMIMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 8/204 (3%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
FR+ +LG GGFG V + + A K++ + R+G + E + ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L K L LV M G L ++YN + + GL LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
++RD+K N+LLD + R+ D GLA G + VGT+GY+APE
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGYMAPEVLNNQ 176
Query: 274 KATTSADVFSFGAFLLEVACGRRP 297
+ T S D + G + E+ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 42/238 (17%)
Query: 97 FREKELLGSGGFGRVY------RGTLPKSKIEIAVKK-----------ISHESRQGMKEF 139
F+EK LG G FG V+ LP + V+K ++ +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 140 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ------------- 186
+ E+ + RL+ N+++LLG C + L ++ +YM NG L+++L +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 187 ----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242
+++ V +A G+ YL +HRD+ N L+ L ++ DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 243 LAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV--ACGRRP 297
++R LY V + ++A E GK TT++DV++FG L E+ C +P
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM-KEFVAEIVSIGRLRHRNLV 155
++ +G G +G V T + +++A+KKIS Q + + EI + R +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 156 QLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR--YGVIKGVALGL 207
+L + ++ +V + M L K + Q ++ + Q Y +++G L
Sbjct: 67 GILDIIRPPSFESFN-DVYIVQELMET-DLYKLIKTQH-LSNDHIQYFLYQILRG----L 119
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYL 265
Y+H V+HRD+K SN+LL+ + ++ DFGLAR+ D D T V T Y
Sbjct: 120 KYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 266 APEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
APE K T + D++S G L E+ RP+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 98 REKELLGSGGFGRVYRGTLPKSKIE----IAVKKIS-HESRQGMKEFVAEIVSIGRLRHR 152
R E LG FG++Y+G L ++ +A+K + + Q EF E + L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP---------------KVTLNWRQRY 197
N+V LLG ++ + ++++Y+ G L ++L + K +L+
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 256
+ +A G+ YL + +H+D+ A N+L+ +L+ ++ D GL+R +Y
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291
+ + ++ PE GK ++ +D++SFG L E+
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 8/208 (3%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
FR +LG GGFG V + + A KK+ + R+G + E + ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L K L LV M G L ++YN + ++ + GL L E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+++RD+K N+LLD + R+ D GLA G + VGT+GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAPEVINNE 176
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQ 301
K T S D + G + E+ G+ P ++
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 72/289 (24%), Positives = 132/289 (45%), Gaps = 43/289 (14%)
Query: 103 LGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156
LG G FG VY G +++ +AVK ++ S + EF+ E + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLY--------NQPKVTLNWRQRYGVIKGVALGLL 208
LLG + L+V + M +G L YL N + ++ + +A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYL 265
YL+ + +HRD+ A N ++ + ++GDFG+ R +Y+ TD G L ++
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRWM 188
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFD--FWNRGEL 322
APE + G TTS+D++SFG L E+ +P + E+ ++ +V D + ++ +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVMDGGYLDQPDN 245
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371
R +L +C +P RP+ ++V +L+ D+
Sbjct: 246 CPERVTDLMR---------------MCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLR 150
+A+ G+ + L G GRV+ T P + V KI G K + E + + +
Sbjct: 63 VASLGYTVIKTLTPGSEGRVFVATKPGQP-DPVVLKI------GQKGTTLIEAMLLQNVN 115
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT-LNWRQRYGVIKGVALGLLY 209
H +++++ +V +P+ S D Y Y + L Q + K + GL Y
Sbjct: 116 HPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
LH Q +IHRDVK N+ ++ +GD G A+ P + GT+ APE
Sbjct: 173 LHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAPEV 227
Query: 270 TRTGKATTSADVFSFGAFLLEV 291
K + AD++S G L E+
Sbjct: 228 LARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMK-EFVAEIVSIGRLR---HRNLVQL 157
+G G +G VY+ P S +A+K + ++ + G+ V E+ + RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 158 LGYCR-----RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+ C R+ ++ LV++++ + L YL P L +++ GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
++HRD+K N+L+ +L DFGLAR+Y T VV TL Y APE
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ 181
Query: 273 GKATTSADVFSFGAFLLEVACGRRPI 298
T D++S G E+ R+P+
Sbjct: 182 STYATPVDMWSVGCIFAEMF-RRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
++G G +G V + ++K +A+KK S E+ + + + E+ + L+ N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR---YGVIKGVALGLLYLHEEWEQ 216
RR+G+L LV++Y+ L+ L P + R Y +IK + H +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAI-------HWCHKN 119
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
++HRD+K N+L+ +L DFG AR G++ T V T Y +PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 277 TSADVFSFGAFLLEVACGR 295
+ D++S G L E++ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNLVQLL 158
E +G G +G V++ ++ +A+K++ + +G+ + EI + L+H+N+V+L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLHEEW 214
+L LV++Y + L KY + N ++K GL + H
Sbjct: 66 DVLHSDKKLTLVFEYC-DQDLKKYFDS-----CNGDIDPEIVKSFMFQLLKGLAFCHS-- 117
Query: 215 EQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
V+HRD+K N+L+ +GEL +L DFGLAR + + VV TL Y P+
Sbjct: 118 -HNVLHRDLKPQNLLINKNGEL--KLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 273 GKA-TTSADVFSFGAFLLEVACGRRPI 298
K +TS D++S G E+A RP+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 44/219 (20%)
Query: 106 GGFGRVY----RGT--------LPKSKIEIAVKKISH---ESR----QGMKEFVAEIVSI 146
G FG VY R T L KS + IA ++++ E QG +VA
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVTNVKAERAIMMIQGESPYVA----- 60
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
+L + K L LV +Y+ G + + +W ++Y I V LG
Sbjct: 61 ---------KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLG 109
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
+ LH+ +IHRD+K N+L+D + +L DFGL+R G + + VGT YLA
Sbjct: 110 VEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENK--KFVGTPDYLA 161
Query: 267 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
PE +D +S G + E G P + P+
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 103 LGSGGFGRVYRGTLPKSKIE---IAVKKI--SHESRQGMKEFV-AEIVSIGRLRHRNLVQ 156
+ G +GRV+ L K K A+K I + R+ + V E + + + +V+
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 157 LLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
L Y +G+ L LV +Y+P G L L N + + + Y I + L L YLH
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY--IAEIVLALEYLHS-- 111
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-------LYDHGTDPQTTHVVGTLGYLAP 267
+IHRD+K N+L+D + +L DFGL++ + + + + +VGT Y+AP
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 268 EHTRTGKATT-SADVFSFGAFLLEVACGRRPIERQGPEE 305
E G+ + + D +S G L E G P + PEE
Sbjct: 171 E-VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 64/270 (23%), Positives = 124/270 (45%), Gaps = 32/270 (11%)
Query: 102 LLGSGGFGRVY--RGTLPKSKI---EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
++G G FG V+ R + + +I V++++ + R + E + L H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIE 63
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L++V +Y P G+L +Y+ + L+ ++ LL LH +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLALHHVHTK 120
Query: 217 VVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+++HRD+K N+LLD ++GDFG++++ + + VVGT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEENL-ILVDWVFDFWNRGELLEARDPNLGTEY 334
+D+++ G L E+A +R E NL LV +++ + Y
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE----AANLPALV---------LKIMSGTFAPISDRY 225
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVV 364
+ +LIL + + DP+ RP + Q++
Sbjct: 226 SPDLRQLILSM----LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRNLVQLLG 159
+G G FG VY T + +AVKK+S+ +Q ++ + E+ + +L+H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
++ LV +Y + D L K L + + G GL YLH +I
Sbjct: 89 CYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTRTGKAT 276
HRD+KA N+LL +L DFG A + P + VGT ++APE G+
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK----SSPANS-FVGTPYWMAPEVILAMDEGQYD 198
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEENL 307
DV+S G +E+A ER+ P N+
Sbjct: 199 GKVDVWSLGITCIELA------ERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 101 ELLGSGGFGRVY--RGTLPKSKIEIAVKKIS----------HESRQGMKEFVAEIVSIG- 147
E LGSG FG VY R + +A+K+I+ E + + + V+E+ I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNL-LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVAL 205
+LRH N+V+ L +V D + L ++ + K + + + + L
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
L YLH+E + ++HRD+ +N++L + + DFGLA+ + + T VVGT+ Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYS 180
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVA 292
PE + ADV++FG L ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 43/207 (20%)
Query: 106 GGFGRVYRGTLPKSKIEI-AVKKIS-HESRQGMKEF----VAEIVSIGRLRHRNLVQL-- 157
G +G VYR K EI A+KK+ + ++G F + EI + +L+H N+V +
Sbjct: 16 GTYGVVYRA-RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKE 71
Query: 158 --LGYCRRKGELLLVYDYMPN---GSLD--KYLYNQPKV-TLNWRQRYGVIKGVALGLLY 209
+G K + +V +Y+ + ++ K + Q +V L + + G+ +
Sbjct: 72 VVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------MLQLLSGVAH 121
Query: 210 LHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
LH+ W ++HRD+K SN+LL+ G L ++ DFGLAR Y P T VV TL Y AP
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGIL--KICDFGLAREYGSPLKPYTQLVV-TLWYRAP 175
Query: 268 E-HTRTGKATTSADVFS----FGAFLL 289
E + +T+ D++S F L
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 7/201 (3%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+G G G V T + ++AVKK+ +Q + E+V + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
EL +V +++ G+L + + +N Q V V L YLH Q VIHRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 282
+K+ ++LL + +L DFG P+ +VGT ++APE T D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 283 SFGAFLLEVACGRRPIERQGP 303
S G ++E+ G P + P
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-13
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 17/226 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 155
F EL+G+G +G+VY+G K+ ++A K+ + +E EI + + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 156 QLLGYCRRKG------ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
G +K +L LV ++ GS+ + N TL + + + GL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE- 268
LH+ VIHRD+K NVLL +L DFG++ D + T +GT ++APE
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 182
Query: 269 ----HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
+D++S G +E+A G P+ P L L+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 103 LGSGGFGRVYRG-TLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGR----LRHRNLVQ 156
+G G +G+V++ L +A+K++ +GM V++ R H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 157 LLGYCR-----RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
L C R+ +L LV++++ + L YL P+ + ++ + GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
V+HRD+K N+L+ +L DFGLAR+Y T VV TL Y APE
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLL 182
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIER 300
T D++S G E+ R+P+ R
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF-RRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
FR +LG GGFG V + + A KK+ + R+G + E + ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L K L LV M G L ++YN + + + GL LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRT 272
+++RD+K N+LLD + R+ D GLA + +T VGT+GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 273 GKATTSADVFSFGAFLLEVACGRRP 297
+ T S D + G + E+ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 7/216 (3%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K + E +G G G VY + E+A+K+++ + + + + EI+ + ++ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V L EL +V +Y+ GSL + + ++ Q V + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLH--- 132
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
VIHRD+K+ N+LL + + +L DFG ++T +VGT ++APE
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D++S G +E+ G P + P L L+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 103 LGSGGFGRVYRGTLPKSKIE---IAVKKISHES---RQGMKEFVAE-IVSIGRLRHRNLV 155
+G G FG+V L K K + AVK + ++ ++ K +AE V + ++H LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L + +L V DY+ G L +L + + R R+ + +A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTG 273
+I+RD+K N+LLD + + L DFGL + G + T+ GT YLAPE R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 274 KATTSADVFSFGAFLLEVACGRRP 297
+ D + GA L E+ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+G G G V T + ++AVKK+ +Q + E+V + +H N+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
EL +V +++ G+L + +N Q V V L +LH Q VIHRD
Sbjct: 87 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHA---QGVIHRD 140
Query: 223 VKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 281
+K+ ++LL + +L DFG A++ P+ +VGT ++APE T D+
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 282 FSFGAFLLEVACGRRP 297
+S G ++E+ G P
Sbjct: 199 WSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ--LLGY 160
+G G FG+VY+ ++ A+K +S KE VA+ + RN++ LL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 161 C----------RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
+ +L LV DYM G L +L + + + + + Y I + L L +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLALEHL 112
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
H+ +++RD+K N+LLD + L DFGL++ + + T GT YLAPE
Sbjct: 113 HK---YDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVL 168
Query: 271 RTGKA-TTSADVFSFGAFLLEVACGRRP 297
K T D +S G + E+ CG P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
H LV L + + L V +Y+ G L ++ Q K+ + Y ++L L YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 112
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 268
HE + +I+RD+K NVLLD E + +L D+G+ + G P T+ GT Y+APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 166
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306
R S D ++ G + E+ GR P + G +N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQLL-G 159
+G G +G V + +KK++ + SR+ K E + +L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
+ G L +V + G L L Q L Q +A+ L YLHE+ ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 279
HRD+K NV L ++GD G+AR+ ++ D +T ++GT Y++PE +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKS 183
Query: 280 DVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339
DV++ G + E+A + + + N ++ ++E + P + +Y E
Sbjct: 184 DVWALGCCVYEMATLKHAFNAK--DMNSLVY----------RIIEGKLPPMPKDYSPELG 231
Query: 340 ELILKLGLLCSHSDPTARPSMRQVVQ 365
ELI +L P RPS++ +++
Sbjct: 232 ELIAT--MLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 LGSGGFGRVY---------RGTLPKSKIEIAVKKISHESRQGMKEFV-AEIVSIGRLRHR 152
LG+G +G+V+ G L K+ +KK + + E E + +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKV---LKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 153 NLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
+ L Y + +L L+ DY+ G L +LY + T + + Y I + L L +LH
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY--IAEIVLALDHLH 122
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
+ +I+RD+K N+LLD E + L DFGL++ + + + GT+ Y+APE R
Sbjct: 123 Q---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 272 TGKA--TTSADVFSFGAFLLEVACGRRPIERQG 302
G + D +S G E+ G P G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 36/278 (12%)
Query: 100 KELLGSGGFGRVY--------RGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLR 150
++ LG G FG VY K EI V +++ +E+ Q +E A+++S +L
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE--AQLLS--KLD 60
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVALGLL 208
H +V+ + ++ +Y LD L TL+ Q + LG+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
Y+H+ + ++HRD+KA N+ L L ++GDFG++RL D TT GT Y++PE
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYYMSPE 175
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328
+ + +D++S G L E+ C E Q N + V ++E P
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVL--------RIVEGPTP 223
Query: 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
+L Y + +L I++ L + DP+ RPS ++++
Sbjct: 224 SLPETY-SRQLNSIMQSML---NKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVS--IGRLRHRN--LVQ 156
++LG G FG+V L AVK + + + +V + L N L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L + K L V +++ G L ++ ++ + L Y + GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAA--EIVCGLQFLHSKG-- 116
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+I+RD+K NV+LD + + ++ DFG+ + G + +T GT Y+APE + K T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEE 305
S D +SFG L E+ G+ P +E
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 47/218 (21%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA------------EIVSIGRLR 150
LG G +G V++ ++K +A+KKI F A EI+ + L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIMFLQELG 64
Query: 151 -HRNLVQLLGYCRRKG--ELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVAL 205
H N+V+LL + + ++ LV++YM + L+ + + + +RY ++ +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLK 118
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTTHVVGT 261
L Y+H VIHRD+K SN+LL+ + +L DFGLAR L ++ +P T V T
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 262 LGYLAPE----HTRTGKATTSADVFSFGAFLLEVACGR 295
Y APE TR T D++S G L E+ G+
Sbjct: 176 RWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-12
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K + E +G G G VY + E+A+++++ + + + + EI+ + ++ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V L EL +V +Y+ GSL + + ++ Q V + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
VIHRD+K+ N+LL + + +L DFG A++ + + + +VGT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK 191
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D++S G +E+ G P + P L L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 7/201 (3%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+G G G V T+ S +AVKK+ +Q + E+V + +H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222
EL +V +++ G+L + + +N Q V V L LH Q VIHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141
Query: 223 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 282
+K+ ++LL + +L DFG P+ +VGT ++APE D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 283 SFGAFLLEVACGRRPIERQGP 303
S G ++E+ G P + P
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 22/225 (9%)
Query: 103 LGSGGFGRVYRGTLPK--SKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+G+G FG+V G + + ++ VK++ S Q +F+ E L+H NL+Q LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPK---VTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
C LLV ++ P G L YL + K +T + + +ALGLL+LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLY---DHGTDPQTTHVVGTLGYLAPE----- 268
IH D+ N LL +L ++GD+GL+ D+ P V L ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEV 177
Query: 269 HTR--TGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILV 310
H T ++V+S G + E+ G +P E+ L
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAE---IVSIGRLR 150
FR +LG G FG+V K+ A+K + +R ++ + E + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
H LV L + + + V +Y G L ++ V R + V LGL YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAAC-VVLGLQYL 117
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
HE +++RD+K N+LLD E ++ DFGL + G +T+ GT +LAPE
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD 315
T + D + G + E+ G P EE VFD
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 17/226 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 155
F E++G+G +G+VY+G K+ ++A K+ + +E EI + + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 156 QLLGYCRRKG------ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
G +K +L LV ++ GS+ + N L + + + GL +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
LH VIHRD+K NVLL +L DFG++ D + T +GT ++APE
Sbjct: 137 LHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 192
Query: 270 TRTGKATTS-----ADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
+ + +D++S G +E+A G P+ P L L+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+GSG +G VY+ + A+K I E + EI+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 163 RKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
R+ +L + ++ GSL D Y P L+ Q V + GL YLH + + +HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 222 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT---RTGKATTS 278
D+K +N+LL + +L DFG++ T + +GT ++APE R G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D+++ G +E+A + P+ P L L+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 101 ELLGSGGFGRVY---------RGTLPKSKI-EIAVKKISHESRQGM-KEFVAEIVSIGRL 149
++LG G FG+V+ G L K+ + A K+ R M ++ +AE+
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------ 55
Query: 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
H +V+L + +G+L L+ D++ G L L + T + Y + +AL L +
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDH 113
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPE 268
LH +I+RD+K N+LLD E + +L DFGL++ DH + + GT+ Y+APE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 168
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLIL 309
T SAD +SFG + E+ G P + + +E +IL
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+G G +G V ++ ++A+KKI++ ++R K + EI + L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 161 ----CRRKGE-LLLVYDYMPNGSLDKYLYN---QPKVTLNWRQRYGVIKGVALGLLYLHE 212
R + +VY+ M D L+ + + +Y + + + GL Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIHS 126
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT-R 271
V+HRD+K SN+LL+ + ++ DFGLAR D T +VV T Y APE
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLN 182
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPI 298
+ TT+ DV+S G E+ GR+P+
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 159
E LG G + V++G ++ +A+K+I E +G + E+ + L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR---YGVIKGVALGLLYLHEEWEQ 216
L LV++Y+ + L +Y+ + + + Y +++G+A Y H +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCHR---R 123
Query: 217 VVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTG 273
V+HRD+K N+L++ GEL +L DFGLAR T + VV TL Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGEL--KLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 274 KATTSADVFSFGAFLLEVACGR 295
+ +T D++ G E+A GR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL--G 159
++G GGFG VY G ++ K + R MK+ E ++ L R ++ L+ G
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQ--GETLA---LNERIMLSLVSTG 54
Query: 160 YC----------RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
C +L + D M G L +L +Q V R+ + + LGL +
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATE-IILGLEH 112
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+H + V++RD+K +N+LLD + R+ D GLA + P + VGT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEV 166
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACGRRPIERQ 301
+ G A +SAD FS G L ++ G P +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNV 228
LV DY G L + + ++ K +R+ + + + LL +H + +IHRD+K++N+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV-LLAVHHVHSKHMIHRDIKSANI 174
Query: 229 LLDGELNGRLGDFGLARLYDHG-TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAF 287
LL +LGDFG +++Y +D GT Y+APE R + AD+FS G
Sbjct: 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVL 234
Query: 288 LLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR-DPNLGTEYVAEELELILKLG 346
L E+ +RP + + EE + + L R DP + ++ E++ I+
Sbjct: 235 LYELLTLKRPFDGENMEEVM------------HKTLAGRYDPLPPS--ISPEMQEIVTA- 279
Query: 347 LLCSHSDPTARPS 359
LL SDP RPS
Sbjct: 280 LLS--SDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 46/289 (15%)
Query: 102 LLGSGGFGRVYRGTLPK---SKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQ 156
+LG G FG V L S ++AVK + + S ++EF+ E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 157 LLG---YCRRKGEL---LLVYDYMPNGSLDKYL---------YNQPKVTLNWRQRYGVIK 201
L+G R KG L +++ +M +G L +L + P TL R+ +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL---VRFMI-- 120
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG 260
+A G+ YL + IHRD+ A N +L+ + + DFGL++ +Y Q
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNR 319
+ +LA E TT +DV++FG + E+ G+ P G E + I +++ +
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY--AGVENSEI-----YNYLIK 230
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
G L + P + LE + +L C +P RPS + + LE
Sbjct: 231 GNRL--KQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 161
LG G + VY+G + +A+K+I E +G + E+ + L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
+ L LV++Y+ + L +YL + +N + + GL Y H + V+HR
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNYCHR---RKVLHR 128
Query: 222 DVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGKATTS 278
D+K N+L++ GEL +L DFGLAR T + VV TL Y P+ + +T
Sbjct: 129 DLKPQNLLINERGEL--KLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEENL 307
D++ G E++ GR EE L
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 122 EIAVKKISHESRQGMKE---FVAEIVSIGRLRHRNLVQLL--GYCRRKGELLLVYDYMPN 176
E+A+K + ++ + + F E RL H N+V LL G G L V++Y+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPG 63
Query: 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH------EEWEQVVIHRDVKASNVLL 230
+L + L G + G L L Q ++HRD+K N+++
Sbjct: 64 RTLREVLAAD-----------GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112
Query: 231 ---DGELNGRLGDFGLARL------YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 281
+ ++ DFG+ L D T +TT V+GT Y APE R T ++D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 282 FSFGAFLLEVACGRRPIE 299
+++G LE G+R ++
Sbjct: 173 YAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 154
++ +GSG +G+V K+ ++A+KK+S +S K E+ + + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 155 VQLLGYCRRKGELLLVYD-YMPNGSLDKYLYN---QPKVTLNWRQ--RYGVIKGVALGLL 208
+ LL L D Y+ + L N K++ + Q Y +++G L
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG----LK 132
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
Y+H +IHRD+K SN+ ++ + ++ DFGLAR TD + T V T Y APE
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPE 185
Query: 269 ------HTRTGKATTSADVFSFGAFLLEVACGR 295
H + D++S G + E+ G+
Sbjct: 186 IMLNWMHY-----NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 161
LG G + V++G ++ +A+K+I E +G + E+ + L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
+ L LV++Y+ + L +YL N + + + + + GL Y H+ + ++HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYCHK---RKILHR 127
Query: 222 DVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGKATTS 278
D+K N+L++ GEL +L DFGLAR T + VV TL Y P+ + + +T
Sbjct: 128 DLKPQNLLINEKGEL--KLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 279 ADVFSFGAFLLEVACGR 295
D++ G L E+A GR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIE---IAVKKISHES---RQGMKEFVAE-IVSIGRLRHRN 153
+++G G FG+V L K K + AVK + ++ ++ +AE V + L+H
Sbjct: 1 KVIGKGSFGKVL---LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LV L + +L V DY+ G L +L + + L R R+ + VA + YLH
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAE-VASAIGYLHS- 114
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTR 271
+I+RD+K N+LLD + + L DFGL + G +P+ T+ GT YLAPE R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 272 TGKATTSADVFSFGAFLLEVACGRRP 297
+ D + GA L E+ G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKI--------SHESRQGMKE----FVA--EIVSIGR 148
LG G +G+V + + +A+KK+ + RQ + F E+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 149 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
++H N++ L+ + LV D M L K + K+ L Q ++ + GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR--KIRLTESQVKCILLQILNGLN 133
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--------------- 253
LH+ + +HRD+ +N+ ++ + ++ DFGLAR Y G P
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY--GYPPYSDTLSKDETMQRRE 188
Query: 254 -QTTHVVGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGR 295
T+ VV TL Y APE + A D++S G E+ G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 38/212 (17%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIE---IAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLV 155
+ LG G + VY+G +SK+ +A+K+I E +G F A E + L+H N+V
Sbjct: 11 DKLGEGSYATVYKG---RSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIV 66
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP--------KVTLNWRQRYGVIKGVALGL 207
L K L LV++Y+ + L +Y+ + ++ L + +++G+A
Sbjct: 67 TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLLRGLA--- 117
Query: 208 LYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
Y H+ + V+HRD+K N+L+ GEL +L DFGLAR + + VV TL Y
Sbjct: 118 -YCHQ---RRVLHRDLKPQNLLISERGEL--KLADFGLARAKSVPSKTYSNEVV-TLWYR 170
Query: 266 APEHTRTGKA--TTSADVFSFGAFLLEVACGR 295
P+ G +TS D++ G E+A GR
Sbjct: 171 PPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 101 ELLGSGGFGRV-----------YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL 149
+LLG G FG+V Y + K ++ IA +++H + E +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNT 52
Query: 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
RH L L + K L V +Y+ G L +L + + + + YG + L Y
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA--EIVSALDY 110
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPE 268
LH +++RD+K N++LD + + ++ DFGL + + TD T GT YLAPE
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPE 165
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
+ D + G + E+ CGR P Q E+ LIL++
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL--G 159
++G GGFG VY G ++ K + R MK+ E ++ L R ++ L+ G
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQ--GETLA---LNERIMLSLVSTG 54
Query: 160 YC----------RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
C +L + D M G L +L +Q V R+ + + LGL +
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAE-IILGLEH 112
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+H + V++RD+K +N+LLD + R+ D GLA + P + VGT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEV 166
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACGRRP 297
+ G A +SAD FS G L ++ G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGT 261
+A+GL +LH + +I+RD+K NV+LD E + ++ DFG+ + ++ +TT GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
Y+APE S D ++FG L E+ G+ P + + +E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLRHRN 153
++LG G FG+V L + A+K + + M E I+++ +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPF 57
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
L L + K L V +Y+ G L + K R R+ + V L L++LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-RSRFYAAE-VTLALMFLHR- 114
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTR 271
VI+RD+K N+LLD E + +L DFG+ + G TT GT Y+APE +
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIERQGPE---ENLILVDWVFDFW 317
+ S D ++ G + E+ G+ P E + E+++ D ++ W
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 97 FREKELLGSGGFGRVY--RGTLPKSKIEIAVKKISHESRQGMKEFV-AEIVSIGRLRHRN 153
+ +G+G FGRV+ R + + + V I R ++ V E + + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+++L + L ++ +Y+P G L YL N + + + Y + L YLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA--SEIVCALEYLHS- 119
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRT 272
+ +++RD+K N+LLD E + +L DFG A+ L D +T + GT YLAPE ++
Sbjct: 120 --KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQS 172
Query: 273 GKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
+ D ++ G + E+ G P P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 14/146 (9%)
Query: 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKAS 226
L V +++ G L ++ Q K+ + Y ++L L +LHE + +I+RD+K
Sbjct: 71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS--AEISLALNFLHE---RGIIYRDLKLD 125
Query: 227 NVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSF 284
NVLLD E + +L D+G+ + G P T+ GT Y+APE R S D ++
Sbjct: 126 NVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 285 GAFLLEVACGRRPIERQG----PEEN 306
G + E+ GR P + G P++N
Sbjct: 183 GVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LV L + L LV +Y+ G L ++ Q K+ + Y +AL L+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---- 113
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTR 271
E+ +I+RD+K NVLLD + + +L D+G+ + G P T+ GT Y+APE R
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIE 299
+ S D ++ G + E+ GR P +
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+GSG +G VY+ + AVK I E EI + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 163 RKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221
+ +L + +Y GSL D Y P L+ Q V + GL YLH + + +HR
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 222 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT---RTGKATTS 278
D+K +N+LL + +L DFG+A T + +GT ++APE + G
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
D+++ G +E+A + P+ P L L+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 158
E LG G + VY+G + +A+K IS ++ +G+ F A E + L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLH 69
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
K L V++YM + L +Y+ P + R + + + GL Y+H Q +
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG---QHI 124
Query: 219 IHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+HRD+K N+L+ GEL +L DFGLAR + ++ VV TL Y P+
Sbjct: 125 LHRDLKPQNLLISYLGEL--KLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 277 TSA-DVFSFGAFLLEVACGR 295
+SA D++ G +E+ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 102 LLGSGGFGRVY----RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+LG G FG+V +GT I+I K + + V + V + L QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG--VALGLLYLHEEWE 215
+ L V +Y+ G L +Y +V +++ + V +A+GL +LH +
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL---MYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG- 121
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+I+RD+K NV+LD E + ++ DFG+ + ++D T T GT Y+APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKTFCGTPDYIAPEIIAYQ 176
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
S D ++FG L E+ G+ P E + +E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 47/273 (17%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLRHRN 153
+LG G FG+V L +S AVK + + M E I+S+ R H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPF 57
Query: 154 LVQLLGYCRRKGE-LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
L QL C + + L V +++ G L ++ + + Y + L++LH+
Sbjct: 58 LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--EITSALMFLHD 114
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHT 270
+ +I+RD+K NVLLD E + +L DFG+ + +++ T T+ GT Y+APE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEIL 168
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA--RDP 328
+ S D ++ G L E+ CG P E + N +L EA D
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE----------------NEDDLFEAILNDE 212
Query: 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMR 361
+ +++++ ILK + T P+MR
Sbjct: 213 VVYPTWLSQDAVDILK-AFM------TKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 64/219 (29%), Positives = 92/219 (42%), Gaps = 17/219 (7%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVS 145
L + + F +++G G FG V SK A+K +S ++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 146 IGRLRHRN---LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG 202
I + H N +VQL + L +V +YMP G L + N + W + Y
Sbjct: 96 I--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFY--TAE 150
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 262
V L L +H IHRDVK N+LLD + +L DFG D + VGT
Sbjct: 151 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207
Query: 263 GYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRP 297
Y++PE ++ G D +S G FL E+ G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 48/233 (20%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKIS----HESRQGM-----KEFVAEIVSIGRLRHR 152
++G G FG V+ + A+K + + Q ++ +A+ S
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS------P 61
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+V+L + + L LV +YMP G L L + + Y I + L L +H+
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--IAELVLALDSVHK 119
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLA--------RLYD---------------H 249
IHRD+K N+L+D + + +L DFGL R Y
Sbjct: 120 ---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 250 GTDPQTTHV-----VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
D + V VGT Y+APE R D +S G L E+ G P
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 15/218 (6%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL----RHRNLVQ 156
+LLG G FG+V + A+K + E K+ VA V+ R+ RH L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTA 59
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L + L V +Y G L +L + T + YG + L YLH +
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--EIVSALEYLHS---R 114
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPEHTRTGKA 275
V++RD+K N++LD + + ++ DFGL + + +D T GT YLAPE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
+ D + G + E+ CGR P Q E LIL++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 113 RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172
RG+ PK K+ ++ E + +E+ + H +V+ + +LLL+ +
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145
Query: 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY------LHEEWEQVVIHRDVKAS 226
Y G L+K + + K L + Q Y V GLL+ L E + ++HRD+K++
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPF-QEYEV------GLLFYQIVLALDEVHSRKMMHRDLKSA 198
Query: 227 NVLLDGELNGRLGDFGLARLY-DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFG 285
N+ L +LGDFG ++ Y D + + GT YLAPE + + AD++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 286 AFLLEVACGRRPIERQGPEENLIL 309
L E+ RP +GP + I+
Sbjct: 259 VILYELLTLHRPF--KGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 97 FREKELLGSGGFGRVY--RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR-----L 149
F ++LG+G +G+V+ R ++ K+ ++ K E R +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 150 RHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
R + L Y + + +L L+ DY+ G + +LY + + + + Y + L L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS--GEIILALE 119
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
+LH+ +++RD+K N+LLD E + L DFGL++ + +T GT+ Y+APE
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 269 HTRT----GKATTSADVFSFGAFLLEVACGRRPIERQG 302
R GKA D +S G + E+ G P +G
Sbjct: 177 IIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 48/148 (32%), Positives = 66/148 (44%), Gaps = 10/148 (6%)
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+VQL + L +V +YMP G L + N V W + Y V L L +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFY--TAEVVLALDAIHS- 160
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT- 272
+IHRDVK N+LLD + +L DFG D + VGT Y++PE ++
Sbjct: 161 --MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 273 ---GKATTSADVFSFGAFLLEVACGRRP 297
G D +S G FL E+ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 102 LLGSGGFGRVY----RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+LG G FG+V +GT I+I K + + V + V + + L QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG--VALGLLYLHEEWE 215
+ L V +Y+ G L +Y+ +V +++ V +++GL +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDL---MYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR--- 119
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPEHTRTGK 274
+ +I+RD+K NV+LD E + ++ DFG+ + +H D TT GT Y+APE
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
S D +++G L E+ G+ P + + +E
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 51/224 (22%)
Query: 100 KELLGSGGFGRVYR---------------GTLPKSKIEIAVKKISHESRQGMKEFVAEIV 144
++LG GG+G+V++ L K+ I K +H AE
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--------AERN 52
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGV----- 199
+ ++H +V L+ + G+L L+ +Y+ G L +L +R G+
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----------EREGIFMEDT 101
Query: 200 ----IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255
+ ++L L +LH+ Q +I+RD+K N+LLD + + +L DFGL + + +
Sbjct: 102 ACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTV 156
Query: 256 THV-VGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRP 297
TH GT+ Y+APE R+G + D +S GA + ++ G P
Sbjct: 157 THTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQ--GMKEFV-AEIVSIGRLRH- 151
F ++LG+G +G+V+ V+K+S H+S + MK A IV +
Sbjct: 2 FELLKVLGTGAYGKVF-----------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEH 50
Query: 152 -RNLVQLLGYCRR-------------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY 197
R Q+L + R+ +L L+ DY+ G L +L + + Q Y
Sbjct: 51 TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257
+ L L +LH+ +I+RD+K N+LLD + L DFGL++ + +
Sbjct: 111 --SGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165
Query: 258 VVGTLGYLAPEHTRTGKA--TTSADVFSFGAFLLEVACGRRPIERQGPEEN 306
GT+ Y+AP+ R G + D +S G + E+ G P G E+N
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLG 159
E +G G +G+VY+ T K AVK I +E AE + L H N+V+ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 160 YCRRK-----GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG------VIKGVALGLL 208
+ G+L LV + GS+ + + K L QR ++ G LGL
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAP 267
+LH +IHRDVK +N+LL E +L DFG+ A+L T+ VGT ++AP
Sbjct: 143 HLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 197
Query: 268 EHTRTGKATTSA-----DVFSFGAFLLEVACGRRPIERQGPEENL 307
E + + DV+S G +E+ G P+ P + L
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 101 ELLGSGGFGRV-----------YRGTLPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
+LLG G FG+V Y + K ++ IA +++H ESR +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-----------VL 49
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
RH L L + L V +Y G L +L + + + + YG ALG
Sbjct: 50 QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG 109
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYL 265
YLH V++RD+K N++LD + + ++ DFGL + + +D T GT YL
Sbjct: 110 --YLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
APE + D + G + E+ CGR P Q E+ LIL++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 103 LGSGGFGRVYRGTLPKSKIE--IAVKKISHESRQGM--KEFVAEIVSIGRLR-HRNLVQL 157
LG G +G V ++ E +A+KKI++ + + K + E+ + R H+N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQP-KVTLNWRQRYGV----------IKGVALG 206
++ +V+ N YLY + + L+ R G I + G
Sbjct: 68 Y-------DMDIVFPGNFNEL---YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 207 LLYLHEEWEQVVIHRDVKASNVL--LDGELNGRLGDFGLARLYDHG---TDPQTTHVVGT 261
L Y+H V+HRD+K N+L D EL ++ DFGLAR + T V T
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCEL--KICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 262 LGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGRRPI 298
Y APE + ++ T A DV+S G L E+ GR+P+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 103 LGSGGFGRVY----RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
+G G FG+V R T ++ ++K SR + +AE + ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK-TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
+ +L LV ++ G L +L + + L R R+ + L LH+ V
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDL-SRARF-YTAELLCALENLHK---FNV 114
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
I+RD+K N+LLD + + L DFGL +L D +T GT YLAPE T +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 279 ADVFSFGAFLLEVACGRRP 297
D ++ G L E+ G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRN 153
F E LG+G FGRV + A+K + MK+ E + L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V ++ + + + + +++ G L +L + + + Y + L YLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLHS- 136
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+ +I+RD+K N+LLD + + ++ DFG A+ D +T + GT YLAPE ++
Sbjct: 137 --KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PD-RTFTLCGTPEYLAPEVIQSK 190
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGP 303
+ D ++ G L E G P P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA---------EIVSIGRLRHRN 153
+G G FG V + +A+KKI MK F E+ + LRH N
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 154 LVQLLG-YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
++ L + ++ V + + L + L ++P + + Q + + + GL Y+H
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP-LEKQFIQYF--LYQILRGLKYVHS 126
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
V+HRD+K SN+L++ + ++ DFGLAR+ DPQ T V T Y APE T
Sbjct: 127 AG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLT 179
Query: 273 -GKATTSADVFSFGAFLLEVACGR 295
K D++S G E+ G+
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162
+G G FG V+ T P+ +A+KK M +VS R+ R L ++L + +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK--------MPNVFQNLVSCKRV-FREL-KMLCFFK 57
Query: 163 RKGELLLVYDYMPNGSLDKY--LY----------------NQP------KVTLNWRQRYG 198
L + D + +D + +Y QP KV L Y
Sbjct: 58 HDNVLSAL-DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL-----YQ 111
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 258
+++ GL YLH ++HRD+K N+L++ ++ DFGLAR+ + T
Sbjct: 112 ILR----GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 259 VGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGRRPIERQGPEENLILV 310
V T Y APE + TSA D++S G E+ R + Q P + L L+
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+GSG +G V K+ + +AVKK+S +S K E+ + ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 161 ---CRRKGELLLVY--DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
R E VY ++ L+ + Q K+T + Q +I + GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 138
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 274
+IHRD+K SN+ ++ + ++ DFGLAR TD + T V T Y APE
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 275 ATTSADVFSFGAFLLEVACGR 295
+ D++S G + E+ GR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 21/184 (11%)
Query: 117 PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV---YDY 173
PK + IA K++ SR + + EI+++GRL H N++++ R + ++ YD+
Sbjct: 190 PKCERLIA-KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 174 MPNGSLDKYLYNQPKVTLNWR------QRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227
L ++Y++ +W+ Q ++K + + Y+H+ + +IHRD+K N
Sbjct: 248 ----DLYSFMYDE---AFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 228 VLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAF 287
+ L+ + LGDFG A ++ + VGT+ +PE D++S G
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 288 LLEV 291
LL++
Sbjct: 358 LLDM 361
|
Length = 501 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIE---IAVKKISHE---SRQGMKEFVAEI-VSIGRLRHRN 153
+++G G FG+V L K K++ AVK + + +R+ K +AE V + ++H
Sbjct: 1 KVIGKGSFGKVL---LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LV L + +L V D++ G L + + Q + + + +A L YLH
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS- 114
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+++RD+K N+LLD + + L DFGL + +D TT GT YLAPE R
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-FCGTPEYLAPEVIRKQ 171
Query: 274 KATTSADVFSFGAFLLEVACGRRP 297
+ D + GA L E+ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIE---IAVKKISHESRQGMK-EFVAEIVSIGRLRHR 152
+ + E LG G + VY+G KSK+ +A+K I + +G + E + L+H
Sbjct: 7 YEKLEKLGEGSYATVYKG---KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N+V L K L LV++Y+ + L +Y+ P L+ + + GL Y+H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQ 121
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTR 271
+ ++HRD+K N+L+ +L DFGLAR + + VV TL Y P+
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLG 177
Query: 272 TGKATTSADVFSFGAFLLEVACG 294
+ + +T D++ G +E+ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 64/238 (26%), Positives = 93/238 (39%), Gaps = 55/238 (23%)
Query: 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVS 145
RY DL LG G G V+ +AVKKI Q +K + EI
Sbjct: 6 RYMDLRP----------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 146 IGRLRHRNLVQLLGYCRRKGE--------------LLLVYDYMPNGSLDKYLYNQP---- 187
I RL H N+V++ G + +V +YM L L P
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEE 114
Query: 188 KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARL 246
L Q + GL Y+H V+HRD+K +NV ++ E L ++GDFGLAR+
Sbjct: 115 HARLFMYQ-------LLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
Query: 247 YDHGTDPQTTH------VVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGR 295
DP +H + T Y +P T + D+++ G E+ G+
Sbjct: 165 ----VDPHYSHKGYLSEGLVTKWYRSPRLLLSPN--NYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 101 ELLGSGGFGRV-----------YRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL 149
+LLG G FG+V Y + K ++ +A +++H + E +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNS 52
Query: 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
RH L L + L V +Y G L +L + + + + YG + L Y
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDY 110
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAP 267
LH E V++RD+K N++LD + + ++ DFGL + + D T GT YLAP
Sbjct: 111 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 165
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
E + D + G + E+ CGR P Q E+ LIL++
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 50/244 (20%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVS-- 145
KD I T+ +G GG+G+V+ + +A+K++ + E V +++
Sbjct: 1 KDFQILTQ-------VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTER 52
Query: 146 --IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGV 203
+ + LV+LL + L L +Y+P G L N
Sbjct: 53 DILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN------------------ 94
Query: 204 ALGLL-------YLHEEWEQV-------VIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249
LG+L Y+ E +E V IHRD+K N L+D + +L DFGL++
Sbjct: 95 -LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK---- 149
Query: 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI- 308
G VVG+ Y+APE R + D +S G L E CG P P E
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 309 LVDW 312
L W
Sbjct: 210 LKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEI-VSIGRLRHRNLVQ 156
+++G G FG+V + AVK + ++ ++ K ++E V + ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L + +L V DY+ G L +L + + L R R+ + +A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+++RD+K N+LLD + + L DFGL + + +GT T+ GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHKQP 172
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
+ D + GA L E+ G P + E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 46/238 (19%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 153
F++ +LLG G GRV+ L + A+K + + R +K + E + L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 154 LVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIK----GVALGL 207
L L Y + E L LV DY P G L + L QP L V + V L L
Sbjct: 63 LPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCL----SEEVARFYAAEVLLAL 116
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-------------- 253
YLH +++RD+K N+LL + L DF L++ D P
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 254 --------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
++ VGT Y+APE ++ D ++ G L E+ G P
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 63/224 (28%), Positives = 85/224 (37%), Gaps = 33/224 (14%)
Query: 95 KGFREKELLGSGGFGRVYRGTLPKSKIE---IAVKKISHES--RQGMKEFVAEIVSIGRL 149
K F K L+G G FG V + + K A+K + Q F E I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQ---VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 150 RHRN-LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
+ + QL + K L LV +Y P G L L+ RY +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQF 106
Query: 209 YLHEEWEQV-------VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
YL E + +HRD+K NVL+D + +L DFG A + VGT
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 262 LGYLAPEHTRT----GKAT--TSADVFSFGAFLLEVACGRRPIE 299
Y+APE T GK T D +S G E+ GR P
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 35/215 (16%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFV---AEIVSIGRLRHRNLVQLLG 159
+ + + +AVKKI+ +S ++ EI++ +L+H N++ +
Sbjct: 10 FEDLMIVHLAKHK--PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
EL +V M GS + L L ++K V L Y+H + I
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FI 123
Query: 220 HRDVKASNVLLDGELNGRL-----------GDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
HR VKAS++LL G+ L ++D V L +L+PE
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLSPE 178
Query: 269 ------HTRTGKATTSADVFSFGAFLLEVACGRRP 297
K +D++S G E+A G P
Sbjct: 179 VLQQNLQGYNEK----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 30/174 (17%)
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-- 260
VA G+ +L + IHRDV A NVLL ++ DFGLAR D D + +VV
Sbjct: 221 VAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLAR--DIMND--SNYVVKGN 273
Query: 261 ---TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVF-D 315
+ ++APE T +DV+S+G L E+ + G+ P ILV+ F
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG-------ILVNSKFYK 326
Query: 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
RG + D + E+ I+K +C + +PT RP+ Q+ Q+++R
Sbjct: 327 MVKRGYQMSRPD------FAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 13/219 (5%)
Query: 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEI 143
+ +DL + + + +++G G FG V ++ A+K +S ++ F E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 144 VSIGRLRHRN-LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG 202
I + +VQL + L +V +YMP G L + N V W + Y
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFY--TAE 150
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 262
V L L +H IHRDVK N+LLD + +L DFG + + VGT
Sbjct: 151 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 263 GYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRP 297
Y++PE ++ G D +S G FL E+ G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 50/155 (32%), Positives = 67/155 (43%), Gaps = 25/155 (16%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 275
IHRD+ A N+LL ++ DFGLAR D DP L ++APE
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 276 TTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
TT +DV+SFG L E+ + G P E +F R +D GT
Sbjct: 254 TTQSDVWSFGVLLWEIFSLGASPYPGVQINE---------EFCQR-----LKD---GTRM 296
Query: 335 VAEELEL--ILKLGLLCSHSDPTARPSMRQVVQIL 367
A E I ++ L C DP RP+ +V+IL
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGR 148
+ K +++ + +GSG G V I +AVKK+S +++ K E+V +
Sbjct: 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76
Query: 149 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
+ H+N++ LL + L D Y+ +D L + L+ + ++ + G+
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
+LH +IHRD+K SN+++ + ++ DFGLAR T+ T V T Y AP
Sbjct: 137 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAP 191
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACG 294
E + D++S G + E+ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 91 YIATKGFREKELLGSGGFGRV---YRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVS 145
+ K ++ + +GSG G V Y L ++ +A+KK+S +++ K E+V
Sbjct: 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 146 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA 204
+ + H+N++ LL + L D Y+ +D L ++ L+ + ++ +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
G+ +LH +IHRD+K SN+++ + ++ DFGLAR GT T V T Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGR 295
APE + D++S G + E+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 83 HRFRYKDL-YIATKGFREKELLGSGGFGRVYRGTLPKSKIE-IAVKKISHES--RQGMKE 138
++ +Y+D +I T LG+G FGRV T +A+K+ +Q +
Sbjct: 25 NKMKYEDFNFIRT--------LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 139 FV-AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY 197
V +E + + H V L G + + L LV +++ G +L + +
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPNDV 132
Query: 198 GVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255
G + L++ E+ Q +++RD+K N+LLD + ++ DFG A++ D +T
Sbjct: 133 GCFYAAQIVLIF---EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRT 185
Query: 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
+ GT Y+APE +AD ++ G F+ E+ G P P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 101 ELLGSGGFGRVYRGTL-PKS-----------KIEIAVKKISHESRQGMKEFVAEIVSIGR 148
E LG G ++Y G L K +I++ + K+ S + + E S+ R
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKV-ILKVLDPSHRDISLAFFETASMMR 59
Query: 149 -LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKV-TLNWRQRYGVIKGVALG 206
+ H+++V L G C R E ++V +++ G LD +++ + V T W ++ V K +A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASA 117
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTT----HVVGT 261
L YL ++ ++H +V N+LL E ++G G F +L D G P T V
Sbjct: 118 LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGI-PITVLSRQECVER 171
Query: 262 LGYLAPEHTRTGKA-TTSADVFSFGAFLLEV 291
+ ++APE K + +AD +SFG L E+
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 103 LGSGGFGRVYRGTLP--KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL--- 157
+G G +G VY+ K + A+K+I E EI + L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 158 -LGYCRRKGELLLVYDYMPNGSLDKYLY------NQPKVTLNWRQRYGVIKGVALGLLYL 210
L + RK + L++DY + + N+ V L ++ + G+ YL
Sbjct: 67 FLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDP--QTTHVVGTLGY 264
H W V+HRD+K +N+L+ GE R + D G ARL++ P VV T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 265 LAPEHTRTGKATTSA-DVFSFGAFLLEV 291
APE + T A D+++ G E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 103 LGSGGFGRVYRGTLP--KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL--- 157
+G G +G VY+ K + E A+K+I E EI + L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 158 -LGYCRRKGELLLVYDYMPNGSLDKY----LYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
L + RK LL Y + K+ N+ + L ++ + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 213 EWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDP--QTTHVVGTLGYLA 266
W V+HRD+K +N+L+ GE R + D G ARL++ P VV T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 267 PEHTRTGKATTSA-DVFSFGAFLLEV 291
PE + T A D+++ G E+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 9e-08
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 91 YIATKGFREKELLGSGGFGRV---YRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVS 145
+ K ++ + +GSG G V Y L ++ +A+KK+S +++ K E+V
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 146 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA 204
+ + H+N++ LL + L D Y+ +D L ++ L+ + ++ +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
G+ +LH +IHRD+K SN+++ + ++ DFGLAR GT T V T Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEV 291
APE + D++S G + E+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+GSG +G V + + ++AVKK+S +S + E+ + ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 161 ------CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
E+ LV + M L+ + Q K++ Q +I + GL Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEHVQF--LIYQLLRGLKYIHSAG 138
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTG 273
+IHRD+K SNV ++ + R+ DFGLAR D + T V T Y APE
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWM 191
Query: 274 KATTSADVFSFGAFLLEVACGR 295
+ D++S G + E+ G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 25/159 (15%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TLGYLAPEHTRTG 273
IHRD+ A N+LL ++ DFGLAR D D + +VV + ++APE
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR--DIRND--SNYVVKGNARLPVKWMAPESIFNC 291
Query: 274 KATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
T +DV+S+G L E+ + G P + VD F ++++ L
Sbjct: 292 VYTFESDVWSYGILLWEIFSLGSSPYPG-------MPVDSKF-----YKMIKEGYRMLSP 339
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371
E E+ I+K C +DP RP+ +Q+VQ++E+ +
Sbjct: 340 ECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 275
IHRD+ A N+LL ++ DFGLAR D DP L ++APE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 276 TTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNR-GELLEARDPNLGTE 333
TT +DV+SFG L E+ + G P +E +F R E R P E
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---------EFCRRLKEGTRMRAP----E 299
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
Y E+ I+ L C H++P RP+ ++V+IL
Sbjct: 300 YATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
E +G G +G+VY+ + +A+KK +R M E E + LR +L+Q+L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKK----TRLEMDE---EGIPPTALREISLLQMLSE 59
Query: 161 C---------------RRKGELLLVYDYMPNGSLDKYLYNQ--------PKVTLNWRQRY 197
K L LV++Y+ + L K++ + P T+ Y
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK-SFMY 117
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDP--Q 254
++KGVA + H+ V+HRD+K N+L+D + ++ D GL R + + P
Sbjct: 118 QLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKS 167
Query: 255 TTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVA 292
TH + TL Y APE +T D++S G E++
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 40/218 (18%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 154
+R+ + +GSG +G V ++ ++A+KK+ +S K E+ + ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKY----------------LYNQPKVTLNWRQRYG 198
+ LL + P+ SLD++ L K++ + R ++
Sbjct: 77 IGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED-RIQFL 123
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 258
V + + GL Y+H +IHRD+K N+ ++ + ++ DFGLAR TD + T
Sbjct: 124 VYQ-MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGY 175
Query: 259 VGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGR 295
V T Y APE T + D++S G + E+ G+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 103 LGSGGFGRVYRGTL--PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+G+G FG+V + + VK++ ++ S + EF+ + L+H N++Q LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIK-------GVALGLLYLHE 212
C LLV++Y G L YL + W +R + +A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--VVGTLGYLAPE-- 268
+ +H D+ N L +L ++GD+G+ + D T L +LAPE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 269 ---HTR--TGKATTSADVFSFGAFLLEV-ACGRRP 297
H T + T ++V++ G L E+ +P
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 152
K ++ ++G+G FG VY + ++A+KK+ + + + E++ + L H
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHI 119
Query: 153 NLVQLLGY----CRRKGE----LLLVYDYMPNGSLDKYL----YNQPKVTLNWRQRYGVI 200
N++ L Y C +K E L +V +++P ++ KY+ N + L + Y
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY- 177
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVV 259
+ L Y+H ++ + HRD+K N+L+D + +L DFG A+ G ++ +
Sbjct: 178 -QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYI 231
Query: 260 GTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACG 294
+ Y APE TT D++S G + E+ G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 32/85 (37%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTR-----T 272
+HRD+K NVLLD + RL DFG RL GT Q+ VGT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGK 182
Query: 273 GKATTSADVFSFGAFLLEVACGRRP 297
G+ D +S G + E+ G P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 167 LLLVYDYMPNGSLDKYLYN-QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKA 225
L LV DY G L L + ++ + + Y +A +L +H + +HRD+K
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLHYVHRDIKP 130
Query: 226 SNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSA 279
NVLLD + RL DFG ++ GT Q++ VGT Y++PE + GK
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189
Query: 280 DVFSFGAFLLEVACGRRP 297
D +S G + E+ G P
Sbjct: 190 DWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 154
++ +E++G G +G V + ++A+KKI+ E + EI + LRH ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 155 VQ----LLGYCRRK-GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQ--RYGVIKGVALGL 207
V+ +L RR+ ++ +V++ M L + + +T Q Y +++ L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRA----L 116
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT--THVVGTLGYL 265
Y+H V HRD+K N+L + + ++ DFGLAR+ + T T V T Y
Sbjct: 117 KYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 266 APEHTRT--GKATTSADVFSFGAFLLEVACGR 295
APE + K T + D++S G EV G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 76/312 (24%), Positives = 136/312 (43%), Gaps = 56/312 (17%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-----FVAEIVSIGRLRHRNLVQL 157
+G+G FG V+ +++ K IS+ +G+KE V E+ + L+H+N+V+
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISY---RGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 158 LGYCRRKG--ELLLVYDYMPNGSLDKYLYNQPKV--TLNWRQRYGVIKGVALGLLYLHEE 213
+ K +L ++ ++ G L + + K+ + + + + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 214 WE----QVVIHRDVKASNVLLD-------------GELNGR----LGDFGLARLYDHGTD 252
+ + V+HRD+K N+ L LNGR +GDFGL++ + G +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIE 195
Query: 253 PQTTHVVGTLGYLAPEHT--RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
VGT Y +PE T +D+++ G + E+ G+ P + LI
Sbjct: 196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI-- 253
Query: 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVV--QILE 368
EL R P+L + ++EL +++K L S + RPS Q + QI+
Sbjct: 254 ---------SEL--KRGPDLPIKGKSKELNILIKNLLNLSAKE---RPSALQCLGYQII- 298
Query: 369 RDVALPAISALG 380
++V P +A G
Sbjct: 299 KNVGPPVGAAGG 310
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 62/216 (28%), Positives = 85/216 (39%), Gaps = 40/216 (18%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIVSI 146
+A GF L G G V+ + P + VK HE+R +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARL-----------L 214
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------NQPKVTLNWRQRYG 198
RL H ++ LL G LV +P D Y Y +VT RQ
Sbjct: 215 RRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLS 271
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH- 257
I Y+H E +IHRD+K NVL++G + LGDFG A + G+ H
Sbjct: 272 AID-------YIHGEG---IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHY 320
Query: 258 -VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA 292
+ GT+ APE T S D++S G + E A
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 10/175 (5%)
Query: 133 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLN 192
R G E + + H +++QL G L+ +P D Y Y K +
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIA 180
Query: 193 WRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252
+ + V + YLHE +IHRD+KA N+ ++ + LGDFG A
Sbjct: 181 ICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237
Query: 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI-ERQGPEEN 306
+ GT+ APE + D++S G L E+A + E+ G + +
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLY 209
H +L + G C R E ++V +++ +G LD L + +V + W + V + +A L Y
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSY 132
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG---TDPQTTHVVGTLGYLA 266
L ++ ++H +V A N+LL L G +L D G T V + ++A
Sbjct: 133 LE---DKNLVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIA 188
Query: 267 PEHTRTGKA-TTSADVFSFGAFLLEVAC--GRRPIERQGPEENLILVDWVFDFWNRGELL 323
PE G + +T+AD +SFG LLE+ C G P++ + P E F+ + L
Sbjct: 189 PECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTPSEKE-------RFYEKKHRL 240
Query: 324 -EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
E L T LI + C +PT RPS R +++ L
Sbjct: 241 PEPSCKELAT--------LISQ----CLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG 159
+G G F V + K+ A+K + +S + + EI ++ RL H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 160 --YCRRKGELLLV--------YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+ R+ G L LV Y+ + K + +V Y ++K L +
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKRVK---SYMYQLLKS----LDH 115
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPE 268
+H + HRD+K N+L+ ++ +L DFG R +Y P T + T Y APE
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168
Query: 269 HTRT-GKATTSADVFSFGAFLLEV 291
T G D+++ G E+
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 47/154 (30%), Positives = 68/154 (44%), Gaps = 23/154 (14%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 275
IHRD+ A N+LL ++ DFGLAR D DP L ++APE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 276 TTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNR-GELLEARDPNLGTE 333
T +DV+SFG L E+ + G P +E +F R E R P +
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFCRRLKEGTRMRAP----D 305
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
Y E + + L C H +P+ RP+ ++V+ L
Sbjct: 306 YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+GSG +G V ++ ++A+KK+S +S K E+ + ++H N++ LL
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 160 Y------CRRKGELLLVYDYMPNGSLDKYL---YNQPKVTLNWRQRYGVIKGVALGLLYL 210
+ LV YM L K + ++ KV ++ + GL Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-------LVYQMLCGLKYI 133
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
H +IHRD+K N+ ++ + ++ DFGLAR D + T V T Y APE
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVI 186
Query: 271 RTG-KATTSADVFSFGAFLLEVACGR 295
+ D++S G + E+ G+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 103 LGSGGFGRVYRGTL-----PKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 155
LGSG FGRV T +S +++AVK + +R K+ ++E+ + L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLY 184
LLG C + G + ++ +Y G L YL+
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 59/252 (23%), Positives = 93/252 (36%), Gaps = 54/252 (21%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-- 154
F +++G G FG V R K I KI ++ KE VA I + R++
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA-----ERDILV 56
Query: 155 -------VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
V++ + K L L+ +++P G + L + ++ Q Y I L +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY--IAETVLAI 114
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL------------------------ 243
+H+ IHRD+K N+LLD + + +L DFGL
Sbjct: 115 DAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 244 ----------ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC 293
A + VGT Y+APE D +S G + E+
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 294 GRRPIERQGPEE 305
G P + P+E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 102 LLGSGGFGRVYRGT---LPKSK--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNL 154
+LGSG FG+V GT L +S+ +++AVK + +R K+ ++E+ + L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY 184
V LLG C + G + ++ +Y G L YL+
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 44/247 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVS----IGRLRHR 152
F +++G G FG V R K + KI ++ KE V I + +
Sbjct: 3 FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+V++ + K L L+ +++P G + L + +T Q Y I L + +H+
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--IAETVLAIDSIHQ 119
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLA------------RLYDHGTDPQTT---- 256
IHRD+K N+LLD + + +L DFGL R +H T
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 257 ------------------HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
VGT Y+APE D +S G + E+ G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 299 ERQGPEE 305
+ P+E
Sbjct: 237 CSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 34/228 (14%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG 159
E +G G +G+V++ L K A KI +E AE + L H N+V+ G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 160 YCRRKG-----ELLLVYDYMPNGSLDKYL---------YNQPKVTLNWRQRYGVIKGVAL 205
+K +L LV + GS+ + +P + ++ +
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-------ILHEALM 135
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGY 264
GL +LH IHRDVK +N+LL E +L DFG+ A+L T+ VGT +
Sbjct: 136 GLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 265 LAPEHTRTGKATTSA-----DVFSFGAFLLEVACGRRPIERQGPEENL 307
+APE + S DV+S G +E+ G P+ P L
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 49/193 (25%), Positives = 74/193 (38%), Gaps = 50/193 (25%)
Query: 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDV 223
K L V DY+P G + L + + Y I + + +H+ IHRD+
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--IAELTCAIESVHK---MGFIHRDI 127
Query: 224 KASNVLLDGELNGRLGDFGL---------ARLYDHGTDPQ-------------------- 254
K N+L+D + + +L DFGL ++ Y G +
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 255 ------------TTH-VVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
H +VGT Y+APE RTG T D +S G L E+ G+ P
Sbjct: 188 LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLA 246
Query: 301 QGP-EENLILVDW 312
P E L +++W
Sbjct: 247 DTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTRT----- 272
+HRD+K N+L+D + RL DFG +L + GT Q++ VGT Y++PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGK 182
Query: 273 GKATTSADVFSFGAFLLEVACGRRP 297
GK D +S G + E+ G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 69/274 (25%), Positives = 102/274 (37%), Gaps = 71/274 (25%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 153
F + + LG G FG V +K A+K + + R + AE + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE- 212
+V+L + K L V DY+P G + L R G+ L Y+ E
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----------RMGIFPE-DLARFYIAEL 110
Query: 213 --EWEQV----VIHRDVKASNVLLDGELNGRLGDFGL---------ARLYDHGT------ 251
E V IHRD+K N+L+D + + +L DFGL ++ Y G
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 252 --------DPQTTH-----------------------VVGTLGYLAPE-HTRTGKATTSA 279
DP +VGT Y+APE RTG T
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 229
Query: 280 DVFSFGAFLLEVACGRRPIERQGP-EENLILVDW 312
D +S G L E+ G+ P Q P E + +++W
Sbjct: 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 153
F +L+ +G +G VY +++ A+KKI+ ++ R +++ E + +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V + K L +V +Y+ G L N + ++ + Y L L YLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY--FAETVLALEYLHNY 120
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR---------LYDHGTDPQT-----THVV 259
++HRD+K N+L+ + +L DFGL++ LY+ + T V
Sbjct: 121 G---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
GT Y+APE D ++ G L E G P PEE
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 61/243 (25%), Positives = 87/243 (35%), Gaps = 60/243 (24%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISH---ESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
L+G GG G VY P +A+KKI E+ K F+ E L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 159 GYCRRKGELLLVYDYMP----------------NGSLDKYLYNQPKVTLNWRQRYGVIKG 202
C VY MP SL K L + V + +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG-----DFGLAR------------ 245
+ Y+H + V+HRD+K N+LL G G D+G A
Sbjct: 126 IE----YVHS---KGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 246 -------LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
Y T P +VGT Y+APE A+ S D+++ G L ++ P
Sbjct: 174 DVDERNICYSSMTIP--GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 299 ERQ 301
R+
Sbjct: 232 RRK 234
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 16/148 (10%)
Query: 106 GGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFV-AEIVSIGRLRHRNLVQLLGYCR 162
G FG+VY G + AVK K + + M V AE ++ + +V L +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 163 RKGELLLVYDYMPNGSLDKYL----YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
+ LV +Y+ G + L Y ++ + + I VAL L YLH +
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALALDYLHR---HGI 125
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARL 246
IHRD+K N+L+ E + +L DFGL+++
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT-HVVGTLGYLAPEHTRTGKATT 277
+HRD+ A NVLL ++ DFGLAR H ++ + + ++APE TT
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 278 SADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNR-GELLEARDPNLGTEYV 335
+DV+S+G L E+ + G P ++VD F+N+ P+ T+
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPG-------MIVD--STFYNKIKSGYRMAKPDHATQ-- 367
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
E ++++K C +S+P RPS + I+E
Sbjct: 368 -EVYDIMVK----CWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 15/197 (7%)
Query: 113 RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172
R T + + + + + + + + +K E+V RH N++ L ++
Sbjct: 20 RHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79
Query: 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232
+M GS + L ++ ++ G GL YLH+ IHR++KAS++L+ G
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136
Query: 233 ELNGRLGDFGLARLYDHGTDPQTTHVV--------GTLGYLAPEHTRTGKA--TTSADVF 282
+ G + GL+ LY + Q VV L +L+PE R +D++
Sbjct: 137 D--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194
Query: 283 SFGAFLLEVACGRRPIE 299
S G E+A GR P +
Sbjct: 195 SVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
G+ +LH +IHRD+K SN+++ + ++ DFGLAR GT T V T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGR 295
APE + D++S G + E+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 19/126 (15%)
Query: 180 DKYLYNQPKVT-----------LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNV 228
D+YL + P+ T L++ G VA G+ +L + +HRD+ A NV
Sbjct: 214 DQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270
Query: 229 LL-DGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFG 285
L+ +G+L ++ DFGLAR + D + + + L ++APE TT +DV+SFG
Sbjct: 271 LICEGKLV-KICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFG 328
Query: 286 AFLLEV 291
L E+
Sbjct: 329 ILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 9/143 (6%)
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N+V L Y + + LV + G L ++ + +R+ VAL L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH--- 102
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
+ ++ RD+ +N+LLD + +L F + D + + Y APE
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGI 156
Query: 273 GKATTSADVFSFGAFLLEVACGR 295
+ T + D +S GA L E+ G+
Sbjct: 157 SEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 61/266 (22%), Positives = 99/266 (37%), Gaps = 55/266 (20%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F + + LG G FG V + A+K + + +R + AE + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V+L + K L V DY+P G + L + Y I + L + +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--IAELTLAIESVHK- 119
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGL---------ARLYDHGT-------DPQ--- 254
IHRD+K N+L+D + + +L DFGL ++ Y G+ +P
Sbjct: 120 --MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 255 ---------------------------TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAF 287
+VGT Y+APE T D +S G
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 288 LLEVACGRRPIERQGP-EENLILVDW 312
L E+ G+ P P E L +++W
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 24/164 (14%)
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
+ N ++L +L+ DY+ +G L L + K L+ + +I+ + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDL 125
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLAR------LYDHGTDPQTTHVVGTLG 263
H+ +IH D+K NVL D + L D+GL + YD GTL
Sbjct: 126 HK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-----------GTLD 171
Query: 264 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307
Y +PE + S D ++ G E+ G+ P + +E L
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE-DEDEEL 214
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 103 LGSGGFGRVYRGT---LPK--SKIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 155
LG+G FG+V T L K + + +AVK + + +E ++E+ + L +H+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLN 192
LLG C G +L++ +Y G L +L + + LN
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.93 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.35 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.68 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.54 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.46 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.39 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.32 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.23 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.54 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.51 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.29 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.14 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-58 Score=440.46 Aligned_cols=289 Identities=46% Similarity=0.798 Sum_probs=254.7
Q ss_pred CCCccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeee
Q 036051 81 GPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160 (420)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 160 (420)
....|+++++..+|++|...+.||+|+||.||+|...++ ..||||++.........+|.+|+.++.+++|||+++++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 456799999999999999999999999999999999654 6799998876543214669999999999999999999999
Q ss_pred eeeCC-eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 161 CRRKG-ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 161 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
|.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 59999999999999999987654378999999999999999999999888899999999999999999999999
Q ss_pred eecCcccccCCCCCccccc-ccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 240 DFGLARLYDHGTDPQTTHV-VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+.+|+...+.
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999654431 1111112 799999999999999999999999999999999999999887665555668999999999
Q ss_pred cCccccccCCCCC-CcccH-HHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 319 RGELLEARDPNLG-TEYVA-EELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 319 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
++.+.+++|+.+. ..+.. +++..+.+++.+|++.+|.+||+|.||++.|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 56554 68899999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=390.70 Aligned_cols=256 Identities=35% Similarity=0.532 Sum_probs=209.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-eEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-ELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 172 (420)
.+...+.||+|+||+||+|.+.+.. .||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. .+++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3344566999999999999996432 39999997653 222568999999999999999999999999987 7999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc-EEecccCCCCEEEcCCC-cEEEeeecCcccccCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV-VIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG 250 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~ 250 (420)
|+++|+|.++++......+++..+++++.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999987544589999999999999999999999 66 99999999999999997 9999999999865432
Q ss_pred CCCcccccccCCccccccccc--CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTR--TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+.. . .. . .+.....+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~--~~---~-----v~~~~~Rp 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-V--AS---A-----VVVGGLRP 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-H--HH---H-----HHhcCCCC
Confidence 2 2333468999999999999 5689999999999999999999999998776522 1 10 0 01122223
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.... .+...+..++.+||+.||..||++.+++..|+...
T Consensus 266 ~~p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 266 PIPK----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 2222 24556788888899999999999999999998543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=388.02 Aligned_cols=256 Identities=33% Similarity=0.496 Sum_probs=218.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.+.+...+.||+|.||+||.|.+.++ ..||+|.+..... ..++|.+|+++|++|+|+|||+++|+|...+.++|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 34445678899999999999999654 4699999976532 236789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
|+.|+|.++|+...+..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+++....+...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999999998666689999999999999999999999 99999999999999999999999999999966655554
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......+..|+|||.+....++.|||||||||+||||+| |+.||......+. .+.++.....
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRl 423 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRL 423 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcC
Confidence 5555566889999999999999999999999999999998 9999987765542 2222333333
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+..++..+.++|..||+.+|++|||+..+...|+..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 44455677799999999999999999999999888753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=366.09 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=210.7
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-eEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-ELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 173 (420)
+++..+.||+|..|+||+++++.++..+|+|++... .....+++.+|++++...+|||||.+||.|..++ ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445678899999999999999999999999999554 4455688999999999999999999999999998 59999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
|++|+|++++...+ .+++...-+|+.+|++||.|||+ ..+|+||||||+|||++..|++||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999998764 58999999999999999999996 388999999999999999999999999999876543
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....+||..|||||-+.+..|+.++||||||+.++|+++|+.||....+.. ....+.+.. +.....|.++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~~------Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLCA------IVDEPPPRLPEG 305 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHHH------HhcCCCCCCCcc
Confidence 4456899999999999999999999999999999999999999997652211 111111111 112223444443
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....++..++..||++||.+|||+.|+++
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23345778888899999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=359.66 Aligned_cols=205 Identities=30% Similarity=0.523 Sum_probs=187.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..+|...+.||.|.|++||+|+++..+..||||.+... .....+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35688888899999999999999999999999999876 5666777899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC------CcEEEeeecCcc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE------LNGRLGDFGLAR 245 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~------~~~kl~Dfg~~~ 245 (420)
|||.||||.++|+..+ .+++.....++.|||.||++||+ ++||||||||+|||++.. -.+||+|||+++
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998876 68999999999999999999999 999999999999999764 458999999999
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
.+... ....+.+|++-|||||++..+.|+.|+|+||.|+++|++++|+.||......+
T Consensus 164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 87743 24556899999999999999999999999999999999999999998776654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=373.43 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=211.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..|...+.||+|||+.||.+++..+|..||+|++.+. .....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999999889999999999764 3334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|+|++++|.++++.+ ..+++.+++.+..||+.||.|||+ .+|+|||||..|+|++++.++||+|||+|.......
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999854 389999999999999999999999 999999999999999999999999999999876532
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
....+.+|||.|+|||++.....+..+||||+||++|-|+.|++||+...-.+.. .. .+..+...+
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety----------~~---Ik~~~Y~~P 238 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY----------NK---IKLNEYSMP 238 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH----------HH---HHhcCcccc
Confidence 3556789999999999999999999999999999999999999999865433211 11 111122222
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .......+|+.++|++||.+|||+.+|+.
T Consensus 239 ~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 S----HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred c----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2 22233556777799999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=388.91 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=222.5
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
..+...+....+.||+|+||+||+|+..+ ..+.||||.++..... ...+|.+|+++++.++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34456667778899999999999998742 3467999999877554 77899999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCC------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQP------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
++.+++|+|||..|||.+||.... ..+|+..+.+.||.|||.|+.||-+ ..+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence 999999999999999999997532 1238899999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeecCcccc-cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchh
Q 036051 232 GELNGRLGDFGLARLY-DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLIL 309 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~ 309 (420)
++..|||+|||+++.. ..+.........-+.+|||||.+..++++.+||||||||+|||+++ |+.||.+...++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 9999999999999843 3333333334456889999999999999999999999999999987 999999887765
Q ss_pred hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
|.+.++.|.+ .+.+..++..+.+||..||+.+|.+||+++||-..|+...
T Consensus 714 ---VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 ---VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ---HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 3334444444 3344566778999999999999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=387.23 Aligned_cols=272 Identities=27% Similarity=0.509 Sum_probs=232.7
Q ss_pred ccchHHHHHHh---------cCCCccceecccCceEEEEEEeCCCc---eeeeeeccccc-chhHHHHHHHHHHHhccCC
Q 036051 84 RFRYKDLYIAT---------KGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLR 150 (420)
Q Consensus 84 ~~~~~~~~~~~---------~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~ 150 (420)
.++|+|..-+- ....+.++||.|.||+|++|+++..+ ..||||.++.. ......+|+.|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 36677654433 44567789999999999999997544 56999999876 4556789999999999999
Q ss_pred cceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 151 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
||||+++.|+.......++|.|||+||+|+.||+.+.. .+++.++..++++||.|+.||.+ .++|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 99999999999999999999999999999999998865 59999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCccccccc--CCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 231 DGELNGRLGDFGLARLYDHGTDPQTTHVVG--TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
+.+..+|++|||+++...++.....+..-| +.+|.|||.+...+++.+|||||||+++||.++ |.+||-...+.+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-- 842 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 842 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--
Confidence 999999999999999876654333222222 579999999999999999999999999999655 999997766543
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCCc
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPA 375 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 375 (420)
+++.++..+..+.+.+++..|.+||+.||++|-.+||++.+|+..|++++..|.
T Consensus 843 --------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 --------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 344455555555667888899999999999999999999999999999987665
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=348.16 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=211.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeee-eeeeCCe-EEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLG-YCRRKGE-LLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 170 (420)
.+|++.+.||+|.||+||++....++..||.|.+... +....+++..|+.+|++|+||||+++++ .+.++++ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3567788999999999999999999999999998754 4555678999999999999999999998 4555544 9999
Q ss_pred EeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 171 YDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||||..|+|...++. .++..+++..+|+++.|++.||.++|+.... -+.||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999974 3455799999999999999999999984422 3889999999999999999999999999988
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+.+-.+ +...+.+++ .
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd-----~ 245 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGD-----Y 245 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCC-----C
Confidence 6543 23455799999999999999999999999999999999999999998763211 112222221 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
+.++. ......+.+++..|+..||+.||+.-.++..+...
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 11221 23455677778889999999999976666666553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=356.25 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=207.0
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
..+.|.+.+.||+|+||.|-+|..+.+++.||||+++... ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999999999999999997641 112234579999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC---CcEEEeeec
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE---LNGRLGDFG 242 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfg 242 (420)
..|||+||++||+|.+++-.+. .+.+..-..++.|++.|+.|||+ +||+||||||+|||++.+ -.+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999997765 56777778899999999999999 999999999999999766 679999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCC---CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
+|+.... .....+.+||+.|.|||++.++.. ..+.|+||+||+||-+++|..||......... .+.+..
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQILK 396 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHHHhc
Confidence 9998653 335667899999999999976543 34789999999999999999999865543211 111111
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
|.. ........+..++..+++.+||..||++|||+.|+++
T Consensus 397 G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 1111223345667889999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=347.70 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=203.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..++|++.++||+|+||+||.++.+++++.+|+|++++. .....+...+|..+|.+++||+|++++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 457899999999999999999999999999999999865 33446778899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+||+.||.|..+|.+++ .+++..+.-++..|+.||.|||+ ++|+||||||+|||+|.+|+++|+|||+++..-.
T Consensus 103 Vld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999998776 68889899999999999999999 9999999999999999999999999999985433
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. .......+||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..... . .+..+. .+.
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~-~I~~~k-----~~~ 244 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------D-KILKGK-----LPL 244 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------H-HHhcCc-----CCC
Confidence 2 22445589999999999999999999999999999999999999999876643311 1 111111 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARP 358 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 358 (420)
.+.-.+ ....+++.+.++.||++|.
T Consensus 245 ~p~~ls----~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLS----EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCC----HHHHHHHHHHhccCHHHhc
Confidence 111122 2355666678899999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=334.87 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=211.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+.|+....+|+|+||.||+++++++|+.||||++... +..-.+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577788999999999999999999999999999654 23334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++..-|.++ ...+. .++...+.+++.|++.|+.|+|+ ++++||||||+|||++.++.+||||||+|+.+.. ..
T Consensus 82 ~~dhTvL~eL-e~~p~-G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHEL-ERYPN-GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHH-HhccC-CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9987666554 33333 57889999999999999999999 9999999999999999999999999999998764 23
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh---------hcccCcc
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD---------FWNRGEL 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 322 (420)
..-+..+.|.+|.|||.+.+ ..|....||||.||++.||++|.+.|.+.+.-+++..+..... +..+...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 34566889999999999877 6899999999999999999999999988776655443321111 1111111
Q ss_pred cccc-----CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEAR-----DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. ++.....-.+.....++++++.|++.||++|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111 111111222334457889999999999999999888764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.42 Aligned_cols=266 Identities=27% Similarity=0.465 Sum_probs=216.1
Q ss_pred hHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC
Q 036051 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK 164 (420)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (420)
.++-.+..+++.+.+.||+|.||+||+|.|-+ .||||++... ..+..+.|++|+..+++-+|.||+-+.|+|...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34455666777888999999999999999965 3999999765 455678999999999999999999999999998
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
+. .+|+.+|+|.+|+.+|+... ..++..+.+.|+.|||.|+.|||. ++|||||||+.|||+.+++.|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence 87 99999999999999998765 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCC-CCCcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC
Q 036051 245 RLYDHG-TDPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 245 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
.....- ...+.....|...|||||++.. .+|++.+||||||+|+|||++|..||.....+..+. .+.+|
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------Eeccc
Confidence 753321 1223334557788999999853 468999999999999999999999998444332111 11122
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.++ +.+ .....++.+.+.+|+..||.+++++||.+.+|+..|+..+.
T Consensus 609 ~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 111 12234556678888888999999999999999999987765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=347.43 Aligned_cols=272 Identities=28% Similarity=0.415 Sum_probs=209.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhc--cCCcceEeeeeeeeeeCC----eE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG--RLRHRNLVQLLGYCRRKG----EL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~ 167 (420)
-...+..++||+|+||.||+|++. ++.||||++..... +.|.+|-++.+ .|+|+||+++++.-.... ++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 345566788999999999999995 46899999976654 44566655544 578999999999877665 89
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc------cCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW------EQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
+||++|.++|+|.++|..+ .++|....+|+..+++||+|||+.. +++|+|||||++||||..|+++.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999999877 7999999999999999999999854 678999999999999999999999999
Q ss_pred cCcccccCCCCC-cccccccCCcccccccccCCC------CCccchhhhhHHHHHHHhcCCccCC-CCCCcccchhhhh-
Q 036051 242 GLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACGRRPIE-RQGPEENLILVDW- 312 (420)
Q Consensus 242 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~el~tg~~p~~-~~~~~~~~~~~~~- 312 (420)
|++..+...... .....+||.+|||||++.+.- .-.+.||||+|.|||||+++-.-+. +..++-++....-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988755433 334479999999999997642 2236899999999999998765443 2222111111101
Q ss_pred ----hhhhcccCccccccCCCCCCcccH-HHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 313 ----VFDFWNRGELLEARDPNLGTEYVA-EELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 313 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
-.+.+.+-.+.+..+|.++..+.. ..+..+.+.+..||+.||+.|.|+.=+-+++.+..-+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111222233455666766655432 3477889999999999999999999888888776533
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.93 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=206.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--eEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 172 (420)
.++...+.||+|.||+||++.+.+++...|||.....+....+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 44666788999999999999998888899999887664444677899999999999999999999855444 6999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCcccccC--
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDH-- 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~-- 249 (420)
|+++|+|.+++.+.+. .+++..+..++.||++||+|||+ ++++||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998876 79999999999999999999998 99999999999999999 79999999999987653
Q ss_pred CCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCC-CCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQ-GPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
..........||+.|||||++.++ ....++|||||||++.||+||+.||... .. .+++....... ..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEALLLIGRED-----SL 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHHHHHhccC-----CC
Confidence 222234457899999999999853 3345999999999999999999999763 11 11111111111 11
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
| .++........+++.+|++.||++|||+.++++..--
T Consensus 242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2 2222334456677778999999999999999986543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=338.82 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=213.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.+.|++.+.||.|..++||+|+....+..||||++..+ .....+.+.+|+..+..++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 56789999999999999999999888899999999865 34446889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
||.+|++.++++..-...+++..+..|++++++||.|||. +|.||||||+.|||++.+|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999987766679999999999999999999999 9999999999999999999999999998875543322
Q ss_pred C---cccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 253 P---QTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 253 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. .....+||++|||||++.. ..|+.|+||||||++..||.+|..||....+.+.+..- +.+ ......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t------Lqn-~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT------LQN-DPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH------hcC-CCCCccc
Confidence 2 1145689999999999643 46999999999999999999999999988775432110 000 0000000
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..++.+........+.+++..||+.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 01111111122346788888899999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=348.58 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=215.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh-HHHHHHHHHHHhccCC-cceEeeeeeeeeeCC-eEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG-ELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l 169 (420)
..++|...+.||.|.||.||+|+....+..||||+++..-.. ....=++|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788889999999999999999999999999998765222 2223467999999998 999999999998887 9999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||| ..+|+++++.+ +..+++..+..|+.||+.||+|+|. +|++|||+||+|||+..+..+||+|||+|+....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 99999 66999999988 5589999999999999999999998 9999999999999999999999999999997654
Q ss_pred CCCCcccccccCCcccccccc-cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc------
Q 036051 250 GTDPQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL------ 322 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 322 (420)
...-+..+.|..|.|||++ ....|+.+.|+||+|||++|+.+-++.|.+.++.+++..+.-+.+......+
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3345678899999999987 5678999999999999999999999999887776654433222221111111
Q ss_pred ---ccccCCCCC----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 323 ---LEARDPNLG----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 323 ---~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
+...-|... ....+.......+++.+|++.||.+|||+.|+++.-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111 111223456688899999999999999999999743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=346.22 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=209.0
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (420)
...+|..++.||.|.|++|++|+.+.++..+|||++.+.- ....+-...|-..|.+| .||.|++++..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467778899999999999999999999999999997651 12234466788888888 8999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+++|+|.++|+..+ .+++.....++.+|+.||+|||+ .|||||||||+|||||+|+++||+|||.|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999998876 68999999999999999999999 999999999999999999999999999999775
Q ss_pred CCCCC------------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 249 HGTDP------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 249 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
..... .....+||..|.+||++.....++.+|+|+|||+||+|+.|++||...++.-.. +
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-------q- 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-------Q- 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-------H-
Confidence 43211 124589999999999999999999999999999999999999999876543211 0
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.+ ..++..+...++ ....+|+.+.|..||.+|+|..+|-+.
T Consensus 298 ----kI-~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 ----KI-QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HH-HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 01 112223333333 456677777889999999999888764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.42 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCceEEEEEEeC-----CCceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC-
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK- 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~- 164 (420)
+.++|++.+.||+|+||.||+|.+. ..+..||||++.... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4568899999999999999999752 234579999987542 33446789999999999 899999999988764
Q ss_pred CeEEEEEeecCCCChhhhhccCC---------------------------------------------------------
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------------------------------------------------- 187 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 187 (420)
+..+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999986431
Q ss_pred ---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-CcccccccCCc
Q 036051 188 ---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLG 263 (420)
Q Consensus 188 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~ 263 (420)
...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1247788999999999999999999 9999999999999999999999999999975432221 11222345678
Q ss_pred ccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHH
Q 036051 264 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELI 342 (420)
Q Consensus 264 y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 342 (420)
|+|||++.+..++.++|||||||++|||++ |..||......+. +......+.. .... ......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~~~----~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MRAP----ENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CCCC----CCCCHHH
Confidence 999999998899999999999999999997 9999976443221 1111111111 1111 1223457
Q ss_pred HHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 343 LKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 343 ~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.+++.+||+.||.+|||+.|+++.|+...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 88999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=348.53 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=214.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
...|...+.||+|+.|.||.|.....++.||||++........+-+++|+.+|+..+|+|||++++.|...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45677788999999999999999999999999999877666667789999999999999999999999888999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
|++|+|.+.+... .+++.++..|+.+++.||+|||. ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred cCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999998765 58999999999999999999999 9999999999999999999999999999987765433
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....+||+.|||||++....|.+|.||||||++++||+-|++||-...+-..+.+. -....|.+ .
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------------a~ng~P~l--k 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ATNGTPKL--K 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------------hhcCCCCc--C
Confidence 455678999999999999999999999999999999999999999876554322111 11111222 1
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.|+.+||++.|+|+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12233445778888899999999999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=374.50 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=214.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc-----eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK-----IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
..+....+.||+|.||.||.|...+.. ..||||.+... +.+...+|++|..+|+.++||||++++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 555667789999999999999985433 34999999776 456678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccC-----CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 168 LLVYDYMPNGSLDKYLYNQ-----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
++++|||++|||..+|++. +...++..+.+.++.|||+|+.||++ +++|||||.++|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999865 13478999999999999999999999 999999999999999999999999999
Q ss_pred Ccccc-cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccC
Q 036051 243 LARLY-DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 243 ~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
+|+.. ............-+.+|||||.+..+.++.|+|||||||++||++| |..||....+.+.+ ..+.++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------LDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------HHHHhC
Confidence 99943 3322222222345679999999999999999999999999999998 88999877665422 111111
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
. ..+.+..+.+.+.++|..||+.+|++||++..+++.+....
T Consensus 921 g---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 921 G---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred C---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1 12233456677889999999999999999999999887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=339.52 Aligned_cols=267 Identities=28% Similarity=0.382 Sum_probs=212.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (420)
.+.|+.+++||+|.||.||+|++..++..||+|++..+. ........+||.+|++|+||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456777899999999999999999999999999998764 33345567899999999999999999987765 78999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+|||++ ||.-++... ...+++.++..++.|++.||+|+|+ .++.|||||.+|||||.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999965 898888654 4579999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh-----hhcccCccc
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF-----DFWNRGELL 323 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 323 (420)
......+..+-|..|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+..+-+++..+-.+- ..|....+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 766667778889999999998764 69999999999999999999999998887665543221111 111111111
Q ss_pred --cccCCCCC-Ccc----cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 --EARDPNLG-TEY----VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 --~~~~~~~~-~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.+... ... ........++|+..+|..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111110 000 1111244677888899999999999999886
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=315.16 Aligned_cols=201 Identities=28% Similarity=0.416 Sum_probs=186.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-++|+..+.||.|.||+|.+++.+.++..+|+|++.+.. ..+.+...+|..+|+.+.||+++++++.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356788899999999999999999999999999998763 34456678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||++||.|..+|+..+ .+++..+.-++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||+++....
T Consensus 123 meyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred EeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999998876 68999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
...+.+|||.|+|||++..+.++.++|.|||||++|||+.|.+||....+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 46778999999999999999999999999999999999999999988776
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=332.40 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=206.0
Q ss_pred hcCCCccceecccCceEEEEEEeC---CCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+.... ......|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999874 346689999987653 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 268999999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
..........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+. . .....+. ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~~-----~~ 227 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I----KAVEDGF-----RL 227 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHHCCC-----CC
Confidence 21111122345678999999998999999999999999999775 9999976543321 1 1111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. ........+.+++..||+.+|.+||++.+|++.|++.
T Consensus 228 ~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 P----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 1122345678889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=329.99 Aligned_cols=266 Identities=29% Similarity=0.420 Sum_probs=212.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhc--cCCcceEeeeeeeeeeC----C
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG--RLRHRNLVQLLGYCRRK----G 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~----~ 165 (420)
...++..+.+.||+|+||+||+|.|+++ .||||++...+.. .+.+|.++.. .|+|+||+.+++.-..+ .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCC--ceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4567788899999999999999999654 5999999766543 3455555554 56999999999976544 3
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhc-----ccCcEEecccCCCCEEEcCCCcEEEee
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE-----WEQVVIHRDVKASNVLLDGELNGRLGD 240 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiH~dlk~~NIll~~~~~~kl~D 240 (420)
++|||++|.++|+|+++|... +++....++++..+|.||+|||.+ .++.|.|||||+.|||+.+++.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 799999999999999999875 799999999999999999999974 367899999999999999999999999
Q ss_pred ecCcccccCCCC---CcccccccCCcccccccccCC------CCCccchhhhhHHHHHHHhc----C------CccCCCC
Q 036051 241 FGLARLYDHGTD---PQTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVAC----G------RRPIERQ 301 (420)
Q Consensus 241 fg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~el~t----g------~~p~~~~ 301 (420)
+|+|.......+ ......+||.+|||||++... ..-..+||||||.|+||++. | +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999987765432 244567999999999998543 12346899999999999864 2 3355433
Q ss_pred CCcccchhhhhhhhhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.+ .|-..+.+++-...+..+|..+..+ +.+.+..+.++|+.||..+|.-|-|+--+-+.|.+..
T Consensus 440 Vp------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VP------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CC------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 22 2233444555566777788877665 4556889999999999999999999999999988754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=337.69 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=214.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
...|...+.||+|.||.||+|.+...++.||+|++..+ ......++.+|+.+|.+++++||.++|+.+..+..+|++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34567778999999999999999999999999999866 44456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
||.+|++.+.|+... .+++..+.-|++++..||.|||+ .+.+|||||+.|||+..+|.+|++|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999998764 45788888899999999999999 9999999999999999999999999999987765444
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.. .+.+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+...+.+ +.+...|.+..
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~ 233 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG 233 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc
Confidence 33 678999999999999988999999999999999999999999988777443221 12233344444
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ....+.+++..||+.||+.||++.++++
T Consensus 234 ~----~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 D----FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c----cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3 3344777788899999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=333.07 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=202.9
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++.+++|+|++++++++...+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999998889999999886542 2233467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++|+|..++.......+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988865544468999999999999999999999 999999999999999999999999999997653322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......||..|+|||++.+..++.++|||||||++|||++|+.||........... +...... .. .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~------~~----~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKE------DQ----E 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhc------cc----c
Confidence 22345689999999999999999999999999999999999999986543221100 0000000 00 1
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
.+.......+.+++.+||+.||.+||+ +.++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122345778888999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.30 Aligned_cols=263 Identities=27% Similarity=0.493 Sum_probs=212.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
...|...+.||+|+||.||+|++..++..||||++...... ...|++.+++++||||++++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677888999999999999999888889999988644321 13468889999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|.++++ .++|.++.+|+.|+|.||+|||+.+.++++||||||+||+++.++.+++. ||.......
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999995 37899999999999999999996545899999999999999999888875 665543221
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC-
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT- 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 332 (420)
.....++..|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+|+.............++....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1223678999999999999999999999999999999999999954322 2233455655444444344444554422
Q ss_pred -cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 333 -EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 333 -~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
....++...+.+++.+||+.||++||||.||++.|++...
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3345677789999999999999999999999999987653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.65 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=207.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc----ch-hHHHHHHHHHHHhccCC-cceEeeeeeeeeeCC
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE----SR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 165 (420)
.....|...+.||+|.||+|+.|.+..++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456889999999999999999999888899999977653 11 22355668999999998 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLA 244 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~ 244 (420)
..++||||+.+|+|.+++...+ .+.+..+..++.|++.|++|+|+ .+|+||||||+|||+|.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999998843 68889999999999999999999 999999999999999999 99999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCC-CC-ccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK-AT-TSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||......... ..+..+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------~ki~~~-- 238 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------RKIRKG-- 238 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------HHHhcC--
Confidence 8764 2334566789999999999998877 75 7899999999999999999999874322110 111111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.... ...+..++.+|+..||.+|+|+.+|++
T Consensus 239 ----~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 ----EFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----CccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111111111 345778888899999999999999993
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=331.26 Aligned_cols=246 Identities=17% Similarity=0.288 Sum_probs=198.3
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeEEEEEe
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLVYD 172 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e 172 (420)
...||+|++|.||+|.+ ++..||||++..... ...+.|.+|+.++.+++||||+++++++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 46799999999999998 467899999876532 225678899999999999999999999876 457899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++|+|.+++.... .+++.....++.+++.||.|||+ ..+++||||||+||++++++.+||+|||++......
T Consensus 103 y~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 103 YCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred eCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 999999999997654 68899999999999999999997 247889999999999999999999999998865432
Q ss_pred CcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .. .... ...+..
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~---i~~~-----~~~~~~ 243 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DL---IINK-----NNSLKL 243 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HH---HHhc-----CCCCCC
Confidence 123467899999999976 67899999999999999999999999865432211 10 0000 011111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
+. .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 244 ~~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 PL----DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 2334577888999999999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.05 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=211.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchh--HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.+|...+.||+|.||.||+|++..+++.||||++...... -.....+|++.|+.++|+||+.++++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999999999999999999765322 12456899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|| ..+|+..++.... .++-.++..++.++++||+|+|. +.|.||||||.|+|++.+|.+||+|||+++.+.....
T Consensus 82 fm-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 5699999987654 78889999999999999999999 9999999999999999999999999999998876443
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc---------c
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE---------L 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 322 (420)
.....+-|..|.|||.+.+ ..|+...|+||.|||+.||+.|.+-|.+.+.-+++...=.+........ .
T Consensus 157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3334478999999999876 4699999999999999999999988877765554322111110000000 0
Q ss_pred ccc-cCCC-CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 323 LEA-RDPN-LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 323 ~~~-~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.+. ..|. ......+......++++..++..||.+|+|+.|+++.=
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 000 0111 11113334445568999999999999999999998743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=345.99 Aligned_cols=258 Identities=29% Similarity=0.401 Sum_probs=209.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc---ee-eeeecccc---cchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK---IE-IAVKKISH---ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.++....+.||+|+||.||+|++...+ .. ||||.... .......+|++|+++|++++||||++++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 344555689999999999999986432 23 89998874 356778899999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+++|||+|.||+|.++|+..+. .++..++..++.+.|.||+|||+ ++++||||.++|+|++.++.+||+|||+++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999998765 69999999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
-... ........-+.+|+|||.+....++.++|||||||++||+++ |..||.+....+. ..++
T Consensus 312 ~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI------------ 375 (474)
T KOG0194|consen 312 GSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKI------------ 375 (474)
T ss_pred Ccce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHH------------
Confidence 4311 111111235689999999999999999999999999999988 8889987664421 1111
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.........+...+..+..++..||..+|++||||.++.+.++...
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 0111111222244555677777899999999999999999998654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=336.91 Aligned_cols=242 Identities=23% Similarity=0.283 Sum_probs=198.1
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
+.||+|+||.||++++..++..||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999888999999998754 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 9999987654 68999999999999999999999 99999999999999999999999999998753221 122334
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ....+ .......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~----~~~~~------~~~~p~~---- 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E----LILME------EIRFPRT---- 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---H----HHHcC------CCCCCCC----
Confidence 57999999999999999999999999999999999999999754322111 0 00000 1111122
Q ss_pred HHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234577888899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=336.88 Aligned_cols=267 Identities=28% Similarity=0.460 Sum_probs=215.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.+.+...+.+.||+|.||+|.++... ++..||||.++... .....+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 45566777899999999999999985 46789999998774 44458999999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc-cC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY-DH 249 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~-~~ 249 (420)
+|||++|+|..++..+....+.-....+|+.|||.|++||.+ .+++||||.++|+|+++++++||+|||+++-+ ..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999988755455667778899999999999999 99999999999999999999999999999843 33
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHh--cCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA--CGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
+........+-+.+|||+|.+..++++.+||||+||+++||++ +...||+....+.. ++-...+.+.+.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~------ 761 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG------ 761 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC------
Confidence 3333344556789999999999999999999999999999974 58899976654431 111111111111
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+......+.-+...+.+++..||..|..+||+++++...|+...
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11111123345566889999999999999999999999997643
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=325.96 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=208.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|...+.||+|++|.||+|.+.+.+..|++|.+.... ....++.+|++.+.+++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999998888899999986543 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999976555578999999999999999999998 899999999999999999999999999998654432222
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ......+ ..+....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~-----~~~~~~~- 228 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKG-----YRMERPE- 228 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC-----CCCCCCC-
Confidence 222334678999999988899999999999999999998 9999875443221 1111110 1111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.....+.+++.+||+.||++|||+.++++.|+..
T Consensus 229 ---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 ---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2234578889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=328.78 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=205.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||.||+|++..++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688899999999999999999988999999998654 22334668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++++.+..+.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99887776554332 268899999999999999999998 9999999999999999999999999999987644333
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh---------hhhhcccCccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW---------VFDFWNRGELL 323 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 323 (420)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....... ...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 333445789999999999888899999999999999999999999976543322111110 00011111111
Q ss_pred cccCCCCCCc------ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTE------YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+..... +.......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111000 11112346889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=332.07 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=208.1
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
....++|+.+.+||+|+||.||+|+-+++|..+|+|++.+. .....+..+.|-.+|...++|+||+++-.|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678899999999999999999999999999999999876 345567788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||||||++||++..+|.+.+ .|++..+..++.+++.|++-||+ .|+|||||||+|+|||..|++||+|||++.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999998766 79999999999999999999999 99999999999999999999999999998532
Q ss_pred cC---------------C-------CCC-----c-------------------ccccccCCcccccccccCCCCCccchh
Q 036051 248 DH---------------G-------TDP-----Q-------------------TTHVVGTLGYLAPEHTRTGKATTSADV 281 (420)
Q Consensus 248 ~~---------------~-------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv 281 (420)
.. . ... . ....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0 000 0 012589999999999999999999999
Q ss_pred hhhHHHHHHHhcCCccCCCCCCcccc-hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-
Q 036051 282 FSFGAFLLEVACGRRPIERQGPEENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS- 359 (420)
Q Consensus 282 ~slGvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt- 359 (420)
||||||+|||+.|.+||....+.+.. .+..|-.... .|.- .. ......+||.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP~~-~~----~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FPEE-VD----LSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CCCc-Cc----ccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999988876532 2223321111 1110 11 11446677777887 9999986
Q ss_pred --HHHHH
Q 036051 360 --MRQVV 364 (420)
Q Consensus 360 --~~evl 364 (420)
+.||-
T Consensus 437 ~G~~EIK 443 (550)
T KOG0605|consen 437 KGAEEIK 443 (550)
T ss_pred ccHHHHh
Confidence 44543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=340.99 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=210.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|.+.+.||+|.||+||||+.+.+.+.||+|.+.+. .....+.+.+|+++++.++||||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5688889999999999999999999999999999765 44456779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+.| +|..+|...+ .++++++..|+.+++.||.|||+ .+|.|||+||+|||+++++.+|+||||+++.+... .
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 9965 9999998765 79999999999999999999999 99999999999999999999999999999987653 3
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
...+...|||-|||||.+.++.|+..+|.||+||++||+++|++||....... .+..... |+ .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------Lv~~I~~--------d~---v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------LVKSILK--------DP---V 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------HHHHHhc--------CC---C
Confidence 34566789999999999999999999999999999999999999997543211 1111111 11 1
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.++.+....+..++...+.+||.+|.|-.+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122244455777777889999999999988875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=342.18 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=204.5
Q ss_pred HhcCCCccceecccCceEEEEEEe-----CCCceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
..++|+..+.||+|+||.||+|++ .+++..||||++.... ....+.+.+|+.++..+ +||||++++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 355788899999999999999974 3456679999986542 33346788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCC----------------------------------------------------------
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP---------------------------------------------------------- 187 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (420)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986421
Q ss_pred ---------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 188 ---------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 188 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
...+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 1247888999999999999999999 9999999999999999999999999999986543221
Q ss_pred C-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 253 P-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 253 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... ....+. .+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~-----~~~~ 338 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGY-----RMLS 338 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCc-----cCCC
Confidence 1 1112334678999999999999999999999999999998 8889875433221 111 111111 0001
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. . .....+.+++.+||+.||++|||+.||++.|++.
T Consensus 339 ~-~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 P-E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C-C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 1 1124577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=327.58 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=207.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCc-----eeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSK-----IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
++|+..+.||+|+||.||+|.+...+ ..|++|.+.... ......|.+|+..+.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46788899999999999999875544 679999886543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC--------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 169 LVYDYMPNGSLDKYLYNQPK--------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999865421 357889999999999999999999 8999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhh
Q 036051 235 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDW 312 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 312 (420)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~----- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence 999999999875433221 12233456788999999988889999999999999999998 99999765543211
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
..+..+.. ..........+.+++.+||+.||.+||++.||++.|++
T Consensus 237 --~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 11122334668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=330.28 Aligned_cols=250 Identities=35% Similarity=0.574 Sum_probs=196.0
Q ss_pred ccceecccCceEEEEEEeC----CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 99 EKELLGSGGFGRVYRGTLP----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..+.||.|.||.||+|.+. ..+..|+||.+... .....+.|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999997 44678999999654 344478899999999999999999999999988889999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD- 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 252 (420)
+++|+|.++|.......+++.+++.|+.||+.||.|||+ .+++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999998755579999999999999999999999 8999999999999999999999999999987632211
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
...........|+|||.+.+..++.++||||||+++|||++ |+.||......+ + . ....++... .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~---~-~~~~~~~~~-----~-- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I---I-EKLKQGQRL-----P-- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H---H-HHHHTTEET-----T--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---c-ccccccccc-----e--
Confidence 12233456788999999988889999999999999999999 778886653322 1 1 111111111 1
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
........+.+++..||+.||++|||+.++++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234577889999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=339.63 Aligned_cols=280 Identities=24% Similarity=0.342 Sum_probs=223.9
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCe
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (420)
...-++|...++||+|.||+|+++..+.+++.+|||++++. .+...+..+.|..++... +||.+++++.++...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34567899999999999999999999999999999999876 344556777888887776 59999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+|+||||+.||++..+.+.. .+++..+.-++..|+.||.|||+ ++||+||||.+|||||.+|.+||+|||+++.
T Consensus 444 l~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999955554433 69999999999999999999999 9999999999999999999999999999985
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
--. ......+.+||+.|||||++.+..|+...|+|||||+||||+.|+.||.++++++.... ....
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-------------I~~d 583 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-------------IVND 583 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------------HhcC
Confidence 332 22356778999999999999999999999999999999999999999998877653211 1112
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCH----HHHH------------HHHhcCCCCCcccccCCCcccccccC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSM----RQVV------------QILERDVALPAISALGLSARGITYQE 390 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl------------~~L~~~~~~~~~~~~~~~~~~~~~~~ 390 (420)
++..+.. ...+.+.++.+++..+|++|..+ .+.+ +.+.+.+.+|..|......+....++
T Consensus 584 ~~~yP~~----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~ 659 (694)
T KOG0694|consen 584 EVRYPRF----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDE 659 (694)
T ss_pred CCCCCCc----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccch
Confidence 2333222 33446667777899999999876 3332 24456677777777765555544444
Q ss_pred CCCc
Q 036051 391 GFDD 394 (420)
Q Consensus 391 ~~~~ 394 (420)
.|..
T Consensus 660 eFt~ 663 (694)
T KOG0694|consen 660 EFTS 663 (694)
T ss_pred hhhc
Confidence 4443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=341.78 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=223.4
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
....++...++||.|.||.||.|.|++-...||||.++.+..+ .++|+.|..+|+.++|||+|+++|+|......|||+
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 3344566678999999999999999998889999999766543 589999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|||..|+|.++|+...+..++-...+.++.||+.|++||.. +++|||||.++|+|+.++..+|++|||+++++..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999999998888788888999999999999999998 999999999999999999999999999999987765
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.........++.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+-.. +...+ +..+
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LL---------Ekgy 483 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLL---------EKGY 483 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHH---------hccc
Confidence 554444556789999999999999999999999999999987 889997654222 22222 2233
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..+.+..++..+.+||+.||+.+|.+||++.|+-+.++.+.
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 33344566778999999999999999999999998887663
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=336.50 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=206.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999998888899999987542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997654 68899999999999999999999 9999999999999999999999999999975543
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... ...... ..+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~~~~--~~~~~- 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK------YWKETL--QRPVY- 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH------hccccc--cCCCC-
Confidence 2334578999999999998899999999999999999999999997655433111000 000000 01111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001223457788888999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.68 Aligned_cols=243 Identities=24% Similarity=0.286 Sum_probs=198.5
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
+.||+|+||.||++....++..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999888999999998754 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
+|..++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 9999887654 68899999999999999999999 99999999999999999999999999998753221 112234
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .....+....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~-------~~~~~~p~~~--- 218 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LIL-------MEDIKFPRTL--- 218 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------Hhc-------cCCccCCCCC---
Confidence 578999999999998899999999999999999999999997644322110 000 0111122222
Q ss_pred HHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARP-----SMRQVVQI 366 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 366 (420)
...+.+++.+||+.||.+|| ++.|+++.
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 -SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34467888899999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.70 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=202.9
Q ss_pred hcCCCccceecccCceEEEEEEeCC----------------Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK----------------SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 156 (420)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+... ......+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578889999999999999998632 3446999998764 3344567999999999999999999
Q ss_pred eeeeeeeCCeEEEEEeecCCCChhhhhccCC-----------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEE
Q 036051 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQP-----------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219 (420)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 219 (420)
+++++...+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ .+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999885432 1246888999999999999999999 8999
Q ss_pred ecccCCCCEEEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc--CCc
Q 036051 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRR 296 (420)
Q Consensus 220 H~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t--g~~ 296 (420)
||||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765332211 1223345788999999988889999999999999999986 566
Q ss_pred cCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 297 PIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 297 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
||......+. ...+......... .. .... .......+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~-~~-~~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGR-QV-YLFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhccc-cc-cccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765443221 1111111111100 00 0000 1122345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=324.76 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=211.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+..+|+..+.||.|+||.||+|.+.+ +..+++|.+..........+.+|+.+++.++|||++++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45678889999999999999999977 67899999987766556788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999987655678999999999999999999998 8999999999999999999999999999976543221
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+.. +.+. .+ ..+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~-----~~~--- 223 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT----AG-----YRM--- 223 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH----hC-----CcC---
Confidence 1 223345778999999988889999999999999999998 89999765432211 1111 00 011
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112233557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.96 Aligned_cols=241 Identities=27% Similarity=0.429 Sum_probs=202.3
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
...+-||.|+.|.||+|++. +..||||+++.-. ..+|+-|++|+||||+.|.|+|.....+|||||||+.|
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 34567999999999999995 3469999885332 25788899999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
-|.+.|+... .++-.....+..+||.|+.|||. +.|||||||+-||||..+..|||+|||.++..... .....
T Consensus 198 qL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 198 QLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred cHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 9999998765 67778889999999999999999 99999999999999999999999999999876543 23445
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
+.||..|||||++.+.+.++|.||||||||||||+||..||..-+... . +..+....+....+.+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------I---------IwGVGsNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------I---------IWGVGSNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------e---------EEeccCCcccccCccc
Confidence 789999999999999999999999999999999999999997543321 1 1112223333344556
Q ss_pred HHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 338 ELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+++-+.-|++.||+..|.+||++.+++..|+-
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 66667778888999999999999999998863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=332.03 Aligned_cols=246 Identities=23% Similarity=0.276 Sum_probs=202.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999998888999999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997654 68899999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+. ....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~------~~~~ 218 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAGK------LEFP 218 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC------cCCC
Confidence 22356899999999999888999999999999999999999999765432211 0000110 1111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 366 (420)
... ...+.+++.+||+.||.+||+ +.++++.
T Consensus 219 ~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112 234778889999999999995 7777743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.62 Aligned_cols=202 Identities=28% Similarity=0.388 Sum_probs=178.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|+..+.||+|+||.||++++..++..+|+|.+... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46889999999999999999999988999999998765 33345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997654 58899999999999999999997 246999999999999999999999999998755332
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233568999999999998899999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.78 Aligned_cols=256 Identities=29% Similarity=0.419 Sum_probs=206.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|+..+.||+|++|.||+|.+.. +..||+|.+.... ...+++.+|+.++++++|||++++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35678889999999999999999854 4679999986543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999999976654578999999999999999999998 8999999999999999999999999999987653222
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
........+..|+|||++.+..++.++||||||+++|||++ |+.||......... ...... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~-----~~~--- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQG-----YRM--- 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC-----CCC---
Confidence 21222233468999999988899999999999999999999 99999754432211 011010 000
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.05 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=207.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|++|.||+|.+.+ +..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4678889999999999999999754 45699998865432 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999976655578899999999999999999998 99999999999999999999999999999866443222
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||++.+..++.++||||||+++|||++ |+.||........ ...+. .+ .......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~----~~-----~~~~~~~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQ----RG-----YRMPRME 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHH----cC-----CCCCCCC
Confidence 2223345678999999988889999999999999999998 9999976443221 11111 11 0111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.....+.+++.+||+.+|++||++.++.+.|++
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=306.13 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=213.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-++|++.+.||+|.||.||.|+.++++-.||+|++.+.. .....++.+|+++...|+||||+++++++.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357889999999999999999999999999999997652 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||..+|.|...|..+....+++.....++.|+|.||.|+|. ++++||||||+|+|++.++..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999997777789999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+||..|.+||...+..++...|+|++|++.||++.|.+||+.....+... +-.-.+..+|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk----------rI~k~~~~~p-- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK----------RIRKVDLKFP-- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH----------HHHHccccCC--
Confidence 334566899999999999999999999999999999999999999998766333111 0001111222
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........+++.+|+..+|.+|.+..|++..
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233446778888999999999999998753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.02 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=204.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
...++|++.+.||+|+||.||+|++.. +...||+|++.... ......+.+|+.+++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 345678899999999999999998633 33579999997542 33346788999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC---------------------------------------------------------
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------------------------------------------------- 187 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 187 (420)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred -----------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC-cc
Q 036051 188 -----------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QT 255 (420)
Q Consensus 188 -----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~ 255 (420)
...+++.++++++.||+.||.|||+ .+++||||||+|||+++++.+||+|||++......... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1247888999999999999999999 99999999999999999999999999998755332211 11
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......... ......+ ..+.....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~~-----~~~~~~~~- 339 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKRG-----YQMSRPDF- 339 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHcc-----cCccCCCC-
Confidence 12234678999999988899999999999999999997 99999765432211 0111111 01111111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
....+.+++.+||+.||.+|||+.++++.|++.
T Consensus 340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 124577888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=335.24 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=202.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999999889999999986542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997654 57888999999999999999999 99999999999999999999999999999865432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+. ...+
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~------~~~p 235 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGR------LKFP 235 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCC------cCCC
Confidence 2235789999999999998899999999999999999999999976443211 01111111 1111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
... ...+.+++.+||+.||.+||+ +.++++
T Consensus 236 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112 234678889999999999997 577664
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.49 Aligned_cols=242 Identities=24% Similarity=0.290 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
+.||+|+||.||+++...++..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999888999999998754 2334456788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
+|..++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 9998887654 68999999999999999999999 99999999999999999999999999998753221 112234
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... . ........+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~~~-~------~~~~~p~~~--- 218 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LIL-M------EEIRFPRTL--- 218 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHh-c------CCCCCCCCC---
Confidence 578999999999998899999999999999999999999997654322110 000 0 011111222
Q ss_pred HHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
...+.+++.+||+.||.+|| ++.++++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 -SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 34467888899999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=319.51 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=201.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|+..+.||+|+||.||+|.++. +..+|+|.+..... ...+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457788999999999999999864 45699998764422 2367889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++|+|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+..........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 82 ENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999999875432 58899999999999999999998 999999999999999999999999999987654322222
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+. .+. ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~----~~~--~~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMIS----RGF--RLYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCC--CCCCCC----
Confidence 223345678999999988889999999999999999999 8999975543221 11111 111 001111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.....+.+++.+||+.+|++||++.++++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1124578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=325.59 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=196.4
Q ss_pred cCCCccceecccCceEEEEEEeCC-Cceeeeeecccccc--hhHHHHHHHHHHHhccC---CcceEeeeeeeee-----e
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK-SKIEIAVKKISHES--RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCR-----R 163 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 163 (420)
++|++.+.||+|+||.||+|++.. ++..||+|++.... ......+.+|+..+..+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999999843 46789999886432 12223455676666554 7999999999885 3
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
....++|+||++ ++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 699999876655568999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hhhhhhcccCcc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DWVFDFWNRGEL 322 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 322 (420)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..... +.. ........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEEDW 233 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChhhc
Confidence 9765432 2233456899999999998888999999999999999999999999865543221100 000 00000000
Q ss_pred c-------cccCCCC---CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 L-------EARDPNL---GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~-------~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ....+.. .....++....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000 00111122345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=319.45 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=206.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|+..+.||+|+||.||+|.+... ...||+|.+... ......+|.+|+..+.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 45788899999999999999998543 457999988754 33345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
+|||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999976543 68999999999999999999998 9999999999999999999999999999987642
Q ss_pred CCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..+.+ ..+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-----~ 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGY-----R 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC-----C
Confidence 2111 1122344678999999998899999999999999999998 999986543221 11111 1110 0
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ........+.+++.+||+.+|++||++.|+++.|++.
T Consensus 227 ~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LP----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0112335578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.41 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=201.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|+..+.||+|+||.||+|....++..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999998888999999886542 22235678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ ++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 96 599998865432 57889999999999999999999 999999999999999999999999999987543222 1
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh---------hhhcccCccc
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV---------FDFWNRGELL 323 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 323 (420)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ..........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233567899999998865 56899999999999999999999999765543322111000 0000000000
Q ss_pred cccCCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTE----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+..... ..........+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111000 00111245678999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=344.46 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=211.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeee-eeee------C
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG-YCRR------K 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~------~ 164 (420)
...++++.+.|.+|||+.||+|++.+.+..||+|++-..+....+.+.+|+++|++|. |+|||.+++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3456677899999999999999998876889999988778888899999999999996 999999999 3221 1
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
-+.+|.||||++|.|-+++..+....|++.++++|+.++++|+++||. ++.+|||||||-+||||+.+++.||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 368999999999999999986655569999999999999999999997 3578999999999999999999999999998
Q ss_pred ccccCCC-CCc-------ccccccCCcccccccc---cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh
Q 036051 245 RLYDHGT-DPQ-------TTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 245 ~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 313 (420)
.-.-... ... .-...-|+.|+|||.+ .+..+++|+|||||||+||-|+....||+..+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 7432222 111 1112458999999976 67789999999999999999999999998765432
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
++.-++.-.-.+.....+.+||..||+.||.+||++.+|++.+-++.
T Consensus 266 -----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 -----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred -----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 11222222223456677889999999999999999999998886554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=337.71 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=207.7
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
|++++.||.|+.|.|-+|++..+|+.+|||++... .......+.+|+-+|+.+.|||+++++++++++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 56688999999999999999999999999999765 222345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|-|++++...+ .+++.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|..-..+ .
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 99999999998776 68999999999999999999999 99999999999999999999999999999864432 3
Q ss_pred cccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
...+.||.+.|.+||++.+.+| ..++||||+|||||.|+||+.||++++... +..++..|... +
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLlKV~~G~f~------M-- 231 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLLKVQRGVFE------M-- 231 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCccc------C--
Confidence 4566799999999999999887 568999999999999999999998554322 12222333221 1
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+........+|+.+|+..||..|.|+.||++.
T Consensus 232 --Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 --PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12223346677888999999999999999983
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=328.43 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCce----eeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..+|+..+.||+|+||.||+|++..++. .||+|++... .....+++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 4568899999999999999999755444 3899998654 334457789999999999999999999998765 568
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+++||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+|||+++++.+||+|||++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999976543 58889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCc-ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~----- 228 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE----- 228 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCC-----
Confidence 332211 112234678999999999999999999999999999997 9999976433221 11111110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
...... .....+.+++.+||+.||.+||++.+++..+.....
T Consensus 229 ~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000011 122357788899999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.82 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=203.9
Q ss_pred CCCccceecccCceEEEEEEeCCC-ceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKS-KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.|.+.+.||+|++|.||+|....+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999998766 6778999876655555567888999999999999999999999999999999999
Q ss_pred CCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
++|+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23468899999999999999999999 9999999999999999999999999999986643322
Q ss_pred -CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 -PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... .+. .. ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~-~~~----~~-~~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVL-YGK----YD-PF- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCC----CC-CC-
Confidence 123345799999999999998999999999999999999999999975433211 01100 010 00 11
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++||++.+++.
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122345788889999999999999998864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.63 Aligned_cols=240 Identities=25% Similarity=0.275 Sum_probs=194.3
Q ss_pred ecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||.||+|++..++..||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999888889999998643 233446688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ........
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccccc
Confidence 99997654 58899999999999999999999 99999999999999999999999999998753322 12233457
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... + ...... ...
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~------~~~~~~----~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-E------PLRFPD----GFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-C------CCCCCC----cCC
Confidence 8999999999999899999999999999999999999997543321 1111110 0 011111 223
Q ss_pred HHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.+++.+||+.||.+||++..+.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 45678888999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.88 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=214.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe-EEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-LLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 171 (420)
++|...+++|+|+||.++..+++.++..+++|.+... .....+...+|+.++++++||||+.+.+.+..++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999999989999999988654 23333467899999999999999999999988887 99999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
+|++||+|.+.|..+.+..+++.++++++.|++.|+.|||+ ..|+|||||+.|||++.+..|||+|||+++.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999998877789999999999999999999998 999999999999999999999999999999887654
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......+||+.|+.||.+.+.+|+.|+|||||||++|||++-+.+|...+...-. .. +.... .
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li------~k------i~~~~----~ 223 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI------LK------INRGL----Y 223 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH------HH------Hhhcc----C
Confidence 2445678999999999999999999999999999999999999999876543211 11 01111 1
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
...+......+..++..|++.+|..||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22233344557788888999999999999999875
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=327.93 Aligned_cols=238 Identities=26% Similarity=0.284 Sum_probs=190.2
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHH-HhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999889999999986542 222344555554 45778999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 99999987654 68899999999999999999999 99999999999999999999999999998753221 12233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... .+ .......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~-~~------~~~~~~~--- 218 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNIL-NK------PLRLKPN--- 218 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHH-cC------CCCCCCC---
Confidence 45789999999999998999999999999999999999999976543221 00000 00 0111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMR 361 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~ 361 (420)
....+.+++.+||+.||.+||++.
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 -ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234577888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=333.14 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=195.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.+|+..+.||+|+||.||+|++..+++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44566788999999999999998888999999986542 33346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+.. ..++..+..++.||+.||+|||+ .+++||||||+|||+++++.+||+|||++........
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999987643 35667888999999999999999 9999999999999999999999999999986543221
Q ss_pred cccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 254 QTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+.. .. .....+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~------~~~~~~ 294 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI------CMSQPP 294 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HH------hccCCC
Confidence 2234578999999998743 234568999999999999999999997433221111000 00 000011
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 295 ~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11223457888899999999999999999863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.13 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=178.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..++|++.+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 347899999999999999999999888888999988654 3334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999997654 58889999999999999999997 247999999999999999999999999998754322
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223468999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=320.84 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=206.2
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|.+.+.||+|+||.||+|.+.+ ++..||+|.+...... ..+.+.+|++++..++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567888999999999999998743 3467999998765433 457899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCC------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc
Q 036051 168 LLVYDYMPNGSLDKYLYNQP------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~ 235 (420)
++||||+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999997542 2357899999999999999999998 89999999999999999999
Q ss_pred EEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhh
Q 036051 236 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 313 (420)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .+.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence 99999999875432211 11223345788999999999999999999999999999998 9999976543321 1111
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
..+.. +.. .......+.+++.+||+.||++||++.||++.|++
T Consensus 238 ----~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ----TQGRL-----LQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HcCCc-----CCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 011 11223457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.26 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=207.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|...+.||+|++|.||+|++..++..|++|.+... .......+.+|+.++++++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467789999999999999999888899999988643 344567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 999999999987645578999999999999999999998 9999999999999999999999999999886544322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+++.|+|||++.+..++.++|+||||+++|||++|+.||........ ...+ ..+ ..+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~-----~~~~~--- 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILKI----IRG-----VFPPV--- 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcC-----CCCCC---
Confidence 22334678899999999988899999999999999999999999976543211 1100 011 11111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11234568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.56 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=195.1
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHH---hccCCcceEeeeeeeeeeCCeEEEE
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVS---IGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
|++.+.||+|+||.||+|.+..++..||||++.... ....+.+..|+.+ +..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999998889999999986542 2233456666554 4567899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|..++... .+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888643 68999999999999999999999 99999999999999999999999999998743221
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ... ..+ ....
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i-~~~------~~~~ 220 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSI-VND------EVRY 220 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HhC------CCCC
Confidence 12233467899999999999989999999999999999999999999765432211 000 000 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
... ....+.+++.+||+.||.+|| ++.++++
T Consensus 221 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 PRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112 234467888999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.55 Aligned_cols=238 Identities=26% Similarity=0.306 Sum_probs=189.1
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHH-HhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..++..||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998889999999986532 222344555554 57788999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
++|...+.... .+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 99998886543 57888999999999999999998 99999999999999999999999999998753221 12233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .+ ... .. .... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~-~~------~~~~----~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YD---NIL-HK------PLQL----PG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HH---HHh-cC------CCCC----CC
Confidence 45789999999999988899999999999999999999999976542211 10 000 00 0111 11
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMR 361 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~ 361 (420)
.....+.+++.+||+.||.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2234577889999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=334.90 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=205.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||+||+|++..++..||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999998888999999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999997663 68899999999999999999999 999999999999999999999999999998654332
Q ss_pred ----------------------------CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 252 ----------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 252 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345789999999999999999999999999999999999999976553
Q ss_pred cccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-HHHHHHH
Q 036051 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS-MRQVVQI 366 (420)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 366 (420)
.+... ...... .....+.. .. ....+.+++.+|++ ||.+||+ +.++++.
T Consensus 236 ~~~~~------~i~~~~--~~~~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYN------KIINWK--ESLRFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHH------HHhccC--CcccCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22110 000000 00000110 11 23446777888997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.26 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=201.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc-eeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK-IEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|+..+.||+|+||.||+|.+...+ ..||+|++... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457888999999999999999875544 67999988643 22334678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997654 58899999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+... ......+. ..
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~------~~ 246 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGI------IY 246 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCC------CC
Confidence 22345789999999999888899999999999999999999999976543211 11111111 11
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQI 366 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 366 (420)
.+...+ ..+.+++.+|++.||.+|+ ++.++++.
T Consensus 247 ~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111222 3467888899999999995 78888653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.19 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=198.2
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
+.||+|+||.||+|++..++..||+|.+... .......+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999999888889999987654 334456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc-ccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THV 258 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 258 (420)
.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986543 258899999999999999999998 9999999999999999999999999999875432211111 111
Q ss_pred ccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 259 ~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..+..|+|||.+.+..++.++||||||+++|||++ |..||.......... .... .... .....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~-----~~~~----~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQ-----GVRL----PCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHc-----CCCC----CCccc
Confidence 23457999999988889999999999999999997 888886543322110 0000 0011 11112
Q ss_pred HHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 338 ELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=328.34 Aligned_cols=253 Identities=24% Similarity=0.269 Sum_probs=202.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||+||++....++..||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999999889999999987542 234466888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 99999999999976532 68999999999999999999999 999999999999999999999999999998665433
Q ss_pred CCcccccccCCccccccccc------CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 252 DPQTTHVVGTLGYLAPEHTR------TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......... ............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 230 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLKF 230 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccCC
Confidence 32333457899999999986 456789999999999999999999999765432211 111111000000
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+ . .......+.+++..|++ +|.+|||+.++++
T Consensus 231 --~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 --P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 0 01122346677778997 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=330.77 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=198.0
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----CeEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GELL 168 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 168 (420)
+|++.+.||+|+||.||+|++..++..||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999999888999999988643 223345688999999999999999999987543 3589
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+ +++|.+++.... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 578999887654 58999999999999999999999 999999999999999999999999999997543
Q ss_pred CCCC--CcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhh
Q 036051 249 HGTD--PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDF 316 (420)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~ 316 (420)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 12234578999999999865 67899999999999999999999999765432211100000 000
Q ss_pred cccCc---cccccCCCCCCccc---HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WNRGE---LLEARDPNLGTEYV---AEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~~---~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.... .............. +.....+.+++.+||+.||++|||+.|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00000000000000 112245678999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.22 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=198.9
Q ss_pred CCCccceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 96 GFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
+|++.+.||+|+||.||+++.. .++..||+|++.... ....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998863 357789999986431 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999987654 58899999999999999999998 99999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .+.... ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~------~~~ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRI------LKC 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHH------hcC
Confidence 44333334456799999999999765 47889999999999999999999997543322110 011100 011
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
++..... ....+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1222222 234467888899999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.73 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=204.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|++.++. .||+|++..... ..+.|.+|++++.+++||||+++++++.. ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 456888999999999999999986554 599999875432 23578899999999999999999998754 567999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999976544468999999999999999999999 99999999999999999999999999999866443322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||+..+..++.++||||||+++|||++ |+.||......+.. .....+ . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~-----~----~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG-----Y----RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcC-----C----CC
Confidence 2223446778999999988889999999999999999999 88888655432211 000000 0 01
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
....+....+.+++.+|++.||++||++.+++++|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.94 Aligned_cols=252 Identities=30% Similarity=0.452 Sum_probs=201.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|...+.||+|+||.||+|.+.+ +..+|+|.+..... ...+|.+|+.++.+++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 457778999999999999998854 44599998865432 2367899999999999999999999999988999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++..... .+++.+++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.+..........
T Consensus 82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999976543 68999999999999999999998 999999999999999999999999999987654332222
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .+.+ ..+. .+....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~-----~~~~~~- 224 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKV----SQGL-----RLYRPH- 224 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----hcCC-----CCCCCC-
Confidence 222345678999999988889999999999999999998 9999875443221 1111 1110 011111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.....+.+++.+||+.||.+||++.++++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12356788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.54 Aligned_cols=261 Identities=27% Similarity=0.413 Sum_probs=205.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC-----ceeeeeecccccc-hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 165 (420)
..++|.+.+.||+|+||.||+|++... +..||||++.... ....+.+.+|+.+++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356888899999999999999987432 3469999997543 333467899999999996 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCC----------------------------------------------------------
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP---------------------------------------------------------- 187 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (420)
..++||||+++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred ------------------------------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 188 ------------------------------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 188 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
...+++..+..++.|++.||+|||+ .+++|+||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 1247888899999999999999998 9999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchh
Q 036051 232 GELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLIL 309 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~ 309 (420)
+++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 999999999999976533221 12223456788999999988889999999999999999997 99998754332111
Q ss_pred hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......+. ... ........+.+++.+||+.||++||++.+|.+.|++..
T Consensus 350 ----~~~~~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ----YNKIKSGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHHhcCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111110 111 11223456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=316.43 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=211.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
..+|++.+.||+|.||.|-+|+....++.||||.+.++ +.+..-.+.+|+++|..|+||||+.++.+|++.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35677788999999999999999889999999999765 444556688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||..+|.|++++...+ .|++.+...++.||..|+.|+|. ++++|||||.+|||+|.|+++||+|||++.++...
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999998776 79999999999999999999998 99999999999999999999999999999887643
Q ss_pred CCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. -..+++|.+-|.+||++.+.+| .+..|-|||||+||-|+.|..||++.+-... + ..+.+|.. ..|.
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---v----rQIs~GaY---rEP~ 274 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---V----RQISRGAY---REPE 274 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---H----HHhhcccc---cCCC
Confidence 3 4567899999999999999887 5789999999999999999999987654321 1 11222222 1222
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
-+ ....-|+.|||-.||++|.|+.+|....
T Consensus 275 ~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 TP--------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 21 2245678889999999999999998754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.23 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=203.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCC-----Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.+++|+..+.||+|+||.||+|.+.+ .+..||+|++... ......+|.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999998642 3467999988643 23344678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCC--------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQP--------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 1246788899999999999999998 89999999999999999999999
Q ss_pred eeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+.. + .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---R----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----H
Confidence 999998754332211 1122345778999999988889999999999999999999 78888655432211 1 0
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
...+.. +... ......+.+++.+||+.||++|||+.|+++.|++
T Consensus 234 ~~~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGL-----LDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCc-----CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 011110 0111 1223457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.91 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+|+..+.||+|+||+||++.+..++..||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999998888899999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++|+|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999998876544568999999999999999999999 999999999999999999999999999987654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ..+...... . ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~------~----~~ 222 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE------D----QE 222 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh------c----cc
Confidence 223346899999999998888999999999999999999999999764432211 001110000 0 01
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
.+.......+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11222345578889999999999999 7778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=322.41 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=208.2
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCC-----Cceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
....++|+..+.||+|+||.||+|.+.+ ....+|+|.+... ......++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455678889999999999999998753 3367999988754 334456788999999999 79999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccC--------------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQ--------------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
++..+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence 99999999999999999998642 23468999999999999999999998 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
+++++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 999999999999999865432211 1122334678999999988899999999999999999997 99998754432211
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+. .+ .........+.+++.+||+.||++|||+.|+++.|+..+
T Consensus 245 -------~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 -------KLLKEGY-----RM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -------HHHHcCC-----cC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 00 111123456888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.04 Aligned_cols=260 Identities=21% Similarity=0.218 Sum_probs=200.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..+|++.+.||+|+||.||++.+..+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999999998999999997532 3467899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+ .++|..++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 165 ~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 Y-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9 578988886543 58899999999999999999999 89999999999999999999999999999754332222
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc----hhhhhhhhhcc--------c--
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL----ILVDWVFDFWN--------R-- 319 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~--------~-- 319 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+..... .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 334467999999999999889999999999999999999999887543221100 00000000000 0
Q ss_pred Cccc-------c--ccCCCCCCcc--cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELL-------E--ARDPNLGTEY--VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~-------~--~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. . ...+.....+ .......+.+++.+||+.||.+|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0 0001000001 1123456888999999999999999999985
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.43 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=207.8
Q ss_pred hcCCCccceecccCceEEEEEEeC-----CCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|.+.+.||+|+||.||++... .++..+|+|.+..........+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457888999999999999999852 345568999987666566678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC-----------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 169 LVYDYMPNGSLDKYLYNQP-----------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
+|+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 1358999999999999999999998 9999999999999999999999
Q ss_pred EeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhh
Q 036051 238 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFD 315 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 315 (420)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. . .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----E 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----H
Confidence 999999875432211 11223345778999999988889999999999999999998 8999865543221 1 1
Q ss_pred hcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....+.. +...... ...+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 234 ~i~~~~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRV-----LQRPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCc-----CCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1111122 234788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.70 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=208.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|+...++..||||.+... .......+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999999888889999987542 3344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 22357889999999999999999998 9999999999999999999999999999886543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....... .++.. ... ....+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~-~~~-----~~~~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQ-KIE-----QCDYPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHH-HHh-----cCCCCC
Confidence 221 1223467889999999988889999999999999999999999986543221 11111 100 111111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. ........+.+++.+||+.+|++||++.+|++.++++
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1123345688899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=335.29 Aligned_cols=256 Identities=24% Similarity=0.260 Sum_probs=203.4
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
...++|+..+.||+|+||.||++++..++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3456889999999999999999999988999999998643 2233355788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998654 47888899999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccccccccCC----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--- 264 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN--- 264 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC---
Confidence 3322223346799999999998653 4788999999999999999999999765432110 11110000
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQI 366 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 366 (420)
...... .......+.+++.+||+.+|.+ ||++.|+++.
T Consensus 265 --~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000111 0112345677888899999987 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.66 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=203.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3568889999999999999998864 45699998865433 23568999999999999999999998754 567999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999976555568999999999999999999999 89999999999999999999999999999865443222
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..+... .+ ..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~-----~~~---- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE----RG-----YRM---- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cC-----CCC----
Confidence 2222345678999999988889999999999999999999 889997544322 111110 00 011
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.........+.+++.+||+.+|++|||+.++.++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.36 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=208.2
Q ss_pred cCCCccceecccCceEEEEEEeCC-----CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.+|...+.||+|+||.||+|.+.. ++..+++|.+........+.+.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457778999999999999998532 445689999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc
Q 036051 170 VYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~ 235 (420)
||||+++++|.+++.... ...+++..++.++.||+.||+|||+ .+++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986532 1348899999999999999999998 99999999999999999999
Q ss_pred EEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhh
Q 036051 236 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 313 (420)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---I--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---
Confidence 99999999875433221 11223456788999999998899999999999999999998 9999876544321 1
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+.... . .......+.+++.+||+.||++|||+.+|+++|+...
T Consensus 236 -~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 -ECITQGRVLE-----R----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -HHHhCCCCCC-----C----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111111111 1 1112345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=298.93 Aligned_cols=266 Identities=26% Similarity=0.282 Sum_probs=211.0
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----C
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----G 165 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 165 (420)
.+..++|.+.+.||+|||+-||+++.-.++..+|+|++.....+..+..++|++..++++|||++++++++..+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34567899999999999999999998888889999999888777788899999999999999999999987543 3
Q ss_pred eEEEEEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
..|++++|+..|+|.+.+... ++..+++.+.+.|+.+|++||++||+.. .+++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 589999999999999998754 2347899999999999999999999832 3599999999999999999999999999
Q ss_pred cccccCCCC--------CcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 244 ARLYDHGTD--------PQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 244 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
+....-... +.......|..|.|||.+. +...++++|||||||+||+|+.|..||+..-....-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl---- 251 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL---- 251 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE----
Confidence 875432111 1112235689999999884 4467899999999999999999999997543321110
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.-.+.++.+ ..|+ .....+.+.+++++|++.||.+||++.+++..++..
T Consensus 252 -aLAv~n~q~---s~P~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -ALAVQNAQI---SIPN-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -EEeeecccc---ccCC-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000011111 1111 111456688999999999999999999999998764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.55 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=202.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCce----eeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.+|+..+.||+|+||.||+|.+..++. .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467788999999999999999865554 47888875442 3344678889999999999999999998764 45789
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
++||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999976433 68999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .+ ....+... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~----~~~~~~~~--~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PD----LLEKGERL--AQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHCCCcC--CC
Confidence 221 12223456778999999988899999999999999999998 9999976543221 11 11111111 01
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
+ .. ....+.+++.+||..||.+|||+.|+++.|....+.
T Consensus 233 ~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 233 P---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1 11 123467788899999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.88 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=198.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|+...++..||+|++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4679999999999999999999988888999999865422 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+ .++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 99 568888876543 258889999999999999999999 999999999999999999999999999987543221
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc---cCcc-----c
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN---RGEL-----L 323 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-----~ 323 (420)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+..... .... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhc
Confidence 12233567899999998865 45888999999999999999999999764322110 000000000 0000 0
Q ss_pred cccCCC-----CCCcccH-----HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPN-----LGTEYVA-----EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~-----~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+. ....... .....+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000000 01235678889999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.04 Aligned_cols=256 Identities=24% Similarity=0.436 Sum_probs=202.6
Q ss_pred cCCCccceecccCceEEEEEEe----CCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
++|+..+.||+|+||.||+|.+ ...+..|++|.+... .......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999985 234567999998743 34445778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCC---------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 170 VYDYMPNGSLDKYLYNQP---------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
+|||+++++|.+++.... ...+++.+.+.++.|++.||.|||+ .+++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 2357889999999999999999999 8999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhh
Q 036051 235 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDW 312 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 312 (420)
.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+. .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~-- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---I-- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H--
Confidence 999999999976533221 12223345678999999988889999999999999999998 9889875443221 1
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
........ ..... .....+.+++.+||+.||.+||++.+|++.|..
T Consensus 237 --~~~~~~~~-----~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 --EMVRKRQL-----LPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCc-----CCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 01111 223457788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=333.39 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=199.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|+||+||+|++..+++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999998889999999986542 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997654 68999999999999999999999 999999999999999999999999999987543211
Q ss_pred CC-------------------------------------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcC
Q 036051 252 DP-------------------------------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 294 (420)
Q Consensus 252 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg 294 (420)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124689999999999988999999999999999999999
Q ss_pred CccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC---HHHHHH
Q 036051 295 RRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS---MRQVVQ 365 (420)
Q Consensus 295 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 365 (420)
..||......+... ....... ....+. ...+ ...+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~~~~------~i~~~~~--~~~~~~-~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETYR------KIINWKE--TLQFPD-EVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHHH------HHHcCCC--ccCCCC-CCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99997654332110 0000000 000000 0011 2335566677886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.67 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=197.9
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.|+..+.||+|+||+||+|++.+++..||+|++... .......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999999999999999998654 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987654 58888999999999999999999 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------CcccccccCCcccccccccCCCCCccchhhhhHH
Q 036051 253 ----------------------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA 286 (420)
Q Consensus 253 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGv 286 (420)
......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012347999999999998888999999999999
Q ss_pred HHHHHhcCCccCCCCCCcccch-hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhc--ccccCCCCCCCHHHH
Q 036051 287 FLLEVACGRRPIERQGPEENLI-LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLL--CSHSDPTARPSMRQV 363 (420)
Q Consensus 287 vl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~ev 363 (420)
++|||++|+.||......+... ...| ... .. .+ .....+.+ +.+++.+ |+..+|..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~-~~--~~-~~~~~s~~----~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENT-LH--IP-PQVKLSPE----AVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc-cC--CC-CCCCCCHH----HHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999997655432110 0000 000 00 00 01122333 3344443 567777789999999
Q ss_pred HHH
Q 036051 364 VQI 366 (420)
Q Consensus 364 l~~ 366 (420)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=312.72 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=203.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-----hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
++|...+.||+|++|.||+|....++..|++|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999998888999999876431 2234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999987654 58889999999999999999999 9999999999999999999999999999875543
Q ss_pred CCCCcc--cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDPQT--THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-----~~~~ 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIAT-----QPTN 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhc-----cCCC
Confidence 221111 2345788999999999888999999999999999999999999754332111 00000 0011
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+ .........+.+++.+||..+|.+|||+.++++.
T Consensus 226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 P----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 1122233457788889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.70 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=204.2
Q ss_pred HhcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.+++|.+.+.||+|++|.||+|.+.. .+..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45778899999999999999999976 66789999886543 3344678999999999999999999999999889
Q ss_pred EEEEEeecCCCChhhhhccCCC-----ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPK-----VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl 238 (420)
.++||||+++++|.+++..... ..+++.++..++.||+.||+|||+ .+++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865431 358999999999999999999999 8999999999999998654 5999
Q ss_pred eeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
+|||++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||......+.. + .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~----~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E----F 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----H
Confidence 99999986532211 11112233568999999988889999999999999999997 99999765433211 1 1
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.... ..... .......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~-----~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG-----GRLDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC-----CcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1000 00111 1122345788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.67 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=197.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++.+++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999999889999999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997654 57888899999999999999999 999999999999999999999999999975321000
Q ss_pred ------------------------------------------CCcccccccCCcccccccccCCCCCccchhhhhHHHHH
Q 036051 252 ------------------------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLL 289 (420)
Q Consensus 252 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ 289 (420)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012347999999999999999999999999999999
Q ss_pred HHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC---CHHHHHHH
Q 036051 290 EVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARP---SMRQVVQI 366 (420)
Q Consensus 290 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~evl~~ 366 (420)
||++|+.||....+.+... ...... .............+ +.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~------~i~~~~---~~~~~~~~~~~s~~----~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQL------KVINWE---TTLHIPSQAKLSRE----ASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHH------HHhccC---ccccCCCCCCCCHH----HHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999998665432111 000000 00000001122223 444555554 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=319.41 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=206.4
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh--------------HHHHHHHHHHHhccCCcceE
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--------------GMKEFVAEIVSIGRLRHRNL 154 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~ni 154 (420)
+-...-++|++.+.||+|.||.|-+|+...+++.||||++.+.... ..+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3345568899999999999999999999999999999999754211 12468899999999999999
Q ss_pred eeeeeeeeeC--CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 155 VQLLGYCRRK--GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 155 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
|+++.+..+. +.+|||+|||..|.+...=.... .+++.++++++.++..||+|||. ++|+||||||+|+|+++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence 9999998765 57999999999888765432221 38999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecCcccccCCCC----CcccccccCCcccccccccCCC----CCccchhhhhHHHHHHHhcCCccCCCCCCc
Q 036051 233 ELNGRLGDFGLARLYDHGTD----PQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIERQGPE 304 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~el~tg~~p~~~~~~~ 304 (420)
+|++||+|||.+..+..+.. ......+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999987744322 2334478999999999986632 356889999999999999999999865433
Q ss_pred ccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
+.. .++....+.-.-.+++-..+.+|++++|++||++|.+..+|....
T Consensus 326 ~l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ELF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 210 111222222222335566788899999999999999999987654
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.25 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=203.6
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeee-CC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR-KG 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~ 165 (420)
.++|++.+.||+|+||.||+|.+.+ ++..||+|++.... ....+.+.+|+.++.++ +|+||++++++|.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4578889999999999999997543 24679999987542 33456788999999999 89999999998764 45
Q ss_pred eEEEEEeecCCCChhhhhccCCC---------------------------------------------------------
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPK--------------------------------------------------------- 188 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 188 (420)
.+++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999999999998854211
Q ss_pred --ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-CcccccccCCccc
Q 036051 189 --VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYL 265 (420)
Q Consensus 189 --~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~ 265 (420)
..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.++|+|||++........ .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 267899999999999999999998 9999999999999999999999999999986533221 1222345577899
Q ss_pred ccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHH
Q 036051 266 APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILK 344 (420)
Q Consensus 266 aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 344 (420)
|||++.+..++.++|||||||++|||++ |..||......+.. ......+.. +.. .......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~-----~~~----~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF------CRRLKEGTR-----MRA----PEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH------HHHHhccCC-----CCC----CccCCHHHHH
Confidence 9999999999999999999999999997 99999754332211 111111110 111 1122345788
Q ss_pred HhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 345 LGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 345 l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
++.+||+.+|++||++.|+++.|+..+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.83 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=200.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....|.+|++++++++||||+++++++...+..++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 457788999999999999999864 55699998864332 2356888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 82 ANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999976543 68999999999999999999999 899999999999999999999999999987654322111
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .. ...+ .......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~-----~~~~~~~- 224 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ES----VSAG-----YRLYRPK- 224 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HH----HHcC-----CcCCCCC-
Confidence 122234567999999988899999999999999999998 88998754432211 00 0011 1111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.....+.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 ---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1234588899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.41 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhcc-CCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++.+++..||+|++.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999998888899999986542 2233445566666664 4899999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999987654 58899999999999999999999 999999999999999999999999999997543222 2333
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... .. ..+..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i-~~------~~~~~~~~--- 218 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSI-LN------DRPHFPRW--- 218 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHH-Hc------CCCCCCCC---
Confidence 457899999999999889999999999999999999999999765432211 000 00 11112122
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMR-QVV 364 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~-evl 364 (420)
....+.+++.+||+.||.+||++. +++
T Consensus 219 -~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 -ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223467788899999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=327.56 Aligned_cols=204 Identities=25% Similarity=0.351 Sum_probs=178.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999998889999999986542 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997654 68999999999999999999999 999999999999999999999999999987543211
Q ss_pred C----------------------------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCcc
Q 036051 252 D----------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297 (420)
Q Consensus 252 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p 297 (420)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999998999999999999999999999999
Q ss_pred CCCCCC
Q 036051 298 IERQGP 303 (420)
Q Consensus 298 ~~~~~~ 303 (420)
|.....
T Consensus 236 f~~~~~ 241 (363)
T cd05628 236 FCSETP 241 (363)
T ss_pred CCCCCH
Confidence 976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.70 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=204.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|...+ +..||+|.+..... ....+.+|+.++++++|+|++++++++. .+..++++|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 35678889999999999999999754 56799998875433 2367889999999999999999999874 456899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999876655678999999999999999999998 9999999999999999999999999999976553222
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ... ...+ .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~-----~~~~~- 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERG-----YRMPR- 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcC-----CCCCC-
Confidence 22223345678999999988889999999999999999998 9999975543221 110 0011 01111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.......+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123458889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=313.25 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=204.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..+|++.+.||+|+||.||+|++..++..||+|++..........+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999999888889999998765544556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987543 68899999999999999999998 9999999999999999999999999999986543221
Q ss_pred cccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....+.+..... .... ...+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCCCC
Confidence 223346888999999874 345788999999999999999999998654432211000 0000 000111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.. .......+.+++.+||+.+|++|||+.++++.+
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 112234678889999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.62 Aligned_cols=259 Identities=24% Similarity=0.269 Sum_probs=202.3
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
++....++|+..+.||+|+||.||++++..++..+|+|++... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3444567899999999999999999999988889999998643 2223456788999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999999654 47888999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCC----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~ 264 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKN 264 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCc
Confidence 6643322233456799999999998654 3788999999999999999999999765432211 11111000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQI 366 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 366 (420)
...... .......+.+++.+|++.++.+ ||++.|+++.
T Consensus 265 -----~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001111 1112334566777788755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=313.85 Aligned_cols=257 Identities=29% Similarity=0.526 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc---eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|+..+.||+|+||.||+|++..++ ..+++|.+... .....+.+.+|+.++.+++|||++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457788899999999999999986544 36999988655 33445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997543 368999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCCccc--ccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 250 GTDPQTT--HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 250 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
....... ....+..|+|||++.+..++.++||||||+++|||++ |+.||......+. ... ...+. .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~-i~~~~----~ 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKA-INDGF----R 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHH-HhcCC----C
Confidence 3221111 1223457999999988889999999999999999987 9999965443221 111 11110 0
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+ ...+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 229 ~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01 1112335578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.85 Aligned_cols=243 Identities=24% Similarity=0.289 Sum_probs=196.9
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
+.||+|+||.||++.+..++..||+|++... .......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999888999999998754 2233466788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
+|..++.... .+++..+..++.||+.||+|||+ ..+++||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9999886654 68999999999999999999996 2689999999999999999999999999987432211 12234
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ....+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~------~~~~~p~~~--- 219 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILM------EEIRFPRTL--- 219 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhc------CCCCCCCCC---
Confidence 568999999999998899999999999999999999999997654322111 0000 011111222
Q ss_pred HHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
...+.+++.+||+.||++|+ ++.++++
T Consensus 220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 -SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23467888899999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.39 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred ceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 101 ELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+.||+|+||.||+++.. ..++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 457789999986532 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+.+..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 99999999987654 57888899999999999999999 999999999999999999999999999987432221 1
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .+. ..+...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~~------~~~~~~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KGK------LNLPPY 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCC------CCCCCC
Confidence 223457899999999998888999999999999999999999999765432211 1110 110 111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
....+.+++.+||+.||++|| ++.++++
T Consensus 223 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 ----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234577888999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=311.58 Aligned_cols=253 Identities=29% Similarity=0.440 Sum_probs=202.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|.+.+.||+|++|.||+|.+..+. .+|+|.+..... ..+.+.+|+.++++++|||++++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 55788899999999999999986554 599998765432 23568899999999999999999998754 5689999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999976555568999999999999999999998 899999999999999999999999999997654332222
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||...+..++.++||||||+++|||++ |+.||......+. ..+.. .+ ..+ .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~~-----~~~----~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQVE----RG-----YRM----P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cC-----CCC----C
Confidence 223345678999999988889999999999999999999 8999976443221 11110 00 001 1
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
........+.+++.+||+.||++||++.+++++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234568888899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=312.70 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=208.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.+|+..+.||+|++|.||+|++..++..++||.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999999888889999987643 2334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 23468999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
... ......++..|+|||++.+..++.++|+||||+++|||++|..||........ .... .......+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~------~~~~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK------KIEQCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh------hhhcCCCCC
Confidence 221 22334688999999999888899999999999999999999999965432210 0000 011111111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ......+.+++.+||+.||++|||+.+|++.+++.
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 12344577888899999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=316.45 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=205.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC-----ceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
..++|.+.+.||+|+||.||+|.+.+. +..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 346788899999999999999998543 3679999986543 3445678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCC--------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQP--------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 1247889999999999999999998 99999999999999999999999
Q ss_pred eeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~----~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---K----F 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---H----H
Confidence 99999875543221 12233456789999999988889999999999999999998 99998754433211 1 1
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
...+. .+..... ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ~~~~~-----~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VIDGG-----HLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HhcCC-----CCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 1111111 2456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=316.08 Aligned_cols=272 Identities=25% Similarity=0.356 Sum_probs=201.9
Q ss_pred cCCCccceecccCceEEEEEEe----CCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 168 (420)
.+|++.+.||+|+||.||++.. ..++..||+|.+........+.|.+|++++.+++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5678889999999999999984 34577899999977766667789999999999999999999998754 34689
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999996543 258999999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCCc--ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
...... .....++..|+|||++.+..++.++||||||+++|||++|..|+......-................+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 322211 111223456999999988889999999999999999999887654322110000000000000000000000
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...............+.+++.+||+.+|++|||+.||++.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000011112234588899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=318.54 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=206.6
Q ss_pred HhcCCCccceecccCceEEEEEEe-----CCCceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
..++|...+.||+|+||.||+|.+ ...+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345788899999999999999975 2345579999887543 33456789999999999 7999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++++||+++|+|.+++.......+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999976544458999999999999999999998 899999999999999999999999999987
Q ss_pred cccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 246 LYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 246 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. . .....+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~----~~~~~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y----KLIKEGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H----HHHHcCC--
Confidence 65432211 1122345678999999988889999999999999999998 99998765432211 0 1111110
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+.... .....+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 262 ---~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ---RMAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---cCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 011111 1224578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.52 Aligned_cols=256 Identities=26% Similarity=0.340 Sum_probs=204.8
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG---- 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 165 (420)
...++|.+.+.||+|+||+||+|++..+++.||||++... .......+.+|+..+..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4457899999999999999999999888999999998654 3444567889999999999999999988664332
Q ss_pred ----eEEEEEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 166 ----ELLLVYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 166 ----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
.+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 3789999999999999986532 2468899999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCC-CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 240 DFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 240 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~~~- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKTL- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHh-
Confidence 999998654322 1223346799999999999998999999999999999999999999975433211 11110
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.+. . ..+.. .....+.+++.+||+.||.+||++.++++.
T Consensus 259 ~~~----~-~~~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR----Y-DPLPP----SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC----C-CCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 0 11111 223457788899999999999999998763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.92 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=197.0
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..++..||+|++... .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999988999999999754 223345678899999888 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...... .....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 99999886553 68999999999999999999999 99999999999999999999999999998742211 11233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc--cchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....++......... ...+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~~ 228 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPRSL 228 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCCCC
Confidence 4578999999999999999999999999999999999999996433221 1111122222211111 1111222
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCC------HHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPS------MRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~ 365 (420)
...+.+++.+||+.||.+||+ +.++++
T Consensus 229 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 229 ----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 234778888999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=315.76 Aligned_cols=249 Identities=27% Similarity=0.331 Sum_probs=197.2
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||.||++....++..||+|++.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999998889999999886432 12234556799999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998876655578999999999999999999999 999999999999999999999999999987654322 223356
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+...... ... .. .. .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~----~~--~~---~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDE----VK--FE---HQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-ccc----cc--cc---cccCC
Confidence 899999999998888999999999999999999999999754322110 00001000 000 00 00 01123
Q ss_pred HHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
..+.+++.+||+.||.+||++.|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 44778888999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.48 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=204.5
Q ss_pred hcCCCccceecccCceEEEEEEeC-----CCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|...+.||+|+||.||++... ..+..+++|.+..........|.+|++.++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356777899999999999999742 345679999887766666678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC-------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc
Q 036051 169 LVYDYMPNGSLDKYLYNQPK-------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~ 235 (420)
+++||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence 99999999999999875431 258899999999999999999998 99999999999999999999
Q ss_pred EEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhh
Q 036051 236 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 313 (420)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----- 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----- 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH-----
Confidence 99999999875432211 11122345678999999988899999999999999999998 899986544322110
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....+. ...... .....+.+++.+||+.||.+||++.||++.|+
T Consensus 236 --~~~~~~-----~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 --CITQGR-----ELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHHcCc-----cCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000110 011111 12345778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=316.79 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=203.5
Q ss_pred CCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
+|++.+.||+|+||.||+|+... ....+++|.+.... ......+.+|+..++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998742 23468999886543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCC----------------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 170 VYDYMPNGSLDKYLYNQP----------------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
++||+.+++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999875421 1357899999999999999999998 999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEE 305 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~ 305 (420)
|++++++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433221 11222345678999999988889999999999999999998 999997654332
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
. ......+. ...... .....+.+++.+||+.+|++||++.|+++.|++..
T Consensus 238 ~-------~~~~~~~~-----~~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 L-------FNLLKTGY-----RMERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred H-------HHHHhCCC-----CCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1 11111110 111111 22345778899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.30 Aligned_cols=242 Identities=22% Similarity=0.315 Sum_probs=195.7
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 171 (420)
+|++.+.||+|+||.||+|++.++++.||+|++... .....+.+..|..++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999999888889999998754 22344667889999998865 56888999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999987654 58899999999999999999999 99999999999999999999999999998643221
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... .. ......
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~------~~i-~~------~~~~~~ 221 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QSI-ME------HNVSYP 221 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH-Hc------CCCCCC
Confidence 11233457899999999999989999999999999999999999999765432211 000 00 011111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
... ...+.+++.+||+.||.+|++.
T Consensus 222 ~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 222 2346788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=312.21 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=207.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|.+.+.||+|+||.||+|.+. +++.|++|.+..... ..+++.+|+..+++++|+|++++++++......+++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4578889999999999999999985 446799999875432 34678999999999999999999999999899999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999987655578999999999999999999998 8999999999999999999999999999876543222
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .+... . .......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~----~-----~~~~~~~ 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVE----R-----GYRMPRP 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----c-----CCCCCCC
Confidence 22222334678999999998889999999999999999998 9999965433221 11110 0 0000111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. .....+.+++.+||+.+|.+||++.++++.|+.
T Consensus 227 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 P----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1 123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=315.37 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=195.4
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||+||++.+..+++.||+|.+.... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999998888899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccc
Q 036051 180 DKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 180 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
..++... ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887432 23468999999999999999999999 9999999999999999999999999999876543222 2234
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . ... ...... ..+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~--------~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQ--------RILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-HHH--------hhcccC--CCCccc
Confidence 578999999999999999999999999999999999999997543321100 0 000 000000 111122
Q ss_pred HHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
....+.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 344577888899999999999 6667764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=310.52 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=205.0
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+|++.+.||+|+||.||++.+..++..+|+|.+... .....+.+.+|+.++++++|+|++++++++...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999999888899999988543 3344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++.......+++.....++.|++.||.|||+ .+++|+||||+||++++++.++|+|||.+....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999998876544568899999999999999999998 999999999999999999999999999987654322 12
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||......... . ....+.. +....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~-~~~~~~~-----~~~~~-- 222 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------L-KVCQGSY-----KPLPS-- 222 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------H-HHhcCCC-----CCCCc--
Confidence 23356889999999998888999999999999999999999999754332110 0 0001110 11111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.....+.+++.+||+.||++||++.+++..
T Consensus 223 --~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 --HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223457788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.45 Aligned_cols=267 Identities=25% Similarity=0.344 Sum_probs=209.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccc--ccchhHHHHHHHHHHHhccCCcceEeeeeeeeee-----CC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-----KG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 165 (420)
....|...+.||+|+||.|+.+.+..++..||||++. ..+....+.-.+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999999999999999997 3455556778899999999999999999998765 35
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..|+|+|+| ..+|...++.++ .++......++.|+++||.|+|+ .+++||||||+|++++.+-.+||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence 789999999 789999998775 58899999999999999999999 999999999999999999999999999999
Q ss_pred cccCC-CCCcccccccCCcccccccc-cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh--------
Q 036051 246 LYDHG-TDPQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD-------- 315 (420)
Q Consensus 246 ~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-------- 315 (420)
..... .....+..+.|..|.|||++ ....|+.+.||||.|||+.||++|++.|.+.+.-.++.+.-.+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 77543 12344677889999999987 456899999999999999999999999987765544332221111
Q ss_pred hcccCcc---ccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRGEL---LEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... .+.........+ .+......++|+.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111 111111111111 1122345678888899999999999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.70 Aligned_cols=255 Identities=25% Similarity=0.474 Sum_probs=200.7
Q ss_pred CCccceecccCceEEEEEEeCCC---ceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe-----
Q 036051 97 FREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE----- 166 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 166 (420)
|.+.+.||+|+||.||+|.+..+ +..||+|++... .......+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997543 367999988754 23445678999999999999999999998865543
Q ss_pred -EEEEEeecCCCChhhhhccC----CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 167 -LLLVYDYMPNGSLDKYLYNQ----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 167 -~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
.++++||+++|+|..++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988543 22368999999999999999999998 89999999999999999999999999
Q ss_pred cCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhccc
Q 036051 242 GLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 242 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..+++. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 999865433221 1222335678999999988889999999999999999999 888886544322 111111 1
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
+. .... .......+.+++.+||+.||++|||+.|+++.|++.
T Consensus 231 ~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN-----RLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----CCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1111 112334688888899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=316.42 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=206.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|+..+.||+|++|.||+|....++..|++|.+..........+.+|+.+++.++|||++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999998888899999987665555577889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 999999998653 57899999999999999999998 999999999999999999999999999987643322 12
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .....+ .+.. ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~------~~~~--~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG------TPEL--QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCC------CCCC--CC
Confidence 233468899999999988889999999999999999999999997654322110 000000 0110 11
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12233557788999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=312.27 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=199.1
Q ss_pred CCccceecccCceEEEEEEeCCCce--eeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------Ce
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKI--EIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GE 166 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 166 (420)
|.+.+.||+|+||.||+|++..++. .+|+|.+... .....+.+..|+..++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457889999999999999876654 5899987654 344467889999999999999999999987432 35
Q ss_pred EEEEEeecCCCChhhhhccC----CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 167 LLLVYDYMPNGSLDKYLYNQ----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
.++++||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999887421 22358999999999999999999998 999999999999999999999999999
Q ss_pred CcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccC
Q 036051 243 LARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 243 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ + ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence 99865432211 1122345778999999998899999999999999999999 788986543321 1 1111111
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... .. .......+.+++.+||+.||++|||+.++++.|++.
T Consensus 231 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-----KQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 11 112234578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.77 Aligned_cols=257 Identities=24% Similarity=0.434 Sum_probs=215.8
Q ss_pred HHHhcCCCccceecccCceEEEEEEeC----CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLP----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
++..+.....+.||.|-||.||+|.+. +....||||..+.+ .....+.|+.|..+|++++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 344555566789999999999999873 33456999999875 455578899999999999999999999999865
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..|+|||.++.|.|..+|+.+.. .++......++.||+.||+|||+ ..++||||..+|||+.....+||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 67999999999999999987654 68889999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.+............-+..|||||.+.-.+++.+||||.|||++||+++ |..||.+-...+ +..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~ 603 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIG 603 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEE
Confidence 887766555555556789999999999999999999999999999865 999998755443 222
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.++..-..+.++.++..+..++.+||+.||.+||++.|+...|+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 22233334445566777889999999999999999999887775
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=314.39 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=204.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCce----eeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|+..+.||+|+||+||+|++..++. .||+|++... .......+.+|+..+..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4678889999999999999999765554 4899988654 334456788999999999999999999998754 578
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997643 268999999999999999999999 999999999999999999999999999998664
Q ss_pred CCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +..++. .+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~----- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGE----- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCC-----
Confidence 32211 1112234678999999988899999999999999999998 899986543322 111111 110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 374 (420)
.+.. .......+.+++.+||+.||++||++.++++.|+....-|
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 RLPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred cCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0111 1122345778899999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.20 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=200.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|+..+.||+|+||.||+|.+..++..||+|++... .......+.+|++++++++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999999888899999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|..+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 46788899999999999999999 99999999999999999999999999998765332
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-hhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-LVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ......... ....+....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV------DEDPPVLPV 222 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh------ccCCCCCCC
Confidence 2233578999999999998889999999999999999999999997543222110 000000000 000111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
......+.+++.+||+.||++||++.|+++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122347788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=313.80 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=201.8
Q ss_pred CCccceecccCceEEEEEEe----CCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEE
Q 036051 97 FREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL 169 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (420)
|+..+.||+|+||+||++.. ..++..||+|.+.... ......|.+|++.+++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 3456789999987553 23456788999999999999999999987653 46899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
+|||+++++|.+++... .+++.+++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999754 58999999999999999999999 9999999999999999999999999999886543
Q ss_pred CCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......++..|+|||++.+..++.++||||||+++|||++|..|+........ ................+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 2211 11223456679999999888899999999999999999999999865432110 00000000000001111111
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..............+.+++..||+.+|++|||+.++++.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111222345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=322.25 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=193.0
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..+++.||+|++... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999988999999998754 233345677888888776 899999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 99998886553 68999999999999999999999 99999999999999999999999999998753221 11233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCccc--chhhhhhhhhcccCccccccCCCCCCcc
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN--LILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+++........ ..++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~~- 227 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPRS- 227 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCCC-
Confidence 45789999999999999999999999999999999999999964322111 111112222111111 111122
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
....+.+++.+||+.||.+||++
T Consensus 228 ---~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 228 ---LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCHHHHHHHHHHhcCCHHHcCCC
Confidence 23446788889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.08 Aligned_cols=262 Identities=23% Similarity=0.267 Sum_probs=204.7
Q ss_pred hHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
+.++....++|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 455666778999999999999999999999999999999998643 22234567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998654 47888899999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCC----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence 986643332233456799999999998654 378899999999999999999999976543211 1111110
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQIL 367 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~L 367 (420)
..... ... .......+.+++.+|+..++.+ ||++.|+++..
T Consensus 263 ~~~~~-----~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLT-----FPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCccc-----CCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000 000 1122334667777788744433 78999988743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=312.15 Aligned_cols=257 Identities=27% Similarity=0.492 Sum_probs=204.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCC---ceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..+|++.+.||+|+||.||+|.+..+ +..+|+|.+.... ......+.+|+..+.+++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 35688899999999999999987533 3469999886542 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999976543 68999999999999999999998 9999999999999999999999999999986644
Q ss_pred CCCCcc--cccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 250 GTDPQT--THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 250 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
...... ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||......+. ...+. ++ .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----~~-----~ 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----EG-----Y 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----CC-----C
Confidence 322111 11223568999999988889999999999999999886 9999976543321 11111 11 0
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.... .......+.+++.+||+.+|.+||++.++++.|++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0001 112234577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=316.74 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=202.2
Q ss_pred cCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.+|.+.+.||+|+||.||+|.+.+ .+..||+|++..... .....+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677889999999999998753 346799999975533 33466889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 169 LVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
+++||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 1357888999999999999999998 9999999999999999999
Q ss_pred cEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhh
Q 036051 235 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDW 312 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 312 (420)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~-- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I-- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H--
Confidence 999999999876533221 11223345788999999988889999999999999999998 8888875443221 1
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.....+.. . ....+....+.+++..||+.+|.+||++.+|++.|+.
T Consensus 237 --~~i~~~~~-----~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 --EMIRNRQV-----L----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHcCCc-----C----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 1 1112234457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=309.66 Aligned_cols=256 Identities=27% Similarity=0.319 Sum_probs=211.8
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..-+.|+..+.||+|.-|+||++.+.+++..+|+|++.+.. +........|-++|+.++||.++.+|..++.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34456777889999999999999999998999999998763 334456778899999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
++||||+||+|..+++.++...+++..+.-++..++.||+|||. .|||.|||||+||||-++|++-|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999999899999999999999999999998 999999999999999999999999999875321
Q ss_pred C---------------------------------C-C---------------------CCcccccccCCcccccccccCC
Q 036051 249 H---------------------------------G-T---------------------DPQTTHVVGTLGYLAPEHTRTG 273 (420)
Q Consensus 249 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 273 (420)
. . . .......+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0112235889999999999999
Q ss_pred CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccC
Q 036051 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSD 353 (420)
Q Consensus 274 ~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 353 (420)
..+.+.|+|+|||++|||+.|..||.+.+..+... .++...+.-.-.++....+.+||.+.|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999999887665321 111111111111244456778888899999
Q ss_pred CCCCCC----HHHHHH
Q 036051 354 PTARPS----MRQVVQ 365 (420)
Q Consensus 354 P~~RPt----~~evl~ 365 (420)
|.+|.. +.||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 777754
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=312.08 Aligned_cols=256 Identities=28% Similarity=0.502 Sum_probs=203.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCc---eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+|..|+..+++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34777899999999999999986554 35999998754 344457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||+++++|.+++..... .+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999876533 68999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCc-ccc-c--ccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 251 TDPQ-TTH-V--VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 251 ~~~~-~~~-~--~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
.... ... . ..+..|+|||++.+..++.++||||||+++||+++ |..||......+ ...++.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~----~----- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQ----D----- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHc----C-----
Confidence 2111 111 1 12457999999998899999999999999999886 999997544322 1111110 0
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ....+....+.+++.+||+.+|.+||++.+++..|++.
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 11112334578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.70 Aligned_cols=250 Identities=33% Similarity=0.496 Sum_probs=205.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+|++++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888999999999999999984 56799999976644 457889999999999999999999999989999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999999987655578999999999999999999999 9999999999999999999999999999986532211
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
....+..|+|||++.+..++.++||||||+++|||++ |..||......+. . .....+ .....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~-----~~~~~-- 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PHVEKG-----YRMEA-- 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHhcC-----CCCCC--
Confidence 2334678999999988889999999999999999997 9999865533221 1 111111 01111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.......+.+++.+||+.+|++||++.|++++|++
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11223557888999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.23 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=202.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCce--eeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (420)
++|++.+.||+|+||.||+|.+..++. .+++|.+... .....+.|.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999876553 4688887643 334456789999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhccCCC--------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcE
Q 036051 171 YDYMPNGSLDKYLYNQPK--------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~ 236 (420)
+||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999965321 248889999999999999999998 999999999999999999999
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFD 315 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 315 (420)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||......+.. .
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------E 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 999999986432111 1111223567999999988889999999999999999997 99999765433211 1
Q ss_pred hcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....+ ..+.... .....+.+++.+||+.+|.+|||+.++++.|+...
T Consensus 230 ~~~~~-----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KLPQG-----YRMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHhcC-----CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1111111 22345778999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=307.79 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=209.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|++|.||+|....+++.||+|.+... .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999999888889999987532 2333567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||+++++|.+++... ....+++.+++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 23468999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+... ....+. .+.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~-----~~~ 227 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEKCD-----YPP 227 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-hhhcCC-----CCC
Confidence 221 223356888999999998888999999999999999999999998654321 111110 111110 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. .......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 113345678889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=323.25 Aligned_cols=242 Identities=25% Similarity=0.265 Sum_probs=191.8
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHH-HhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|++..+++.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999999888999999998654 2223345556655 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++.++..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 99998887544 68899999999999999999999 99999999999999999999999999998743221 12234
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~-~~~------~~~~~~--- 218 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNIL-HKP------LVLRPG--- 218 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHH-cCC------ccCCCC---
Confidence 457899999999999999999999999999999999999999765432211 1111 110 011111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.+++.+|++.||.+||++.+.++
T Consensus 219 -~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 -ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 2234667888899999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.19 Aligned_cols=203 Identities=27% Similarity=0.360 Sum_probs=176.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.|+..+.||+|+||+||+|+...++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999999889999999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT- 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 251 (420)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987653 57888999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------CCcccccccCCcccccccccCCCCCccchhhhhHH
Q 036051 252 ---------------------------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA 286 (420)
Q Consensus 252 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGv 286 (420)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999889999999999999
Q ss_pred HHHHHhcCCccCCCCCC
Q 036051 287 FLLEVACGRRPIERQGP 303 (420)
Q Consensus 287 vl~el~tg~~p~~~~~~ 303 (420)
++|||++|+.||....+
T Consensus 237 il~elltG~~Pf~~~~~ 253 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999976554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=321.65 Aligned_cols=242 Identities=22% Similarity=0.301 Sum_probs=195.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+|+..+.||+|+||.||+|++..++..||+|++.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999998888899999987542 22334567788887776 5899999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999987654 58899999999999999999998 99999999999999999999999999998753321
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ... ....+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i----~~~------~~~~p 221 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSI----MEH------NVAYP 221 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HHH----HhC------CCCCC
Confidence 11233457899999999999999999999999999999999999999765433211 100 010 01111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
. .....+.+++.+|++.||.+|++.
T Consensus 222 ~----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 K----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 223456788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=330.04 Aligned_cols=253 Identities=22% Similarity=0.259 Sum_probs=197.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||.||++....++..||||++... .......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999999989999999988653 2233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997654 68888999999999999999999 999999999999999999999999999986332100
Q ss_pred C------------C----------------------------------cccccccCCcccccccccCCCCCccchhhhhH
Q 036051 252 D------------P----------------------------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFG 285 (420)
Q Consensus 252 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG 285 (420)
. . .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124689999999999988999999999999
Q ss_pred HHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCC---CCHHH
Q 036051 286 AFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR---PSMRQ 362 (420)
Q Consensus 286 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~e 362 (420)
|++|||++|+.||......+... ....... ....+.. .. ....+.+++.+|++ +|.+| +++.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~------~i~~~~~--~~~~p~~-~~----~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYR------KIINWRE--TLYFPDD-IH----LSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHH------HHHccCC--ccCCCCC-CC----CCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999997654432110 0000000 0000110 01 12346677777887 66665 59988
Q ss_pred HHHH
Q 036051 363 VVQI 366 (420)
Q Consensus 363 vl~~ 366 (420)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.92 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=197.7
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
++||+|+||.||+|... ++..+|+|.+.... ......+.+|++.+++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999975 56679999887653 33345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...............
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99986543 258899999999999999999998 99999999999999999999999999998754433222222234
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 338 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (420)
++..|+|||++.+..++.++||||||+++||+++ |..||......... .....+ ..... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~----~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKG-----YRMSC----PQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcC-----CCCCC----CCCC
Confidence 4678999999988889999999999999999998 99999754332110 111111 01111 1123
Q ss_pred HHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 339 LELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 339 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
...+.+++.+||+.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 356888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=328.35 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=201.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-----eEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELL 168 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 168 (420)
+|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999999888899999988643 2334567889999999999999999999988776 789
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+. ++|.+.+.... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 68888876543 68999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc--------cc
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW--------NR 319 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~ 319 (420)
...........++..|+|||++.+. .++.++|||||||++|||++|+.||....+.+............ ..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3332233345678999999998764 47899999999999999999999997665433211110000000 00
Q ss_pred C---ccc-cccCCC-CC--CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 320 G---ELL-EARDPN-LG--TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 320 ~---~~~-~~~~~~-~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+ .+. ....+. .. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000 000000 00 00111123457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.36 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=195.7
Q ss_pred eecccCceEEEEEEe--CCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 102 LLGSGGFGRVYRGTL--PKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
.||+|+||.||+|.+ .+++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 4556789999886542 334577899999999999999999999886 45679999999999
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc--c
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--T 255 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~ 255 (420)
+|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997543 68899999999999999999998 999999999999999999999999999998654332211 1
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .+ ....+.. +....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~i~~~~~-----~~~~~-- 221 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ----MIESGER-----MECPQ-- 221 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHCCCC-----CCCCC--
Confidence 22234578999999988889999999999999999998 9999976543221 11 1111111 11111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.....+.+++.+||+.||++||++.+|.+.|++
T Consensus 222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.47 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=195.0
Q ss_pred ecccCceEEEEEEeC--CCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLP--KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||.||+|.+. +.+..||+|++.... ....+.|.+|+.++++++||||+++++++.. ...++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999774 445579999987653 3334678999999999999999999998864 578999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc--ccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTH 257 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~ 257 (420)
.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99987543 368999999999999999999998 899999999999999999999999999987554322211 111
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
..++..|+|||++.+..++.++||||||+++|||++ |..||......+.. .....+. .+. .+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~----~~~ 221 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGK-----RLD----CPA 221 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC-----CCC----CCC
Confidence 233578999999988889999999999999999996 99999765433211 1111111 111 112
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.....+.+++.+||+.||++||++.+|.+.|+.
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 234557788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=318.70 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=201.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCce--eeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||.||+|.+..++. .+++|.+... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4578888999999999999999876554 4677776543 334456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc
Q 036051 170 VYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~ 235 (420)
|+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 999999999999986432 1357899999999999999999998 99999999999999999999
Q ss_pred EEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhh
Q 036051 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 314 (420)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||......+.. +
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~--- 234 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E--- 234 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H---
Confidence 999999998632211 11112234668999999988889999999999999999998 99999754432210 0
Q ss_pred hhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
....+ ....... .....+.+++.+||+.+|++||++.++++.|+..
T Consensus 235 -~~~~~-----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLPQG-----YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHhcC-----CcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 0011111 1233578889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=320.63 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=194.7
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|++..++..||+|++... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999988999999999754 223345688899998888 699999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 99999886543 68999999999999999999999 99999999999999999999999999998743221 11233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............++........ ....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~p~~--- 225 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PIRIPRF--- 225 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CCCCCCC---
Confidence 4678999999999999999999999999999999999999997543332222222222222111 0111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCH
Q 036051 337 EELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
....+.+++.+||+.||.+||++
T Consensus 226 -~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 -LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCC
Confidence 22346788888999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.52 Aligned_cols=237 Identities=24% Similarity=0.329 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..++..||+|++... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999888889999998653 223345677888888776 699999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999887654 68899999999999999999998 999999999999999999999999999987532211 1233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+. ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~------~~~~~~--- 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDE------VVYPTW--- 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCC------CCCCCC---
Confidence 457899999999999889999999999999999999999999765432211 1111111 111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCH
Q 036051 337 EELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
....+.+++.+||+.||.+||++
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 -LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCC
Confidence 22456788889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.03 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=192.9
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..++..||+|++.... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999889999999987542 22334566777777654 899999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 99999987653 58889999999999999999999 99999999999999999999999999998743221 12234
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... ...+......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-------~~~~~------~~~~~~~~~~-- 219 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-------FESIR------VDTPHYPRWI-- 219 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHH------hCCCCCCCCC--
Confidence 46789999999999999999999999999999999999999976543221 11110 0111221222
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMR-QVV 364 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~-evl 364 (420)
...+.+++.+||+.||++||++. +++
T Consensus 220 --~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 --TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23467788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=328.42 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=205.9
Q ss_pred HHHhcCCCccceecccCceEEEEEEeC-----CCceeeeeecccccc-hhHHHHHHHHHHHhccCC-cceEeeeeeeeee
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR 163 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 163 (420)
.+..++|.+.+.||+|+||.||+|++. ..+..||+|++.... ....+.+.+|+.++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344567888899999999999999964 244679999997653 233457889999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCCC-------------------------------------------------------
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPK------------------------------------------------------- 188 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 188 (420)
.+..++|+||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999864321
Q ss_pred -----------------------------------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 189 -----------------------------------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 189 -----------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 236778889999999999999998 999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEE 305 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~ 305 (420)
||+++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999976432221 11223456788999999988889999999999999999998 889986543322
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. ......+. .+.. .......+.+++.+||+.+|.+||++.||++.|++.+
T Consensus 350 ~~------~~~~~~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QF------YNAIKRGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH------HHHHHcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 10 11111110 0111 1112345788888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=314.60 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=201.6
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999999999999999886532 22235577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999876555568999999999999999999998 999999999999999999999999999987543322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............ .... .........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~------~~~~~~~~~- 226 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLV------KEVQEEYSE- 226 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhh------hhhhhhcCc-
Confidence 122346899999999999889999999999999999999999999764322110000 0000 000011111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
.....+.+++.+||+.||.+||| +.|+++
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 ---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 22344778888999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=321.83 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=194.9
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++..++..||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999998888899999987542 23345677888888765 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|...+.... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 99999887554 68899999999999999999999 999999999999999999999999999987532221 1233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+. ...+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~-~~~------~~~p~~~-- 219 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESIL-HDD------VLYPVWL-- 219 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCC------CCCCCCC--
Confidence 457899999999999889999999999999999999999999765533211 1110 110 1111111
Q ss_pred HHHHHHHHHhhcccccCCCCCC-------CHHHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARP-------SMRQVVQ 365 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~ 365 (420)
...+.+++.+||+.||++|| ++.++++
T Consensus 220 --~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 --SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 23467888889999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=320.72 Aligned_cols=239 Identities=25% Similarity=0.319 Sum_probs=192.3
Q ss_pred ceecccCceEEEEEEe---CCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
+.||+|+||.||+++. ..++..||+|++.... ......+..|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3467889999987542 2233457789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+|+|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 999999986543 68999999999999999999999 999999999999999999999999999987543321 223
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... ... ...+.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~-~~~------~~~p~--- 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMIL-KAK------LGMPQ--- 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHH-cCC------CCCCC---
Confidence 3457899999999998888999999999999999999999999764432211 0000 000 11111
Q ss_pred HHHHHHHHHHhhcccccCCCCCCCHHH
Q 036051 336 AEELELILKLGLLCSHSDPTARPSMRQ 362 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt~~e 362 (420)
.....+.+++.+||+.||.+||++.+
T Consensus 220 -~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 -FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12344678888999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=308.87 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=204.5
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
++.+++++.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 44566777778899999999999999988888999999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccC--cHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCccc
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTL--NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARL 246 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~ 246 (420)
++||+++++|.+++..... .+ ++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975422 34 788899999999999999998 99999999999999986 67999999999875
Q ss_pred ccCCCCCcccccccCCcccccccccCCC--CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
..... .......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.......... +... ..
T Consensus 159 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~-------~~ 227 (268)
T cd06624 159 LAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVG-------MF 227 (268)
T ss_pred cccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhh-------hh
Confidence 53221 1222345789999999986543 7889999999999999999999996543211100 0000 00
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+. .+......+.+++.+||+.+|.+|||+.|+++
T Consensus 228 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 KIHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111 12223355778899999999999999999885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.97 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=205.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc----------------eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK----------------IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 156 (420)
..+|++.+.||+|+||.||+|.+.+.+ ..||+|.+... .....+++.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457888999999999999999875432 45899998765 3345678899999999999999999
Q ss_pred eeeeeeeCCeEEEEEeecCCCChhhhhccCC---------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQP---------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
+++++..++..++++||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987543 1258999999999999999999998 999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc--CCccCCCCCCc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIERQGPE 304 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t--g~~p~~~~~~~ 304 (420)
|+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433221 12223456788999999988889999999999999999988 67787654322
Q ss_pred ccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+ ................. ..........+.+++.+||+.||.+|||+.|+++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2 11111111111110000 01111223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=303.22 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=206.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh-HH-HHHHHHHHHhccCCcceEeeeeeeeee--CCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GM-KEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 169 (420)
-++|+..+.|++|.||.||+|+++.++..||+|+++.+... .. -.-++||.+|.+.+|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35678889999999999999999999999999999765321 11 235789999999999999999887654 357999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|||||+. +|..++.+.+ .++...++..+..|+++|++|||+ ..|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999965 9999998765 478889999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh--------hhhhcccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW--------VFDFWNRG 320 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 320 (420)
... ..+..+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+.++.+++..+-. +|..+..-
T Consensus 230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 432 3455677999999999866 4699999999999999999999999988776554332110 11111110
Q ss_pred ccc------cccCCCCCCcccHH-HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 ELL------EARDPNLGTEYVAE-ELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 ~~~------~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... +.....+...+... ..+.-++++...+..||.+|.|+.|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 11111111112111 2245567778889999999999999986
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=321.05 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=195.8
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|.+..++..||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998888899999987542 23345677888888877 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|..++.... .+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccc
Confidence 99999887654 68999999999999999999998 99999999999999999999999999998643221 11223
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ......
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~------~~~~~~---- 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILED------EVRYPR---- 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcC------CCCCCC----
Confidence 456899999999999999999999999999999999999999754432210 000011 111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSM-----RQVVQ 365 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 365 (420)
.....+.+++.+||+.||.+||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 123457788899999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.97 Aligned_cols=257 Identities=27% Similarity=0.471 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|+..+.||+|+||.||+|.+.. .+..||+|.+.... .....+|.+|+.++++++|||++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4678889999999999999998743 46789999987553 34456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCC--------------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 168 LLVYDYMPNGSLDKYLYNQP--------------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
++++||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986421 1257888999999999999999998 999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEE 305 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~ 305 (420)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11222344678999999988899999999999999999997 888886544322
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. . .....+... . ........+.+++.+||+.||.+|||+.|+++.|++
T Consensus 241 ~------~-~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V------I-YYVRDGNVL-----S----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H------H-HHHhcCCCC-----C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1 111111111 0 111223568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.77 Aligned_cols=248 Identities=31% Similarity=0.507 Sum_probs=197.9
Q ss_pred ceecccCceEEEEEEeCCCc---eeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSK---IEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|.+...+ ..+|+|.+..... ...+.+.+|+.+++++.|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875444 6799999876543 34567899999999999999999999876 4567999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc-
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT- 255 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~- 255 (420)
++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997665 68999999999999999999998 8999999999999999999999999999986643322211
Q ss_pred -cccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 256 -THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 256 -~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ...++. .... . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~~-----~----~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGER-----L----P 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCCc-----C----C
Confidence 11223568999999988899999999999999999998 999997654322 111111 1100 0 0
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
........+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.70 Aligned_cols=264 Identities=28% Similarity=0.370 Sum_probs=196.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccC---CcceEeeeeeeeee-----CC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRR-----KG 165 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 165 (420)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999999899999999886432 11123455666666554 79999999998764 34
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++++||++ ++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999996 589888876555568999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-hhhhh----hhcccC
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-VDWVF----DFWNRG 320 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-~~~~~----~~~~~~ 320 (420)
...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+.... ..... ..+...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 654321 22335678999999999888899999999999999999999999976543321110 00000 000000
Q ss_pred -ccc-cccCCCC---CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 -ELL-EARDPNL---GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 -~~~-~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... ....+.. ......+....+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000 01111223455788999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.89 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=192.9
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhcc-CCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|++..++..||+|++.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999998888899999987542 2233456677777775 4899999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCcee
Confidence 99999997643 58889999999999999999999 99999999999999999999999999998743221 11233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... ...+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~----~i~------~~~~~~~~~--- 218 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---Q----SIR------MDNPCYPRW--- 218 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---H----HHH------hCCCCCCcc---
Confidence 457899999999999889999999999999999999999999765432211 0 000 011111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMR-QVV 364 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~-evl 364 (420)
....+.+++.+||+.||++||++. ++.
T Consensus 219 -~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 -LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 223467888899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=326.64 Aligned_cols=247 Identities=30% Similarity=0.472 Sum_probs=208.4
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChh
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 180 (420)
-+||+|.||+||.|++..+...+|||.+...+....+-+..|+..-++++|.|||+++|.+..++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999999999999999998777666677889999999999999999999999999999999999999999
Q ss_pred hhhccC-CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEEeeecCcccccCCCCCccccc
Q 036051 181 KYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRLGDFGLARLYDHGTDPQTTHV 258 (420)
Q Consensus 181 ~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 258 (420)
++|+.. +...-++...-.+.+||++||.|||+ +.|+|||||-+|||++ -.|.+||+|||.++.+.. .++...+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 999764 22233778888899999999999999 9999999999999997 468899999999987643 45667778
Q ss_pred ccCCcccccccccCC--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 259 VGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 259 ~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
.||..|||||++..+ .|..++|||||||++.||.||++||-..+..... +.+..--..-.+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFKVGMYKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhhhcceecCCCCcH
Confidence 999999999999654 5899999999999999999999999765443211 111111122234456
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.......++++|+.+||.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 66777888999999999999999999986
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=312.77 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=206.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..+|+..+.||+|++|.||+|....++..||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999999888889999998765544556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 9999999998654 57889999999999999999999 899999999999999999999999999987654322 1
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+...... . .....+. ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~------~~~~~~~--~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------I------ATNGTPE--LQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------e------ccCCCCC--CC
Confidence 22335688899999999988899999999999999999999999976543221110 0 0000011 01
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223345778889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.44 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=209.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-c-----ceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-H-----RNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 168 (420)
-+|.+.+.||+|.||.|-+|.+.++++.||||+++... ....+-..|+.+|..|+ | -|+|++++++...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 37889999999999999999999999999999997553 33456678999999986 4 59999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC--CcEEEeeecCccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE--LNGRLGDFGLARL 246 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfg~~~~ 246 (420)
||+|.+ ..+|+++|+.+.-..++...+..|+.||+.||.+||. .+|||+||||+||||.+- ..+||+|||.++.
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999 7799999998887789999999999999999999998 999999999999999754 3699999999987
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh--------hhhh----
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV--------DWVF---- 314 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~--------~~~~---- 314 (420)
..... ....-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+++..+ .++.
T Consensus 341 ~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 55432 2456688899999999999999999999999999999999999887766543311 1111
Q ss_pred ---hhccc-C---------c-----------------cccccCCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 315 ---DFWNR-G---------E-----------------LLEARDPNLGTE----YVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 315 ---~~~~~-~---------~-----------------~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
.+... . . ..+...|.-... .....-..+++++++|+..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 01111 0 0 000111100001 111334568999999999999999999
Q ss_pred HHHHH
Q 036051 361 RQVVQ 365 (420)
Q Consensus 361 ~evl~ 365 (420)
.++++
T Consensus 497 ~qal~ 501 (586)
T KOG0667|consen 497 AQALN 501 (586)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=305.44 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=206.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||.||+|.+..++..+++|.+..... .+++.+|++.+++++|||++++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578889999999999999999988788899999865533 57899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 154 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-A 154 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc-c
Confidence 99999999986543 368999999999999999999998 899999999999999999999999999988654322 1
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....+....... .....+.. .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPPTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCCCC--C
Confidence 223345788999999998889999999999999999999999999765433211100 00000010 1
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11222345788889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=312.38 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=203.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999999888888999988654 333446688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999997653 68899999999999999999997 258999999999999999999999999998754322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc------------
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE------------ 321 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 321 (420)
......++..|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 22345688999999999888899999999999999999999999965432221100000000000000
Q ss_pred ------------cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 322 ------------LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 322 ------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
......+..... .....+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111000 123457899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.65 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=204.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|.+.+ +..+++|.+.... .....+.+|+.++++++|+|++++++++.. ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34678889999999999999998754 4469999886543 234678899999999999999999999877 77899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999977655578899999999999999999998 8999999999999999999999999999976543322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......++..|+|||++....++.++|+||||+++|++++ |+.||........ ..+. ..+.. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~-----~--- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----ERGYR-----M--- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----hCCCC-----C---
Confidence 22223345678999999988889999999999999999998 8999975443221 1111 11100 0
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111233457888899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=305.86 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=207.0
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||.|+||.||.++...++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999999888899999987654 344557789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999987644578999999999999999999998 8999999999999999999999999999986544321
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..... .+.. .+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~----~~----- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNY----TP----- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCC----CC-----
Confidence 23345689999999999888889999999999999999999999975443221 11111 1111 00
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112223457788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.80 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=201.6
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC------
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK------ 164 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------ 164 (420)
.++..|+..+.||+|+||.||+|.+.+++..||+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999998889999999986543 2335678899999998 799999999988653
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 468999999999999999986554578999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....+...... ..
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------~~-- 229 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP-- 229 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hh--
Confidence 7653322 2233456889999999985 34578899999999999999999999965433221100 00
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.... ......+.+++.+||..||.+|||+.++++
T Consensus 230 ----~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 ----RNPAPRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----cCCCCCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000111111 112345788899999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=310.16 Aligned_cols=253 Identities=32% Similarity=0.499 Sum_probs=202.0
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHH--HHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM--KEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|+..+.||+|+||+||++....++..+|+|++........ .....|+..+.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999999999999999987644332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++... ..+++..++.++.|++.||++||+ .+++|+||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999833 268999999999999999999999 999999999999999999999999999987641 12234
Q ss_pred ccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||......+...... ..... ...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~-~~~~~~------~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR-PLPSSS------Q 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT-HHHHHT------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc-cccccc------c
Confidence 44567899999999998 7889999999999999999999999998652111111110 00000 000000 0
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001166889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.38 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=201.5
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56678899999999999999888889999998766666667899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99998876532 268999999999999999999999 999999999999999999999999999987543221 1223
Q ss_pred ccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 257 HVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
...++..|+|||++. +..++.++|||||||++|||++|+.||......+.. . .... ...+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~----~~~~------~~~~~~- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--L----KIAK------SEPPTL- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--H----HHhh------cCCCCC-
Confidence 356889999999873 345788999999999999999999999765432211 0 0000 000110
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.........+.+++.+||+.||.+||++.++++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123457788899999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=306.85 Aligned_cols=249 Identities=32% Similarity=0.451 Sum_probs=200.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeee-eCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 172 (420)
..+|.+.+.||+|+||.||+|... +..|++|...... ..+.+.+|+.++++++|+|++++++++. .++..++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357888899999999999999874 5569999886543 2367889999999999999999999754 5567899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999999987655568999999999999999999998 999999999999999999999999999987543221
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+ ..+ ..+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~----~~~-----~~~~-- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKG-----YKMD-- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcC-----CCCC--
Confidence 22334668999999988889999999999999999997 9999865432211 1111 011 0111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111234557788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.45 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=203.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee-CCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 172 (420)
+|++.+.||+|++|.||++.+..+++.|++|.+... .....+.+.+|++.+++++|+|++++++.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999999888889999998654 23445678899999999999999999988764 456899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++.++..++.+++.|+++||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999976544568999999999999999999998 999999999999999999999999999998654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......+++.|+|||++.+..++.++||||||++++||++|+.||........ .... ..+.. +..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~-~~~~~-----~~~-- 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRI-IEGKL-----PPM-- 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHH-HhcCC-----CCC--
Confidence 223345688999999999988999999999999999999999999975432211 1111 01111 111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.++++
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1223356888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=316.19 Aligned_cols=255 Identities=23% Similarity=0.259 Sum_probs=197.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||+||++++..++..||+|++... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788899999999999999999888889999998653 2223455788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999976422 68889999999999999999999 999999999999999999999999999997654433
Q ss_pred CCcccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~----- 225 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEE----- 225 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCC-----
Confidence 223334579999999999865 46788999999999999999999999754432211 11110000
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 365 (420)
....... ..+....+.+++.+|+..++.+ |+++.++++
T Consensus 226 ~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 RFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0001111 1112344666777777765543 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.28 Aligned_cols=245 Identities=28% Similarity=0.407 Sum_probs=205.8
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.|...+.||.|.||.||-|++..+...||||+++-. ..+.+.+++.|+..|.+++|||++.+-|||......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355568899999999999999999999999998754 45668899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|| -|+-.+++.-.. .++.+.++..|+.+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.+....+
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 678888776543 378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccCCcccccccc---cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 253 PQTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
...++|||.|||||++ ..+.|+-|+||||||++..||.-.++|+...+.-..+. .+-++-.|.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------------HIAQNesPt 244 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPT 244 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------------HHHhcCCCC
Confidence 3457899999999987 35789999999999999999999999998766533211 111222333
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+. ..+-.+.+..++..||++-|.+|||..++++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 33 3344566778888899999999999888765
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=314.79 Aligned_cols=204 Identities=25% Similarity=0.312 Sum_probs=176.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||++++..++..||+|++... .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999999888889999998643 2223456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999996532 268899999999999999999999 999999999999999999999999999987654433
Q ss_pred CCcccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 323333568999999999863 457889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.39 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceEEEEEEeC-------CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
..+|.+.+.||+|+||.||+|+.. .....+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457788999999999999999753 23456899988754 334456788999999999 699999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+..++++||+++|+|.+++.... ...+++.++..++.|++.||.|||+ .+++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 99999999999999999986532 1358899999999999999999998 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~- 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF- 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 99999999999999765432111 1122234567999999988889999999999999999998 88898654432211
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+.. ... .......+.+++.+||+.||++|||+.|+++.|++..
T Consensus 247 ------~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 ------KLLREGHR-----MDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ------HHHHcCCC-----CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111111 011 1122345778899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=320.41 Aligned_cols=244 Identities=25% Similarity=0.284 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHH-HhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|++..++..||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999998888899999986532 122234444544 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+.+.....++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 99999987654 57788888999999999999999 99999999999999999999999999998753221 12233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. + ... .. ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~-~~------~~~~~~---- 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NIL-NK------PLQLKP---- 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---H---HHH-hC------CcCCCC----
Confidence 457999999999999999999999999999999999999999765432211 1 000 00 001111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.....+.+++.+||+.||.+||++.+.+..+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 2234477888889999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=308.79 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=196.2
Q ss_pred ceecccCceEEEEEEeCCCce--eeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|++.+++. .+++|.+... .......+.+|+..+.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999876654 4688888643 344456788999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 177 GSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 177 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
|+|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1247899999999999999999998 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||......+.. .....+.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EKLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-------HHHhCCC
Confidence 98532211 11111233567999999988889999999999999999997 99999654332210 0111110
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.... .......+.+++.+||+.||.+|||+.+++..|++.
T Consensus 229 -----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 -----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----CCCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011 111234578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=310.10 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.+.|++.+.||+|+||.||+|++..++..+++|.+..........+.+|+.+++.++|||++++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 35688899999999999999999888899999999877766678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ..
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999988876543 268999999999999999999998 99999999999999999999999999998754322 11
Q ss_pred cccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 254 QTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
......++..|+|||++. ...++.++|||||||++|||++|+.||......... .... . ...+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-~-----~~~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIA-K-----SEPP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHh-c-----CCCc
Confidence 223456788999999984 345688999999999999999999999754432110 0000 0 0011
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. .........+.+++.+||+.||++||++.++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 011122345778889999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.75 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=206.2
Q ss_pred HHhcCCCccceecccCceEEEEEEeC-------CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLP-------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR 162 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 162 (420)
....+|.+.+.||+|+||.||+|++. ..+..||+|.+... .......+.+|+..+..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999752 23457999988654 234457789999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCE
Q 036051 163 RKGELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNV 228 (420)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NI 228 (420)
.....+++|||+++|+|.+++.... ...+++.++..++.||+.||.|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 9999999999999999999987542 2357888999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCccc
Q 036051 229 LLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEEN 306 (420)
Q Consensus 229 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~ 306 (420)
++++++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999999866432221 1222345678999999988889999999999999999998 7888865433221
Q ss_pred chhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......+.. .. ........+.+++.+||+.+|.+|||+.|+++.|++..
T Consensus 249 -------~~~~~~~~~-----~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 249 -------FKLLKEGHR-----MD----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred -------HHHHHcCCc-----CC----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111111110 00 11123355778899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=309.06 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=205.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|+..+.||.|++|.||+|.+..++..|++|.+.... ......+.+|+++++.++|+|++++++++......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999998889999999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998765 68999999999999999999998 899999999999999999999999999998765432 2
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......++..|+|||++.+..++.++||||||+++|||++|+.||....+.... .... ....+.....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~-----~~~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIP-----KNNPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhh-----hcCCCCCccc
Confidence 233456788999999998888999999999999999999999999765432211 0000 0111111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.+++.+||..+|++|||+.++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02335778888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.13 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=200.4
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++.+++|+|++++.+++..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999998888899999986542 22234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999998876544579999999999999999999998 999999999999999999999999999987543221
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||........... +....... ....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~------~~~~--- 224 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLET------EEVY--- 224 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcc------cccc---
Confidence 22335689999999999888899999999999999999999999976443211100 00000000 0111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
.......+.+++..||+.||++||+ +.+++.
T Consensus 225 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 -SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122334678888899999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.73 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
..++|++.+.||+|+||.||+|..++ .+..||+|.+.... ......+.+|+..++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46788999999999999999997642 34579999886543 2334568899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCC--------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQP--------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996432 1345677889999999999999998 99999999999999999999999
Q ss_pred eeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~----~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL----KF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HH
Confidence 99999875433221 11222345678999999988889999999999999999998 788886543322 11 11
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...+.. .... ......+.+++.+||+.||++|||+.++++.|++..
T Consensus 234 ~~~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGY-----LDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCC-----CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111 1111 112356888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=306.89 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=206.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..|+..+.||.|+||.||+|.+..++..||+|.+... .......+.+|+.++++++|||++++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3567788899999999999999888889999988654 234457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++... .+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-c
Confidence 9999999998654 58889999999999999999998 999999999999999999999999999997654322 1
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......++..|+|||++.+..++.++|+||||+++|||++|+.||....+..... .........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCCC
Confidence 2233467889999999988889999999999999999999999997654332110 001111122
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 233455678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.75 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=206.0
Q ss_pred HHhcCCCccceecccCceEEEEEEeCC----Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeee-CC
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPK----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KG 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 165 (420)
+..++|++.+.||+|+||.||+|.+.. .+..|++|++... .......+.+|+.++++++|||++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346788889999999999999999865 2577999988654 33445778899999999999999999998766 56
Q ss_pred eEEEEEeecCCCChhhhhccCCC------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPK------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
..++++||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence 78999999999999999865422 368999999999999999999998 999999999999999999999999
Q ss_pred eecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhc
Q 036051 240 DFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 240 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....+.+ +..++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---
Confidence 99999755332211 1122345678999999988889999999999999999998 999997654322 111111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+. .... .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 -~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 -DGY-----RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -cCC-----CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 110 1111 111234578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.03 Aligned_cols=262 Identities=25% Similarity=0.413 Sum_probs=202.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCC--------------ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS--------------KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLL 158 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~ 158 (420)
.++|++.+.||+|+||.||++++.+. ...||+|.+... .......|.+|++.+.+++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45788899999999999999987432 235899998764 333456789999999999999999999
Q ss_pred eeeeeCCeEEEEEeecCCCChhhhhccCC----------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCE
Q 036051 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQP----------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNV 228 (420)
Q Consensus 159 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NI 228 (420)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 99999999999999999999999986432 1247889999999999999999998 9999999999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc--CCccCCCCCCcc
Q 036051 229 LLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIERQGPEE 305 (420)
Q Consensus 229 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t--g~~p~~~~~~~~ 305 (420)
++++++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875432221 11222345678999999988889999999999999999988 566776544322
Q ss_pred cchhhhhhhhhcccC-ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 306 NLILVDWVFDFWNRG-ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.. .......... ....... .......+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VI---ENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH---HHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11 1111111110 0000000 1112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=316.38 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=200.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|...+.||+|+||.||+|++..++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999998888899999886542 22234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ ++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 96 488888765432 57889999999999999999999 9999999999999999999999999999875433221
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh---------hcccCccc
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD---------FWNRGELL 323 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 323 (420)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......... ........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2223467899999998865 4688999999999999999999999976554332111100000 00000000
Q ss_pred cccCCCCCC----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGT----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 001112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.30 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceEEEEEEeCC-------Cceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
.++|.+.+.||+|+||.||++.+.+ ....+|+|.+... ......++..|+.++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678899999999999999998632 2346999998754 234456788999999999 799999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+..++|+||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999997542 1258899999999999999999998 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||.+......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 99999999999998755322111 1112234568999999988889999999999999999998 8888865432211
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......+.. . .........+.+++.+||+.+|++|||+.++++.|+...
T Consensus 252 -----~~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 252 -----FKLLKEGHR-----M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -----HHHHHcCCC-----C----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111110 1 111122346778889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.77 Aligned_cols=204 Identities=25% Similarity=0.319 Sum_probs=176.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||++++..++..+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688899999999999999999888889999998643 2223345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976432 68899999999999999999999 999999999999999999999999999987554332
Q ss_pred CCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 22333457999999999985 3467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=317.71 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceEEEEEEeCC-------Cceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
..+|.+.+.||+|+||.||+|++.+ ....||+|.+... .....+++.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468889999999999999998632 2236899988754 334457889999999999 799999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+..++++||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 99999999999999999986532 2357889999999999999999998 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 99999999999998765432211 1122234567999999988889999999999999999998 88888654432211
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.....+. .... .......+.+++.+||+.+|++||++.|+++.|++...
T Consensus 247 ------~~~~~~~-----~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 ------KLLKEGH-----RMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ------HHHHcCC-----CCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111111 0111 11223457788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.97 Aligned_cols=249 Identities=32% Similarity=0.529 Sum_probs=203.6
Q ss_pred ceecccCceEEEEEEeCCC---ceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKS---KIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|.+... +..|++|.+...... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999765 778999999766433 367889999999999999999999999999999999999999
Q ss_pred CChhhhhccCC-------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 177 GSLDKYLYNQP-------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 177 g~L~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
++|.+++.... ...+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 2478999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. . .....+. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~-----~ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L----EYLRKGY-----R 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCC-----C
Confidence 321 12333557889999999988889999999999999999999 6999976543221 1 1111111 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.. ........+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 226 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LP----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 11122456788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=303.62 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=207.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||.||+|.+..++..+++|.+........+.+.+|+.++++++|||++++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788899999999999999999888888999999876555668899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999887642 268899999999999999999998 999999999999999999999999999987654321 1
Q ss_pred cccccccCCcccccccccCC---CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+....... .... ...+..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~---~~~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSN---FPPPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hhcc---CCCccc
Confidence 22335678899999999776 7899999999999999999999999765433211100 0000 000111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.+|.+|||+.+++.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=307.06 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=203.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|...+.||+|+||.||+|++..++..||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34677788999999999999999888999999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 99999999987654 68899999999999999999999 899999999999999999999999999987654322 2
Q ss_pred cccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......|+..|+|||++. ...++.++|||||||++|||++|+.||....+....... . .... ..+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~-~~~~---~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------T-KSNF---QPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------h-ccCC---CCCcc
Confidence 233457899999999874 456888999999999999999999998654432211100 0 0000 00111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. .......+.+++.+||+.+|++||++.++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0011234778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=310.85 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=203.1
Q ss_pred hcCCCccceecccCceEEEEEEeC----------------CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP----------------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 156 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 156 (420)
.++|++.+.||+|+||.||++.+. ++...||+|++... ......+|.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998643 23456899998754 3344567899999999999999999
Q ss_pred eeeeeeeCCeEEEEEeecCCCChhhhhccCCC---------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPK---------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
+++++...+..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 99999999999999999999999999875421 247788999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc--CCccCCCCCCc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIERQGPE 304 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t--g~~p~~~~~~~ 304 (420)
|+++.++.++|+|||++..+...... ......++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998755332211 1122344678999999888889999999999999999998 77888654433
Q ss_pred ccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+... .......... .....+. ...+...+.+++.+||+.||.+||++.||++.|++
T Consensus 241 ~~~~---~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIE---NTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHH---HHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2111 0111110000 0000111 11123568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=311.55 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=205.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|+..+.||.|++|.||+|.+..+++.|++|.+........+.+.+|+..++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999998888999999887655445577889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999988654 58999999999999999999999 9999999999999999999999999999876543221 2
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||....+....... ... ..+.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~------~~~~~--~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN------GTPEL--QN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc------CCccc--CC
Confidence 23346889999999998888999999999999999999999999765443211100 000 00000 01
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122345778888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=305.50 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=201.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ...+|.+|++++++++|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467778999999999999999854 55799998865432 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 82 EHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999875432 57899999999999999999998 899999999999999999999999999987553322211
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .. ...+ .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~---~~-~~~~--~~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V---ET-INAG--FRLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H---HH-HhCC--CCCCCCCC---
Confidence 222335678999999988889999999999999999998 9999875443221 1 11 1111 01111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.90 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=203.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCC---ceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..+|.+.+.||+|+||.||+|.+... ...|++|...... ....+.+.+|+.++++++|||++++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35677889999999999999987543 3468999887654 4456789999999999999999999998875 45789
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999976533 58999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
..........++..|+|||.+....++.++||||||+++|||++ |+.||......+.. .++ ..+. ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~-----~~ 227 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGE-----RL 227 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCC-----cC
Confidence 32222222334568999999988889999999999999999886 99999765433211 111 1111 01
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.... .....+.+++.+|+..+|++|||+.++++.|++.
T Consensus 228 ~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 PMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 2234578888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=309.23 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=202.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999998888899999887442 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 999999988653 58899999999999999999998 999999999999999999999999999987654321 12
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+....+..... . ......+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~-----~~~~~~~~~---- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------L-----IPKNSPPTL---- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------h-----hhcCCCCCC----
Confidence 223457889999999998889999999999999999999999987544322110 0 001111111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12234557888999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=304.15 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=200.4
Q ss_pred ceecccCceEEEEEEeCC-Cc--eeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPK-SK--IEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|++|.||+|.+.. ++ ..||+|.+..... ...+.+.+|+..+++++||||+++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999854 22 3689999987655 566789999999999999999999999888 889999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC--c
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--Q 254 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 254 (420)
++|.+++.......+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999977643468999999999999999999999 99999999999999999999999999999866432211 1
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ........ . ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~-------~--~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL------KKIDKEGE-------R--LE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCC-------c--CC
Confidence 122456788999999988899999999999999999998 99999654332211 00000000 0 00
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
........+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123356888999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=309.61 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=205.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||.|+||.||+|.+..++..+|+|.+........+.|.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46788899999999999999999888889999999776666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 ~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~ 158 (280)
T cd06611 84 CDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQ 158 (280)
T ss_pred cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc-cc
Confidence 999999999876432 68999999999999999999999 99999999999999999999999999988754322 12
Q ss_pred cccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 254 QTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||......... . . ...+ ..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~-~~~~-----~~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----K-ILKS-----EPP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----H-HhcC-----CCC
Confidence 223456889999999874 345678999999999999999999999765432211 0 0 0011 001
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.+. ........+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 110 011123356788889999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=305.48 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=201.1
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccch---------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
+|.+...||+|++|.||+|.+..++..+|+|.+..... ...+.+.+|+.++.+++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36678899999999999999988888999998754321 223568899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++++||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997653 68889999999999999999998 8999999999999999999999999999886
Q ss_pred ccCCCC-----CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 247 YDHGTD-----PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 247 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~------ 223 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FK------ 223 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HH------
Confidence 642211 1112245788999999998888999999999999999999999999754322110 00
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+.... .....+.+++.+||+.||.+||++.|+++
T Consensus 224 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111122222 23355778888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=303.31 Aligned_cols=252 Identities=32% Similarity=0.531 Sum_probs=203.0
Q ss_pred CCccceecccCceEEEEEEeCCCc----eeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSK----IEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
|++.+.||.|+||.||++.+...+ ..||+|++...... ..+.+.+|+..+..++|+|++++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356788999999999999997655 78999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.......+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999976543338999999999999999999999 899999999999999999999999999998665432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........++..|+|||.+.+..++.++||||||++++||++ |..||........ .. ....+.. ...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~----~~~~~~~-----~~~ 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LE----YLKKGYR-----LPK 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhcCCC-----CCC
Confidence 222212336789999999988889999999999999999998 7888865432211 11 1111110 111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.. .....+.+++.+||+.||++|||+.|+++.|
T Consensus 226 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1334578889999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.32 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=178.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|+||.||++....++..||+|++... .......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999999988999999998643 2233466888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997654 58899999999999999999999 999999999999999999999999999987442211
Q ss_pred C----------------------------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCcc
Q 036051 252 D----------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297 (420)
Q Consensus 252 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p 297 (420)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234789999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 036051 298 IERQGPE 304 (420)
Q Consensus 298 ~~~~~~~ 304 (420)
|....+.
T Consensus 236 f~~~~~~ 242 (360)
T cd05627 236 FCSETPQ 242 (360)
T ss_pred CCCCCHH
Confidence 9765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=303.36 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=204.7
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|+||.+|++....+++.|++|.+... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999999888889999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999999876544468899999999999999999998 8999999999999999999999999999976543221
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||......+. +.... .+ ..+..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~-----~~~~~--- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RG-----SYPPV--- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cC-----CCCCC---
Confidence 12234578899999999888899999999999999999999999975432211 11111 01 01111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.+|++||++.+|++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1223445788889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=318.64 Aligned_cols=264 Identities=23% Similarity=0.255 Sum_probs=198.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-----
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----- 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 165 (420)
..++|+..+.||+|+||.||++.+..++..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999888999999998643 3334567889999999999999999999886543
Q ss_pred -eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 166 -ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 166 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
..++||||++ ++|...+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 5799999995 466666632 47888999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh------------hh-
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL------------VD- 311 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~------------~~- 311 (420)
...... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ..
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 754321 123345789999999999999999999999999999999999999976543211000 00
Q ss_pred ---hhhhhcccCccc-----cccCCCC----CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 312 ---WVFDFWNRGELL-----EARDPNL----GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 312 ---~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.+.......... ....+.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 0000000 000011123457889999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=306.34 Aligned_cols=250 Identities=31% Similarity=0.495 Sum_probs=197.5
Q ss_pred ceecccCceEEEEEEeCCCc------eeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 101 ELLGSGGFGRVYRGTLPKSK------IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+.||+|+||.||+|++.+.. ..+++|.+.... ......+.+|+..++.++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 35899999999999985433 679999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC-----CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-----cEEEeeecC
Q 036051 174 MPNGSLDKYLYNQP-----KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-----NGRLGDFGL 243 (420)
Q Consensus 174 ~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-----~~kl~Dfg~ 243 (420)
+++++|.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 2347889999999999999999998 8999999999999999877 899999999
Q ss_pred cccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 244 ARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 244 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
+........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH----HhcCC
Confidence 875432211 11222345788999999998899999999999999999998 999986543322 1111 00110
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.. .........+.+++.+||+.+|.+||++.++++.|++
T Consensus 231 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -----RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.11 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=194.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (420)
+|+..+.||+|+||+||+|.+..++..||+|++.... ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999998889999999987542 233456778888888875 678888999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999987654 58999999999999999999998 999999999999999999999999999987532211
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ... .. .....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~---~i~-~~------~~~~p 221 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQ---SIM-EH------NVSYP 221 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHH-hC------CCCCC
Confidence 122345689999999999988999999999999999999999999976543221 11 100 00 01111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
.. ....+.+++.+||+.||.+|++.
T Consensus 222 ~~----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KS----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cc----CCHHHHHHHHHHcccCHhhCCCC
Confidence 12 22456788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=308.27 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=202.1
Q ss_pred cCCCccceecccCceEEEEEEe----CCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (420)
..|++.+.||+|+||.||++.+ ..++..||+|.+.... ......+.+|+.++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567889999999999999984 3457789999987553 34456789999999999999999999998775 568
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999999865432 58999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc--------cchhhhhhhhhc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--------NLILVDWVFDFW 317 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~ 317 (420)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|........ ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 432211 1223456778999999988889999999999999999999877653211100 000000000111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+.. . +........+.+++.+||+.||++|||+.++++.|+..
T Consensus 240 ~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR-----L----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc-----C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11100 0 01112345688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=307.08 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCce----eeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..+|+..+.||+|+||.||+|.++.++. .+|+|...... .....++.+|+..+++++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4567888999999999999999865543 58999886553 3445778999999999999999999999887 7889
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999976533 58999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCc-ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
...... .....++..|+|||.+....++.++|+||||+++||+++ |+.||......+. . .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---P----DLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---H----HHHhCCCC----
Confidence 332211 111223568999999988889999999999999999998 9999976543321 1 11111110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..... .....+.+++.+||..||.+||++.++++.|+...
T Consensus 230 -~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -LPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -CCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00011 12234778888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.11 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=198.6
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
+.||+|+||.||++.+.+ ++.|++|.+..... .....+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999977 78899998876533 3457899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc-ccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THV 258 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 258 (420)
.+++..... .+++..+..++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++........... ...
T Consensus 80 ~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999865432 67899999999999999999998 9999999999999999999999999999875542221111 122
Q ss_pred ccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 259 ~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..+..|+|||.+.+..++.++|+||||+++|||++ |..||.......... . ...+ .. ......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~----~~~~-----~~----~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---R----IESG-----YR----MPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---H----HhcC-----CC----CCCCcc
Confidence 34567999999988889999999999999999999 888886654322110 0 0000 00 011112
Q ss_pred HHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 338 ELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3346888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=304.47 Aligned_cols=240 Identities=26% Similarity=0.420 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEeCC------------CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 101 ELLGSGGFGRVYRGTLPK------------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
+.||+|+||.||+|++.. ....|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998632 22358999887665555667889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc-------EEEeee
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN-------GRLGDF 241 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~-------~kl~Df 241 (420)
++|||+++++|..++.... ..+++..++.++.||+.||+|||+ .+++||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 258999999999999999999999 99999999999999986654 899999
Q ss_pred cCcccccCCCCCcccccccCCccccccccc-CCCCCccchhhhhHHHHHHHh-cCCccCCCCCCcccchhhhhhhhhccc
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+.. ... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~-~ 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY-E 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-h
Confidence 998654321 2245788899999986 467899999999999999997 588887654322110 000 0
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
+. ...... ....+.+++.+||+.||.+||++.+|++.+
T Consensus 224 ~~------~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQ------CMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cC------ccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 001111 124577889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=307.86 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=206.6
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
.++.++..+...|+..+.||+|+||.||+|.+..+++.+|+|++..... ...++..|+.++.++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 3556666677899999999999999999999988889999999865432 335688899999988 79999999998753
Q ss_pred ------CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 164 ------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 164 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
....+++|||+++|+|.+++.......+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4678999999999999999976555568888999999999999999999 9999999999999999999999
Q ss_pred EeeecCcccccCCCCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
|+|||++....... .......++..|+|||.+. +..++.++|||||||++|||++|+.||....+......
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--- 237 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--- 237 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence 99999987543221 1223356889999999875 34678899999999999999999999975443221110
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+... .......+.+++.+||+.||.+|||+.|+++
T Consensus 238 ---------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000111111 1122345888899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=307.98 Aligned_cols=271 Identities=27% Similarity=0.397 Sum_probs=205.1
Q ss_pred cCCCccceecccCceEEEEEEeCC----Cceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeee--CCeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK----SKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 167 (420)
+.|+..+.||+|+||.||+|.+.. ++..||+|++...... ....|.+|++.++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 456778999999999999999743 3678999999765443 46789999999999999999999999877 5678
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++++||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 58999999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ...........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHH
Confidence 532211 1112344567999999988889999999999999999999999986533221000000 0000000000000
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
................+.+++.+||+.+|++|||+.||+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000000011112235688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=339.89 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=203.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|++..++..||+|++... .....+.|.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788899999999999999999888999999998653 2233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCC---------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 172 DYMPNGSLDKYLYNQP---------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
||+++++|.+++.... ...+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1245677889999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCC-----------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 243 LARLYDHGTD-----------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 243 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01122468999999999999999999999999999999999999997633221
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHhcC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARP-SMRQVVQILERD 370 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~ 370 (420)
... .... ..+..... ..+....+.+++.+|++.||++|| ++.++++.|+..
T Consensus 239 i~~----------~~~i---~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISY----------RDVI---LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh----------hhhc---cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 100 0000 01100000 112334577888999999999996 567777776654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=301.43 Aligned_cols=268 Identities=26% Similarity=0.353 Sum_probs=206.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh--HHHHHHHHHHHhccCCcce-EeeeeeeeeeCC-----
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--GMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKG----- 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 165 (420)
...|...+.||+|.||+||+|+.+.+|+.||+|++...... .-....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34466677899999999999999999999999999765332 2245679999999999999 999999998877
Q ss_pred -eEEEEEeecCCCChhhhhccCCC--ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 166 -ELLLVYDYMPNGSLDKYLYNQPK--VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 166 -~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
.+++|+||+ ..+|..++...+. ..++...+..+..||+.||+|||+ ++|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 899999999 6699999987653 256778899999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh-----h
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD-----F 316 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-----~ 316 (420)
+|+.+.-... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++..|.+..+.+++...=.+.. .
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9996553222 34556789999999999776 799999999999999999999999988776443321100100 1
Q ss_pred cccCccccccC---CCC--CCcccHHHH---HHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 317 WNRGELLEARD---PNL--GTEYVAEEL---ELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 317 ~~~~~~~~~~~---~~~--~~~~~~~~~---~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
|.......... +.. ......... ....+++.+|++.+|.+|.|++.+++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11000000000 111 011111111 367889999999999999999999974
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=329.32 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=194.2
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-------- 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 164 (420)
...+|++.+.||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3567999999999999999999998888899999885432 2234799999999999999998876432
Q ss_pred CeEEEEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeee
Q 036051 165 GELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDF 241 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Df 241 (420)
..+++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 24779999996 577776643 223468999999999999999999999 9999999999999999664 7999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc-
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR- 319 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 319 (420)
|+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+..............
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9998654322 2234568999999999865 46899999999999999999999999876543322111000000000
Q ss_pred ------CccccccCCCCC-----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 ------GELLEARDPNLG-----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ------~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+... ..++......+.+++.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000001110 0111122356789999999999999999999985
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.62 Aligned_cols=264 Identities=19% Similarity=0.223 Sum_probs=196.5
Q ss_pred ccceeccc--CceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 99 EKELLGSG--GFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 99 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+.++||+| +|++||++....++..||+|++... .......+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999999999999999998754 2333456778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC-
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP- 253 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 253 (420)
++|+|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976544468999999999999999999998 99999999999999999999999999865433211100
Q ss_pred -----cccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh--hhhhhhhcc------
Q 036051 254 -----QTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL--VDWVFDFWN------ 318 (420)
Q Consensus 254 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~------ 318 (420)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........... ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122346778999999865 4688999999999999999999999975432211000 000000000
Q ss_pred -----------------cCccccccCC----CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 -----------------RGELLEARDP----NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 -----------------~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+.......+ .............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000000000 0000112223346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=307.80 Aligned_cols=265 Identities=28% Similarity=0.380 Sum_probs=198.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|++|.||+|++..++..||+|++.... ......+.+|+.++.+++|||++++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999998888999999886442 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 174 MPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
++ ++|.+++..... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 689888865432 468999999999999999999998 999999999999999999999999999987553321
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-hhhh----hhhcccCcccccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-VDWV----FDFWNRGELLEAR 326 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 326 (420)
.......+++.|+|||++.+ ..++.++||||||+++|||++|+.||........... .... ...+.........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12223456889999998865 4578899999999999999999999976443211100 0000 0000000000000
Q ss_pred C---CCCCC----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 D---PNLGT----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~---~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. +.... .........+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000 000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.60 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=203.6
Q ss_pred cCCCccceecccCceEEEEEEeCC-----Cceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
++|+..+.||+|+||.||+|+.+. ....|++|.+...... ....+.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999999743 3456999988655433 4577999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC-------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 169 LVYDYMPNGSLDKYLYNQPK-------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975541 258999999999999999999998 89999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccC
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH----HHHcC
Confidence 9987443222222333456778999999988888999999999999999998 7888865432211 11 11111
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.... .... .....+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 235 ~~~~----~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL----PVPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC----CCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 0111 22346888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.37 Aligned_cols=195 Identities=26% Similarity=0.330 Sum_probs=168.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
....+|++.+.||+|+||.||+|++..++..||+|+.... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4556899999999999999999999888889999975433 2346899999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|++ .++|.+++.... ..+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred Ecc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 999 568888886543 368999999999999999999999 89999999999999999999999999998753221
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
.......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234568999999999998899999999999999999998665553
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=303.64 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=199.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|++.+.||+|+||.||+|.. ++..||+|.+..... ...+.+|+.++.+++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999976 456799999865432 35788999999999999999999998765 479999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999999987655578999999999999999999998 99999999999999999999999999998754321
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+.. .....+. .+..
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-----~~~~--- 218 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGY-----RMEP--- 218 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCC-----CCCC---
Confidence 112234568999999988889999999999999999997 99998765432211 1111111 1111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.......+.+++.+||+.+|++||++.++++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223557788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=330.13 Aligned_cols=267 Identities=24% Similarity=0.297 Sum_probs=196.0
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC------cceEeeeeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR------HRNLVQLLGYCR 162 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~ 162 (420)
++...+++|++.+.||+|+||+||+|.+...+..||||++..... ...++..|+.++..++ |.+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344567889999999999999999999988888999999864322 2234455666665554 556889999887
Q ss_pred eC-CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-------
Q 036051 163 RK-GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL------- 234 (420)
Q Consensus 163 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~------- 234 (420)
.. +..|+|||++ +++|.+++.... .+++..+..|+.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 54 5789999988 788988887653 68999999999999999999997 24999999999999998765
Q ss_pred ---------cEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 235 ---------NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 235 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754221 2334678999999999999999999999999999999999999997655433
Q ss_pred cchhhhhhhhhccc--------Cc---cc---cccCCCCCCc----------c-cHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 306 NLILVDWVFDFWNR--------GE---LL---EARDPNLGTE----------Y-VAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 306 ~~~~~~~~~~~~~~--------~~---~~---~~~~~~~~~~----------~-~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
.............. .. +. ....+..... . .......+.+|+.+||+.||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 22211111000000 00 00 0000000000 0 00112457799999999999999999
Q ss_pred HHHHH
Q 036051 361 RQVVQ 365 (420)
Q Consensus 361 ~evl~ 365 (420)
.|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99996
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=317.03 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=200.6
Q ss_pred hcCCCccceecccCceEEEEEEeC-----CCceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeee-CC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR-KG 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~ 165 (420)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 457889999999999999999852 346789999987542 33456788999999999 78999999998765 45
Q ss_pred eEEEEEeecCCCChhhhhccCC----------------------------------------------------------
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP---------------------------------------------------------- 187 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 187 (420)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986421
Q ss_pred -------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-Ccccccc
Q 036051 188 -------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVV 259 (420)
Q Consensus 188 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~ 259 (420)
...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1236788899999999999999998 9999999999999999999999999999876432211 1122234
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 338 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (420)
++..|+|||.+.+..++.++||||||+++|||++ |..||......... ......+.. .......
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~-----~~~~~~~---- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR-----MRAPDYT---- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCC-----CCCCCCC----
Confidence 5678999999988889999999999999999997 89998654322110 111111111 1111111
Q ss_pred HHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 339 LELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 339 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...+.+++..||+.||.+|||+.|+++.|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 234778889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.20 Aligned_cols=195 Identities=28% Similarity=0.325 Sum_probs=169.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.+|.+.+.||+|+||.||+|.+...++.||||.... ..+.+|++++++++|+||+++++++...+..++|+|++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 468899999999999999999998888999996432 34568999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC-
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP- 253 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 253 (420)
.++|.+++..... .+++.+++.|+.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 243 -~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 -RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred -CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5789888865433 68999999999999999999999 99999999999999999999999999999865432211
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~ 300 (420)
......||..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 22235689999999999999999999999999999999998876643
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=301.46 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=196.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 167 (420)
.+|+..+.||+|+||.||+|.+..++..|++|++... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999999888889999987543 12334568899999999999999999998865 3678
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999997654 57889999999999999999998 99999999999999999999999999998755
Q ss_pred cCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~-----~~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIAT-----QP 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhc-----CC
Confidence 32211 1122345788999999998888999999999999999999999999754322111 00000 00
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.. .......+.+++ .||..+|++||+++||++
T Consensus 226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111 112223344444 588899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=311.12 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=200.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|...+.||+|+||.||+|++..++..||+|.+.... ......+.+|+..+++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999998888899999886442 22234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ ++|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 689888865433 58899999999999999999999 9999999999999999999999999999875432211
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh---------hhhhhcccCccc
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD---------WVFDFWNRGELL 323 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 323 (420)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... ............
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2223456889999998865 457889999999999999999999997655432111000 000000000000
Q ss_pred cccCCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTE----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001111110 01112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=305.74 Aligned_cols=239 Identities=26% Similarity=0.385 Sum_probs=188.7
Q ss_pred eecccCceEEEEEEeCC------------------------CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeee
Q 036051 102 LLGSGGFGRVYRGTLPK------------------------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 157 (420)
.||+|+||.||+|.+.. ....|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 124589999876555555678899999999999999999
Q ss_pred eeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---
Q 036051 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL--- 234 (420)
Q Consensus 158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~--- 234 (420)
++++......++||||+++|+|..++.... ..+++..+..++.||+.||+|||+ .+++||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986543 268899999999999999999998 8999999999999997643
Q ss_pred ----cEEEeeecCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHH-hcCCccCCCCCCcccch
Q 036051 235 ----NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLI 308 (420)
Q Consensus 235 ----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el-~tg~~p~~~~~~~~~~~ 308 (420)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||....+.+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987643221 22356788999998865 5689999999999999998 47999997654432111
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
. ... ........ ...+.+++.+||+.+|++|||+.++++.|
T Consensus 233 ---~----~~~-------~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 ---F----YEK-------KHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---H----HHh-------ccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0 000 00111111 13477889999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=316.47 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=187.6
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC---CcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
||+|+||+||+|++..++..||+|++.... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999998889999999986532 12233455666666654 699999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 99999987654 68899999999999999999999 999999999999999999999999999987532221 2233
Q ss_pred ccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 257 HVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
...||..|+|||++.+. .++.++|||||||++|||++|+.||......+.. .....+. ..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~------~~~~~~-- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGK------VRFPKN-- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCC------CCCCCc--
Confidence 45789999999998654 4899999999999999999999999764432210 1111111 111111
Q ss_pred HHHHHHHHHHhhcccccCCCCCCC----HHHHHH
Q 036051 336 AEELELILKLGLLCSHSDPTARPS----MRQVVQ 365 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 365 (420)
.....+.+++.+||+.||.+||+ +.++++
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234667888999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.27 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=203.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|++|.||++....++..+|+|.+... .......+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999999888999999988654 233457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCcccccCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 252 (420)
+++++|.+++.......+++..+..++.+++.||+|||+ .+++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999977555568999999999999999999999 999999999999999855 468999999998654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ . ..... + .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~---~~~~~-~-----~~~~~-- 221 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---V---LKIMS-G-----TFAPI-- 221 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---H---HHHHh-c-----CCCCC--
Confidence 22335678899999999888899999999999999999999999976543221 1 11000 0 00111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.|+++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112345778889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.98 Aligned_cols=250 Identities=29% Similarity=0.463 Sum_probs=192.5
Q ss_pred ceecccCceEEEEEEeCC---Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeee-eCCeEEEEEeecC
Q 036051 101 ELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELLLVYDYMP 175 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 175 (420)
+.||+|+||.||+|.+.. ....||+|.+... .......+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3457999988543 3444577889999999999999999999775 4556899999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC---
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--- 252 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 252 (420)
+++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976433 46778889999999999999998 8999999999999999999999999999875432111
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcC-CccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......++..|+|||.+.+..++.++||||||+++|||++| ..||......+ +...+ ..+ ..+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~----~~~-----~~~~~~ 224 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL----LQG-----RRLLQP 224 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hcC-----CCCCCC
Confidence 111223456789999999888899999999999999999995 55565432211 11111 011 011111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. .....+.+++.+||+.+|++||++.++++.|++.
T Consensus 225 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 1234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=300.92 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=191.0
Q ss_pred ceecccCceEEEEEEeCC--Cceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 101 ELLGSGGFGRVYRGTLPK--SKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
+.||+|+||.||+|.+.+ .+..+++|.+.... ......+.+|+..+++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 34568999886543 333457889999999999999999999999999999999999999
Q ss_pred ChhhhhccCC---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-C
Q 036051 178 SLDKYLYNQP---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-P 253 (420)
Q Consensus 178 ~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 253 (420)
+|.+++.... ....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 2346777888999999999999998 9999999999999999999999999999865332211 1
Q ss_pred cccccccCCcccccccccCC-------CCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 254 QTTHVVGTLGYLAPEHTRTG-------KATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||....+.+... ....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-------YTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HHhhcccCCC
Confidence 12234567889999998542 35789999999999999996 999997654332110 0001111122
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
..+...... ...+.+++..|| .+|++|||+.||+..|+
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222222121 223566777798 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.98 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=204.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|+..+.||+|++|.||+|.+.++++.|++|++... .....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688899999999999999999888889999998654 23334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++++.+..++.... .+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 998877766654432 58999999999999999999998 8999999999999999999999999999887654433
Q ss_pred CcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh---------hhcccCcc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF---------DFWNRGEL 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~ 322 (420)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... ........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233345678899999999887 78999999999999999999999997544322111000000 00000000
Q ss_pred ccccCCCCCC------cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNLGT------EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.... .+.......+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 011122466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=304.79 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=201.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-----eEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 169 (420)
-.|...+++|.|.||.||+|....++..||||+.-.+.+.. -.|+++|+.++|||||++.-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34666799999999999999999888899999886654321 26899999999999999988775432 4688
Q ss_pred EEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCccc
Q 036051 170 VYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARL 246 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~~ 246 (420)
|||||+. +|.+.++.. .+..++...+.-+..||++||.|||+ .+|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999954 999988742 22357777888899999999999999 999999999999999966 9999999999998
Q ss_pred ccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc---
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL--- 322 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 322 (420)
...+... .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+.+..+++...-.+.+.....++
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 7655432 44567889999999866 57999999999999999999999999987766554433222222221111
Q ss_pred ----ccccCCCCCC-----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 ----LEARDPNLGT-----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ----~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+...|.... -+......+.++++.++++.+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 122334456888999999999999999999875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.09 Aligned_cols=253 Identities=26% Similarity=0.324 Sum_probs=204.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|++|.||+|...+++..||+|.+..... ...+.+..|++.+..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999988888999999875422 24567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+.+++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999986655578999999999999999999998 999999999999999999999999999987543221
Q ss_pred C----------------------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 252 D----------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 252 ~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 011134678899999999888899999999999999999999999976543
Q ss_pred cccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC----HHHHHH
Q 036051 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS----MRQVVQ 365 (420)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 365 (420)
.... .... ...............+.+++.+||+.||++||| +.|++.
T Consensus 238 ~~~~------~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETF------SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH------HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 0000 000000111113456888999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=299.88 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=206.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||.|+||+||+|....++..+++|++.... ....+.+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999998888899999986542 23567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 174 MPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 468999999999999999999998 9999999999999999999999999999876554322
Q ss_pred C---cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 253 P---QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 253 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
. ......++..|+|||++... .++.++|+||||+++|||++|+.||......... .+... . ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~----~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQ----N------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhc----C------CCC
Confidence 2 22334688999999998776 7899999999999999999999999765443211 11000 0 111
Q ss_pred CCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...... .......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111110 1123456788899999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.68 Aligned_cols=252 Identities=27% Similarity=0.338 Sum_probs=213.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 168 (420)
....|++.+.||+|.||.||+++.+.++..+|+|.+.+... .....+.+|+.+|+++. ||||+.+++.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999999999999999976533 23467899999999998 999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC----CcEEEeeecCc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLA 244 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfg~~ 244 (420)
+|||++.||.|.+.+... .+++.++..++.|++.++.|||+ .+++||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999776 39999999999999999999999 999999999999999633 47999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+..+
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~---- 253 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG---- 253 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC----
Confidence 98765 445677899999999999999999999999999999999999999998776543221 11111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.......-.......-+++..|+..||.+|+|+.++++
T Consensus 254 --~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 --DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred --CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 112223333344556777888899999999999999998
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=305.39 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=191.5
Q ss_pred ceecccCceEEEEEEeCCCce-------eeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 101 ELLGSGGFGRVYRGTLPKSKI-------EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+.||+|+||.||+|.+...+. .|++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998855433 4888988766555567889999999999999999999999998999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc--------EEEeeecCcc
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN--------GRLGDFGLAR 245 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~--------~kl~Dfg~~~ 245 (420)
+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 68999999999999999999998 99999999999999987765 6999999886
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCC-ccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGR-RPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....+..... ....
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~---- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED---- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc----
Confidence 5432 223457889999999976 45789999999999999999985 5554433221110 0000
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
...++.. ....+.+++.+||+.||++|||+.++++.|+
T Consensus 221 ---~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---RHQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---cccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111111 1245788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.24 Aligned_cols=239 Identities=28% Similarity=0.471 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEeCCCc----------eeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 101 ELLGSGGFGRVYRGTLPKSK----------IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
+.||+|+||.||+|.+...+ ..+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999997655 35888887655433 5788999999999999999999999888 778999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-------cEEEeeecC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-------NGRLGDFGL 243 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-------~~kl~Dfg~ 243 (420)
+||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+++|+||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 68899999999999999999998 9999999999999999887 799999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCC--CCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccC
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||......+... + +...
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~----~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---F----YQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---H----HhcC
Confidence 876433 2233567789999999776 78999999999999999999 577776543222110 0 0000
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....... ...+.+++.+||+.+|.+|||+.++++.|+
T Consensus 223 -------~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 -------HRLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CCCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 156788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.07 Aligned_cols=264 Identities=23% Similarity=0.248 Sum_probs=199.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------ 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (420)
..++|+..+.||+|+||.||++.+...+..||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999999888889999998653 333446778899999999999999999987543
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999995 467766643 47888999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh--------------
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-------------- 310 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-------------- 310 (420)
...... .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 764332 1223457899999999999889999999999999999999999999765422111000
Q ss_pred --hhhhhhcccC-ccccccCCCC--------CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 311 --DWVFDFWNRG-ELLEARDPNL--------GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 311 --~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..+....... .......+.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 0000000000 001111123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.83 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=208.7
Q ss_pred hcCCCccceecccCceEEEEEEeCC---Cceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.+.....++||+|.||.|++|.|.. .-..||||.+...... ...+|++|+..|.+|+|||++++||+..+ ..+.|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3445566889999999999999953 2346999999876433 56899999999999999999999999887 77899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+|.++.|+|.+.|+......|.......++.|||.|+.||.+ +++|||||..+|+|+-....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999988655678889999999999999999999 9999999999999999999999999999997754
Q ss_pred CCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 250 GTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 250 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
+... ......-...|+|||.++...++.+||||+|||++|||+| |+.||-+..... +.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhc
Confidence 4322 1112233678999999999999999999999999999988 888987765443 22223
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
|......-...+.+.+.++++.||.++|.+|||+..|.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 322223334567788999999999999999999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=305.34 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=202.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|+..+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999998888999999886432 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++++.|..++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888775443 58999999999999999999999 9999999999999999999999999999986543321
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh-----hhh---hhcccCccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD-----WVF---DFWNRGELL 323 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~-----~~~---~~~~~~~~~ 323 (420)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... +.. .........
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223457889999999865 557899999999999999999999997655432211100 000 000000000
Q ss_pred -cccCCCCCCcc-----cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 -EARDPNLGTEY-----VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 -~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+...... .......+.+++.+||+.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00011110000 1112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.06 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=206.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||+||++.+..++..||+|++.... ....+.+.+|++++..++||||+++++++...+..++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356778899999999999999998888899999876543 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++...+ .+++..+..++.+++.||.|||+ ..+++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred cCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999999887643 68899999999999999999996 258999999999999999999999999998654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCccc-----chhhhhhhhhcccCccccccC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN-----LILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 327 (420)
......++..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+.+++...... ..
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------PP 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------cC
Confidence 12235689999999999888899999999999999999999999986543211 0111111111110 01
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
+.+. ..+....+.+++.+||+.||++|||+.|+++..
T Consensus 231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 112345678889999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.43 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=201.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc-----hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
+|+..+.||+|++|.||+|....++..|++|.+.... .+..+.+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667889999999999999998788899999886532 33457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997653 58899999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccccccccCCC-CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......... ....... ..+.
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~-----~~~~ 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSK-----ELPP 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcc-----cCCC
Confidence 2 233456889999999987766 899999999999999999999999765422111 1100000 0011
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .......+.+++.+||+.+|++||++.++++
T Consensus 223 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1122345678888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.38 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=188.1
Q ss_pred eecccCceEEEEEEeCC--Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 102 LLGSGGFGRVYRGTLPK--SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.||+|+||.||+|.... ....+++|.+... .......|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 3456889987644 33345678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCC---ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-Cc
Q 036051 179 LDKYLYNQPK---VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQ 254 (420)
Q Consensus 179 L~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 254 (420)
|.+++..... ...++.....++.||+.||+|||+ .+++||||||+|||+++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 235678889999999999999999 8999999999999999999999999999864322211 11
Q ss_pred ccccccCCccccccccc-------CCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 255 TTHVVGTLGYLAPEHTR-------TGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.....++..|+|||++. ...++.++|||||||++|||++ |..||....+.+.. ....... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhcc-CccCC
Confidence 12234567899999874 2456889999999999999998 77888654432211 1111111 11111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.+..... ....+.+++..|| .||++|||+.+|++.|.
T Consensus 232 ~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222222 2334556667788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=305.60 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=204.6
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeee-
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR- 162 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~- 162 (420)
+.++++..+.++|++.+.||+|+||.||++.+..++..+|+|++..... ...++.+|+.++..+ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3445566678899999999999999999999988888999998765322 235678899999998 6999999999874
Q ss_pred ----eCCeEEEEEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcE
Q 036051 163 ----RKGELLLVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236 (420)
Q Consensus 163 ----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~ 236 (420)
.++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 345789999999999999987532 22368899999999999999999998 999999999999999999999
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~ 311 (420)
+|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....+.....
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--- 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--- 239 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---
Confidence 999999987654321 12233468999999998753 457889999999999999999999997654322110
Q ss_pred hhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.. .. ...+.... .......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ---~~-~~-----~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ---KI-PR-----NPPPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hc-cc-----cCCCcccC--CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 00 00011000 00112357788999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=309.13 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=201.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCce----eeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4567788999999999999999865554 47889886543 23345788999999999999999999998754 467
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999999876532 58899999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ..+++ ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCC----
Confidence 32221 1222345678999999988889999999999999999997 899987543222 11111 11110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..... .....+.+++..||..+|++||++.++++.|+...
T Consensus 230 -~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 -LPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111 12245778889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.64 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=199.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------ 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (420)
..++|...+.||+|+||.||++.+...+..||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999888889999998653 233446788999999999999999999987543
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 577777643 47888999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhhh-
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWVF- 314 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~~- 314 (420)
...... .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++..
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 765332 1223456899999999999999999999999999999999999999765432211000 0000
Q ss_pred ------hhcccCc-c----ccccCCCC----CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 315 ------DFWNRGE-L----LEARDPNL----GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 315 ------~~~~~~~-~----~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
....... . .....+.. ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0 00000000 000111123457889999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=301.47 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=200.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc----------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES----------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
+|...+.||+|++|.||+|....++..||+|.+.... ....+.+.+|+..+.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999998888899999875321 112346788999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997663 68899999999999999999998 899999999999999999999999999987
Q ss_pred cccCCCC-CcccccccCCcccccccccCCC--CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 246 LYDHGTD-PQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 246 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
....... .......++..|+|||.+.... ++.++|+||||+++||+++|..||......+. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~--- 227 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNK--- 227 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcc---
Confidence 6433211 1223346788999999987654 78999999999999999999999964332211 0110000
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+.............+.+++.+||+.+|++|||+.++++
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 --RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred --ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 01111111122233456888889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=299.30 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=197.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (420)
.+|++.+.||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999999888899999987532 123356788999999999999999999988663 568
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++++||+++++|.+++.... .+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987653 57888999999999999999998 89999999999999999999999999998754
Q ss_pred cCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-----~~~ 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIA-----TQP 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHh-----cCC
Confidence 32211 1223346888999999998888999999999999999999999999754322111 0000 000
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+ ..+......+.+++.+|+. +|++||++.|+++
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111 1222334556677777884 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.39 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=204.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+++|++.+.||+|.|+.||+..+..+|+.+|+|++... .....+++.+|+.+...|+||||+++++.+......++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46678889999999999999999999999999988643 3345678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~~~~ 248 (420)
|+|.|++|..-|-.+ .-+++..+-..+.||+++|.|+|. ++|+|||+||+|+++-. .--+||+|||++..++
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766443 367888889999999999999999 99999999999999953 3358999999999877
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
. .......+|||+|||||+++..+|+..+|||+.||+||-|+.|..||.+.+.... .+.+..+ +.
T Consensus 165 ~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------ye~I~~g------~y 229 (355)
T KOG0033|consen 165 D--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YEQIKAG------AY 229 (355)
T ss_pred C--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------HHHHhcc------cc
Confidence 2 3344557899999999999999999999999999999999999999987544321 1111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+...-........+|+.+||..||.+|.|+.|.++
T Consensus 230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1222122223344567788899999999999988764
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=299.40 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=202.9
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
+|+..+.||+|++|.||+|....++..||+|++.... ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999998888899999886432 1234678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCccccc
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYD 248 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~ 248 (420)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997654 68899999999999999999999 9999999999999998776 59999999987654
Q ss_pred CCCC---CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 249 HGTD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 249 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
.... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||............ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~---------~ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FK---------I 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HH---------H
Confidence 3311 1122346788999999998888999999999999999999999999654332211100 00 0
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
................+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000111222234456788999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.58 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=203.9
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|++.+.||+|++|.||+|++..++..|++|++.... ......+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999998888899999987553 33356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987544 368999999999999999999999 89999999999999999999999999999876543322
Q ss_pred cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC------------
Q 036051 254 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG------------ 320 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 320 (420)
......++..|+|||.+.+. .++.++||||||+++|||++|..||......+.. .++.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 4689999999999999999998887654432211 1111100000
Q ss_pred ccccccCCCCC----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 ELLEARDPNLG----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+... .....+....+.+++.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0011122367889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.80 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=197.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------ 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (420)
..++|...+.||+|+||.||+|.+..++..||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3578999999999999999999998888899999986542 22345678899999999999999999987543
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
...+++++++ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 4579999988 88998887643 58999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hh-------hhh
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DW-------VFD 315 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~-------~~~ 315 (420)
..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .. ...
T Consensus 166 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 86543 2234568999999999876 56899999999999999999999999754322111000 00 000
Q ss_pred hcccCcccccc--CCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRGELLEAR--DPNLGTE----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........... .+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0000000 00011234678999999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.24 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=201.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3678889999999999999999888899999988654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 174 MPNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
+++++|..++.... ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999886531 2368999999999999999999996 258999999999999999999999999998755322
Q ss_pred CcccccccCCcccccccccCC------CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
......++..|+|||.+.+. .++.++|+|||||++|||++|+.||........... ... .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~------~~~~~ 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSA------IVDGD 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHH------HhhcC
Confidence 22234578899999998554 357899999999999999999999965432211100 000 00001
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+ ....+....+.+++.+||+.+|++||++.+++.
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11 122234455778889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=299.45 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=203.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 171 (420)
+|++.+.||.|+||.||++.+..++..||+|.+... .....+.+.+|++++++++|||++++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999999888889999988643 33445678899999999999999999997753 45689999
Q ss_pred eecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcc--cCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 172 DYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 172 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||+++++|.+++... ....+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2346899999999999999999999221 289999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... .. .....+. .
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~-----~ 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEGK-----F 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCC-----C
Confidence 54322 1233568999999999988889999999999999999999999997654221 11 1111111 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..........+.+++.+||+.+|++||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222334568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.00 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=200.8
Q ss_pred CCCccceecccCceEEEEEEeCC-Cceeeeeeccccc----------chhHHHHHHHHHHHhcc-CCcceEeeeeeeeee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPK-SKIEIAVKKISHE----------SRQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRR 163 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 163 (420)
+|+..+.||+|+||.||+|.+.. .+..+|+|.+... ......++.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999977 5678999987532 22334567788888865 799999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 164 KGELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
++..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998743 123468999999999999999999995 267999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .. ...+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~---~~-~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---A---TK-IVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---H---HH-Hhhcc
Confidence 9998654332 33345688999999999988899999999999999999999999865432211 0 00 00110
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
. .+.... .....+.+++.+||+.||++||++.|+..+++
T Consensus 230 ~----~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 Y----EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 111101 12345778888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=303.27 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=205.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
..+|...+.||+|+||.||+|....++..|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788899999999999999998777888999998755444557789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999999998654 57889999999999999999998 9999999999999999999999999998875543222
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......+++.|+|||.+.+..++.++||||||+++|++++|+.||....+....... . ....+.. .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~------~~~~~~~--~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A------TNGTPEL--Q 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------h------cCCCCCC--C
Confidence 223346888999999998888999999999999999999999999765443211100 0 0000111 1
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233457788899999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.77 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=201.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|+..+.||+|+||.||+|.+.++++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999998888899999876542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.++..... .+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988775543 48999999999999999999998 899999999999999999999999999987654322
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-hhhhhh-------hcccCcc-
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-VDWVFD-------FWNRGEL- 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-~~~~~~-------~~~~~~~- 322 (420)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...- ..+... .......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233467889999999865 4578899999999999999999999875443211100 000000 0000000
Q ss_pred ccccCCCCCC-----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNLGT-----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000010000 001123456888999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=298.75 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=202.8
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|+||.||+|....++..|++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47788999999999999999988888999999876533 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997653 57889999999999999999999 99999999999999999999999999998866443222
Q ss_pred cc---cccccCCcccccccccCCC---CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 254 QT---THVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 254 ~~---~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.. ....++..|+|||++.+.. ++.++||||||+++||+++|+.||......... ...+. ....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~---------~~~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVG---------AGHK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHh---------cCCC
Confidence 11 1346788999999997766 889999999999999999999999754321110 00000 0011
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.... .......+.+++.+||+.+|.+|||+.+++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 1112345678889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=304.29 Aligned_cols=262 Identities=28% Similarity=0.350 Sum_probs=204.5
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
++..++..+.++|...+.||+|+||.||++....++..+|+|++..... ....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4455666678899999999999999999999988888999999865422 235677899999988 89999999998865
Q ss_pred C-----CeEEEEEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcE
Q 036051 164 K-----GELLLVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236 (420)
Q Consensus 164 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~ 236 (420)
. +..++|+||+++++|.++++.. ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 3689999999999999988632 22368999999999999999999998 899999999999999999999
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccCC-----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~ 311 (420)
||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||..........
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--- 243 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH---
Confidence 9999999876543221 22234678899999987543 36889999999999999999999997654322110
Q ss_pred hhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. .... .+.. ....+....+.+++.+||+.+|++||++.|+++
T Consensus 244 ---~~-~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 ---KI-PRNP-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HH-hcCC-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0000 0111 001122345888999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.20 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=204.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
-..|...+.||+|..+.|-++.++.++..+|+|++.... ....+.-.+|+.+|+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778899999999999999999999999999885421 12234456799999997 699999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
.-+++|+|.|+.|.|.++|... .++++....+|..|+.+|++|||. .+|+||||||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999764 379999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccC------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRT------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
+....+. .....+|||+|+|||.+.. ..|+...|+||+||++|-|+.|.+||-....- . +...+.
T Consensus 171 ~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---l----MLR~Im 241 (411)
T KOG0599|consen 171 CQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---L----MLRMIM 241 (411)
T ss_pred eccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---H----HHHHHH
Confidence 9876543 4567899999999998853 35888999999999999999999999543211 0 111111
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+|.. .+.++--.+.....-+|+.+||+.||.+|.|++|++.
T Consensus 242 eGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1211 1111112234455778888999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.24 Aligned_cols=197 Identities=24% Similarity=0.361 Sum_probs=161.3
Q ss_pred cceecccCceEEEEEEeCC--CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEEEeecC
Q 036051 100 KELLGSGGFGRVYRGTLPK--SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMP 175 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 175 (420)
.+.||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. ....++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 4679999999999999753 567899998865432 2456789999999999999999998754 45789999999
Q ss_pred CCChhhhhccC-------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----cCCCcEEEeeecCc
Q 036051 176 NGSLDKYLYNQ-------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLA 244 (420)
Q Consensus 176 ~g~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfg~~ 244 (420)
+++|.+++... ....+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 46888876532 12358899999999999999999999 999999999999999 45678999999999
Q ss_pred ccccCCCC--CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 245 RLYDHGTD--PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 245 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86643322 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=299.67 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=202.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
-|+..+.||+|+||.||+|.+..++..||+|.+... .......+.+|+..+.+++||||+++++++..+...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466788999999999999999888889999987644 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 999999998653 58899999999999999999998 999999999999999999999999999987554321 12
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.... .. ... ...+.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~-----~~~~~~---- 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------FL-IPK-----NNPPTL---- 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------HH-Hhc-----CCCCCC----
Confidence 23346788999999998888899999999999999999999999754432111 00 000 011111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12233457788889999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=317.24 Aligned_cols=263 Identities=23% Similarity=0.244 Sum_probs=199.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCC--CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPK--SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
...+|.+.+.||+|+||.||++...+ .+..|++|.+... ..+.+|+.++++++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34579999999999999999997643 4567999988643 2346899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
||++ .++|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++......
T Consensus 165 ~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999 57888888443 368999999999999999999999 99999999999999999999999999999765433
Q ss_pred CC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc--------
Q 036051 251 TD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE-------- 321 (420)
Q Consensus 251 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 321 (420)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............-+........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22 223346789999999999988999999999999999999999999976543321111100000000000
Q ss_pred ---------cccccCCCCC-Ccc--cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 322 ---------LLEARDPNLG-TEY--VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 322 ---------~~~~~~~~~~-~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
......+... ... .......+.+++.+||..||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 000 00112356778889999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=325.20 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=210.8
Q ss_pred CCccceecccCceEEEEEEeCCC----ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 97 FREKELLGSGGFGRVYRGTLPKS----KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
....++||+|+||+||+|.|... +.+||+|++... ..+...++++|+..|.+++|||+++++|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45578999999999999998433 346999988655 4455688999999999999999999999998876 88999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
+||+.|+|.++++.+. ..+.-...+.+..|||+|+.|||. +.++||||.++|||+..-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998754 378889999999999999999998 999999999999999999999999999999876554
Q ss_pred CCccc-ccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 252 DPQTT-HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 252 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
..-.. ...-.+.|||=|.+....++.++|||||||++||++| |..|+.+...++. .+.++.+..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~geR------- 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKGER------- 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhcccc-------
Confidence 32221 1223678999999999999999999999999999987 9999988776552 222222221
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
...++.+..++..++.+||..|+..||+++++...+.+++.
T Consensus 919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 23344556678889999999999999999999988876654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=298.29 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
+|...+.||+|+||+||+|... ++..+|+|.+.... ......+.+|++.+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4677899999999999999874 56789999876431 2234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
++||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999997654 57899999999999999999998 8999999999999999999999999999875422
Q ss_pred CC-----CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 250 GT-----DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 250 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.. ........++..|+|||++.+..++.++||||||+++|||++|+.||............ .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~---~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA---HR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh---cc
Confidence 11 11222346889999999998888999999999999999999999999754332211000 00 00
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+..... ....+.+++.+||+.+|.+||++.|+++
T Consensus 225 ~~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111222222 2345778888999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.37 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=201.0
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
|.....||+|+||.||++....++..||||.+........+.+.+|+..++.++|||++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33456799999999999999888889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
++|.+++... .+++..+..++.||+.||.|||+ .+++||||||+||++++++.++|+|||++....... ....
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 176 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK 176 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence 9999988543 58899999999999999999999 899999999999999999999999999987543322 2223
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...++..|+|||.+.+..++.++||||||+++|||++|+.||........... . .....+.... ..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------~-----~~~~~~~~~~--~~ 242 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------I-----RDNLPPRVKD--SH 242 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H-----HhcCCCcccc--cc
Confidence 45688999999999888899999999999999999999999975443221100 0 0011111111 01
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.....+.+++.+||..||.+|||+.|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122346677888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=303.94 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=204.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|+||.||++.+...+..|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999999888899999886543 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997654 68899999999999999999998 899999999999999999999999999886321110
Q ss_pred C--------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 252 D--------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 252 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....+. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 0 011124578899999999888899999999999999999999999975443221 11100
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.+. ...+.... .....+.+++.+||+.||++||++.++.+.|+.
T Consensus 230 -~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 -SDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -hcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 01111111 223457889999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.54 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=199.6
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
....||+|+||.||+|.+..++..||+|.+........+.+.+|+..+..++|||++++++++..++..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 34579999999999999987888999999866544445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccccc
Q 036051 179 LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 258 (420)
Q Consensus 179 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 258 (420)
|.+++... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....... ......
T Consensus 105 L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 105 LTDIVSQT---RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 99987543 58899999999999999999998 899999999999999999999999999987544322 122345
Q ss_pred ccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHH
Q 036051 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 338 (420)
Q Consensus 259 ~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (420)
.++..|+|||++.+..++.++||||||+++|||++|+.||....+.+... .+ .... .+.. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~----~~~~-----~~~~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RL----RDSP-----PPKL--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----hccC-----CCCc--cccCCC
Confidence 68899999999988889999999999999999999999997544322111 00 0000 0000 001112
Q ss_pred HHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 339 LELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 339 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
...+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2347788889999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=299.28 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=201.0
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCC---cceEeeeeeeeeeCCeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 171 (420)
.|+..+.||+|+||.||+|.+..++..|++|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999999888889999988654 3344567888999998886 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998654 68999999999999999999998 999999999999999999999999999998665433
Q ss_pred CCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......... . ......+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~---------~~~~~~~~~ 222 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L---------IPKSKPPRL 222 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c---------cccCCCCCC
Confidence 22333468899999998865 457889999999999999999999997544322110 0 001111111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... .....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13345778888999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=299.54 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------ 165 (420)
++++|++.+.||+|++|.||+|.+..++..+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 56889999999999999999999988888999999876543 346789999999998 7999999999986644
Q ss_pred eEEEEEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886532 3478999999999999999999998 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
+....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......... . ..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----~~-- 230 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--F----KI-- 230 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--H----Hh--
Confidence 87543322 22233568899999998753 34678999999999999999999999754322111 0 00
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.. .........+.+++.+||..||++|||+.++++
T Consensus 231 ----~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 ----PRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----hccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00011111 111223456788999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.82 Aligned_cols=197 Identities=24% Similarity=0.372 Sum_probs=160.8
Q ss_pred cceecccCceEEEEEEeCC--CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEEEeecC
Q 036051 100 KELLGSGGFGRVYRGTLPK--SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMP 175 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 175 (420)
...||+|+||.||+|+..+ .+..||+|.+..... ...+.+|+.++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4679999999999999754 456799998865432 2457789999999999999999998853 567899999995
Q ss_pred CCChhhhhccC-------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----cCCCcEEEeeecCc
Q 036051 176 NGSLDKYLYNQ-------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLA 244 (420)
Q Consensus 176 ~g~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfg~~ 244 (420)
++|.+++... ....+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777776422 12358899999999999999999999 999999999999999 46678999999999
Q ss_pred ccccCCCCC--cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 245 RLYDHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 245 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 866443221 2234578999999999866 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=297.23 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=201.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 171 (420)
++|+..+.||.|++|.||++.+..++..+|+|.+.... ......+.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999998888999999987542 2445678999999999999999999998864 34789999
Q ss_pred eecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23358889999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc--ccchhhhhhhhhcccCccccccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE--ENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+... ...... .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-K 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-c
Confidence 21 12345788999999998889999999999999999999999999765321 11111111111 000000 0
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... .........+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 000112456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=298.97 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=198.0
Q ss_pred CCccceecccCceEEEEEEeCC---Cceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------
Q 036051 97 FREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (420)
|.+.+.||+|+||.||+|.+.. +++.||||++... .....+++.+|++.+++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5567889999999999998643 4678999988654 3345677899999999999999999999876432
Q ss_pred eEEEEEeecCCCChhhhhccC----CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQ----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
..++++||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 12357889999999999999999998 89999999999999999999999999
Q ss_pred cCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhccc
Q 036051 242 GLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 242 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
|++........ .......++..|++||.+.+..++.++||||||+++|||++ |+.||......+ +..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH----c
Confidence 99886543221 11223345678999999988889999999999999999999 888886543321 111111 1
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+. .... .......+.+++.+||+.+|++||++.|+++.|++
T Consensus 231 ~~-----~~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GN-----RLKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10 0011 11233568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=302.50 Aligned_cols=245 Identities=26% Similarity=0.308 Sum_probs=201.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|+..+.||+|++|.||++.+..+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999998888999999886532 233567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997654 68899999999999999999999 99999999999999999999999999998865433
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||........ ......+ .....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~------~~~~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------YEKILEG------KVRFP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcC------CccCC
Confidence 2334688999999999888889999999999999999999999975442210 0000011 11111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
.. ....+.+++.+||+.||.+|| +++|+++
T Consensus 219 ~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11 234577888899999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=302.97 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=201.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchh-----HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
+|+..+.||+|++|.||+|.+..++..|++|.+...... ....+..|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999999888889999998755322 335577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997654 368999999999999999999999 99999999999999999999999999999865443
Q ss_pred CCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hhhh----hhcc-cCccc
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DWVF----DFWN-RGELL 323 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~~~----~~~~-~~~~~ 323 (420)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+..... .... ..+. .....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 21 2223356788999998854 46789999999999999999998877654432211000 0000 0000 00000
Q ss_pred cccCCCCC-----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 324 EARDPNLG-----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 324 ~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 01112234668899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=302.99 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=196.8
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|+||.||+|++..++..|++|++.... ......+.+|+.++++++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999998889999999886532 22235677899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ ++|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 58888776543 268999999999999999999999 9999999999999999999999999999886543221
Q ss_pred cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC------ccccc-
Q 036051 254 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG------ELLEA- 325 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 325 (420)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+......... ........... .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcc
Confidence 22234578899999998664 4789999999999999999999886543321110 00000000000 00000
Q ss_pred ---cCCCCCC-----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 ---RDPNLGT-----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ---~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.... .........+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 011122356778899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=297.98 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=210.0
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
|.+.+.||+|.||.||+|.++.+|+.+|||.+..+. ..+++.+|+.++.+.+.|++|++||.+-....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566788999999999999999999999999987653 357889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|++.+.++.+. .+|.+.++..++...++||+|||. ..-+|||||+.|||++.+|.+||+|||.+-.+.... ....
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 99999987664 489999999999999999999999 888999999999999999999999999997654322 2345
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc--
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY-- 334 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 334 (420)
...||+.|||||++..-.|+.++||||||++..||.-|++||....+-.... .+..+.+..+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------MIPT~PPPTF~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------MIPTKPPPTFKK 251 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------eccCCCCCCCCC
Confidence 5789999999999999899999999999999999999999998766543221 1111111222
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+..-...+.++++.||-++|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 3334677889999999999999999988876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.42 Aligned_cols=265 Identities=26% Similarity=0.336 Sum_probs=199.4
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||.|++|.||+|++..++..||||++.... ......+.+|++.+++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999998888899999886542 22335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+. ++|.+++.......+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 689998876655578999999999999999999998 8999999999999999999999999999875543221
Q ss_pred cccccccCCcccccccccCCC-CCccchhhhhHHHHHHHhcCCccCCCCCCcccch-hhhhh-------hhhccc-Cccc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-LVDWV-------FDFWNR-GELL 323 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~~~~~-------~~~~~~-~~~~ 323 (420)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+... ...+. +..... ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 222335688999999886644 6889999999999999999999997654322110 00000 000000 0000
Q ss_pred cccCCCCC---CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLG---TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........ ..........+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 0000111234678899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=301.68 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=197.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|+..+.||+|++|.||+|....++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 578889999999999999999988888999999865422 2224567899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ ++|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 599998876543 68899999999999999999998 9999999999999999999999999999875432111
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCc-ccchhhhhhhhhcccCcc---------
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPE-ENLILVDWVFDFWNRGEL--------- 322 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--------- 322 (420)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +.................
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346888999998865 45789999999999999999999999654411 110000000000000000
Q ss_pred cc----ccCCCCCCcc--cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LE----ARDPNLGTEY--VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~----~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ...+...... .......+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000000 0001145678899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.68 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=188.1
Q ss_pred eecccCceEEEEEEeCCC--ceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 102 LLGSGGFGRVYRGTLPKS--KIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.||+|+||.||+|....+ ...+++|.+.... ....+.|.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976433 2346677665442 3445789999999999999999999999999999999999999999
Q ss_pred hhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-CCcc
Q 036051 179 LDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-DPQT 255 (420)
Q Consensus 179 L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 255 (420)
|.+++.... ....++..+..++.||+.||+|||+ .+++|+||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 2346777888999999999999998 899999999999999999999999999976422111 1122
Q ss_pred cccccCCcccccccccC-------CCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 256 THVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ...... .+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-hhcccccCC
Confidence 23467889999998743 245789999999999999987 566776443321 111111 111122233
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
+.....+. ..+.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33333333 34566777799 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=297.73 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=202.6
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|...+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.++++++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999999888899999986541 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccccCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 252 (420)
+++++|.+++.......+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999976655568999999999999999999998 9999999999999999885 469999999876543221
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......|++.|+|||++.+..++.++|+||||+++|||++|+.||......+ ++..... +.. +..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~-----~~~-- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYF-----API-- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccC-----CCC--
Confidence 2223458889999999988889999999999999999999999996543222 1111111 110 011
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122345788889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.61 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=198.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
...|+..+.||+|+||.||+|.+..+++.||+|++... ......++.+|+.+++.++|||++++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35588889999999999999999888889999988643 233446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||+. |+|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99995 67777765432 268999999999999999999998 99999999999999999999999999998754321
Q ss_pred CCCcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
....++..|+|||++. ...++.++||||||+++|||++|+.||......... .... ....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~------~~~~ 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA------QNDS 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHh------cCCC
Confidence 2346788999999874 456888999999999999999999999754322110 0000 0001
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+... .......+.+++.+||+.||++||++.+++..
T Consensus 232 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 12234568888999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=336.40 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=199.5
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL 167 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 167 (420)
...++|.+.+.||+|+||+||+|.+...+..||+|++... .......|..|+.++.+++||||+++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4456899999999999999999999988989999988643 33345678999999999999999999998754 4578
Q ss_pred EEEEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcc----cCcEEecccCCCCEEEcC---------
Q 036051 168 LLVYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEW----EQVVIHRDVKASNVLLDG--------- 232 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~iiH~dlk~~NIll~~--------- 232 (420)
|+||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986531 236899999999999999999999732 135999999999999964
Q ss_pred --------CCcEEEeeecCcccccCCCCCcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 233 --------ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 233 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999997654321 2234578999999999854 458899999999999999999999997543
Q ss_pred CcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... +...+..+ +.+... .....+.+++..||+.+|.+||++.|++.
T Consensus 248 ~~~q------li~~lk~~-------p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQ------LISELKRG-------PDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHH------HHHHHhcC-------CCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2211 11111111 111111 11245778888999999999999999984
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=297.66 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=203.6
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+|+..+.||+|++|.||++.+..+++.+++|.+.... ......+.+|++.+++++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999998888899999887653 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999997653 378899999999999999999997 36899999999999999999999999999875532211
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..+.+.... ....+.+...
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~- 227 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV------NEPPPRLPSG- 227 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh------cCCCCCCChh-
Confidence 1256788999999998889999999999999999999999999754321110 111111110 0111111111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.+++.+||..||++|||+.+++.
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13445778888999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=291.22 Aligned_cols=250 Identities=30% Similarity=0.460 Sum_probs=205.9
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
+|...+.||+|++|.||++.+..++..+++|++..........+.+|+..+++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 46778999999999999999988888999999977655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+++|.+++.... ..+++..+..++.|++.||.+||+ .+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999987653 368999999999999999999998 9999999999999999999999999999876654321 3
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
....++..|+|||.+.+..++.++||||||+++++|++|+.||............ . ....+.....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~------~~~~~~~~~~-- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI------A------TNGPPGLRNP-- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------H------hcCCCCcCcc--
Confidence 3456889999999998888999999999999999999999999765432211100 0 0000111111
Q ss_pred HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111345788889999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.67 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=202.4
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
.|...+.||+|++|.||++.+..++..+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 35556899999999999999988888999998866555555678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+++|.+++... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 100 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 99999998763 58899999999999999999999 9999999999999999999999999998875443221 22
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||....+.... ... ..+ ..+.... .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~-~~~-----~~~~~~~--~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRI-RDN-----LPPKLKN--L 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHH-Hhc-----CCCCCcc--c
Confidence 3356889999999998888999999999999999999999999754432211 100 000 0111110 1
Q ss_pred HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112345888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.04 Aligned_cols=253 Identities=30% Similarity=0.417 Sum_probs=206.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++.|+..+.||+|++|.||+|.+...+..|++|++..... ....+.+|++.+++++|+|++++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678888999999999999999987788899999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998754 368999999999999999999998 9999999999999999999999999999875443221
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+..... ... ... .+..
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~-~~~-----~~~~-- 236 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LIT-TKG-----IPPL-- 236 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hcC-----CCCC--
Confidence 2223457889999999988889999999999999999999999997544322110 000 000 0000
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111113355788899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.42 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=207.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|+..+.||+|++|.||+|++..++..|++|++..... .....+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999988889999999876643 4457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++... ..+++..++.++.|++.||+|||+ ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 9999999999765 368999999999999999999996 27899999999999999999999999999886643322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............++. ....+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------~~~~~~~--- 223 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---------DGPPPSL--- 223 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------cCCCCCC---
Confidence 2224567899999999988889999999999999999999999997654311111111111 0011111
Q ss_pred ccHH-HHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 334 YVAE-ELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 334 ~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
... ....+.+++.+||+.+|++||++.++++.
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112 34568888889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.55 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=193.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHH-hccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||.||+|++..++..||+|++.... ......+..|+.. ++.++|||++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999999889999999886542 2233455666665 556789999999999999999999999
Q ss_pred ecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 173 YMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|++ |+|.+++... ....+++..++.++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7888877542 23468999999999999999999998 5 899999999999999999999999999876532
Q ss_pred CCCCcccccccCCcccccccccC----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ ..... ...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~------~~~ 223 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QLKQV------VEE 223 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HHHHH------Hhc
Confidence 21 1223467889999998854 4568899999999999999999999964322100 00000 011
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+..... .....+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111 12345778899999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=297.86 Aligned_cols=248 Identities=26% Similarity=0.313 Sum_probs=203.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++.+++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999998888899999987542 2445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 368899999999999999999998 899999999999999999999999999987654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .++....... ..+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~~~---- 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------ADV---- 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------ccc----
Confidence 2233567889999999988889999999999999999999999998655321 1111111110 011
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCH--HHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSM--RQVV 364 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 364 (420)
..+......+.+++.+||+.||.+||++ .|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111223567888899999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=302.19 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=211.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..-|.+.+.||+|.|..|-+|++-.+|..||||++.+. +.-....+.+|+..|+.++|||||++|.+......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34578889999999999999999999999999999765 3334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE-cCCCcEEEeeecCcccccCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll-~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|.-.+|+|+++|-.+.. .+.+....+++.||+.|+.|+|+ ..++||||||+||.+ .+-|-+||+|||++..+..+
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999976654 68999999999999999999998 899999999999866 46688999999999887755
Q ss_pred CCCcccccccCCcccccccccCCCCC-ccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. .....+|...|-|||++.+..|+ ++.||||||||||.|++|+.||...+..+. +..++|-.
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK 235 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK 235 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence 4 55678999999999999998876 578999999999999999999987655442 22233332
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+ ..+......+.+|+..||..||.+|.+.+||..
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 234455667888899999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.71 Aligned_cols=264 Identities=27% Similarity=0.342 Sum_probs=199.4
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|+..+.||.|++|.||+|.+..++..|++|++.... ......+.+|++.+++++|||++++++++...+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999998888999999886542 222356889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
+++|.+++.......+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5699999877654568999999999999999999998 8999999999999999999999999999875533211 1
Q ss_pred ccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-hhhhh-------hhhc-ccCcccc
Q 036051 255 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-LVDWV-------FDFW-NRGELLE 324 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~~~~~-------~~~~-~~~~~~~ 324 (420)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||.......... ..++. +... .......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2223568899999988654 57889999999999999999999997654321110 00000 0000 0000000
Q ss_pred cc---CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 AR---DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ...............+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000111122356778999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.73 Aligned_cols=264 Identities=28% Similarity=0.345 Sum_probs=200.7
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEEEEe
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLVYD 172 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 172 (420)
|++.+.||+|++|.||+|.+..++..+|+|++.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999998888899999997653 33346788999999999999999999999888 89999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58988886653 368999999999999999999998 8999999999999999999999999999986654432
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc---c-----c
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE---L-----L 323 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-----~ 323 (420)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....................... . .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22333456888999998754 4578999999999999999999999976553221110000000000000 0 0
Q ss_pred cccCCCC------CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNL------GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.. ...+...+...+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 00000112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.28 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=196.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|...+.||+|+||.||++.+..++..||+|.+.... ......+.+|+..+.++. ||||+++++++...+..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999999889999999886542 334567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhh---ccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 174 MPNGSLDKYL---YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 174 ~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+. +++.++. .......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555443 22233468999999999999999999997 258999999999999999999999999998754332
Q ss_pred CCCcccccccCCcccccccccCC---CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...+... .....
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~------~~~~~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQV------VKGDP 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhh------cCCCC
Confidence 1 12233578899999998765 6899999999999999999999999754311 0000100 00111
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+.+...........+.+++.+||+.||++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122122112344568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.84 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=197.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++.+|...+.||+|+||.||+|....++..|++|++..... .....+.+|+..++.++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999999988888999999865432 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+. ++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 77777765443 257788899999999999999998 899999999999999999999999999987543221
Q ss_pred CCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh----------hh----
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF----------DF---- 316 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~----------~~---- 316 (420)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.............|.. ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112234568899999998653 57889999999999999999999997544321100000000 00
Q ss_pred -cccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 -WNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 -~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.................. .......+.+++.+|++.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 0011345678889999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.51 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=200.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 170 (420)
++|+..+.||+|+||.||+|.+..++..+++|.+..... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 468888999999999999999988888999999865422 2234567899999999999999999998877 899999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||++ ++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 599988876443 68999999999999999999999 89999999999999999999999999998865443
Q ss_pred CCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-hhhh-------hh------
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-VDWV-------FD------ 315 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-~~~~-------~~------ 315 (420)
. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||........... .... +.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 122334578899999998654 468899999999999999999999976543221100 0000 00
Q ss_pred hcccCccccccCCCCCCcccHH-HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRGELLEARDPNLGTEYVAE-ELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..............+...+... ....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000001111111111111 2455778899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=292.88 Aligned_cols=243 Identities=25% Similarity=0.333 Sum_probs=196.9
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||.|++|.||+|++..++..|++|++.... ....+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999998888899999986532 23446789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99997654 58899999999999999999999 999999999999999999999999999998664432 223346
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
++..|++||.+.+..++.++|+||||+++|||++|+.||........ +....... + ... ..++....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~-~----~~~----~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILK-G----NGK----LEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhc-c----CCC----CCCCcccC
Confidence 78999999999888899999999999999999999999976552110 11111100 0 001 11111224
Q ss_pred HHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 340 ELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56888999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=295.57 Aligned_cols=242 Identities=28% Similarity=0.334 Sum_probs=192.5
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||+||++.+..++..||+|.+.... ......+.+|+.++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999998888899999886432 22344567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.......+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 999977655568999999999999999999999 99999999999999999999999999998765432 1223345
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .+. .... ...... .....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~~~--~~~~~~----~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELK----RRTL--EMAVEY----PDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHH----hccc--cccccC----CccCC
Confidence 7889999999988889999999999999999999999997544311100 000 0000 001111 11223
Q ss_pred HHHHHHhhcccccCCCCCCCHHH
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQ 362 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~e 362 (420)
..+.+++.+||+.||.+||++.+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 45778889999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=288.72 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=206.4
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLVY 171 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 171 (420)
+|...+.||+|++|.||+|....++..|++|++.... ....+.+.+|+..+++++||||+++++++... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999998888899999987654 24567889999999999999999999999888 8999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997665 78999999999999999999999 999999999999999999999999999998765432
Q ss_pred CC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.. ......++..|+|||.+.+...+.++||||||+++++|++|+.||........ ..... .....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~---------~~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKI---------GSSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhc---------cccCC
Confidence 21 12345688999999999888899999999999999999999999976541110 00100 00011
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...........+.+++.+|++.||++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122223466888899999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=291.06 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=205.8
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|...+.||.|++|.||++.+..++..+++|++.... ......+.+|++.+++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999998888899999987653 24557788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997653 3478999999999999999999999 899999999999999999999999999998654432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||......+ ...... ... .+.+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~-----~~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KGQ-----YPPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cCC-----CCCCC
Confidence 22333568889999999988889999999999999999999999996554221 111111 111 11111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .....+.+++.+||..+|++|||+.|+++
T Consensus 225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 22345778888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=297.83 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=198.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|+..+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|++++++++|||++++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999998888899999886542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCcccccCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~ 251 (420)
|++ ++|.+++.......+++..+..++.||+.||+|||+ .+++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 688888866555557888899999999999999998 89999999999999985 5679999999997543321
Q ss_pred CCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hhhh----hhcccCc-cc-
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DWVF----DFWNRGE-LL- 323 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~~~----~~~~~~~-~~- 323 (420)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..... .... ..+.... +.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 12233456889999998865 45789999999999999999999999765432211100 0000 0000000 00
Q ss_pred -cccCCCCCC----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 -EARDPNLGT----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 -~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.... .........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 011122345788999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=298.77 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=198.3
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
|...+.||+|+||.||+|++..++..||+|++... .......+.+|+..+++++|||++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66678899999999999999888889999988643 233446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 57877775433 368999999999999999999998 9999999999999999999999999999865432
Q ss_pred cccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......... ...... ..+..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~------~~~~~ 244 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN------ESPTL 244 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhc------cCCCC
Confidence 22346788999999873 456889999999999999999999998654322111 000000 00111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. .......+.+++.+||+.+|.+||++.++++.+...
T Consensus 245 ~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 Q---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred C---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1 112234578888999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=291.24 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=204.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|++.+.||+|+||.||++.+..++..+++|.+... .......+.+|+..+++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999999888889999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 12468999999999999999999998 99999999999999999999999999999876543
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.. .....+ ..+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~-----~~~--- 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRG-----KYP--- 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC-----CCC---
Confidence 222345788999999999888999999999999999999999999765432210 000111 111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.86 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=207.0
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.++..||.|+||.||+|..+..+...|.|++.....+...+|+-|+++|+..+||+|+++++.|...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44567799999999999999988877889999888888889999999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|-.+..+..-++ .|++.++.-+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+..... ......
T Consensus 114 GAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred chHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 999998876544 79999999999999999999999 9999999999999999999999999999864322 122345
Q ss_pred ccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 257 HVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.+.|||.|||||+.. ..+|++++||||||++|.||..+.+|-...++...+.. +.+--.|.+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK------------iaKSePPTLl 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------------IAKSEPPTLL 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH------------HhhcCCCccc
Confidence 578999999999874 46799999999999999999999999866554321110 0011111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+..-...+.+++.+||..||..||++.++++
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12334556788888999999999999998876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=294.45 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=200.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+|+..+.||.|++|.||+|++..++..||+|++..... .....+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47888999999999999999988899999998875532 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 175 PNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 175 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+ ++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 48888876543 2468999999999999999999998 8999999999999999999999999999975543221
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hhh-------hhhcccCcccc
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DWV-------FDFWNRGELLE 324 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~ 324 (420)
......++..|++||++.+ ..++.++||||||+++|||++|+.||......+..... +.. +..+.......
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 2223456889999998855 45788999999999999999999999765433211100 000 00000000000
Q ss_pred ccCCCCC----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLG----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+... ....+.....+.+++.+|++.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122355778999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=297.94 Aligned_cols=268 Identities=26% Similarity=0.322 Sum_probs=199.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG---- 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 165 (420)
...++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999998888899999986542 222356778999999999999999999887654
Q ss_pred ------eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 166 ------ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 166 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 79999999965 777777654 2368999999999999999999999 899999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.............
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998664433222222346788999998854 4578899999999999999999999975443221111000000000
Q ss_pred cCcc--------ccccCC------CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGEL--------LEARDP------NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~--------~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... ....++ ..... .......+.+++..||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000000 00000 0112356788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=297.12 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=195.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCe-----
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGE----- 166 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 166 (420)
++|+..+.||+|+||.||+|.+..++..||+|...... ......+.+|+.+++.+. |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999998889999999876542 222356888999999994 6999999998876655
Q ss_pred EEEEEeecCCCChhhhhccCC---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeec
Q 036051 167 LLLVYDYMPNGSLDKYLYNQP---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFG 242 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg 242 (420)
.++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+ .+++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8888876432 2368999999999999999999999 99999999999999998 8899999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-hhhhhhh----h
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-LVDWVFD----F 316 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~----~ 316 (420)
++........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+... ....+.. .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9875533211 1222356888999998855 457899999999999999999999997644322110 0000000 0
Q ss_pred cc---c-Cccc--cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WN---R-GELL--EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~---~-~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+. . .... ....+.............+.+++.+||+.||.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 0000 000000000011123455788999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=303.47 Aligned_cols=264 Identities=22% Similarity=0.245 Sum_probs=200.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------ 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 164 (420)
..++|+..+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999888999999998643 233445678899999999999999999987543
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
...++|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 588887754 27888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-h--------hhh---
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-L--------VDW--- 312 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~--------~~~--- 312 (420)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... + .++
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8654322 2233467889999999999899999999999999999999999997544221100 0 000
Q ss_pred ----hhhhcccCc------ccccc----CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 313 ----VFDFWNRGE------LLEAR----DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 313 ----~~~~~~~~~------~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
......... ..+.. .+.............+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000 0110011111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.54 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=198.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (420)
.+|++.+.||+|++|.||+|.+..++..|++|.+... .......+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999888899999987432 223456788999999999999999999988664 468
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++++||+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987654 57889999999999999999998 99999999999999999999999999999865
Q ss_pred cCCC--CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGT--DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
.... ........++..|+|||++.+..++.++|+||||+++|||++|+.||......... . +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~---------~~ 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------F---------KI 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------H---------HH
Confidence 3211 11223356889999999998888999999999999999999999999754322111 0 00
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+......+.+++..||+ +|..||+..+++.
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00001111222333557778888998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=287.86 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=204.3
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|+..+.||+|++|.||+|++..++..|++|.+..... .....+.+|++++.+++|||++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47788999999999999999988888999999876643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 99999999987653 68999999999999999999998 9999999999999999999999999999986654322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......++..|+|||...+..++.++||||||+++|+|++|+.||......... .... ....+...
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~------~~~~~~~~-- 220 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIV------QDDHPPLP-- 220 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHh------ccCCCCCC--
Confidence 123356788999999998878899999999999999999999999754321110 0000 00111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+.+++.+||+.+|++|||+.+++.
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 --EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122345778888999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.71 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=195.1
Q ss_pred ceeccc--CceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSG--GFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
..||+| +||+||++++...++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999999888999999998643 333457788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc--
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-- 254 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 254 (420)
++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999876544468999999999999999999998 899999999999999999999999998654332111100
Q ss_pred ----ccccccCCcccccccccCC--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh---------hc--
Q 036051 255 ----TTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD---------FW-- 317 (420)
Q Consensus 255 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~-- 317 (420)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ...... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence 1112345679999998763 4789999999999999999999999765432211 000000 00
Q ss_pred ---------------------ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 ---------------------NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........................+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000000111111122334567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=304.99 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----CeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 167 (420)
+++|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999999888899999998643 223346678899999999999999999986544 358
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++++||+. ++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 5888877543 58999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCCC--cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC---c
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG---E 321 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 321 (420)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ..+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHH
Confidence 332211 1223567899999998754 56889999999999999999999999654321111 0000000000 0
Q ss_pred c-----------ccccCCCCCCc---ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 322 L-----------LEARDPNLGTE---YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 322 ~-----------~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
. ........... ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000000 011123557899999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.49 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=195.2
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeC--CeEEEEEe
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK--GELLLVYD 172 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 172 (420)
|+..+.||+|+||.||+|....++..||+|++.... ........+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999998888899999886542 222234457888888885 99999999999887 88999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|++ ++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888876543 368999999999999999999999 89999999999999999 999999999998654322
Q ss_pred CcccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh---------hhhhhhhcccCcc
Q 036051 253 PQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL---------VDWVFDFWNRGEL 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~ 322 (420)
......++..|+|||++. +..++.++|||||||++|||++|+.||...+..+.... ..| .........
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRH 231 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccccc
Confidence 122345788999999764 45678899999999999999999999976543221100 000 000000000
Q ss_pred ccccCCCCC----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNLG----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+... ..........+.+++.+||+++|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 0011233567899999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=298.64 Aligned_cols=267 Identities=28% Similarity=0.337 Sum_probs=198.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (420)
.++|+..+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4678999999999999999999988889999998864421 1223467899999999999999999998654 56899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+||+. ++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999995 58888876543 368999999999999999999999 9999999999999999999999999999986643
Q ss_pred CCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-hh-------hhhhcccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-DW-------VFDFWNRG 320 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~~-------~~~~~~~~ 320 (420)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... +. .+......
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 221 2222345788999999865 55789999999999999999999999765443221110 00 00000000
Q ss_pred cccccc--CCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 321 ELLEAR--DPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 321 ~~~~~~--~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
...... ........ .......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00000000 00123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.99 Aligned_cols=243 Identities=24% Similarity=0.314 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHH---hccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVS---IGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
.||+|+||.||++.+..++..+|+|.+.... ......+.+|..+ +...+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999998888899999886431 1112233444433 334479999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999987654 68999999999999999999999 999999999999999999999999999987543321 2
Q ss_pred cccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 256 THVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....|+..|+|||.+. +..++.++|||||||++|||++|+.||..........+. .. .......+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~------~~~~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RM------TLTVNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HH------hhcCCcCC----
Confidence 2346899999999986 456889999999999999999999999754432211100 00 00011111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARP-----SMRQVVQI 366 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 366 (420)
.......+.+++.+||+.||.+|| ++.|+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122334577888899999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=298.84 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=197.1
Q ss_pred CCCccceecccCceEEEEEEeCC--Cceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPK--SKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELL 168 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 168 (420)
+|++.+.||+|++|.||+|.+.. .+..||+|.+.... ......+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999987 78899999987632 33345678899999999999999999999888 8899
Q ss_pred EEEeecCCCChhhhhccCC---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC----CCcEEEeee
Q 036051 169 LVYDYMPNGSLDKYLYNQP---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG----ELNGRLGDF 241 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~----~~~~kl~Df 241 (420)
+||||++ ++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777664321 2368899999999999999999998 99999999999999999 899999999
Q ss_pred cCcccccCCCC--CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc-------hhhh
Q 036051 242 GLARLYDHGTD--PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENL-------ILVD 311 (420)
Q Consensus 242 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~-------~~~~ 311 (420)
|++........ .......++..|+|||++.+ ..++.++||||||++++||++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543222 12233467889999998765 45789999999999999999999999765443200 0000
Q ss_pred hhhhhccc------------Ccccc---cc-CCCCCCcccH-------HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 312 WVFDFWNR------------GELLE---AR-DPNLGTEYVA-------EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 312 ~~~~~~~~------------~~~~~---~~-~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ...+.. ..... .. .......... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 I-FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000 00000 00 0000000000 12345888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.89 Aligned_cols=246 Identities=23% Similarity=0.429 Sum_probs=196.8
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeeccccc----chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--eEEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLVY 171 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 171 (420)
+...+||+|+|-+||+|.+..+|..||--.++.. .....+.|..|+.+|+.|+||||++++.++.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456799999999999999888888775443322 3344578999999999999999999999887654 589999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCcccccCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHG 250 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~~ 250 (420)
|.|..|+|..|+++.. .++...+..++.||++||.|||+. .++|+|||||-+||||+.+ |.|||+|+|+|......
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999998876 577789999999999999999985 4799999999999999966 89999999999987543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. .....|||.|||||.+. ..|++..||||||++++||+|+..||..-....+ +...|........+.++.||
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhccCCH--
Confidence 2 23378999999999996 7899999999999999999999999975443221 11112222222222222222
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+.++|.+|+.. ..+|||+.|+|.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 367888899999 999999999986
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.99 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=188.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCcee-eee------------------ecccccchhHHHHHHHHHHHhccCCcce
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIE-IAV------------------KKISHESRQGMKEFVAEIVSIGRLRHRN 153 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-vav------------------K~~~~~~~~~~~~~~~e~~~l~~l~h~n 153 (420)
...+|++.+.||+|+||+||++.++..... .+. |.+. ........+.+|+.++.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 357899999999999999999876432211 111 1111 12223456889999999999999
Q ss_pred EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCC---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
|+++++++...+..++|++++ .++|.+++.... .......+...|+.||+.||.|||+ .+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 999999999999999999999 567877765432 1123356677899999999999999 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCcc-CCCCCCcccchh
Q 036051 231 DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP-IERQGPEENLIL 309 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p-~~~~~~~~~~~~ 309 (420)
+.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654333333446799999999999999999999999999999999998754 433222111111
Q ss_pred hhhhh-----------------hhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 310 VDWVF-----------------DFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 310 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+. .++........ ...+...+ .......+.+++.+||+.||.+|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000 00000000000 00000000 0001234667788999999999999999986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=291.57 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=198.4
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||.|+||.||++++..++..+++|++..... .....+.+|++.+.+++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988888999999865432 4456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-------
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD------- 252 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~------- 252 (420)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 68999999999999999999998 9999999999999999999999999999875433211
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......++..|+|||...+...+.++||||||+++|||++|+.||......+.. ... ..+. .....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~-~~~~------~~~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNI-LNGK------IEWPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hcCC------cCCCc
Confidence 1223356788999999998888999999999999999999999999765433211 000 0000 00000
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
. ......+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 223 ~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 D--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 012456788899999999999999977666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=291.04 Aligned_cols=261 Identities=26% Similarity=0.326 Sum_probs=197.0
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccC---CcceEeeeeeeeeeCCe-----
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGE----- 166 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 166 (420)
|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++.++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999998878899999986432 12234566777766555 69999999999988776
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.+++|||+. ++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 589998876554468999999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc----
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL---- 322 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 322 (420)
..... ......++..|+|||++.+..++.++|+||||+++|||++|+.||......+... .........+..
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHhcCC
Confidence 54322 1223357889999999988889999999999999999999999987654332110 000000000000
Q ss_pred -----ccccCCCC---CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 -----LEARDPNL---GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 -----~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........ ......+....+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01112233466788999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=295.44 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=199.0
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
...||+|+||.||+|....++..||+|++..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999999888999999998665555567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++....... .......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9987543 57899999999999999999999 899999999999999999999999999987554322 1223356
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.... +.. ...+.... .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~---------~~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRD---------NLPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---------hCCcccCC--cccCC
Confidence 78999999999888889999999999999999999999975433221110 000 00111100 01123
Q ss_pred HHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 34677888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=293.10 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=201.5
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|+..+.||+|++|.||+|....++..+++|.+..... .....+.+|+..+++++|+|++++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 5667889999999999999988899999998865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
+ ++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||.+....... ..
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 6 48888886643 378999999999999999999999 999999999999999999999999999987665432 12
Q ss_pred ccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-h-------hhhhhccc---Ccc
Q 036051 255 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-D-------WVFDFWNR---GEL 322 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~-------~~~~~~~~---~~~ 322 (420)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+..... . ..+..... ...
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578889999998766 7899999999999999999999999765432211000 0 00000000 000
Q ss_pred ccccC--CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARD--PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..... .........+....+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00001112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=302.33 Aligned_cols=266 Identities=25% Similarity=0.336 Sum_probs=199.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC--CeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK--GELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~ 168 (420)
.++|+..+.||+|+||.||+|.+..++..+|+|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 46788889999999999999999888889999988542 233345677899999999 999999999987643 4689
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||++ ++|.+++... .+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999996 6999988654 67899999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC----CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc-----
Q 036051 249 HGTD----PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN----- 318 (420)
Q Consensus 249 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 318 (420)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+.+.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3321 22334568899999998754 5678899999999999999999999975543321110000000000
Q ss_pred ------cCccccccCCC---CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 319 ------RGELLEARDPN---LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 319 ------~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........... ............+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 0001111134568889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=297.14 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=196.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (420)
-++|+..+.||+|+||.||+|....++..||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999998889999999886432 222245678999999999999999999886643
Q ss_pred --eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 166 --ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 166 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
..++|+||+. ++|.+.+.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999995 58888776543 368999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC---cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 244 ARLYDHGTDP---QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 244 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432211 12234568889999988654 4788999999999999999999999765443221111111100000
Q ss_pred C--------cccc-ccCCCCCCcccH------HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 G--------ELLE-ARDPNLGTEYVA------EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~--------~~~~-~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .... ...+........ .....+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 0000 000000000000 01234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.01 Aligned_cols=245 Identities=25% Similarity=0.288 Sum_probs=191.2
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHH-hccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|... ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999998888899999986542 2222334455444 3455899999999999999999999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997654 58899999999999999999999 8999999999999999999999999999875432 22
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
...++..|+|||.+.+..++.++||||||+++|||++|..||........ ......+.. ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRI------NWPEEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc------CCCCcccc
Confidence 34578899999999888889999999999999999999999975443221 000001000 00111111
Q ss_pred HHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 337 EELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 337 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
.....+.+++.+||+.||++||++.++.+.|.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23455788999999999999998876665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.28 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=201.0
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 168 (420)
+....|++.++||+||.+.||++...+.+ .+|+|++... +.....-|.+|+..|.+|+ |.+|+++++|-..++.+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34567899999999999999999986554 5777765433 5566788999999999995 999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
|||||- .-+|..+|.........| .+..+..|++.++.++|. .+|||.||||.|+|+-+ |.+||+|||+|....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999987 669999998776655555 777899999999999999 99999999999998864 689999999998776
Q ss_pred CCCC-CcccccccCCcccccccccCC-----------CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 249 HGTD-PQTTHVVGTLGYLAPEHTRTG-----------KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 249 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
.+.. -.....+||+.||+||.+... +.+.+|||||||||||+|+.|+.||...... |
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~---- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------I---- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------H----
Confidence 5443 345567999999999987432 2567999999999999999999999653321 0
Q ss_pred cccCccccccCCCCCCcccHHH-HHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 317 WNRGELLEARDPNLGTEYVAEE-LELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.++..+.+|....+|+.-- ...++++++.||+.||++|||+.|+|+.
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1123334443322222111 1128899999999999999999999863
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=294.49 Aligned_cols=207 Identities=29% Similarity=0.420 Sum_probs=185.9
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
...+.|..-++||+|+||.||-++.+.+|..+|.|.+.+. .+....-.++|-.+|.+++.+.||.+--.|+..+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456788889999999999999999999999999998654 2333455788999999999999999988899999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+..|.||+|.-+|.+.+...+++..+.-++.+|+.||++||. ..||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999998877789999999999999999999998 999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
.+.. ....+||.+|||||++.++.|+...|+|||||++|||+.|+.||.....
T Consensus 339 ~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 339 EGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 5443 2334899999999999999999999999999999999999999976543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.71 Aligned_cols=267 Identities=25% Similarity=0.314 Sum_probs=201.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 167 (420)
.++|++.+.||+|++|.||+|....++..||+|++.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478889999999999999999998889999999987542 2334667889999999999999999998753 3578
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++|+||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 69999987654 58999999999999999999998 99999999999999999999999999998765
Q ss_pred cCCCCC---cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hh
Q 036051 248 DHGTDP---QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FD 315 (420)
Q Consensus 248 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 315 (420)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 332211 1223468899999998855 46889999999999999999999999765432211100000 00
Q ss_pred hcccCccc---cccCCCCCC---cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 316 FWNRGELL---EARDPNLGT---EYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 316 ~~~~~~~~---~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
........ +........ .........+.+++.+||+.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 000000000 0112234668899999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.96 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=187.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC---ceeeeeecccccchhH-----------HHHHHHHHHHhccCCcceEeeee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHESRQG-----------MKEFVAEIVSIGRLRHRNLVQLL 158 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~ 158 (420)
..++|.+.+.||+|+||.||+|.+.++ +..+++|+........ ......+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999998766 5567777643322111 01123344556677899999999
Q ss_pred eeeeeCC----eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 159 GYCRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 159 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
+++.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+ .+++||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 9765543 457788877 446666665432 35778889999999999999999 8999999999999999999
Q ss_pred cEEEeeecCcccccCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch
Q 036051 235 NGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI 308 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~ 308 (420)
.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999986532211 11223468999999999999999999999999999999999999998664322111
Q ss_pred h---hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 309 L---VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 309 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
. .++.. ....+. ... ......+.+++..|++.+|++||++.++++.++
T Consensus 244 ~~~~~~~~~-~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIK-RLHEGK--------IKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHH-Hhhhhh--------hcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 01111 111111 000 112355778888899999999999999998763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=291.47 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=199.1
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|.+.+.||+|++|+||+|+..+++..|++|++..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999988888999998865422 22234567899999998 999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
+|+|.+++.......+++.++..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 8899998876654578999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred ccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh----------hhhhhhcccCccc
Q 036051 255 TTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV----------DWVFDFWNRGELL 323 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 323 (420)
.....++..|+|||++. +..++.++|+||||+++|||++|+.||......+..... .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23346788999999874 456789999999999999999999999765432211000 0100000000000
Q ss_pred cccCCCCC---CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLG---TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........ ..........+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=301.99 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=199.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----Ce
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 166 (420)
.++|.+.+.||+|+||+||+|++..++..||||.+... .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999999888899999988643 233345677899999999999999999987644 35
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999994 78998887653 68999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhhc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDFW 317 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~ 317 (420)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............-+ ....
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 54322 12233467889999998764 46889999999999999999999999754321111000000 0000
Q ss_pred ccCccc---c----ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 318 NRGELL---E----ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 318 ~~~~~~---~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
...... + ..++.. .....+....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 0 000000 00111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=285.95 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=191.8
Q ss_pred HHHHhcCCCcccee--cccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCe
Q 036051 90 LYIATKGFREKELL--GSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 90 ~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (420)
.....++|++.+.+ |+|+||.||++..+.++..+|+|.+........ |+.....+ +|||++++++++...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344566666666 999999999999988888999999865422111 22222212 79999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLAR 245 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~ 245 (420)
.++||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999997654 78999999999999999999999 8999999999999999988 99999999987
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....++....
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--------- 223 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--------- 223 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---------
Confidence 54322 22457899999999988889999999999999999999999997443221 1111111111
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-HHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPS-MRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 365 (420)
... ..........+.+++.+||+.+|.+||+ +.|+++
T Consensus 224 -~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 0111123345788888999999999996 688873
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=300.14 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=203.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-----eEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELL 168 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 168 (420)
+|++.+.||+|++|.||+|+...++..|++|++.... ....+.+.+|+..++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998888899999887643 344567899999999999999999999987765 789
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
++|||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 58998887654 78999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCC--CcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc-------
Q 036051 249 HGTD--PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN------- 318 (420)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 318 (420)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+......-......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 123335678899999999877 789999999999999999999999976654321110000000000
Q ss_pred -cCccc---cccCCCCC---CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 319 -RGELL---EARDPNLG---TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 319 -~~~~~---~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..... ........ ..........+.+++.+||+.+|.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 00000000 00111234567889999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=294.28 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=197.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..|...+.||+|++|.||+|++..++..+++|.+... ......++.+|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466678899999999999999888889999988642 3344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9995 68887775443 258899999999999999999998 8999999999999999999999999999875432
Q ss_pred CCcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... . ...+ ..+
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~~-----~~~ 232 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQN-----ESP 232 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------H-Hhhc-----CCC
Confidence 12346788999999874 3567889999999999999999999986543322110 0 0000 111
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
... .......+.+++.+||+.+|.+||++.++++...
T Consensus 233 ~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 1123345778899999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=276.34 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=199.2
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+.+....||.|..|.|++++.+.++..+|||..... +.+..+.++..++++..-+ +|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 344566799999999999999999999999998765 5566677888888877665 89999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
| ..-++.+++.-. .++++..+-++...+.+||.||.. +++|+|||+||+|||+|+.|++|+||||++-.+-...
T Consensus 173 M-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 173 M-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 9 556677666543 368999999999999999999998 5899999999999999999999999999997654322
Q ss_pred cccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
..+...|-+.|||||-+. ...|+-++||||||+.|+||.||+.||.+...+-.. +. .+.....|.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-lt----------kvln~ePP~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LT----------KVLNEEPPLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HH----------HHHhcCCCCC
Confidence 334457889999999884 346889999999999999999999999875543211 00 0111112333
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.. ......+.+++..||++|+.+||...++++
T Consensus 316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221 113445788888899999999999999876
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=292.04 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=194.8
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
|...+.||+|+||.||+|++..++..|++|++... .......+.+|+..++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999999888889999988643 223446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+. ++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 95 67877775543 368999999999999999999998 899999999999999999999999999886432
Q ss_pred cccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......++..|+|||++. ...++.++||||||+++|||++|..||......... ...... ..+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~------~~~~~ 240 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN------DSPTL 240 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc------CCCCC
Confidence 122356888999999984 456888999999999999999999998765432211 000000 01111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
. .......+.+++.+||+.+|.+||++.++++.
T Consensus 241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122347788889999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.38 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=203.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 170 (420)
++|...+.||+|+||.||+|....++..|++|++... .....+.+..|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688899999999999999999888999999998653 2233467889999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997654 68999999999999999999998 99999999999999999999999999998865433
Q ss_pred CC-------------------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh
Q 036051 251 TD-------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311 (420)
Q Consensus 251 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~ 311 (420)
.. .......++..|+|||.+.+..++.++||||||++++++++|+.||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---- 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---- 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH----
Confidence 21 1222345788999999998888999999999999999999999999765421100
Q ss_pred hhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCH----HHHHH
Q 036051 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM----RQVVQ 365 (420)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 365 (420)
.... ...... +......+.+++.+||+.+|.+||++ .++++
T Consensus 232 --~~~~-------~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --QKIL-------KLEYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHH-------hcCCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 011111 11224457888999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=291.98 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=195.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (420)
-++|+..+.||+|++|.||+|.+..+++.||||.+.... ......+..|+..+.+.. ||||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456788999999999999999998878899999986542 233456677777676664 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+ .++|.+++..... .+++..+..++.|++.||+|||+ ..+++||||+|+||++++++.+||+|||++.......
T Consensus 94 e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 998 4577777655333 78999999999999999999996 2589999999999999999999999999987654322
Q ss_pred CCcccccccCCcccccccccCCC----CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .+. ...... .
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~~------~ 236 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLT----KILQEE------P 236 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHH----HHhcCC------C
Confidence 1 12235778999999987554 78899999999999999999999965322110 000 000000 0
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+.... .......+.+++.+||+.||.+||++.++++.
T Consensus 237 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 01123457888899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.61 Aligned_cols=263 Identities=28% Similarity=0.466 Sum_probs=211.3
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCC-------Cceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeee
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGY 160 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 160 (420)
.++..++..+.+.||+|.||.|++|...+ ....||||.+... .....+.+..|+++|..+ +|+|++.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34455666677799999999999997531 2567999999765 335567899999999998 69999999999
Q ss_pred eeeCCeEEEEEeecCCCChhhhhccCC------------C--ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCC
Q 036051 161 CRRKGELLLVYDYMPNGSLDKYLYNQP------------K--VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKAS 226 (420)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~ 226 (420)
|...+..++|+||+..|+|.++|+... . ..++..+.+.++.|||.|++||++ .+++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999998664 0 138889999999999999999999 89999999999
Q ss_pred CEEEcCCCcEEEeeecCcccccCCCCCcccccc--cCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCC
Q 036051 227 NVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV--GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGP 303 (420)
Q Consensus 227 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~ 303 (420)
|||+.++..+||+|||+++.............. -+..|||||.+....++.|+|||||||+|||++| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999865443332222222 3567999999999999999999999999999988 8899976332
Q ss_pred cccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... +.+.+++|..++. +..+...+.++|+.||+.+|++||++.++.+.++..
T Consensus 528 ~~~------l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEE------LLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHH------HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 221 1223334433222 223345688999999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.97 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=190.6
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
+.+|.|+ .||.++...++..||+|++... .....+.+.+|+..+++++||||+++++++...+..+++|||+++++
T Consensus 8 ~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 3344444 4555555557888999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC------
Q 036051 179 LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD------ 252 (420)
Q Consensus 179 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~------ 252 (420)
|.+++.......+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999986544468899999999999999999999 9999999999999999999999999998875432111
Q ss_pred CcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh----hccc-------
Q 036051 253 PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD----FWNR------- 319 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~------- 319 (420)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.... ....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhc
Confidence 11223456788999999865 35889999999999999999999999754332111 000000 0000
Q ss_pred Ccccc----ccCC----CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELLE----ARDP----NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..... ..++ .............+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 0000 0011112233456788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=277.19 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=210.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..++|...++||+|.||.|.+++-+.+++.+|+|+++++ .+.....-+.|-++|...+||.+..+--.+...+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 456788899999999999999999999999999999876 34445556778899999999999999888999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||..||.|.-+|.+.. .+++....-+-..|..||.|||+ .+|+.||||.+|.|+|++|++||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999999997654 68888888899999999999999 9999999999999999999999999999974322
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
........+|||.|+|||++....|..+.|+|.+||++|||++|+.||...+.+....+ .-.-+-+
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------------Il~ed~k 386 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------------ILMEDLK 386 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------------HHhhhcc
Confidence 12245668999999999999999999999999999999999999999986554331111 1112223
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH-----------HHhcCCCCCcccccC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ-----------ILERDVALPAISALG 380 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~-----------~L~~~~~~~~~~~~~ 380 (420)
++....++. ..|+...|.+||.+|.. ++||.+ .+++.+..|..|...
T Consensus 387 FPr~ls~eA----ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 387 FPRTLSPEA----KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred CCccCCHHH----HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 333444443 33444467889999974 555543 234555666555443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=296.62 Aligned_cols=267 Identities=23% Similarity=0.296 Sum_probs=200.9
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee-CC
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KG 165 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 165 (420)
++...+++|+..+.||.|+||.||+|....++..||+|++... .....+.+.+|+.++.+++|||++++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3445678899999999999999999999888999999987543 22334677899999999999999999998865 56
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++++||+ +++|.+++... .+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 67898888643 57888888999999999999999 999999999999999999999999999987
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-h--------hhhhhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-L--------VDWVFD 315 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~--------~~~~~~ 315 (420)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... + .++...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5432 2223457889999998765 568999999999999999999999997544321100 0 001110
Q ss_pred hcccCc--cccccCCCCC---CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 316 FWNRGE--LLEARDPNLG---TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 316 ~~~~~~--~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
...... .......... ..........+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 00011123568889999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.15 Aligned_cols=267 Identities=27% Similarity=0.314 Sum_probs=195.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeC-------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------- 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 164 (420)
.++|++.+.||+|+||.||+|++..++..+++|++..... .....+.+|++.+++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999988888999998864422 1224567899999999999999999876443
Q ss_pred -CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 165 -GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 165 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
..+++|+||+. ++|...+... ...+++.++..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 35799999995 4777776543 2368999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC----------cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 244 ARLYDHGTDP----------QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 244 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
+......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765432211 1123456888999998765 4578999999999999999999999975543221111000
Q ss_pred hhhhcccC------cccc----ccCCCCCCc---ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 313 VFDFWNRG------ELLE----ARDPNLGTE---YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 313 ~~~~~~~~------~~~~----~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........ .+.. ......... ........+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000 000000000 00112256788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.39 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHH---HHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEI---VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
.||+|+||.||+|.+..+++.||+|.+.... ......+..|. ..+...+|||++++++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999998888899999886532 11112233443 34445689999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CC
Confidence 999999886543 68999999999999999999999 99999999999999999999999999998755322 12
Q ss_pred cccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 256 THVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||........... .. ......+.....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~------~~~~~~~~~~~~- 221 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DR------MTLTMAVELPDS- 221 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HH------HhhccCCCCCCc-
Confidence 234689999999998654 688999999999999999999999976532221100 00 000111112112
Q ss_pred cHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
....+.+++.+|+..+|.+|| ++.++++
T Consensus 222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 234577888889999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=288.12 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred CCCccceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 96 GFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
+|++.+.||+|+||.||++... .++..||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999874 357789999986532 12335678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987654 57889999999999999999998 99999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccccccccCC--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
............++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~------- 226 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK------- 226 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc-------
Confidence 44332233345688999999998653 467899999999999999999999964332111 1111111100
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
..+.. +......+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 SEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111 112334577888999999999997 5555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=289.60 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=199.8
Q ss_pred CCCccceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 96 GFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
+|+..+.||+|++|.||+++.. .++..||||++.... ......+.+|+.++.++ +|||++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999863 345779999886432 22345688999999999 699999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987543 58899999999999999999998 99999999999999999999999999998765
Q ss_pred cCCCCCcccccccCCcccccccccCCC--CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
............++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ..........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~------- 226 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK------- 226 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc-------
Confidence 443322233356889999999987655 78899999999999999999999964322110 0111111110
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
..+..... ....+.+++.+||+.||++|||+.++.+.|+-
T Consensus 227 ~~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 SKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111111 22446788889999999999999988887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=294.57 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=196.6
Q ss_pred cCCC-ccceecccCceEEEEEEeCCCceeeeeecccccchhH--------------HHHHHHHHHHhccCCcceEeeeee
Q 036051 95 KGFR-EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG--------------MKEFVAEIVSIGRLRHRNLVQLLG 159 (420)
Q Consensus 95 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 159 (420)
++|. ..+.||+|+||+||+|.+..+++.||+|++....... ...+.+|++++.+++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4577999999999999998888999999886442211 124778999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
++...+..++||||+. |+|.+++.... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999995 69999886543 58899999999999999999998 999999999999999999999999
Q ss_pred eecCcccccCCC-------------CCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 240 DFGLARLYDHGT-------------DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 240 Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987654110 1111223467889999998764 46889999999999999999999997655432
Q ss_pred cchhhhhhhhhcccC---ccc--------cccCCCCCC---cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 306 NLILVDWVFDFWNRG---ELL--------EARDPNLGT---EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... .+....... ... ......... .........+.+++.+||+.+|++|||+.|++.
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111 111100000 000 000000000 001122356788999999999999999999996
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=295.70 Aligned_cols=270 Identities=24% Similarity=0.302 Sum_probs=201.9
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
...++...+++|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999999888899999998653 22334567889999999999999999998754
Q ss_pred C------CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 164 K------GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 164 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
. ...+++++++ +++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence 3 3478888887 88998887653 58899999999999999999999 9999999999999999999999
Q ss_pred EeeecCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-h----
Q 036051 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-D---- 311 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~---- 311 (420)
|+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ .
T Consensus 161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999875432 2233567889999998866 56888999999999999999999999654432211100 0
Q ss_pred ---hhhhhcccCc---cccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 312 ---WVFDFWNRGE---LLEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 312 ---~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.....+.... ............+ .......+.+++.+|++.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 0000000000000 00123457789999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=297.85 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=195.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------C
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 165 (420)
..+|...+.||+|+||.||+|++..++..||+|++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888899999999999999999888889999988643 222235678999999999999999999988654 3
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999995 47776652 258899999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~ 316 (420)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ...
T Consensus 166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 5432 2223467889999999866 46889999999999999999999999764432211000000 000
Q ss_pred cccCc---cccccCCCCC-Ccc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH--HHhcC
Q 036051 317 WNRGE---LLEARDPNLG-TEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ--ILERD 370 (420)
Q Consensus 317 ~~~~~---~~~~~~~~~~-~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 370 (420)
..... ..... +... ... .+.....+.+++.+||+.||.+||++.+++. .++..
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhc-CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 00000 0000 000 0112345778999999999999999999984 35443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=295.57 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=206.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
....|.+...||+|.|+.|.+|++..++..||+|.+.+. +......+.+|+++|..++||||++++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 356788899999999999999999999999999999765 333445588999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+.+|.+++++...++ +.+..+..++.|+..|++|+|+ +.|+|||||++||||+.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999988764 5558889999999999999999 99999999999999999999999999999988743
Q ss_pred CCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
......+|++.|.|||++.+..| .+.+|+||+|+++|-|+.|..||++..-.+.. +..+...+.-.
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk~rIp 275 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGKYRIP 275 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeeeeccc
Confidence 35566899999999999988775 67999999999999999999999876543211 11111111111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ....+-+++++++-.+|.+|+++.++.+
T Consensus 276 --~~----ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 --FY----MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --ce----eechhHHHHHHhhccCccccCCHHHhhh
Confidence 11 1123456666788889999999988865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=286.48 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=200.2
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|+..+.||+|++|.||+|+...+++.|++|++.... ......+..|+..+++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999998889999999987653 333467788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 6 59999997653 368999999999999999999999 8999999999999999999999999999876543221 2
Q ss_pred ccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh-h-------hhhhhccc----Cc
Q 036051 255 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-D-------WVFDFWNR----GE 321 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-~-------~~~~~~~~----~~ 321 (420)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+..... . ..+..... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234457789999998766 7899999999999999999999999765432111000 0 00000000 00
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..............+.....+.+++.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000111112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=283.22 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=194.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
+|.+.+.||+|+||.||++.+...+..+++|+.... .......+..|+.++++++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477889999999999999998766555666655431 122234567789999999999999999999999999999
Q ss_pred EeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 171 YDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||+++++|.+++.. .....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 223468999999999999999999998 99999999999999985 569999999987654
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... .....+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~------~~~~~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRI------VEGPTP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH------HcCCCC
Confidence 3221 2223457889999999988888999999999999999999999996433211 00110 011111
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ........+.+++.+||+.||++||++.|+++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 12233456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=297.41 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC---------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--------- 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 164 (420)
..+|...+.||.|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788899999999999999999888999999998766555567788999999999999999999876543
Q ss_pred -----CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEE
Q 036051 165 -----GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRL 238 (420)
Q Consensus 165 -----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl 238 (420)
...++|+||++ ++|.+++... .+++..+..++.||+.||.|||+ .+++||||||+||+++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35799999996 6898888543 58899999999999999999998 8999999999999997 4567899
Q ss_pred eeecCcccccCCCCC--cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--
Q 036051 239 GDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV-- 313 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~-- 313 (420)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+.+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765332111 1122357889999998654 56788999999999999999999999765432211100000
Q ss_pred -------hhhccc--Cccc-cccCCCC-CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 -------FDFWNR--GELL-EARDPNL-GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 -------~~~~~~--~~~~-~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...... .... ....+.. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000 0000000 00011122345778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.69 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=211.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc--c----eEeeeeeeeeeCC
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--R----NLVQLLGYCRRKG 165 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~ 165 (420)
..+++|.+...+|+|.||.|-.+.+...+..||||+++...... +..+-|+++|.++.+ | -++.+.+|+.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999998888899999997654443 445679999999942 2 4778889999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--------------
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-------------- 231 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-------------- 231 (420)
+.|+|+|.+ |-+++++|..+...+++...+..|+.|++++++|||+ ..++|.||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 7799999999888899999999999999999999999 9999999999999992
Q ss_pred ------CCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 232 ------GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 232 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
++-.++|+|||.+...... ....+.|..|.|||++.+-.++.++||||+||||.||.+|...|......+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1345899999999864432 255788999999999999999999999999999999999999998777666
Q ss_pred cchhhhhhhhhc--------------ccCcc-----------ccccCCCCC----CcccHHHHHHHHHHhhcccccCCCC
Q 036051 306 NLILVDWVFDFW--------------NRGEL-----------LEARDPNLG----TEYVAEELELILKLGLLCSHSDPTA 356 (420)
Q Consensus 306 ~~~~~~~~~~~~--------------~~~~~-----------~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~ 356 (420)
++...+.+.+-. ..+.+ ....++..+ ......+...|++|+.+||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 443333222111 11100 000011000 1123455677999999999999999
Q ss_pred CCCHHHHHH
Q 036051 357 RPSMRQVVQ 365 (420)
Q Consensus 357 RPt~~evl~ 365 (420)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.93 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=193.3
Q ss_pred CCCccceecccCceEEEEEEeCCC--ceeeeeeccccc--chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC----Ce
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKS--KIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK----GE 166 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 166 (420)
+|++.+.||+|+||.||++.+... +..||+|++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477789999999999999999877 788999988643 222346678899999999 599999999875432 45
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++++||+. ++|.+++.... .+++..+..++.||+.||.|||+ .+++||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899884 68999886543 68999999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCC---CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhh
Q 036051 247 YDHGTD---PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWV 313 (420)
Q Consensus 247 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~ 313 (420)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543221 11233568999999998765 46899999999999999999999999764422111000 000
Q ss_pred hhhcccC--ccccccC--CCC-CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 FDFWNRG--ELLEARD--PNL-GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 ~~~~~~~--~~~~~~~--~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ....... +.. ...........+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000000 000 00001112345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.03 Aligned_cols=214 Identities=28% Similarity=0.329 Sum_probs=194.0
Q ss_pred ccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeee
Q 036051 84 RFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160 (420)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 160 (420)
--...+++...++|.+.++||+|+||.|..++++.+++.+|+|++++. .+....-|..|-.+|.--+.+-|++++-.
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 345677788889999999999999999999999999999999999874 23445678899999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEee
Q 036051 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240 (420)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 240 (420)
|.+..++|+|||||+||+|-.++.... .+++..+..++..|+.||.-||+ .|+|||||||+|||+|..|++||+|
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 999999999999999999999998776 68999999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCccccccccc----C-CCCCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTR----T-GKATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 241 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
||.+..+..+........+|||.|++||++. + +.|...+|+||+||++|||+.|..||....
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 9999988877666777889999999999984 2 578999999999999999999999997543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=277.84 Aligned_cols=237 Identities=26% Similarity=0.329 Sum_probs=194.1
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
||+|+||.||++.+..++..+++|.+.... ......+..|+.++++++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998888899999886542 22456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 259 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 259 (420)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99997654 58999999999999999999999 999999999999999999999999999987654322 1233456
Q ss_pred cCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 260 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 260 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
++..|+|||...+...+.++|+||||+++|||++|+.||....... .... .. . ..... +....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~-~------~~~~~----~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEK---IL-K------DPLRF----PEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---Hh-c------CCCCC----CCCCC
Confidence 7889999999988888999999999999999999999996544311 1110 00 0 01111 11123
Q ss_pred HHHHHHhhcccccCCCCCCCHHH
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQ 362 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~e 362 (420)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 55778899999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=313.22 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=191.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeee-------
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------- 163 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 163 (420)
.-..+|++.++||+||||.||+++.+-+|+.+|||++... .......+.+|+..+++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456788899999999999999999999999999999766 33445678899999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 036051 164 -------------------------------------------------------------------------------- 163 (420)
Q Consensus 164 -------------------------------------------------------------------------------- 163 (420)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhh
Q 036051 164 ------------------------K--------GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211 (420)
Q Consensus 164 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH 211 (420)
. -.+|+-||||+...|.+++..+.... .....|+++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 13578889998877877776653211 46788999999999999999
Q ss_pred hcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC-----------------CCCCcccccccCCcccccccccCC-
Q 036051 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-----------------GTDPQTTHVVGTLGYLAPEHTRTG- 273 (420)
Q Consensus 212 ~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~- 273 (420)
+ +++|||||||.||++|++..|||+|||++..... ......+..+||.-|+|||++.+.
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 9999999999999999999999999999986210 011244567899999999999654
Q ss_pred --CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccc
Q 036051 274 --KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSH 351 (420)
Q Consensus 274 --~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 351 (420)
.|+.|+|+||||||++||+. ||...- +.. .+...++.+.+.. . ..+.......=.+++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa----~iL~~LR~g~iP~-----~-~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERA----SILTNLRKGSIPE-----P-ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH--HHH----HHHHhcccCCCCC-----C-cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 343211 110 0111222222111 1 22233333445678888999
Q ss_pred cCCCCCCCHHHHHH
Q 036051 352 SDPTARPSMRQVVQ 365 (420)
Q Consensus 352 ~dP~~RPt~~evl~ 365 (420)
+||.+|||+.|+|.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.37 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=197.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-----
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----- 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 165 (420)
..++|+..+.||+|+||.||+|....++..||||++... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999999888999999988543 2333456889999999999999999999886543
Q ss_pred -eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 166 -ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 166 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
..++|+||+ +++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 469999999 78998888643 58999999999999999999998 99999999999999999999999999998
Q ss_pred ccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-h--------hhhhh
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-L--------VDWVF 314 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~--------~~~~~ 314 (420)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......... . .++..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 754332 223457889999999865 458899999999999999999999997543221100 0 00000
Q ss_pred hhcccCcccccc--CCCCC----CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 315 DFWNRGELLEAR--DPNLG----TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 315 ~~~~~~~~~~~~--~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ......... -+... ..........+.+++.+|++.||.+|||+.++++
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000000 00000 0011122345778999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=295.36 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe----
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE---- 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 166 (420)
..++|+..+.||+|++|.||+|++..++..||+|++... .......+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357889999999999999999999888889999988653 23334667889999999999999999988765544
Q ss_pred --EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 167 --LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 167 --~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
.++|+||+ +++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999988753 68999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-hhh-------hhh
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-VDW-------VFD 315 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-~~~-------~~~ 315 (420)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .+. ...
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 765432 233467889999998865 3678899999999999999999999975543221100 000 000
Q ss_pred hcccCc---cccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRGE---LLEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+.... ............+ .......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 0000000000000 0112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=323.48 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=204.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-+-++.-...||.|.||.||-|...++|...|+|.+... .....+...+|+.++..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344556677899999999999999999999999987654 333456678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
||||++|+|.+++.... ..++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999997654 46666777789999999999999 99999999999999999999999999999977654
Q ss_pred CC---CcccccccCCcccccccccCC---CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 251 TD---PQTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 251 ~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.. .......||+-|||||++.+. ...-+.||||+|||++||+||++||...+.+- ..-+ .+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy----~V~~ 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMY----HVAA 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHh----HHhc
Confidence 31 233457899999999999653 35668999999999999999999998765432 1100 0111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
.-.|.. +......=.+++..||..||++|.++.|+++.-
T Consensus 1457 gh~Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1457 GHKPQI----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred cCCCCC----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 112222 222334456777889999999999998888654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=275.36 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=214.1
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCC-----ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLG 159 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~ 159 (420)
+.+++.....+++...++-+|.||+||.|.|.+. .+.|.+|.+... +.-+...++.|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3556777788888899999999999999977533 345788887654 3444567889999999999999999999
Q ss_pred eeee-CCeEEEEEeecCCCChhhhhcc------CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 160 YCRR-KGELLLVYDYMPNGSLDKYLYN------QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 160 ~~~~-~~~~~lv~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
++.. ....++++.++.-|+|..+|.. .....++..+...++.|++.|++|||+ .+++|.||.++|.++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence 8755 4678999999999999999972 123467888999999999999999998 99999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhh
Q 036051 233 ELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILV 310 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~ 310 (420)
..++||+|=.+++.+-..... -......+..||+||.+.+..|+.++|||||||+||||+| |+.||...++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 999999999999855443332 2223345778999999999999999999999999999987 999999888766321
Q ss_pred hhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
++.+|.. ...+.+++++++.++.-||..+|++||++.+++.-|.+
T Consensus 510 -----ylkdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 -----YLKDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----HHhccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2222221 12234567789999999999999999999999987753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.53 Aligned_cols=202 Identities=34% Similarity=0.466 Sum_probs=173.5
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------CeEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GELLLV 170 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv 170 (420)
...+.||+|+||.||+|+++.+|..||||.+.... ....+....|+++|++++|+|||+++++-+.. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34577999999999999999999999999997642 23345567899999999999999999986554 367999
Q ss_pred EeecCCCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--CCC--cEEEeeecCcc
Q 036051 171 YDYMPNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD--GEL--NGRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~--~~kl~Dfg~~~ 245 (420)
||||.+|||...|..-. ...|++.+.+.++.+++.||.|||+ ++|+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999997532 3569999999999999999999998 9999999999999984 333 47999999999
Q ss_pred cccCCCCCcccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPE 304 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~ 304 (420)
....+. .....+||..|.+||.+. .+.|+..+|.|||||++||.+||..||......
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 876543 566789999999999998 488999999999999999999999999765443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=267.67 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=199.1
Q ss_pred HhcCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee----CCe
Q 036051 93 ATKGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR----KGE 166 (420)
Q Consensus 93 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 166 (420)
.+++|.+. ++||-|-.|.|-.+.++.+++.+|+|++.... ...+|++.--.. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35556553 67999999999999999999999999996542 235778765554 69999999998754 467
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecC
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGL 243 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~ 243 (420)
+.+|||.|+||.|+..+..++...+++.++-.|..||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 8999999999999999999888889999999999999999999999 99999999999999974 44689999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
|+.... .......+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +.--....+..|.
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq-- 283 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ-- 283 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC--
Confidence 986543 234556788999999999999999999999999999999999999997544311 1101111111111
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..++.+--....+..-++++..|..+|.+|.|+.+++.
T Consensus 284 ----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 ----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111111223445566777789999999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=269.12 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=204.1
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeC
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK 164 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 164 (420)
+++|++..| .+.||+|+|+.|--+....++..+|||++.+..........+|++++.+.+ |+||+++++||+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 477777777 467999999999999998899999999998886666778899999999985 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeee
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDF 241 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Df 241 (420)
...|||||.|.||+|..+|+.+. .+++.++.++..+|+.||.|||. ++|.|||+||+|||..+-.. +||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998764 68999999999999999999999 99999999999999976543 899999
Q ss_pred cCccccc--CC----CCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc---
Q 036051 242 GLARLYD--HG----TDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL--- 307 (420)
Q Consensus 242 g~~~~~~--~~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~--- 307 (420)
.+..-.. .. ..+.....+|+..|||||+.. ...|+.++|.||||||||-|++|..||.+....+-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875322 11 233455678899999999762 236899999999999999999999999876553311
Q ss_pred -----hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 308 -----ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 308 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.-...+++-+.+|.. .....++ .......-+++...+..|+.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-----eFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-----EFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-----cCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 001111111222211 0011111 111223344555567789999999998876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.67 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=215.3
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee-
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR- 163 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 163 (420)
.++.+...++-|++.+.||.|.+|.||+++..++++..|+|+....... .+++..|.++++.+ +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444455677889999999999999999999999999999998765433 25677889999887 69999999998753
Q ss_pred ----CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 164 ----KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 164 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
++++|||||||.+|+..+++++.....+.|..+..|++.++.|+.|||. ..++|||||-.|||++.++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 4689999999999999999988777789999999999999999999998 999999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccccccccCC-----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 314 (420)
|||++...... ........||+.|||||++... .|+..+|+||||++..||.-|.+|+....+...+.+.
T Consensus 166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---- 240 (953)
T KOG0587|consen 166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 240 (953)
T ss_pred eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----
Confidence 99999866542 2344567899999999998543 4677899999999999999999999877765432211
Q ss_pred hhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...|.+...-+..-.+.+.+++..||.+|-.+||++.++++
T Consensus 241 ----------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 ----------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11222222234455778999999999999999999988875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=270.22 Aligned_cols=221 Identities=21% Similarity=0.176 Sum_probs=177.5
Q ss_pred cCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhcc
Q 036051 106 GGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYN 185 (420)
Q Consensus 106 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 185 (420)
|.+|.||++++..+++.+|+|++.... .+..|...+....|||++++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999986543 223444555556799999999999999999999999999999999876
Q ss_pred CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCccc
Q 036051 186 QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265 (420)
Q Consensus 186 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 265 (420)
.. .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 54 58999999999999999999998 99999999999999999999999999987654432 12234567899
Q ss_pred ccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHH
Q 036051 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKL 345 (420)
Q Consensus 266 aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 345 (420)
|||.+.+..++.++||||+|+++|||++|+.|+........ .......+. .....+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~~----~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIPE----WVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCcc----cCCHHHHHH
Confidence 99999888899999999999999999999988754321100 000001111 123457788
Q ss_pred hhcccccCCCCCCCHH
Q 036051 346 GLLCSHSDPTARPSMR 361 (420)
Q Consensus 346 ~~~cl~~dP~~RPt~~ 361 (420)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.91 Aligned_cols=146 Identities=27% Similarity=0.395 Sum_probs=132.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||.||+|.+..++..||||++... .......+..|+..+..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788899999999999999999888889999998643 2333467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
||+.+++|.+++.... .+++..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 57889999999999999999998 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=266.97 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=170.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCc----eeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeee-CCeE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSK----IEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 167 (420)
..|+....||+|.||.||+|...+++ ..+|+|+++.... .-.....+|+.+++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56888899999999999999665443 2689999976521 112456789999999999999999998776 7889
Q ss_pred EEEEeecCCCChhhhhccCC---CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC----CcEEEee
Q 036051 168 LLVYDYMPNGSLDKYLYNQP---KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE----LNGRLGD 240 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~----~~~kl~D 240 (420)
++++||.+. +|...|+.+. ...++-..+..|+.||+.|+.|||+ +-++||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 8988886432 2478889999999999999999999 999999999999999877 8999999
Q ss_pred ecCcccccCCCCC--cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCC
Q 036051 241 FGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQ 301 (420)
Q Consensus 241 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~ 301 (420)
+|+++.+...-.+ .....+-|..|.|||.+.+. .|+.+.||||.|||+.||+|-++.|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999988765433 34456779999999998775 5899999999999999999999888654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=283.16 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=198.6
Q ss_pred cceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
.++||+|.||+||-|+++++|+.||||++.+. ......++.+|+.+|.+++||.||.+...|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999999999999999999754 3344478899999999999999999999999999999999999 77
Q ss_pred ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC---CcEEEeeecCcccccCCCCCc
Q 036051 178 SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++.+.|...+...|++.....++.||+.||.|||. ++|+|+||||+|||+... -++||||||+++...... -
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 88888877777789999999999999999999999 999999999999999643 479999999999876533 3
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....+||+.|+|||++.++.|+..-|+||.|||+|.-++|..||+.+....+. +.+...+. +...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---------IQNAaFMy------Pp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---------IQNAAFMY------PPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH---------hhcccccc------CCCc
Confidence 45578999999999999999999999999999999999999999764432211 11111111 1111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
-.+.....++++...|+..-.+|-|....+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 223334456667777777888888876543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.38 Aligned_cols=253 Identities=26% Similarity=0.318 Sum_probs=194.8
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
+....||.|+||+|++-.++..++..|||+++..+. ...++++.|.+...+- ++||||+++|.+-..+..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 345679999999999999999999999999987643 5567788888876654 7999999999999999999999999
Q ss_pred CCChhhhhc---cCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 176 NGSLDKYLY---NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 176 ~g~L~~~l~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
..+|+.+-+ .-....+++..+-.|......||.||.. ...|+|||+||+|||+|..|.+||||||++-.+...
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 567766543 3334478898899999999999999998 478999999999999999999999999998765432
Q ss_pred CcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
...+.-.|-..|||||-+.. ..|+-+|||||||++|+|+.||+.||.....- .+.+.... .|. .|.+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv-~gd-----pp~l 290 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVV-IGD-----PPIL 290 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHH-cCC-----CCee
Confidence 23344568889999998843 35899999999999999999999999765431 11111110 111 1111
Q ss_pred CCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 331 GTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 331 ~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.... ..+....+.+++.-|+.+|-..||...++.++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 11234557777778999999999999988753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.72 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=196.7
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCe
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (420)
.+...+|....+||+|.||.|.+|..+++...+|||+++++.. ...+--+.|-++|+.. +-|.+++++.++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4445678889999999999999999999999999999987521 1122234566677665 57899999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+|+||||+.||+|-.+++.-+ .+.+..+.-++..||-||-+||+ ++|+.||||.+|||+|.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999999987765 57788899999999999999999 9999999999999999999999999999974
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
--- ......+.+||+.|+|||++..++|....|+|||||+||||+.|++||++.++++... .+.+
T Consensus 500 ni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-------aI~e------- 564 (683)
T KOG0696|consen 500 NIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-------AIME------- 564 (683)
T ss_pred ccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHH-------
Confidence 221 2234566899999999999999999999999999999999999999999877655221 1111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 359 (420)
.+ -.++.....+...+....+.+.|.+|..
T Consensus 565 -hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 -HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 1222233344555556667889999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.90 Aligned_cols=239 Identities=28% Similarity=0.366 Sum_probs=194.3
Q ss_pred CceEEEEEEeCCCceeeeeecccccchhH-HHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhcc
Q 036051 107 GFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYN 185 (420)
Q Consensus 107 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 185 (420)
+||.||+|.+.+++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998888899999997664433 67899999999999999999999999999999999999999999999876
Q ss_pred CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCccc
Q 036051 186 QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265 (420)
Q Consensus 186 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 265 (420)
.. .+++..++.++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 54 38899999999999999999999 899999999999999999999999999998765432 233456788999
Q ss_pred ccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHH
Q 036051 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKL 345 (420)
Q Consensus 266 aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 345 (420)
+||.+.+..++.++||||||+++++|++|..||......+. ..++ ...+... . ..........+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~----~~~~~~~------~-~~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKK----IGKPKPP------F-PPPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH----HhccCCC------C-ccccccCCHHHHHH
Confidence 99999888889999999999999999999999976322111 1111 1110000 0 00000033568889
Q ss_pred hhcccccCCCCCCCHHHHHH
Q 036051 346 GLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 346 ~~~cl~~dP~~RPt~~evl~ 365 (420)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=283.71 Aligned_cols=240 Identities=25% Similarity=0.296 Sum_probs=194.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++.|.....+|.|+|+.|-.+.+..+++..++|++...... -.+|+.++... +|||++++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56788888899999999999999999999999999766222 23566555554 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE-cCCCcEEEeeecCcccccCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll-~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
.+.++-|.+.+...+. . ..++..|+.+|+.|+.|||+ ++++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~-~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--F-CSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--h-HHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988888766542 2 26777899999999999999 999999999999999 58899999999999876543
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
....+-|..|.|||++....|++++|+||||++||+|++|+.||......... .. .+..+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei------~~--------~i~~~~~- 531 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI------HT--------RIQMPKF- 531 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH------HH--------hhcCCcc-
Confidence 23346688999999999999999999999999999999999999876554111 11 1111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+...+|+.+||+.||.+||+|.++..
T Consensus 532 ---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 ---SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222344567777899999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=240.28 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=196.1
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
+|...+.||+|.||+||+|+..++...||+|+...++. ..-...++|+-+++.++|.||++++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45567889999999999999999999999998875532 2235678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
| ..+|..+...-.+ .++......++.|+++||.|.|+ .++.|||+||+|.|++.+|+.|++|||+++.+.-...
T Consensus 83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 9 6688888765433 68888999999999999999999 9999999999999999999999999999997764332
Q ss_pred cccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcc---ccccCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGEL---LEARDP 328 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 328 (420)
.....+-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+-.+++.-.=|+.....++.+ .+..|.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 22334568999999998775 48899999999999999986 66666665544433322233322222221 122222
Q ss_pred CCCCccc---------HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYV---------AEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....-++ +.....=.+++.+.+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2111111 111111123333444458999999988774
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.80 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=200.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
...-|..++.||-|+||+|.+++-.++...+|+|.+.+.+ +......+.|-++|+.-+.+.||+++-.|.+++.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 3455778899999999999999998888889999997653 4445678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc-
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD- 248 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~- 248 (420)
||+|++||++-.+|-..+ -+++..+..++..++.|+++.|. .|+|||||||+|||||.+|.+||+|||++.-+.
T Consensus 707 VMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 999999999999987765 68888899999999999999998 999999999999999999999999999986431
Q ss_pred --------CCCC--------------------------------CcccccccCCcccccccccCCCCCccchhhhhHHHH
Q 036051 249 --------HGTD--------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFL 288 (420)
Q Consensus 249 --------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl 288 (420)
.+.. ......+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1000 001235899999999999999999999999999999
Q ss_pred HHHhcCCccCCCCCCcccch-hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC
Q 036051 289 LEVACGRRPIERQGPEENLI-LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARP 358 (420)
Q Consensus 289 ~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 358 (420)
|||+.|+.||-...+.+... +..| ...++-........++...+.+| |. +++.|.
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~kL---c~--sad~RL 917 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQKL---CC--SADSRL 917 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHHH---hc--Chhhhh
Confidence 99999999998887765332 2222 12223333345567777777776 55 445554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=288.83 Aligned_cols=256 Identities=18% Similarity=0.246 Sum_probs=170.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC----ceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeee------ee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS----KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY------CR 162 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 162 (420)
..++|+..+.||+|+||.||+|++..+ +..||+|++...... +.+..+ .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999887 788999987543221 111111 1112222222222111 24
Q ss_pred eCCeEEEEEeecCCCChhhhhccCCC------------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccC
Q 036051 163 RKGELLLVYDYMPNGSLDKYLYNQPK------------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK 224 (420)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk 224 (420)
.....++|+||+++++|.+++..... .......+..++.||+.||+|||+ .+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 56789999999999999999865421 011233456799999999999999 899999999
Q ss_pred CCCEEEcC-CCcEEEeeecCcccccCCCCCcccccccCCcccccccccCC----------------------CCCccchh
Q 036051 225 ASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG----------------------KATTSADV 281 (420)
Q Consensus 225 ~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv 281 (420)
|+|||++. ++.+||+|||++..+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986654433344556789999999965321 23456799
Q ss_pred hhhHHHHHHHhcCCccCCCCCCcc-------cchhhhhhhhhcccCccccccCCCCCCc----c--cHHHHHHHHHHhhc
Q 036051 282 FSFGAFLLEVACGRRPIERQGPEE-------NLILVDWVFDFWNRGELLEARDPNLGTE----Y--VAEELELILKLGLL 348 (420)
Q Consensus 282 ~slGvvl~el~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~ 348 (420)
|||||+||||+++..++......- ......|. ....+..... + .........+|+.+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR----------KLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH----------HhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 999999999998766543210000 00011111 0111110000 0 00011234578999
Q ss_pred ccccCCCCCCCHHHHHH
Q 036051 349 CSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 349 cl~~dP~~RPt~~evl~ 365 (420)
||+.||.+|||+.|+++
T Consensus 433 mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 433 MMRFKGRQRISAKAALA 449 (566)
T ss_pred HccCCcccCCCHHHHhC
Confidence 99999999999999997
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=276.26 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=206.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-.+++....||-|+||.|-++........+|+|++++. +....+.+..|-++|.+.+.|.|+++|-.|.+..+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34556667899999999999998766656899988754 444557788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
||-|-||.|+..|+.++ .++.....-++..+.+|++|||+ ++||.|||||+|.++|.+|-+||.|||+|+....+
T Consensus 499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999998876 68888888999999999999999 99999999999999999999999999999987653
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
....+.+||+.|.|||++.++..+.+.|.||||+++|||++|.+||.+.++.....+. .+-++.
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~-- 637 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDK-- 637 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhh--
Confidence 3567789999999999999999999999999999999999999999987765432221 011110
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
..++........+|+++.+..+|.+|.. +.+|-+
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 1122233344566777778889999986 556544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.38 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 169 (420)
-++|.+.++||+|.|..|.+++++++.+.+|+|+++++ ..+.......|-.+..+- +||.+|-++.++.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999999999999999998764 333344455666666554 79999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|.||++||+|--+++.+. .++++.+..+...|..||.|||+ .+|+.||||.+|||+|..|.+||+|||+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999988876654 68999999999999999999999 9999999999999999999999999999974322
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc-ccchhhhhhhhhcccCccccccCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE-ENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
......+.+||+.|+|||++.+..|....|+|+|||+++||+.|+.||+--... .+....+++.+.+-+..+ ..|
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---rip 479 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---RIP 479 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---ccc
Confidence 222456689999999999999999999999999999999999999999643211 122233444444333221 112
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPS 359 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 359 (420)
+. ...+...+++.-+++||.+|..
T Consensus 480 rs-------lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 RS-------LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ce-------eehhhHHHHHHhhcCCcHHhcC
Confidence 21 1223445556678899999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=240.93 Aligned_cols=209 Identities=28% Similarity=0.371 Sum_probs=174.2
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
+++..+.+.....||+|+||.|-+-++..+|...|+|.+... +.+..+..++|+++..+- .+|.+|.++|...+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344555666678899999999999999999999999999765 445567788888877664 799999999999999999
Q ss_pred EEEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 168 LLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
|+.||.| ..+|+.+-.. .....+++..+-+|+..+..||.|||+ +..++|||+||+|||+|.+|++|+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 6688776542 123478999999999999999999999 4789999999999999999999999999997
Q ss_pred cccCCCCCcccccccCCccccccccc----CCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTR----TGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
.+.+.. ..+...|-..|||||.+. +..|+-||||||||+.+.||.+++.||+....
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 664322 233356788999999874 34689999999999999999999999976543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=275.33 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=178.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeC----------------CCceeeeeecccccchhHHHHH--------------HH
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLP----------------KSKIEIAVKKISHESRQGMKEF--------------VA 141 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~ 141 (420)
...++|++.++||+|+||.||+|.+. ..++.||||++........++| ..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35778999999999999999999752 2345799999865433323333 34
Q ss_pred HHHHhccCCcceE-----eeeeeeeee--------CCeEEEEEeecCCCChhhhhccCC---------------------
Q 036051 142 EIVSIGRLRHRNL-----VQLLGYCRR--------KGELLLVYDYMPNGSLDKYLYNQP--------------------- 187 (420)
Q Consensus 142 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~--------------------- 187 (420)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 667777653 356899999999999999986421
Q ss_pred -CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccc
Q 036051 188 -KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266 (420)
Q Consensus 188 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 266 (420)
...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1134677889999999999999998 899999999999999999999999999997654332222222345789999
Q ss_pred cccccCCCC----------------------CccchhhhhHHHHHHHhcCCc-cCCCCCCccc-chhhhhhhhhcccCcc
Q 036051 267 PEHTRTGKA----------------------TTSADVFSFGAFLLEVACGRR-PIERQGPEEN-LILVDWVFDFWNRGEL 322 (420)
Q Consensus 267 PE~~~~~~~----------------------~~~sDv~slGvvl~el~tg~~-p~~~~~~~~~-~~~~~~~~~~~~~~~~ 322 (420)
||.+..... ..+.||||+||++++|++|.. |+........ ....+.....++....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998753221 134799999999999999875 6643211110 0000000111110000
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCC---CCCCCHHHHHH
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDP---TARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~ 365 (420)
...+-.. .........+++.+|+..+| .+|+|+.|+++
T Consensus 459 -~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 -QKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -cCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0001111 11122445666777777655 78999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=263.75 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=197.5
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--h-----hHHHHHHHHHHHhccCCcceEeeeeeeee-e
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--R-----QGMKEFVAEIVSIGRLRHRNLVQLLGYCR-R 163 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~ 163 (420)
...++|-..++||+|||+.||+|.+...++.||||+-.... + ...+...+|..+-+.|+||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34466777899999999999999998888899999765331 1 11345678999999999999999999886 4
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc---CCCcEEEee
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD---GELNGRLGD 240 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~---~~~~~kl~D 240 (420)
....|-|.|||+|.+|+-+|+.+. .+++.++..|+.||+.||.||.. .+.+|||-||||.|||+- .-|.+||+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeee
Confidence 567899999999999999998765 68999999999999999999997 358999999999999994 457899999
Q ss_pred ecCcccccCCCCC------cccccccCCcccccccccC----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh
Q 036051 241 FGLARLYDHGTDP------QTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310 (420)
Q Consensus 241 fg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~ 310 (420)
||+++.+...... ......||.+|++||++.- .+.+.|.||||.|||+|..+.|+.||.......+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--- 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--- 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---
Confidence 9999988665432 2334678999999998742 35788999999999999999999999765433211
Q ss_pred hhhhhhcccCccccccCCCCCC-cccHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 311 DWVFDFWNRGELLEARDPNLGT-EYVAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
+.+..+.+...-.++. +.... ....++.+||+..-++|....++.
T Consensus 694 ------LqeNTIlkAtEVqFP~KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 ------LQENTILKATEVQFPPKPVVSS---EAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------HhhhchhcceeccCCCCCccCH---HHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1122222222211111 11122 244567789999999998765543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=253.67 Aligned_cols=267 Identities=27% Similarity=0.426 Sum_probs=200.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hH-HHHHHHHHHHhccCCcceEeeeeeeeee--------C
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QG-MKEFVAEIVSIGRLRHRNLVQLLGYCRR--------K 164 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 164 (420)
..|....+||+|.||+||+|+.+++++.||+|+.-.++. +. -...++|+.+|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556789999999999999999999999987654322 11 2345789999999999999999998754 2
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
..+++||++|+. +|..+|.+. ...++...+.++..++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999965 888888655 2367888999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCC---CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh-------
Q 036051 245 RLYDHGTD---PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV------- 313 (420)
Q Consensus 245 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~------- 313 (420)
+.+....+ ..-+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||.||.+-+.+..+...+.+....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87754432 23344566999999998865 56999999999999999999999988877665554433322
Q ss_pred -hhhcccCccccccCCC-CCC-cc--cHHHH------HHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 314 -FDFWNRGELLEARDPN-LGT-EY--VAEEL------ELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 314 -~~~~~~~~~~~~~~~~-~~~-~~--~~~~~------~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
|....+-.+.+.+... +.. .+ ..+.+ ...++|+..++..||.+|+++.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111122222222111 111 10 11111 145677778899999999999998763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=277.22 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=187.2
Q ss_pred CCccceecccCceE-EEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGR-VYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
|...+++|.|+.|+ ||+|.. +++.||||++-.... .-..+|+..|+.- +||||+++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45567899999886 799999 567899999865432 3346899999887 6999999999999999999999999
Q ss_pred CCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---C--CcEEEeeecCcccc
Q 036051 175 PNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---E--LNGRLGDFGLARLY 247 (420)
Q Consensus 175 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~--~~~kl~Dfg~~~~~ 247 (420)
..+|.+++... ..........+.+..|+++||+|||+ .+|+||||||+||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 66999999874 11111224567788999999999999 99999999999999975 3 47999999999988
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcC-CccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
..+... ......||.+|+|||++.....+.+.|||||||++|+.++| ..||...-..+.-. . .......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-l-------~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-L-------TGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-h-------cCcccee
Confidence 665432 34456799999999999998888899999999999998885 89997644322110 0 0000011
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+.+ ..++ ...+|+.+|++++|..||++.+|+.
T Consensus 734 ~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 1111 5678888999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=232.56 Aligned_cols=211 Identities=33% Similarity=0.524 Sum_probs=184.5
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 181 (420)
||+|.+|.||++....++..+++|++...... ....+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999877889999999766432 34678999999999999999999999999999999999999999999
Q ss_pred hhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCcccccCCCCCccccccc
Q 036051 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTTHVVG 260 (420)
Q Consensus 182 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 260 (420)
++.... ..+++..+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987652 358899999999999999999999 89999999999999999 89999999999986544321 1233557
Q ss_pred CCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHH
Q 036051 261 TLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339 (420)
Q Consensus 261 t~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (420)
...|++||.+... .++.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999777 788999999999999999
Q ss_pred HHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 340 ELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 340 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..+.+++.+|++.||++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 447788889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=244.89 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----CeEEE
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GELLL 169 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 169 (420)
.+..+.||.|+||.||..++..+++.|++|++... +-...+.+.+|+.+|.-++|.|++..++..... .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34568899999999999999999999999998654 333456788999999999999999988876543 36788
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
++|.| ..+|.+.|-.-+ .++-..+.-+..||++||.|||+ .+|.||||||.|.|++.|-..||||||+++....
T Consensus 135 ~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 99999 668988886543 57777788889999999999999 9999999999999999999999999999998766
Q ss_pred CCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh--------cccC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF--------WNRG 320 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 320 (420)
......+..+-|..|.|||++.+. .|+.+.||||.||++.||+..+..|...++.+++.+..-.... --+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555566667779999999999775 5899999999999999999999999887776654433211110 0111
Q ss_pred cccccc-----CCCCCCcc---c-HHHHHHHHHHhhcccccCCCCCCCHHHHHHHHh
Q 036051 321 ELLEAR-----DPNLGTEY---V-AEELELILKLGLLCSHSDPTARPSMRQVVQILE 368 (420)
Q Consensus 321 ~~~~~~-----~~~~~~~~---~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 368 (420)
....++ .|.+..-+ + .+.-..-+.+...++.+||++|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111 11111101 0 011223345556689999999999998887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=258.44 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=172.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---h-----HHHHHHHHHHHhccCC---cceEeeeeeeee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---Q-----GMKEFVAEIVSIGRLR---HRNLVQLLGYCR 162 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 162 (420)
..+|...+.+|.|+||.|+.|.++.+...|+||.+.++.- . ..-..-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3458888999999999999999999999999998865421 0 0112456999999997 999999999999
Q ss_pred eCCeEEEEEeecC-CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 163 RKGELLLVYDYMP-NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 163 ~~~~~~lv~e~~~-~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
+++.+|+++|-.. +-+|+++|...+ .+++.+...|++|++.|+++||+ ++|+|||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 9999999999763 568999998776 68999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCC
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
|.+.....+ .....+||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876544 3456789999999999998877 556899999999999999998885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=231.45 Aligned_cols=200 Identities=32% Similarity=0.467 Sum_probs=175.3
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
|...+.||+|++|.||++...+++..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678899999999999999887888999999876544 56788999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+++|.+++..... .+++..+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999976542 27899999999999999999999 8999999999999999999999999999987654321123
Q ss_pred cccccCCcccccccc-cCCCCCccchhhhhHHHHHHHhcCCccCCC
Q 036051 256 THVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIER 300 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~el~tg~~p~~~ 300 (420)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=252.17 Aligned_cols=266 Identities=21% Similarity=0.236 Sum_probs=205.8
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC------cceEeeeeeeeeeC
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR------HRNLVQLLGYCRRK 164 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 164 (420)
+....+|.+....|+|-|++|..|.+..-++.||||++.... .-.+.=+.|+++|++|+ --|.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345778999999999999999999998888899999997542 22345578999999995 35788999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeec
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFG 242 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg 242 (420)
+++|||+|-+ ..+|.+.|+..+. ..|....+..++.|+..||.+|.. .+++|.||||.|||+++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCc
Confidence 9999999988 7799999986543 457888999999999999999998 999999999999999976 468999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh-----hc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD-----FW 317 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~ 317 (420)
.|...... ..+.+.-...|.|||++.+..|+...|+||.||+||||.||+..|.+......+.+.--+.. ++
T Consensus 583 SA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 99765432 33334456679999999999999999999999999999999999988765543321111100 00
Q ss_pred ccC---------------------------ccccccCC------------CCCCcccHHHHHHHHHHhhcccccCCCCCC
Q 036051 318 NRG---------------------------ELLEARDP------------NLGTEYVAEELELILKLGLLCSHSDPTARP 358 (420)
Q Consensus 318 ~~~---------------------------~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 358 (420)
+.+ .++....| .+ ..-....+..+.+|+..|+..||++|.
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHHHHHHhccChhhcC
Confidence 000 01111111 11 111234466788999999999999999
Q ss_pred CHHHHHH
Q 036051 359 SMRQVVQ 365 (420)
Q Consensus 359 t~~evl~ 365 (420)
|..+.|.
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=240.83 Aligned_cols=133 Identities=26% Similarity=0.339 Sum_probs=116.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC--------cceEeeeeeeeeeC-
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR--------HRNLVQLLGYCRRK- 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~~- 164 (420)
..+|.+.++||-|.|++||++.+..+.+.||+|+.+.. ....+..+.||.+|++++ ...||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46788999999999999999999999999999998644 333466789999999883 24799999998754
Q ss_pred ---CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 ---GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
.++|||+|+. |.+|..+|.......++...+..|+.||+.||.|||.. .+|||.||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 5899999999 88999999877767899999999999999999999994 689999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=225.89 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=192.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeC--CeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK--GELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 170 (420)
.++|++.+.+|+|.|++||.|....++..++||+++.... +.+.+|+.+|..|. ||||+.+++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999999888888999999975533 56789999999997 99999999998765 467999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCcccccC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDH 249 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~~~~~ 249 (420)
+||+.+.+...+-. +++..++..++.+++.||.|+|+ .||.|||+||.|+++|.. ..++|+|+|+|..+..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999888766542 57778889999999999999999 999999999999999954 5799999999998765
Q ss_pred CCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCC-cccchhhhhhh------hhcccCc
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGP-EENLILVDWVF------DFWNRGE 321 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~------~~~~~~~ 321 (420)
+.. -...+.+..|..||.+-. ..|+..-|+|||||++..|+..+.||..... .+++.-...+. ..+....
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 442 223456677899998854 5688899999999999999999999965433 22222111111 0111000
Q ss_pred cccccCCCCCC--------cc-------cHHH-HHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 322 LLEARDPNLGT--------EY-------VAEE-LELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 322 ~~~~~~~~~~~--------~~-------~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+ .++|.+.. .+ +... ..+.++++.+.|..|-.+|||+.|.+.
T Consensus 264 i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 I--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred c--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 01111100 00 0011 134566777788899999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=260.54 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=205.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+....+|.|.||.||+++++..+...|+|+++........-..+|+-+++..+||||+.++|.+.....+|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788899999999999999999999999999999887666677788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
|.+|+|.+.-+..+ ++++.++...++...+||+|||+ .+-+|||||-.||++++.+.+|++|||.+-...... .
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 99999999876554 79999999999999999999999 999999999999999999999999999987554322 2
Q ss_pred cccccccCCcccccccc---cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 254 QTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......||+.|||||+. +.+.|.+++|||++|+...|+.--+.|.....+.....+... ...+|.-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----------S~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----------SGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----------cCCCCCc
Confidence 34557899999999986 456799999999999999999887777665544332222110 0111111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
..+ ...-...+.++++.|+..+|++||+++.++
T Consensus 237 lkD-k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccC-CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111 112234477788889999999999986654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=224.13 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=189.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeee-eeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGY-CRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~ 171 (420)
.+.|.+.+.||+|.||.+-++.++.++..+++|-+...- ...++|.+|...--.| .|.||+.-|++ |+..+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888899999999999999999999999999886553 3357899998765556 58999988774 67778899999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--CCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~ 249 (420)
||++.|+|.+-+... .+.+....+++.|++.||.|+|+ .+++|||||.+|||+- +..++||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999888654 47788888999999999999999 9999999999999994 345899999999876543
Q ss_pred CCCCcccccccCCcccccccccC---C--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRT---G--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
... ...-+..|.+||.... + ...+.+|||.||++++..+||+.|+......+ . .-|-+..|..+....
T Consensus 176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~--~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-K--PYWEWEQWLKRKNPA 248 (378)
T ss_pred eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-c--hHHHHHHHhcccCcc
Confidence 221 1233567999997633 2 35778999999999999999999997433222 1 222333333333221
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 367 (420)
-|..-..+.+. +.++.++-+.++|++|-...++.++.
T Consensus 249 --~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 249 --LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --CchhhcccCHH----HHHHHHHhcCCcccccchhHHHHHHH
Confidence 12222333433 45555667899999996666665544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=230.63 Aligned_cols=261 Identities=23% Similarity=0.245 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------C
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 165 (420)
..+|.....+|.|.- .|-.+.+.-.+++||+|+.... +....+...+|+..+..++|+|+++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999998 7777877777889999987654 333456677899999999999999999988654 3
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..|+|||+| ..+|...+.. .++...+..|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 679999999 6799998873 57888999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------------
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV--------------- 310 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~--------------- 310 (420)
..... -..+..+.|..|.|||++.+..+.+..||||.||++.||++|+..|.+...-++....
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 64432 3566778899999999998888999999999999999999999999754432211100
Q ss_pred -hhhhhhcccCcc------ccc-cCCCCC--CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 311 -DWVFDFWNRGEL------LEA-RDPNLG--TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 311 -~~~~~~~~~~~~------~~~-~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+..+.+...- .+. .|.... .+.+.-......+++.+||-.||++|-++.++|+
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 001111110000 000 000000 0111223455678888999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=227.53 Aligned_cols=201 Identities=27% Similarity=0.431 Sum_probs=168.2
Q ss_pred HHhcCCCccceecccCceEEEEEEeCC---CceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
...+.|...++||.|.|++||++++.. ....||+|.+...... ..+.+|+++|..+ -+.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 445678889999999999999999876 6778999988765433 4478999999998 499999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARL 246 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~ 246 (420)
++|+||+++....++.. .++..++..+++.+..||.++|. +||+||||||+|+|.+. -+.-.|+|||++..
T Consensus 111 ~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999988875 46678899999999999999999 99999999999999984 46789999999972
Q ss_pred ccCC-------------------C------------------------CCcccccccCCccccccccc-CCCCCccchhh
Q 036051 247 YDHG-------------------T------------------------DPQTTHVVGTLGYLAPEHTR-TGKATTSADVF 282 (420)
Q Consensus 247 ~~~~-------------------~------------------------~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~ 282 (420)
.... . ........||++|.|||++. ....+.+.|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1100 0 00112357899999999984 56688999999
Q ss_pred hhHHHHHHHhcCCccCCCCC
Q 036051 283 SFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 283 slGvvl~el~tg~~p~~~~~ 302 (420)
|.|||++.+++++.||....
T Consensus 263 s~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eccceeehhhccccccccCc
Confidence 99999999999999996544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=263.23 Aligned_cols=195 Identities=18% Similarity=0.275 Sum_probs=137.9
Q ss_pred cCCc-ceEeeeeeee-------eeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEE
Q 036051 148 RLRH-RNLVQLLGYC-------RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219 (420)
Q Consensus 148 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii 219 (420)
.++| +||.++++++ .....+++++|++ +++|.++|.... ..+++.+++.++.||+.||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4455 6777888876 2334678889988 679999997542 368999999999999999999998 9999
Q ss_pred ecccCCCCEEEcCC-------------------CcEEEeeecCcccccCCCC---------------CcccccccCCccc
Q 036051 220 HRDVKASNVLLDGE-------------------LNGRLGDFGLARLYDHGTD---------------PQTTHVVGTLGYL 265 (420)
Q Consensus 220 H~dlk~~NIll~~~-------------------~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~ 265 (420)
||||||+||||+.. +.+|++|||+++....... .......||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4455666666543211000 0011235788999
Q ss_pred ccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHH
Q 036051 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKL 345 (420)
Q Consensus 266 aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 345 (420)
|||++.+..++.++|||||||+||||++|..|+...... ...... ....+.. .........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~---------~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRH---------RVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHH---------hhcChhh-----hhcCHHHHHH
Confidence 999999999999999999999999999998876532110 000000 0011111 1112234577
Q ss_pred hhcccccCCCCCCCHHHHHH
Q 036051 346 GLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 346 ~~~cl~~dP~~RPt~~evl~ 365 (420)
+.+||++||.+||++.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 78899999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-28 Score=213.42 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=193.8
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+....+|.+...|+.|+|+|.++. +++|++... .....++|..|.-.|+-+.||||++++|.|.....+.++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344557889999999999997654 777877543 2333467899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe--eecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG--DFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~--Dfg~~~~~~~~~~ 252 (420)
+.|+|+..|+.+.....+..++.+++.++|+|++|||+.. +-|.--.|.+..|++|++.+++|+ |--++.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 9999999999988878899999999999999999999842 334455789999999999988774 322221
Q ss_pred CcccccccCCcccccccccCCCC---CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
+.....-.+.||+||.+..++- -.++|+|||++++|||.|...||....+-+....+ ..+ .
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----------ale----g 405 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----------ALE----G 405 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------hhc----c
Confidence 1111234688999999976543 35789999999999999999999887776532211 112 2
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+....++.....+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 222333444455777888899999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=203.06 Aligned_cols=166 Identities=20% Similarity=0.158 Sum_probs=124.7
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
|+|.+++.... ..+++.+++.++.|++.||.|||+ .+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999997643 269999999999999999999998 44 999999999999999 99987654321
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccH
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... +..+... .. ...+.. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~------~~~~~~-~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNG-MP------ADDPRD-RSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHH-hc------cCCccc-cccHH
Confidence 25889999999999999999999999999999999999999654322110 1111100 00 000000 01111
Q ss_pred HHHH--HHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 337 EELE--LILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 337 ~~~~--~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.... .+.+++.+||+.||.+||++.|+++.+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2222 58899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=211.34 Aligned_cols=167 Identities=21% Similarity=0.206 Sum_probs=131.1
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCC-Cceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEee-eeeeeee
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPK-SKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQ-LLGYCRR 163 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~ 163 (420)
.....+|...+.||+|+||+||+|++.. ++..||||++... .......|.+|+++|.+++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999998865 6677899986532 1223456899999999999999985 4432
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEeccc-CCCCEEEcCCCcEEEeeec
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDV-KASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Dfg 242 (420)
+..++||||+++++|... .. .. ...++.+++.+|.|||+ .+|+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 467999999999999732 11 11 14678899999999999 99999999 9999999999999999999
Q ss_pred CcccccCCCCC-------cccccccCCcccccccccCC
Q 036051 243 LARLYDHGTDP-------QTTHVVGTLGYLAPEHTRTG 273 (420)
Q Consensus 243 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 273 (420)
+++.+...... ......+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99876543211 12356788899999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-24 Score=202.62 Aligned_cols=259 Identities=23% Similarity=0.215 Sum_probs=192.5
Q ss_pred CCCccceecccCceEEEEEEeCCCc-eeeeeecccccchhHHHHHHHHHHHhccCC----cceEeeeeeee-eeCCeEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSK-IEIAVKKISHESRQGMKEFVAEIVSIGRLR----HRNLVQLLGYC-RRKGELLL 169 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~l 169 (420)
+|.+.+.||+|+||.||++.....+ ..+|+|............+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7899999999999999999986653 568888776543332225677888888776 26888888888 47778899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-----CcEEEeeecCc
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-----LNGRLGDFGLA 244 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-----~~~kl~Dfg~~ 244 (420)
||+.. |.+|.++....+...++....+.|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 8999998876665689999999999999999999999 999999999999999754 46999999999
Q ss_pred c--cccCCCC-----C-c-ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh
Q 036051 245 R--LYDHGTD-----P-Q-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD 315 (420)
Q Consensus 245 ~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 315 (420)
+ .+..... . . .....||.+|.++.+..+...+.+.|+||++.++.|+..|..|+............ ..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---EK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---HH
Confidence 8 3221111 1 1 23456999999999999999999999999999999999999998654432211000 00
Q ss_pred hcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ....... .....+.+...+... +-..+..++|....+...+...
T Consensus 252 ~~----~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 DP----RKLLTDR--FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred Hh----hhhcccc--ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence 00 0000000 122233444444444 4447889999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-22 Score=191.72 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=195.5
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchh---HHHHHHHHHHHhccCCcc-eEeeeeeeeeeCCeEEEEEe
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHR-NLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 172 (420)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+..+..+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566788999999999999996 56899988765322 367899999999999988 79999999977777899999
Q ss_pred ecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccccCC
Q 036051 173 YMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG 250 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~ 250 (420)
++.++++.+++..... ..+.......++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999977765432 258889999999999999999999 8899999999999999988 7999999999855443
Q ss_pred CCC-----cccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCc-ccchhhhhhhhhcccCc
Q 036051 251 TDP-----QTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPE-ENLILVDWVFDFWNRGE 321 (420)
Q Consensus 251 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 321 (420)
... ......++..|+|||.+.+ ..+....|+|++|++++++++|..||...... ......+.+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 221 2456789999999999987 57889999999999999999999997655431 000001111100000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223456777888999999999998877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=218.54 Aligned_cols=254 Identities=22% Similarity=0.250 Sum_probs=189.3
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeeccc-----ccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-----HESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-----~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
...+++|.|++|.|+...........+.|.+. ..... ....+..|+-+-..++|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988887775544445555432 11111 1222666777778889999988887776666555569
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++ +|..++.... .+...++..++.|+..|+.|+|+ .++.|||+|++|++++.++.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999997653 57778899999999999999999 999999999999999999999999999998776544
Q ss_pred C---CcccccccCCcccccccccCCCCCc-cchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 252 D---PQTTHVVGTLGYLAPEHTRTGKATT-SADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 252 ~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. ......+|...|+|||++.+..|.+ ..||||.|+++..|++|+.||......+... ....+. .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~-~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYS-DQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccc-ccccc
Confidence 3 3455678999999999999988876 5799999999999999999997555443221 000000 00001
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..-..............++.++|+.||.+|.|+.+|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11112223444566778888999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=200.20 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=187.9
Q ss_pred hccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCC
Q 036051 146 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKA 225 (420)
Q Consensus 146 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~ 225 (420)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.-...+.++|+.||+|||+ .+-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 46789999999999999999999999999999999999874 3479999999999999999999998 23339999999
Q ss_pred CCEEEcCCCcEEEeeecCcccccCCC-CCcccccccCCcccccccccCC-------CCCccchhhhhHHHHHHHhcCCcc
Q 036051 226 SNVLLDGELNGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTG-------KATTSADVFSFGAFLLEVACGRRP 297 (420)
Q Consensus 226 ~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvvl~el~tg~~p 297 (420)
.|.++|..+.+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987654211 1111122345679999998663 146789999999999999999999
Q ss_pred CCCCCCcccc-hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC----
Q 036051 298 IERQGPEENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA---- 372 (420)
Q Consensus 298 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~---- 372 (420)
|......... .+..++.. .......|...... +....+..++..||..+|.+||++..|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~ 230 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSS 230 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccc
Confidence 9864433221 11211111 11112222221111 334468899999999999999999988777654321
Q ss_pred --------------------------------------------CCcccccCCCcccccccCCCCccceeecCccccccc
Q 036051 373 --------------------------------------------LPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRP 408 (420)
Q Consensus 373 --------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~ 408 (420)
+|..-+..........++.++..++-+|+.+++|.-
T Consensus 231 ~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~fsDiv~fT~l 310 (484)
T KOG1023|consen 231 KGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIYFSDIVGFTVL 310 (484)
T ss_pred cchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeeeeHHHHHHHHH
Confidence 222223334445566678899999999999999876
Q ss_pred ccc
Q 036051 409 SSL 411 (420)
Q Consensus 409 ~~~ 411 (420)
++.
T Consensus 311 ~~~ 313 (484)
T KOG1023|consen 311 SSN 313 (484)
T ss_pred Hhc
Confidence 644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-23 Score=177.98 Aligned_cols=207 Identities=22% Similarity=0.276 Sum_probs=174.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 171 (420)
-...|...+.||.|.||.+|.|....+|..||||+-+..... .++..|..+...|++ ..|+.+.-+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 456799999999999999999999999999999987665433 556788888888864 77888888888888899999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~~~~ 248 (420)
+.. |.+|+++..-..+ .++....+-++-|++.-++|+|. .+++||||||+|+|..- ...+.++|||+++.+.
T Consensus 91 dLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 8899998765433 68889999999999999999998 99999999999999963 3468999999998764
Q ss_pred CCC------CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCccc
Q 036051 249 HGT------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306 (420)
Q Consensus 249 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~ 306 (420)
... ........||.+|.+-....+...+.+.|+-|+|.+|.++--|..||.+..+...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 432 2344567899999998888888888999999999999999999999988766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=179.58 Aligned_cols=205 Identities=19% Similarity=0.267 Sum_probs=174.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.-.|.+.++||+|.||.++.|+.--++++||||.-...+. ..++..|....+.| ..++|+.++-|-..+.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4578899999999999999999988899999997655433 25677888888877 47999999988888888899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-----CCcEEEeeecCcccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARLY 247 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfg~~~~~ 247 (420)
.. |-+|+++..-.++ .++...+..+|.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 105 LL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99 8899988765544 78999999999999999999999 99999999999999953 345899999999977
Q ss_pred cCCC------CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 248 DHGT------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 248 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
.... ........||.+||+-....+...+.+.|+-|||-++.+++-|..||.+.....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 5432 234455789999999999999999999999999999999999999998776544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=180.25 Aligned_cols=172 Identities=13% Similarity=0.133 Sum_probs=132.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHH---H------HHHHHHHHhccCCcceEeeeeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM---K------EFVAEIVSIGRLRHRNLVQLLGYCR 162 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~------~~~~e~~~l~~l~h~niv~~~~~~~ 162 (420)
....+|+..+++|.|+||.||+... ++..+|+|++........ . .+.+|+..+.+++|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3578899999999999999999766 344699999975432221 2 2678999999999999999988755
Q ss_pred eC--------CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 163 RK--------GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 163 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
.. +..+++|||++|.+|.++. .++. ....+++.++..+|. .+++|||+||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 33 3589999999999998873 2222 245689999999999 9999999999999999988
Q ss_pred cEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHh
Q 036051 235 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA 292 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~ 292 (420)
++|+|||............ .+.....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999886543211110 1333445667999999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-22 Score=174.40 Aligned_cols=140 Identities=15% Similarity=0.087 Sum_probs=107.1
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchh--H-------H-----------------HHHHHHHHHhccCCcce
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--G-------M-----------------KEFVAEIVSIGRLRHRN 153 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~n 153 (420)
...||+|++|.||+|.+. +|..||||++...... . . .....|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 7889999998654210 0 0 12234899999998777
Q ss_pred EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHh-hhcccCcEEecccCCCCEEEcC
Q 036051 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL-HEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~dlk~~NIll~~ 232 (420)
+.....+.. ...++||||++++++...+... ..++..+...++.|++.+|.++ |+ .+++||||||+|||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 643332222 2238999999888776553322 2688899999999999999999 67 8999999999999998
Q ss_pred CCcEEEeeecCccccc
Q 036051 233 ELNGRLGDFGLARLYD 248 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~ 248 (420)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=205.57 Aligned_cols=248 Identities=21% Similarity=0.208 Sum_probs=177.1
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHH--hccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVS--IGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++...+.||+++|=+|.+|++.+ |. |+||++-+.. .-..+.|.+++.- ...++|||.+++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 56678889999999999999964 43 8999986653 2233444444333 445689999999888888888899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc--cCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHG 250 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~--~~~ 250 (420)
|. .-+|++.|..++ -+...+...|+.|++.||..+|. .+|+|||||.+|||++...-+.|+||..-+.. ..+
T Consensus 102 yv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 99 559999998776 57778888999999999999998 99999999999999999888999999765521 221
Q ss_pred CCCccccc----ccCCcccccccccCC-----------CCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhh
Q 036051 251 TDPQTTHV----VGTLGYLAPEHTRTG-----------KATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 251 ~~~~~~~~----~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 314 (420)
........ ..-.+|+|||-+... ..+++.||||+||++.||++ |++||.-.. +..+-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhc
Confidence 11111111 223579999966321 15678999999999999977 678875211 000000
Q ss_pred h-hcccCc-cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 315 D-FWNRGE-LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 315 ~-~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. ...... +.++.| ..+..++..|++.||.+|.++++.++.-.+
T Consensus 250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0 000000 111111 136788888999999999999999987433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=175.43 Aligned_cols=232 Identities=22% Similarity=0.299 Sum_probs=152.5
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCC----------cceEeeeeee---
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLR----------HRNLVQLLGY--- 160 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~----------h~niv~~~~~--- 160 (420)
+...+.||.|+++.||.+++..+++.+|+|++... .....+++.+|.-....+. |-.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 44568899999999999999999999999988544 2334677777775555532 2122222221
Q ss_pred ------eeeCC--------eEEEEEeecCCCChhhhhcc---C--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEec
Q 036051 161 ------CRRKG--------ELLLVYDYMPNGSLDKYLYN---Q--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHR 221 (420)
Q Consensus 161 ------~~~~~--------~~~lv~e~~~~g~L~~~l~~---~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 221 (420)
..... ..+++|+-+ .+||.+++.. . ....+....++.+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11111 246778877 6788887642 1 12245566677888999999999999 999999
Q ss_pred ccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccC--------CCCCccchhhhhHHHHHHHhc
Q 036051 222 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT--------GKATTSADVFSFGAFLLEVAC 293 (420)
Q Consensus 222 dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvvl~el~t 293 (420)
||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999988765433111 1344577999997633 247889999999999999999
Q ss_pred CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCC
Q 036051 294 GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357 (420)
Q Consensus 294 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 357 (420)
|..||....+.... +| .. ..+. +.++.+..|+..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~---~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP---EW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS---GG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc---cc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999866443211 00 01 2334 666778888889999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=165.96 Aligned_cols=142 Identities=18% Similarity=0.152 Sum_probs=109.7
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchh--------------------------HHHHHHHHHHHhccCCcce
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--------------------------GMKEFVAEIVSIGRLRHRN 153 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n 153 (420)
...||+|++|.||+|.+. +|+.||||++...... ....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 7889999998754210 0122457889999999988
Q ss_pred EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC
Q 036051 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE 233 (420)
Q Consensus 154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~ 233 (420)
+.....+... ..++||||++++++....... ..++..+...++.|++.++.++|+ ..+++||||||+||+++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence 7544433322 248999999887654432222 257788899999999999999997 37999999999999999 7
Q ss_pred CcEEEeeecCcccccC
Q 036051 234 LNGRLGDFGLARLYDH 249 (420)
Q Consensus 234 ~~~kl~Dfg~~~~~~~ 249 (420)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=161.51 Aligned_cols=188 Identities=17% Similarity=0.098 Sum_probs=140.4
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchh----HHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEe
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ----GMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 172 (420)
.....|++|+||+||.+.. .+.+++.+.+...... ....|.+|+++|++++ |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997776 4556887777654321 1235789999999995 5889999886 34699999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEeccc-CCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDV-KASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|+.|.+|...+.. ....++.|++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||++.......
T Consensus 79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999998754321 113567899999999999 99999999 7999999999999999999998654332
Q ss_pred CC----c--------ccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 252 DP----Q--------TTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 252 ~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
.. . ......++.|++|+...- ..--...+.++-|.-+|.++|++.+.-.+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 0 111235777888875432 2223567999999999999999988765544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=172.98 Aligned_cols=196 Identities=23% Similarity=0.316 Sum_probs=136.8
Q ss_pred CcceEeeeeeeeee---------------------------CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHH
Q 036051 150 RHRNLVQLLGYCRR---------------------------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG 202 (420)
Q Consensus 150 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 202 (420)
+||||+++.++|.+ +..+|+||..+ .-+|..++..+ ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999987643 23679999988 45999999776 3555667778999
Q ss_pred hHhHhHHhhhcccCcEEecccCCCCEEEc--CCC--cEEEeeecCcccccCCC-----CCcccccccCCcccccccccCC
Q 036051 203 VALGLLYLHEEWEQVVIHRDVKASNVLLD--GEL--NGRLGDFGLARLYDHGT-----DPQTTHVVGTLGYLAPEHTRTG 273 (420)
Q Consensus 203 ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~ 273 (420)
+++|+.|||. +++.|||+|++|||+. +|+ ...|+|||.+..-.... .......-|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999998 9999999999999994 443 47899999876432211 1111223467788999987542
Q ss_pred C------CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhh
Q 036051 274 K------ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGL 347 (420)
Q Consensus 274 ~------~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 347 (420)
+ .-.|+|.|+.|.+.||+++...||...++.. +. .....+..-|.++...+ ..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~----------~r~Yqe~qLPalp~~vp----p~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LD----------TRTYQESQLPALPSRVP----PVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ec----------hhhhhhhhCCCCcccCC----hHHHHHHH
Confidence 2 2358999999999999999999998644321 00 01111222233333333 34667777
Q ss_pred cccccCCCCCCCHHHHHHHH
Q 036051 348 LCSHSDPTARPSMRQVVQIL 367 (420)
Q Consensus 348 ~cl~~dP~~RPt~~evl~~L 367 (420)
..++.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 78999999999965444333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=190.27 Aligned_cols=226 Identities=24% Similarity=0.253 Sum_probs=174.0
Q ss_pred eecccCceEEEEEEe---CCCceeeeeecccccchhH--HHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEeecC
Q 036051 102 LLGSGGFGRVYRGTL---PKSKIEIAVKKISHESRQG--MKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
.+|+|.||.|++..- .+.+..+|+|++.+..... ......|-.++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987543 3456678888876542111 113456777778886 9999999999999999999999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcc
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
+|+|...+.... .+++.....+...++-+++++|+ .+++|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999999887765 56777777888899999999998 9999999999999999999999999999986543221
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
.+||..|||||++. .....+|.||||++++||+||..||.. +. . . .+.. .....+
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~-~------~---------~Il~--~~~~~p 207 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT-M------K---------RILK--AELEMP 207 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH-H------H---------HHhh--hccCCc
Confidence 28999999999997 567889999999999999999999976 11 0 0 0000 011223
Q ss_pred HHHHHHHHHHhhcccccCCCCCCCH
Q 036051 336 AEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
.+......+++..++..+|.+|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3444445556666777889888765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-20 Score=162.83 Aligned_cols=137 Identities=18% Similarity=0.260 Sum_probs=108.2
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-----CcceEeeeeeeeeeCC---e-E
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-----RHRNLVQLLGYCRRKG---E-L 167 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~ 167 (420)
+...+.||+|+||.||. ++.+... +||++........+.+.+|+..+..+ +||||++++|++.++. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 44568899999999996 6555554 69988765444557789999999999 5799999999998863 4 3
Q ss_pred EEEEee--cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHh-HHhhhcccCcEEecccCCCCEEEcC----CCcEEEee
Q 036051 168 LLVYDY--MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL-LYLHEEWEQVVIHRDVKASNVLLDG----ELNGRLGD 240 (420)
Q Consensus 168 ~lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~iiH~dlk~~NIll~~----~~~~kl~D 240 (420)
.+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +++++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 478999 5579999999653 35544 35577888777 99999 99999999999999974 34799999
Q ss_pred ecCc
Q 036051 241 FGLA 244 (420)
Q Consensus 241 fg~~ 244 (420)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=191.28 Aligned_cols=252 Identities=19% Similarity=0.167 Sum_probs=183.4
Q ss_pred HHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC---cceEeeeeeeeeeC
Q 036051 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRK 164 (420)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 164 (420)
.+.......|.+.+.||+|+||+||+|...+ ++.||+|+-...+... |.--.+++.+|+ -+-|..+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3445566778889999999999999999976 8899999987665432 222233344444 23334444444556
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-------CCCcEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-------GELNGR 237 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-------~~~~~k 237 (420)
+.-++|+||.+.|+|.+++... ..++|.....++.|++..+++||. .+|||+||||+|.||. ++..++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 6779999999999999999844 379999999999999999999999 9999999999999993 234689
Q ss_pred EeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 238 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
|+|||.+..+.--.. ......++|-.+-.+|...|..+++..|.|.|+.+++-|+.|+..-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------ 903 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------ 903 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------
Confidence 999999875543222 2445567899999999999999999999999999999999997532
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+|... .....+..-+..+....++.+++. .|-..=|...++...+++.
T Consensus 904 ~~~g~~~-~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 904 VKNGSSW-MVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEV 953 (974)
T ss_pred hcCCcce-eccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHH
Confidence 0111111 122223344455666777776443 4444446777776666653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=159.92 Aligned_cols=144 Identities=15% Similarity=0.113 Sum_probs=111.5
Q ss_pred cCCCccceecccCceEEEEEE-eCCCceeeeeecccccchh------------------------HHHHHHHHHHHhccC
Q 036051 95 KGFREKELLGSGGFGRVYRGT-LPKSKIEIAVKKISHESRQ------------------------GMKEFVAEIVSIGRL 149 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 149 (420)
.-|.+.+.||+|++|.||+|. +..+++.||+|++...... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347788999999999999999 5567889999988643210 112356799999999
Q ss_pred Ccc--eEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc-EEecccCCC
Q 036051 150 RHR--NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV-VIHRDVKAS 226 (420)
Q Consensus 150 ~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~dlk~~ 226 (420)
.+. .+++++++ ...++||||+++++|........ .+...+...++.|++.++.+||+ .+ ++|+||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence 753 34444443 23489999999988877653332 45566678999999999999999 88 999999999
Q ss_pred CEEEcCCCcEEEeeecCccccc
Q 036051 227 NVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 227 NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 7899999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=182.17 Aligned_cols=172 Identities=26% Similarity=0.370 Sum_probs=130.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
...+|+.+++|..|+||.||..+++...+.+|+|+ ++++. +.+- ++.....|.++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-----------------
Confidence 34678999999999999999999988888899944 33211 1110 22222333333
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT- 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 251 (420)
|+-...++.-+. ++. +++.+++|||+ .+|+|||+||+|.+++.-|.+|++|||+.+.-....
T Consensus 136 ----gDc~tllk~~g~--lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP--LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCCC--Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 555556655443 322 23789999999 999999999999999999999999999987432111
Q ss_pred -------------CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCccc
Q 036051 252 -------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306 (420)
Q Consensus 252 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~ 306 (420)
.......+||+.|.|||++..+.|....|+|++|+|+||.+-|..||.++.+++.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 0123446899999999999999999999999999999999999999999888763
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-20 Score=175.33 Aligned_cols=123 Identities=26% Similarity=0.445 Sum_probs=108.1
Q ss_pred CeEEEEEeecCCCChhhhhccC-CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
.++++.|++|...+|.++|... .....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3689999999999999999743 34567888999999999999999 5789999999999999999999999999
Q ss_pred cccccCCC-----CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc
Q 036051 244 ARLYDHGT-----DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC 293 (420)
Q Consensus 244 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t 293 (420)
........ ....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88765443 234566789999999999999999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=174.02 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=112.6
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccc-cc-------chhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HE-------SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
.....|...+.||+|+||+||+|.+.+.. +++|+.. .. .....+.+.+|++++.+++|++++....++..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 34455677899999999999999986544 3343321 11 11123568899999999999999888877777
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
....++||||+++++|.+++. ....++.+++.+|.+||+ .+++||||||+||++ +++.++|+|||+
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 778899999999999998874 356789999999999999 999999999999999 577999999999
Q ss_pred ccc
Q 036051 244 ARL 246 (420)
Q Consensus 244 ~~~ 246 (420)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=154.30 Aligned_cols=134 Identities=20% Similarity=0.264 Sum_probs=111.6
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccch--------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+.||+|++|.||+|.+ .+..+++|+...... .....+.+|+..+..+.|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5699999999999998 445688887543211 112457889999999999998877777777778899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
|++|++|.+++.... . .+..++.+++.+|.++|+ .+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999886432 2 788999999999999999 9999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-18 Score=150.02 Aligned_cols=144 Identities=15% Similarity=0.100 Sum_probs=110.7
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch----------------------hHHHHHHHHHHHh
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR----------------------QGMKEFVAEIVSI 146 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l 146 (420)
++......|...+.||+|+||.||++... ++..||||++..... .....+..|+..+
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445778899999999999999985 678899998654210 0112356788888
Q ss_pred ccCCcce--EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccC
Q 036051 147 GRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK 224 (420)
Q Consensus 147 ~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk 224 (420)
..+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++|+ .+++|+|||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence 8887774 444443 2455899999999998775421 2456788999999999999 999999999
Q ss_pred CCCEEEcCCCcEEEeeecCccccc
Q 036051 225 ASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 225 ~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-18 Score=149.55 Aligned_cols=130 Identities=19% Similarity=0.290 Sum_probs=104.9
Q ss_pred eecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.||+|++|.||+|.+. +..|++|+..... ......+.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 3899999999999963 4568899754321 11135577899999999888766555555566677999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
++|++|.+++..... .++.+++.+|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754321 789999999999999 9999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-16 Score=131.73 Aligned_cols=135 Identities=19% Similarity=0.183 Sum_probs=113.7
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc--ceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35779999999999999854 5699999865543 4568899999999976 5889999988888889999999988
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+.+..+ +......++.+++.++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 4566778899999999999984445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-17 Score=168.23 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred hcCCCccceecccCceEEEEEEeCC-Cceeeeeecccccc--hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-SKIEIAVKKISHES--RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 169 (420)
...|...+.||+|.|+.|-...... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567788889999999999887743 34456777765543 222334445777777776 9999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhh-hcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccc
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH-EEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLY 247 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~ 247 (420)
+.+|..++++.+.+........+....-.++.|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||++..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999883222214555667778999999999999 6 8999999999999999999 9999999999876
Q ss_pred cC--CCCCccccccc-CCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 248 DH--GTDPQTTHVVG-TLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 248 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~------- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK------- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-------
Confidence 55 33444455678 9999999999774 4567889999999999999999998765543311 11111110
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
. ...............++..+++..+|..|.+.+++-
T Consensus 248 ---~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 ---G-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---c-ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0 000011112233456677778889999999987764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.1e-16 Score=135.39 Aligned_cols=137 Identities=18% Similarity=0.160 Sum_probs=96.3
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchh--HHHH----------------------HHHHHHHhccCCcce--
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ--GMKE----------------------FVAEIVSIGRLRHRN-- 153 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n-- 153 (420)
.+.||+|+||+||+|.+. +++.||||++...... .... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 6778999987653211 1111 124555555554332
Q ss_pred EeeeeeeeeeCCeEEEEEeecCCCChhhh-hccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKY-LYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
+++.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|. ..+++|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 3334432 245899999998554321 21111 11 5678899999999999996 37899999999999999
Q ss_pred CCcEEEeeecCccccc
Q 036051 233 ELNGRLGDFGLARLYD 248 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~ 248 (420)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=137.21 Aligned_cols=135 Identities=19% Similarity=0.225 Sum_probs=103.9
Q ss_pred cceec-ccCceEEEEEEeCCCceeeeeecccccc-------------hhHHHHHHHHHHHhccCCcceE--eeeeeeeee
Q 036051 100 KELLG-SGGFGRVYRGTLPKSKIEIAVKKISHES-------------RQGMKEFVAEIVSIGRLRHRNL--VQLLGYCRR 163 (420)
Q Consensus 100 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~ 163 (420)
...|| .|+.|+||.+... +..++||.+.... ......+.+|+..+.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45687 8999999999884 4468898775321 1122457889999999998775 666766433
Q ss_pred C-C---eEEEEEeecCC-CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 164 K-G---ELLLVYDYMPN-GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 164 ~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
. . ..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+|+||||.|||++.++.++|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 2 23599999997 6898887643 34433 35789999999999 99999999999999999889999
Q ss_pred eeecCccc
Q 036051 239 GDFGLARL 246 (420)
Q Consensus 239 ~Dfg~~~~ 246 (420)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.4e-14 Score=138.82 Aligned_cols=141 Identities=18% Similarity=0.189 Sum_probs=98.5
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHH----------------------------------------HHH
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM----------------------------------------KEF 139 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 139 (420)
.+.||.|++|.||+|++. +|+.||||+......... -+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 468999999999999986 567899999865421110 024
Q ss_pred HHHHHHhccCC-----cceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHh-HhHHhhhc
Q 036051 140 VAEIVSIGRLR-----HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL-GLLYLHEE 213 (420)
Q Consensus 140 ~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~ 213 (420)
.+|...+.++. ++++.-..-+....+..++||||++|++|.++...... .. ....++..++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~- 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR- 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh-
Confidence 45555555542 33332211222234457999999999999987643211 12 23456666666 4677887
Q ss_pred ccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 214 ~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
.+++|+|++|.||+++++++++++|||++..+.
T Consensus 276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-14 Score=139.96 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=179.1
Q ss_pred cCCCccceecc--cCceEEEEEEe--CCCceeeeeecccccch--hHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 95 KGFREKELLGS--GGFGRVYRGTL--PKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 95 ~~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
..|.....+|. |.+|.||.+.. ..++..+|+|.-+.... .....=.+|+.....+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566778999 99999999998 77888899998543311 2112224566666666 499999988899999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHh----HhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeec
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFG 242 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg 242 (420)
++-+|++ +.+|..+.+.-.. .++....+.+..+... ||.++|+ .+++|-|+||.||+...+ ...+++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 9999999 6788888765432 4677778888888888 9999999 999999999999999999 889999999
Q ss_pred CcccccCCCCC----cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 243 LARLYDHGTDP----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 243 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
+...+....-. ......+...|++||..+ ..++..+|+|++|.++.+-.++..+........ | ...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W--~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W--SQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c--cccc
Confidence 99877654321 122236788999999985 467889999999999999988876654321110 1 0001
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+ ....++.......+...+..+++.+|..|++...+..
T Consensus 340 ~~--------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QG--------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 10 0112222122223444667789999999999877653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-14 Score=129.29 Aligned_cols=201 Identities=20% Similarity=0.310 Sum_probs=139.4
Q ss_pred HHHhccCCcceEeeeeeeeeeC-----CeEEEEEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhccc
Q 036051 143 IVSIGRLRHRNLVQLLGYCRRK-----GELLLVYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWE 215 (420)
Q Consensus 143 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 215 (420)
...+-++-|.||++++.|+.+. .+..++.|||..|+|..+|++.. ...+......+++.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 4455667899999999987654 35799999999999999997543 2457777888999999999999998 45
Q ss_pred CcEEecccCCCCEEEcCCCcEEEeeecCcccccC----CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHH
Q 036051 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH----GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291 (420)
Q Consensus 216 ~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el 291 (420)
++++|+++..+-|++..++-+|+.--- ...... ..........+.++|.+||+=.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999888874321 111111 011122334567899999987777778899999999999999
Q ss_pred hcCCcc-CCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 292 ACGRRP-IERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 292 ~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.-+..- -+.....+...-. ..+.......+ =..++.+|++..|..||+|++++.
T Consensus 276 ailEiq~tnseS~~~~ee~i---------a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENI---------ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhh---------hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 877643 2211111000000 00001111111 124566799999999999988754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-13 Score=136.72 Aligned_cols=145 Identities=17% Similarity=0.164 Sum_probs=94.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhH----------------------------------HH--
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG----------------------------------MK-- 137 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~-- 137 (420)
-..|+. +.||.|++|+||+|+++++|+.||||+........ .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 78999999999999998778899999997542110 01
Q ss_pred ----HHHHHHHHhccCC----cceEeeeeeeee-eCCeEEEEEeecCCCChhhh--hccCC--CccCcHHHHHHHHHHhH
Q 036051 138 ----EFVAEIVSIGRLR----HRNLVQLLGYCR-RKGELLLVYDYMPNGSLDKY--LYNQP--KVTLNWRQRYGVIKGVA 204 (420)
Q Consensus 138 ----~~~~e~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~--l~~~~--~~~l~~~~~~~i~~~ia 204 (420)
+|.+|+..+.++. +.+.+.+-.++. -....++||||++|+.+.++ +...+ ...+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2344444444442 333333323332 24567899999999999874 22221 0123333333333333
Q ss_pred hHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecCcccccC
Q 036051 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGLARLYDH 249 (420)
Q Consensus 205 ~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~~~~~~~ 249 (420)
.. .+++|+|+||.||+++.++ +++++|||++..++.
T Consensus 277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 8899999999999999888 999999999876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-12 Score=128.65 Aligned_cols=170 Identities=17% Similarity=0.202 Sum_probs=129.5
Q ss_pred EEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCc
Q 036051 113 RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLN 192 (420)
Q Consensus 113 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~ 192 (420)
.|..+.++.+|.|......+........+.++.|+.++||||++++..++..+..|+|+|.+ ..|..++++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----
Confidence 45666677788888887665544455778889999999999999999999999999999988 35777775432
Q ss_pred HHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccC
Q 036051 193 WRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272 (420)
Q Consensus 193 ~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 272 (420)
.......++||+.||.|||+ ..+++|++|....|+++..|..||++|.++........ .......-..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 45566678999999999997 37899999999999999999999999988764432211 1111222334666665532
Q ss_pred CCCCccchhhhhHHHHHHHhcC
Q 036051 273 GKATTSADVFSFGAFLLEVACG 294 (420)
Q Consensus 273 ~~~~~~sDv~slGvvl~el~tg 294 (420)
.. -..|.|-||++++|++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-12 Score=112.29 Aligned_cols=131 Identities=18% Similarity=0.125 Sum_probs=95.0
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeecCCCC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.+.|+.|.++.||+++.. +..+++|....... ....+..|+..+..+.+.++ ++++.+.. ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 467899999999999974 55799999865432 12345788888888865444 34554432 34589999999988
Q ss_pred hhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc--cCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 179 LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 179 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+...- . ....++.+++.+|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76530 1 11245678999999999821 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-11 Score=107.08 Aligned_cols=138 Identities=17% Similarity=0.126 Sum_probs=98.1
Q ss_pred ceecccCceEEEEEEeCC------Cceeeeeecccccc-----h-----------------hHHHHH----HHHHHHhcc
Q 036051 101 ELLGSGGFGRVYRGTLPK------SKIEIAVKKISHES-----R-----------------QGMKEF----VAEIVSIGR 148 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~-----~-----------------~~~~~~----~~e~~~l~~ 148 (420)
..||.|.-+.||.|...+ .+..+|||+..... . ...+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 24679999775320 0 001222 378888888
Q ss_pred CCc--ceEeeeeeeeeeCCeEEEEEeecCCCChhh-hhccCCCccCcHHHHHHHHHHhHhHhHHh-hhcccCcEEecccC
Q 036051 149 LRH--RNLVQLLGYCRRKGELLLVYDYMPNGSLDK-YLYNQPKVTLNWRQRYGVIKGVALGLLYL-HEEWEQVVIHRDVK 224 (420)
Q Consensus 149 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~dlk 224 (420)
+.. -++++++++ ..-++||||+.++.+.. .++.. .++..+...+..+++.+|..| |. .+++|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 843 455566654 45689999997654422 22221 344456677889999999999 77 899999999
Q ss_pred CCCEEEcCCCcEEEeeecCcccccC
Q 036051 225 ASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 225 ~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
+.||++++ +.+.|+|||.+....+
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCC
Confidence 99999974 6899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-11 Score=121.34 Aligned_cols=251 Identities=18% Similarity=0.157 Sum_probs=172.5
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeC-CCceeeeeecccccchhHHHH--HHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLP-KSKIEIAVKKISHESRQGMKE--FVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
......+|.....||.|.|+.|+..... .++..+++|...........+ -+.|+.+...+ .|.++++....+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3444567888999999999999987765 567789999776542221111 23455555555 4888888877777777
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLA 244 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~ 244 (420)
..++--||++++++...+.. ...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence 77899999999988776632 2357788899999999999999998 999999999999999876 78899999998
Q ss_pred ccccCCCCCcccccccCCccc--ccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYL--APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
..+.- ........-+++ +++......+..+.|+|+||.-+.|.+++...-.....- ..+
T Consensus 415 t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------------~~i 475 (524)
T KOG0601|consen 415 TRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------------LTI 475 (524)
T ss_pred cccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---------------eee
Confidence 64211 111112233344 555556677888999999999999999887543221110 001
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
....-+.... . ...+..+...+..+++..||.+.++....+.
T Consensus 476 ~~~~~p~~~~----~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTPNLPG----L-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccccCCCc----h-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111111111 1 1345555566888999999998887665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=104.97 Aligned_cols=143 Identities=19% Similarity=0.196 Sum_probs=109.2
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCc--ceEeeeeeeeeeC---CeEEEEEee
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRK---GELLLVYDY 173 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~ 173 (420)
.+.|+.|..+.||++...+ +..+++|....... .....+..|+..+..+.+ .++++++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998854 46799998765432 134567889999998865 4456777776654 366899999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc---------------------------------------
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW--------------------------------------- 214 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 214 (420)
+++.++.+.+.. ..++..+...++.+++.+|..||+..
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999988886632 14677778888888888888888521
Q ss_pred --------------cCcEEecccCCCCEEEcC--CCcEEEeeecCccc
Q 036051 215 --------------EQVVIHRDVKASNVLLDG--ELNGRLGDFGLARL 246 (420)
Q Consensus 215 --------------~~~iiH~dlk~~NIll~~--~~~~kl~Dfg~~~~ 246 (420)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-10 Score=96.41 Aligned_cols=143 Identities=18% Similarity=0.203 Sum_probs=102.7
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeec-ccccc-------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKK-ISHES-------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
...++-||+-+.|+++.+. |+...||. +.+.- .-..+...+|+..+.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4678999999999999984 44556663 32221 11124567899988887644444444455566666899
Q ss_pred EeecCC-CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEEeeecCccc
Q 036051 171 YDYMPN-GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARL 246 (420)
Q Consensus 171 ~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfg~~~~ 246 (420)
|||+++ .++.+++...-...........++..|-..+.-||. .+++|+||..+||++..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999966 478888765533233333447788999999999999 9999999999999997554 458999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.3e-10 Score=106.33 Aligned_cols=170 Identities=18% Similarity=0.278 Sum_probs=130.3
Q ss_pred CceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeee----eCCeEEEEEeecCC-CChhh
Q 036051 107 GFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR----RKGELLLVYDYMPN-GSLDK 181 (420)
Q Consensus 107 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~ 181 (420)
.-.+.|++...-+|..|++|+++............-++.++++.|+|+|++..++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678999998889899999995432222223345678899999999999998876 34578999999885 46766
Q ss_pred hhccC-------------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 182 YLYNQ-------------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 182 ~l~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+-... .....++..+|.++.|++.||.++|+ .|+.-+-|.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54322 12357789999999999999999999 899999999999999999999999888876654
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCcc
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p 297 (420)
.+.. |-+ .--++-|.=.||.+++-|.||..-
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 3320 111 123467999999999999999653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.1e-10 Score=94.14 Aligned_cols=131 Identities=21% Similarity=0.261 Sum_probs=97.2
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecc-ccc--ch-----hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHE--SR-----QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~--~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..+++|+-+.+|.+.+.+. .+++|.- ++. .+ -....-.+|+.++.+++--.|....-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999987432 3666633 221 11 112335678888888865555544555666777789999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
|++|..|.+.+... ...++..+-.-+.-||. .+|+|+||.++||++..+. +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888654 24567777888888998 9999999999999998764 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.7e-11 Score=124.31 Aligned_cols=251 Identities=22% Similarity=0.200 Sum_probs=168.5
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
...+.+.+.+.+-+|.++.++.+.-...+...+.|+...... ...+....+-.++-.-++|.+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345667777888999999999887766665555555433211 11122222222222234566665554445567889
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
++++|..+++|...|++.+ ..+..-....+..+..++++||. ..+.|+|++|.|++...++..+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999998775 45555566667778899999998 669999999999999999999999998432211
Q ss_pred CC--------C----------------------CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccC
Q 036051 249 HG--------T----------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298 (420)
Q Consensus 249 ~~--------~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~ 298 (420)
.. . ........+|+.|.+||...+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 01123357899999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHH
Q 036051 299 ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMR 361 (420)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 361 (420)
....+.... +.+.++ .+..+.. ..+......+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f-------~ni~~~---~~~~p~g----~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF-------ENILNR---DIPWPEG----PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh-------hccccC---CCCCCCC----ccccChhhhhhhhhhhccCchhccCcc
Confidence 876654321 111111 1111111 111222344555556677888988765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-09 Score=97.52 Aligned_cols=141 Identities=20% Similarity=0.140 Sum_probs=98.8
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchh-HHH----------HHHHHHHHhccCCcceE--eeeeeeeee----
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMK----------EFVAEIVSIGRLRHRNL--VQLLGYCRR---- 163 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~ni--v~~~~~~~~---- 163 (420)
+.+-......|.+..+ +|+.+.||........ ..+ .+.+|...+.++..-+| ++.+++...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4455445556777776 4567999976433211 111 36788888877743232 233444432
Q ss_pred -CCeEEEEEeecCCC-ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-------CC
Q 036051 164 -KGELLLVYDYMPNG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-------EL 234 (420)
Q Consensus 164 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-------~~ 234 (420)
...-++|+|++++. +|.+++........+...+..++.+++..+.-||. .+++|+|++++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999876 79888854322245566778899999999999999 99999999999999975 46
Q ss_pred cEEEeeecCccc
Q 036051 235 NGRLGDFGLARL 246 (420)
Q Consensus 235 ~~kl~Dfg~~~~ 246 (420)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=89.17 Aligned_cols=126 Identities=21% Similarity=0.259 Sum_probs=80.7
Q ss_pred EEEEEEeCCCceeeeeecccccc--------------h------------hHHHHHHHHHHHhccCCcc--eEeeeeeee
Q 036051 110 RVYRGTLPKSKIEIAVKKISHES--------------R------------QGMKEFVAEIVSIGRLRHR--NLVQLLGYC 161 (420)
Q Consensus 110 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~ 161 (420)
.||.|... ++..+|||+..... + .......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48889884 45689999764320 0 0112466799999998654 456666542
Q ss_pred eeCCeEEEEEeecC--CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHh-hhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 162 RRKGELLLVYDYMP--NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL-HEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 162 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
.-++||||++ |..+..+. .. .++......++.+++..+..+ |. .+++|+||.+.||+++++ .+.|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ----CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 54554433 22 122445667778888866664 66 899999999999999988 9999
Q ss_pred eeecCccccc
Q 036051 239 GDFGLARLYD 248 (420)
Q Consensus 239 ~Dfg~~~~~~ 248 (420)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-07 Score=89.75 Aligned_cols=194 Identities=15% Similarity=0.169 Sum_probs=130.2
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeee------eee-CCeEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGY------CRR-KGELLL 169 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~-~~~~~l 169 (420)
...+.||+|+-+.+|-.---.+ .+.|++.........+- +..|... .||-+-.=+.| --+ ....-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4467899999999996433222 34577766544333322 2233333 46544331221 111 223677
Q ss_pred EEeecCCCC-hhhhhc----cCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 170 VYDYMPNGS-LDKYLY----NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 170 v~e~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
+|..+++.. +..++. ++.-...+|.-.++.+..+|.+.+-||. .|.+-+|++++|+|+.+++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 788776642 222222 1112357899999999999999999999 99999999999999999999999985543
Q ss_pred ccccCCCCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcC-CccCCCCC
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACG-RRPIERQG 302 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg-~~p~~~~~ 302 (420)
....+ .......+|...|.+||.-. +..-+...|.|.||+++++|+.| +.||.+..
T Consensus 165 qi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 165 QINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 33221 22333457889999999653 44567789999999999998775 99997643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-09 Score=109.09 Aligned_cols=152 Identities=22% Similarity=0.315 Sum_probs=100.5
Q ss_pred HHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC--------cccccccCCccccccccc
Q 036051 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--------QTTHVVGTLGYLAPEHTR 271 (420)
Q Consensus 200 ~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~ 271 (420)
+.+++.|+.|+|. ...+||++|.|++|.+++++..||+.|+.+......... ...-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4456699999998 588999999999999999999999999988754432111 001112345799999998
Q ss_pred CCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhccc
Q 036051 272 TGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCS 350 (420)
Q Consensus 272 ~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 350 (420)
+...+.++|+||+|+++|-+.. |+.-+...+....... ++....... ..+..+...++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~---------~~~~~~~~~----~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF---------SRNLLNAGA----FGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh---------hhccccccc----ccccccCcHHHHHHHHHHh
Confidence 8888999999999999999984 5444443322110000 000011111 1112233344555556678
Q ss_pred ccCCCCCCCHHHHHHH
Q 036051 351 HSDPTARPSMRQVVQI 366 (420)
Q Consensus 351 ~~dP~~RPt~~evl~~ 366 (420)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 8999999987776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.1e-08 Score=87.36 Aligned_cols=135 Identities=16% Similarity=0.150 Sum_probs=94.4
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccc---------h-------------hHHHHHHHHHHHhccCCcc--
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---------R-------------QGMKEFVAEIVSIGRLRHR-- 152 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~-------------~~~~~~~~e~~~l~~l~h~-- 152 (420)
..+...||-|.-+.||.|... .+.++|||.-.... + .......+|.+.|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 455788999999999999996 45579999532210 0 0112456788888888644
Q ss_pred eEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
.+++.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-. .|++|+|+.+-||++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 66666554 4568999999887666542 1223333444445444444445 89999999999999999
Q ss_pred CCcEEEeeecCccc
Q 036051 233 ELNGRLGDFGLARL 246 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~ 246 (420)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999966554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.6e-08 Score=99.68 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=91.5
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchhHHH----------------------------------------HHH
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK----------------------------------------EFV 140 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~ 140 (420)
+.|+.++-|.||+|+++. |+.||||+....-.+..+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999964 778999998765322111 133
Q ss_pred HHHHHhccC-----CcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHh-HHhhhcc
Q 036051 141 AEIVSIGRL-----RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL-LYLHEEW 214 (420)
Q Consensus 141 ~e~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~ 214 (420)
.|...+.++ +.+++.--.-|.+-.+...++|||++|-.+.+...... ...+ +..++..++.+. ..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~--- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---
Confidence 444444443 13333222223334567799999999999988842221 1233 222233222221 1222
Q ss_pred cCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
..+++|.|.+|.||+++.++++.+.|||+....+.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 27899999999999999999999999999876654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=83.61 Aligned_cols=138 Identities=18% Similarity=0.156 Sum_probs=103.0
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCCc--ceEeeeeeeeee----CCeEEEE
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRR----KGELLLV 170 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~----~~~~~lv 170 (420)
-|+||-+.|+.-...+. .+-+|...... +.....|.+|+..+.++.. -.+++...+... .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 47789999999887433 58899775221 2245789999999988853 224444422211 1246899
Q ss_pred EeecCC-CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc--EEEeeecCcc
Q 036051 171 YDYMPN-GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfg~~~ 245 (420)
+|-+++ -+|.+++......+.+...+..++.+++..+.-||+ .++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 588888876544456778888999999999999999 99999999999999986666 9999997665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.2e-07 Score=83.02 Aligned_cols=105 Identities=24% Similarity=0.298 Sum_probs=80.5
Q ss_pred HHHHHHHHHhccCCc--ceEeeeeeeeeeC----CeEEEEEeecCCC-ChhhhhccCCCccCcHHHHHHHHHHhHhHhHH
Q 036051 137 KEFVAEIVSIGRLRH--RNLVQLLGYCRRK----GELLLVYDYMPNG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209 (420)
Q Consensus 137 ~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~ 209 (420)
....+|...+.++.. -..++.+++.... ..-++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 346677777766642 2234455555442 2458999999874 79998876432 5566788899999999999
Q ss_pred hhhcccCcEEecccCCCCEEEcCCC---cEEEeeecCccc
Q 036051 210 LHEEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARL 246 (420)
Q Consensus 210 LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfg~~~~ 246 (420)
||. .+++|+|+++.|||++.+. .+.++||+-+..
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 9999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.1e-06 Score=77.67 Aligned_cols=138 Identities=14% Similarity=0.165 Sum_probs=93.6
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHH---------HHHHHHhccCC---cceEeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---------VAEIVSIGRLR---HRNLVQLLG 159 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~ 159 (420)
....+|...+++-......|.+-.. ++..+++|.........++.| .+++..+.+++ ......++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4567788888888888888887776 445799999876644333322 23333333332 222333333
Q ss_pred eee-----eCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 160 YCR-----RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 160 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
+.. -....+++|||++|..|.+... ++. .++..++.++.-||. .|++|+|.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 222 2345679999999988877642 222 244567788999999 999999999999999965
Q ss_pred cEEEeeecCcc
Q 036051 235 NGRLGDFGLAR 245 (420)
Q Consensus 235 ~~kl~Dfg~~~ 245 (420)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.3e-07 Score=80.37 Aligned_cols=132 Identities=15% Similarity=0.151 Sum_probs=83.3
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcce--EeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
..||+|..+.||+.. +..+++|....... .....+|.+.+..+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 679999999999842 22477888865432 244678998888875433 4667788877888899999998863
Q ss_pred -hhhhhccCCCccCcHHHHHHHHHHhHhH---------------------------------------hHHhhh-cccCc
Q 036051 179 -LDKYLYNQPKVTLNWRQRYGVIKGVALG---------------------------------------LLYLHE-EWEQV 217 (420)
Q Consensus 179 -L~~~l~~~~~~~l~~~~~~~i~~~ia~~---------------------------------------L~~LH~-~~~~~ 217 (420)
+...+... ......++.+++.. ..+|.. .....
T Consensus 81 ~~~~~~~~~------~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 81 SFSRIISDN------PSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred chhhhhcCC------HHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 22111100 00011111111111 112211 11245
Q ss_pred EEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 218 VIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 218 iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.1e-08 Score=95.04 Aligned_cols=186 Identities=18% Similarity=0.140 Sum_probs=137.2
Q ss_pred CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcce-EeeeeeeeeeCCeEEEEEeecC
Q 036051 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 97 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~ 175 (420)
+...+-+++|+++.++|.+...+...+ ++.+... ....-++++|.+++||| .+..++-+......+++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 333456899999999999876554333 5554333 33456789999999999 6666777777788999999998
Q ss_pred CC-ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 176 NG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 176 ~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
.+ +-..... .....+...+...+...-+++++++|+ ..-+|+| ||+..+ +..+..||+....+.... .
T Consensus 318 ~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 318 TGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred CCccccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 77 2222221 112345566677778888899999998 5558888 777765 578999999987665543 3
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCC
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
.....+++.++|||+.....+..+.|+|++|+--.++.-|-.|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 345678999999999999999999999999987777777766654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=9e-06 Score=73.60 Aligned_cols=142 Identities=22% Similarity=0.227 Sum_probs=82.7
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc--eEeeeeeeee---eCCeEEEEEeec
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR--NLVQLLGYCR---RKGELLLVYDYM 174 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~ 174 (420)
.+.++.|..+.||+....+ + .+++|..... .....+..|...+..+... .+++++.++. .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4679999999999999865 4 6999987655 3445667788887777422 3556666443 334579999999
Q ss_pred CCCChhh----------------hh---ccC--CCccCcHHH---------HHHH------------HHHhHh-HhHHhh
Q 036051 175 PNGSLDK----------------YL---YNQ--PKVTLNWRQ---------RYGV------------IKGVAL-GLLYLH 211 (420)
Q Consensus 175 ~~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH 211 (420)
++..+.. .+ +.. ......+.. .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 000011000 0000 111222 233333
Q ss_pred hc----ccCcEEecccCCCCEEEc-CCCcEEEeeecCcc
Q 036051 212 EE----WEQVVIHRDVKASNVLLD-GELNGRLGDFGLAR 245 (420)
Q Consensus 212 ~~----~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg~~~ 245 (420)
.. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 236799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4e-06 Score=83.94 Aligned_cols=141 Identities=16% Similarity=0.220 Sum_probs=89.7
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHH-------------------------------------HHHHHH
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM-------------------------------------KEFVAE 142 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~e 142 (420)
.+.||.-..|.||+|++++ |+.||||+.+..-+... -+|.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3679999999999999976 78899999876522210 024445
Q ss_pred HHHhccC----Ccce------EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhh
Q 036051 143 IVSIGRL----RHRN------LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212 (420)
Q Consensus 143 ~~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 212 (420)
.+...+. .|-+ |++++- .-.....|+||||+|..+.+.-.-... .++-.. ++..+.++. ++.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~---i~~~l~~~~--~~q 316 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHD---ILNKLVEAY--LEQ 316 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHH---HHHHHHHHH--HHH
Confidence 5443333 3444 333322 223567999999999888776332111 233333 333333322 222
Q ss_pred cccCcEEecccCCCCEEEcC----CCcEEEeeecCcccccC
Q 036051 213 EWEQVVIHRDVKASNVLLDG----ELNGRLGDFGLARLYDH 249 (420)
Q Consensus 213 ~~~~~iiH~dlk~~NIll~~----~~~~kl~Dfg~~~~~~~ 249 (420)
-...|++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22368999999999999983 67899999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.3e-06 Score=73.30 Aligned_cols=103 Identities=20% Similarity=0.164 Sum_probs=81.3
Q ss_pred HHHHHhccCCc-ceEeeeeeeeeeCCeEEEEEeecCCCChhhhhcc-CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcE
Q 036051 141 AEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYN-QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218 (420)
Q Consensus 141 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 218 (420)
+|.-++..+++ +++++++|+|- .+++.||...+++...-.. ..-...+|..+.+|+.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57777777865 69999999993 3779999987766432100 011257899999999999999999998655568
Q ss_pred EecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 219 IHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 219 iH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
.-.|++++|+-+++++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-05 Score=73.33 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=83.0
Q ss_pred eecccCc-eEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 102 LLGSGGF-GRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 102 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
.|..|.. ..||+....+ ..+.+|+..... ...+.+|+..+..+. +--+++++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3455555 7899998643 468888876543 234567888877763 34456777777766778999999998877
Q ss_pred hhhh-------------------ccCC--CccCcH--HHHHHHHHH--------------------hHhHhHHhhh----
Q 036051 180 DKYL-------------------YNQP--KVTLNW--RQRYGVIKG--------------------VALGLLYLHE---- 212 (420)
Q Consensus 180 ~~~l-------------------~~~~--~~~l~~--~~~~~i~~~--------------------ia~~L~~LH~---- 212 (420)
.... +..+ ...+.. .....-... +...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 1110 001110 000000000 0111111111
Q ss_pred cccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 213 ~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112568999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.5e-05 Score=70.01 Aligned_cols=156 Identities=17% Similarity=0.141 Sum_probs=100.2
Q ss_pred CccchHHHHHHhcCCCccc---eecccCceEEEEEEeCCCceeeeeecccccchhH------------------------
Q 036051 83 HRFRYKDLYIATKGFREKE---LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG------------------------ 135 (420)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------ 135 (420)
...+.+.+....++..+.. .|++|..+.||+|.. +++..+|||++.......
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3455666666666655554 466788889999987 456689999886432111
Q ss_pred HHHHHHHHHHhccCC--cceEeeeeeeeeeCCeEEEEEeecCCC-ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhh
Q 036051 136 MKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGELLLVYDYMPNG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212 (420)
Q Consensus 136 ~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 212 (420)
.....+|+..|.++. +=.+++.+++. .-.|||||+... .-.-.|+.- .+...+...+..++++.+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH
Confidence 011345666666653 22333334433 237899999543 112222222 23333566777788888877765
Q ss_pred cccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 213 ~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
..++||+||..=|||+. ++.+.|+|||-+....+
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 37899999999999999 78999999998876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.9e-05 Score=83.66 Aligned_cols=80 Identities=13% Similarity=0.226 Sum_probs=57.7
Q ss_pred cceecccCceEEEEEEeCCCc--eeeeeecccccc-hhHHHHHHHHHHHhccCC-cceE--eeeeeeeeeC---CeEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSK--IEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNL--VQLLGYCRRK---GELLLV 170 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 170 (420)
.+.++.|.+..+|+.....++ ..+++|+..... ......+.+|+.+++.+. |+++ ++++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998875432 357778765432 122346789999999885 6665 7788888764 467999
Q ss_pred EeecCCCCh
Q 036051 171 YDYMPNGSL 179 (420)
Q Consensus 171 ~e~~~~g~L 179 (420)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.2e-05 Score=65.57 Aligned_cols=130 Identities=18% Similarity=0.267 Sum_probs=89.1
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccc----------------hhHHHHHHHHHHHhccCC------cceEe
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES----------------RQGMKEFVAEIVSIGRLR------HRNLV 155 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv 155 (420)
.....||+|+.-.||.--. +. ..+||+..... ....+++.+|+.....+. +.+|.
T Consensus 4 ~~~~~i~~G~~R~cy~HP~--dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHPD--DP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CCCcccccCCCceEEECCC--CC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 3456799999999996433 32 36788886655 112355666666555544 88999
Q ss_pred eeeeeeeeCCeEEEEEeecCC------CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 156 QLLGYCRRKGELLLVYDYMPN------GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 156 ~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
+++|+.+.+.-.-+|+|.+.+ -+|.+++... .++. ..... +-+-..||-. ..|+.+|++|.||+
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIV 150 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEE
Confidence 999999999989999998643 3577777544 3443 33333 3344456665 78999999999999
Q ss_pred EcCC--C--cEEEee
Q 036051 230 LDGE--L--NGRLGD 240 (420)
Q Consensus 230 l~~~--~--~~kl~D 240 (420)
+..+ + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9532 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.6e-05 Score=68.46 Aligned_cols=75 Identities=19% Similarity=0.162 Sum_probs=45.8
Q ss_pred cceecccCce-EEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc---eEeeeeeeeeeC---CeEEEEEe
Q 036051 100 KELLGSGGFG-RVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---NLVQLLGYCRRK---GELLLVYD 172 (420)
Q Consensus 100 ~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e 172 (420)
.+.|+.|+.. .||+.. + .+++|...... ....+..|.+.+..+... -++++++..... ...+++|+
T Consensus 2 ~~~~~~gG~~n~vy~~~----~-~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRLG----D-DMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEcC----C-ceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 3567777766 589752 1 36778765432 234678888888776421 233444443332 24588999
Q ss_pred ecCCCChhh
Q 036051 173 YMPNGSLDK 181 (420)
Q Consensus 173 ~~~~g~L~~ 181 (420)
+++|.++.+
T Consensus 75 ~i~G~~l~~ 83 (235)
T cd05155 75 WLEGETATA 83 (235)
T ss_pred eecCCCCCc
Confidence 999877753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00015 Score=68.54 Aligned_cols=78 Identities=10% Similarity=0.038 Sum_probs=56.0
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc---ceEeeeeeeeee---CCeEEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH---RNLVQLLGYCRR---KGELLLVY 171 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~ 171 (420)
...+.||.|..+.||.....++ .+++|..+.... ...|..|...|+.+.- -.+++++++|.. .+..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG--NPMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCC--CEEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3457799999999999876433 366777533111 2467889988888742 367788887754 36689999
Q ss_pred eecCCCCh
Q 036051 172 DYMPNGSL 179 (420)
Q Consensus 172 e~~~~g~L 179 (420)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99988765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.2e-05 Score=63.19 Aligned_cols=128 Identities=20% Similarity=0.231 Sum_probs=86.2
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEee-eeeeeeeCCeEEEEEeecCC
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ-LLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~ 176 (420)
...+.|++|.+|.||+|.+.+ ..+|+|+-..++.. ..+..|+++|..+.--++.+ ++.|-. -++.|||..|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccC--ceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 345679999999999999954 37999987766443 66788999998887655543 444432 2445999988
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccC-C-CCEEEcCCCcEEEeeecCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK-A-SNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk-~-~NIll~~~~~~kl~Dfg~~~~ 246 (420)
-.|.+.-... +-.. ...+++.-.-|-. .+|-|+.|. | .||++.+ +.+.|+||.-|..
T Consensus 97 ~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 7887654321 1112 2334455333443 788888887 4 4555554 4999999998873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=65.55 Aligned_cols=76 Identities=12% Similarity=0.177 Sum_probs=47.2
Q ss_pred cceecccCceEEEEEEeCC-CceeeeeecccccchhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCeEEEEEeecCCC
Q 036051 100 KELLGSGGFGRVYRGTLPK-SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYDYMPNG 177 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g 177 (420)
.+.|..|-...+|+....+ .+..|++|+....... .-+..+|+.++..+.. .-.+++++.+. + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence 4567888889999998653 2446889977543221 1222467777777743 22344444332 2 4799999887
Q ss_pred Chh
Q 036051 178 SLD 180 (420)
Q Consensus 178 ~L~ 180 (420)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 663
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.9e-05 Score=68.23 Aligned_cols=137 Identities=16% Similarity=0.074 Sum_probs=76.4
Q ss_pred ecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeecCCCChhh
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPNGSLDK 181 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 181 (420)
+..|-...+|+... ++..+++|..........-+..+|..+++.+....+ ++++..+. -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 56788889998874 445688887654322211134677777777753322 33444332 368999998876643
Q ss_pred h-----------------hccCC--CccCcHHH-HHHHHHHh---------HhHhHHhhh-----cccCcEEecccCCCC
Q 036051 182 Y-----------------LYNQP--KVTLNWRQ-RYGVIKGV---------ALGLLYLHE-----EWEQVVIHRDVKASN 227 (420)
Q Consensus 182 ~-----------------l~~~~--~~~l~~~~-~~~i~~~i---------a~~L~~LH~-----~~~~~iiH~dlk~~N 227 (420)
. |+..+ ...++... ......++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11112111 11111111 111111111 112468999999999
Q ss_pred EEEcCCCcEEEeeecCccc
Q 036051 228 VLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~ 246 (420)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00043 Score=60.68 Aligned_cols=125 Identities=28% Similarity=0.388 Sum_probs=88.1
Q ss_pred cCCCccceecccCc-eEEEEEEeCCCceeeeeecccc---cc---------h---------hHHHHHHHHHHHhccCC--
Q 036051 95 KGFREKELLGSGGF-GRVYRGTLPKSKIEIAVKKISH---ES---------R---------QGMKEFVAEIVSIGRLR-- 150 (420)
Q Consensus 95 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~---------~---------~~~~~~~~e~~~l~~l~-- 150 (420)
.+++..+.||.|.- |.||+++. +|..+|+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67888999999999 99999999 455899999321 10 0 11235788888887774
Q ss_pred -cceE--eeeeeeeeeC------------------CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHH
Q 036051 151 -HRNL--VQLLGYCRRK------------------GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209 (420)
Q Consensus 151 -h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~ 209 (420)
+.++ ++.+||..-. ....||.||.+... .+... -+.+|.+-+..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 5566 8999986322 12467777775533 12222 24556677788
Q ss_pred hhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 210 LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 998 99999999999976 3489999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=76.47 Aligned_cols=197 Identities=19% Similarity=0.174 Sum_probs=131.3
Q ss_pred HHHHHHHHhccCCcceEeeeeeeeeeCC----eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhc
Q 036051 138 EFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213 (420)
Q Consensus 138 ~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 213 (420)
.-..|+..+.++.|+|++.++.|-.... ...+..+++...++...+..-. .++....+.+..++..||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 3445777888889999999998865442 2345567788888888776654 56778888889999999999998
Q ss_pred ccCcEEecccCCC---CEEEcCCCcEEEe--eecCcccccCCCCCcccccccCCcccccccccCCCCCc--cchhhhhHH
Q 036051 214 WEQVVIHRDVKAS---NVLLDGELNGRLG--DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT--SADVFSFGA 286 (420)
Q Consensus 214 ~~~~iiH~dlk~~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDv~slGv 286 (420)
....|.-+..+ +--.+.++.+.++ ||+......... .......+..+.+||......+.. ..|+|++|.
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 44444444444 3444555666666 888776554322 222234466788888876655544 479999999
Q ss_pred HHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 287 FLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 287 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.+..+..|..+-..... ...-+...... .+.+...+|+..++++|+++.+++..
T Consensus 381 l~~~~~~~~~i~~~~~~----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccc----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999887654321110 00001011111 35566778999999999999999875
Q ss_pred H
Q 036051 367 L 367 (420)
Q Consensus 367 L 367 (420)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 5
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00073 Score=63.81 Aligned_cols=141 Identities=20% Similarity=0.183 Sum_probs=82.2
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcce--Eeeeeee------eeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGY------CRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~ 171 (420)
.+.+..|....+|+....+ + .+++|+..... ......|+.++..+.+.+ +++++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~-~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-G-RYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-C-cEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4567888888999987633 3 58889876422 234556666666663222 3444332 23345678999
Q ss_pred eecCCCChhhh--------------hccC----CC-----ccCcHHHHH----------HHHHHhHhHhHHhhh----cc
Q 036051 172 DYMPNGSLDKY--------------LYNQ----PK-----VTLNWRQRY----------GVIKGVALGLLYLHE----EW 214 (420)
Q Consensus 172 e~~~~g~L~~~--------------l~~~----~~-----~~l~~~~~~----------~i~~~ia~~L~~LH~----~~ 214 (420)
+|++|..+... ++.. .. ....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99988775430 0100 00 011222111 011112333444432 12
Q ss_pred cCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..+++|+|+.|.||+++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3569999999999999988777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0009 Score=65.40 Aligned_cols=77 Identities=12% Similarity=0.103 Sum_probs=52.3
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccc-------hhHHHHHHHHHHHhccCC---cceEeeeeeeeeeCCeEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 169 (420)
.+.||.|.+..||++...++++.|+||.-.... .-..+.+..|.+.|..+. -.++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 457999999999999996554579999753211 112344566777777652 34567777763 355789
Q ss_pred EEeecCCCC
Q 036051 170 VYDYMPNGS 178 (420)
Q Consensus 170 v~e~~~~g~ 178 (420)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00069 Score=64.19 Aligned_cols=77 Identities=19% Similarity=0.303 Sum_probs=47.6
Q ss_pred cceecccCceEEEEEEeCCC------ceeeeeecccccchhHHHHHHHHHHHhccCCcce-EeeeeeeeeeCCeEEEEEe
Q 036051 100 KELLGSGGFGRVYRGTLPKS------KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 172 (420)
.+.+..|-...+|+....++ +..+++|+...... ...+..+|..++..+.... .+++++++.. .+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 35577777789999887432 45788998765432 2233456777777664222 3345555532 35899
Q ss_pred ecCCCChhh
Q 036051 173 YMPNGSLDK 181 (420)
Q Consensus 173 ~~~~g~L~~ 181 (420)
|++|..+..
T Consensus 78 ~i~G~~l~~ 86 (302)
T cd05156 78 FIPSRTLTT 86 (302)
T ss_pred eeCCCcCCH
Confidence 998876643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0021 Score=61.46 Aligned_cols=141 Identities=17% Similarity=0.152 Sum_probs=74.6
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-----CcceEeeee-e--eeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-----RHRNLVQLL-G--YCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~ 171 (420)
.+.++.|....+|+....+ + .+++|++...... ....|+..+..| ..|.+++-. | +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCC-C-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3557778878999987643 3 5889987522222 222333333333 233333211 1 123356679999
Q ss_pred eecCCCChhhh--------------hccCC-C--------ccCcH-HHHHH------------HH-HHhHhHhHHhhh--
Q 036051 172 DYMPNGSLDKY--------------LYNQP-K--------VTLNW-RQRYG------------VI-KGVALGLLYLHE-- 212 (420)
Q Consensus 172 e~~~~g~L~~~--------------l~~~~-~--------~~l~~-~~~~~------------i~-~~ia~~L~~LH~-- 212 (420)
+|++|..+... ++... . ..+.| ..... .. ..+...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 99988754210 11100 0 01111 11111 01 111112222221
Q ss_pred --cccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 213 --EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 213 --~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
....+++|+|+.+.||+++++...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 124689999999999999976556899999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00022 Score=66.37 Aligned_cols=136 Identities=13% Similarity=0.040 Sum_probs=87.7
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeeccccc---------ch--------hHH-----HHHHHHHHHhccCC-cc
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---------SR--------QGM-----KEFVAEIVSIGRLR-HR 152 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~--------~~~-----~~~~~e~~~l~~l~-h~ 152 (420)
-+...++||-|.-+.+|.+-+. +|.+.++|.-... .+ ..| -...+|+..|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4567899999999999999985 4567888843211 00 000 12445777777663 22
Q ss_pred e-EeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 153 N-LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 153 n-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
. +++.++ .+..++|||++.+..|...-+-.. ...++ ..+..-+--|-. .|+||+|..-=||+++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d-----~~~ly---~~lm~~Iv~la~---~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHVED-----PPTLY---DDLMGLIVRLAN---HGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeecCC-----hHHHH---HHHHHHHHHHHH---cCceecccchheeEEe
Confidence 2 223333 346799999999888876543221 11222 222222233333 8999999999999999
Q ss_pred CCCcEEEeeecCcccc
Q 036051 232 GELNGRLGDFGLARLY 247 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~ 247 (420)
+++.++++||--+...
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0047 Score=57.90 Aligned_cols=75 Identities=16% Similarity=0.234 Sum_probs=46.9
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC---CcceEeeeeeeeeeCCeEEEEEeec
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+..+.++.|....+|+... ++..+.||+-.... ...|..|..-|+.| .--.+++++++....+..+||+||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~--~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDT--DGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEET--TS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEEC--CCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3457799999999999883 55679999876322 24567787777777 3456778888887777779999999
Q ss_pred CCC
Q 036051 175 PNG 177 (420)
Q Consensus 175 ~~g 177 (420)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0044 Score=58.90 Aligned_cols=142 Identities=17% Similarity=0.145 Sum_probs=79.4
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc--eEeeeeee------eeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR--NLVQLLGY------CRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~ 171 (420)
.+.++.|....+|+.... ++ .+++|+....... .....|++++..|... .+++++.. ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~--~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKA--EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCCCH--HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 456778878899998753 33 4778876543211 2334455555555321 13343332 12345679999
Q ss_pred eecCCCChhhh--------------hccCCC-c---------cCcHHHHHH------------HHHHhHhHhHHhhh---
Q 036051 172 DYMPNGSLDKY--------------LYNQPK-V---------TLNWRQRYG------------VIKGVALGLLYLHE--- 212 (420)
Q Consensus 172 e~~~~g~L~~~--------------l~~~~~-~---------~l~~~~~~~------------i~~~ia~~L~~LH~--- 212 (420)
+|++|..+... ++.... . .-.|..... ....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654211 111000 0 011111110 01112334444432
Q ss_pred -cccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 213 -EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 213 -~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
....+++|+|+++.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224789999999999999988767899998874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0062 Score=58.85 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=79.2
Q ss_pred cceecccCceEEEEEEeCC----CceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeec
Q 036051 100 KELLGSGGFGRVYRGTLPK----SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 174 (420)
...+..|-.-.+|+..... .+..|++|+......... +-.+|..++..+..-++ +++++.+..+ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3456667888999987532 235688998865432221 22567777777743333 3455555332 589999
Q ss_pred CCCChhhh-----------------hccCC----CccCcHHHHHHHHHHh-----------------HhHhHHh----hh
Q 036051 175 PNGSLDKY-----------------LYNQP----KVTLNWRQRYGVIKGV-----------------ALGLLYL----HE 212 (420)
Q Consensus 175 ~~g~L~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~~L~~L----H~ 212 (420)
++.+|... ++... .....+.++.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77666421 11111 0011122222222111 1111122 11
Q ss_pred -cccCcEEecccCCCCEEEcC-CCcEEEeeecCcc
Q 036051 213 -EWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLAR 245 (420)
Q Consensus 213 -~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~ 245 (420)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11346899999999999986 4689999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.013 Score=55.50 Aligned_cols=137 Identities=18% Similarity=0.180 Sum_probs=81.4
Q ss_pred ceecccCceEEEEEEeCCCceeeeeeccc-ccchhHHHHHHHHHHHhccCCc--ceEeeeeeeeeeCC--eEEEEEeecC
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKG--ELLLVYDYMP 175 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~ 175 (420)
+.+..|-.-.+|..... ++.++++.-. ...........+|+..++.+.- --+...+++|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34444444455655553 5567777221 1223334455667777776632 23345667777665 7899999998
Q ss_pred CCChhhhhccCCCccCcHHHHHHHH-HHhHhHhHHhhhc-----------------------------------------
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVI-KGVALGLLYLHEE----------------------------------------- 213 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~-~~ia~~L~~LH~~----------------------------------------- 213 (420)
|..+.+.+.... .. .+++ ..+++.|.-||+-
T Consensus 109 Ge~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 109 GEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred ceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 855444332211 00 1111 2344444444431
Q ss_pred --------------ccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 214 --------------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 214 --------------~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
....++|+|+++.|++++.+.-+=|.||+++..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 135699999999999999888899999999865
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0098 Score=55.55 Aligned_cols=31 Identities=26% Similarity=0.502 Sum_probs=25.7
Q ss_pred CcEEecccCCCCEEEcCCCc-EEEeeecCccc
Q 036051 216 QVVIHRDVKASNVLLDGELN-GRLGDFGLARL 246 (420)
Q Consensus 216 ~~iiH~dlk~~NIll~~~~~-~kl~Dfg~~~~ 246 (420)
..++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0012 Score=65.21 Aligned_cols=49 Identities=24% Similarity=0.388 Sum_probs=39.3
Q ss_pred HHHHHHHHHhccCCcceEeeeeeeeeeC-CeEEEEEeecCCCChhhhhccC
Q 036051 137 KEFVAEIVSIGRLRHRNLVQLLGYCRRK-GELLLVYDYMPNGSLDKYLYNQ 186 (420)
Q Consensus 137 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~ 186 (420)
.+++....+++.+.|+|+...+.+.... ....+|+|++ +.+|++.+..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 4566777888999999999999887644 4578899998 88999988655
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.00028 Score=77.22 Aligned_cols=189 Identities=13% Similarity=0.010 Sum_probs=123.3
Q ss_pred eEEEEEEeCCCcee-eeeecccccchhHHH-----HHHHHHHHhccCCcceEeeeeeeee--eCCeEEEEEeecCCCChh
Q 036051 109 GRVYRGTLPKSKIE-IAVKKISHESRQGMK-----EFVAEIVSIGRLRHRNLVQLLGYCR--RKGELLLVYDYMPNGSLD 180 (420)
Q Consensus 109 g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~ 180 (420)
+.-+++++-+.... +.+|+....+-+... -...|.+.++...|+++.....-.. .+.+.+..++|+..|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 44455555322211 355555443322222 2334444555668988877655433 234678899999999999
Q ss_pred hhhccCCC--ccCcHHHHHHHHHHhHhHhHHhhhcc--cCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 181 KYLYNQPK--VTLNWRQRYGVIKGVALGLLYLHEEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 181 ~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
+.|-.... ..++..-....-.+......-+|+.. ..-.+|+++|+-|.++..+.++|+.++|+.+...+. .....
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~G 1398 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFG 1398 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-Hhhhh
Confidence 98865422 22333333332333355555555432 234789999999999999999999999999843322 22233
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccC
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~ 298 (420)
...+++.|+.|++...-.++.++|+|..|+-+|++.-|..+|
T Consensus 1399 l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1399 LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 456788899999998888898999999999999998888776
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.025 Score=53.74 Aligned_cols=32 Identities=25% Similarity=0.389 Sum_probs=28.4
Q ss_pred cCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
..+++|+|+.+.||++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 35799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.051 Score=53.22 Aligned_cols=80 Identities=16% Similarity=0.125 Sum_probs=50.4
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccch-------hHHHHHHHHHHHhccCC---cceEeeeeeeeeeCCeEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-------QGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 169 (420)
.+.||.|....||+.... +..++||.-..... .....-..|...|..+. ..++++++.++.+ .-++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 567899999999998873 33588997652111 01122233455555442 3578888888874 4578
Q ss_pred EEeecCC--CChhhhh
Q 036051 170 VYDYMPN--GSLDKYL 183 (420)
Q Consensus 170 v~e~~~~--g~L~~~l 183 (420)
+||++++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999976 3444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.014 Score=55.99 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=77.5
Q ss_pred cceecccCceEEEEEEeCCC---ceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeecC
Q 036051 100 KELLGSGGFGRVYRGTLPKS---KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 175 (420)
.+.|..|=...+|+....+. +..|++|+........ -+-.+|..++..+..-++ +++++++. ++ +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence 34566677888998876432 2368899876543221 122467777777754333 34555553 22 4899987
Q ss_pred CCChhhh-----------------hccCCC----ccCcHHHHHHHHHHh----------------------HhHhHHhhh
Q 036051 176 NGSLDKY-----------------LYNQPK----VTLNWRQRYGVIKGV----------------------ALGLLYLHE 212 (420)
Q Consensus 176 ~g~L~~~-----------------l~~~~~----~~l~~~~~~~i~~~i----------------------a~~L~~LH~ 212 (420)
+..|... ++..+. ..--|..+.++..++ ..-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 7655321 111110 011122222222221 111111111
Q ss_pred -----cccCcEEecccCCCCEEEcC-CCcEEEeeecCcc
Q 036051 213 -----EWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLAR 245 (420)
Q Consensus 213 -----~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~ 245 (420)
....-++|+|+.+.||++++ ++.++++||..+.
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11234799999999999975 5789999998874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.01 Score=56.47 Aligned_cols=102 Identities=18% Similarity=0.135 Sum_probs=70.9
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
.+.|++|++. |++|.-. + ...+.+...++.+.+..++-+.. +.+.-|||+.-.|||++ +|++.|+||-++
T Consensus 299 ~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence 4567777776 6665432 1 35688999999999998888887 46889999999999999 999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhh
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFS 283 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s 283 (420)
+.-... . ...-.+.--|-.+.| .-+.+-|||-
T Consensus 369 Rl~~~q-~-----~isy~rldhp~lF~G-~dd~QFeIYr 400 (488)
T COG5072 369 RLSYSQ-G-----IISYNRLDHPDLFNG-VDDYQFEIYR 400 (488)
T ss_pred ecccCC-c-----eeeccccCchhhhcC-ccceeeeHHH
Confidence 842211 1 111122334444443 3366677776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.021 Score=50.61 Aligned_cols=150 Identities=16% Similarity=0.093 Sum_probs=89.0
Q ss_pred CceEEEEEEeCCCceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhcc
Q 036051 107 GFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYN 185 (420)
Q Consensus 107 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 185 (420)
+..+.-.+.-+- | +..+|++..-.-. ...-|.++.+++++++ .|+++..- +.-..-++.|+|..-..
T Consensus 74 gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 74 GNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344444444432 2 3567766543222 3355778888888875 45665522 33356788888833111
Q ss_pred CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCccc
Q 036051 186 QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265 (420)
Q Consensus 186 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 265 (420)
. ...++..=..+|.-.|+. ..+.+|+|-.|+||+-|++|.+||.|-+.... . +.-|.
T Consensus 142 -----~----~~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~~v 198 (308)
T PF07387_consen 142 -----N----FSNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVNMV 198 (308)
T ss_pred -----c----hhHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h-----------eeeEE
Confidence 1 111222224667788853 37899999999999999999999999875421 0 11122
Q ss_pred ccccccCCCCCccchhhhhHHHHHHHhcC
Q 036051 266 APEHTRTGKATTSADVFSFGAFLLEVACG 294 (420)
Q Consensus 266 aPE~~~~~~~~~~sDv~slGvvl~el~tg 294 (420)
--| ....++++.+-+|=.-++++...
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHH
Confidence 211 12456777777777777777653
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.037 Score=53.24 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=44.1
Q ss_pred eecccCceEEEEEEeCCCceeeeeecccccc-------hhHHHHHHHHHHHhccCC--cc-eEeeeeeeeeeCCeEEEEE
Q 036051 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLR--HR-NLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 171 (420)
.||.|....||++...+++..|+||.-.... +-......-|...|.... .| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 4799999999999986544569999543211 111223345556665442 34 44445443 344557999
Q ss_pred eecCC
Q 036051 172 DYMPN 176 (420)
Q Consensus 172 e~~~~ 176 (420)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.008 Score=53.70 Aligned_cols=30 Identities=30% Similarity=0.449 Sum_probs=21.3
Q ss_pred CcEEecccCCCCEEE-cCCCcEEEeeecCcc
Q 036051 216 QVVIHRDVKASNVLL-DGELNGRLGDFGLAR 245 (420)
Q Consensus 216 ~~iiH~dlk~~NIll-~~~~~~kl~Dfg~~~ 245 (420)
..++|+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 468899999999999 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.27 Score=46.60 Aligned_cols=29 Identities=24% Similarity=0.268 Sum_probs=25.6
Q ss_pred CcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 216 QVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 216 ~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 67899999999999997 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.1 Score=49.90 Aligned_cols=141 Identities=16% Similarity=0.111 Sum_probs=92.3
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeeccccc-----chh--------------------H-HHHHHHHHHHhccCCcc
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQ--------------------G-MKEFVAEIVSIGRLRHR 152 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~--------------------~-~~~~~~e~~~l~~l~h~ 152 (420)
+...|..|.-+.||.|+-.+ |..+|||+++.. ++. - .-....|+..|.+|+..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34578899999999999854 556999987532 110 0 01234677778877654
Q ss_pred eEeeeeeeeeeCCeEEEEEeecCCCCh-hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 153 NLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
.|+..--... ....|||+|+..... .-.|+.. .++...+..+-.+++.-+.-|.+. ..+||.||.--|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence 4332211111 234789999943221 1223222 466667777778888888888773 6799999999999987
Q ss_pred CCCcEEEeeecCccccc
Q 036051 232 GELNGRLGDFGLARLYD 248 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~~ 248 (420)
+ |.+.|+|.+-+....
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 4 589999988776443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.19 Score=55.65 Aligned_cols=31 Identities=39% Similarity=0.445 Sum_probs=26.4
Q ss_pred cCcEEecccCCCCEEEcCCC--cEE-EeeecCcc
Q 036051 215 EQVVIHRDVKASNVLLDGEL--NGR-LGDFGLAR 245 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~--~~k-l~Dfg~~~ 245 (420)
..++||+|+.+.||+++.+. ++. |+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 46799999999999999875 565 99999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.039 Score=53.39 Aligned_cols=62 Identities=23% Similarity=0.148 Sum_probs=45.7
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
...++-+|++|-++..++.... .++....+++.-.+.|+-.+-- -.+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 4567778888889999887653 4445666677767777665554 267999999999999953
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.32 Score=46.54 Aligned_cols=139 Identities=21% Similarity=0.233 Sum_probs=77.9
Q ss_pred eecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC---cce---Eeeeeee--eeeCC--eEEEEE
Q 036051 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRN---LVQLLGY--CRRKG--ELLLVY 171 (420)
Q Consensus 102 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~~--~~~~~--~~~lv~ 171 (420)
.|.+ .-..+|+....++. +++|+.... ....+...|+..+..+. .+= +...=|- ..-.+ ..+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGR--YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCC--eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 55678988885443 489988765 22244455666665552 111 2222221 11223 788999
Q ss_pred eecCCCChhh-hh--------------c----cCC------CccCcHHH-------------HHHHHHHhHhHhHHhhhc
Q 036051 172 DYMPNGSLDK-YL--------------Y----NQP------KVTLNWRQ-------------RYGVIKGVALGLLYLHEE 213 (420)
Q Consensus 172 e~~~~g~L~~-~l--------------~----~~~------~~~l~~~~-------------~~~i~~~ia~~L~~LH~~ 213 (420)
+|++|..+.. .- + ..+ .....|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999888773 11 0 000 01223320 011223333444444332
Q ss_pred ----ccCc---EEecccCCCCEEEcCCCc-EEEeeecCcc
Q 036051 214 ----WEQV---VIHRDVKASNVLLDGELN-GRLGDFGLAR 245 (420)
Q Consensus 214 ----~~~~---iiH~dlk~~NIll~~~~~-~kl~Dfg~~~ 245 (420)
.... +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999998875 8999998774
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.059 Score=52.52 Aligned_cols=75 Identities=12% Similarity=0.112 Sum_probs=45.5
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCC--cc-eEeeeeeeeeeCCeEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLR--HR-NLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 170 (420)
.+.||.|.-.-||++.+..++..|+||.-.... +-..+...-|.+.|+... .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 457899999999999984334468998543211 111233445666666542 34 45555544 34455788
Q ss_pred EeecCC
Q 036051 171 YDYMPN 176 (420)
Q Consensus 171 ~e~~~~ 176 (420)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.23 Score=44.52 Aligned_cols=77 Identities=23% Similarity=0.351 Sum_probs=55.8
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC---CcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
..+.+..|..-..|...+ +..++.||+-. ......|..|+.-|..| +.-++++++.+-...++.++|+||.+
T Consensus 20 er~~v~gG~inea~~v~d--g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 20 EREEVSGGDINEAWRLRD--GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred cccccCCccccceeEeec--CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 345566677677777665 44568888653 33346678888777666 44668888888888999999999998
Q ss_pred CCChh
Q 036051 176 NGSLD 180 (420)
Q Consensus 176 ~g~L~ 180 (420)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 87665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.14 Score=50.15 Aligned_cols=76 Identities=14% Similarity=0.204 Sum_probs=44.4
Q ss_pred cceecccCceEEEEEEeCCCc-e-----eeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEe
Q 036051 100 KELLGSGGFGRVYRGTLPKSK-I-----EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 172 (420)
.+.|..|-...+|++...+.. . .|.++....... ..-+-.+|+.++..+...++ +++++.+.. ++++|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~-l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNS-LVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCc-eEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 345666888899998764331 1 244444322211 11122467888888854444 445555532 68999
Q ss_pred ecCCCChh
Q 036051 173 YMPNGSLD 180 (420)
Q Consensus 173 ~~~~g~L~ 180 (420)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887664
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.35 Score=45.44 Aligned_cols=71 Identities=20% Similarity=0.240 Sum_probs=43.5
Q ss_pred cccCceEEEEEEeCC--------Cceeeeeecccccch-----hHHHHHHHHHHHhccCC-------------cceEeee
Q 036051 104 GSGGFGRVYRGTLPK--------SKIEIAVKKISHESR-----QGMKEFVAEIVSIGRLR-------------HRNLVQL 157 (420)
Q Consensus 104 g~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~-------------h~niv~~ 157 (420)
|.|-.|.+|+.+... ....++||....... .....|.+|+.....+- ....+++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677888998876632 124588998762211 12345777877665441 1245566
Q ss_pred eeeeeeCCeEEEEEeec
Q 036051 158 LGYCRRKGELLLVYDYM 174 (420)
Q Consensus 158 ~~~~~~~~~~~lv~e~~ 174 (420)
+....+.+..+||+|-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66655555678999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 420 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-23 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-130
Identities = 123/303 (40%), Positives = 181/303 (59%), Gaps = 7/303 (2%)
Query: 74 EDWELDYG-PHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES 132
ED E+ G RF ++L +A+ F K +LG GGFG+VY+G L +AVK++ E
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-LVAVKRLKEER 66
Query: 133 RQGMK-EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP--KV 189
QG + +F E+ I HRNL++L G+C E LLVY YM NGS+ L +P +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 190 TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249
L+W +R + G A GL YLH+ + +IHRDVKA+N+LLD E +GDFGLA+L D+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP--EENL 307
TT V GT+G++APE+ TGK++ DVF +G LLE+ G+R + ++++
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
+L+DWV +L D +L Y EE+E ++++ LLC+ S P RP M +VV++L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 368 ERD 370
E D
Sbjct: 307 EGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-122
Identities = 114/297 (38%), Positives = 167/297 (56%), Gaps = 13/297 (4%)
Query: 83 HRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAE 142
+R DL AT F K L+G G FG+VY+G L ++A+K+ + ES QG++EF E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETE 85
Query: 143 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--NQPKVTLNWRQRYGVI 200
I ++ RH +LV L+G+C + E++L+Y YM NG+L ++LY + P ++++W QR +
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--- 257
G A GL YLH +IHRDVK+ N+LLD ++ DFG+++ GT+ TH
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLST 199
Query: 258 -VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316
V GTLGY+ PE+ G+ T +DV+SFG L EV C R I + P E + L +W +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373
N G+L + DPNL + E L + C RPSM V+ LE + L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-118
Identities = 96/315 (30%), Positives = 154/315 (48%), Gaps = 22/315 (6%)
Query: 71 EELEDWELDYGPHRFRYKDLYIATKGFREKE------LLGSGGFGRVYRGTLPKSKIEIA 124
E D H F + +L T F E+ +G GGFG VY+G + + +A
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVA 58
Query: 125 VKKISH----ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 180
VKK++ + + ++F EI + + +H NLV+LLG+ +L LVY YMPNGSL
Sbjct: 59 VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 181 KYLYNQPKV-TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239
L L+W R + +G A G+ +LHE IHRD+K++N+LLD ++
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKIS 175
Query: 240 DFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
DFGLAR + T+ +VGT Y+APE G+ T +D++SFG LLE+ G +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 299 ERQGPEENLILVDWVFDFW-NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357
+ + L+D + + + D + + + +E + + C H R
Sbjct: 235 DEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKR 291
Query: 358 PSMRQVVQILERDVA 372
P +++V Q+L+ A
Sbjct: 292 PDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 6e-84
Identities = 73/307 (23%), Positives = 129/307 (42%), Gaps = 29/307 (9%)
Query: 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIV 144
++LY + + E+ G FG V++ L +AVK + +Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSW-QNEYEVY 70
Query: 145 SIGRLRHRNLVQLLGYCRR----KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI 200
S+ ++H N++Q +G +R +L L+ + GSL +L ++W + +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIA 127
Query: 201 KGVALGLLYLHEE-------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
+ +A GL YLHE+ + + HRD+K+ NVLL L + DFGLA ++ G
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 254 -QTTHVVGTLGYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307
T VGT Y+APE A D+++ G L E+A + E L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 308 ILVDWVFDFWNRGELLEA-----RDPNLGTEYVAEE-LELILKLGLLCSHSDPTARPSMR 361
+ + + ++ E + P L + + ++ + C D AR S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 362 QVVQILE 368
V + +
Sbjct: 308 CVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-66
Identities = 73/319 (22%), Positives = 119/319 (37%), Gaps = 40/319 (12%)
Query: 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIV 144
+ + + EL+G G +G VY+G+L + +AVK S +RQ I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQNFINEK-NIY 59
Query: 145 SIGRLRHRNLVQLLGYCRR-----KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGV 199
+ + H N+ + + R + E LLV +Y PNGSL KYL T +W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRL 116
Query: 200 IKGVALGLLYLHEEWEQ------VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-- 251
V GL YLH E + + HRD+ + NVL+ + + DFGL+
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 252 -----DPQTTHVVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLEVACGRRPI- 298
D VGT+ Y+APE A D+++ G E+ +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 299 ------ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELEL--ILKLGLLCS 350
E Q + + F+ E + P + L + + + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 351 HSDPTARPSMRQVVQILER 369
D AR + + + +
Sbjct: 297 DQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-63
Identities = 82/303 (27%), Positives = 143/303 (47%), Gaps = 36/303 (11%)
Query: 70 AEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI- 128
A + +D ++ + DL I KE +G+G FG V+R ++AVK +
Sbjct: 26 AMDGDDMDIPW-------CDLNI-------KEKIGAGSFGTVHRAEW--HGSDVAVKILM 69
Query: 129 -SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ- 186
+ + EF+ E+ + RLRH N+V +G + L +V +Y+ GSL + L+
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 187 PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246
+ L+ R+R + VA G+ YLH ++HR++K+ N+L+D + ++ DFGL+RL
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
Query: 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306
T + GT ++APE R + +DV+SFG L E+A ++P N
Sbjct: 189 KAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG------N 241
Query: 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
L V + + LE + ++ I++ C ++P RPS ++ +
Sbjct: 242 LNPAQVVAAVGFKCKRLEIP------RNLNPQVAAIIEG---CWTNEPWKRPSFATIMDL 292
Query: 367 LER 369
L
Sbjct: 293 LRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-61
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 39/301 (12%)
Query: 82 PHR-FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFV 140
PHR FR DL E+LG G FG+ + T ++ + +K++ + + F+
Sbjct: 3 PHRIFRPSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 141 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI 200
E+ + L H N+++ +G + L + +Y+ G+L + + W QR
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFA 114
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD------------ 248
K +A G+ YLH +IHRD+ + N L+ N + DFGLARL
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 249 -HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307
+ VVG ++APE DVFSFG L E+ P
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQIL 367
++ + P+ + ++ C DP RPS ++ L
Sbjct: 232 FGLN--VRGFLDRYCPPNCPPSF--------FPITVR----CCDLDPEKRPSFVKLEHWL 277
Query: 368 E 368
E
Sbjct: 278 E 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-60
Identities = 67/310 (21%), Positives = 124/310 (40%), Gaps = 49/310 (15%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR 133
L ++ ++ +G GGFG V++G L K K +A+K +
Sbjct: 12 RLPTLAD-------NEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 134 QG-------MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ 186
+G +EF E+ + L H N+V+L G +V +++P G L L ++
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK 115
Query: 187 PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-----GELNGRLGDF 241
+ W + ++ +ALG+ Y+ ++HRD+++ N+ L + ++ DF
Sbjct: 116 AH-PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPIE 299
GL++ H + ++G ++APE T AD +SF L + G P +
Sbjct: 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 300 RQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS 359
E + + ++ G R P + + +I C DP RP
Sbjct: 230 ----EYSYGKIKFINMIREEGL----R-PTIPEDCPPRLRNVIEL----CWSGDPKKRPH 276
Query: 360 MRQVVQILER 369
+V+ L
Sbjct: 277 FSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 70/323 (21%), Positives = 135/323 (41%), Gaps = 56/323 (17%)
Query: 64 RRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEI 123
R+ + + L++W++ + + L I EL+G G FG+VY G E+
Sbjct: 16 RKASQTSIFLQEWDIPF-------EQLEI-------GELIGKGRFGQVYHGRW---HGEV 58
Query: 124 AVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
A++ I ++ +K F E+++ + RH N+V +G C L ++ +L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL--G 239
+ + K+ L+ + + + + G+ YLH + ++H+D+K+ NV D NG++
Sbjct: 119 VVRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVIT 171
Query: 240 DFGLARL----YDHGTDPQTTHVVGTLGYLAPEHTRTGKA---------TTSADVFSFGA 286
DFGL + + + G L +LAPE R + +DVF+ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 287 FLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLG 346
E+ P + Q E + + G +G E +++L
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQM-------GTGMKPNLSQIGMGKEIS----DILLF-- 278
Query: 347 LLCSHSDPTARPSMRQVVQILER 369
C + RP+ +++ +LE+
Sbjct: 279 --CWAFEQEERPTFTKLMDMLEK 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+E++G G FG V + ++A+K+I ES K F+ E+ + R+ H N+V+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVK 65
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L G C + LV +Y GSL L+ P + G+ YLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 216 QVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ +IHRD+K N+LL ++ DFG A T+ G+ ++APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSN 179
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
+ DVFS+G L EV R+P + + W R L++ +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 234
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L+ + C DP+ RPSM ++V+I+
Sbjct: 235 -----SLMTR----CWSKDPSQRPSMEEIVKIMTH 260
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-58
Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 49/305 (16%)
Query: 76 WELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI----SHE 131
E+D+ +L + +E++G GGFG+VYR E+AVK +
Sbjct: 2 LEIDF-------AELTL-------EEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDED 45
Query: 132 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
Q ++ E L+H N++ L G C ++ L LV ++ G L++ L + +
Sbjct: 46 ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---I 102
Query: 192 NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR--------LGDFGL 243
+A G+ YLH+E +IHRD+K+SN+L+ ++ + DFGL
Sbjct: 103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162
Query: 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
AR + T G ++APE R + +DV+S+G L E+ G P
Sbjct: 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---- 215
Query: 304 EENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
+ + + L P E +++ C + DP +RPS +
Sbjct: 216 --GIDGLAVAYGVAMNKLALPI--P----STCPEPFAKLMED---CWNPDPHSRPSFTNI 264
Query: 364 VQILE 368
+ L
Sbjct: 265 LDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-57
Identities = 62/303 (20%), Positives = 116/303 (38%), Gaps = 45/303 (14%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHE 131
+ +D+ K L TK L G +++G +I VK +
Sbjct: 3 KHSGIDF-------KQLNFLTK-------LNENHSGELWKGRW--QGNDIVVKVLKVRDW 46
Query: 132 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMPNGSLDKYLYNQPKV 189
S + ++F E + H N++ +LG C+ L+ +MP GSL L+
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 190 TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249
++ Q +A G+ +LH E ++ + + +V++D ++ R+ + +
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163
Query: 250 GTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306
Q+ + ++APE SAD++SF L E+ P E
Sbjct: 164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219
Query: 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
+ V LE P + ++ + ++K+ C + DP RP +V I
Sbjct: 220 GMKV-----------ALEGLRPTI-PPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPI 264
Query: 367 LER 369
LE+
Sbjct: 265 LEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-57
Identities = 66/312 (21%), Positives = 130/312 (41%), Gaps = 39/312 (12%)
Query: 64 RRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEI 123
+ +DWE+ + + + +GSG FG VY+G ++
Sbjct: 7 HHHHGSRDAADDWEIPD-------GQITV-------GQRIGSGSFGTVYKGKW---HGDV 49
Query: 124 AVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
AVK + + + Q ++ F E+ + + RH N++ +GY +L +V + SL
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYH 108
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
+L+ + ++ + + A G+ YLH + +IHRD+K++N+ L + ++GDF
Sbjct: 109 HLHA-SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 242 GLARLYDHGTDPQT-THVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 297
GLA + + G++ ++APE + + +DV++FG L E+ G+ P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 298 IERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357
+ +I + + L N L+ + C R
Sbjct: 225 YSNINNRDQII---EMVGRGSLSPDLSKVRSNCPKRMK----RLMAE----CLKKKRDER 273
Query: 358 PSMRQVVQILER 369
PS +++ +E
Sbjct: 274 PSFPRILAEIEE 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 29/292 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+ +G G +G V+ G ++AVK EI +RH N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAA 99
Query: 161 CRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE--- 213
+ +L L+ DY NGSL YL + TL+ + + GL +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 214 --WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ---TTHVVGTLGYLAPE 268
+ + HRD+K+ N+L+ + D GLA + T+ VGT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 269 ------HTRTGKATTSADVFSFGAFLLEVACGRRPI----ERQGPEENLILVDWVFDFWN 318
+ ++ AD++SFG L EVA E Q P +L+ D ++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 319 RGELLEARDPNLGTEYVAEE-LELILKLGLLCSHSDPTARPSMRQVVQILER 369
++ P+ + ++E L + KL C +P +R + +V + L +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-55
Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 31/293 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
E +G G +G V+RG+ +AVK S + + +E E+ + LRH N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 160 YCRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L L+ Y GSL YL TL+ ++ +A GL +LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 216 Q-----VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ---TTHVVGTLGYLAP 267
+ HRD+K+ N+L+ + D GLA ++ T+ VGT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 268 E------HTRTGKATTSADVFSFGAFLLEVACGRRPI----ERQGPEENLILVDWVFDFW 317
E + D+++FG L EVA + + P +++ D F+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 318 NRGELLEARDPNLGTEYVAEE-LELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ ++ + PN+ + ++ L + KL C + +P+AR + ++ + L +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-54
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 31/293 (10%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
E +G G FG V+RG E+AVK S E R +E AEI LRH N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103
Query: 160 YCRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ +L LV DY +GSL YL T+ + A GL +LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 216 Q-----VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT---THVVGTLGYLAP 267
+ HRD+K+ N+L+ + D GLA +D TD H VGT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 268 E------HTRTGKATTSADVFSFGAFLLEVACGRRPI----ERQGPEENLILVDWVFDFW 317
E + + ++ AD+++ G E+A + Q P +L+ D +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 318 NRGELLEARDPNL-GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + PN+ E L ++ K+ C +++ AR + ++ + L +
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 31/277 (11%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
E +G G FG V+ G L +AVK +F+ E + + H N+V+L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
G C +K + +V + + G +L + L + ++ A G+ YL +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY----LAPEHTRTGK 274
IHRD+ A N L+ + ++ DFG++R D G APE G+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 275 ATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
++ +DV+SFG L E G P ++ +F +G L P E
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLPC--P----E 338
Query: 334 YVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + L+ + C +P RPS + Q L+
Sbjct: 339 LCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQS 371
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 72/272 (26%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 158
LG G +G VY G K + +AVK K + EF+ E + ++H NLVQLL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
G C R+ ++ ++M G+L YL + ++ + ++ + YL ++
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
IHR++ A N L+ ++ DFGL+RL T + + APE K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 279 ADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337
+DV++FG L E+A G P + V++ + +E P E V E
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER--PEGCPEKVYE 450
Query: 338 ELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L C +P+ RPS ++ Q E
Sbjct: 451 -------LMRACWQWNPSDRPSFAEIHQAFET 475
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
K LG G +G VY G K + +AVK + E ++EF+ E + ++H NLVQLLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C R+ ++ ++M G+L YL + ++ + ++ + YL ++ I
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 220 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGKATT 277
HRD+ A N L+ ++ DFGL+RL D T H APE K +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 278 SADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336
+DV++FG L E+A G P + V++ + +E P E V
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER--PEGCPEKVY 242
Query: 337 EELELILKLGLLCSHSDPTARPSMRQVVQILER 369
E L C +P+ RPS ++ Q E
Sbjct: 243 E-------LMRACWQWNPSDRPSFAEIHQAFET 268
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 154
+ +G G F VY+G ++ +E+A ++ ++ + F E + L+H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 155 VQLLGY----CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
V+ + K ++LV + M +G+L YL + + + + + + GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW--CRQILKGLQFL 145
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
H +IHRD+K N+ + G G +GD GLA L V+GT ++APE
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE 200
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRP 297
K S DV++FG +LE+A P
Sbjct: 201 -MYEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 71/290 (24%), Positives = 117/290 (40%), Gaps = 37/290 (12%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 155
LG G FG V + +AVK++ H ++F EI + L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 156 QLLGYCRRKGE--LLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+ G G L LV +Y+P+G L +L ++ ++ + + + G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLG- 144
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----AP 267
+ +HRD+ A N+L++ E + ++ DFGLA+L D +VV G AP
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWYAP 199
Query: 268 EHTRTGKATTSADVFSFGAFLLEVA-CGRRP-------IERQGPEENLILVDWVFDFWNR 319
E + +DV+SFG L E+ + + G E ++ + + +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G+ L A P V E L LC P RPS + L+
Sbjct: 260 GQRLPA--PPACPAEVHE-------LMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 44/289 (15%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRN 153
FR ++ +G G F VYR + +A+KK+ K + EI + +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPK--------VTLNW-RQRYGVIKGVA 204
+++ EL +V + G L + + + K + Q +
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-------LC 146
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
L ++H + V+HRD+K +NV + +LGD GL R + T + +VGT Y
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 202
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL-- 322
++PE +D++S G L E+A + P + D N L
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--------------FYGDKMNLYSLCK 248
Query: 323 --LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ P L +++ +EEL ++ +C + DP RP + V + +R
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKR 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 23/270 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
LG G FG V+ GT +A+K + + F+ E + +LRH LVQL
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
+ + +V +YM GSL +L + L Q + +A G+ Y+ +H
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
RD++A+N+L+ L ++ DFGLARL + + + APE G+ T +D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 281 VFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339
V+SFG L E+ GR P E V D RG + P E + +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPC--PPECPESLHD-- 412
Query: 340 ELILKLGLLCSHSDPTARPSMRQVVQILER 369
L C +P RP+ + LE
Sbjct: 413 -----LMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-38
Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 23/270 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
LG G FG V+ GT +A+K + + F+ E + +LRH LVQL
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
+ + +V +YM GSL +L + L Q + +A G+ Y+ +H
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 280
RD++A+N+L+ L ++ DFGLARL + + + APE G+ T +D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 281 VFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 339
V+SFG L E+ GR P E V D RG + P E + +
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPC--PPECPESLHD-- 495
Query: 340 ELILKLGLLCSHSDPTARPSMRQVVQILER 369
L C +P RP+ + LE
Sbjct: 496 -----LMCQCWRKEPEERPTFEYLQAFLED 520
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 31/279 (11%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
E++G G FG VY GTL KI AVK + + +F+ E + + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 157 LLGYC-RRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
LLG C R +G L+V YM +G L ++ T+ + G VA G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLAS-- 146
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHTR 271
+ +HRD+ A N +LD + ++ DFGLAR +YD L ++A E +
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 272 TGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
T K TT +DV+SFG L E+ G P + + + +G L P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ--P-- 254
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
EY + L ++ L C H RPS ++V +
Sbjct: 255 --EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 74/339 (21%), Positives = 136/339 (40%), Gaps = 38/339 (11%)
Query: 78 LDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQG 135
+D G ++ + + + + +G G FG+ + + +K+I+ S +
Sbjct: 11 VDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 136 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQ 195
+E E+ + ++H N+VQ G L +V DY G L K + Q V Q
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 196 RYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255
+ L L ++H+ + ++HRD+K+ N+ L + +LGDFG+AR+ + +
Sbjct: 127 ILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD 315
+GT YL+PE +D+++ G L E+ + F+
Sbjct: 184 A-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----------------FE 226
Query: 316 FWNRGELL----EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371
+ L+ P + Y + +L ++ +P RPS V ILE+
Sbjct: 227 AGSMKNLVLKIISGSFPPVSLHY-SYDLRSLVS---QLFKRNPRDRPS---VNSILEKGF 279
Query: 372 ALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSS 410
I LS + I + F+ S + RP+S
Sbjct: 280 IAKRIEKF-LSPQLIAEEFCLKTFSKFGSQPIPAKRPAS 317
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 76/303 (25%), Positives = 118/303 (38%), Gaps = 42/303 (13%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTL--PKSKIEIAVK--KIS 129
++ LD K L + K LGSG FG V +G K +AVK K
Sbjct: 9 KEVYLDR-------KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE 55
Query: 130 HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKV 189
E +AE + +L + +V+++G C + +LV + G L+KYL V
Sbjct: 56 ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHV 114
Query: 190 TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249
++ V++G+ YL E +HRD+ A NVLL + ++ DFGL++
Sbjct: 115 KDK--NIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169
Query: 250 GTDPQTTHVVGTL--GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEEN 306
+ G + APE K ++ +DV+SFG + E G++P E
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE- 228
Query: 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
V +GE + P + + L LC D RP V
Sbjct: 229 ------VTAMLEKGERMGC--PAGCPREMYD-------LMNLCWTYDVENRPGFAAVELR 273
Query: 367 LER 369
L
Sbjct: 274 LRN 276
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 34/279 (12%)
Query: 101 ELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 155
++LGSG FG VY+G K KI +A+K++ S + KE + E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+LLG C + L+ MP G L Y+ ++ + + +A G+ YL +
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLED-- 135
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTR 271
+ ++HRD+ A NVL+ + ++ DFGLA+L + + H G + ++A E
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 272 TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
T +DV+S+G + E+ G +P + E + +GE L P +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ--PPI 243
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
T V ++ K C D +RP R+++ +
Sbjct: 244 CTIDV---YMIMRK----CWMIDADSRPKFRELIIEFSK 275
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 84/280 (30%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
E++G G FG VY GTL KI AVK + + +F+ E + + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 157 LLGYC-RRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
LLG C R +G L+V YM +G L ++ T+ + G VA G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLAS-- 210
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHTR 271
+ +HRD+ A N +LD + ++ DFGLAR +YD D L ++A E +
Sbjct: 211 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 272 TGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
T K TT +DV+SFG L E+ G P + + + +G L P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ--P-- 318
Query: 331 GTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
EY + L E++LK C H RPS ++V +
Sbjct: 319 --EYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISA 352
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
++ +LG G +G VY G +++ IA+K+I + + EI L+H+N+VQ
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG-----------VALG 206
LG G + + + +P GSL L R ++G +K + G
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALL----------RSKWGPLKDNEQTIGFYTKQILEG 134
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLA-RLYDHGTDPQTTHVVGTLG 263
L YLH + ++HRD+K NVL++ +G + DFG + RL +T GTL
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET--FTGTLQ 188
Query: 264 YLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 297
Y+APE G +AD++S G ++E+A G+ P
Sbjct: 189 YMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPP 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 30/287 (10%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 155
+ LG G FG V + +AVKK+ H + + +++F EI + L+H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 156 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ G C G L L+ +Y+P GSL YL K ++ + + G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTR 271
+ IHRD+ N+L++ E ++GDFGL ++ + G + APE
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 272 TGKATTSADVFSFGAFLLEVA--CGRRPIERQGPEENLILVDW-------VFDFWNRGEL 322
K + ++DV+SFG L E+ + + + +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L P+ + + + C +++ RPS R + +++
Sbjct: 251 LPR--PDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 59/286 (20%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F+E EL+GSGGFG+V++ +K++ + + + +E + ++ +L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE--VKALA--KLDHVNIVH 68
Query: 157 LLGY----------------CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI 200
G + L + ++ G+L++++ + L+ +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 260
+ + G+ Y+H + +I+RD+K SN+ L ++GDFGL + D + T G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRTRSKG 183
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320
TL Y++PE + D+++ G L E+ +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AFETS 225
Query: 321 ELLE-ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ RD + + +E L+ KL L P RP+ ++++
Sbjct: 226 KFFTDLRDGIISDIFDKKEKTLLQKL-L---SKKPEDRPNTSEILR 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 29/274 (10%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+ +GSG FG V+ G +K ++A+K I E ++F+ E + +L H LVQL G
Sbjct: 13 VQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C + + LV ++M +G L YL + G+ V G+ YL E VI
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVI 126
Query: 220 HRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGY--LAPEHTRTGKAT 276
HRD+ A N L+ ++ DFG+ R + D D T+ +PE + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 277 TSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+ +DV+SFG + EV G+ P E + E V + + G L P L + +V
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRLYK--PRLASTHV 234
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + C P RP+ ++++ L
Sbjct: 235 YQ-------IMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 27/277 (9%)
Query: 100 KELLGSGGFGRVYRGTL---PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 155
++++GSG G V G L + + +A+K + + + + ++F++E +G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L G R ++V +YM NGSLD +L Q G+++GV G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL--APEHTRTG 273
+HRD+ A NVL+D L ++ DFGL+R+ + D T G + APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 274 KATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
++++DV+SFG + EV G RP + V G L A P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRLPA--PMGCP 280
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + L L C H D RP Q+V +L+
Sbjct: 281 HALHQ-------LMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+ LGSG FG V G K + ++AVK I E EF E ++ +L H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
C ++ + +V +Y+ NG L YL + K L Q + V G+ +L I
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 220 HRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGY--LAPEHTRTGKAT 276
HRD+ A N L+D +L ++ DFG+ R + D D + V APE K +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 277 TSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+ +DV++FG + EV G+ P + E V ++G L P+L ++ +
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHRLYR--PHLASDTI 234
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ + C H P RP+ +Q++ +E
Sbjct: 235 YQ-------IMYSCWHELPEKRPTFQQLLSSIE 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K LG G FG+V+ + K+ +AVK + S ++F E + L+H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-------------YNQPKVTLNWRQRYGVIK 201
V+ G C LL+V++YM +G L+++L + L Q V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
VA G++YL +HRD+ N L+ L ++GDFG++R + TD + VG
Sbjct: 166 QVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTD---YYRVGG 218
Query: 262 LGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFD 315
L PE K TT +DV+SFG L E+ G++P + E D
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AID 271
Query: 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPA 375
+G LE P E+ I+ C +P R S++ V L+ P
Sbjct: 272 CITQGRELER--P----RACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQALAQAPP 322
Query: 376 I 376
+
Sbjct: 323 V 323
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+ LG+G FG V G + + ++A+K I E EF+ E + L H LVQL G
Sbjct: 29 LKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 160 YCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
C ++ + ++ +YM NG L YL + + +Q + K V + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLE---SKQF 141
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL---GYLAPEHTRTGKA 275
+HRD+ A N L++ + ++ DFGL+R D + T VG+ + PE K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 276 TTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
++ +D+++FG + E+ G+ P ER E + +G L P+L +E
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLYR--PHLASEK 249
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
V + C H RP+ + ++ +
Sbjct: 250 VYT-------IMYSCWHEKADERPTFKILLSNILD 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 36/290 (12%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 155
+ LG G FG V + +AVKK+ H + + +++F EI + L+H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 156 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ G C G L L+ +Y+P GSL YL + K ++ + + G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----APE 268
+ IHRD+ N+L++ E ++GDFGL ++ + + V G APE
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---YYKVKEPGESPIFWYAPE 218
Query: 269 HTRTGKATTSADVFSFGAFLLEVA--CGRRPIERQGPEENLILVDW-------VFDFWNR 319
K + ++DV+SFG L E+ + + + +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L P+ + + + C +++ RPS R + +++
Sbjct: 279 NGRLPR--PDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 27/277 (9%)
Query: 99 EKELLGSGGFGRVYRGTL--PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 155
LG G FG V +G K +I++A+K + + +E + E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L+G C+ + L+LV + G L K+L + + ++ V++G+ YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEE--- 128
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 273
+ +HRD+ A NVLL ++ DFGL++ T G + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 274 KATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
K ++ +DV+S+G + E G++P ++ E V F +G+ +E P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC--PPECP 239
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ L C RP V Q +
Sbjct: 240 PELYA-------LMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 84/277 (30%), Positives = 123/277 (44%), Gaps = 39/277 (14%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM--KEFVAEIVSIGRLRHRNLVQL 157
+ +G G FG V G +K+ AVK I + + F+AE + +LRH NLVQL
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNKV--AVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 158 LGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
LG KG L +V +YM GSL YL ++ + L V + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 136
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGK 274
+HRD+ A NVL+ + ++ DFGL + + +T G L APE R K
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 275 ATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
+T +DV+SFG L E+ GR P R ++ V +G ++A P +
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDA--P----D 237
Query: 334 YVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ E++ C H D RPS Q+ + LE
Sbjct: 238 GCPPAVYEVMKN----CWHLDAAMRPSFLQLREQLEH 270
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 35/284 (12%)
Query: 98 REKELLGSGGFGRVYRGTL---PKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHR 152
++G G FG VY G +++I+ A+K E +Q ++ F+ E + + L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHP 82
Query: 153 NLVQLLGYC-RRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYL 210
N++ L+G +G ++ YM +G L +++ Q T+ + VA G+ YL
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL 140
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAP 267
E Q +HRD+ A N +LD ++ DFGLAR + D H L + A
Sbjct: 141 AE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 268 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326
E +T + TT +DV+SFG L E+ G P P + + F +G L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRRLPQ- 249
Query: 327 DPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
P EY + L +++ + C +DP RP+ R +V +E+
Sbjct: 250 -P----EYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQ 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-37
Identities = 68/294 (23%), Positives = 110/294 (37%), Gaps = 58/294 (19%)
Query: 100 KELLGSGGFGRVYRGTL-------PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 152
E LG G F ++++G + E+ +K + R + F + +L H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+LV G C E +LV +++ GSLD YL +N + V K +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLE- 130
Query: 213 EWEQVVIHRDVKASNVLLDGELNGR--------LGDFGLARLYDHGTDPQTTHVVGTLGY 264
E +IH +V A N+LL E + + L D G++ V+
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDIL 177
Query: 265 ------LAPEHTRTGKA-TTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDF 316
+ PE K + D +SFG L E+ G +P+ + F
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQF 230
Query: 317 WNRGELLEARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ L A EL LI C +P RPS R +++ L
Sbjct: 231 YEDRHQLPAPKA--------AELANLINN----CMDYEPDHRPSFRAIIRDLNS 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 83/323 (25%), Positives = 145/323 (44%), Gaps = 33/323 (10%)
Query: 100 KELLGSGGFGRVYRGTL---PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 155
+++G+G FG V G L K +I +A+K + + + ++F+ E +G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L G + +++V +YM NGSLD +L + Q G+++G+A G+ YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL--APEHTRTG 273
+HRD+ A N+L++ L ++ DFGL R+ + + T G + +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 274 KATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
K T+++DV+S+G L EV G RP ++ V + G L P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGYRLPP--PMDCP 276
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALGLSARGITYQEGF 392
+ + L L C D RP Q+V IL++ + P + SA
Sbjct: 277 AALYQ-------LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLL 329
Query: 393 DDFAVSYSSSMGFTRPSSLAESL 415
D S++ T + + L
Sbjct: 330 DQ------SNVDITTFRTTGDWL 346
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
E LG+G FG V+ G ++AVK K S F+AE + +L+H+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 73
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
++ + ++ +YM NGSL +L + L + + +A G+ ++ E +
Sbjct: 74 YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGKA 275
IHRD++A+N+L+ L+ ++ DFGLARL + + T APE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 276 TTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
T +DV+SFG L E+ GR P E V RG + P+ E
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRMVR--PDNCPEE 238
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + L LC P RP+ + +LE
Sbjct: 239 LYQ-------LMRLCWKERPEDRPTFDYLRSVLED 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 76/324 (23%), Positives = 136/324 (41%), Gaps = 67/324 (20%)
Query: 71 EELEDWELDYGPHRFRYKDLYIATKGFREK----ELLGSGGFGRVYRGTL---PKSKIEI 123
+LED +D R ++LG G FG V G L + +++
Sbjct: 24 NKLEDVVID------------------RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 124 AVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-----RRKGELLLVYDYMPN 176
AVK K+ + S++ ++EF++E + H N+++LLG C + + +++ +M
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 177 GSLDKYL----YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232
G L YL + + + +ALG+ YL + +HRD+ A N +L
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182
Query: 233 ELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGA 286
++ + DFGL++ +Y + G + + A E T+ +DV++FG
Sbjct: 183 DMTVCVADFGLSKKIYS-----GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 287 FLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKL 345
+ E+A G P E ++D+ G L+ P E +EL I+
Sbjct: 238 TMWEIATRGMTPYPGVQNHE-------MYDYLLHGHRLKQ--P----EDCLDELYEIM-- 282
Query: 346 GLLCSHSDPTARPSMRQVVQILER 369
C +DP RP+ + LE+
Sbjct: 283 -YSCWRTDPLDRPTFSVLRLQLEK 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNL 154
++++G+G FG VY+G L K ++ +A+K + + + +F+ E +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
++L G + ++++ +YM NG+LDK+L + + Q G+++G+A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRT 272
+HRD+ A N+L++ L ++ DFGL+R+ + + T G + APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 273 GKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
K T+++DV+SFG + EV G RP E V N G L P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPT--PMDC 275
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + L + C + RP +V IL++
Sbjct: 276 PSAIYQ-------LMMQCWQQERARRPKFADIVSILDK 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 38/290 (13%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNL 154
LG G FG+V + +AVK + + Q + EI + L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 155 VQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
++ G C G L LV +Y+P GSL YL P+ ++ Q + + G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----AP 267
Q IHRD+ A NVLLD + ++GDFGLA+ G + + V G AP
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWYAP 206
Query: 268 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDW-------VFDFWNR 319
E + K ++DV+SFG L E+ LI + + + R
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
GE L P+ V L C ++ + RP+ ++ IL+
Sbjct: 267 GERLPR--PDKCPAEVYH-------LMKNCWETEASFRPTFENLIPILKT 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 50/296 (16%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 154
K LG G FG+V+ K K+ +AVK + + K+F E + L+H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YNQPKVTLNWRQRYGVI 200
V+ G C L++V++YM +G L+K+L Q K L Q +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVV 259
+A G++YL Q +HRD+ N L+ L ++GDFG++R +Y + V
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRV 191
Query: 260 GTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWV 313
G L PE K TT +DV+SFG L E+ G++P + E V
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 244
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ +G +LE P +E+ ++ L C +P R +++++ +IL
Sbjct: 245 IECITQGRVLER--P----RVCPKEVYDVM---LGCWQREPQQRLNIKEIYKILHA 291
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 71/329 (21%), Positives = 125/329 (37%), Gaps = 68/329 (20%)
Query: 67 RKFAEELEDWELDYGPHRFRYKDLYIATKGFREK----ELLGSGGFGRVYRGTL---PKS 119
+ E+LED + ++ +LG G FG V L S
Sbjct: 9 DELKEKLEDVLIP------------------EQQFTLGRMLGKGEFGSVREAQLKQEDGS 50
Query: 120 KIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ELLLVY 171
+++AVK K + ++EF+ E + H ++ +L+G R +++
Sbjct: 51 FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL 110
Query: 172 DYMPNGSLDKYL----YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227
+M +G L +L + L + + +A G+ YL + IHRD+ A N
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARN 167
Query: 228 VLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADV 281
+L ++ + DFGL+R +Y + G L A E T +DV
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPVKWLALESLADNLYTVHSDV 222
Query: 282 FSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELE 340
++FG + E+ G+ P E ++++ G L+ P EE+
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLIGGNRLKQ--P----PECMEEVY 269
Query: 341 LILKLGLLCSHSDPTARPSMRQVVQILER 369
++ C +DP RPS + LE
Sbjct: 270 DLM---YQCWSADPKQRPSFTCLRMELEN 295
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 30/290 (10%)
Query: 97 FREKELLGSGGFGRVYRGTL----PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRH 151
+ LG G FG+V + ++AVK + + + EI + L H
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 152 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
N+V+ G C G + L+ +++P+GSL +YL K +N +Q+ + G+ Y
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDY 141
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAP 267
L + +HRD+ A NVL++ E ++GDFGL + + + T + AP
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 268 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLIL-------VDWVFDFWNR 319
E K ++DV+SFG L E+ +I V + +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G+ L P + V + L C P+ R S + +++ E
Sbjct: 259 GKRLPC--PPNCPDEVYQ-------LMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 45/291 (15%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 153
LG G FG VY G + S +++AVK + S Q +F+ E + I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRYGVIKGVALGLL 208
+V+ +G + ++ + M G L +L +L V + +A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRL---GDFGLAR-LYDHGTDPQTTHVVGTLGY 264
YL E IHRD+ A N LL GR+ GDFG+AR +Y + G
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAM 206
Query: 265 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWN 318
L PE G T+ D +SFG L E+ G P + +E V +F
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT 259
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G ++ P + + I+ C P RP+ +++ +E
Sbjct: 260 SGGRMDP--P----KNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 301
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 100 KELLGSGGFGRVYRGTL----PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNL 154
++LGSG FG V++G KI + +K I RQ + +++IG L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
V+LLG C L LV Y+P GSL ++ ++ + +A G+ YL E
Sbjct: 78 VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLEE- 133
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTR 271
++HR++ A NVLL ++ DFG+A L D Q + ++A E
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIH 190
Query: 272 TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
GK T +DV+S+G + E+ G P E V D +GE L P +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLAQ--PQI 241
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
T V +++K C D RP+ +++ R
Sbjct: 242 CTIDVY---MVMVK----CWMIDENIRPTFKELANEFTR 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 101 ELLGSGGFGRVYRGTL----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLV 155
++LGSG FG VY+G K KI +A+K++ + + KE + E + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+LLG C + L+ MP G L Y+ + K + + +A G+ YL +
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 273
+ ++HRD+ A NVL+ + ++ DFGLA+L + + G + ++A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMALESILHR 194
Query: 274 KATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
T +DV+S+G + E+ G +P + E + +GE L P + T
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ--PPICT 245
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
V +++K C D +RP R+++ +
Sbjct: 246 IDV---YMIMVK----CWMIDADSRPKFRELIIEFSK 275
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 83/274 (30%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+ +G G FG V G +K+ AVK I +++ + F+AE + +LRH NLVQLLG
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 160 YC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
KG L +V +YM GSL YL ++ + L V + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGKAT 276
+HRD+ A NVL+ + ++ DFGL + + +T G L APE R K +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 277 TSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
T +DV+SFG L E+ GR P R ++ V +G ++A P+ V
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDA--PDGCPPAV 415
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + C H D RP+ Q+ + LE
Sbjct: 416 YD-------VMKNCWHLDAATRPTFLQLREQLEH 442
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 45/291 (15%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 153
LG G FG VY G + S +++AVK + S Q +F+ E + I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRYGVIKGVALGLL 208
+V+ +G + ++ + M G L +L +L V + +A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRL---GDFGLAR-LYDHGTDPQTTHVVGTLGY 264
YL E IHRD+ A N LL GR+ GDFG+AR +Y G + G
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAM 247
Query: 265 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWN 318
L PE G T+ D +SFG L E+ G P + +E V +F
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT 300
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G ++ P + + I+ C P RP+ +++ +E
Sbjct: 301 SGGRMDP--P----KNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEY 342
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 45/292 (15%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 153
LG G FG VY G + + +A+K + S + EF+ E + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------YNQPKVTLNWRQRYGVIKGVAL 205
+V+LLG + L++ + M G L YL N + + + +A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGY 264
G+ YL+ +HRD+ A N ++ + ++GDFG+ R +Y+ + G G
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGL 201
Query: 265 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWN 318
L +PE + G TT +DV+SFG L E+A +P + E+ V F
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVM 254
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370
G LL+ P + + L ++ +C +P RPS +++ ++ +
Sbjct: 255 EGGLLDK--P----DNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKEE 297
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 72/280 (25%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 100 KELLGSGGFGRVYRGTL---PKSKIEIAVKKI---SHESRQGMKEFVAEIVSIGRLRHRN 153
E LG G FG V RG + +AVK + + M +F+ E+ ++ L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
L++L G + +V + P GSL L +Q L VA G+ YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES 139
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHT 270
+ IHRD+ A N+LL ++GDFGL R D + + APE
Sbjct: 140 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 271 RTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
+T + ++D + FG L E+ G+ P + L +D GE L P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERLPR--PE 248
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + ++++ C P RP+ + L
Sbjct: 249 DCPQDI---YNVMVQ----CWAHKPEDRPTFVALRDFLLE 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160
+ LG+G FG V+ T ++AVK + ++ F+AE + L+H LV+L
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220
++ + ++ ++M GSL +L + + +A G+ ++ + + IH
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307
Query: 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGKATTS 278
RD++A+N+L+ L ++ DFGLAR+ + + T APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 279 ADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337
+DV+SFG L+E+ GR P E V RG + P E +
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPR--PENCPEELYN 416
Query: 338 ELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + C + P RP+ + +L+
Sbjct: 417 -------IMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRL-RHRN 153
F+ LG G +G V++ + AVK+ + +AE+ S ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
V+L G L L + SL ++ +L Q +G ++ L L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHS- 175
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
Q ++H DVK +N+ L +LGDFGL + G Y+APE + G
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-G 230
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
T+ADVFS G +LEVAC P +L + P T
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL-----P----------HGGEGWQQLRQGYLPPEFTA 275
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
++ EL +L + DP R + ++
Sbjct: 276 GLSSELRSVLV---MMLEPDPKLRATAEALLA 304
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 34/279 (12%)
Query: 100 KELLGSGGFGRVYRGTL---PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 155
+LG G FG VY G KI +AVK + ++F++E V + L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+L+G + ++ + P G L YL N+ + + + + YL
Sbjct: 77 KLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLES-- 131
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL---GYLAPEHTR 271
+HRD+ N+L+ +LGDFGL+R + D T +++PE
Sbjct: 132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESIN 187
Query: 272 TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
+ TT++DV+ F + E+ G++P ++ V +G+ L P+L
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLPK--PDL 238
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ L C DP+ RP ++V L
Sbjct: 239 CPPVLYT-------LMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 100 KELLGSGGFGRVYRGTL--PKSKIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 156
LG G FG V +G K +I++A+K + + + E + E + +L + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L+G C+ + L+LV + G L K+L + + ++ V++G+ YL E +
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGK 274
+HR++ A NVLL ++ DFGL++ T G APE K
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 275 ATTSADVFSFGAFLLEVA-CGRRPIER-QGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
++ +DV+S+G + E G++P ++ +GPE V F +G+ +E P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMEC--PPECP 565
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ L C RP V Q +
Sbjct: 566 PELYA-------LMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 36/284 (12%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 155
+G G FG V++G + +A+K K ++F+ E +++ + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIV 79
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+L+G + ++ + G L +L + + L ++ L YL
Sbjct: 80 KLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLES-- 134
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL---GYLAPEHTR 271
+ +HRD+ A NVL+ +LGDFGL+R + D ++APE
Sbjct: 135 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESIN 190
Query: 272 TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
+ T+++DV+ FG + E+ G +P + + V GE L P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM--PPN 241
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374
+ L C DP+ RP ++ L +
Sbjct: 242 CPPTLYS-------LMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 100 KELLGSGGFGRVYRGTL--PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 155
++++G G FG+V + + +++ A+K++ + S+ ++F E+ + +L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YNQPKVTLNWRQRYGVIK 201
LLG C +G L L +Y P+G+L +L N TL+ +Q
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
VA G+ YL ++ IHRD+ A N+L+ ++ DFGL+R + +V T
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 262 LGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFD 315
+G L A E TT++DV+S+G L E+ G P E +++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252
Query: 316 FWNRGELLEARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILER 369
+G LE P +E+ +L+ + C P RPS Q++ L R
Sbjct: 253 KLPQGYRLEK--P----LNCDDEVYDLMRQ----CWREKPYERPSFAQILVSLNR 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNL 154
+ +G+G +GR + + K++ + + + V+E+ + L+H N+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 155 VQLLG--YCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVALGLLYL 210
V+ R L +V +Y G L + + + L+ V+ + L L
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 211 HE--EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
H + V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T T VGT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPE 186
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL----LE 324
+D++S G L E+ P F +++ EL E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKELAGKIRE 230
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ + Y ++EL I+ +L + RPS+ ++++
Sbjct: 231 GKFRRIPYRY-SDELNEIIT-RML--NLKDYHRPSVEEILE 267
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 101 ELLGSGGFGRVYRGTL---PKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 155
+G G FG V++G + +A+K K ++F+ E +++ + H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIV 454
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+L+G + ++ + G L +L + + L ++ L YL
Sbjct: 455 KLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLES-- 509
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHTR 271
+ +HRD+ A NVL+ +LGDFGL+R + D G L ++APE
Sbjct: 510 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESIN 565
Query: 272 TGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
+ T+++DV+ FG + E+ G +P + + V GE L P
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM--P-- 614
Query: 331 GTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374
L L+ K C DP+ RP ++ L +
Sbjct: 615 --PNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 60/308 (19%), Positives = 123/308 (39%), Gaps = 52/308 (16%)
Query: 81 GPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKE 138
G ++ + + + + + +GSGG +V++ K +I A+K ++ E Q +
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDS 72
Query: 139 FVAEIVSIGRLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR 196
+ EI + +L+ + ++L Y + +V + N L+ +L + + R+
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 131
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLAR-LYDHGTDP 253
Y K + + +H + ++H D+K +N L+ +G L DFG+A + T
Sbjct: 132 Y--WKNMLEAVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 183
Query: 254 QTTHVVGTLGYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRP-IERQ 301
VGT+ Y+ PE K + +DV+S G L + G+ P +
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243
Query: 302 GPEENL---ILVDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTAR 357
L I + +F + ++L +++ C DP R
Sbjct: 244 NQISKLHAIIDPNHEIEFP---------------DIPEKDLQDVLKC----CLKRDPKQR 284
Query: 358 PSMRQVVQ 365
S+ +++
Sbjct: 285 ISIPELLA 292
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 57/299 (19%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHR 152
E LG FG+VY+G L + +A+K K E +EF E + RL+H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHEAMLRARLQHP 72
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YNQPKVTLNWRQRYG 198
N+V LLG + L +++ Y +G L ++L K L
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTH 257
++ +A G+ YL V+H+D+ NVL+ +LN ++ D GL R +Y +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA-----ADYY 184
Query: 258 VVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVD 311
+ L APE GK + +D++S+G L EV G +P ++
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 238
Query: 312 WVFDFWNRGELLEARD--PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
V + ++L D P + L + C + P+ RP + + L
Sbjct: 239 -VVEMIRNRQVLPCPDDCP-----------AWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 59/299 (19%), Positives = 120/299 (40%), Gaps = 52/299 (17%)
Query: 90 LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIG 147
+ + + + + +GSGG +V++ K +I A+K ++ E Q + + EI +
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 148 RLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
+L+ + ++L Y + +V + N L+ +L + + R+ Y K +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNMLE 119
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLAR-LYDHGTDPQTTHVVGTL 262
+ +H + ++H D+K +N L+ +G L DFG+A + T VGT+
Sbjct: 120 AVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 263 GYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRP-IERQGPEENL--- 307
Y+ PE K + +DV+S G L + G+ P + L
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
I + +F + ++L +++ C DP R S+ +++
Sbjct: 234 IDPNHEIEFP---------------DIPEKDLQDVLKC----CLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 49/228 (21%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVS 145
+ + + + + + +GSGG +V++ K +I A+K ++ E Q + + EI
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAY 107
Query: 146 IGRLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGV 203
+ +L+ + ++L Y + +V + N L+ +L + + R+ Y K +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNM 164
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY-DHGTDPQTTHVVG 260
+ +H + ++H D+K +N L+ +G L DFG+A T VG
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 261 TLGYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRP 297
+ Y+ PE K + +DV+S G L + G+ P
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ +G G FG V+R ++ + AVKK+ E + V E+V+ L +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG---------VIKGVALGL 207
L G R + + + + GSL + + ++ G + GL
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLI-----------KQMGCLPEDRALYYLGQALEGL 163
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGR---LGDFG----LARLYDHGTDPQTTHVVG 260
YLH + ++H DVKA NVLL +G L DFG L + ++ G
Sbjct: 164 EYLH---TRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
T ++APE D++S +L + G P
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 62/303 (20%), Positives = 103/303 (33%), Gaps = 42/303 (13%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG 147
+ I K + + LG GGF V A+K+I +Q +E E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 148 RLRHRNLVQLLGYCRR----KGELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIK 201
H N+++L+ YC R K E L+ + G+L + L Q ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV--- 258
G+ GL +H + HRD+K +N+LL E L D G + +
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 259 -----VGTLGYLAPE--HTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENL--- 307
T+ Y APE ++ DV+S G L + G P + + +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 308 -ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
+ R + + +L+ DP RP + ++
Sbjct: 259 AVQNQLSIPQSPR--------------HSSALWQLLNS----MMTVDPHQRPHIPLLLSQ 300
Query: 367 LER 369
LE
Sbjct: 301 LEA 303
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 72/303 (23%), Positives = 116/303 (38%), Gaps = 61/303 (20%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F E +LG G FG+V + A+KKI H + + ++E++ + L H+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 157 LLG-------------YCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNW-RQRY 197
++K L + +Y NG+L + L Q RQ
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ-- 124
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-------- 249
+ L Y+H Q +IHRD+K N+ +D N ++GDFGLA+
Sbjct: 125 -----ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 250 -----GTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRP-IERQG 302
G+ T +GT Y+A E TG D++S G E+ +ER
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362
+ L V F P+ + E ++I L+ DP RP R
Sbjct: 237 ILKKLRSVSIEF------------PPDFDDNKMKVEKKIIRL--LID--HDPNKRPGART 280
Query: 363 VVQ 365
++
Sbjct: 281 LLN 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 155
F + LG GGFG V+ A+K+I +R+ +E + E+ ++ +L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 156 QLLGYC------------RRKGELLLVYDYMPNGSLDKYLYNQPKVT-LNWRQRYGVIKG 202
+ K L + +L ++ + + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---- 258
+A + +LH + ++HRD+K SN+ + ++GDFGL D + QT
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 259 -------VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311
VGT Y++PE + D+FS G L E+ P E L D
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-QMERVRTLTD 239
Query: 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ + P L T+ E ++ + L P RP +++
Sbjct: 240 ----------VRNLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINIIE 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 73/305 (23%), Positives = 123/305 (40%), Gaps = 59/305 (19%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 153
+G G FGRV++ P + +AVK + S +F E + + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL----------------------YNQPKVTL 191
+V+LLG C + L+++YM G L+++L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 192 NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 250
+ ++ + + VA G+ YL E+ +HRD+ N L+ + ++ DFGL+R +Y
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS-- 226
Query: 251 TDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPE 304
D + + PE + TT +DV+++G L E+ G +P E
Sbjct: 227 AD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364
E V + G +L P E EL ++ LC P RPS +
Sbjct: 284 E-------VIYYVRDGNILAC--P----ENCPLELYNLM---RLCWSKLPADRPSFCSIH 327
Query: 365 QILER 369
+IL+R
Sbjct: 328 RILQR 332
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 74/288 (25%), Positives = 110/288 (38%), Gaps = 29/288 (10%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 158
KE LG+GGFG V R + ++A+K+ E +E EI + +L H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 159 ------GYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLH 211
LL +Y G L KYL + L ++ ++ L YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
E +IHRD+K N++L + D G A+ D G VGTL YLAPE
Sbjct: 139 E---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPE 193
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV------DWVFDFWNRGEL 322
K T + D +SFG E G RP + + + +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 323 LEAR----DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
++ PN + +A +LE L+ L R + Q +
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPNV 298
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 74/305 (24%), Positives = 129/305 (42%), Gaps = 59/305 (19%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 153
+ LG G FG+V + T +AVK + + S +++ ++E + ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG----------- 202
+++L G C + G LLL+ +Y GSL +L KV + G
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 203 -----------VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 250
++ G+ YL E ++HRD+ A N+L+ ++ DFGL+R +Y+
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 251 TDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPE 304
++V + G + A E TT +DV+SFG L E+ G P PE
Sbjct: 205 -----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364
+F+ G +E P + +EE+ ++ L C +P RP +
Sbjct: 260 R-------LFNLLKTGHRMER--P----DNCSEEMYRLM---LQCWKQEPDKRPVFADIS 303
Query: 365 QILER 369
+ LE+
Sbjct: 304 KDLEK 308
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 100 KELLGSGGFGRVYRGTL-------PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-R 150
+ LG G FG+V PK + +AVK + + + + + V+E+ + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YNQPKVTLNWRQR 196
H+N++ LLG C + G L ++ +Y G+L +YL P+ + ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 255
+A G+ YL Q IHRD+ A NVL+ ++ DFGLAR + +
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----- 211
Query: 256 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLIL 309
+ T G L APE T +DV+SFG + E+ G P EE
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+F G ++ P EL +++ C H+ P+ RP+ +Q+V+ L+R
Sbjct: 268 ---LFKLLKEGHRMDK--P----ANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 315
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 54/306 (17%)
Query: 100 KELLGSGGFGRVYRGTL-------PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-R 150
+ LG G FG+V P ++AVK + S + + + + ++E+ + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG-------- 202
H+N++ LLG C + G L ++ +Y G+L +YL + L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 203 ------VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 255
VA G+ YL + IHRD+ A NVL+ + ++ DFGLAR ++
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----- 245
Query: 256 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLIL 309
+ T G L APE T +DV+SFG L E+ G P EE
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 301
Query: 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+F G ++ P EL +++ C H+ P+ RP+ +Q+V+ L+R
Sbjct: 302 ---LFKLLKEGHRMDK--P----SNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 349
Query: 370 DVALPA 375
VAL +
Sbjct: 350 IVALTS 355
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 54/300 (18%)
Query: 100 KELLGSGGFGRVYRGTL-------PKSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-R 150
+ LG G FG+V PK + +AVK + + + + + V+E+ + + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKG------- 202
H+N++ LLG C + G L ++ +Y G+L +YL +P V +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 203 ------VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 255
+A G+ YL Q IHRD+ A NVL+ ++ DFGLAR + +
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----- 257
Query: 256 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLIL 309
+ T G L APE T +DV+SFG + E+ G P EE
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313
Query: 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+F G ++ P EL +++ C H+ P+ RP+ +Q+V+ L+R
Sbjct: 314 ---LFKLLKEGHRMDK--P----ANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 361
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 55/304 (18%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHR 152
+ LG+G FG+V T + + +AVK + + ++E+ + L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG---------- 202
N+V LLG C G L++ +Y G L +L + + + +++
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 203 ------VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 255
VA G+ +L + IHRD+ A N+LL ++ DFGLAR + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----- 199
Query: 256 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRP-IERQGPEENLI 308
+VV L APE T +DV+S+G FL E+ G P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ G + + P E+ E+ I+ C +DP RP+ +Q+VQ++E
Sbjct: 257 ----FYKMIKEGFRMLS--P----EHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLIE 303
Query: 369 RDVA 372
+ ++
Sbjct: 304 KQIS 307
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 37/295 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 155
F + LG+G G V++ + S + +A K I E + + + E+ + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
G GE+ + ++M GSLD+ + + + + V V GL YL E+ +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
++HRDVK SN+L++ +L DFG++ +L D VGT Y++PE +
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTH 206
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
+ +D++S G L+E+A GR PI +E ++ + R P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 335 VA----------EELELILKLGL-----------------LCSHSDPTARPSMRQ 362
E L+ I+ C +P R ++Q
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 52/294 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRN 153
F E E +GSG FG V++ A+K+ + + E+ + L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRYGVIKGVALGLLYLH 211
+V+ +L+ +Y GSL + + + ++ V GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 212 EEWEQVVIHRDVKASNVLLD-------------------GELNGRLGDFGLARLYDHGTD 252
++H D+K SN+ + ++ ++GD G +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISS 186
Query: 253 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311
PQ G +LA E + AD+F+ ++ A P+ R G + + I
Sbjct: 187 PQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQWHEI--- 240
Query: 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+G L P + E EL+ H DP RPS +V+
Sbjct: 241 ------RQGRL-----PRIPQVLSQEFTELLKV----MIHPDPERRPSAMALVK 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 21/222 (9%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLR 150
+ + ++LG G V+RG K+ A+K ++ S + E + +L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 151 HRNLVQLLGY--CRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGL 207
H+N+V+L +L+ ++ P GSL L L + V++ V G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 208 LYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 263
+L E ++HR++K N++ DG+ +L DFG AR + + + GT
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEE 180
Query: 264 YLAPE--------HTRTGKATTSADVFSFGAFLLEVACGRRP 297
YL P+ K + D++S G A G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKE-FVAEIVSIGRLRHRNLVQL 157
LG GGF + + + +K A K + + +E EI L H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
G+ + +V + SL + + +T + Y ++ + LG YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NR 135
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
VIHRD+K N+ L+ +L ++GDFGLA ++ + + + GT Y+APE +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 278 SADVFSFGAFLLEVACGRRPIERQGPEE---NLILVDWVFDFWNRGELLEARDPNLGTEY 334
DV+S G + + G+ P E +E + ++ A
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN---PVAAS------- 244
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
LI K+ L +DPTARP++ +++
Sbjct: 245 ------LIQKM-L---QTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKE-FVAEIVSIGRLRHRNLVQL 157
LG GGF + + + +K A K + + +E EI L H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
G+ + +V + SL + + +T + Y ++ + LG YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NR 161
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
VIHRD+K N+ L+ +L ++GDFGLA ++ + + + GT Y+APE +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 278 SADVFSFGAFLLEVACGRRPIERQGPEE---NLILVDWVFDFWNRGELLEARDPNLGTEY 334
DV+S G + + G+ P E +E + ++ A
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN---PVAAS------- 270
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
LI K+ L +DPTARP++ +++
Sbjct: 271 ------LIQKM-L---QTDPTARPTINELLN 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 158
++LG G V+RG K+ A+K ++ S + E + +L H+N+V+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 159 GY--CRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+L+ ++ P GSL L L + V++ V G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 216 QVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 268
++HR++K N++ DG+ +L DFG AR + + + GT YL P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 269 -----HTRTGKATTSADVFSFGAFLLEVACGRRP 297
K + D++S G A G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 18/223 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 154
++ +G G +G V + S +AVK+I + K+ + ++ V + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI----KGVALGLLYL 210
VQ G R+G+ + + M + S DK Y L+ ++ L +L
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPE- 268
E + +IHRD+K SN+LLD N +L DFG+ +L D T G Y+APE
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPER 196
Query: 269 ---HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI 308
+DV+S G L E+A GR P + + +
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 84/347 (24%), Positives = 137/347 (39%), Gaps = 59/347 (17%)
Query: 58 GVVYVIRRKRKFAEELEDWELDYGPHRFRYKDLYIATKG-----FREK----ELLGSGGF 108
GV Y ++K K+ + E Y + + + D R + LG+G F
Sbjct: 1 GVDYKYKQKPKYQVRWKIIE-SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAF 59
Query: 109 GRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC 161
G+V T + +++AVK + S + ++E+ + L +H N+V LLG C
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 162 RRKGELLLVYDYMPNGSLDKYL------------YNQPKVTLNWRQRYGVIKGVALGLLY 209
G +L++ +Y G L +L + T + R VA G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL--- 265
L + IHRDV A NVLL ++GDFGLAR + + ++V L
Sbjct: 180 LA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVK 231
Query: 266 --APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILVDWVFDFWNRGEL 322
APE T +DV+S+G L E+ G P G N + G
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--PGILVN----SKFYKLVKDGYQ 285
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ P + + + I+ C +PT RP+ +Q+ L+
Sbjct: 286 MAQ--P----AFAPKNIYSIM---QACWALEPTHRPTFQQICSFLQE 323
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 10/206 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG G FG+VY+ ++ A K I +S + +++++ EI + H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
LLG G+L ++ ++ P G++D + + L Q V + + L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SK 136
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-----HTR 271
+IHRD+KA NVL+ E + RL DFG++ + + +GT ++APE +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195
Query: 272 TGKATTSADVFSFGAFLLEVACGRRP 297
AD++S G L+E+A P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQLL 158
LLG G F VYR + +E+A+K I ++ + GM + V E+ +L+H ++++L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
Y + LV + NG +++YL N+ K R+ + + G+LYLH +
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHS---HGI 133
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
+HRD+ SN+LL +N ++ DFGLA + T + GT Y++PE
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEE---NLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+DV+S G + GR P + + ++L D+ + +EA+D
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS---IEAKD-------- 241
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365
LI +L L +P R S+ V+
Sbjct: 242 -----LIHQL-L---RRNPADRLSLSSVLD 262
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 52/299 (17%)
Query: 100 KELLGSGGFGRVYRGTLP-----KSKIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHR 152
+ LG G FG+V + +AVK + + + ++E+ + + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 153 NLVQLLGYCRRKGE-LLLVYDYMPNGSLDKYL--------------YNQPKVTLNWRQRY 197
N+V LLG C + G L+++ ++ G+L YL + K L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 256
VA G+ +L + IHRD+ A N+LL + ++ DFGLAR +Y
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----D 203
Query: 257 HVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQGPEENLILV 310
+V L APE T +DV+SFG L E+ G P G + +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID---- 257
Query: 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ G + A P +Y E+ + L C H +P+ RP+ ++V+ L
Sbjct: 258 EEFCRRLKEGTRMRA--P----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 34/270 (12%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFV-AEIVSIGRLRHRNLVQLL 158
LG G FG VY +SK +A+K + + G++ + E+ LRH N+++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
GY + L+ +Y P G++ + L K Y I +A L Y H + V
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRV 130
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
IHRD+K N+LL ++ DFG + +T + GTL YL PE
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEGRMHDEK 187
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEE---NLILVDWVFDFWNRGELLEARDPNLGTEYV 335
D++S G E G+ P E +E + V++ F + ARD
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE---GARD-------- 236
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365
LI + LL +P+ RP +R+V++
Sbjct: 237 -----LISR--LLK--HNPSQRPMLREVLE 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 33/305 (10%), Positives = 73/305 (23%), Gaps = 52/305 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI---SHESRQGMKEFVAEIVSIGRLRHRN 153
+ E L G V+ + + A+K + SR ++ + RL +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 154 LVQLLGYCR--------------------------RKGELLLVYDYMPNGSLDKYL---- 183
+ R LL+ + L+
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLD 182
Query: 184 -YNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242
+ + + + L + ++H N+ + + LGD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 243 LARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
+ + Y E + T T + + + G + V C P
Sbjct: 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
P L + + ++ ++ L D R
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTP-----LPDFVKTLIG-RFLN--FDRRRRLLP 347
Query: 361 RQVVQ 365
+ ++
Sbjct: 348 LEAME 352
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 155
F + E +G G FG V++G +++ +A+K I E + +++ EI + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G + +L ++ +Y+ GS L P L+ Q +++ + GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 137
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+ IHRD+KA+NVLL +L DFG+A + T VGT ++APE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
+ AD++S G +E+A G P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 154
LG G +G V + S +AVK+I Q K + ++ +S+ +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY-GVI-KGVALGLLYLHE 212
V G R+G++ + + M + SLDK+ + G I + L +LH
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPE--- 268
+ VIHRDVK SNVL++ ++ DFG+ L D + G Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDI-DAGCKPYMAPERIN 182
Query: 269 -HTRTGKATTSADVFSFGAFLLEVACGRRPI-ERQGPEENLILVDWVFDFWNRGELLEAR 326
+ +D++S G ++E+A R P P + L V +E
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------------VEEP 230
Query: 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362
P L + + E C + RP+ +
Sbjct: 231 SPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPE 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ E +G G G VY + E+A+++++ + + + + EI+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L EL +V +Y+ GSL + ++ Q V + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SN 135
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
VIHRD+K+ N+LL + + +L DFG A++ + + +VGT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
D++S G +E+ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 49/288 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEI---VSIGR--LRH 151
F K++LG G G + + ++ ++AVK+I E + V + R H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRIL-------PECFSFADREVQLLRESDEH 77
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
N+++ + + + + +L +Y+ Q + +++ GL +LH
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 212 EEWEQVVIHRDVKASNVLL-----DGELNGRLGDFGLARLYDHG--TDPQTTHVVGTLGY 264
++HRD+K N+L+ G++ + DFGL + G + + + V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 265 LAPE---HTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLIL---VDWVFDFW 317
+APE T + D+FS G V G P + + IL
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ E + AR+ LI K DP RPS + V++
Sbjct: 253 EKHEDVIARE-------------LIEK----MIAMDPQKRPSAKHVLK 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 9/202 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+G G G V S ++AVK + +Q + E+V + +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
+ EL ++ +++ G+L + LN Q V + V L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
VIHRD+K+ ++LL + +L DFG A++ P+ +VGT ++APE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
T D++S G ++E+ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
F E LG G +G VY+ ++ +A+K++ ES ++E + EI + + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
G + +L +V +Y GS+ + TL + +++ GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF---M 144
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
IHRD+KA N+LL+ E + +L DFG+A + T V+GT ++APE +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 203
Query: 277 TSADVFSFGAFLLEVACGRRP 297
AD++S G +E+A G+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 15/216 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 154
+GSG G+V++ K+ IAVK++ ++ K + ++ V + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
VQ G ++ + + M + Q + + + + L YL E+
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEK- 143
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPE----- 268
VIHRDVK SN+LLD +L DFG+ RL D + G Y+APE
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDR-SAGCAAYMAPERIDPP 199
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE 304
ADV+S G L+E+A G+ P + +
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 77/310 (24%), Positives = 119/310 (38%), Gaps = 62/310 (20%)
Query: 100 KELLGSGGFGRVYRGTL-----PKSKIEIAVKKI-SHESRQGMKEFVAEI---VSIGRLR 150
++LGSG FG+V T I++AVK + + ++E+ +G
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-- 107
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG-------- 202
H N+V LLG C G + L+++Y G L YL ++ + Y K
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 203 -------------VALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD 248
VA G+ +L + +HRD+ A NVL+ ++ DFGLAR +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 249 HGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIERQG 302
+VV L APE G T +DV+S+G L E+ G P
Sbjct: 225 DS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362
+ N + G ++ P Y EE+ +I+ C D RPS
Sbjct: 280 VDAN------FYKLIQNGFKMDQ--P----FYATEEIYIIM---QSCWAFDSRKRPSFPN 324
Query: 363 VVQILERDVA 372
+ L +A
Sbjct: 325 LTSFLGCQLA 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 57/312 (18%), Positives = 104/312 (33%), Gaps = 43/312 (13%)
Query: 81 GPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFV 140
F + + + R + +L GGF VY S E A+K++ + + +
Sbjct: 14 DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 141 AEIVSIGRLR-HRNLVQLLGYC--------RRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
E+ + +L H N+VQ + E LL+ + ++ + + L
Sbjct: 74 QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 192 NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251
+ + + ++H + + +IHRD+K N+LL + +L DFG A H
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 252 DPQTTH-----------VVGTLGYLAPE--HTRTGK-ATTSADVFSFGAFLLEVACGRRP 297
D + T Y PE + D+++ G L + + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 298 IERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357
E I+ G+ LI +P R
Sbjct: 253 FEDGAKLR--IV---------NGKYSIPPHDT----QYTVFHSLIRA----MLQVNPEER 293
Query: 358 PSMRQVVQILER 369
S+ +VV L+
Sbjct: 294 LSIAEVVHQLQE 305
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 15/213 (7%)
Query: 97 FREKELLGSG--GFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHR 152
+ ++G G V + + V++I+ S + + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
N+V EL +V +M GS + +N +++GV L Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHV-----VGTLGYLA 266
+HR VKAS++L+ + L + HG + H V L +L+
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 267 PE--HTRTGKATTSADVFSFGAFLLEVACGRRP 297
PE +D++S G E+A G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLV 155
+ +E++GSG V K ++A+K+I+ E Q M E + EI ++ + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLD---KYLYNQPKV---TLNWRQRYGVIKGVALGLLY 209
K EL LV + GS+ K++ + + L+ +++ V GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTH---VVGTLGYL 265
LH+ IHRDVKA N+LL + + ++ DFG+ A L G + VGT ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 266 APEHTRTGKA-TTSADVFSFGAFLLEVACGRRP 297
APE + AD++SFG +E+A G P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 55/293 (18%), Positives = 102/293 (34%), Gaps = 39/293 (13%)
Query: 103 LGSGGFGRVYRGT----------LPKSKIE----IAVKKISHESRQGMKEFVA-EIVSIG 147
L G F ++ KS +E S + + E+ I
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG------VIK 201
+++ + G E+ ++Y+YM N S+ K+ + N+ +IK
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
V Y+H E + + HRDVK SN+L+D +L DFG + + D + GT
Sbjct: 159 SVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESE---YMVDKKIKGSRGT 213
Query: 262 LGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL---IL-VDWVF- 314
++ PE + D++S G L + P + L I + +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 315 -DFWNRGELLEARDPNLGTEYVAEELE-LILKLGLLCSHSDPTARPSMRQVVQ 365
D + L + +++ E + L +P R + ++
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL--FLR--KNPAERITSEDALK 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA----EIVSIGRLRHRNLVQ 156
+ LG GG VY I++A+K + +E + E+ + +L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
++ LV +Y+ +L +Y+ + L+ + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD---M 130
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
++HRD+K N+L+D ++ DFG+A+ + QT HV+GT+ Y +PE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 277 TSADVFSFGAFLLEVACGRRP 297
D++S G L E+ G P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 158
LG G FG VY ++K +A+K + S ++G++ + EI LRH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218
Y + + L+ ++ P G L K L + + ++ +A L Y HE + V
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCHE---RKV 135
Query: 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 278
IHRD+K N+L+ + ++ DFG + + + GTL YL PE
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEK 192
Query: 279 ADVFSFGAFLLEVACGRRPIERQGPEE 305
D++ G E G P + E
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 10/206 (4%)
Query: 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA----EIVSIGRLRH 151
+R + L+G GG G VY + +A+K + E+ F E + GRL+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
++V + + G+L + + L L Q L + +++ + L H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAH 151
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
HRDVK N+L+ + L DFG+A Q + VGTL Y+APE
Sbjct: 152 A---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 272 TGKATTSADVFSFGAFLLEVACGRRP 297
AT AD+++ L E G P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 37/308 (12%), Positives = 73/308 (23%), Gaps = 63/308 (20%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH-R 152
+LG T ++ V +K+ E++ + LR +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 153 NLVQLLGYCRRKGE----------------------------LLLVYDYMPNGSLDKYLY 184
N Q + R L + + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 185 NQPKV--TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242
+ +L R + V L LH ++H ++ +++LD L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRP 297
A T + D ++ G + + C P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 298 IERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357
+W+F + + + +L+ G L R
Sbjct: 317 NTDDAALG---GSEWIFRSCKN---------------IPQPVRALLE-GFLR--YPKEDR 355
Query: 358 PSMRQVVQ 365
Q ++
Sbjct: 356 LLPLQAME 363
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRN 153
F + +G G FG VY ++ +A+KK+S +S + ++ + E+ + +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+Q G R+ LV +Y + D L K L + V G GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HT 270
+IHRDVKA N+LL +LGDFG A VGT ++APE
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAM 225
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRP 297
G+ DV+S G +E+A + P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 155
F EL+G+G +G+VY+G K+ A+K + +E EI + + HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 156 QLLG------YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
G +L LV ++ GS+ + N TL + + + GL +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
LH+ VIHRD+K NVLL +L DFG++ D + T +GT ++APE
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200
Query: 270 TRTGKATTS-----ADVFSFGAFLLEVACGRRP 297
+ + +D++S G +E+A G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 42/271 (15%), Positives = 78/271 (28%), Gaps = 35/271 (12%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGT-----LPKSKIEIAVKKISHESRQGMKEFVAE 142
+ + +K LLG G F +VY T K+K + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 143 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRY 197
+ + ++ + +LV + G+L + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL-----------DGELNGRLGDFGLAR- 245
+ + +H + +IH D+K N +L D L D G +
Sbjct: 178 --AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPE 304
+ T T G+ E + K D F A + + G +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 305 ENLILVD----WVFDFWNR--GELLEARDPN 329
E D WN +L D +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/271 (22%), Positives = 97/271 (35%), Gaps = 33/271 (12%)
Query: 63 IRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREK----ELLGSGGFGRVYRGTLPK 118
I R + D + ++ + + I + E LG+G FG V+R T
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 119 SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 178
+ A K + + EI ++ LRH LV L E++++Y++M G
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 179 L------DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232
L + ++ + RQ V GL ++H E +H D+K N++
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQ-------VCKGLCHMH---ENNYVHLDLKPENIMFTT 290
Query: 233 ELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---F 287
+ + L DFGL D GT + APE D++S G
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 288 LLEVACGRRP---IERQGPEENLILVDWVFD 315
LL G P N+ DW D
Sbjct: 349 LL---SGLSPFGGENDDETLRNVKSCDWNMD 376
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 42/317 (13%), Positives = 85/317 (26%), Gaps = 74/317 (23%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG---MKEFVAEIVSIGRLR 150
+ +LG T ++ V R +K+ E++ + LR
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 151 -------------------------HRNLVQLLGYCRRKGELLLVYDYM----PNGSLDK 181
+ ++++ R L + Y + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 182 YLYNQPKV--TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239
L + +L R + V L LH ++H ++ +++LD L
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPE-----------HTRTGKATTSADVFSFGAFL 288
F + G+ PE R T S D ++ G +
Sbjct: 249 GFEHLVRDGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 289 LEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLL 348
+ C PI + +W+F + + + +L+ G L
Sbjct: 304 YWIWCADLPITKDAALG---GSEWIFRSCKN---------------IPQPVRALLE-GFL 344
Query: 349 CSHSDPTARPSMRQVVQ 365
R Q ++
Sbjct: 345 R--YPKEDRLLPLQAME 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 16/207 (7%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA----EIVSIGRLRHRNLVQ 156
E+LG GG V+ + ++AVK + F E + L H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 157 LLGYCRRKGELL----LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+ + +V +Y+ +L ++ + + ++ VI L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHT 270
+IHRDVK +N+++ ++ DFG+AR + QT V+GT YL+PE
Sbjct: 135 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRP 297
R +DV+S G L EV G P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 55/250 (22%), Positives = 95/250 (38%), Gaps = 33/250 (13%)
Query: 84 RFRYKDLYIATKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF 139
++ + + + + E LGSG FG V+R + K I+
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 95
Query: 140 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL------DKYLYNQPKVTLNW 193
EI + +L H L+ L K E++L+ +++ G L + Y ++ +V
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGT 251
RQ GL ++H E ++H D+K N++ + + + DFGLA +
Sbjct: 156 RQ-------ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEE--- 305
+ T + APE D+++ G LL G P + E
Sbjct: 206 IVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL---SGLSPFAGEDDLETLQ 260
Query: 306 NLILVDWVFD 315
N+ DW FD
Sbjct: 261 NVKRCDWEFD 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG 147
Y + E+LG G FG+V++ + +++A K I + +E EI +
Sbjct: 86 NSFYT----VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL------DKYLYNQPKVTLNWRQRYGVIK 201
+L H NL+QL K +++LV +Y+ G L + Y + L +Q
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ------ 195
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVV 259
+ G+ ++H + ++H D+K N+L ++ DFGLAR Y +
Sbjct: 196 -ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NF 249
Query: 260 GTLGYLAPEHTRTGKATTSADVFSFG 285
GT +LAPE + D++S G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVG 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 52/300 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 155
+++LG G G V + + +AVK++ + EI + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGR-PVAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYL-----YNQPKVTLNWRQRYGVIKGVALGLLYL 210
+ L + + N +L + ++ +++ +A G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGR-------------LGDFGLARLYDHGTDPQTTH 257
H +IHRD+K N+L+ + DFGL + D G T+
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 258 ---VVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEEN 306
GT G+ APE + T S D+FS G + G+ P + E+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 307 LILVDWVFDFWNRGEL-LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
I+ RG L+ +AE +LI + ++ DP RP+ +V++
Sbjct: 249 NII---------RGIFSLDEMKCLHDRSLIAEATDLISQ--MID--HDPLKRPTAMKVLR 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 51/293 (17%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 158
+G G +G V++ + +A+KK + + +A EI + +L+H NLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLHEEW 214
RRK L LV++Y + ++ L + ++K + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPE-----HLVKSITWQTLQAVNFCHKHN 122
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTR 271
IHRDVK N+L+ +L DFG ARL +D V T Y +PE
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDT 178
Query: 272 TGKATTSADVFSFGAFLLEVACGR--------------------RPIERQ--GPEENLIL 309
+ DV++ G E+ G I R N
Sbjct: 179 --QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362
E LE + PN+ L L+ L DPT R + Q
Sbjct: 237 SGVKIPDPEDMEPLELKFPNIS----YPALGLLKGC-LHM---DPTERLTCEQ 281
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 69/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 158
K LGSG FG V+ S +E +K I+ + Q E + EI + L H N++++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 159 GYCRRKGELLLVYDYMPNGSL-DKYLYNQPKV-TLNWRQRYGVIKGVALGLLYLHEEWEQ 216
+ +V + G L ++ + Q + L+ ++K + L Y H Q
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQ 143
Query: 217 VVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
V+H+D+K N+L ++ DFGLA L+ GT Y+APE +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-R 200
Query: 274 KATTSADVFSFGA---FLLEVACGRRPIERQGPEE--NLIL-VDWVFD--FWNRGELLEA 325
T D++S G FLL G P EE + + +A
Sbjct: 201 DVTFKCDIWSAGVVMYFLL---TGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP--QA 255
Query: 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
D L+ + +L DP RPS QV+
Sbjct: 256 VD-------------LLKQ--MLT--KDPERRPSAAQVLH 278
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-24
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAE---IVSIGRLR 150
F ++G GGFG VY + A+K + + +QG + E + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 151 HRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+V + Y +L + D M G L +L + + Y + LGL +
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEH 307
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+H + V++RD+K +N+LLD + R+ D GLA + + VGT GY+APE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEV 361
Query: 270 TRTGKA-TTSADVFSFGAFLLEVACGRRP 297
+ G A +SAD FS G L ++ G P
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-24
Identities = 64/343 (18%), Positives = 109/343 (31%), Gaps = 99/343 (28%)
Query: 97 FREKELLGSGGFGRVYRGT-------------------LPKSKIEIAVK---KISHE--- 131
F + +G GGFG V+ L + K+ VK K+ H
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 132 ---------------------------------SRQGMKEFVAEIVSIGRLRHRNLVQLL 158
S M +I + +N V L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQ-----PKVTLNWRQRYGVIKGVALGLLYLHEE 213
K L + +L ++ + + + + +A + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH----IFIQIAEAVEFLHS- 182
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-----------THVVGTL 262
+ ++HRD+K SN+ + ++GDFGL D + QT T VGT
Sbjct: 183 --KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322
Y++PE + D+FS G L E+ E I+ D +
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST----QMERVRIITD----------V 286
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ P L T+ +E ++ + S PT RP +++
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQD---MLSP-SPTERPEATDIIE 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 23/207 (11%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 158
E LG+G + VY+G + + +A+K++ +S +G A EI + L+H N+V+L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENIVRLY 69
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLHEEW 214
+ +L LV+++M N L KY+ ++ ++K GL + HE
Sbjct: 70 DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 215 EQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE--- 268
++HRD+K N+L++ G+L +LGDFGLAR + G T + V TL Y AP+
Sbjct: 129 ---ILHRDLKPQNLLINKRGQL--KLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLM 181
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGR 295
+RT +TS D++S G L E+ G+
Sbjct: 182 GSRT--YSTSIDIWSCGCILAEMITGK 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 51/282 (18%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ +LG G FG V + E AVK IS + + + + E+ + +L H N+++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 157 LLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GVIKGVALGLLY 209
L + KG LV + G L D+ + R+R+ +I+ V G+ Y
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDE---------IISRKRFSEVDAARIIRQVLSGITY 141
Query: 210 LHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
+H + ++HRD+K N+LL + N R+ DFGL+ ++ + +GT Y+A
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIA 196
Query: 267 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLIL---VDWVFDFWNRGE 321
PE G DV+S G L + G P + + + W +
Sbjct: 197 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
A+D LI K +L P+ R S R
Sbjct: 256 -ESAKD-------------LIRK--MLT--YVPSMRISARDA 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 46/279 (16%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+ LGSG +G V + +E A+K I + S + + E+ + L H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 158 LGYCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+ K LV + G L + +N+ +IK V G+ YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVLSGVTYLH- 153
Query: 213 EWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+ ++HRD+K N+LL + + ++ DFGL+ ++++ + +GT Y+APE
Sbjct: 154 --KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEV 209
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLIL---VDWVFDFWNRGELLE 324
R K DV+S G L + G P Q +E + + W
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS-EG 267
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
A+D LI + +L D R S +Q
Sbjct: 268 AKD-------------LIKQ--MLQ--FDSQRRISAQQA 289
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 98 REKELLGSGGFGRVY--RGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 155
E +G G +G VY + K + A+K+I EI + L+H N++
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVI 81
Query: 156 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY---GVIKGVAL----G 206
L + + L++DY + L + N + G++K + G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDPQT--THVVG 260
+ YLH W V+HRD+K +N+L+ GE R + D G ARL++ P VV
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 261 TLGYLAPE 268
T Y APE
Sbjct: 198 TFWYRAPE 205
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 158
L+G G +G V + + +A+KK M + +A EI + +LRH NLV LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLHEEW 214
C++K LV++++ + ++ L P Y V++ G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLD-----YQVVQKYLFQIINGIGFCHSHN 144
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH-TRTG 273
+IHRD+K N+L+ +L DFG AR + V T Y APE
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDV 200
Query: 274 KATTSADVFSFGAFLLEVACGR 295
K + DV++ G + E+ G
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 41/208 (19%), Positives = 79/208 (37%), Gaps = 21/208 (10%)
Query: 97 FREKELLGSGGFGRVYRGT-LPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNL 154
+ K + GG G +Y + + +K + H + +AE + + H ++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 155 VQLLGY-----CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
VQ+ + +V +Y+ SL + Q L + + + L Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQK---LPVAEAIAYLLEILPALSY 197
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
LH +++ D+K N++L E +L D G + ++ GT G+ APE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEI 248
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRP 297
R T + D+++ G L +
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 69/298 (23%), Positives = 109/298 (36%), Gaps = 62/298 (20%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQL 157
KE +G G + R + +E AVK I R +E + I +H N++ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-----IEILLRYGQHPNIITL 81
Query: 158 LGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
+ +V + M G L DK + + R+ V+ + + YLH Q
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSEREASAVLFTITKTVEYLH---AQ 135
Query: 217 VVIHRDVKASNVLLDGELNG----RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---H 269
V+HRD+K SN+L E R+ DFG A+ T T ++APE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEVLER 194
Query: 270 TRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWV----FDF----WN 318
A D++S G +L G P + ++ + F WN
Sbjct: 195 QGYDAA---CDIWSLGVLLYTML---TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 319 R-GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ---ILERDVA 372
+ A+D L+ K+ L H DP R + V++ I+ D
Sbjct: 249 SVSD--TAKD-------------LVSKM-L---HVDPHQRLTAALVLRHPWIVHWDQL 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 72/234 (30%), Positives = 101/234 (43%), Gaps = 45/234 (19%)
Query: 93 ATKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKIS--------HESRQGMKEFV 140
+T GF E E+LG G V R + E AVK I E Q ++E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 141 AEIVSIGRLR----HRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQ 195
+ V I LR H N++QL LV+D M G L D KVTL+ ++
Sbjct: 71 LKEVDI--LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKE 125
Query: 196 RYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 255
+++ + + LH+ ++HRD+K N+LLD ++N +L DFG + D G +
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 256 THVVGTLGYLAPE---------HTRTGKATTSADVFSFGA---FLLEVACGRRP 297
V GT YLAPE H GK D++S G LL G P
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKE---VDMWSTGVIMYTLL---AGSPP 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNL 154
+ + + LG G + VY+G + +A+K+I E +G A E+ + L+H N+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANI 62
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYL 210
V L + L LV++Y+ L +YL + + +K GL Y
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM-----HNVKLFLFQLLRGLAYC 116
Query: 211 HEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
H + V+HRD+K N+L++ GEL +L DFGLAR T VV TL Y P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGEL--KLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
Query: 269 ---HTRTGKATTSADVFSFGAFLLEVACGR 295
+ +T D++ G E+A GR
Sbjct: 171 ILLGST--DYSTQIDMWGVGCIFYEMATGR 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 70/314 (22%), Positives = 120/314 (38%), Gaps = 57/314 (18%)
Query: 82 PHRFRYKDLY-----IATKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKIS--- 129
F + DL + K R++ + LGSG G V K+ ++A++ IS
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172
Query: 130 -----HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY 184
EI + +L H ++++ + + + +V + M G L +
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVV 231
Query: 185 NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDF 241
L + L + YLH E +IHRD+K NVLL + + ++ DF
Sbjct: 232 G--NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 242 GLARLYDHGTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
G +++ + +T + GT YLAPE T + D +S G L G P
Sbjct: 287 GHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344
Query: 299 ERQGPEENL---IL---VDWVFDFWNR-GELLEARDPNLGTEYVAEELELILKLGLLCSH 351
+ +L I +++ + W E +A D L+ K LL
Sbjct: 345 SEHRTQVSLKDQITSGKYNFIPEVWAEVSE--KALD-------------LVKK--LLV-- 385
Query: 352 SDPTARPSMRQVVQ 365
DP AR + + ++
Sbjct: 386 VDPKARFTTEEALR 399
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 64/285 (22%), Positives = 104/285 (36%), Gaps = 49/285 (17%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLL 158
+ LG G F + KS AVK IS ++ EI ++ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 159 GYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
+ LV + + G L ++ + K + + +++ + + ++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMH---DVG 126
Query: 218 VIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
V+HRD+K N+L + L ++ DFG ARL P T TL Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQNG 185
Query: 275 ATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL--------- 322
S D++S G +L G+ P + + +G+
Sbjct: 186 YDESCDLWSLGVILYTML---SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 323 --LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
EA+D LI L L DP R M +
Sbjct: 243 VSQEAKD-------------LIQGL-L---TVDPNKRLKMSGLRY 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEF----VAEIVSIGRLR- 150
+ +G G +G VY+ P S +A+K + G V E+ + RL
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 151 --HRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGV 203
H N+V+L+ R+ ++ LV++++ L YL P L IK +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET----IKDL 125
Query: 204 AL----GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THV 258
GL +LH ++HRD+K N+L+ +L DFGLAR+Y T V
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPV 179
Query: 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
V TL Y APE T D++S G E+ R+P+
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 155
E +G G +G V++ ++ +A+K++ + E V EI + L+H+N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIV 64
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLH 211
+L +L LV+++ L KY + ++K GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGFCH 118
Query: 212 EEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE 268
V+HRD+K N+L++ GEL +L +FGLAR + G + + V TL Y P+
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGEL--KLANFGLARAF--GIPVRCYSAEVVTLWYRPPD 171
Query: 269 HTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
K +TS D++S G E+A RP+
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 66/299 (22%), Positives = 110/299 (36%), Gaps = 75/299 (25%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKIS-------------HESRQGMKEFVAEIVSI 146
LGSG +G V E A+K I + +E EI +
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GV 199
L H N+++L K LV ++ G L ++ + R ++ +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ---------IINRHKFDECDAANI 151
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTT 256
+K + G+ YLH + ++HRD+K N+LL + LN ++ DFGL+ + +
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD- 207
Query: 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWV 313
+GT Y+APE + K DV+S G LL CG P
Sbjct: 208 -RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL---CGYPP---------------- 246
Query: 314 FDFW--NRGELLEA---RDPNLGTEY---VAEE-LELILKLGLLCSHSDPTARPSMRQV 363
F N ++++ +++E ELI +L D R + +
Sbjct: 247 --FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL--MLT--YDYNKRCTAEEA 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 159
+ LG G +G V ++ +AVK + + E + EI L H N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWEQV 217
+ R L +Y G L + + QR+ ++ GV YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG---IG 125
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKA 275
+ HRD+K N+LLD N ++ DFGLA ++ + + + + GTL Y+APE R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
DV+S G L + G P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 61/186 (32%), Positives = 92/186 (49%), Gaps = 32/186 (17%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVA--EIVSIGRLRHRNLVQLLG 159
+G G FG V++ K+ ++A+KK+ E+ ++G A EI + L+H N+V L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83
Query: 160 --------YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GL 207
Y R KG + LV+D+ + L L + V + IK V GL
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSE----IKRVMQMLLNGL 137
Query: 208 LYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT---THVVGTL 262
Y+H ++HRD+KA+NVL+ G L +L DFGLAR + + Q T+ V TL
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVL--KLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 263 GYLAPE 268
Y PE
Sbjct: 193 WYRPPE 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 71/308 (23%), Positives = 119/308 (38%), Gaps = 67/308 (21%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNL 154
E++G G F V R ++ + AVK K + ++ E L+H ++
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSL---------DKYLYNQPKVTLNWRQRYGVIKGVAL 205
V+LL G L +V+++M L ++Y++ + RQ +++ +
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ---ILEALR- 144
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTL 262
Y H + +IHRDVK VLL + N +LG FG+A VGT
Sbjct: 145 ---YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTP 197
Query: 263 GYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRPI--ERQGPEENLILVDWVF 314
++APE GK DV+ G LL G P ++ E +I +
Sbjct: 198 HFMAPEVVKREPYGKP---VDVWGCGVILFILL---SGCLPFYGTKERLFEGIIKGKYKM 251
Query: 315 D--FWNR-GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ---ILE 368
+ W+ E A+D L+ + +L DP R ++ + + + E
Sbjct: 252 NPRQWSHISE--SAKD-------------LVRR--MLM--LDPAERITVYEALNHPWLKE 292
Query: 369 RDVALPAI 376
RD I
Sbjct: 293 RDRYAYKI 300
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEI-AVKKISHES-RQG-----------MKEFVAEI 143
+ +G G +G+V++ K+ A+K++ ++ +G ++
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH----- 67
Query: 144 VSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG 198
+ H N+V+L R+ +L LV++++ L YL P+ +
Sbjct: 68 --LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET--- 121
Query: 199 VIKGVAL----GLLYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD 252
IK + GL +LH V+HRD+K N+L+ G++ +L DFGLAR+Y
Sbjct: 122 -IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI--KLADFGLARIYS---F 172
Query: 253 PQT-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
T VV TL Y APE T D++S G E+ R+P+
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 36/223 (16%)
Query: 94 TKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIV 144
+ F + E LG G F V R + +E A K K+S Q ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EAR 57
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGV 203
+L+H N+V+L + + LV+D + G L + + + + I+ +
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQI 114
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVG 260
+ Y H ++HR++K N+LL + G +L DFGLA + G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAG 169
Query: 261 TLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 297
T GYL+PE K D+++ G LL G P
Sbjct: 170 TPGYLSPEVLKKDPYSKP---VDIWACGVILYILL---VGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 47/248 (18%), Positives = 84/248 (33%), Gaps = 53/248 (21%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNL 154
K +G G +G V +++ A+K KI + + ++ E+ + +L H N+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSL----------------------------------- 179
+L + + LV + G L
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 180 ---DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236
+ +++ + L YLH Q + HRD+K N L +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSF 207
Query: 237 RL--GDFGLARLY---DHGTDPQTTHVVGTLGYLAPE--HTRTGKATTSADVFSFGAFLL 289
+ DFGL++ + ++G T GT ++APE +T D +S G L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 290 EVACGRRP 297
+ G P
Sbjct: 268 LLLMGAVP 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQL 157
E LG G FG V+R SK K + + +K+ EI + RHRN++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHL 66
Query: 158 LGYCRRKGELLLVYDYMPNGSL------DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
EL+++++++ + + N+ ++ Q V + + +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ---VCEALQ----FLH 119
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+ H D++ N++ + + +FG AR G + + + Y APE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174
Query: 270 TRTGKATTSADVFSFGA---FLLEVACGRRP 297
+ +T+ D++S G LL G P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLL---SGINP 202
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 6e-22
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
FR+ +LG GGFG V + + A KK+ + R+G + E + ++ R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 154 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
+V L Y K L LV M G L ++Y+ + + + GL LH
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTR 271
+ +++RD+K N+LLD + R+ D GLA H + QT VGT+GY+APE +
Sbjct: 305 ---ERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 272 TGKATTSADVFSFGAFLLEVACGRRP 297
+ T S D ++ G L E+ G+ P
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-22
Identities = 63/288 (21%), Positives = 105/288 (36%), Gaps = 62/288 (21%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+ +G G +G V ++I A KKI + + F EI + L H N+++L
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 160 YCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GVIKGVALGLLYLHE 212
++ LV + G L ++ + ++ + ++K V + Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFER---------VVHKRVFRESDAARIMKDVLSAVAYCH- 123
Query: 213 EWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+ V HRD+K N L + +L DFGLA + G +T VGT Y++P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQV 179
Query: 270 TRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWVFDFW--NRGELLE 324
G D +S G LL CG P F E++
Sbjct: 180 LE-GLYGPECDEWSAGVMMYVLL---CGYPP------------------FSAPTDSEVML 217
Query: 325 A---RDPNLGTEY---VAEE-LELILKLGLLCSHSDPTARPSMRQVVQ 365
+ V+ + LI + LL P R + Q ++
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIRR--LLT--KSPKQRITSLQALE 261
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 159
+ LG G +G V ++ +AVK + + E + EI L H N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWEQV 217
+ R L +Y G L + + QR+ ++ GV YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG---IG 125
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKA 275
+ HRD+K N+LLD N ++ DFGLA ++ + + + + GTL Y+APE R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 276 TTSADVFSFGAFLLEVACGRRP 297
DV+S G L + G P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 27/201 (13%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKIS------HESRQGMKEFVAEIVSIGRLRHRN 153
E LGSG F V + + +E A K I +E E+ + ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
++ L + +++L+ + + G L K ++ + T +Q + G+
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-------ILDGVN 129
Query: 209 YLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
YLH + + H D+K N++L + +L DFGLA + G + + + GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184
Query: 265 LAPEHTRTGKATTSADVFSFG 285
+APE AD++S G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 93 ATKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR 148
A K F +K +++G G V R + E AVK + + + E + E+ R
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 149 -----LR----HRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYG 198
LR H +++ L+ + LV+D M G L D KV L+ ++
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRS 204
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 258
+++ + + +LH ++HRD+K N+LLD + RL DFG + + G + +
Sbjct: 205 IMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--L 259
Query: 259 VGTLGYLAPE---------HTRTGKATTSADVFSFGA---FLLEVACGRRP 297
GT GYLAPE H GK D+++ G LL G P
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKE---VDLWACGVILFTLL---AGSPP 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 72/305 (23%)
Query: 92 IATKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVS 145
I F E+ E LG G F V R + E A I S + ++ E
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 146 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------G 198
L+H N+V+L +G L++D + G L + + R+ Y
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED---------IVAREYYSEADASH 114
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQT 255
I+ + +L+ H + V+HR++K N+LL +L G +L DFGLA +
Sbjct: 115 CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 256 THVVGTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLIL 309
GT GYL+PE GK D+++ G LL G P
Sbjct: 172 G-FAGTPGYLSPEVLRKDPYGKP---VDLWACGVILYILL---VGYPP------------ 212
Query: 310 VDWVFDFW--NRGELLEA---RDPNLGTEY---VAEE-LELILKLGLLCSHSDPTARPSM 360
FW ++ L + + + V E +LI K +L +P+ R +
Sbjct: 213 ------FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK--MLT--INPSKRITA 262
Query: 361 RQVVQ 365
+ ++
Sbjct: 263 AEALK 267
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ + +++G+G FG VY+ L S +A+KK+ Q + E+ + +L H N+V+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 157 LLGYCRRKGE------LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG----VALG 206
L + GE L LV DY+P ++ + + + Y +K +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 168
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
L Y+H + HRD+K N+LLD + +L DFG A+ G +P +++ + Y
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYIC-SRYYR 223
Query: 266 APE--HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
APE T T+S DV+S G L E+ +PI
Sbjct: 224 APELIFGAT-DYTSSIDVWSAGCVLAEL-LLGQPI 256
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKIS------HESRQGMKEFVAEIVSIGRLRHRN 153
E LGSG F V + + +E A K I +E E+ + ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
++ L + +++L+ + + G L K ++ + T +Q ++ GV
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ---ILDGVN---- 129
Query: 209 YLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264
YLH + + H D+K N++L + +L DFGLA + G + + + GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184
Query: 265 LAPEHTRTGKATTSADVFSFG 285
+APE AD++S G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 56/284 (19%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+LG G FG V + ++ E AVK I + + + E+ + +L H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 158 LGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GVIKGVALGLLYL 210
+V + G L D+ + R+R+ +IK V G+ Y+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDE---------IIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 211 HEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
H + ++HRD+K N+LL + + + ++ DFGL+ + T + +GT Y+AP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAP 192
Query: 268 EHTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEE--NLIL---VDWVFDFWNR 319
E R G DV+S G LL G P + + + + W
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILL---SGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363
+A+D LI K +L P+ R + Q
Sbjct: 249 IS-DDAKD-------------LIRK--MLT--FHPSLRITATQC 274
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKI------SHESRQGMKEFVAEIVSIGRLRHRN 153
E LGSG F V + + E A K I S +E E+ + +RH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
++ L K +++L+ + + G L +K + + T +Q ++ GV
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ---ILDGVH---- 122
Query: 209 YLHEEWEQVVIHRDVKASNVLL---DGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGY 264
YLH + + H D+K N++L + +L DFG+A + G + + + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEF 177
Query: 265 LAPEHTRTGKATTSADVFSFG 285
+APE AD++S G
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 56/294 (19%)
Query: 94 TKGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIG 147
F E+ +LG G FG V + ++ E AVK I + + + E+ +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALG 206
+L H N+++L +V + G L D+ + + + +IK V G
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSG 133
Query: 207 LLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 263
+ Y+H + ++HRD+K N+LL + + + ++ DFGL+ + T + +GT
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAY 188
Query: 264 YLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWVFDFW--N 318
Y+APE R G DV+S G LL G P F+ N
Sbjct: 189 YIAPEVLR-GTYDEKCDVWSAGVILYILL---SGTPP------------------FYGKN 226
Query: 319 RGELLEA---RDPNLGTEY---VAEE-LELILKLGLLCSHSDPTARPSMRQVVQ 365
++L+ ++++ +LI K +L P+ R + Q ++
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRK--MLT--FHPSLRITATQCLE 276
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 60/181 (33%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 155
+ LG G F VY+ + +A+KKI R K+ + EI + L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GLLYLH 211
LL K + LV+D+M L+ + + V IK L GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP-----SHIKAYMLMTLQGLEYLH 129
Query: 212 EEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT--THVVGTLGYLAP 267
+ W ++HRD+K +N+LLD G L +L DFGLA+ + P TH V T Y AP
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVL--KLADFGLAKSF---GSPNRAYTHQVVTRWYRAP 181
Query: 268 E 268
E
Sbjct: 182 E 182
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 151
+R LG G +G VY+ + +A+K+I E +E V E+ + L+H
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQH 92
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GL 207
RN+++L L L+++Y N L KY+ P V++ VIK G+
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM------RVIKSFLYQLINGV 145
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGR-----LGDFGLARLYDHGTDPQT-THVVGT 261
+ H +HRD+K N+LL +GDFGLAR + G + TH + T
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIIT 200
Query: 262 LGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGR 295
L Y PE +R +TS D++S E+
Sbjct: 201 LWYRPPEILLGSRH--YSTSVDIWSIACIWAEMLMKT 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 44/219 (20%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNL 154
KE LG G F V R + +E A K K+S Q ++ E +L+H N+
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNI 90
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GVIKGVALGL 207
V+L + + LV+D + G L + + R+ Y I+ + +
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFED---------IVAREFYSEADASHCIQQILESI 141
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGY 264
Y H ++HR++K N+LL + G +L DFGLA + GT GY
Sbjct: 142 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGY 196
Query: 265 LAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 297
L+PE K D+++ G LL G P
Sbjct: 197 LSPEVLKKDPYSKP---VDIWACGVILYILL---VGYPP 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 153
F+ ++LG G F V + E A+K + + E + RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
V+L + +L Y NG L KY+ + Y + L YLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--EIVSALEYLHG- 148
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRT 272
+ +IHRD+K N+LL+ +++ ++ DFG A++ + + VGT Y++PE
Sbjct: 149 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 273 GKATTSADVFSFGAFLLEVACGRRP 297
A S+D+++ G + ++ G P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 151
+++ E +G G +G VY+ + +I +A+K+I ++ E + EI + L H
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAE---DEGIPSTAIREISLLKELHH 78
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GL 207
N+V L+ + L LV+++M L K L + IK G+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD-----SQIKIYLYQLLRGV 132
Query: 208 LYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 264
+ H+ ++HRD+K N+L++ G L +L DFGLAR + G ++ TH V TL Y
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGAL--KLADFGLARAF--GIPVRSYTHEVVTLWY 185
Query: 265 LAPE---HTRTGKATTSADVFSFGAFLLEVACGR 295
AP+ ++ +TS D++S G E+ G+
Sbjct: 186 RAPDVLMGSKK--YSTSVDIWSIGCIFAEMITGK 217
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
E+LGSG F V+ + A+K I EI + +++H N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 160 YCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY------GVIKGVALGLLYLHE 212
LV + G L D+ L R Y VI+ V + YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILE---------RGVYTEKDASLVIQQVLSAVKYLH- 123
Query: 213 EWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
E ++HRD+K N+L + + DFGL+++ +G + GT GY+APE
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEV 178
Query: 270 TRTGKATTSADVFSFGA---FLLEVACGRRP 297
+ + D +S G LL CG P
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILL---CGYPP 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 62/304 (20%)
Query: 81 GPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFV 140
G +R D + + LG G VYR ++ A+K + K
Sbjct: 45 GSNRDALSDFFEV------ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVR 96
Query: 141 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRY-- 197
EI + RL H N+++L E+ LV + + G L D+ + + Y
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR---------IVEKGYYSE 147
Query: 198 ----GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG 250
+K + + YLH E ++HRD+K N+L + ++ DFGL+++ +H
Sbjct: 148 RDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENL 307
+T V GT GY APE R D++S G LL CG P + ++ +
Sbjct: 205 VLMKT--VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL---CGFEPFYDERGDQFM 259
Query: 308 ---IL---VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMR 361
IL ++ +W+ L A+D L+ K L+ DP R +
Sbjct: 260 FRRILNCEYYFISPWWDEVS-LNAKD-------------LVRK--LIV--LDPKKRLTTF 301
Query: 362 QVVQ 365
Q +Q
Sbjct: 302 QALQ 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 65/309 (21%), Positives = 102/309 (33%), Gaps = 74/309 (23%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLL 158
+++LG G RV + E AVK I + E+ + + + HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 159 GYCRRKGELLLVYDYMPNGSL-DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
+ + LV++ M GS+ + N + V++ VA L +LH +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASALDFLH---NKG 131
Query: 218 VIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPE 268
+ HRD+K N+L + ++ DF L D P+ G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 269 -----HTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320
D++S G LL G P F R
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILL---SGYPP------------------FVGRC 230
Query: 321 ELLEARDPNLGTEYVAEEL------------------------ELILKLGLLCSHSDPTA 356
D L +LI K LL D
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK--LLV--RDAKQ 286
Query: 357 RPSMRQVVQ 365
R S QV+Q
Sbjct: 287 RLSAAQVLQ 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 30/227 (13%)
Query: 82 PHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA 141
P ++ D Y +K ++LG G G+V ++ + A+K + +
Sbjct: 21 PKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----- 70
Query: 142 EIVSIGRL-RHRNLVQLLGYC----RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR 196
E+ + ++V +L K LL++ + M G L + + R+
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDP 253
+++ + + +LH + HRDVK N+L + + +L DFG A+
Sbjct: 131 AEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--- 184
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRP 297
T Y+APE K S D++S G LL CG P
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL---CGFPP 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKI------SHESRQGMKEFVAEIVSIGRLRHRN 153
E LGSG F V + + ++ A K I S ++ E+ + ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
++ L K +++L+ + + G L +K + + T +Q ++ GV
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---ILNGVY---- 128
Query: 209 YLHEEWEQVVIHRDVKASNVLL---DGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGY 264
YLH + H D+K N++L + ++ DFGLA D G + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183
Query: 265 LAPEHTRTGKATTSADVFSFGA---FLLEVACGRRP 297
+APE AD++S G LL G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILL---SGASP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F + +LG GGFG V+ + + A KK++ + R+G + + E + ++ R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 154 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG--VALGLLYL 210
+V L Y K +L LV M G + ++YN + +++ + + GL +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEH 269
H+ + +I+RD+K NVLLD + N R+ D GLA + T GT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPEL 360
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRP 297
+ S D F+ G L E+ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 151
+ E +G G +G VY+ + A+KKI E E + EI + L+H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKE---DEGIPSTTIREISILKELKH 59
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL----GL 207
N+V+L K L+LV++++ L K L + K L G+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES-----VTAKSFLLQLLNGI 113
Query: 208 LYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 264
Y H+ V+HRD+K N+L++ GEL ++ DFGLAR + G + TH + TL Y
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGEL--KIADFGLARAF--GIPVRKYTHEIVTLWY 166
Query: 265 LAPE---HTRTGKATTSADVFSFGAFLLEVACGR 295
AP+ ++ +T+ D++S G E+ G
Sbjct: 167 RAPDVLMGSKK--YSTTIDIWSVGCIFAEMVNGT 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLV 155
+ +++G+G FG V++ L +S E+A+KK+ + R +E + I R ++H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRE-----LQIMRIVKHPNVV 95
Query: 156 QLLGYCRRKGE------LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG----VAL 205
L + G+ L LV +Y+P ++ + + K+ IK +
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLL--IKLYMYQLLR 152
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGY 264
L Y+H + HRD+K N+LLD +L DFG A++ G +P +++ + Y
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYIC-SRYY 207
Query: 265 LAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
APE T TT+ D++S G + E+ +P+
Sbjct: 208 RAPELIFGAT-NYTTNIDIWSTGCVMAEL-MQGQPL 241
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 159
+ +GSG FG +K +AVK I E + E V EI++ LRH N+V+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWEQV 217
L ++ +Y G L + + N + + + + + ++ GV+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCHS---MQ 136
Query: 218 VIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPEH-TRTGK 274
+ HRD+K N LLDG RL DFG ++ + P++T VGT Y+APE R
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEY 194
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQ 301
ADV+S G L + G P E
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDP 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQL 157
+ LG G FG+V G + ++AVK ++ + + + EI ++ RH ++++L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWE 215
+ +V +Y+ G L Y+ +V +R ++ V Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHR--- 129
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 274
+V+HRD+K NVLLD +N ++ DFGL+ + G +T+ G+ Y APE G+
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 186
Query: 275 -ATTSADVFSFGAFLLEVACGRRP 297
A D++S G L + CG P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 51/278 (18%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNLVQL 157
+G G F +V + E+A+K +++ S Q + E+ + L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG--VIKGVALGLLYLHEEWE 215
+ L L+ +Y G + YL ++ + ++ V Y H+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQ--- 132
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 274
+ ++HRD+KA N+LLD ++N ++ DFG + + G G Y APE + GK
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKK 189
Query: 275 -ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA------RD 327
DV+S G L + G P FD N EL E R
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLP----------------FDGQNLKELRERVLRGKYRI 233
Query: 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
P Y++ + E +LK L +P R ++ Q+++
Sbjct: 234 P----FYMSTDCENLLK-RFLV--LNPIKRGTLEQIMK 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 56/283 (19%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVA------EIVSIGRLRHR 152
LGSG FG V+ + E+ VK I E E EI + R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYNQPKVTLN-----WRQRYGVIKGVALG 206
N++++L +G LV + +G L ++ P++ +RQ ++ V
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ---LVSAVG-- 144
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
YL + +IHRD+K N+++ + +L DFG A + G T GT+ Y A
Sbjct: 145 --YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCA 197
Query: 267 PEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324
PE G +++S G L + P F E +E
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP------------------FCELEETVE 238
Query: 325 A--RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
A P V++EL ++ GLL P R ++ ++V
Sbjct: 239 AAIHPPY----LVSKELMSLVS-GLL--QPVPERRTTLEKLVT 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 52/281 (18%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVA-EIVSIGRLRHR-- 152
LLGSGGFG VY G + +A+K +IS V E+V + ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 153 NLVQLLGYCRRKGELLLVYDY-MPNGSLDKYLYNQPKVTLN-----WRQRYGVIKGVALG 206
+++LL + R +L+ + P L ++ + + + Q V++ V
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ---VLEAVR-- 163
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
+ H V+HRD+K N+L+D +L DFG L D T GT Y
Sbjct: 164 --HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 215
Query: 266 APEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324
PE R + SA V+S G L ++ CG P E + I+ RG++
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEII---------RGQV-- 260
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
V+ E + +++ L P+ RP+ ++
Sbjct: 261 -FFRQ----RVSSECQHLIR-WCL--ALRPSDRPTFEEIQN 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 67/285 (23%), Positives = 106/285 (37%), Gaps = 40/285 (14%)
Query: 34 KKRSKFLTIGLPVICVSLILAAVSGVVY-----VIRRKRKFAEELEDWELDYGPHRFRYK 88
+K L + +L + +VY +R+ + L ++ + +
Sbjct: 7 EKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYK----DTINKIR 62
Query: 89 DLYIATKGFREKELLGSGGFGRVY----RGT--------LPKSKIEIAVKKISHESRQGM 136
DL + + + +++G G FG V + T L K ++ I +
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------ 115
Query: 137 KEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR 196
F E + +VQL + L +V +YMP G L + N V W +
Sbjct: 116 --FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARF 172
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256
Y V L L +H IHRDVK N+LLD + +L DFG + +
Sbjct: 173 Y--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 257 HVVGTLGYLAPE----HTRTGKATTSADVFSFGAFLLEVACGRRP 297
VGT Y++PE G D +S G FL E+ G P
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQL 157
++LG G G+V + +++ + A+K + + +E V + + ++V++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-RE-----VELHWRASQCPHIVRI 120
Query: 158 LGYC----RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ + LL+V + + G L + ++ R+ ++K + + YLH
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 178
Query: 214 WEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
+ HRDVK N+L + +L DFG A+ T T Y+APE
Sbjct: 179 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 235
Query: 271 RTGKATTSADVFSFGA---FLLEVACGRRP 297
K S D++S G LL CG P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILL---CGYPP 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 11/193 (5%)
Query: 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHR-NLV 155
+ LG G F V + + E A K + + E + EI + + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L E++L+ +Y G + + ++ +IK + G+ YLH +
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---Q 149
Query: 216 QVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
++H D+K N+LL ++ DFG++R H + + ++GT YLAPE
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNY 207
Query: 273 GKATTSADVFSFG 285
TT+ D+++ G
Sbjct: 208 DPITTATDMWNIG 220
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 47/302 (15%)
Query: 19 ELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVY-----VIRRKRKFAEEL 73
E+ L QL + GP + + V +L + + +RR++ E L
Sbjct: 3 EVRLRQLEQFILDGPAQTNG------QCFSVETLLDILICLYDECNNSPLRREKNILEYL 56
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVY----RGT--------LPKSKI 121
E P + K + + + F +++G G FG V + L K ++
Sbjct: 57 EW----AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 122 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 181
+ + + F E + + + L + L LV DY G L
Sbjct: 113 -LKRAETAC--------FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163
Query: 182 YLYN-QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240
L + ++ + Y + + + + +H+ +HRD+K N+L+D + RL D
Sbjct: 164 LLSKFEDRLPEEMARFY--LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 241 FGLARLYDHGTDPQTTHVVGTLGYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGR 295
FG Q++ VGT Y++PE G+ D +S G + E+ G
Sbjct: 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 296 RP 297
P
Sbjct: 279 TP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 68/312 (21%), Positives = 115/312 (36%), Gaps = 45/312 (14%)
Query: 63 IRRKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIE 122
+ + + A+ L+ E P R K++ + F +++G G F V + ++
Sbjct: 33 LAQDKYVADFLQWAE----PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 123 IAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGS 178
A+K ++ R + F E + R + QL + + + L LV +Y G
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGD 147
Query: 179 LDKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237
L L ++ + Y + + + + +H +HRD+K N+LLD + R
Sbjct: 148 LLTLLSKFGERIPAEMARFY--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIR 202
Query: 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLE 290
L DFG ++ VGT YL+PE TG D ++ G F E
Sbjct: 203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 291 VACGRRPIERQGPEE--NLILVDWV-FDFWNRGELL--EARDPNLGTEYVAEELELILKL 345
+ G+ P E I+ E + EARD ++
Sbjct: 263 MFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD--------------FIQ- 307
Query: 346 GLLCSHSDPTAR 357
LLC P R
Sbjct: 308 RLLC---PPETR 316
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 153
F+ + + G G FG V G + + +A+KK+ + R +E + + + L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 154 LVQLLGYCRRKGE-------LLLVYDYMPNGSLDKYL--YNQPKVTLNWRQ----RYGVI 200
+VQL Y GE L +V +Y+P+ +L + Y + +V + +I
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHV 258
+ + LH V HRD+K NVL++ E +G L DFG A+ +P ++
Sbjct: 140 RSIG----CLHLP-SVNVCHRDIKPHNVLVN-EADGTLKLCDFGSAKKLSPS-EPNVAYI 192
Query: 259 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
+ Y APE + TT+ D++S G E+ PI
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPI 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQL 157
+ LG G FG+V G + ++AVK ++ + + + EI ++ RH ++++L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWE 215
++ +V +Y+ G L Y+ ++ +R ++ GV Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCHR--- 134
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 274
+V+HRD+K NVLLD +N ++ DFGL+ + G +T+ G+ Y APE G+
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 191
Query: 275 -ATTSADVFSFGAFLLEVACGRRP 297
A D++S G L + CG P
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLP 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVS----IGRLRHR 152
F +G G FG+V +K A+K ++ + E V + + L H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHP 75
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
LV L + + ++ +V D + G L +L + + I + + L YL
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMALDYLQN 133
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HT 270
Q +IHRD+K N+LLD + + DF +A + T T + GT Y+APE +
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSS 188
Query: 271 RTGKA-TTSADVFSFGAFLLEVACGRRP 297
R G + + D +S G E+ GRRP
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 58/299 (19%)
Query: 95 KGFREK----ELLGSGGFGRVYRGTLPKSKIEIAVKKIS--------HESRQGMKEFVAE 142
K R++ + LGSG G V K+ ++A+K IS E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 143 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKG 202
I + +L H ++++ + + + +V + M G L + L
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQ 122
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVV 259
+ L + YLH E +IHRD+K NVLL + + ++ DFG +++ + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC 177
Query: 260 GTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRPIERQGPEENL---IL- 309
GT YLAPE T + D +S G L G P + +L I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL---SGYPPFSEHRTQVSLKDQITS 234
Query: 310 --VDWVFDFWNR-GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+++ + W E +A D L+ K LL DP AR + + ++
Sbjct: 235 GKYNFIPEVWAEVSE--KALD-------------LVKK--LLV--VDPKARFTTEEALR 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 54/283 (19%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVK-----KISHESRQGMKEFVA-EIVSIGRLR---- 150
LLG GGFG V+ G ++++A+K ++ S E+ + ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 151 HRNLVQLLGYCRRKGELLLVYDY-MPNGSLDKYLYNQPKVTLN-----WRQRYGVIKGVA 204
H +++LL + + +LV + +P L Y+ + + + Q V+ +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ---VVAAIQ 153
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLG 263
+ H + V+HRD+K N+L+D +L DFG L H GT
Sbjct: 154 ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRV 203
Query: 264 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322
Y PE + A V+S G L ++ CG P E + IL EL
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEIL---------EAEL 250
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
P +V+ + +++ L P++RPS+ +++
Sbjct: 251 ---HFPA----HVSPDCCALIR-RCL--APKPSSRPSLEEILL 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 49/224 (21%), Positives = 81/224 (36%), Gaps = 49/224 (21%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVA-EIVSIGRLRHRNLVQ 156
+LLG G +G+V ++ AVK + + + V EI + RLRH+N++Q
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 157 L---------------LGYCRRKGELLLVYDYMPNGSLD-----KYLYNQPKVTLNWRQR 196
L + YC + + D +P Y Q
Sbjct: 71 LVDVLYNEEKQKMYMVMEYC--VCGMQEMLDSVPEKRFPVCQAHGYF----------CQ- 117
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256
+I G+ YLH Q ++H+D+K N+LL ++ G+A T
Sbjct: 118 --LIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 257 HVV-GTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRP 297
G+ + PE + D++S G L + G P
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVA-EIVSIGRLRHRNLVQL 157
E LG G FG+V T K++ ++A+K IS + + M V EI + LRH ++++L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 158 LGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRY--GVIKGVALGLLYLHEEWE 215
++++V +Y G L Y+ + ++T + +R+ +I + Y H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHR--- 126
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 274
++HRD+K N+LLD LN ++ DFGL+ + G +T+ G+ Y APE GK
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GKL 183
Query: 275 -ATTSADVFSFGAFLLEVACGRRP 297
A DV+S G L + GR P
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 50/235 (21%)
Query: 100 KELLGSGGFGRVYRGT------------LPKSKI-------------EIAVKKISHESRQ 134
K+ +G G +G V L K K+ +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 135 GMKEFVA-EIVSIGRLRHRNLVQLLGY----CRRKGELLLVYDYMPNGSLDKYLYNQP-- 187
G E V EI + +L H N+V+L + L +V++ + G + + +P
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 188 -KVTLNW-RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245
+ + +IKG+ YLH Q +IHRD+K SN+L+ + + ++ DFG++
Sbjct: 136 EDQARFYFQD---LIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT---TSADVFSFGAFLLEVACGRRP 297
+ D ++ VGT ++APE + + DV++ G L G+ P
Sbjct: 186 EFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 18/201 (8%)
Query: 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYC 161
LG G + V+ + ++ VK + + K+ EI + LR N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 162 R--RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVI 219
+ LV++++ N + +T + Y + + L Y H ++
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFY--MYEILKALDYCHSMG---IM 152
Query: 220 HRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TT 277
HRDVK NV++D E RL D+GLA Y G + V + + PE +
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDY 210
Query: 278 SADVFSFGAFLLEVACGRRPI 298
S D++S G L + + P
Sbjct: 211 SLDMWSLGCMLASMIFRKEPF 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 83 HRFRYKD-LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEF 139
+ D + K ++ + +GSG G V +A+KK+S +++ K
Sbjct: 49 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 108
Query: 140 VAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL-N 192
E+V + + H+N++ LL ++ LV + M D L ++ L +
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDH 163
Query: 193 WRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252
R Y + + + G+ +LH +IHRD+K SN+++ + ++ DFGLAR T
Sbjct: 164 ERMSYLLYQML-CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TS 217
Query: 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
T V T Y APE + D++S G + E+ + +
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKIL 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 34/286 (11%), Positives = 89/286 (31%), Gaps = 49/286 (17%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
+R G + ++ ++A+ + + ++E ++ + + R+
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+ ++L + L+V +++ GSL + P ++ +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA 148
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
V S V + + G + V+ +
Sbjct: 149 G---VALSIDHPSRVRVSID--GDV-------------------VLAYPATMPD------ 178
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
A D+ GA L + R P+ G L + G+ +E D +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA----GQPIEPADIDRD-- 231
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPAISAL 379
+ ++ + + D R + ++ ++++ A+ + +
Sbjct: 232 -IPFQISAVA-ARSV--QGDGGIRSAS-TLLNLMQQATAVADRTEV 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 153
F + LG+G FGRV +S A+K + + +K+ + E + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LV+L + L +V +Y+ G + +L + + + Y + L YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLTFEYLHS- 159
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+I+RD+K N+L+D + ++ DFG A+ T T + GT LAPE +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WT-LCGTPEALAPEIILSK 213
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLIL 309
+ D ++ G + E+A G P P + I+
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 81 GPHRFR-YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMK 137
G +R K + +R+ + +GSG +G V ++ ++A+KK+ +S K
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 69
Query: 138 EFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
E+ + +RH N++ LL + LV +M L K + ++ L
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---L 125
Query: 192 NWRQR----YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247
+ Y ++KG L Y+H +IHRD+K N+ ++ + ++ DFGLAR
Sbjct: 126 GEDRIQFLVYQMLKG----LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-- 176
Query: 248 DHGTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
D + T V T Y APE + T + D++S G + E+ + +
Sbjct: 177 --QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTL 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 83 HRFRYKD-LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEF 139
+ D + K ++ + +GSG G V + +A+KK+S +++ K
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA 71
Query: 140 VAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL-N 192
E+V + + H+N++ LL ++ +V + M D L ++ L +
Sbjct: 72 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDH 126
Query: 193 WRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252
R Y + + + G+ +LH +IHRD+K SN+++ + ++ DFGLAR T
Sbjct: 127 ERMSYLLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TS 180
Query: 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298
T V T Y APE + D++S G + E+ +
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVL 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 81 GPHRFR-YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMK 137
G ++ K + K + +GSG +G V +S ++A+KK+S +S K
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 138 EFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
E++ + ++H N++ LL R + LV +M L +
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKF 123
Query: 192 NWRQR----YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247
+ + Y ++K GL Y+H V+HRD+K N+ ++ + ++ DFGLAR
Sbjct: 124 SEEKIQYLVYQMLK----GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-- 174
Query: 248 DHGTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
D + T V T Y APE + D++S G + E+ + +
Sbjct: 175 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTL 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 153
F +LLG G FG+V + A+K + E E + E + RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 154 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
L L Y + L V +Y G L +L + + + + YG + L YLH
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDYLHS 266
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGYLAPEHTR 271
E + V++RD+K N++LD + + ++ DFGL + + D T GT YLAPE
Sbjct: 267 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
+ D + G + E+ CGR P Q E+ LIL++
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIV 144
K ++ + ++ +GSG +G V K+ + +AVKK+S +S K E+
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 145 SIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQ--R 196
+ ++H N++ LL ++ LV M L+ + Q +T + Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-LTDDHVQFLI 138
Query: 197 YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256
Y +++G L Y+H +IHRD+K SN+ ++ + ++ DFGLAR T + T
Sbjct: 139 YQILRG----LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMT 187
Query: 257 HVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
V T Y APE + D++S G + E+ R +
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTL 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVS 145
++ + +G G +G V +K+ +A+KKIS E + + + EI
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI 78
Query: 146 IGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL-NWRQRYGV 199
+ R RH N++ + + ++ +V D M L K L Q L N Y +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSNDHICYFL 134
Query: 200 IKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD--HGTDPQTTH 257
+ + GL Y+H V+HRD+K SN+LL+ + ++ DFGLAR+ D H T
Sbjct: 135 YQ-ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 258 VVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
V T Y APE K T S D++S G L E+ RPI
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPI 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 28/221 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ + + LG GG G V+ +A+KKI Q +K + EI I RL H N+V+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT-LNWRQRYGVIKGVAL---------- 205
+ G L Y+ + T L V++ L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-----NVLEQGPLLEEHARLFMY 127
Query: 206 ----GLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQT--THV 258
GL Y+H V+HRD+K +N+ ++ E L ++GDFGLAR+ D + +
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 259 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 298
+ T Y +P + T + D+++ G E+ + +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTL 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA----- 141
+L+ + + + SG +G V G + I +A+K++ + G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 142 ------EIVSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT 190
EI + H N++ L +L LV + M L + +++Q V
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI 131
Query: 191 LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250
+Y + + LGL LHE V+HRD+ N+LL + + DF LAR
Sbjct: 132 SPQHIQY-FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-- 185
Query: 251 TDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 298
D TH V Y APE + T D++S G + E+ R+ +
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 22/226 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-------HESRQGMKE-FVAEIVSIGR 148
F +LG G FG+V + AVK + + M E V +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--- 399
Query: 149 LRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
+ L QL C + L V +Y+ G L ++ + Y +A+GL
Sbjct: 400 -KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGL 455
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
+L + +I+RD+K NV+LD E + ++ DFG+ + + T GT Y+AP
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAP 511
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
E S D ++FG L E+ G+ P E + +E I+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 73/257 (28%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 153
+K + + LG+G FG V +S A+KK+ + R +E + + L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 154 LVQLLGYCRRKGE--------------------------------------LLLVYDYMP 175
+++L+ Y G+ L ++ +Y+P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 176 NGSLDKYLYNQPKVTLNWRQR----------YGVIKGVALGLLYLHEEWEQVVIHRDVKA 225
+ +L K L + + + Y + + V ++H + HRD+K
Sbjct: 122 D-TLHKVLKSFIRS----GRSIPMNLISIYIYQLFRAVG----FIHS---LGICHRDIKP 169
Query: 226 SNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADV 281
N+L++ L +L DFG A+ +P ++ + Y APE T S D+
Sbjct: 170 QNLLVNSKDNTL--KLCDFGSAKKLIPS-EPSVAYIC-SRFYRAPELMLGATEYTPSIDL 225
Query: 282 FSFGAFLLEVACGRRPI 298
+S G E+ +P+
Sbjct: 226 WSIGCVFGEL-ILGKPL 241
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 97 FREKELLGSGGFGRVY----RGT--------LPKSKIEIAVKKISHESRQGMKEFVAEIV 144
F+ LG+G FGRV+ R L K + + +K++ H E +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHT--------NDERL 58
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA 204
+ + H ++++ G + ++ ++ DY+ G L L + + Y V
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVC 116
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLG 263
L L YLH + +I+RD+K N+LLD + ++ DFG A+ P T+ + GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPD 168
Query: 264 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
Y+APE T S D +SFG + E+ G P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 52/241 (21%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS-HESRQGMKEFVAEIVSI 146
+ +Y + F+ K LLG G +G V T + +A+KKI + + EI +
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 147 GRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIK 201
+H N++ + E+ ++ + M L+ VI
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHR-------------VIS 105
Query: 202 GVAL--------------GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247
L + LH VIHRD+K SN+L++ + ++ DFGLAR+
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 248 D---------HGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRP 297
D G V T Y APE T + + DV+S G L E+ RRP
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRP 221
Query: 298 I 298
I
Sbjct: 222 I 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 102 LLGSGGFGRVY--RGTLPKSKIEI-AVKKISHESRQGMKEFVAEIVS----IGRLRHRN- 153
+LG+G +G+V+ R ++ A+K + + + + + +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 154 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
LV L Y + + +L L+ DY+ G L +L + + T + Q Y + + L L +LH+
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY--VGEIVLALEHLHK 177
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---H 269
+I+RD+K N+LLD + L DFGL++ + + GT+ Y+AP+
Sbjct: 178 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306
+G + D +S G + E+ G P G + +
Sbjct: 235 GDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 53/227 (23%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 102 LLGSGGFGRVY--RGTLPKSKIEI-AVKKISHESRQGMKEFVA----EIVSI-------G 147
+LG GG+G+V+ R + +I A+K + K + +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76
Query: 148 RLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
++H +V L+ Y + G+L L+ +Y+ G L L + + Y + +++
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--LAEISMA 133
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
L +LH+ + +I+RD+K N++L+ + + +L DFGL + H T GT+ Y+A
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 267 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
PE + D +S GA + ++ G P + ++ + IL
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 102 LLGSGGFGRVY--RGTLPKSKIEI-AVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQ 156
+LG G FG+V+ + ++ A+K + + + E + + H +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 157 LLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L Y + +G+L L+ D++ G L L + T + Y + +AL L +LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDHLHS--- 144
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+I+RD+K N+LLD E + +L DFGL++ + GT+ Y+APE
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH 203
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
T SAD +SFG + E+ G P + + +E +IL
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 102 LLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRNLVQLL 158
LLG G FG+V + A+K + E E V E + RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 159 GYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV 217
Y + L V +Y G L +L + T + YG + L YLH +
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--EIVSALEYLHS---RD 125
Query: 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGYLAPEHTRTGKAT 276
V++RD+K N++LD + + ++ DFGL + + +D T GT YLAPE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
+ D + G + E+ CGR P Q E LIL++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 38/229 (16%)
Query: 102 LLGSGGFGRVY----RGT--------LPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
++G G FG+V + L K I + K+ H E V +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI-LKKKEEKHIMSERN----------VLL 93
Query: 147 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
++H LV L + + +L V DY+ G L +L + + Y +A
Sbjct: 94 KNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--AAEIAS 150
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGY 264
L YLH +++RD+K N+LLD + + L DFGL + ++ TT GT Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEY 205
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
LAPE + D + GA L E+ G P + E + IL
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 70/356 (19%), Positives = 108/356 (30%), Gaps = 106/356 (29%)
Query: 97 FREK----ELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHESRQG-----------M 136
R++ + LG G FG+V + +AVK + + +
Sbjct: 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 79
Query: 137 KEF----------------------VAEIVSIGRLRH---RNLVQLLGYCRRKGELLLVY 171
+ E G L + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139
Query: 172 DYMPNGSLDKYLYN-------------------------------QPKVTLNWRQRYGVI 200
DY+ +D K L
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 260
VA G+ +L + IHRD+ A N+LL + ++ DFGLAR D DP +V
Sbjct: 200 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP--DYVRK 252
Query: 261 TLGYL-----APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPI-ERQGPEENLILVDWV 313
L APE T +DV+SFG L E+ G P + EE
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------F 305
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G + A P +Y E+ + L C H +P+ RP+ ++V+ L
Sbjct: 306 CRRLKEGTRMRA--P----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 352
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 102 LLGSGGFGRV----YRGT--------LPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
+LG G FG+V +GT L K + I + E R V +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKR------VLALPG- 78
Query: 147 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
+ L QL C + L V +Y+ G L ++ + Y +A+
Sbjct: 79 ---KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAI 132
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
GL +L + +I+RD+K NV+LD E + ++ DFG+ + T GT Y+
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYI 188
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
APE S D ++FG L E+ G+ P E + +E I+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 97 FREKELLGSGGFGRV----YRGT--------LPKSKIEIAVKKISH---ESRQGMKEFVA 141
F ++LG G FG+V ++ T L K + + + E R V
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKR------VL 71
Query: 142 EIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVI 200
+ H L + + K L V +Y+ G L ++ + K L+ Y
Sbjct: 72 SLAW----EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--A 124
Query: 201 KGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 260
+ LGL +LH + +++RD+K N+LLD + + ++ DFG+ + + D +T G
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCG 180
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
T Y+APE K S D +SFG L E+ G+ P Q EE + I +D
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 48/275 (17%)
Query: 102 LLGSGGFGRVY----RGT--------LPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
++G G + +V + T + K + + I E V E S
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKH------VFEQAS- 67
Query: 147 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
H LV L C + + L V +Y+ G L ++ Q K+ + Y ++L
Sbjct: 68 ---NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--ISL 121
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGY 264
L YLHE + +I+RD+K NVLLD E + +L D+G+ + + TT GT Y
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNY 176
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324
+APE R S D ++ G + E+ GR P + G +N D L +
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN-------PDQNTEDYLFQ 229
Query: 325 A--RDPNLGTEYVAEELELILKLGLLCSHSDPTAR 357
++ + +LK L + DP R
Sbjct: 230 VILEKQIRIPRSLSVKAASVLK-SFL--NKDPKER 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 49/210 (23%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 151
+ + L+G+G +G V K +A+KKI EI + RL H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNRLNH 111
Query: 152 RNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR--YGVIKGVA 204
++V++L + EL +V + + K +T + Y ++ G
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG-- 168
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH--------------- 249
+ Y+H ++HRD+K +N L++ + + ++ DFGLAR D+
Sbjct: 169 --VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 250 -----------GTDPQTTHVVGTLGYLAPE 268
Q T V T Y APE
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 102 LLGSGGFGRVY----RGT--------LPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
+LG G FG+V + T L K I + + E R + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKR------ILSLAR- 81
Query: 147 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
H L QL C + L V +++ G L ++ + + Y +
Sbjct: 82 ---NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIIS 135
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGY 264
L++LH+ + +I+RD+K NVLLD E + +L DFG+ + + + TT GT Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDY 190
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE--NLILVD 311
+APE + + D ++ G L E+ CG P E + ++ IL D
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 102 LLGSGGFGRVY----RGT--------LPKSKIEIAVKKISH---ESRQGMKEFVAEIVSI 146
++G G + +V + T + K + + I E V E S
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKH------VFEQAS- 110
Query: 147 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
H LV L C + + L V +Y+ G L ++ Q K+ + Y ++L
Sbjct: 111 ---NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--ISL 164
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGY 264
L YLHE + +I+RD+K NVLLD E + +L D+G+ + + TT GT Y
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNY 219
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 297
+APE R S D ++ G + E+ GR P
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 7e-13
Identities = 35/216 (16%), Positives = 65/216 (30%), Gaps = 51/216 (23%)
Query: 80 YGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------- 132
GP F + + T+ + E +G G FG V++ + +A+K I+ E
Sbjct: 8 KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGS 62
Query: 133 -RQGMKEFVAEIV---------SIGRLRHRNLVQLLGYCRRKG----ELLLVYDYM---- 174
++ +E + EI+ R + L +G LL +D+
Sbjct: 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 175 --PNGSLDKYLYNQ-----------------PKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
N D + +Q + ++ + L
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR 182
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251
HRD+ NVLL +L + +
Sbjct: 183 --FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 65 RKRKFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIA 124
R+ + + +++ + Y L+G G +G VY ++ +A
Sbjct: 11 RENLYFQGIKNVHVPD-----NYIIK----------HLIGRGSYGYVYLAYDKNTEKNVA 55
Query: 125 VKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNG 177
+KK++ E K + EI + RL+ +++L + EL +V + +
Sbjct: 56 IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS- 114
Query: 178 SLDKYLYNQPKVTLNWRQR--YGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235
L K +T + Y ++ G ++HE +IHRD+K +N LL+ + +
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLG----ENFIHE---SGIIHRDLKPANCLLNQDCS 167
Query: 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 277
++ DFGLAR + D + + P + K T
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 81 GPH---RFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK 137
GPH + K I ++LG G G+V + +++ + A+K + + + +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR 59
Query: 138 EFVAEIVSIGR--LRHRNLVQLLGYC----RRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
E V + + ++V+++ + LL+V + + G L + ++
Sbjct: 60 E-----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 192 NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLA 244
R+ ++K + + YLH + HRDVK N+L +L DFG A
Sbjct: 115 TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 62/242 (25%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISH--ESRQGMKEFVAEIVSIGRLR-HRN 153
+ + LG G +G V++ ++ +AVKKI ++ + EI+ + L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 154 LVQLLGYCRRKG--ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL------ 205
+V LL R ++ LV+DYM + L+ VI+ L
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYM-----ETDLHA-------------VIRANILEPVHKQ 112
Query: 206 --------GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY---------- 247
+ YLH ++HRD+K SN+LL+ E + ++ DFGL+R +
Sbjct: 113 YVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 248 ----------DHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRR 296
P T V T Y APE T D++S G L E+ +
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGK 228
Query: 297 PI 298
PI
Sbjct: 229 PI 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 31/240 (12%)
Query: 79 DYGP---HRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI---SHES 132
DY P H + Y + + LG G F V+ + +A+K + +
Sbjct: 1 DYRPGGYHPAFKGEPYKDAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT 59
Query: 133 RQGMKEF-------VAEIVSIGRLRHRNLVQLLGYCRRKGE----LLLVYDYMPNGSLDK 181
E A+ + ++++LL + KG +++V++ + +L
Sbjct: 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA 118
Query: 182 YLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD------GELN 235
+ + + K + LGL Y+H +IH D+K NVL++ +
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQ 176
Query: 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 295
++ D G A YD T+ + T Y +PE AD++S + E+ G
Sbjct: 177 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-08
Identities = 9/29 (31%), Positives = 15/29 (51%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRV 31
+ YIL W F N Q+ + + P++ R
Sbjct: 227 TVYILSWRFSSNLQSTSVKAAMEPEITRT 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 6e-08
Identities = 55/408 (13%), Positives = 125/408 (30%), Gaps = 93/408 (22%)
Query: 59 VVYVIRRKRK-----FAEELEDWELDYG----PHRFRYKDLYIATKGFRE-KELLGSGG- 107
+ + + K++ F EE+ ++Y P + + + T+ + E ++ L +
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVL--RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 108 -FGR--VYRGTLPKSKIEIAVKKISHESR---QGMKEF-----VAEIVSIGRLRHRNLVQ 156
F + V R P K+ A+ ++ G+ ++ +++ + +
Sbjct: 125 VFAKYNVSRLQ-PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK 183
Query: 157 L----LGYCRRKGELL-----LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
+ L C +L L+Y PN + ++ + N + R I+ L
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWT------SRSDHSSNIKLRIHSIQAELRRL 237
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG------T-DPQTTHVVG 260
L +++ +V+ + ++ T Q T +
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAW---------------NAFNLSCKILLTTRFKQVTDFLS 282
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQG--PEE-NLI---LVDWV- 313
T +V S L+ P E P ++I + D +
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA 342
Query: 314 -FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ---ILER 369
+D W ++L I++ L + +P R++ +
Sbjct: 343 TWDNWKH--------------VNCDKLTTIIESSL--NVLEP---AEYRKMFDRLSVFPP 383
Query: 370 DVALPAISALGLSARGITYQEGFDDFAVSYSSSMGFTRPSSLAESLLS 417
+P L L + + + S+ +P S+ S
Sbjct: 384 SAHIPT-ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 9e-05
Identities = 50/288 (17%), Positives = 85/288 (29%), Gaps = 75/288 (26%)
Query: 17 AQELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSLILAAVSGVVYVIRRKR--------- 67
+ L+ LPR P +S+I ++ +
Sbjct: 308 LKYLDCR-PQDLPREVLT--------TNPRR-LSIIAESIR--DGLATWDNWKHVNCDKL 355
Query: 68 -----KFAEELEDWELDYGPHRFRYKDLYIATKGFRE-----KELLGSGGFGRVYRGTLP 117
LE E R + L + F LL + +
Sbjct: 356 TTIIESSLNVLEPAEY-----RKMFDRLSV----FPPSAHIPTILLS------LIWFDVI 400
Query: 118 KSKIEIAVKKISHES---RQGMKEFVAEIVSIG-RLR---------HRNLVQLLGYCRRK 164
KS + + V K+ S +Q KE I SI L+ HR++V Y K
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQP-KESTISIPSIYLELKVKLENEYALHRSIVD--HYNIPK 457
Query: 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK 224
D + LD+Y Y+ L + + +++L + + I D
Sbjct: 458 T---FDSDDLIPPYLDQYFYSHIGHHLKNIEHPE--RMTLFRMVFLDFRFLEQKIRHDST 512
Query: 225 ASNVLLDGELNGRLGDFGLARLY-DHGTD--PQTTHVVGTLGYLAPEH 269
A N G + L + Y + D P+ +V + P+
Sbjct: 513 AWNA--SGSILNTLQQL---KFYKPYICDNDPKYERLVNAILDFLPKI 555
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 59/382 (15%), Positives = 104/382 (27%), Gaps = 132/382 (34%)
Query: 77 ELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM 136
+ + G H+++YKD+ V+ K + + +
Sbjct: 8 DFETGEHQYQYKDIL------------------SVF---EDAFVDNFDCKDVQDMPKSIL 46
Query: 137 -KEFVAEIVSIGRLRHRNLVQLLGYCRRKG--------ELLLVYDY------------MP 175
KE + I+ L L K E +L +Y P
Sbjct: 47 SKEEIDHIIMSKDAVSGTLR-LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 176 NGSLDKY------LYN--QPKVTLN-WR-QRYGVIKGVALGLLYLHEEWEQVVIH----- 220
+ Y LYN Q N R Q Y ++ L L + V+I
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL--RPAKN--VLIDGVLGS 161
Query: 221 -RDVKASNVLLDGELNGRLGD------FG-----------LARLYDHGTDPQTTHVVGTL 262
+ A +V L ++ ++ L +L + DP T
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTS----- 215
Query: 263 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322
+H+ K S A L RR ++ + E L+++ + N +
Sbjct: 216 ---RSDHSSNIKLRIH----SIQAEL------RRLLKSKPYENCLLVLL---NVQNA-KA 258
Query: 323 LEA-----------RDPNL-----GTEYVAEELELILK-------LGLL--CSHSDPTAR 357
A R + L+ LL P
Sbjct: 259 WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 358 PSMRQVVQILERDVALPAISAL 379
P R+V+ R +++ I+
Sbjct: 319 P--REVLTTNPRRLSI--IAES 336
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 70/393 (17%), Positives = 116/393 (29%), Gaps = 112/393 (28%)
Query: 71 EELEDWELDYGPHRFRYKDLYIATKG------FREKELLGSGGFGRVYRGTLPKSKIEIA 124
+E ED DY + ++ G + LG G F V+ + K +A
Sbjct: 13 DEQEDPN-DYCKGGY-----HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVA 66
Query: 125 VK---KISHESRQGMKEF-VAEIVSIGRLRHRN---LVQLLGYCRRKGE----LLLVYDY 173
+K H + + E + + V N +VQLL + G + +V++
Sbjct: 67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV 126
Query: 174 MPNG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL-- 230
+ G L K++ L +I+ V GL YLH + +IH D+K N+LL
Sbjct: 127 L--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSV 182
Query: 231 -----------------------------------------------DGELNGRLGDFGL 243
+L ++ D G
Sbjct: 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
Query: 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303
A T + T Y + E T AD++S E+A G E
Sbjct: 243 ACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298
Query: 304 EENLILVD---------------------WVFDFWNR-GELLEARDPNLGT--------- 332
EE D + +F+ + G+L
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E+ EE L P R + + ++
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 45/207 (21%), Positives = 72/207 (34%), Gaps = 55/207 (26%)
Query: 97 FREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHESRQGMKEF-----VAEIVSI 146
++ +G GGFG +Y + S VK ++ E A+ I
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 147 GRLRHRNLVQLLG-----YCRRKGELLLVYDYM------PNGSLDKYLYNQP-----KVT 190
+ ++ LG + Y +M L K K
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKRFSRKTV 154
Query: 191 LNWRQRYGVIKGVALGLL----YLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLA 244
L ++L +L Y+HE +H D+KASN+LL+ + + L D+GLA
Sbjct: 155 LQ----------LSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 245 RLY-DHGT------DPQTTHVVGTLGY 264
Y G DP+ H GT+ +
Sbjct: 202 YRYCPEGVHKAYAADPKRCH-DGTIEF 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 39/204 (19%), Positives = 68/204 (33%), Gaps = 49/204 (24%)
Query: 97 FREKELLGSGGFGRVYRGT--------LPKSKIEIAVK------KISHES----RQGMKE 138
++ K G +Y K + ++K ++ +E R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 139 FVAEIVSIGRLRHRNLVQLLGYCRRKGEL-LLVYDYMPNG-SLDKYLYNQPKVTLNWRQR 196
V + + + +G+ + + LV + G SL L PK L+
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLS---- 157
Query: 197 YGVIKGV---ALGLL----YLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY 247
+ V A LL +LH E +H +V A N+ +D E + L +G A Y
Sbjct: 158 ---ERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 248 -DHGT------DPQTTHVVGTLGY 264
G ++ H G L +
Sbjct: 212 CPSGKHVAYVEGSRSPH-EGDLEF 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 42/203 (20%), Positives = 72/203 (35%), Gaps = 50/203 (24%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFV--------AEIVSIGR 148
+ + +GSGGFG +Y + A + E ++ F A+ I +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 149 LRHRNLVQLLG--YCRRKGELL--------LVYDYMPNG-SLDKYLYNQPKVTLNWRQRY 197
R + LG G +V + + G L K
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKK------ 150
Query: 198 GVIKGV---ALGLL----YLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY- 247
V + +L Y+HE +H D+KA+N+LL + + L D+GL+ Y
Sbjct: 151 ---STVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 248 DHGT------DPQTTHVVGTLGY 264
+G +P+ H GT+ +
Sbjct: 205 PNGNHKQYQENPRKGH-NGTIEF 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 40/210 (19%), Positives = 83/210 (39%), Gaps = 31/210 (14%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHES--RQGMKE--FVAEIVSIGRLRHRNLV 155
+++G G FG+V + K +A+K + + + RQ +E + + + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 156 QLLGYCRRKGELLLV--------YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
+L + + + Y+ + Q +L +++ + L
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNK------FQG-FSLPLVRKFA--HSILQCL 213
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNG--RLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
LH + +IH D+K N+LL + ++ DFG + + T++ + Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFYR 266
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGR 295
APE + D++S G L E+ G
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 40/183 (21%), Positives = 69/183 (37%), Gaps = 35/183 (19%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFVAEIVS 145
L + FR + +G G FG + G + +A+K + + Q E+
Sbjct: 3 GVLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL 61
Query: 146 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG-SLDKYLYNQPKVTLNWRQRYGVIKGV- 203
+ Q+ + +V + + G SL+ + R +K V
Sbjct: 62 GS---GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLF--------DLCDRTFSLKTVL 108
Query: 204 --ALGLL----YLHEEWEQVVIHRDVKASNVLLDGELNGR-----LGDFGLARLYDHGTD 252
A+ L+ Y+H + +I+RDVK N L+ N + DF LA+ Y D
Sbjct: 109 MIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY---ID 162
Query: 253 PQT 255
P+T
Sbjct: 163 PET 165
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 91 YIATKG------FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI-SHES--RQGMKE--F 139
YI G + L+G G FG+V + + +A+K I + ++ Q E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL 103
Query: 140 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YNQPKVTLNWRQRY 197
+ + +V L + + L LV++ + + +L L N V+LN +++
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 198 GVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG--RLGDFGLARLYDHGTDPQT 255
+ + LL+L E +IH D+K N+LL ++ DFG +
Sbjct: 163 A--QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIY 216
Query: 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 295
++ + Y +PE + D++S G L+E+ G
Sbjct: 217 QYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 35/177 (19%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV- 155
FR +GSG FG +Y GT ++ E+A+K + +++ + E L+ +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIP 66
Query: 156 QLLGYCRRKGELLLVYDYMPNG-SLDKYLYNQP-----KVTLNWRQRYGVIKGVALGLL- 208
+ + +LV D + G SL+ K L +A ++
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM----------LADQMIN 114
Query: 209 ---YLHEEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLARLYDHGTDPQT-THV 258
++H + +HRD+K N L+ + DFGLA+ Y D T H+
Sbjct: 115 RVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTSTHQHI 165
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 40/177 (22%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 154
++ +G G FG ++ GT + ++A+K ++ Q E+ + G +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGI 68
Query: 155 VQLLGYCRRKGELLLVYDYMPNG-SLDKYLYNQP-----KVTLNWRQRYGVIKGVALGLL 208
+ + + +LV D + G SL+ L K A +L
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM----------AAKQML 116
Query: 209 ----YLHEEWEQVVIHRDVKASNVLLDGELNGR------LGDFGLARLYDHGTDPQT 255
+HE + +++RD+K N L+ G N + + DFG+ + Y DP T
Sbjct: 117 ARVQSIHE---KSLVYRDIKPDNFLI-GRPNSKNANMIYVVDFGMVKFY---RDPVT 166
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 41/181 (22%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR 148
+L + + +R +GSG FG +Y GT + E+A+K +++ E
Sbjct: 4 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKM 60
Query: 149 LRH-RNLVQLLGYCRRKGELLLVYDYMPNG-SLDKYLYNQP-KVTLNWRQRYGVIKGVAL 205
++ + + ++V + + G SL+ K +L + +A
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK------TVLLLAD 112
Query: 206 GLL----YLHEEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQT-TH 257
++ Y+H + IHRDVK N L+ G + DFGLA+ Y D +T H
Sbjct: 113 QMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY---RDARTHQH 166
Query: 258 V 258
+
Sbjct: 167 I 167
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.4 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.84 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.71 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.2 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.05 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.26 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.23 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 90.46 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 85.79 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 82.75 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=441.91 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=208.7
Q ss_pred cCCCccceecccCceEEEEEEeCC-----CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
++|.+.+.||+|+||+||+|++.+ ++..||||++........++|.+|+++|++++|||||+++|+|.+.+.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456778899999999999999753 577899999987777777889999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCC-------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcE
Q 036051 170 VYDYMPNGSLDKYLYNQP-------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~ 236 (420)
|||||++|+|.++|+... ...++|.+++.|+.|||.||+|||+ ++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997542 2369999999999999999999999 999999999999999999999
Q ss_pred EEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhh
Q 036051 237 RLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 314 (420)
||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......+. ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~--- 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID--- 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence 9999999986543322 23345679999999999999999999999999999999999 8999986554321 11
Q ss_pred hhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
.+..+. .+..+..+ ...+.+++.+||+.||++||||.||++.|+.....
T Consensus 272 -~i~~g~-----~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 -CITQGR-----ELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHHHTC-----CCCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHcCC-----CCCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111 12222222 34578889999999999999999999999876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=438.44 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=213.1
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----CceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|.+.+.||+|+||+||+|++.+ ++..||||++........++|.+|+++|++++|||||+++|+|.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3567788999999999999998753 46789999998777777788999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC-----------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 169 LVYDYMPNGSLDKYLYNQP-----------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
+|||||++|+|.++|+... ...++|.+++.|+.|||.||+|||+ ++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997542 3469999999999999999999999 9999999999999999999999
Q ss_pred EeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhh
Q 036051 238 LGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFD 315 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 315 (420)
|+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+. . .
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~----~ 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----E 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H----H
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----H
Confidence 9999999865433221 2234568999999999999999999999999999999998 8999987554321 1 1
Q ss_pred hcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+..+.. +..+.. ....+.+++.+||+.||++|||+.||++.|++.
T Consensus 242 ~i~~~~~-----~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CITQGRV-----LQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCC-----CCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111211 112222 234578899999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=435.93 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=209.9
Q ss_pred cCCCccceecccCceEEEEEEeC-----CCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.+++..+.||+|+||+||+|++. .+++.||||++.... ....++|.+|+.++++++||||++++|+|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999974 356789999997542 334578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC
Q 036051 169 LVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~ 234 (420)
+|||||++|+|.++|.... ...++|.+++.|+.|||.||+|||+ .+|+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 9999999999999996532 2368999999999999999999999 9999999999999999999
Q ss_pred cEEEeeecCcccccCCC-CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhh
Q 036051 235 NGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDW 312 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 312 (420)
.+||+|||+++...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+ +.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~-- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VV-- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HH--
Confidence 99999999998654322 223345679999999999999999999999999999999998 899998765432 11
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+..+.. +..+. ++...+.+++.+||+.||++||||.||++.|+..
T Consensus 258 --~~i~~~~~-----~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 --EMIRNRQV-----LPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHcCCC-----CCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112211 11112 2345578899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=427.51 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=203.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|.+.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+.++++++||||++++|+|.+ +.+++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4677888999999999999999853 4899988643 44556789999999999999999999999865 5689999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|||++|+|.++|+.... .++|.+++.|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 111 Ey~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp ECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999976533 69999999999999999999999 999999999999999999999999999998664322
Q ss_pred -CCcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 252 -DPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 252 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||......... ......+ ...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----YAS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCC
Confidence 223445689999999999853 46899999999999999999999999765543211 1111111 111
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
|.+ .....++...+.+++.+||+.||++||||.||++.|+..
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 112223345678899999999999999999999988753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=434.73 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=206.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.|.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6799999999999999999999999999999998654 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
||++|+|.++|.......+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 9999999999987666678999999999999999999999 999999999999999999999999999998654211
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+.. .... .+ ..+....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~-~~-----~~~~~~~ 247 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV------LKII-SG-----SFPPVSL 247 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-HT-----CCCCCCT
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHH-cC-----CCCCCCc
Confidence 1234568999999999999999999999999999999999999999765433211 1111 11 1112222
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.++ ..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233 34778888999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=426.53 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=210.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
..|+..+.||+|+||+||+|+++.+++.||||++........+.+.+|+.+|++++||||+++++++.+.+.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999999999999999997654444566889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999999764 58999999999999999999999 999999999999999999999999999998765432 23
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+... .+. ....+.+..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~---------~~~~~~~~~-- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIR---------DNLPPRLKN-- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH---------HSSCCCCSC--
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHH---------cCCCCCCCc--
Confidence 455789999999999999999999999999999999999999997654432111 111 111111111
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122345778888999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=412.30 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=198.8
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeEEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLVY 171 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 171 (420)
+..+.||+|+||+||+|.+..++..||+|++... .....+.|.+|+.++++++|||||++++++.+ .+.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999999999999999998654 34445779999999999999999999999865 35689999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEcC-CCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDG-ELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~ 248 (420)
|||++|+|.+++.... .+++..+..++.||+.||+|||+ ++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999997654 68999999999999999999998 66 999999999999984 7899999999998643
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||......... ......+. .+
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~------~~~i~~~~-----~~ 248 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV-----KP 248 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC-----CC
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH------HHHHHcCC-----CC
Confidence 2 23445789999999999865 6999999999999999999999999754432211 11111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.......+.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111234778889999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=415.99 Aligned_cols=270 Identities=27% Similarity=0.335 Sum_probs=205.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----eEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 170 (420)
++|.+.+.||+|+||+||+|++ +++.||||++...... ...+..|+..+.+++||||++++++|.+.+ .+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4577789999999999999998 4678999999755332 233456777778899999999999998654 68999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc-----cCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW-----EQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
||||++|+|.++|+.. .++|..+.+++.|++.||+|||+.. .++|+||||||+|||++.++++||+|||+++
T Consensus 80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999999865 5899999999999999999999731 2489999999999999999999999999998
Q ss_pred cccCCCCC---cccccccCCcccccccccCC------CCCccchhhhhHHHHHHHhcCCccCCCCCCcccc----hhhhh
Q 036051 246 LYDHGTDP---QTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACGRRPIERQGPEENL----ILVDW 312 (420)
Q Consensus 246 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~----~~~~~ 312 (420)
........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.||......+.. ...++
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543321 22346799999999998654 4678999999999999999999887654332211 00001
Q ss_pred hhhhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 313 VFDFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
....+.........+|.++... ..+....+.+++.+||+.||++||||.||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111111223344443332 345677899999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-56 Score=421.94 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=206.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+.|+..+.||+|+||+||+|+++.+++.||||+++.... ..+|+.++++++|||||++++++.+.+.+|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457778899999999999999999999999999975422 247999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccccCCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 253 (420)
++|+|.++|+..+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 69999999999999999999999 9999999999999999987 6999999999876543211
Q ss_pred ----cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 254 ----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 254 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+.... ......-.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~~~~------ 275 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEPPPI------ 275 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHSCCGG------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcCCCCc------
Confidence 22345799999999999999999999999999999999999999987654432111 00000000
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..........+.+++.+||+.||.+|||+.|+++.|...
T Consensus 276 --~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 --REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111122334577888899999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=414.04 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=209.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+++|++++||||+++++++.+.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999999999999999999754 2233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.++|...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 69999999999999999999999 999999999999999999999999999999765432
Q ss_pred -CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 -DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+.. ..+..+ ...+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~------~~~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-------AKIIKL------EYDF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHT------CCCC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC------CCCC
Confidence 23445678999999999999999999999999999999999999999765432211 111111 1122
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
+..++ ..+.+++.+||+.||++|||+.|++
T Consensus 254 p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 22333 3467888899999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=427.80 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=211.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.+.|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.+|++++||||+++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999999999999999999765444456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
|++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 9999999999764 58999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+... .+. ....+.+..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~---------~~~~~~~~~- 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIR---------DNLPPRLKN- 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH---------HSCCCCCSC-
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHH---------cCCCCCCcc-
Confidence 3456789999999999999999999999999999999999999997655432111 111 111111111
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.|+++
T Consensus 370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112234778888999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=423.79 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=214.1
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCCC-----ceeeeeeccccc-chhHHHHHHHHHHHhccCCc-ceEeeeeeeee
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCR 162 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~ 162 (420)
-++..++|++.+.||+|+||+||+|++.+. ++.||||++... .....+.|.+|+.+|.+++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 345668899999999999999999997543 357999998765 33445789999999999965 99999999987
Q ss_pred eC-CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCC
Q 036051 163 RK-GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASN 227 (420)
Q Consensus 163 ~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~N 227 (420)
.. +.+++|||||++|+|.++|+... ...+++.+++.++.|||.||+|||+ ++|+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccc
Confidence 64 67899999999999999997532 2358999999999999999999999 999999999999
Q ss_pred EEEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcc
Q 036051 228 VLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEE 305 (420)
Q Consensus 228 Ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~ 305 (420)
||+++++.+||+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999866543322 3345678999999999999999999999999999999998 999998755432
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
. +...+.++. .+..+..+ ...+.+++.+||+.||++|||+.||++.|++.+
T Consensus 296 ~------~~~~i~~g~-----~~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 E------FCRRLKEGT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp H------HHHHHHHTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H------HHHHHHcCC-----CCCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1 111121221 12222222 345778889999999999999999999997653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=400.21 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=193.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998654 2233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+ +|+|.+++...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 789999997764 69999999999999999999999 999999999999999999999999999998654322
Q ss_pred CCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+..+. ......+ ...+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~------~~~~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNG------VYTL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHT------CCCC
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcC------CCCC
Confidence 3345789999999999988776 5799999999999999999999976443221 1111111 1112
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 232 p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22222 34678888999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=405.85 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=197.0
Q ss_pred cCCCccceecccCceEEEEEEeC---CCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
++|++.+.||+|+||+||+|++. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999873 456789999986542 2223467889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.++|.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 68999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+... . ..++ ...
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~-i~~~------~~~ 244 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------M-ILKA------KLG 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHC------CCC
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH------H-HHcC------CCC
Confidence 22 23345789999999999999999999999999999999999999998655432111 1 1111 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSM-----RQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 365 (420)
.+...+ ..+.+++.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 222233 346788889999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=398.59 Aligned_cols=250 Identities=21% Similarity=0.361 Sum_probs=190.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--------
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-------- 165 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 165 (420)
++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999999899999999987543 334567899999999999999999999886543
Q ss_pred ----eEEEEEeecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEee
Q 036051 166 ----ELLLVYDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240 (420)
Q Consensus 166 ----~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 240 (420)
.+|+||||+++|+|.+++..... ...++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999986543 235567788999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCC-----------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh
Q 036051 241 FGLARLYDHGTDP-----------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL 309 (420)
Q Consensus 241 fg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~ 309 (420)
||+++........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence 9999876543211 2234579999999999999999999999999999999996 7753211 0000
Q ss_pred hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+. ....... .....+....+.+++.+||+.||.+|||+.|+++
T Consensus 237 ---~~---------~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 ---LT---------DVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HH---------HHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HH---------HHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0011111 1112233344667899999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.85 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=204.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee------CCe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KGE 166 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 166 (420)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+|++++||||+++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999999999999999998654 33445678899999999999999999998754 367
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+|+|||||+ |+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 78999997654 69999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCC---CCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc---
Q 036051 247 YDHGT---DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR--- 319 (420)
Q Consensus 247 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 319 (420)
+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+..............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 54321 2234457899999999998765 5699999999999999999999999876543322111000000000
Q ss_pred -----Cc---cccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 -----GE---LLEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 -----~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ......+.....+ .+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000111111100 0111245778899999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=377.45 Aligned_cols=284 Identities=38% Similarity=0.662 Sum_probs=244.5
Q ss_pred ccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 84 RFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
++.+.++...+++|+..+.||+|+||.||+|++. ++..||||++........+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3445555667899999999999999999999975 567899999877666667889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997553 2358999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCC-CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC
Q 036051 242 GLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 242 g~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
|++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654322 222334568999999999988899999999999999999999999998877766666666766666666
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.+....++........+....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 666777777777778888999999999999999999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=378.24 Aligned_cols=289 Identities=41% Similarity=0.736 Sum_probs=246.7
Q ss_pred CCccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh-HHHHHHHHHHHhccCCcceEeeeeee
Q 036051 82 PHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGY 160 (420)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~ 160 (420)
...|++.++....++|+..+.||+|+||.||+|++. ++..||||++...... ....+.+|+.++.+++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 467899999999999999999999999999999874 5778999998765322 22368899999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChhhhhccCCC--ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 161 CRRKGELLLVYDYMPNGSLDKYLYNQPK--VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
+...+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+..+++||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999986532 35999999999999999999999922229999999999999999999999
Q ss_pred eeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCC--CCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQ--GPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~--~~~~~~~~~~~~~~~ 316 (420)
+|||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||... .........+|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999876554444445566999999999998888999999999999999999999999632 122334456677777
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..........+......+..+....+.+++.+||+.||.+|||+.||++.|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 7777777777777777888899999999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=404.40 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=211.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|++.+.||+|+||+||+|+++.+++.||+|++........+.+.+|+.+|+.++||||+++++++.+.+.+++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 67999999999999999999999999999999997766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC--CcEEEeeecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE--LNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfg~~~~~~~~~~ 252 (420)
++|+|.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999986543 269999999999999999999999 999999999999999854 79999999999876543
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.... +.. .+.....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~-------i~~------~~~~~~~ 377 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-------VKS------CDWNMDD 377 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHT------TCCCCCS
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------HHh------CCCCCCc
Confidence 234556899999999999999999999999999999999999999986554332110 000 0111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+|+.+||+.||.+|||+.|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345778899999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=376.13 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=171.4
Q ss_pred HhcCCCccceecccCceEEEEEEeC---CCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (420)
..+.|++.+.||+|+||+||+|+++ ..++.||+|++..... ...+.+|+++|..+ +||||+++++++.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999864 4577899998865433 24678999999988 6999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCcccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLY 247 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~~~ 247 (420)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999984 48899999999999999999999 999999999999999877 79999999999754
Q ss_pred cCCCC---------------------------CcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCC
Q 036051 248 DHGTD---------------------------PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 248 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
..... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 33211 112345799999999998765 58999999999999999999999996
Q ss_pred CCC
Q 036051 300 RQG 302 (420)
Q Consensus 300 ~~~ 302 (420)
...
T Consensus 249 ~~~ 251 (361)
T 4f9c_A 249 KAS 251 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=397.24 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=202.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
-++|++.++||+|+||+||+|+++.+++.||||++.... .........++.++..++||||+++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999999999999999986431 11122234457778888999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
|+||||++||+|.++|...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999998654 68999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
... .....+||+.|||||++. +..|+.++|||||||++|||++|+.||......+...+.... ...
T Consensus 343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----------~~~ 409 (689)
T 3v5w_A 343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTM 409 (689)
T ss_dssp SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----------HHC
T ss_pred CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----------cCC
Confidence 543 234568999999999996 457999999999999999999999999764433211111100 011
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
.......++ ..+.+++.+||+.||.+|++ +.||++
T Consensus 410 ~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 122222333 34678888899999999998 677754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=363.62 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=213.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|...+.||+|+||+||+|.+..++..||+|++........+.|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45788899999999999999999988999999998776777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999987433 68999999999999999999999 99999999999999999999999999999866433211
Q ss_pred -------------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC
Q 036051 254 -------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 254 -------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
......||+.|+|||++.+..++.++||||||+++|||++|..|+............. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~---- 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGF---- 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHH----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhcc----
Confidence 1114579999999999999999999999999999999999999987654432111000 0000
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
......+. ....+.+++.+||+.||++|||+.++++.|+..
T Consensus 240 -~~~~~~~~--------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 240 -LDRYCPPN--------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -HHHTCCTT--------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccccCCCC--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00001111 123477889999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=358.51 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=210.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||+||+|.+..++..||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999999888999999998766555557789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|.+++... .+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999765 58999999999999999999999 9999999999999999999999999999986654322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .. ...+.. .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~------~~~~~~--~ 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------AT------NGTPEL--Q 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH------HCSCCC--S
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh------CCCCCC--C
Confidence 334467999999999999999999999999999999999999999765433211100 00 001111 1
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11122345778899999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.05 Aligned_cols=270 Identities=26% Similarity=0.380 Sum_probs=210.4
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----eE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----EL 167 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 167 (420)
...++|++.+.||+|+||+||+|++. +..||||++...... ...+..|+.++.+++||||+++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 34578899999999999999999985 578999999765433 345567999999999999999999988754 47
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC----------cEEecccCCCCEEEcCCCcEE
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ----------VVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~iiH~dlk~~NIll~~~~~~k 237 (420)
++||||+++|+|.+++... .+++..++.++.|++.||+|||+ . +++||||||+|||++.++.+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 9999999999999999765 58999999999999999999998 6 999999999999999999999
Q ss_pred EeeecCcccccCCCC-CcccccccCCcccccccccCC-----CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh
Q 036051 238 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD 311 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~ 311 (420)
|+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999986654332 223345789999999999763 45678999999999999999999998755433222111
Q ss_pred hhhhhcc-----cCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 312 WVFDFWN-----RGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 312 ~~~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
....... .........+.+...+ .......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100000 0001111222222221 224556789999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=365.38 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=211.8
Q ss_pred hcCCCccceecccCceEEEEEEeC-------CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
.++|.+.+.||+|+||.||+|++. .++..||||++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999863 34567999999765 344567899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997643 1358899999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~- 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999999999986544322 22333467889999999999999999999999999999999 99999765443211
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+. .+.... .....+.+++.+||+.||.+|||+.|+++.|++.+
T Consensus 316 ------~~~~~~~-----~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 316 ------KLLKEGH-----RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ------HHHHTTC-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHhcCC-----CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 111112 22345788889999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.48 Aligned_cols=262 Identities=23% Similarity=0.395 Sum_probs=209.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+.+.+|+..+.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788999999999999999999888999999988543 344457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 68999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ..+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~------~~~~~ 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD------SVPNV 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS------CCCCH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc------cCCCc
Confidence 333444567999999999999999999999999999999999999999765432211 000000 00111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHhcCCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARP-SMRQVVQILERDVA 372 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 372 (420)
......+....+.+++.+||+.||.+|| ++.++.+.|+....
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0111122335688889999999999998 89999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=361.80 Aligned_cols=265 Identities=28% Similarity=0.454 Sum_probs=205.5
Q ss_pred hHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC
Q 036051 87 YKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK 164 (420)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (420)
..+..+...+|++.+.||+|+||+||+|++ .+..||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 334445567899999999999999999988 4667999998654 344457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEcCCCcEEEeee
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999976542 348999999999999999999998 78 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
|++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... .
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~------- 252 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---G------- 252 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---H-------
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-------
Confidence 999754332 12234467899999999999999999999999999999999999999765443211100 0
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
...........++ ..+.+++.+||+.||.+|||+.++++.|+..+.
T Consensus 253 -~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 253 -FKCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -HSCCCCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -hcCCCCCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0011111222222 347788899999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.12 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=208.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc---eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..+|++.+.||+|+||.||+|.+..++ ..||||++... .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999996443 45999999765 44455789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999975533 68999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 250 GTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 250 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. .....+ .
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~-----~ 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-------SSVEEG-----Y 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTT-----C
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHcC-----C
Confidence 3221 2223345778999999988899999999999999999999 99999765433211 111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
...... .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus 272 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 272 RLPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111 223457888999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=354.65 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=215.4
Q ss_pred CccchHHHHHHhcC----------CCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc
Q 036051 83 HRFRYKDLYIATKG----------FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 152 (420)
Q Consensus 83 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 152 (420)
..++++++..+++. |...+.||+|+||.||+|++..++..||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888777764 66678999999999999999888899999998766555567789999999999999
Q ss_pred eEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998654 58999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 233 ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~~ 252 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR 252 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence 99999999999986654322 234467999999999999999999999999999999999999999765432211 11
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+ .....+.... .......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~---------~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 253 L---------RDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H---------HHSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H---------hcCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1111111111 1122345778888999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=373.38 Aligned_cols=265 Identities=21% Similarity=0.230 Sum_probs=213.0
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYC 161 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~ 161 (420)
+.+.++....++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4566777788999999999999999999999999899999999865321 1223488999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 162 RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 162 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
.+.+.+++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999997642 268999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
|+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+... ..
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~------~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH------hh
Confidence 999866544333344568999999999986 5678999999999999999999999998654332111 00
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHH
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 365 (420)
.... .....|......+ ..+.+++.+||+.+|++ ||++.|+++
T Consensus 294 ~~~~--~~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHK--ERFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHH--HHCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhcc--ccccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 0011111111222 34667788888888887 999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=380.91 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=216.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+...+|++.+.||+|+||.||+|++..++..||||++..... ..++|.+|+.++++++||||++++++|...+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345678888999999999999999988888999999976533 3578999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999987655679999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+..+ .....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~ 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKD-----YRMER 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTT-----CCCCC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC-----CCCCC
Confidence 222333456789999999988889999999999999999999 99999765543211 111111 11111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 441 ----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11223457888899999999999999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=356.10 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=207.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..+|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45789999999999999999999888999999998654 3445577889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999997654 58999999999999999999999 99999999999999999999999999999865433
Q ss_pred CCcccccccCCcccccccccCCCCC-ccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......+||+.|+|||++.+..+. .++|||||||++|||++|+.||......+.. .....+ ....
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~------~~~~ 233 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRG------KYRI 233 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------CCCC
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC------CCCC
Confidence 234456899999999999887765 7999999999999999999999765432211 111111 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+... ...+.+++.+||+.||.+|||+.|+++
T Consensus 234 p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYM----STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122 234678888999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=356.33 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=203.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||+|+||+||+|++..++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 578899999999999999999998899999999865432 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-C
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-D 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 252 (420)
+++|+|.+++.... .+++.+++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++..+.... .
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999997654 58999999999999999999999 999999999999999999999999999998654322 1
Q ss_pred CcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+... . ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~----~-----~~---- 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----K-----TY---- 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT----C-----TT----
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc----c-----cc----
Confidence 22334679999999999987765 77999999999999999999999765443211 1111110 0 00
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011223446788899999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=345.80 Aligned_cols=281 Identities=33% Similarity=0.584 Sum_probs=226.9
Q ss_pred CCCccchHHHHHHhcCCCcc------ceecccCceEEEEEEeCCCceeeeeeccccc----chhHHHHHHHHHHHhccCC
Q 036051 81 GPHRFRYKDLYIATKGFREK------ELLGSGGFGRVYRGTLPKSKIEIAVKKISHE----SRQGMKEFVAEIVSIGRLR 150 (420)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~ 150 (420)
....|++.++..++++|... +.||+|+||.||+|.+ ++..||||++... .....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34679999999999999887 8999999999999998 4567999988643 2334577899999999999
Q ss_pred cceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 151 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999986432 2368999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI 308 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~ 308 (420)
++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 999999999999999865443221 2234578999999998865 5889999999999999999999999865543311
Q ss_pred hhhhhhhhccc-CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 309 LVDWVFDFWNR-GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 309 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+....... ..+....++.. ..........+.+++.+||+.||.+|||+.++++.|++.
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111 11222223322 334567778899999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=370.02 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=210.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
...++|.+.+.||+|+||.||+|++..++..||||++... .......|.+|+.++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3456788899999999999999999888889999998754 333446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999997543 358999999999999999999999 99999999999999999999999999999764332
Q ss_pred CCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 251 TDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 251 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ......+. ..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~-----~~ 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGG-----RL 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTC-----CC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC-----CC
Confidence 111 1112235778999999988889999999999999999998 9999976543321 11111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.... .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 335 ~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 PCPE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111 1234577889999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.60 Aligned_cols=261 Identities=28% Similarity=0.500 Sum_probs=201.0
Q ss_pred HhcCCCccceecccCceEEEEEEeC---CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
...+|++.+.||+|+||.||+|++. ..+..||||++... .....+.|.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3467899999999999999999986 45677999998765 3445578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999997653 368999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 249 HGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 249 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. .....+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-------~~i~~~~---- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-------KAVDEGY---- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-------HHHHTTE----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC----
Confidence 43221 1122345778999999998899999999999999999998 99999765432211 1111110
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
.... .......+.+++.+||+.||.+||++.++++.|+.....
T Consensus 268 -~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -RLPP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -ECCC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111 112234578899999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.20 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=206.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|+..+.||+|+||+||+|++..+++.||+|++... .......+.+|+.++..++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35788899999999999999999988999999998654 223356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999997643 68999999999999999999999 99999999999999999999999999999754322
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .+ ....
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~---~i~-~~------~~~~ 224 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E---LIL-ME------EIRF 224 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-HC------CCCC
T ss_pred -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---H---HHH-cC------CCCC
Confidence 12334568999999999999999999999999999999999999999764432211 0 000 00 1112
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
+... ...+.+++.+||+.||.+|| ++.|+++
T Consensus 225 p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 PRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 2222 23477888889999999999 8999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=357.19 Aligned_cols=264 Identities=24% Similarity=0.388 Sum_probs=206.3
Q ss_pred hcCCCccceecccCceEEEEEE----eCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGT----LPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 167 (420)
.++|++.+.||+|+||+||+|+ ...++..||||++........+.+.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4678889999999999999998 4567889999999877777778899999999999999999999998653 568
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999976543 58999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCccc---------chhhhhhhhh
Q 036051 248 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEEN---------LILVDWVFDF 316 (420)
Q Consensus 248 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~---------~~~~~~~~~~ 316 (420)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43321 122234567789999999988999999999999999999999998864321100 0000001111
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ...... .......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 245 ~~~-----~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 245 LKN-----NGRLPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHT-----TCCCCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc-----cCcCCC----CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111 111111 122335588889999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.02 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=207.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh------HHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.+.|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46788999999999999999999988999999998754221 246789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecC
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL 243 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~ 243 (420)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997654 68999999999999999999999 9999999999999998776 799999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+..+
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~-------~i~~~--- 233 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NITAV--- 233 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTT---
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhc---
Confidence 98765432 2344679999999999999899999999999999999999999997654332110 00000
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...............+.+++.+||+.||.+|||+.|+++
T Consensus 234 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 ---SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111111112345778899999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=357.05 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=201.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCcee----eeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIE----IAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|+..+.||+|+||+||+|++..++.. ||+|.+... .....+.|.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 45688899999999999999998766654 578877543 2344578999999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+++|+|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999976543 68999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+... ....+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~----- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE----- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTC-----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-------HHHcCC-----
Confidence 43221 2233456889999999999999999999999999999999 999997655433111 111110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
...... .....+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 237 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111 223457788899999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.87 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=217.0
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
...++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34677888999999999999999998889999999987543 34577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999987666679999999999999999999999 899999999999999999999999999998765544
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .... ......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------~~~~-----~~~~~~ 233 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEK-----DYRMER 233 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHT-----TCCCCC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhc-----cCCCCC
Confidence 334444567889999999998899999999999999999999 999997655432111 1101 111111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 234 ~~~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 234 PEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 122 234578888999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=347.26 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=208.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||.||+|++.. +..||+|++...... .+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4678889999999999999999964 567999999755322 36789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999999976543 68999999999999999999999 99999999999999999999999999999865432222
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....+ ..+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~~~ 230 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG-----FRLYKPR 230 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT-----CCCCCCT
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhcC-----ccCCCCC
Confidence 2333456788999999998899999999999999999999 99999765433211 011111 1111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ...+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 231 ~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 231 LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 12 24477888899999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=344.77 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=209.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3567888999999999999999986 4567999998755322 3678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred ccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999997653 258999999999999999999999 9999999999999999999999999999986654433
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+... ....+. .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~ 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-------KVSQGH-----RLYRP 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTTC-----CCCCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-------HHHcCC-----CCCCC
Confidence 33334456778999999988889999999999999999999 999997654332111 000110 11111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
... ...+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 228 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 235778889999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.52 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=207.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|.+.+.||+|+||.||+|++..++..||+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367889999999999999999999999999999986543 3346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC--CCcEEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~ 251 (420)
+++|+|.+++.... ..+++.+++.++.||+.||.|||+ .+++||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999997543 368999999999999999999999 99999999999999987 7899999999998765322
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. . ... .+. ....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~i~-~~~------~~~~ 223 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---E---NIM-NAE------YTFD 223 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHH-HTC------CCCC
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---H---HHH-cCC------CCCC
Confidence 334567899999999999888999999999999999999999999765432211 0 000 000 0010
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..........+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112345788999999999999999999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.58 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=210.0
Q ss_pred hcCCCccceecccCceEEEEEEeC-----CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||+||+|++. .++..||||++... .......+.+|+.++.+++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999953 45678999998654 344456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCC-----CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEEe
Q 036051 168 LLVYDYMPNGSLDKYLYNQP-----KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRLG 239 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~ 239 (420)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997542 2358999999999999999999999 9999999999999999554 59999
Q ss_pred eecCcccccCC-CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhc
Q 036051 240 DFGLARLYDHG-TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 240 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
|||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-------~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------EFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHH
Confidence 99999754322 2223344568999999999988899999999999999999998 99999765433211 111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 374 (420)
..+. ....... ....+.+++.+||+.||.+|||+.+|++.|+.....+
T Consensus 300 ~~~~-----~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSGG-----RMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcCC-----CCCCCcc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111 1111122 2345778899999999999999999999998765433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.14 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=214.3
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEE-----eCCCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGT-----LPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQL 157 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 157 (420)
+...+.....++|++.+.||+|+||.||+|+ ...++..||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3444555667899999999999999999998 4556788999999764 334457799999999999 79999999
Q ss_pred eeeeeeCC-eEEEEEeecCCCChhhhhccCCC------------------------------------------------
Q 036051 158 LGYCRRKG-ELLLVYDYMPNGSLDKYLYNQPK------------------------------------------------ 188 (420)
Q Consensus 158 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 188 (420)
++++...+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988754 48999999999999999976532
Q ss_pred ----------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 189 ----------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 189 ----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128999999999999999999999 9999999999999999999999999999986543322
Q ss_pred -CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 253 -PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 253 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ......+ .....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~-----~~~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEG-----TRMRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHT-----CCCCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcC-----CCCCC
Confidence 23344568899999999998999999999999999999998 99999765543211 1111111 11111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.... ...+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 318 ~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1222 23477888899999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=356.18 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=213.0
Q ss_pred HHHhcCCCccceecccCceEEEEEEeC-----CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK 164 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 164 (420)
....++|++.+.||+|+||.||+|++. .++..||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999986 34578999999765 344457799999999999999999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC----------------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP----------------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 222 (420)
+..++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ .+++|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 99999999999999999997642 1468999999999999999999999 9999999
Q ss_pred cCCCCEEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCC
Q 036051 223 VKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIER 300 (420)
Q Consensus 223 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~ 300 (420)
|||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976533221 22334567899999999988899999999999999999999 9999976
Q ss_pred CCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
....+. ......+.. +..... ....+.+++.+||+.||.+|||+.++++.|++...
T Consensus 280 ~~~~~~-------~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEV-------IYYVRDGNI-----LACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHH-------HHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHH-------HHHHhCCCc-----CCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 543221 111111111 111122 23457888999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.07 Aligned_cols=273 Identities=21% Similarity=0.257 Sum_probs=215.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--eEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 170 (420)
.++|.+.+.||+|+||+||+|++..++..||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888999999999999999999889999999987543 233567889999999999999999999987765 78999
Q ss_pred EeecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----cCCCcEEEeeecCcc
Q 036051 171 YDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfg~~~ 245 (420)
|||+++++|.+++..... ..+++.+++.++.||+.||+|||+ .+++||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976532 238999999999999999999999 999999999999999 788889999999998
Q ss_pred cccCCCCCcccccccCCccccccccc--------CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc-hhhhhhhhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTR--------TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL-ILVDWVFDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~ 316 (420)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......... .....+...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 765432 233457899999999885 577899999999999999999999999754432211 111111110
Q ss_pred cccCc-----------cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 317 WNRGE-----------LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 317 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..... ..-.................+.+++.+||+.||++|||+.|+++....+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 00000 00000111223455677888999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=356.24 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=209.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999988999999999776555566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC--CCcEEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~ 251 (420)
+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++.......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999997653 368999999999999999999999 99999999999999974 4679999999998765422
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+. .... ...+...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~----~~~~--~~~~~~~ 274 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK----RCDW--EFDEDAF 274 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----HCCC--CCCSSTT
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC--CCCcccc
Confidence 234457999999999999999999999999999999999999999765432211 1000 0000 0111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 275 ~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 S----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 223457889999999999999999999873
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.13 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=211.7
Q ss_pred HhcCCCccceecccCceEEEEEEe-----CCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
..++|.+.+.||+|+||.||+|++ ..++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788899999999999999987 345578999999764 34456789999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCC----------------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccC
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPK----------------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK 224 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk 224 (420)
.++||||+++++|.+++..... ..+++.+++.++.||+.||+|||+ .+++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999976432 248899999999999999999999 999999999
Q ss_pred CCCEEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCC
Q 036051 225 ASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQG 302 (420)
Q Consensus 225 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~ 302 (420)
|+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543322 12233456889999999988889999999999999999999 999997655
Q ss_pred CcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..... .....+. .+..... ....+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 258 ~~~~~-------~~~~~~~-----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERLF-------NLLKTGH-----RMERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGHH-------HHHHTTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH-------HHhhcCC-----cCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 43311 1111111 1111122 234578888999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=351.08 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=206.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|.+.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568889999999999999999998899999998865422 1356789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecC
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL 243 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~ 243 (420)
++||||+++++|.+++.... .+++.+++.++.||+.||.|||+ .+++||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999997643 68999999999999999999999 9999999999999999887 799999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~--------- 230 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---VS--------- 230 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HH---------
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HH---------
Confidence 98764322 23345799999999999988999999999999999999999999976543221110 00
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.................+.+++.+||+.||.+|||+.|+++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 -AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00011111111112345778899999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=344.73 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=200.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhcc--CCcceEeeeeeeeee----CCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRR----KGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~ 167 (420)
.++|++.+.||+|+||+||+|++ ++..||||++..... ..+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46789999999999999999998 467899999865432 344555555554 899999999998654 3568
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhh--------hcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH--------EEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
++||||+++|+|.++++.. .+++..++.++.|++.||+||| + .+++||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999999654 6899999999999999999999 6 899999999999999999999999
Q ss_pred eecCcccccCCCCC---cccccccCCcccccccccCC------CCCccchhhhhHHHHHHHhcC----------CccCCC
Q 036051 240 DFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACG----------RRPIER 300 (420)
Q Consensus 240 Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~el~tg----------~~p~~~ 300 (420)
|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765443221 12334789999999999776 455799999999999999999 777765
Q ss_pred CCCcccchhhhhhhhhcccCccccccCCCCCC-cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGT-EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
........ . ...... ......+.... .........+.+++.+||+.||.+|||+.|+++.|++
T Consensus 236 ~~~~~~~~-~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSF-E-DMRKVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCH-H-HHHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcch-h-hhhHHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 43322111 0 001100 11111222222 2234567789999999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=373.29 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=211.9
Q ss_pred HHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.+..+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.++++++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 3344566788899999999999999999964 5679999997543 23578999999999999999999999987 5678
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++|+|.+++.......+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999986544468899999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
............+|..|+|||++....++.++|||||||++|||++ |+.||......+.. . .+..+ .
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~~~-----~ 402 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R----ALERG-----Y 402 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HHHHT-----C
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcC-----C
Confidence 4321111223346788999999988899999999999999999999 99999765433211 1 11111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...... .....+.+++.+||+.||++|||+.+|++.|+...
T Consensus 403 ~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 RMPRPE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111111 22345788899999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=365.91 Aligned_cols=251 Identities=29% Similarity=0.410 Sum_probs=206.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-eEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-ELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 171 (420)
..++|++.+.||+|+||.||+|.+. +..||||++.... ..+.|.+|+.++++++||||+++++++.... ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 4567888999999999999999985 5689999997654 3467999999999999999999999987665 799999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.......+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999987655558999999999999999999999 99999999999999999999999999999854322
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+..+. ....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~-----~~~~ 407 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGY-----KMDA 407 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHTTC-----CCCC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-----CCCC
Confidence 122356889999999999999999999999999999998 99999866543311 1111111 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. .....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 408 p~----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 408 PD----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12 2234578889999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=355.66 Aligned_cols=269 Identities=25% Similarity=0.396 Sum_probs=198.1
Q ss_pred HHHHHHhcCCCccceecccCceEEEEEEeCCCce---eeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeee
Q 036051 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKI---EIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162 (420)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 162 (420)
++..+..++|++.+.||+|+||.||+|++..++. .||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3444556789999999999999999999876654 7999998754 3445678999999999999999999999998
Q ss_pred eCCeE------EEEEeecCCCChhhhhccCC----CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 163 RKGEL------LLVYDYMPNGSLDKYLYNQP----KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 163 ~~~~~------~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
..... ++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence 77654 99999999999999986432 2258999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhh
Q 036051 233 ELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILV 310 (420)
Q Consensus 233 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~ 310 (420)
++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+...
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-- 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN-- 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH--
Confidence 99999999999986543322 22233456789999999999899999999999999999999 999997655433111
Q ss_pred hhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCCc
Q 036051 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPA 375 (420)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 375 (420)
....+. ...... .....+.+++.+||+.||.+|||+.++++.|++.+.-|.
T Consensus 251 -----~~~~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 -----YLIGGN-----RLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -----HHHTTC-----CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -----HHhcCC-----CCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 000110 111111 223457889999999999999999999999998754433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.21 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=196.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..++|++.+.||+|+||.||+|.+..+ +..||+|++... .....+.+.+|+..+++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 356788899999999999999998543 456999998754 3344567899999999999999999999985 45789
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999997653 368999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.. .. ...+. .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~----i~~~~-----~ 235 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR----IENGE-----R 235 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HH----HHTTC-----C
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HH----HHcCC-----C
Confidence 433333334556889999999988899999999999999999996 99999765443211 11 11111 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...... ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 236 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 LPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122 234577888999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.50 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=212.3
Q ss_pred HhcCCCccceecccCceEEEEEEeC-------CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP-------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
..++|.+.+.||+|+||.||+|++. ..+..||||++... .......+.+|+.++.++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3567888999999999999999964 23467999998765 344557899999999999 99999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
.+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ .+++||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 999999999999999999997653 1358999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986644322 22334467889999999999999999999999999999999 9999976543321
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...+..+. .......+ ...+.+++.+||+.||++|||+.|+++.|++..
T Consensus 303 ------~~~~~~~~-----~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 ------FKLLKEGH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ------HHHHHTTC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHcCC-----CCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111 11111222 345778889999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=361.84 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=205.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 56789999999999999999999999999999998654 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc---CCCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~ 248 (420)
||+++|+|.+.+.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++....
T Consensus 90 E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999998764 68999999999999999999999 9999999999999998 46789999999998665
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. .....+..
T Consensus 165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~------ 230 (444)
T 3soa_A 165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-------QQIKAGAY------ 230 (444)
T ss_dssp TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCC------
T ss_pred CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHhCCC------
Confidence 432 2234467999999999999989999999999999999999999999765432211 11111110
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0001101112345778888999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.09 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=205.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999999889999999987542 22346688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999998654 68999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+ ....
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~-~~------~~~~ 222 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKIL-NA------ELRF 222 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-HC------CCCC
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hC------CCCC
Confidence 233467999999999999999999999999999999999999999764432211 1111 01 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
...++ ..+.+++.+||+.||.+|| ++.|+++
T Consensus 223 p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12222 3477888889999999999 8888874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=351.42 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=203.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999998899999999986542 122356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+ +|+|.+++.... .+++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 789999887654 68999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .... .....
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~------~~~~~ 227 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNS------CVYVM 227 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCS------SCCCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHc------CCCCC
Confidence 2344579999999999988776 689999999999999999999997654332110 0000 01111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+... ...+.+++.+||+.||.+|||+.|+++
T Consensus 228 p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFL----SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccC----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122 234778899999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=344.85 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch--------------------------hHHHHHHHHHHHhc
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--------------------------QGMKEFVAEIVSIG 147 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 147 (420)
.++|++.+.||+|+||.||+|++..++..||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678899999999999999999988999999999865421 11356889999999
Q ss_pred cCCcceEeeeeeeeee--CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCC
Q 036051 148 RLRHRNLVQLLGYCRR--KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKA 225 (420)
Q Consensus 148 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~ 225 (420)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++.+++.++.||+.||+|||+ .+++||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 9999999999999986 56899999999999999876543 68999999999999999999999 9999999999
Q ss_pred CCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCC---CCccchhhhhHHHHHHHhcCCccCCCCC
Q 036051 226 SNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIERQG 302 (420)
Q Consensus 226 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~el~tg~~p~~~~~ 302 (420)
+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998664322 2233457899999999997655 4788999999999999999999997543
Q ss_pred CcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... .. ........ ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~---~~----~~~~~~~~----~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMC---LH----SKIKSQAL----EFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHH---HH----HHHHHCCC----CCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHH---HH----HHHhcccC----CCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 00 11101100 00001112 244778889999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=353.96 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=206.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46789999999999999999999988999999998654 3344577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfg~~~~~~ 248 (420)
||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999987654 68999999999999999999999 9999999999999998654 59999999998665
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .. ....+. .
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~----~i~~~~------~ 247 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA----QIKAGA------Y 247 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHTC------C
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH----HHHhCC------C
Confidence 322 23346799999999999998999999999999999999999999976443221 11 111110 0
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111111223457788899999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=355.57 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=201.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (420)
..++|++.+.||+|+||+||+|+++.+++.||+|++.... ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467899999999999999999999999999999987542 22334578899998887 8999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999997654 68999999999999999999999 999999999999999999999999999997532
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc--hhhhhhhhhcccCcccccc
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL--ILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 326 (420)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...+.+.......
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------ 277 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 277 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------
Confidence 22 22344568999999999999999999999999999999999999999754322211 0111111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
....+..++ ..+.+++.+||+.||.+||++
T Consensus 278 ~~~~p~~~s----~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QIRIPRSLS----VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCCTTSC----HHHHHHHHHHTCSCTTTSTTC
T ss_pred ccCCCCcCC----HHHHHHHHHHhcCCHhHcCCC
Confidence 112222222 346788889999999999995
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=349.75 Aligned_cols=246 Identities=26% Similarity=0.321 Sum_probs=195.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|+..+.||+|+||+||+|++..++..||||++... .......+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999999888999999987653 233344556666666555 899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779999887653 369999999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ..+..+ ..
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~--------~~ 269 (311)
T 3p1a_A 211 G--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQG--------YL 269 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTT--------CC
T ss_pred C--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhcc--------CC
Confidence 2 2334568999999999876 7899999999999999999998776432110 000111 01
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+.......+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111122356888999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.44 Aligned_cols=274 Identities=23% Similarity=0.275 Sum_probs=214.6
Q ss_pred CCccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-----cceEee
Q 036051 82 PHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----HRNLVQ 156 (420)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 156 (420)
...+++++.....++|.+.+.||+|+||+||+|++..++..||||++... ......+..|+.++..+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34566777777789999999999999999999999888999999998643 333456778898888886 999999
Q ss_pred eeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC----
Q 036051 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---- 232 (420)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---- 232 (420)
+++++...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 9999999987765579999999999999999999999 99999999999999975
Q ss_pred ---------------------CCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHH
Q 036051 233 ---------------------ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 291 (420)
Q Consensus 233 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el 291 (420)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999864432 2345789999999999999999999999999999999
Q ss_pred hcCCccCCCCCCcccchhhhhhh---------hh--------cccCccccccCCCCCCcc-------------cHHHHHH
Q 036051 292 ACGRRPIERQGPEENLILVDWVF---------DF--------WNRGELLEARDPNLGTEY-------------VAEELEL 341 (420)
Q Consensus 292 ~tg~~p~~~~~~~~~~~~~~~~~---------~~--------~~~~~~~~~~~~~~~~~~-------------~~~~~~~ 341 (420)
++|+.||......+......... .. ...... ....+...... .......
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL-KLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT-EECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc-eecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999997654332211111000 00 000000 00001100000 0001155
Q ss_pred HHHHhhcccccCCCCCCCHHHHHH
Q 036051 342 ILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 342 l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.+++.+||+.||.+|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 779999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=342.17 Aligned_cols=253 Identities=25% Similarity=0.501 Sum_probs=203.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh-------HHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.++|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999999888999999998654221 1167899999999999999999999987665
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEcCCCc-----EEEe
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDGELN-----GRLG 239 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~~~~~-----~kl~ 239 (420)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999886654 368999999999999999999998 78 999999999999988776 9999
Q ss_pred eecCcccccCCCCCcccccccCCcccccccc--cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHT--RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
|||++..... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.......... .... .
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~ 243 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMI---R 243 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHH---H
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHH---h
Confidence 9999975332 33446789999999998 44567899999999999999999999997655432111 1000 0
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. ....+..... ....+.+++.+||+.||.+|||+.|+++.|++
T Consensus 244 ~-----~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 E-----EGLRPTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H-----SCCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred c-----cCCCCCCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0 1111222222 23457888999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=339.18 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=205.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 169 (420)
.++|++.+.||+|+||.||+|++. +..||||++... .....+.|.+|+.++.+++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467888999999999999999984 667999998754 344557799999999999999999999999877 78899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||+....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999988766579999999999999999999998 77 999999999999999999999999987643
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCc---cchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATT---SADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.. ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||......+.. .... ..
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~-----~~ 226 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVA-----LE 226 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHH-----HS
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHH-----hc
Confidence 22 2346899999999998765544 799999999999999999999765432211 0111 01
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...+...... ...+.+++.+||+.||++|||+.|+++.|+..
T Consensus 227 ~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 227 GLRPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112222222 34577888899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=339.53 Aligned_cols=262 Identities=17% Similarity=0.203 Sum_probs=210.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|++..++..||||++..... ...+.+|+..+.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4678899999999999999999988899999998864432 24577899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc-----EEEeeecCcccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN-----GRLGDFGLARLY 247 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfg~~~~~ 247 (420)
|+ +++|.+++..... .+++..++.++.||+.||+|||+ .+++||||||+||+++.++. +||+|||++...
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986533 58999999999999999999998 99999999999999987766 999999999876
Q ss_pred cCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 248 DHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 248 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 54322 123456799999999999999999999999999999999999999987654332211111111000000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. .........+.+++.+||+.||++|||+.+|++.|++..
T Consensus 242 ~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 242 LR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00 001112345788899999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=348.52 Aligned_cols=260 Identities=17% Similarity=0.157 Sum_probs=209.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678899999999999999999988899999999865432 24578999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc-----EEEeeecCcccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN-----GRLGDFGLARLY 247 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfg~~~~~ 247 (420)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999998652 379999999999999999999999 99999999999999998887 999999999876
Q ss_pred cCCCCC------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 248 DHGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 248 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~---- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK---- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH----
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh----
Confidence 443221 1245679999999999999999999999999999999999999998765443221111111000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. ..+ ......... .+.+++..||+.||.+||++.+|++.|+..
T Consensus 237 ~---~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 R---ATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp H---HSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred c---cCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 000 000000012 688888999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=345.02 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=205.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4567888999999999999999986 5667999999755322 3678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999997632 268999999999999999999999 9999999999999999999999999999986543222
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+... .... .......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~-----~~~~~~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQ-----GLRLYRP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHT-----TCCCCCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-------HHhc-----ccCCCCC
Confidence 22233456788999999998899999999999999999998 999997655332111 0001 1111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ...+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 244 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111 24577888999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.04 Aligned_cols=267 Identities=20% Similarity=0.226 Sum_probs=207.7
Q ss_pred hcCCCccceeccc--CceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSG--GFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+| +||+||+|++..++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5678999999999 9999999999988999999998754 24445778899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999987655579999999999999999999999 9999999999999999999999999998865422
Q ss_pred CC------CCcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc---
Q 036051 250 GT------DPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN--- 318 (420)
Q Consensus 250 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 318 (420)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCccc
Confidence 11 111223478999999999987 679999999999999999999999997655433211 00000000
Q ss_pred -c-----C-------------cccccc---CCC------CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 -R-----G-------------ELLEAR---DPN------LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 -~-----~-------------~~~~~~---~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. . ...... .+. ....+.......+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0 000000 000 000111222356888999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=353.63 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=206.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999999999999999986542 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+.+|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999998654 68999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............+. ...
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------~~~ 236 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------TTV 236 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----------HCC
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----------hcc
Confidence 23445689999999999864 458999999999999999999999997654432211111110 011
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCC-HHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPS-MRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 365 (420)
......+ ...+.+++.+||+.||.+||+ +.++++
T Consensus 237 ~~~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcC----CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111222 245778888999999999998 677654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.49 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=205.2
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.+..++|++.+.||+|+||.||+|.+.+ +..||||++..... ..+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3456778889999999999999999965 45699999976532 24679999999999999999999999876 678999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.......+++.+++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999975433468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .....+. ...
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~-----~~~ 401 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-----RMP 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC-----CCC
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-----CCC
Confidence 3223334456889999999988899999999999999999999 99999765433211 1111111 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
. +......+.+++.+||+.||++|||+.++++.|+...
T Consensus 402 ~----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1 1123345788899999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.87 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=210.5
Q ss_pred HHhcCCCccceecccCceEEEEEEe-----CCCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
...++|.+.+.||+|+||.||+|++ ..++..||+|++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 4567889999999999999999997 345678999998754 233346789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCC---------------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEeccc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPK---------------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDV 223 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dl 223 (420)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+++||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999976532 247999999999999999999999 99999999
Q ss_pred CCCCEEEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCC
Q 036051 224 KASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQ 301 (420)
Q Consensus 224 k~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~ 301 (420)
||+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866443222 2334567889999999988899999999999999999998 99999766
Q ss_pred CCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...... ......+ ..+..... ....+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 279 ~~~~~~------~~~~~~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDANF------YKLIQNG-----FKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSHHH------HHHHHTT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHHHH------HHHHhcC-----CCCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 543211 1111111 11111111 2345788889999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.52 Aligned_cols=263 Identities=23% Similarity=0.324 Sum_probs=201.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999999988999999998654 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++ +|.+.+.... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9965 6666555432 268999999999999999999999 999999999999999999999999999998764322
Q ss_pred CcccccccCCcccccccccCCC-CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc---cCc---cccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN---RGE---LLEA 325 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~ 325 (420)
.......+|+.|+|||++.+.. ++.++|||||||++|||++|..||......... ...+..... ... ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhccc
Confidence 2334457899999999997765 899999999999999999998886543322111 000000000 000 0000
Q ss_pred cC---------CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RD---------PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+ ..............+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00001111223355778899999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=346.17 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=206.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|+..+.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367888999999999999999999889999999986542 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999997654 58999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..+ ....
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~------~~~~ 257 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSG------KVRF 257 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------CCCC
T ss_pred ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------HHHHcC------CCCC
Confidence 233467999999999999999999999999999999999999999765432211 111111 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
+..+ ...+.+++.+||+.||.+||+ +.|+++
T Consensus 258 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2222 244778888999999999998 888865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=351.76 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=202.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceee----eeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEI----AVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|++.+.||+|+||.||+|++..++..+ ++|.+... .....+.+.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999987776655 66666433 3334578899999999999999999999998765 78
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+.+|+|.+++..... .+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999976543 68999999999999999999999 999999999999999999999999999998664
Q ss_pred CCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+... ....+ .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~-----~ 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKG-----E 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTT-----C
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcC-----C
Confidence 3322 12233456789999999999999999999999999999999 999997665433111 11111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 374 (420)
....... ....+.+++.+||+.||.+|||+.|+++.|++....|
T Consensus 237 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 237 RLPQPPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1111112 2334778889999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.78 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=201.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||+||+|++. ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 467888999999999999999995 47789999986542 223467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9996 58888876653 368999999999999999999999 999999999999999999999999999998764322
Q ss_pred CCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc--------
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL-------- 322 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 322 (420)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.................
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 22334578999999999876 56899999999999999999999999866554322111000000000000
Q ss_pred -----ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 -----LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 -----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...................+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000011112345778999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.65 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=199.2
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999999888999999999876656667899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE--cCCCcEEEeeecCcccccCCCCCcccc
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTH 257 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 257 (420)
.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....... ....
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 99887543 368999999999999999999999 999999999999999 567899999999998765432 2334
Q ss_pred cccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHH
Q 036051 258 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAE 337 (420)
Q Consensus 258 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (420)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..........
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~~~-----------~~~~~~~~~~ 314 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILACR-----------WDLEDEEFQD 314 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHTC-----------CCSCSGGGTT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcc-----------CCCChhhhcc
Confidence 57999999999999889999999999999999999999999765433211 1000000 0011111112
Q ss_pred HHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 338 ELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 338 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.+++.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2345788999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=351.94 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 167 (420)
...++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999999988999999998754 223346678899999988 799999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999997654 68999999999999999999999 99999999999999999999999999999753
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..+ .
T Consensus 175 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~------~ 240 (353)
T 3txo_A 175 ICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILND------E 240 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------C
T ss_pred ccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC------C
Confidence 322 22344568999999999998888999999999999999999999999765443211 111111 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCH------HHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSM------RQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 365 (420)
...+... ...+.+++.+||+.||.+||++ .|+++
T Consensus 241 ~~~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111222 2346788889999999999998 66664
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=342.50 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=205.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc-------eeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK-------IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.++|.+.+.||+|+||.||+|++..++ ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888999999999999999987654 4699999977666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc--------EEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN--------GRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~--------~kl 238 (420)
.++||||+++++|.+++..... .+++..++.++.||+.||.|||+ .+++||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999986542 58999999999999999999999 99999999999999998887 999
Q ss_pred eeecCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
+|||++.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|..|+......... . ...
T Consensus 163 ~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~----~~~ 231 (289)
T 4fvq_A 163 SDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--L----QFY 231 (289)
T ss_dssp CCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H----HHH
T ss_pred ccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--H----HHh
Confidence 9999986542 2234568999999999987 67899999999999999999965554332221110 0 000
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.. ........ ...+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 232 ~~-------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 ED-------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HT-------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hc-------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 01111111 1236788889999999999999999999988764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=351.27 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=204.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCcee----eeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIE----IAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|++.+.||+|+||+||+|++..++.. ||+|.+.... ......+.+|+.++.+++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35788899999999999999998777665 6777664332 222345778999999999999999999986 45689
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999997653 368999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
..... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+... ....+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~---- 235 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGER---- 235 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCB----
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCC----
Confidence 43322 2344567889999999998899999999999999999999 999998755433111 1111110
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 374 (420)
...... ....+.+++.+||+.||.+|||+.|+++.|+.....|
T Consensus 236 -~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 236 -LAQPQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -CCCCTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -CCCCCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001111 1123677888999999999999999999998776443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=350.02 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=191.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|++..++..||||++.... ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 567889999999999999999999888899999987543 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCcccccCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~~~~~~ 250 (420)
+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999997654 58999999999999999999999 89999999999999975 889999999999865432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... ..
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~i~~~~~------~~ 270 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------FRRILNCEY------YF 270 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------HHHHHTTCC------CC
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------HHHHHhCCC------cc
Confidence 1 233457899999999999989999999999999999999999999765433211 011111100 00
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+....+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111122345788999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=338.40 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=193.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch----hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR----QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|+..+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467888999999999999999984 66799999865422 224678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc---EEecccCCCCEEEcC--------CCcEEE
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV---VIHRDVKASNVLLDG--------ELNGRL 238 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---iiH~dlk~~NIll~~--------~~~~kl 238 (420)
||||+++++|.+++... .+++..++.++.|++.||.|||+ .+ ++||||||+||+++. ++.+||
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999998643 68999999999999999999999 66 999999999999986 678999
Q ss_pred eeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...
T Consensus 158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~- 227 (271)
T 3dtc_A 158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVA- 227 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHH-
T ss_pred ccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhh-
Confidence 9999998654322 224578999999999998899999999999999999999999997654322110 000
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. ......... .....+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 228 ~----~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 M----NKLALPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp T----SCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred c----CCCCCCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 011111112 223457888999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.96 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=210.4
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 162 (420)
.+.++....++|++.+.||+|+||+||+|++..++..||+|++.... ......+.+|+.++..++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556667789999999999999999999999999999999986532 112244788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 163 RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
+.+.+++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999999764 58999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCC----CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
++..............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+... ....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMN 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH------HHHh
Confidence 99876543322334568999999999997655 7899999999999999999999997654332110 1100
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCC--CCCHHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA--RPSMRQVVQI 366 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 366 (420)
+. .....+. ...++ ..+.+++.+||+.+|.+ ||++.||++.
T Consensus 288 -~~-~~~~~p~-~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 -HK-NSLTFPD-DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HH-HHCCCCT-TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -cc-ccccCCC-ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0001111 01122 34677888899999988 9999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.56 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=212.2
Q ss_pred HhcCCCccceecccCceEEEEEEe-----CCCceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
..++|+..+.||+|+||.||+|++ ..++..||+|++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356788899999999999999985 4567889999987553 34457789999999999 9999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCC----------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPK----------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
..++||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999976532 248999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876543322 2233457889999999988899999999999999999999 99999765543211
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...... ...+..... ....+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 258 ------~~~~~~-----~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ------YKMIKE-----GFRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ------HHHHHH-----TCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHhcc-----CCCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111 111111111 2345788889999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=351.96 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=203.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-----hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999999889999999986432 113467899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeeecC
Q 036051 169 LVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDFGL 243 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg~ 243 (420)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887543 22358999999999999999999999 99999999999999986654 99999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +. .....+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~----~~i~~~~~- 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF----EGIIKGKY- 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH----HHHHHTCC-
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH----HHHHcCCC-
Confidence 98765432 2233457999999999999999999999999999999999999999763211 00 00000100
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||++|||+.|+++
T Consensus 250 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000112345778899999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=346.70 Aligned_cols=251 Identities=20% Similarity=0.326 Sum_probs=199.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC-------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------- 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 165 (420)
.++|++.+.||+|+||.||+|++..++..||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999998889999999986543 334577999999999999999999999886543
Q ss_pred --------------------------------------------------eEEEEEeecCCCChhhhhccCCC-ccCcHH
Q 036051 166 --------------------------------------------------ELLLVYDYMPNGSLDKYLYNQPK-VTLNWR 194 (420)
Q Consensus 166 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~ 194 (420)
..++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999986543 345667
Q ss_pred HHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC-----------CcccccccCCc
Q 036051 195 QRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-----------PQTTHVVGTLG 263 (420)
Q Consensus 195 ~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~ 263 (420)
.++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 789999999999999999 9999999999999999999999999999987654321 12234579999
Q ss_pred ccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHH
Q 036051 264 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELIL 343 (420)
Q Consensus 264 y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 343 (420)
|+|||++.+..++.++||||||+++|||++|..|+.... .. ... ...... ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~----~~~--------~~~~~~-~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RI----ITD--------VRNLKF-PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HH----HHH--------HHTTCC-CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HH----HHH--------hhccCC-CcccccCChhHH
Confidence 999999999999999999999999999999876642110 00 000 000111 111233345568
Q ss_pred HHhhcccccCCCCCCCHHHHHH
Q 036051 344 KLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 344 ~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+++.+||+.||.+|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.54 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=205.1
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCe
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 166 (420)
....++|.+.+.||+|+||.||+|+++.+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999999999999999987542 23345678899998876 89999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999997643 68999999999999999999999 9999999999999999999999999999975
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... .
T Consensus 168 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~------~ 233 (345)
T 1xjd_A 168 NMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRM------D 233 (345)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHH------C
T ss_pred cccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHh------C
Confidence 4322 12344568999999999999999999999999999999999999999765432211 00100 1
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMR-QVV 364 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 364 (420)
.+...... ...+.+++.+||+.||.+||++. +++
T Consensus 234 ~~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 NPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11122222 23477888899999999999997 664
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=341.76 Aligned_cols=267 Identities=27% Similarity=0.331 Sum_probs=202.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch-----hHHHHHHHHHHHhccC---CcceEeeeeeeeeeC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-----QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRK 164 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 164 (420)
..++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999988899999999864321 1123456677666665 599999999998775
Q ss_pred C-----eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 165 G-----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 165 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
. ..++||||+. ++|.+++.......+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999995 699999987765569999999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..............
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998654322 334567899999999999999999999999999999999999999765543321111000000000
Q ss_pred Cccc-------cccCCCCC---CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELL-------EARDPNLG---TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~-------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. ....+... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 00000000 0011122356788999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.46 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=204.5
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-----chhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
++....++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3455678899999999999999999999989999999988643 23445789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccC--------------------------------------CCccCcHHHHHHHHHHhHh
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQ--------------------------------------PKVTLNWRQRYGVIKGVAL 205 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 205 (420)
.+..++||||+++|+|.+++... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0123467788899999999
Q ss_pred HhHHhhhcccCcEEecccCCCCEEEcCCC--cEEEeeecCcccccCCCC---CcccccccCCcccccccccC--CCCCcc
Q 036051 206 GLLYLHEEWEQVVIHRDVKASNVLLDGEL--NGRLGDFGLARLYDHGTD---PQTTHVVGTLGYLAPEHTRT--GKATTS 278 (420)
Q Consensus 206 ~L~~LH~~~~~~iiH~dlk~~NIll~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 278 (420)
||+|||+ .+++||||||+||+++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 899999999986543221 12345678999999999865 678999
Q ss_pred chhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC
Q 036051 279 ADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARP 358 (420)
Q Consensus 279 sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 358 (420)
+||||||+++|||++|+.||......+.. ....... ..............+.+++.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKK-------LCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-------CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcc-------cccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999765433211 1111000 0011111112234577888999999999999
Q ss_pred CHHHHHH
Q 036051 359 SMRQVVQ 365 (420)
Q Consensus 359 t~~evl~ 365 (420)
|+.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=338.71 Aligned_cols=261 Identities=26% Similarity=0.478 Sum_probs=197.5
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
+..++|++.+.||+|+||+||+|++.+ .||+|++... .....+.|.+|+.++++++||||+++++++ ..+..++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 446789999999999999999999853 4999988654 344567899999999999999999999965 4556899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999996553 368999999999999999999999 9999999999999999999999999999976543
Q ss_pred CC-CCcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 250 GT-DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 250 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
.. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+.. ......+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~--- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSL--- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHHHHHTSC---
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHHhccccc---
Confidence 21 22233457899999999986 567888999999999999999999999765443211 111111111
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.+.. ..........+.+++.+||+.||.+|||+.++++.|+...
T Consensus 244 -~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 -SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111 1111223356888999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=342.27 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=206.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 467888999999999999999985 456799999865432 34678999999999999999999999864 468999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999999976543468999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ....+ .......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~-----~~~~~~~ 233 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQ----NLERG-----YRMVRPD 233 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTT-----CCCCCCT
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HH----HHhcc-----cCCCCcc
Confidence 3334456889999999988889999999999999999999 8999976543221 11 11111 1111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. ....+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 234 N----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 2 234577888899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=358.76 Aligned_cols=265 Identities=21% Similarity=0.225 Sum_probs=211.6
Q ss_pred ccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeee
Q 036051 84 RFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGY 160 (420)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~ 160 (420)
.+++++.....++|++.+.||+|+||+||+|+++.+++.||+|++.... ......+.+|..++..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3556677777899999999999999999999999889999999986532 2223457889999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEee
Q 036051 161 CRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240 (420)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 240 (420)
+.+.+.+++||||+++|+|.+++...+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999997643 268999999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccCCCCCcccccccCCccccccccc-------CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh
Q 036051 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-------TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 241 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 313 (420)
||++..............+||+.|+|||++. +..++.++|||||||++|||++|+.||......+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----- 280 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG----- 280 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH-----
Confidence 9999876543332334468999999999986 4568999999999999999999999997654332111
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCC---CCHHHHHH
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR---PSMRQVVQ 365 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~ 365 (420)
...... .....+.....+ ...+.+++.+||+ +|.+| |++.|+++
T Consensus 281 -~i~~~~--~~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 -KIVHYK--EHLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHTHH--HHCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HHHhcc--cCcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000000 000111111122 2457788889999 99998 58999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=342.16 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=201.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-++|++.+.||+|+||.||+|++..++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46799999999999999999999888999999998754 233357789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997653 68999999999999999999999 99999999999999999999999999999866543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.........+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... + .
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~------~-~ 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI------P-R 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC------C-C
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC------C-C
Confidence 3333345678999999999999899999999999999999999999997543221 011110000 0 0
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHhcCCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARP-SMRQVVQILERDVA 372 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 372 (420)
...........+.+++.+||+.||++|| ++.++++.|+....
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0011112223477889999999999999 99999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=336.14 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=206.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46789999999999999999999988999999998654 3444577889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg~~~~~~ 248 (420)
||+++++|.+.+.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887654 68999999999999999999999 99999999999999986655 9999999997654
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ....+..
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~------ 224 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-------QIKAGAY------ 224 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCC------
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH-------HHHhccc------
Confidence 322 2334578999999999999999999999999999999999999997654322110 0001100
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000001112244778888999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=338.58 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=207.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467888999999999999999996 4567999999765332 36789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999997653 268999999999999999999999 99999999999999999999999999999865432111
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. . ....+ .......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~i~~~-----~~~~~~~ 228 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTG-----FRLYKPR 228 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTT-----CCCCCCT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---H----HHhcC-----CcCCCCc
Confidence 2233456788999999988889999999999999999999 89999765432211 1 11111 1111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ...+.+++.+||+.||.+|||+.++++.|+..
T Consensus 229 ~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 229 LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12 24577888999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.84 Aligned_cols=250 Identities=25% Similarity=0.329 Sum_probs=201.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (420)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999999989999999998754 334456788999999987 899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997653 68999999999999999999999 99999999999999999999999999999853322
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc--hhhhhhhhhcccCccccccCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL--ILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+......... ..
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------~~ 236 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------QI 236 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------CC
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------CC
Confidence 12344568999999999999999999999999999999999999999753322110 0011111111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
..+... ...+.+++.+||+.||.+||++
T Consensus 237 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPRSL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 122222 2347788889999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=338.79 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=198.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++ .++..||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688899999999999999998 5677899999865422 223678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 9964 9999887543 268999999999999999999999 999999999999999999999999999998654321
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh-----hcccCcccccc
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD-----FWNRGELLEAR 326 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 326 (420)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.......... .+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 12334578999999999865 4589999999999999999999999976543321110000000 00000000001
Q ss_pred CCCCC-------CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 DPNLG-------TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11100 0111122345778999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=349.04 Aligned_cols=273 Identities=24% Similarity=0.303 Sum_probs=211.5
Q ss_pred hcCCCccceecccCceEEEEEE----eCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeee--eCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGT----LPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 167 (420)
.++|++.+.||+|+||.||+|+ ...++..||||++........+.+.+|+.++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4678889999999999999999 45678899999998777666778999999999999999999999886 45679
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999976432 68999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||.......... ..+.........+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHHH
Confidence 443221 2233467888999999988889999999999999999999999986432211000 0000000000000011
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
................+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111112223355788899999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.19 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=206.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45788899999999999999999988889999998766555567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccccCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999887654 58999999999999999999999 999999999999999 78889999999999866533
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. ......+|+.|+|||++.+. ++.++||||||+++|||++|+.||......+... ....+. ...
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~------~~~ 226 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML-------KIREGT------FTF 226 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC------CCC
T ss_pred c--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhCC------CCC
Confidence 2 33445789999999998654 8999999999999999999999997654322110 000100 001
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...........+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000012345788899999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=343.47 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=190.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch-hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|+..+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999999988899999999865432 233668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCC----CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 173 YMPNGSLDKYLYNQP----KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
|++ |+|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886431 2358899999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh-----hcccCcc
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD-----FWNRGEL 322 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~ 322 (420)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.......... .+.....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3222 2334578999999999876 4689999999999999999999999976554322111000000 0000000
Q ss_pred ccccCCCC----CCcc--------cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LEARDPNL----GTEY--------VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~~~~~~~----~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+.. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 0000 0011245788999999999999999999885
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=342.70 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=207.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4568889999999999999999988899999999865422 1256789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecC
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL 243 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~ 243 (420)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997654 68999999999999999999999 9999999999999999887 799999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .. ..
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i-~~---- 232 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NI-TS---- 232 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HH-HT----
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-Hh----
Confidence 98765432 2234578999999999999999999999999999999999999997654322110 00 00
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
................+.+++.+||+.||.+|||+.|+++
T Consensus 233 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 --VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0001111111112345788999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.79 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=193.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||++++..++..||||++...... .+.+.+|+..+++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46789999999999999999999989999999998654322 25678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc--EEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfg~~~~~~~~~ 251 (420)
+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++......
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999997654 58999999999999999999999 99999999999999987765 999999998743322
Q ss_pred CCcccccccCCcccccccccCCCCCcc-chhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTS-ADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ..+...... ....
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~~-------~~~~ 241 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILSV-------KYSI 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHTT-------CCCC
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhcC-------CCCC
Confidence 22334579999999999988777655 899999999999999999997654432211 111111000 0000
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... ......+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDD--IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCc--CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000 011244778889999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=348.82 Aligned_cols=269 Identities=24% Similarity=0.431 Sum_probs=215.4
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeC-----CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLL 158 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~ 158 (420)
+..++.....++|++.+.||+|+||.||+|++. ..+..||+|++... .......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455566788999999999999999999875 34678999998754 334456789999999999999999999
Q ss_pred eeeeeCCeEEEEEeecCCCChhhhhccCC--------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQP--------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 159 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ .+++||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 99999999999999999999999987532 1357899999999999999999999 899999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 250 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL- 250 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH-
Confidence 9999999999999976543221 12233456889999999988899999999999999999999 88998765432211
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.....+.. +.... .....+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 251 ------~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 ------RFVMEGGL-----LDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHcCCc-----CCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111 11111 223457788899999999999999999999988654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.02 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=204.0
Q ss_pred HhcCCCccceecccCceEEEEEEeCC---Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..++|.+.+.||+|+||.||+|++.. .+..||+|++... .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35678889999999999999998643 3456999998765 344567899999999999999999999998754 568
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 258999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
...........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. . ....+. .
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~----~~~~~~-----~ 232 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---G----VLEKGD-----R 232 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---H----HHHHTC-----C
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---H----HHhcCC-----C
Confidence 433333344567889999999988899999999999999999998 99999755433211 1 111110 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
......+ ...+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 233 ~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 LPKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1111112 24477888999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=340.63 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=201.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++..++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788899999999999999999988999999988654 23335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999887553 58999999999999999999999 9999999999999999999999999999986543222
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh--------hhcccCc-c
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF--------DFWNRGE-L 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~-~ 322 (420)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+......... ....... .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2334578999999999865 678999999999999999999999997765433221111000 0000000 0
Q ss_pred cc--ccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 LE--ARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~~--~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ..++...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0111100000 0122345788999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=347.85 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=197.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----e
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----E 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 166 (420)
.++|++.+.||+|+||.||+|++..+++.||||++... .......+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999999889999999998754 3344567899999999999999999999987654 3
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997654 68999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 247 YDHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 247 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~---- 235 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRED---- 235 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCC----
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC----
Confidence 543322 2233457899999999999999999999999999999999999999765432211 1111110
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH-HHh
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ-ILE 368 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~-~L~ 368 (420)
+.............+.+++.+||+.||.+||+..+++. .+.
T Consensus 236 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 236 ---PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp ---CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 00000001112345778899999999999997666553 443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.44 Aligned_cols=251 Identities=22% Similarity=0.257 Sum_probs=181.4
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+..+..+. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999999889999999986542 356778999999997 9999999999999999999999999999
Q ss_pred hhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEEeeecCcccccCCCCCcc
Q 036051 179 LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARLYDHGTDPQT 255 (420)
Q Consensus 179 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~ 255 (420)
|.+++.... .+++.++..++.||+.||+|||+ .+++||||||+|||++.++ .+||+|||++....... ...
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 999998764 68999999999999999999999 9999999999999997665 89999999998654322 233
Q ss_pred cccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCccc
Q 036051 256 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335 (420)
Q Consensus 256 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (420)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+......+. ........
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcccc
Confidence 445789999999999999999999999999999999999999976543221111111111111111 11111111
Q ss_pred HHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 336 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 223456788999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.73 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=209.5
Q ss_pred HhcCCCccceecccCceEEEEEEeC-------CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP-------KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
..++|.+.+.||+|+||.||+|++. .++..||+|++... .......+.+|+.++.++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578899999999999999999975 34567999999765 344567789999999999 89999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCCC--------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPK--------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
.+..++||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+++||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 9999999999999999999976532 248999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999986543321 12233456789999999988889999999999999999999 99999765432211
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+. .+..... ....+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 270 -------~~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 270 -------KLLKEGH-----RMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -------HHHHHTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHhcCC-----CCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111 1111122 2345778889999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=348.16 Aligned_cols=243 Identities=22% Similarity=0.320 Sum_probs=202.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch--------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
.++|++.+.||+|+||.||+|++..++..||||++..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4678999999999999999999998999999998865421 12345778999999999999999999999999
Q ss_pred eEEEEEeecCCC-ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 166 ELLLVYDYMPNG-SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 166 ~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 9999997664 58999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~ 238 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------E 238 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------T
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------h
Confidence 8765432 2344679999999999988776 889999999999999999999996422110 0
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.... ....+ ...+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~--~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIH--PPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCC--CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccC--CCccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 11112 2347788889999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.73 Aligned_cols=258 Identities=28% Similarity=0.515 Sum_probs=202.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCC----ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS----KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
..+|...+.||+|+||.||+|.+..+ +..||||++... .......+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 35667789999999999999988544 345999998754 3344567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++++|.+++.... ..+++.+++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999997653 368999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 249 HGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 249 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. . .....+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~----~~~~~~----- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M----KAINDG----- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHTT-----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHCC-----
Confidence 33211 1222345788999999998899999999999999999998 9999976543221 1 111111
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....... .....+.+++.+||+.||.+||++.++++.|++..
T Consensus 267 ~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 FRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111111 22345788899999999999999999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=357.12 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=197.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..++|++.+.||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346789999999999999999999999999999998754 23334667899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999997654 68999999999999999999995 27899999999999999999999999999975432
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+ . . ....
T Consensus 302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i---~-~------~~~~ 367 (446)
T 4ejn_A 302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELI---L-M------EEIR 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---H-H------CCCC
T ss_pred C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HHH---H-h------CCCC
Confidence 2 22334568999999999999999999999999999999999999999765432211 100 0 0 0111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
.....+ ..+.+++.+||+.||.+|| ++.|+++
T Consensus 368 ~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112222 4477888899999999999 9999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=344.71 Aligned_cols=264 Identities=19% Similarity=0.294 Sum_probs=209.0
Q ss_pred ccchHHHHHHhcCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccC-CcceEeeeee
Q 036051 84 RFRYKDLYIATKGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRL-RHRNLVQLLG 159 (420)
Q Consensus 84 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~ 159 (420)
...+.....-.+.|.+. +.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455555566777776 89999999999999999889999999987542 23356789999999998 5699999999
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcE
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNG 236 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~ 236 (420)
++...+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999999976655579999999999999999999999 99999999999999997 7899
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... .
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~-- 246 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---S-- 246 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H--
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---H--
Confidence 999999998764322 233457999999999999999999999999999999999999999765433211100 0
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ................+.+++.+||+.||.+|||+.|+++
T Consensus 247 --~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 --Q------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --H------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --h------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 0001111111122345778889999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.40 Aligned_cols=272 Identities=25% Similarity=0.347 Sum_probs=203.1
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhc--cCCcceEeeeeeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG--RLRHRNLVQLLGYCRR 163 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~ 163 (420)
.........++|++.+.||+|+||.||+|++. +..||||++..... ..+..|.+++. .++||||+++++++..
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 33334445678999999999999999999985 67899999864432 23344444444 4599999999999887
Q ss_pred C----CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc-----cCcEEecccCCCCEEEcCCC
Q 036051 164 K----GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW-----EQVVIHRDVKASNVLLDGEL 234 (420)
Q Consensus 164 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlk~~NIll~~~~ 234 (420)
. ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+++||||||+|||++.++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7 7899999999999999999765 5899999999999999999999810 12999999999999999999
Q ss_pred cEEEeeecCcccccCCCCC---cccccccCCcccccccccCCCCCcc------chhhhhHHHHHHHhcC----------C
Q 036051 235 NGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRTGKATTS------ADVFSFGAFLLEVACG----------R 295 (420)
Q Consensus 235 ~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~slGvvl~el~tg----------~ 295 (420)
.+||+|||++......... ......||+.|+|||++.+.....+ +|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999765433221 1224579999999999987766655 9999999999999999 5
Q ss_pred ccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 296 RPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 296 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.||.......... ...... .......+.....+ ..+....+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 260 ~p~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 260 LPYHDLVPSDPSY--EDMREI----VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CTTTTTSCSSCCH--HHHHHH----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCch--hhhHHH----HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 5554332221110 000000 01112223232222 2356778999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=341.10 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=205.0
Q ss_pred HHhcCCCccc-eecccCceEEEEEEe--CCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 92 IATKGFREKE-LLGSGGFGRVYRGTL--PKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 92 ~~~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
...++|.+.+ .||+|+||.||+|.+ ...+..||||++.... ....+.+.+|+.++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456677777 999999999999954 5667889999987542 33357799999999999999999999999 5667
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 899999999999999998754 58999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 247 YDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 247 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .....+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T----AMLEKGE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----HHHHTTC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCC--
Confidence 6543221 1222346788999999988889999999999999999999 9999976543321 1 1111111
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+.... .....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 238 ---~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 ---RMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---CCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111112 2234578889999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=333.57 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=184.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 568889999999999999999988888999999865421 22467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999997653 368999999999999999999999 999999999999999999999999999998654322
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... .. ...+....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-------~~~~~~~~ 232 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KV-------VLADYEMP 232 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C-------CSSCCCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HH-------hhcccCCc
Confidence 1 2234578999999999998889999999999999999999999997654332110 00 00011111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... ...+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122 235778889999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=343.58 Aligned_cols=264 Identities=23% Similarity=0.364 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceEEEEEE----eCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--Ce
Q 036051 94 TKGFREKELLGSGGFGRVYRGT----LPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 166 (420)
.+.|+..+.||+|+||.||+|+ ...++..||+|++.... ....+.+.+|+.++.+++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3457889999999999999999 45678899999987542 33457789999999999999999999999876 67
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 8999999999999999965432 68999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc--------ccchhhhhhhhh
Q 036051 247 YDHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE--------ENLILVDWVFDF 316 (420)
Q Consensus 247 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~--------~~~~~~~~~~~~ 316 (420)
...... .......+|..|+|||++.+..++.++||||||+++|||++|..|+...... ........+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654332 1233456788899999998888999999999999999999999986432110 000000000111
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ..... ........+.+++.+||+.||.+|||+.++++.|+..
T Consensus 256 ~~~-----~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKE-----GKRLP----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHT-----TCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc-----cCCCC----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111 11111 1122335578899999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.51 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=204.9
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (420)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999999889999999987542 23346688899999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997644 58999999999999999999999 999999999999999999999999999998533
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+ ..
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~-~~------~~ 238 (353)
T 2i0e_A 173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIM-EH------NV 238 (353)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-HC------CC
T ss_pred cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hC------CC
Confidence 22 12344568999999999999999999999999999999999999999765432211 1110 11 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
..+... ...+.+++.+||+.||.+||+ +.++++
T Consensus 239 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111222 245778888999999999995 466654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=350.16 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=192.8
Q ss_pred cCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhcc-CCcceEeeeeeeeee----CCeEE
Q 036051 95 KGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRR----KGELL 168 (420)
Q Consensus 95 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~ 168 (420)
++|... +.||+|+||+||+|.+..++..||||++... ..+.+|+.++.+ .+||||+++++++.. .+.++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455555 6899999999999999989999999998643 345678887744 589999999998875 56799
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~ 245 (420)
+||||+++|+|.+++.......+++.++..|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999987655579999999999999999999999 99999999999999997 7889999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~--- 284 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY--- 284 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCC---
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCcc---
Confidence 65432 22345678999999999999999999999999999999999999997654332110 00011111110
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.............+.+++.+||+.||.+|||+.|+++.
T Consensus 285 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000011223457889999999999999999999973
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=340.43 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=197.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||.||+|++. +..||+|++.... ..+.|.+|+..+++++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 356888899999999999999984 5679999986543 34678999999999999999999998874 47999999
Q ss_pred cCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc-EEEeeecCcccccCCC
Q 036051 174 MPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGT 251 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~-~kl~Dfg~~~~~~~~~ 251 (420)
+++++|.+++..... ..+++..++.++.|++.||+|||+....+++||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999986543 24788999999999999999999854468999999999999998886 799999999754332
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+ . ... ...+...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~--~-~~~-----~~~~~~~ 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--MW--A-VHN-----GTRPPLI 226 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--HH--H-HHT-----TCCCCCB
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--HH--H-Hhc-----CCCCCcc
Confidence 233468999999999999999999999999999999999999997544322110 00 0 000 1111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. ....+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22 2345778889999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.29 Aligned_cols=247 Identities=30% Similarity=0.417 Sum_probs=201.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+.|+..+.||+|+||+||+|++..++..||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999999888999999998643 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9996 68888875432 368999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ..... ...+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~------~~~~ 271 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ------NESP 271 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH------SCCC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh------cCCC
Confidence 23357899999999984 567899999999999999999999999765432211 11111 1111
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..... .....+.+++.+||+.||++|||+.++++.
T Consensus 272 ~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 112346788889999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=347.92 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=211.9
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCce-----eeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKI-----EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC 161 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 161 (420)
+.....++|...+.||+|+||.||+|.+...+. .||+|++... .....+.+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344567889999999999999999999865543 6999998765 334457789999999999 899999999999
Q ss_pred eeCCeEEEEEeecCCCChhhhhccCC------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 162 RRKGELLLVYDYMPNGSLDKYLYNQP------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 162 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence 99999999999999999999987532 2357899999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~ 307 (420)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 999999999999999865433221 2233456889999999988899999999999999999998 99999765433211
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
......+ ........ ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 277 ------~~~~~~~-----~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 ------YKLVKDG-----YQMAQPAF----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ------HHHHHHT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhcC-----CCCCCCCC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111 11111111 124577888999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=333.96 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=202.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999999999899999986542 22246788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999987653 58999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... ... ......
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~------~~~~~~ 226 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RIS------RVEFTF 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHH------HTCCCC
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHH------hCCCCC
Confidence 2334578999999999999999999999999999999999999997654322110 000 011111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 227 ~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1122 2446788889999999999999999963
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=335.86 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=205.8
Q ss_pred cCCCccc-eecccCceEEEEEEeC--CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKE-LLGSGGFGRVYRGTLP--KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
++|.+.+ .||+|+||.||+|.+. +++..||+|++... .....+.+.+|+.++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999864 45778999999764 344567899999999999999999999999 55678999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999997543 368999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 251 TDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 251 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. . ....+. .
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~----~i~~~~-----~ 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGK-----R 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTC-----C
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHhcCC-----c
Confidence 221 1223456889999999988889999999999999999998 99999765543211 1 111111 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+.... .....+.+++.+||+.||.+||++.++++.|+...
T Consensus 232 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 MECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112 22345788899999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=331.74 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=205.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35788899999999999999999888889999998654 23345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT- 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~- 251 (420)
|+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999997653 68999999999999999999999 999999999999999999999999999998654322
Q ss_pred CCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+... . .. .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----~----~~--~ 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-----K----TY--L 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT-----C----TT--S
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc-----c----cc--c
Confidence 112334578999999999987665 7799999999999999999999976543321 11111110 0 00 0
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122345778899999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.47 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=199.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
..+|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788899999999999999999888899999988642 344567789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 171 YDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998642 23368999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... .......+++.|+|||++.+..++.++||||||+++|||++|+.||........ .+. ....... .+
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~-----~~ 256 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----KKIEQCD-----YP 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHH----HHHHTTC-----SC
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHH----HHhhccc-----CC
Confidence 322 122345689999999999999999999999999999999999999975432211 011 1111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.... ......+.+++.+||+.||.+|||+.++++.|++..+
T Consensus 257 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 PLPS---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp CCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcc---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111 1122457788889999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.48 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=194.4
Q ss_pred hcCCCccceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
.++|++.+.||+|+||.||+|+.. .++..||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467889999999999999999984 577889999987542 2334567889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997643 58899999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. . ... ..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~-~~------ 236 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---D---KIL-KC------ 236 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H---HHH-HT------
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---H---HHH-hC------
Confidence 43221 1233457899999999999889999999999999999999999999765432211 1 100 00
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
........ ...+.+++.+||+.||.+|| ++.|+++
T Consensus 237 ~~~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 KLNLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111222 24577888899999999999 7778775
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=371.59 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=208.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+..++|++.+.||+|+||.||+|.+.+ +..||||++..... ..++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 455678889999999999999999965 45699999976532 24679999999999999999999999876 6789999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.++|.......+++.+++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999975433468999999999999999999999 999999999999999999999999999998654321
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+..+. ....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~-----~~~~ 485 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-----RMPC 485 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTTC-----CCCC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-----CCCC
Confidence 111223346788999999988899999999999999999999 99999765433211 1111111 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. .....+.+++.+||+.||++|||+.+|++.|+...
T Consensus 486 ~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 22345788899999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.52 Aligned_cols=269 Identities=25% Similarity=0.383 Sum_probs=214.1
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEe-----CCCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQL 157 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 157 (420)
+...+.....++|++.+.||+|+||.||+|++ ..++..||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678899999999999999999985 346788999998765 334456789999999999 79999999
Q ss_pred eeeeeeCC-eEEEEEeecCCCChhhhhccCCC--------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecc
Q 036051 158 LGYCRRKG-ELLLVYDYMPNGSLDKYLYNQPK--------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRD 222 (420)
Q Consensus 158 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~d 222 (420)
++++...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987654 58999999999999999976542 128899999999999999999999 9999999
Q ss_pred cCCCCEEEcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCC
Q 036051 223 VKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIER 300 (420)
Q Consensus 223 lk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~ 300 (420)
|||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986544322 22334567889999999988899999999999999999998 9999976
Q ss_pred CCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....+.. ......+ ......... ...+.+++.+||+.||.+|||+.|+++.|+..+
T Consensus 254 ~~~~~~~------~~~~~~~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEEF------CRRLKEG-----TRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHHH------HHHHHHT-----CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHH------HHHhccC-----ccCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 5433211 1111111 111111222 234778888999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.76 Aligned_cols=263 Identities=23% Similarity=0.228 Sum_probs=206.8
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeee----eCCeE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR----RKGEL 167 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~ 167 (420)
+..++|++.+.||+|+||.||++++..++..||||++........+.+.+|+.++++++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 44678999999999999999999998889999999987766666788999999999999999999999986 33578
Q ss_pred EEEEeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 168 LLVYDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
++|+||+++|+|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999998752 23468999999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCC--------cccccccCCcccccccccCCC---CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh
Q 036051 246 LYDHGTDP--------QTTHVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 246 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 314 (420)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.......... .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~ 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-----A 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-----H
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-----h
Confidence 54321110 112345799999999987654 6889999999999999999999995421111000 0
Q ss_pred hhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
..... ......... ....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 258 ~~~~~-----~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 258 LAVQN-----QLSIPQSPR----HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHC-----C--CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HHhhc-----cCCCCcccc----CCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00000 000011111 2345788889999999999999999999998765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=345.82 Aligned_cols=268 Identities=19% Similarity=0.209 Sum_probs=203.2
Q ss_pred HhcCCCccceecccCceEEEEEEeCCC-----ceeeeeecccccchhHH-----------HHHHHHHHHhccCCcceEee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKS-----KIEIAVKKISHESRQGM-----------KEFVAEIVSIGRLRHRNLVQ 156 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~ 156 (420)
..++|++.+.||+|+||.||+|.+..+ +..||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998664 46799999865532211 22445667778889999999
Q ss_pred eeeeeeeC----CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-
Q 036051 157 LLGYCRRK----GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD- 231 (420)
Q Consensus 157 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~- 231 (420)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 99998764 4589999999 999999997653 369999999999999999999999 8999999999999999
Q ss_pred -CCCcEEEeeecCcccccCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc
Q 036051 232 -GELNGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE 304 (420)
Q Consensus 232 -~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~ 304 (420)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999976543211 1123456999999999999999999999999999999999999999854332
Q ss_pred ccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 305 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
... ......... ..+....++.+... .....+.+++..||+.||.+||++.++++.|+...
T Consensus 268 ~~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 PKY--VRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHH--HHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHH--HHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 211 111111000 01111111111100 11245778888899999999999999999997643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=332.17 Aligned_cols=263 Identities=17% Similarity=0.226 Sum_probs=203.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeee-eeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 171 (420)
..++|++.+.||+|+||.||+|++..++..||||++...... ..+.+|+.++..++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999999888999999986544222 3578899999999888777666654 6778899999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~ 248 (420)
||+ +++|.+++..... .+++..++.++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++....
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999999975433 68999999999999999999999 999999999999999 788999999999998765
Q ss_pred CCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 249 HGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 249 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4322 1233467899999999999999999999999999999999999999875543322111111100000000
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
. .........+.+++.+||+.||++|||+.++++.|+...
T Consensus 240 -~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 240 -E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -H--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -h--------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 000111245888899999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=341.26 Aligned_cols=267 Identities=25% Similarity=0.447 Sum_probs=202.8
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCC---Cceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGY 160 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 160 (420)
.++++....++|.+.+.||+|+||.||+|.+.. ++..||+|++... .....+.+.+|+.++.+++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 344455567889999999999999999998754 4568999998754 34445779999999999999999999999
Q ss_pred eeeCC-----eEEEEEeecCCCChhhhhccC----CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 161 CRRKG-----ELLLVYDYMPNGSLDKYLYNQ----PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 161 ~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
+...+ ..++||||+++++|.+++... ....+++..++.++.||+.||.|||+ .+++||||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEc
Confidence 87654 359999999999999998432 23468999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchh
Q 036051 232 GELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLIL 309 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~ 309 (420)
.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 259 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-- 259 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--
Confidence 999999999999986543321 22334467889999999999999999999999999999999 88998765443211
Q ss_pred hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. ...+ ..+.... .....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 260 -~~----~~~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 -DY----LLHG-----HRLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -HH----HHTT-----CCCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH----HHcC-----CCCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111 1111111 22345788899999999999999999999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=335.44 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=201.7
Q ss_pred CCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE-EEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL-LLV 170 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 170 (420)
.|...+.||+|+||+||+|.+.++ +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 355568999999999999997443 337999998754 334567899999999999999999999999776654 999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 368999999999999999999999 89999999999999999999999999999755332
Q ss_pred C---CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 251 T---DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 251 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+........ .... ...+. .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~----~~~~~-----~ 246 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHF----LAQGR-----R 246 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHH----HHTTC-----C
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHH----hhcCC-----C
Confidence 1 1223345678899999999999999999999999999999996665543322211 1111 11110 1
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...... ....+.+++.+||+.||.+|||+.++++.|++.
T Consensus 247 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 LPQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 224578888999999999999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.98 Aligned_cols=264 Identities=24% Similarity=0.408 Sum_probs=207.9
Q ss_pred hcCCCccceecccCceEEEEEEe----CCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--eE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--EL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 167 (420)
.++|++.+.||+|+||.||+|++ ..++..||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 5578899999998776666788999999999999999999999886644 78
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999976532 68999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc---------ccchhhhhhhhh
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE---------ENLILVDWVFDF 316 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~---------~~~~~~~~~~~~ 316 (420)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ........+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 543221 122345677899999998888999999999999999999999988642110 000000001111
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...+ ....... .....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 276 ~~~~-----~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 276 LKNN-----GRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHTT-----CCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcC-----CCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 0111111 2234578889999999999999999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=369.12 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=201.2
Q ss_pred CCCccc-eecccCceEEEEEEeC--CCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 96 GFREKE-LLGSGGFGRVYRGTLP--KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 96 ~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++.+.+ .||+|+||.||+|.+. +++..||||++... .....++|.+|+.++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999875 35667999999765 33346789999999999999999999999976 5689999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999997553 368999999999999999999999 999999999999999999999999999998764332
Q ss_pred CC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 252 DP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 252 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.. ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+..+. ..
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~-----~~ 558 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK-----RM 558 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTC-----CC
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCC-----CC
Confidence 21 1222345689999999998899999999999999999998 99999876543311 1111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. +......+.+++.+||+.||++||++.+|++.|+..
T Consensus 559 ~~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CC----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 122335588899999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.71 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=206.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccch---hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3578889999999999999999988899999999865421 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999997654 68999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ . .....+. ..
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~----~~i~~~~------~~ 234 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F----KKICDGI------FY 234 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H----HHHHTTC------CC
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H----HHHhcCC------cC
Confidence 2 2344679999999999988765 6899999999999999999999976543221 1 1111111 01
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111122 34778888999999999999999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=330.79 Aligned_cols=261 Identities=18% Similarity=0.231 Sum_probs=205.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeee-eeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|++..+++.||||++...... +.+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999999888999999988654332 4578999999999988766665554 66778899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccccC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+ +++|.+++..... .+++.+++.++.|++.||+|||+ .+++||||||+|||+ +.++.+||+|||++.....
T Consensus 86 ~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 9999999974432 68999999999999999999999 999999999999999 4788999999999987654
Q ss_pred CCCC------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 250 GTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 250 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 3321 234567899999999999999999999999999999999999999875443322111111110000000
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. .... .....+.+++.+||+.||.+|||+.++++.|+..
T Consensus 240 ~----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 E----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred H----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 0001 1124578889999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=343.16 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceee--eeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEI--AVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999997777654 99988653 333456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc
Q 036051 170 VYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN 235 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~ 235 (420)
||||+++++|.+++.... ...+++.+++.++.||+.||.|||+ .+++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997653 2368999999999999999999999 99999999999999999999
Q ss_pred EEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhh
Q 036051 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVF 314 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 314 (420)
+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y 251 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------H
Confidence 999999998743221 12233456889999999988889999999999999999998 9999976543221 1
Q ss_pred hhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+ ........+ ...+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 252 ~~~~~~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKLPQG-----YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHGGGT-----CCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcC-----CCCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111 111111222 245778889999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.74 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=200.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 168 (420)
..|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4467788999999999999999989999999988654 34456778999999999999999999998865 35689
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEc-CCCcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLD-GELNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~-~~~~~kl~Dfg~~~ 245 (420)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+ ++||||||+||+++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999997643 68899999999999999999998 77 99999999999998 78999999999997
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......... . .....+.
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~----~~~~~~~---- 246 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y----RRVTSGV---- 246 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H----HHHTTTC----
T ss_pred ccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H----HHHhccC----
Confidence 54332 2344578999999998864 5899999999999999999999999764432211 0 0111110
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 247 -~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 -K---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -C---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -C---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 01111112245788899999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=348.92 Aligned_cols=256 Identities=29% Similarity=0.419 Sum_probs=194.6
Q ss_pred CCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeee-eCCeEEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELLLV 170 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv 170 (420)
.|...+.||+|+||.||+|++..+ ...||+|.+... .....+.|.+|+.++++++||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 356678999999999999987432 346899988654 3445678999999999999999999999865 45688999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997653 368899999999999999999999 99999999999999999999999999999865432
Q ss_pred CC---CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 251 TD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 251 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.. .. ...+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~----~~~~~----- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VY----LLQGR----- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HH----HHTTC-----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HH----HHcCC-----
Confidence 21 12233457889999999999999999999999999999999 67777655433211 11 11111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....... ....+.+++.+||+.||++|||+.|+++.|+...
T Consensus 314 ~~~~p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 RLLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 2345788889999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=364.15 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=209.4
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
..++|+..+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999999899999999986542 2234668899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999987665569999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .....
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~------~~~~~ 407 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK------EVPEE 407 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHH------HCCCC
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhh------ccccc
Confidence 32 23345899999999999998999999999999999999999999986543221110 011000 01111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
....+ ...+.+++.+||+.||.+|| ++.|+++
T Consensus 408 ~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 YSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 22222 24577888899999999999 7788875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=349.76 Aligned_cols=204 Identities=30% Similarity=0.451 Sum_probs=167.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCC--eE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG--EL 167 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~ 167 (420)
..++|++.+.||+|+||.||+|.+..++..||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357899999999999999999999989999999988543 3445567889999999997 999999999987543 78
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999998764 68899999999999999999999 99999999999999999999999999999865
Q ss_pred cCCC--------------------CCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 248 DHGT--------------------DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 248 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3211 112334679999999999876 6789999999999999999999999986554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=333.80 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch------hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 568889999999999999999988889999998865421 13577899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecCc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGLA 244 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~~ 244 (420)
+||||+++++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997643 68999999999999999999999 9999999999999998877 8999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||......+... . ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~----- 225 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------N-ISA----- 225 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHT-----
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH------H-hHh-----
Confidence 8654322 2234568999999999998899999999999999999999999997654322110 0 000
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
................+.+++.+||+.||.+|||+.|+++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 -VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0011111111122345788999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.92 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=199.0
Q ss_pred cCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
+.|.+. +.||+|+||.||+|++..++..||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457664 7899999999999999888999999999766555567789999999885 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeeecCcccccC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDFGLARLYDH 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg~~~~~~~ 249 (420)
|+++++|.+++.... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997653 68999999999999999999999 89999999999999998776 99999999875532
Q ss_pred CC------CCcccccccCCcccccccccC-----CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh--------
Q 036051 250 GT------DPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV-------- 310 (420)
Q Consensus 250 ~~------~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~-------- 310 (420)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 112233568999999999865 45789999999999999999999999865543211000
Q ss_pred hhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+......+ ...............+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~i~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEG------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHC------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcc------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000011010 001110000112345788999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.10 Aligned_cols=268 Identities=26% Similarity=0.349 Sum_probs=205.0
Q ss_pred CCCccceecccCceEEEEEEe----CCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeC--CeEE
Q 036051 96 GFREKELLGSGGFGRVYRGTL----PKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELL 168 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 168 (420)
.|++.+.||+|+||+||++.+ ..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 348899999999999988864 3467889999997653 34457799999999999999999999999874 6789
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++++|.+++... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999999765 48999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... .......+|..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.........+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence 4322 12233457888999999998889999999999999999999999986432110 00000000000000011111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...............+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111222335688899999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.95 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=205.7
Q ss_pred HhcCCCccceecccCceEEEEEEe-----CCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTL-----PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
..++|++.+.||+|+||.||+|++ ..++..||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999994 345678999999654 34455678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCC-----ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEE
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPK-----VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRL 238 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl 238 (420)
.++||||+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976532 358999999999999999999999 99999999999999984 456999
Q ss_pred eeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhh
Q 036051 239 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~---- 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEF---- 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHH----
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHH----
Confidence 99999975533221 22334567899999999988899999999999999999998 9999976543221 111
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
...+. .+.....+ ...+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 258 ~~~~~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 VTSGG-----RMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHTTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcCC-----CCCCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11111 11111222 24577888999999999999999999999865433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.24 Aligned_cols=273 Identities=21% Similarity=0.257 Sum_probs=213.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC--eEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 170 (420)
.++|.+.+.||+|+||+||+|++..++..||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999999889999999987543 233567889999999999999999999988755 78999
Q ss_pred EeecCCCChhhhhccCCC-ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----cCCCcEEEeeecCcc
Q 036051 171 YDYMPNGSLDKYLYNQPK-VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfg~~~ 245 (420)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976432 238999999999999999999999 999999999999999 777889999999998
Q ss_pred cccCCCCCcccccccCCcccccccccC--------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc-hhhhhhhhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT--------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENL-ILVDWVFDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~ 316 (420)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .....+...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 654322 2234578999999999864 46788999999999999999999999754332211 111000000
Q ss_pred cc-----------cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 317 WN-----------RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 317 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. .+.+.-..+..............+.+++.+||+.||++||++.|+++.++..+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 00 00000000111223445677888999999999999999999999999887654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.28 Aligned_cols=250 Identities=30% Similarity=0.424 Sum_probs=197.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-CeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-GELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|.+. +..||||++.... ..+.+.+|+.++.+++||||+++++++... +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467888999999999999999984 6689999987553 346789999999999999999999986544 57899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999976544458899999999999999999999 99999999999999999999999999998754432
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....+ ..+...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~~ 236 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKG-----YKMDAP 236 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTT-----CCCCCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcC-----CCCCCc
Confidence 223357889999999988899999999999999999998 99999765433211 111111 111111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 237 ~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 237 DG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 22 234577888999999999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=343.24 Aligned_cols=265 Identities=18% Similarity=0.185 Sum_probs=199.2
Q ss_pred hcCCCccceecccCceEEEEEEeCC---CceeeeeecccccchhH-----------HHHHHHHHHHhccCCcceEeeeee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHESRQG-----------MKEFVAEIVSIGRLRHRNLVQLLG 159 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~ 159 (420)
.++|.+.+.||+|+||.||+|.+.. ++..||+|+........ ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4678889999999999999999976 77889999886543211 134667888999999999999999
Q ss_pred eeee----CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-
Q 036051 160 YCRR----KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL- 234 (420)
Q Consensus 160 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~- 234 (420)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+ .+++||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 9887 67899999999 999999997654 78999999999999999999999 8999999999999999877
Q ss_pred -cEEEeeecCcccccCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc
Q 036051 235 -NGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307 (420)
Q Consensus 235 -~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~ 307 (420)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999986543211 1224457899999999999989999999999999999999999999653322111
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. . ......... ........... ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 270 ~-~-~~~~~~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 V-Q-TAKTNLLDE-LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp H-H-HHHHHHHHT-TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred H-H-HHHHhhccc-ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 0 0 000000000 00000000000 01224578888899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=335.20 Aligned_cols=258 Identities=29% Similarity=0.441 Sum_probs=201.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeee-eeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 168 (420)
..+|+..+.||+|+||.||+|++..+ ...||+|.+... .....+.+.+|+.++++++||||+++++++ ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34577889999999999999997543 345899988754 344557899999999999999999999985 4556889
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999997643 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC---CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 249 HGTD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 249 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ... ..+
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~----~~~---- 248 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQG---- 248 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHH----HTT----
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHH----hcC----
Confidence 3221 12334567889999999998899999999999999999999 55566544332211 000 000
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......... ...+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 249 -~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 249 -RRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp -CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011111112 245788889999999999999999999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=346.01 Aligned_cols=247 Identities=24% Similarity=0.288 Sum_probs=194.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHH-hccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||.||+|+++.++..||+|++.... ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999999999999999987542 2334556777776 567899999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 68899999999999999999999 9999999999999999999999999999985432
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .+ ...
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~-~~------~~~ 257 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNIL-NK------PLQ 257 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHHH-HS------CCC
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hc------ccC
Confidence 2 22344568999999999999999999999999999999999999999764432211 0110 11 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQV 363 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 363 (420)
....+. ..+.+++.+||+.||.+||++.+.
T Consensus 258 ~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 LKPNIT----NSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCSSSC----HHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCC----HHHHHHHHHHcccCHHhCCCCCCC
Confidence 112222 347788889999999999998543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.31 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=197.6
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee-----CCeE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-----KGEL 167 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~ 167 (420)
..++|++.+.||+|+||.||+|++ ++..||||++....... .....|+..+..++||||+++++++.. ....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 346788999999999999999987 56789999986554322 122344555666899999999985532 3467
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC---------cEEecccCCCCEEEcCCCcEEE
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ---------VVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~iiH~dlk~~NIll~~~~~~kl 238 (420)
++||||+++|+|.+++... ..++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 9999999999999999765 35889999999999999999998 6 9999999999999999999999
Q ss_pred eeecCcccccCCC-------CCcccccccCCcccccccccC-------CCCCccchhhhhHHHHHHHhcCCccCCCCCCc
Q 036051 239 GDFGLARLYDHGT-------DPQTTHVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVACGRRPIERQGPE 304 (420)
Q Consensus 239 ~Dfg~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~ 304 (420)
+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998664321 112234579999999999976 35667899999999999999998777543322
Q ss_pred ccchhh-h----------hhhhhcccCccccccCCCCCCc--ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 305 ENLILV-D----------WVFDFWNRGELLEARDPNLGTE--YVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 305 ~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...... . ........ ....+.+... ........+.+++.+||+.||++|||+.|+++.|+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSR----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTT----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcc----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 211000 0 00000000 1111222211 12345667999999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=344.54 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=190.2
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeee--------
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCR-------- 162 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------- 162 (420)
....+|++.+.||+|+||.||+|++..++..||||++........+.+.+|+..+.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34567889999999999999999998889999999987766666778999999999995 999999999983
Q ss_pred eCCeEEEEEeecCCCChhhhhccC-CCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEcCCCcEEEe
Q 036051 163 RKGELLLVYDYMPNGSLDKYLYNQ-PKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~~~~~~kl~ 239 (420)
.....++|+||+ +|+|.+++... ....+++..++.++.||+.||.|||+ .+ ++||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence 345689999999 47999988641 22369999999999999999999998 77 9999999999999999999999
Q ss_pred eecCcccccCCCCC-----------cccccccCCcccccccc---cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 240 DFGLARLYDHGTDP-----------QTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 240 Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
|||++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876543211 11234689999999998 56678999999999999999999999997543321
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. .+. ......... ...+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 261 ~~-----------~~~----~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 IV-----------NGK----YSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hh-----------cCc----ccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 000 000001111 123678888999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=336.53 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=207.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.+.|+..+.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999998889999999986542 3445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 99999999998653 68999999999999999999999 999999999999999999999999999998654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+ .....+....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~---------~~~~~~~~~~ 241 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---LI---------PKNNPPTLEG 241 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HH---------HHSCCCCCCS
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---Hh---------hcCCCCCCcc
Confidence 12334578999999999999999999999999999999999999997654322110 00 0111122222
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.++ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 NYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222 347788889999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=343.86 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=200.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|.++.+++.||||++..... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4678899999999999999999998999999999865532 234678888887 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC----CcEEEeeecCccccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLARLYD 248 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfg~~~~~~ 248 (420)
|+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||++....
T Consensus 97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999997654 68999999999999999999999 999999999999998543 359999999998664
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. .....+..
T Consensus 172 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~------ 240 (342)
T 2qr7_A 172 AEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF------ 240 (342)
T ss_dssp CTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC------
T ss_pred CCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc------
Confidence 432 2234467899999999998878899999999999999999999999764322211111 11111111
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111122345778888999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=336.75 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=203.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|.+.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46788899999999999999999888899999999765544456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccccCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~~ 250 (420)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||++ ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999987543 68999999999999999999999 999999999999999 78889999999998754321
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . .....+.. ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~----~~i~~~~~------~~ 226 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---F----EKIKEGYY------EF 226 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H----HHHHHCCC------CC
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHcCCC------CC
Confidence 23345789999999999999999999999999999999999999976543221 1 11111110 00
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...........+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111122345788899999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=343.95 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=195.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCc--ceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||.||+|.+. ++..||||++... .....+.+.+|+.++.+++| |||+++++++...+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467889999999999999999985 5778999988644 34455788999999999976 999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
|||+ .+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||++.....
T Consensus 87 v~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9995 5889999998754 68999999999999999999999 9999999999999997 57899999999986644
Q ss_pred CCCC-cccccccCCcccccccccC-----------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 250 GTDP-QTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 250 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~-- 232 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA-- 232 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHH--
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHH--
Confidence 3221 2334679999999999854 6789999999999999999999999975432110 0111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 233 -------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111111112457788889999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=338.86 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=205.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 169 (420)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46788899999999999999999988999999998654 34445779999999999999999999998754 578999
Q ss_pred EEeecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCc-----EEecccCCCCEEEcCCCcEEEeeec
Q 036051 170 VYDYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQV-----VIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 2358999999999999999999998 66 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
++....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ +. .....+.
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~i~~~~- 232 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGK- 232 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTC-
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH----HHHhhcc-
Confidence 998654321 12234578999999999998899999999999999999999999997654321 11 1111111
Q ss_pred ccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.+.....+ ...+.+++.+||+.||.+|||+.|+++.+...
T Consensus 233 ----~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 233 ----FRRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ----CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ----cccCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11121222 34577888999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=335.92 Aligned_cols=270 Identities=26% Similarity=0.370 Sum_probs=210.8
Q ss_pred ccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhcc--CCcceEeeeeeee
Q 036051 84 RFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYC 161 (420)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~ 161 (420)
.....-.....++|.+.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 344444455678899999999999999999998 46789999986543 3556778888776 7899999999999
Q ss_pred eeCC----eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhh--------hcccCcEEecccCCCCEE
Q 036051 162 RRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH--------EEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 162 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~dlk~~NIl 229 (420)
.... ..++||||+++|+|.+++... .+++.+++.++.|++.||+||| + .+++||||||+|||
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNIL 179 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEE
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEE
Confidence 8775 899999999999999999764 5899999999999999999999 6 89999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCC---cccccccCCcccccccccCC------CCCccchhhhhHHHHHHHhcC------
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACG------ 294 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~el~tg------ 294 (420)
++.++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999866543321 22345789999999999765 234789999999999999999
Q ss_pred ----CccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 295 ----RRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 295 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+.||......... ...+ .... ......+.....+ ..+....+.+++.+||+.||++|||+.||++.|+.
T Consensus 260 ~~~~~~p~~~~~~~~~~-~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPS-VEEM-RKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCCTTTTTSCSSCC-HHHH-HHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccCccccCcCccc-HHHH-HHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6677654332211 0001 1111 1112223332222 34667789999999999999999999999999986
Q ss_pred C
Q 036051 370 D 370 (420)
Q Consensus 370 ~ 370 (420)
.
T Consensus 334 i 334 (342)
T 1b6c_B 334 L 334 (342)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=341.50 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=196.9
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch--hHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
....++|++.+.||+|+||+||+|++..++..||||++..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3456789999999999999999999998999999999975532 23456789999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-----CCCcEEEeeecC
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-----GELNGRLGDFGL 243 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-----~~~~~kl~Dfg~ 243 (420)
+||||++ |+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999996 59999998765 58999999999999999999999 9999999999999994 455699999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGEL 322 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (420)
+....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.................
T Consensus 184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 98664322 223445689999999999774 4899999999999999999999999765433211100000000000000
Q ss_pred --------ccccCCCCCCcccH-----HHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 --------LEARDPNLGTEYVA-----EELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 --------~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+........ .....+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000111111001 12255788999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.51 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=194.7
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
...++|.+.+.||+|+||+||+|.+..++..||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999999999999999986532 1122347899999999999999999999754
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cEEEee
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NGRLGD 240 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~kl~D 240 (420)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999999987654 68999999999999999999999 8999999999999997544 599999
Q ss_pred ecCcccccCCCCCcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 241 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 241 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+ ..
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~----~i 357 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD----QI 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH----HH
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH----HH
Confidence 9999876432 23345679999999999853 56888999999999999999999999764433211 10 01
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 358 ~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGK------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCC------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1110 00000111112355788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=330.90 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=207.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|...+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46788899999999999999999988999999988654 234456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987643 68999999999999999999999 99999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .. .... ....
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~------~~~~ 234 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LR-IKKN------EYSI 234 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH-HHTT------CCCC
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-Hhhc------cCCC
Confidence 2 2233457899999999999888999999999999999999999999764432211 00 0000 1111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 235 PKHI----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1222 234778888999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=348.07 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=196.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCC--cceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l 169 (420)
..+|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3568999999999999999999865 778999998654 3445678999999999996 5999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||++.....
T Consensus 134 v~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 999 55889999998764 68889999999999999999999 9999999999999996 57899999999987643
Q ss_pred CCCC-cccccccCCcccccccccC-----------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 250 GTDP-QTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 250 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHHHh
Confidence 3221 2344679999999999865 368899999999999999999999997543211 0011111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
... ......... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 282 ~~~-----~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPN-----HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTT-----SCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccc-----ccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 100 011111111 2457788889999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.74 Aligned_cols=242 Identities=14% Similarity=0.144 Sum_probs=190.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHH---HHhccCCcceEeeee-------ee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEI---VSIGRLRHRNLVQLL-------GY 160 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 160 (420)
.++|.+.+.||+|+||+||+|++..++..||||++... .....+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888889999998643 334557889999 556666899999998 55
Q ss_pred eeeCC-----------------eEEEEEeecCCCChhhhhccCC-----CccCcHHHHHHHHHHhHhHhHHhhhcccCcE
Q 036051 161 CRRKG-----------------ELLLVYDYMPNGSLDKYLYNQP-----KVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218 (420)
Q Consensus 161 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 218 (420)
+...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 379999999 689999997532 1234568899999999999999999 999
Q ss_pred EecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCC-----------CCCccchhhhhHHH
Q 036051 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-----------KATTSADVFSFGAF 287 (420)
Q Consensus 219 iH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvv 287 (420)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3344567 999999999877 79999999999999
Q ss_pred HHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 288 LLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 288 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+|||++|+.||.......... .+ .. .. ..+ ...+.+++.+||+.||.+|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~---~~------------~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE---WI------------FR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSG---GG------------GS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchh---hh------------hh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997654432111 00 00 00 112 234778889999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.32 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=205.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999998889999999986542 22246788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999997654 58999999999999999999998 99999999999999999999999999998755432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. .... . .+...
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~-~------~~~~~ 231 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIV-N------VDLKF 231 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-T------TCCCC
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHh-c------cccCC
Confidence 223457899999999999999999999999999999999999999754432211 0000 0 11111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... ...+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1222 245778889999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=331.09 Aligned_cols=252 Identities=26% Similarity=0.325 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888999999999999999998889999999986553 2345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccc
Q 036051 173 YMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLY 247 (420)
Q Consensus 173 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~ 247 (420)
|+++|+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 12368999999999999999999999 999999999999999 45678999999999765
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+..... . .. ....
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~---~----~~---~~~~ 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---T----YK---EPNY 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H----HC---CCCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh---c----cC---Cccc
Confidence 4322 234457899999999985 56899999999999999999999999765432211000 0 00 0000
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ...+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111 234678888999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=341.73 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=202.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35788899999999999999999988999999988544 3334566889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988876544 58999999999999999999999 999999999999999999999999999997654322
Q ss_pred CCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh--------hhhhccc-Cc
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW--------VFDFWNR-GE 321 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~-~~ 321 (420)
.......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....... ....+.. ..
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 123345689999999999765 789999999999999999999999976554322110000 0000000 00
Q ss_pred cccccCCCCCCcc-----cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 322 LLEARDPNLGTEY-----VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 322 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0011111111111 1122456889999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.13 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=200.8
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
+|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 45556799999999999999988899999999877655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-CCcEEEeeecCcccccCCCCC
Q 036051 176 NGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 176 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||++....... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999997653 3456788999999999999999999 99999999999999987 8999999999998654321 2
Q ss_pred cccccccCCcccccccccCC--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......|++.|+|||++.+. .++.++||||||+++|||++|+.||............ . ......+...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~------~~~~~~~~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK----V------GMFKVHPEIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH----H------HHHCCCCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh----h------cccccccccc
Confidence 23345789999999998654 3789999999999999999999999754332111000 0 0001122222
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 345778888999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=336.97 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=207.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|.+.+.||+|+||.||++++..++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45788899999999999999999988999999998654 334457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++.+++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 68999999999999999999999 99999999999999999999999999999866432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ... .. .....
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~-~~------~~~~~ 260 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRI-KK------NEYSI 260 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH-HH------TCCCC
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHH-hc------CCCCC
Confidence 2 2234457899999999999889999999999999999999999999764432211 000 00 01111
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 PKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12222 34678888999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=353.08 Aligned_cols=262 Identities=22% Similarity=0.247 Sum_probs=198.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------C
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 165 (420)
.++|++.+.||+|+||+||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999989999999998654 344457788999999999999999999998654 4
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57666643 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhh---
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWV--- 313 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~--- 313 (420)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..... .+.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 65432 2334568999999999999999999999999999999999999999765532211100 000
Q ss_pred ----hhhcccC------ccccccCCC---CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 ----FDFWNRG------ELLEARDPN---LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 ----~~~~~~~------~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ......... ............+.+++.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000000 000111122456889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.86 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=198.1
Q ss_pred ceecccCceEEEEEEe--CCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTL--PKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||.||+|.+ .+.+..||||++.... ....++|.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 4566889999997642 3345789999999999999999999999965 458999999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC--Cc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQ 254 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 254 (420)
|+|.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 68999999999999999999999 9999999999999999999999999999987644322 12
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+..+. ......
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~-----~~~~p~- 595 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGE-----RMGCPA- 595 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTC-----CCCCCT-
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC-----CCCCCC-
Confidence 233456789999999999999999999999999999998 9999977554321 11111111 111112
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.....+.+++..||+.||++|||+.+|++.|+.
T Consensus 596 ---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 596 ---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 233557888999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=342.59 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=196.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhH-HHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|.+.+.||+|+||+||+|++..++..||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999998889999999986543221 12456799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
++ |+|.+++..... .+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 96 699998876543 68999999999999999999999 999999999999999999999999999997654322 2
Q ss_pred cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh---------hcccCccc
Q 036051 254 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD---------FWNRGELL 323 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 323 (420)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.......... ........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2334578999999999876 5689999999999999999999999987654332211100000 00000000
Q ss_pred cccCCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTE----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000110000 01112345778999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=329.04 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=198.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..++..||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46788899999999999999999888999999998753 333456788999999999 999999999999999999999
Q ss_pred EeecCCCChhhhhccCCC--ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC---------------
Q 036051 171 YDYMPNGSLDKYLYNQPK--VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE--------------- 233 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~--------------- 233 (420)
|||+++++|.+++..... ..+++..++.++.||+.||+|||+ .+++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975421 368999999999999999999999 999999999999999844
Q ss_pred ----CcEEEeeecCcccccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccch
Q 036051 234 ----LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLI 308 (420)
Q Consensus 234 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~ 308 (420)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|..|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence 479999999998654322 23589999999999765 5678999999999999999998876432110
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+ ..+.....++ ..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ------~~~~~~-----~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ------HEIRQG-----RLPRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHTT-----CCCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHcC-----CCCCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111 1122222222 44778888999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.94 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=178.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46788899999999999999999988999999998765 34445778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
|+++++|.+++.... .+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999997654 58899999999999999999998 5 8999999999999999999999999998754322
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22335789999999999999999999999999999999999999976543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=333.01 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=205.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee----------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR---------- 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 163 (420)
..+|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999998888999999987554 246789999999999999999998754
Q ss_pred ------CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 164 ------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 164 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 4568999999999999999976544579999999999999999999999 9999999999999999999999
Q ss_pred EeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|..|+.... .. ....
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~-~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KF-FTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HH-HHHH
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HH-HHHh
Confidence 99999998765432 2334568999999999999899999999999999999999998874211 00 0111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
.. ......++ ..+.+++.+||+.||.+|||+.|+++.|+.....
T Consensus 232 ~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 RD--------GIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HT--------TCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11 11112222 3467888899999999999999999999875443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.71 Aligned_cols=195 Identities=27% Similarity=0.381 Sum_probs=157.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee-----CCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-----KGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 166 (420)
.++|++.+.||+|+||+||+|++..++..||||++... .....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36789999999999999999999988999999988653 34455778999999999999999999999843 357
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999998 679999987653 68999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC--------------------------CcccccccCCcccccccc-cCCCCCccchhhhhHHHHHHHhcC
Q 036051 247 YDHGTD--------------------------PQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACG 294 (420)
Q Consensus 247 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~el~tg 294 (420)
...... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643211 123446789999999976 566799999999999999999993
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=336.13 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=186.9
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
+..++|++.+.||+|+||.||+|.+..++..||||++.... ....+.+.+|+..+.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44678999999999999999999998888899999986543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhcc------CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 171 YDYMPNGSLDKYLYN------QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
|||+++++|.+++.. .....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999863 123368999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC----CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 245 RLYDHGTD----PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 245 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ... ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~-~~~ 245 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQN-DPP 245 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTS-SCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hcc-CCC
Confidence 76543221 12234578999999999865 56899999999999999999999999765543211100 000 000
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......++.....+ ...+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000001111111222 235778888999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.99 Aligned_cols=254 Identities=12% Similarity=0.049 Sum_probs=184.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHH---HHhccCCcceEeeee-------ee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEI---VSIGRLRHRNLVQLL-------GY 160 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 160 (420)
..+|...+.||+|+||.||+|++..++..||||++.... ....+.+.+|+ ..+.. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345888999999999999999998889999999997653 23345677784 45555 799988754 44
Q ss_pred eeeC-----------------CeEEEEEeecCCCChhhhhccCCCccCcHHHH------HHHHHHhHhHhHHhhhcccCc
Q 036051 161 CRRK-----------------GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQR------YGVIKGVALGLLYLHEEWEQV 217 (420)
Q Consensus 161 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 217 (420)
+... ...++||||++ |+|.+++..... .+++..+ +.++.||+.||+|||+ .+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 4332 34899999998 899999976432 3455566 7888999999999999 99
Q ss_pred EEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCC
Q 036051 218 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGR 295 (420)
Q Consensus 218 iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~ 295 (420)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2224567799999999987 67999999999999999999999
Q ss_pred ccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 296 RPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 296 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.||....+....... .......................+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999876543211100 00000000111111111122345778889999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.70 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=197.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (420)
.++|+..+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999999888999999998543 3344567899999999999999999999987653
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 88999999764 58999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh--------hhhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW--------VFDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~ 316 (420)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....... ....
T Consensus 177 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6543 2334578999999999876 6799999999999999999999999976543321110000 0000
Q ss_pred cccCc---cccccC---CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WNRGE---LLEARD---PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~~---~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.... ...... ..............+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000 000000 00000111122345788889999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=357.72 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=206.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|...+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.+++||||+++++++...+.+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999998889999999996542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCC--CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 172 DYMPNGSLDKYLYNQP--KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 3468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .. ...
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~-~~------~~~ 411 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVL-EQ------AVT 411 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHH-HC------CCC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHh-hc------ccC
Confidence 322 233458999999999999999999999999999999999999999765432111 00111100 00 111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSM-----RQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 365 (420)
.+..+ ...+.+++.+||+.||.+||++ .++++
T Consensus 412 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 YPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11222 3446788888999999999975 56653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=348.75 Aligned_cols=200 Identities=28% Similarity=0.382 Sum_probs=170.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----Ce
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 166 (420)
.++|++.+.||+|+||.||+|++..++..||||++... .....+.+.+|+.++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999999999999999998653 344457789999999999999999999998766 57
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999995 69999997653 68999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC---------------------CcccccccCCcccccccc-cCCCCCccchhhhhHHHHHHHhcCCccCC
Q 036051 247 YDHGTD---------------------PQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 247 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
...... ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 643321 123556899999999986 56679999999999999999998655553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=338.97 Aligned_cols=266 Identities=24% Similarity=0.314 Sum_probs=199.3
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh-----HHHHHHHHHHHhccCCcceEeeeeeeeeeCCe
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE 166 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 166 (420)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999999888899999998754221 12467899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999965 8988887653 368899999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc---cCcc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN---RGEL 322 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 322 (420)
..... .......+|+.|+|||++.+. .++.++|||||||++|||++|..||......+... . +..... ....
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~-i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--R-IFETLGTPTEEQW 237 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCTTTS
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHHcCCCChhhh
Confidence 64322 233446789999999998654 58999999999999999999999997654322111 0 000000 0000
Q ss_pred c------cccCCCCCCccc-----HHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 323 L------EARDPNLGTEYV-----AEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 323 ~------~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
. +........... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000000001 1223568889999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.56 Aligned_cols=255 Identities=17% Similarity=0.143 Sum_probs=200.6
Q ss_pred HHHHHhcCCCccceecccCceEEEEEE-----eCCCceeeeeecccccchhHHHHHHHHHHHhccCC---cceEeeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGT-----LPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGY 160 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~ 160 (420)
++....++|.+.+.||+|+||+||+|. ...++..||||++..... .++..|+..+.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334456789999999999999999994 456678899999976544 34566666666665 9999999999
Q ss_pred eeeCCeEEEEEeecCCCChhhhhccC---CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-----
Q 036051 161 CRRKGELLLVYDYMPNGSLDKYLYNQ---PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG----- 232 (420)
Q Consensus 161 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~----- 232 (420)
+...+..++||||+++|+|.+++... ....+++..++.|+.||+.||+|||+ .+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCc
Confidence 99999999999999999999999742 23469999999999999999999999 99999999999999998
Q ss_pred ------CCcEEEeeecCcccccCC-CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcc
Q 036051 233 ------ELNGRLGDFGLARLYDHG-TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305 (420)
Q Consensus 233 ------~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~ 305 (420)
++.+||+|||++..+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 899999999999765422 2223445679999999999999999999999999999999999999996433211
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCC-CCHHHHHHHHhcC
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTAR-PSMRQVVQILERD 370 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~~ 370 (420)
.. ...........+ .+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 ~~------------------~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 CK------------------PEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp EE------------------ECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ee------------------echhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00 011111112233 34566667999999998 6788888877764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.90 Aligned_cols=263 Identities=19% Similarity=0.183 Sum_probs=204.4
Q ss_pred hcCCCccceecccCceEEEEEEeCC--------CceeeeeecccccchhHHHHHHHHHHHhccCCcceEee---------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK--------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ--------- 156 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 156 (420)
.++|.+.+.||+|+||.||+|++.. .++.||+|++... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678999999999999999999976 4778999998654 35778999999999999987
Q ss_pred ------eeeeeee-CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 157 ------LLGYCRR-KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 157 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
+++++.. .+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ .+++||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5667665 67899999999 9999999987644579999999999999999999999 89999999999999
Q ss_pred EcCCC--cEEEeeecCcccccCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCC
Q 036051 230 LDGEL--NGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQ 301 (420)
Q Consensus 230 l~~~~--~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~ 301 (420)
++.++ .+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 899999999986543211 1223457899999999999989999999999999999999999999865
Q ss_pred CCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 302 GPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
...... ........... ........... ......+.+++.+||+.||.+|||+.++++.|++..
T Consensus 272 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNTED-IMKQKQKFVDK--PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCHHH-HHHHHHHHHHS--CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCHHH-HHHHHHhccCC--hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 432211 11111111000 00111111000 011245778888999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=339.46 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=205.8
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccC-CcceEeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRL-RHRNLVQLLG 159 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~ 159 (420)
......++|++.+.||+|+||.||+|++..++..||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999998888899999886432 12245678999999999 7999999999
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999997543 68999999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCCcccccccCCcccccccccC------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 313 (420)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~i 317 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML---RMI 317 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH---HHH
Confidence 999998765432 2344679999999998853 35889999999999999999999999754322111 000
Q ss_pred hhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 318 ----~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 ----MEGQ------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHTC------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HhCC------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 00000000011245788899999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=340.63 Aligned_cols=260 Identities=26% Similarity=0.378 Sum_probs=201.6
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR 163 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 163 (420)
+.+.++....++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3344445567889999999999999999999988889999999865432 236788999999998 79999999999876
Q ss_pred ------CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEE
Q 036051 164 ------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237 (420)
Q Consensus 164 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~k 237 (420)
.+..++||||+++++|.+++.......+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 4689999999999999999987655578999999999999999999999 8999999999999999999999
Q ss_pred EeeecCcccccCCCCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
|+|||++....... .......||+.|+|||++. +..++.++||||||+++|||++|+.||..........
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 244 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----
Confidence 99999987654321 1233457899999999986 5678999999999999999999999997544322111
Q ss_pred hhhhcccCccccccCCCC-CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 313 VFDFWNRGELLEARDPNL-GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. .....+.. ...+ ...+.+++.+||+.||.+|||+.++++
T Consensus 245 --~~------~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 --LI------PRNPAPRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HH------HHSCCCCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --Hh------hcCccccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00011111 1122 245778888999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.59 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=206.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC--------cceEeeeeeeee---
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR--------HRNLVQLLGYCR--- 162 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--- 162 (420)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999999889999999999654 334567889999999885 888999999987
Q ss_pred -eCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCC------
Q 036051 163 -RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGEL------ 234 (420)
Q Consensus 163 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~------ 234 (420)
.....++||||+ +++|.+.+.......+++..++.++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 6777777765544579999999999999999999998 7 999999999999999775
Q ss_pred -------------------------------------------cEEEeeecCcccccCCCCCcccccccCCccccccccc
Q 036051 235 -------------------------------------------NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271 (420)
Q Consensus 235 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 271 (420)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865432 23457899999999999
Q ss_pred CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh---hhhh------------------hccc-CccccccCCC
Q 036051 272 TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD---WVFD------------------FWNR-GELLEARDPN 329 (420)
Q Consensus 272 ~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~------------------~~~~-~~~~~~~~~~ 329 (420)
+..++.++|||||||++|||++|+.||......+.....+ .+.. .... +.........
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9899999999999999999999999998655433111000 0000 0000 0000000000
Q ss_pred C---------CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 L---------GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ...+..+....+.+++.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234566778999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=332.46 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=201.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4577999999999999999999998889999999986543 23678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 999999999986432 268999999999999999999999 999999999999999999999999999997654322
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .. .....+...
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~------~~~~~~~~~- 246 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MI------PTNPPPTFR- 246 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH------HHSCCCCCS-
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH------hcCCCcccC-
Confidence 12334578999999999999899999999999999999999999997644322110 00 000111110
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........+.+++.+||+.||.+|||+.++++
T Consensus 247 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11112345778899999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=339.61 Aligned_cols=267 Identities=25% Similarity=0.342 Sum_probs=201.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeee--------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-------- 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 163 (420)
.++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367889999999999999999998889999999886542 2223567899999999999999999999876
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
.+..++||||++ ++|.+.+..... .+++.++..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 456899999996 577777765433 68999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCC---CCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh---
Q 036051 244 ARLYDHGT---DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF--- 316 (420)
Q Consensus 244 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 316 (420)
+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98664322 122344578999999999876 45899999999999999999999999875543322111110000
Q ss_pred -----cccCccccccCCCC-CCcccHHH------HHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 -----WNRGELLEARDPNL-GTEYVAEE------LELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 -----~~~~~~~~~~~~~~-~~~~~~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............. ......+. ...+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000000000000 00011111 234778999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=353.48 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=203.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46789999999999999999999888999999998643 2233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc---CCCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~ 248 (420)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++....
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999887654 68999999999999999999999 9999999999999995 45679999999998664
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+... .+..+. .
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~------~ 239 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-------RVETGK------Y 239 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTC------C
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCC------C
Confidence 332 2344579999999999976 58999999999999999999999997654332111 011110 0
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011111122345778899999999999999999997
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.92 Aligned_cols=202 Identities=19% Similarity=0.271 Sum_probs=176.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC------CcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL------RHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 167 (420)
..+|++.+.||+|+||+||+|.+..++..||||++.... .....+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457899999999999999999999889999999996543 3335667777777666 678999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc--EEEeeecCcc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLAR 245 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfg~~~ 245 (420)
++||||+. ++|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 799999987765569999999999999999999999 89999999999999999887 9999999997
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPE 304 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~ 304 (420)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 6433 233457899999999999999999999999999999999999999766543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=353.32 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=199.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|+..+.||+|+||+||+|++..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999999889999999986542 223467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC---CcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfg~~~~~~ 248 (420)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||++....
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999887653 68999999999999999999999 999999999999999764 459999999998765
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+... .+..+..
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~------ 254 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR-------KVEKGKY------ 254 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCC------
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCC------
Confidence 432 334467999999999986 469999999999999999999999997655432111 1111100
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0011111122345778889999999999999999885
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=335.67 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=200.2
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 35678999999999999999999988889999999977665666789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999999886533 268999999999999999999999 999999999999999999999999999875322110
Q ss_pred CcccccccCCcccccccc-----cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 253 PQTTHVVGTLGYLAPEHT-----RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.......||+.|+|||++ .+..++.++||||||+++|||++|+.||......... ..... . ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~-----~~ 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK-S-----DP 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-S-----CC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhc-c-----CC
Confidence 112234689999999998 4667899999999999999999999999765432211 00000 0 00
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.. .........+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 011122345778889999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=328.86 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=204.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---------hhHHHHHHHHHHHhccCC-cceEeeeeeeeee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---------RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 163 (420)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468889999999999999999999899999999986432 223456889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999997643 68999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCccccccccc------CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTR------TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
+....... ......+++.|+|||++. ...++.++||||||+++|||++|+.||......... . ..
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~~ 241 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---R----MI 241 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---H----HH
Confidence 98665332 233457899999999884 456889999999999999999999999754432110 0 00
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCC------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0110 00111111123345788899999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=354.51 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=206.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..++..||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46788899999999999999999989999999998543 233457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccc
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLY 247 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~ 247 (420)
+||+.+|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999987654 68999999999999999999999 999999999999999 56789999999999876
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+... .+..+..
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~----- 244 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK-------KVEKGKY----- 244 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCC-----
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCC-----
Confidence 5432 3345679999999999876 68999999999999999999999997654332111 1111110
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 245 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 -TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0111111122345778899999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.56 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=200.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc----hhHHHHHHHHHHHhccCCcceEeeeeeee--eeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYC--RRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~ 167 (420)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999998889999999987542 23457789999999999999999999998 445689
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||++++ |.+++.......+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999766 7777776555579999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCC-CCcccccccCCcccccccccCCC--CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 248 DHGT-DPQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 248 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+. ......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~---- 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKG---- 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHC----
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcC----
Confidence 4322 22233456899999999987644 47799999999999999999999976432211 0111111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+ ...+.+++.+||+.||.+|||+.|+++.
T Consensus 229 --~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 --SYAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111222 2457788889999999999999999963
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=352.60 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch-------------hHHHHHHHHHHHhccCCcceEeeeee
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-------------QGMKEFVAEIVSIGRLRHRNLVQLLG 159 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 159 (420)
..++|.+.+.||+|+||+||+|++..++..||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999998899999999865421 23467889999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC---cE
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL---NG 236 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~---~~ 236 (420)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999987653 68999999999999999999999 9999999999999998775 69
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDF 316 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 316 (420)
||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+... .
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK-------K 258 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------H
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------H
Confidence 999999998765432 334467999999999986 468999999999999999999999998655432111 1
Q ss_pred cccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+..+.. .............+.+++.+||+.||.+|||+.|+++
T Consensus 259 i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111100 0000000112345788899999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.26 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=206.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 168 (420)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456799999999999999999999999999999998754 223346678899999987 7999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998654 68999999999999999999999 999999999999999999999999999998543
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .... .+ ..
T Consensus 494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~------~~i~-~~------~~ 559 (674)
T 3pfq_A 494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIM-EH------NV 559 (674)
T ss_dssp CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-SS------CC
T ss_pred cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hC------CC
Confidence 22 22344568999999999999999999999999999999999999999865433211 1111 11 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCH-----HHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSM-----RQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 365 (420)
..+... ...+.+++.+||+.||.+||++ .||++
T Consensus 560 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCccC----CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111222 3457788888999999999997 67654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.51 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=205.8
Q ss_pred hcCCCccceecccCceEEEEEEe-CCCceeeeeecccccchhHHHHHHHHHHHhccCCcce------EeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTL-PKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN------LVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 166 (420)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... ...+.+.+|+.++..++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46789999999999999999998 5578899999986543 34467889999999887665 9999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC--------------
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-------------- 232 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-------------- 232 (420)
.++||||+ +++|.+++.......+++..+..++.||+.||+|||+ .+++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8999999987766678999999999999999999999 99999999999999987
Q ss_pred -----CCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc
Q 036051 233 -----ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307 (420)
Q Consensus 233 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~ 307 (420)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 66899999999986443 223457899999999999989999999999999999999999999765543321
Q ss_pred hhhhhhhh--------hcccCcccc------------------ccCCC-CCCcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 308 ILVDWVFD--------FWNRGELLE------------------ARDPN-LGTEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 308 ~~~~~~~~--------~~~~~~~~~------------------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
........ ......... ...+. ............+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11110000 000000000 00000 0001122445678899999999999999999
Q ss_pred HHHHH
Q 036051 361 RQVVQ 365 (420)
Q Consensus 361 ~evl~ 365 (420)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=332.51 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=198.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
.++|.+.+.||+|+||.||+|++..++..||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467899999999999999999999889999999986532 112345889999999999999999999987665
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeeec
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDFG 242 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg 242 (420)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+ .+++||||||+||+++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999987654 68999999999999999999999 99999999999999987654 9999999
Q ss_pred CcccccCCCCCcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
++...... .......||+.|+|||++. +..++.++||||||+++|||++|+.||......... ...+ ..
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~----~~ 234 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI----TS 234 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHH----HH
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHH----Hh
Confidence 99865432 1223457899999999973 567899999999999999999999999765433211 1111 01
Q ss_pred CccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 320 GELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.. .............+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 100 0000001112356788999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=330.05 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=187.7
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3567889999999999999999998899999999987542 22233444555568888999999999999999999999
Q ss_pred EeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 171 YDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
|||++ |+|.+++... ....+++..++.++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 5888877531 23379999999999999999999998 6 9999999999999999999999999999865
Q ss_pred cCCCCCcccccccCCcccccccc----cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHT----RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......... .......
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~---- 229 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEE---- 229 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHS----
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhcc----
Confidence 4322 22334689999999996 5667899999999999999999999999754322111 0111110
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 --PSPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CCCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111 112244778888999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=344.65 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=203.1
Q ss_pred hcCCCccceecccCceEEEEEEeC---CCceeeeeecccccc----hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLP---KSKIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
.++|++.+.||+|+||.||+|++. .++..||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367889999999999999999984 467889999986532 12234567899999999 6999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997654 68999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~------ 279 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRIL------ 279 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHH------
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHh------
Confidence 654333333445679999999999975 347899999999999999999999997654332111 1111100
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQIL 367 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L 367 (420)
...+..... ....+.+++.+||+.||.+|| ++.|+++..
T Consensus 280 -~~~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 -KSEPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -HCCCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -ccCCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011122222 234577888999999999999 999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.10 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=196.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999998888899999986542 22346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997654 58899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ . .....+ ...
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~----~~~~~~------~~~ 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---F----KKIRGG------VFY 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHC------CCC
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H----HHhhcC------ccc
Confidence 2 2234568999999999987765 6899999999999999999999975432211 1 111111 011
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122 2347788889999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.97 Aligned_cols=265 Identities=26% Similarity=0.300 Sum_probs=203.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----CeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 167 (420)
..+|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46799999999999999999999889999999998754 334457789999999999999999999998655 468
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++|+||+. ++|.+++... .+++.++..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 6999998764 58999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCC--cccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC----
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG---- 320 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 320 (420)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......+...............
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 432211 224457899999999865 4558999999999999999999999997765443221110000000000
Q ss_pred --------ccccccCCCCC--CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 --------ELLEARDPNLG--TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 --------~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0001112345788999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=331.40 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=197.3
Q ss_pred hcCCCccceecccCceEEEEEEeCC---Cceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||+||+|++.. .+..||+|++... .....+.+.+|+.++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4678889999999999999998632 2346899998754 2344678999999999999999999999998765 8
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 368999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~---- 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG---- 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccC----
Confidence 443221 1223457888999999988889999999999999999999 99999765432211 1111110
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....... .....+.+++.+||+.||.+|||+.++++.|++..
T Consensus 242 -~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 -ERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CCCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0111111 22345788889999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.55 Aligned_cols=262 Identities=21% Similarity=0.238 Sum_probs=195.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (420)
.++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36789999999999999999999888999999998653 3444567889999999999999999999987654
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 578888853 48899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhh---
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWV--- 313 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~--- 313 (420)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ++.
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65432 1233467899999999999989999999999999999999999999765432211000 000
Q ss_pred ----hhhcccC------ccccccCC---CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 ----FDFWNRG------ELLEARDP---NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 ----~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ........ .............+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000 00000000 0001112233567889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.72 Aligned_cols=211 Identities=20% Similarity=0.246 Sum_probs=178.3
Q ss_pred chHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cc-----eEeeeee
Q 036051 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HR-----NLVQLLG 159 (420)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~ 159 (420)
...+.....++|++.+.||+|+||+||+|++..+++.||||++... .....++..|+.++..++ |+ +++++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 3333444567899999999999999999999988999999999654 233456777888887774 44 5999999
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--CCCcEE
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD--GELNGR 237 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~~~k 237 (420)
++...+..++||||++ ++|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+|
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 9999999999999995 6999999876555799999999999999999999941 27899999999999995 577899
Q ss_pred EeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 238 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 238 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876432 2345789999999999999999999999999999999999999986543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=345.57 Aligned_cols=261 Identities=17% Similarity=0.218 Sum_probs=206.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||.||+|++..++..||||++...... .++..|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999999888999999987654322 357889999999976 566666677788889999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE---cCCCcEEEeeecCcccccC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfg~~~~~~~ 249 (420)
|+ +++|.+++..... .+++..++.|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999975433 69999999999999999999999 999999999999999 6889999999999987654
Q ss_pred CCCC------cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 250 GTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 250 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 2235679999999999999999999999999999999999999998765543222111111110000000
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
. ........+.+++..||+.||++||++.+|++.|+..
T Consensus 239 ~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 A---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 0011134578899999999999999999999988653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.50 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=200.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeee--CCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR--KGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|++..++..||||++.... .+.+.+|+.++.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 67889999999999999999998889999999987543 356889999999997 9999999999987 66789999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccccCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG 250 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~ 250 (420)
||+++++|.+++. .+++.++..++.||+.||+|||+ .+++||||||+|||++.++ .+||+|||++......
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999884 47889999999999999999999 9999999999999999776 8999999999866543
Q ss_pred CCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch-----------hhhhhhhhc-
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-----------LVDWVFDFW- 317 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-----------~~~~~~~~~- 317 (420)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..+++....
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 2334578999999999876 678999999999999999999999996543321110 000000000
Q ss_pred -------------ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 -------------NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 -------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
........... .........+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccc----cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000111 111112355788999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=340.79 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=186.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------C
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 165 (420)
.++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36789999999999999999999989999999998653 334457788999999999999999999998654 5
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++|+|++ +++|.+++... .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 78999998753 68999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh--------hh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF--------DF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~ 316 (420)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+......... ..
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6443 2344678999999999876 678999999999999999999999997655332211100000 00
Q ss_pred cccCc---cccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 317 WNRGE---LLEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 317 ~~~~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
..... ............+ .......+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 0000000000000 01113457889999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.79 Aligned_cols=252 Identities=23% Similarity=0.422 Sum_probs=194.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee----------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR---------- 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 163 (420)
.++|++.+.||+|+||.||+|++..++..||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788899999999999999999888899999998643 3445778999999999999999999998754
Q ss_pred ---CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEee
Q 036051 164 ---KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 240 (420)
Q Consensus 164 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 240 (420)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999997643 367889999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccCCC-------------CCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCccc
Q 036051 241 FGLARLYDHGT-------------DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306 (420)
Q Consensus 241 fg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~ 306 (420)
||++....... ........||+.|+|||++.+. .++.++||||||+++|||++ ||......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-- 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-- 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence 99998654321 1122345689999999999764 68999999999999999998 54321110
Q ss_pred chhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ... ..... ........+.......+.+++.+||+.||.+|||+.++++
T Consensus 235 ~---~~~-~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 V---NIL-KKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H---HHH-HHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H---HHH-Hhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 000 11100 1111222233334455788899999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.22 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=204.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhH-----------------HHHHHHHHHHhccCCcceEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-----------------MKEFVAEIVSIGRLRHRNLVQ 156 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~ 156 (420)
.++|.+.+.||+|+||.||+|.+ ++..||+|++....... .+.+.+|+.++.+++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46889999999999999999999 67889999986542211 177899999999999999999
Q ss_pred eeeeeeeCCeEEEEEeecCCCChhhh------hccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 157 LLGYCRRKGELLLVYDYMPNGSLDKY------LYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 157 ~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ ..+++||||||+||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence 99999999999999999999999999 665435579999999999999999999996 3799999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCC-CCCc-cchhhhhHHHHHHHhcCCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATT-SADVFSFGAFLLEVACGRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~slGvvl~el~tg~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||++...... ......++..|+|||++.+. .++. ++||||||+++|||++|+.||.........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL- 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH-
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-
Confidence 99999999999999865432 33446789999999999877 6666 999999999999999999999865542111
Q ss_pred hhhhhhhhcccCcccc---------ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 309 LVDWVFDFWNRGELLE---------ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...+ ..+.... ...+.............+.+++.+||+.||.+|||+.|+++
T Consensus 262 -~~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 -FNNI----RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHH----TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHH----hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 1110000 00000000001222356788999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.26 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=201.0
Q ss_pred HhcCCCccceecccCceEEEEEEeC-CCceeeeeecccccch--hHHHHHHHHHHHhccC---CcceEeeeeeeee----
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP-KSKIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCR---- 162 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 162 (420)
..++|++.+.||+|+||.||+|++. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999984 6778899998864321 1123455677666655 8999999999987
Q ss_pred -eCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeee
Q 036051 163 -RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241 (420)
Q Consensus 163 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 241 (420)
.....++||||++ |+|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567999999996 699999987655569999999999999999999999 99999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh----------h
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV----------D 311 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~----------~ 311 (420)
|++...... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||......+..... +
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999765422 1233457899999999999889999999999999999999999999765432211100 0
Q ss_pred hhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 312 WVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
|.....................+.......+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000000000001111223345778899999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=340.72 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=196.8
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee-------
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------- 163 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 163 (420)
....++|++.+.||+|+||.||+|++..++..||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999889999999988654322 2479999999999999999998843
Q ss_pred -------------------------------CCeEEEEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHh
Q 036051 164 -------------------------------KGELLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYL 210 (420)
Q Consensus 164 -------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~L 210 (420)
....++||||++ |+|.+.+.. .....+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999997 588777753 2233789999999999999999999
Q ss_pred hhcccCcEEecccCCCCEEEc-CCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHH
Q 036051 211 HEEWEQVVIHRDVKASNVLLD-GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFL 288 (420)
Q Consensus 211 H~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl 288 (420)
|+ .+|+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 98 9999999999999998 68899999999998654332 23345789999999998765 489999999999999
Q ss_pred HHHhcCCccCCCCCCcccchhhhhhhhhcc-------cCccccccCCCCCCc-----ccHHHHHHHHHHhhcccccCCCC
Q 036051 289 LEVACGRRPIERQGPEENLILVDWVFDFWN-------RGELLEARDPNLGTE-----YVAEELELILKLGLLCSHSDPTA 356 (420)
Q Consensus 289 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~ 356 (420)
|||++|+.||......+............. .........+..... +.......+.+++.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999987554332111000000000 000000111111100 11122345788999999999999
Q ss_pred CCCHHHHHH
Q 036051 357 RPSMRQVVQ 365 (420)
Q Consensus 357 RPt~~evl~ 365 (420)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=337.83 Aligned_cols=270 Identities=22% Similarity=0.250 Sum_probs=199.7
Q ss_pred cchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-----------hhHHHHHHHHHHHhccCCcce
Q 036051 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-----------RQGMKEFVAEIVSIGRLRHRN 153 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~n 153 (420)
....++....++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++.+++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456778889999999999999999999999865 7789999885431 222477899999999999999
Q ss_pred Eeeeeeeeee-----CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCE
Q 036051 154 LVQLLGYCRR-----KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNV 228 (420)
Q Consensus 154 iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NI 228 (420)
|+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 9999999844 346899999996 68888887543 368999999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc
Q 036051 229 LLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307 (420)
Q Consensus 229 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~ 307 (420)
+++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999754332 23344578999999999876 67899999999999999999999999765432211
Q ss_pred hhhhhhhhhcccC-----------c----cccccCCCCCC---cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 308 ILVDWVFDFWNRG-----------E----LLEARDPNLGT---EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 308 ~~~~~~~~~~~~~-----------~----~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. +....... . ........... .........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NK---IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HH---HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH---HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 10 00000000 0 00000000000 011122345788999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=331.53 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=196.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeee-----------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR----------- 162 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 162 (420)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367888999999999999999999889999999997776666788999999999999999999998873
Q ss_pred ---eCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEE
Q 036051 163 ---RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRL 238 (420)
Q Consensus 163 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl 238 (420)
..+..++||||++ |+|.+++... .+++..++.++.|++.||+|||+ .+++||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4468899999996 6999998653 58899999999999999999999 9999999999999997 5679999
Q ss_pred eeecCcccccCCCC--CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhh
Q 036051 239 GDFGLARLYDHGTD--PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFD 315 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 315 (420)
+|||++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999986543211 12334567999999998865 6789999999999999999999999986553221110000000
Q ss_pred hcccCcc-----------c-cccCCCCC-CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRGEL-----------L-EARDPNLG-TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~~~-----------~-~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... . ....+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 0 00000000 0001122356888999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=328.88 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=179.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHH-HhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|+..+.||+|+||.||+|.+..+++.||||++... .......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46788899999999999999999888999999998764 2333455666666 677789999999999999999999999
Q ss_pred eecCCCChhhhhcc---CCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 172 DYMPNGSLDKYLYN---QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 172 e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||++ ++|.+++.. .....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9996 488777752 223468999999999999999999998 7 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccCCcccccccc----cCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHT----RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......... ... ..
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~------~~ 243 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQ------VV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC------CC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHH------Hh
Confidence 4322 22334689999999998 4567899999999999999999999999764322110 000 01
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....+.+...........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111111122345788889999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.42 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=205.4
Q ss_pred HHHHhcCCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 90 LYIATKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
..+..++|++.+.||+|+||.||+|.+..+ +..||+|++... .....+.|.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 334456788889999999999999998543 457999998754 3344577999999999999999999999985 45
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 6899999999999999997653 368999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.. .. ...+
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~----i~~~---- 608 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR----IENG---- 608 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH----HHHT----
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH----HHcC----
Confidence 765443333334567889999999988899999999999999999997 99999765433211 11 1111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
........ ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 609 -~~~~~~~~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 -ERLPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111122 234577889999999999999999999999764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.12 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=202.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-----------cceEeeeeeeee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----------HRNLVQLLGYCR 162 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 162 (420)
..+|.+.+.||+|+||+||+|++..++..||||++.... .....+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467889999999999999999998889999999986542 33466788999888876 899999999987
Q ss_pred eCC----eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEc------
Q 036051 163 RKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLD------ 231 (420)
Q Consensus 163 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~------ 231 (420)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+ . +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 9999999987655579999999999999999999999 7 999999999999994
Q ss_pred CCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch---
Q 036051 232 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI--- 308 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~--- 308 (420)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4457999999999865432 233578999999999999999999999999999999999999997654321100
Q ss_pred -hhhhh-----------------hhhcccCccccccCCC-C---------CCcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 309 -LVDWV-----------------FDFWNRGELLEARDPN-L---------GTEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 309 -~~~~~-----------------~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
+.... ................ . ...+.......+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 00000 0000000000000000 0 012345667889999999999999999999
Q ss_pred HHHHH
Q 036051 361 RQVVQ 365 (420)
Q Consensus 361 ~evl~ 365 (420)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=333.12 Aligned_cols=265 Identities=24% Similarity=0.288 Sum_probs=200.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----CeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 167 (420)
.++|++.+.||+|+||.||+|++..++..||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788999999999999999999888999999998654 334456788999999999999999999987654 678
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++|+||+. ++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998764 58999999999999999999999 99999999999999999999999999999866
Q ss_pred cCCCCC---------cccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 248 DHGTDP---------QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 248 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......-.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432211 1223578999999998754 678999999999999999999999997654322111000000000
Q ss_pred c---------cCcc---ccccCCCCCC---cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 N---------RGEL---LEARDPNLGT---EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~---------~~~~---~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .... .......... .........+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0000 0000000000 001122345778999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=331.45 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=201.2
Q ss_pred HHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC
Q 036051 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG 165 (420)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 165 (420)
++..+..++|++.+.||+|+||.||+|.+.+ .||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3334456788999999999999999999854 38999886542 222355778999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
..++|+||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+++||||||+||+++ ++.+||+|||++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999997653 368999999999999999999999 9999999999999998 6799999999987
Q ss_pred cccCCC----CCcccccccCCcccccccccC---------CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhh
Q 036051 246 LYDHGT----DPQTTHVVGTLGYLAPEHTRT---------GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312 (420)
Q Consensus 246 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~ 312 (420)
...... ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----- 252 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----- 252 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 543211 122233468999999999864 45788999999999999999999999765433211
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.....+ ..+..... .....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 253 --~~~~~~-----~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 253 --WQMGTG-----MKPNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp --HHHHTT-----CCCCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred --HHhccC-----CCCCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 011111 11111110 11123778889999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=328.96 Aligned_cols=263 Identities=19% Similarity=0.234 Sum_probs=203.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc-eeeeeecccccchhHHHHHHHHHHHhccCCcce------EeeeeeeeeeCCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK-IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN------LVQLLGYCRRKGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 166 (420)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ...+.+.+|+.++.+++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999987655 789999996543 33467888999999987766 8999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----------------
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL---------------- 230 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll---------------- 230 (420)
.++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 7788888776655579999999999999999999999 999999999999999
Q ss_pred ---cCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccc
Q 036051 231 ---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL 307 (420)
Q Consensus 231 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~ 307 (420)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999999986433 223457899999999999999999999999999999999999999865543221
Q ss_pred hhhhhhhh--------hcccCcccc---ccCC--------------CC--CCcccHHHHHHHHHHhhcccccCCCCCCCH
Q 036051 308 ILVDWVFD--------FWNRGELLE---ARDP--------------NL--GTEYVAEELELILKLGLLCSHSDPTARPSM 360 (420)
Q Consensus 308 ~~~~~~~~--------~~~~~~~~~---~~~~--------------~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 360 (420)
........ ......... ...+ .. ...........+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 11110000 000000000 0000 00 001122345578899999999999999999
Q ss_pred HHHHH
Q 036051 361 RQVVQ 365 (420)
Q Consensus 361 ~evl~ 365 (420)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=322.27 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=203.1
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3567999999999999999999998888899999986542 23457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC---CcEEEeeecCcccc
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLY 247 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfg~~~~~ 247 (420)
+||+++++|.+++.... .+++.+++.++.||+.||.|||+ .+++|+||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999886543 68999999999999999999999 999999999999999754 46999999999865
Q ss_pred cCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+. . .....+..
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~----~~~~~~~~----- 239 (287)
T 2wei_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---L----KRVETGKY----- 239 (287)
T ss_dssp CCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHCCC-----
T ss_pred cCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCCC-----
Confidence 4332 2234468899999999865 489999999999999999999999976543221 1 11111110
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 240 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000001112345778899999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=328.73 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=176.4
Q ss_pred hcCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeEE
Q 036051 94 TKGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELL 168 (420)
Q Consensus 94 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 168 (420)
.++|.+. +.||+|+||.||+|++..+++.||||++..... ...+ ....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678874 469999999999999998899999999865422 1122 2233456799999999999876 45689
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~ 245 (420)
+||||+++|+|.+++.......+++.+++.++.||+.||.|||+ .+++||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999987765679999999999999999999999 89999999999999986 4559999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~------ 247 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRL------ 247 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhc------
Confidence 65432 2334578999999999988889999999999999999999999997654332100 00000000
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH--HHhcC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ--ILERD 370 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 370 (420)
................+.+++.+||+.||.+|||+.|+++ .+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0001111111122345778889999999999999999998 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=329.56 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=197.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe-----
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE----- 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 166 (420)
.++|...+.||+|+||.||+|++..++..||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788899999999999999999989999999998654 33445678999999999999999999999887654
Q ss_pred -EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 167 -LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 167 -~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.++||||+. ++|.+++.. .+++.++..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 689888743 48999999999999999999999 999999999999999999999999999997
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhhhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWVFD 315 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~~~ 315 (420)
.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..... ++..
T Consensus 175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~- 249 (353)
T 3coi_A 175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ- 249 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT-
T ss_pred CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH-
Confidence 6432 2334578999999999876 67899999999999999999999999865432211100 0000
Q ss_pred hcccC-------ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 316 FWNRG-------ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 316 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+... .+.....+.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000000111 1111223455788899999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=334.10 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=198.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE----
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL---- 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 167 (420)
.++|...+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36788899999999999999999989999999998754 334457788999999999999999999999877654
Q ss_pred --EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 168 --LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 168 --~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 688888743 48999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~ 316 (420)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ...
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 6543 2334578999999999877 67899999999999999999999999765432211100000 000
Q ss_pred cccC---ccccccCCCCCCc---ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 317 WNRG---ELLEARDPNLGTE---YVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 317 ~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
+... ............. ........+.+++.+||+.||.+|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000000000 011123568889999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.07 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=194.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------CeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 168 (420)
.+|+..+.||+|+||.||+|++..++..||||++..... .+.+|++++++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 458888999999999999999988899999998865422 234699999999999999999987542 2478
Q ss_pred EEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~~ 245 (420)
+||||+++ +|.+.+.. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999965 66666542 123478999999999999999999999 999999999999999965 568999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh-----hhcc-
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF-----DFWN- 318 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~- 318 (420)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.....-... ..+.
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 654332 22345789999999998764 78999999999999999999999998755332211100000 0000
Q ss_pred -cCccccccCCCCCCc-----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 -RGELLEARDPNLGTE-----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 -~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+...+..... +.......+.+|+.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000011111111110 11122356888999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=332.64 Aligned_cols=271 Identities=21% Similarity=0.249 Sum_probs=190.9
Q ss_pred HHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe-
Q 036051 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE- 166 (420)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 166 (420)
.+.....++|++.+.||+|+||.||+|++..++..||||++..... ....+.+++..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 4455677899999999999999999999988899999998854422 22345678888888999999999999866433
Q ss_pred ------EEEEEeecCCCChhhhhcc--CCCccCcHHHHHHHHHHhHhHhHHhh--hcccCcEEecccCCCCEEEcC-CCc
Q 036051 167 ------LLLVYDYMPNGSLDKYLYN--QPKVTLNWRQRYGVIKGVALGLLYLH--EEWEQVVIHRDVKASNVLLDG-ELN 235 (420)
Q Consensus 167 ------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~iiH~dlk~~NIll~~-~~~ 235 (420)
.++||||+++ +|...+.. .....+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 8999999975 55544432 22346889999999999999999999 7 99999999999999996 899
Q ss_pred EEEeeecCcccccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh---
Q 036051 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD--- 311 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~--- 311 (420)
+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999998665332 23345789999999998654 48999999999999999999999998755432211100
Q ss_pred ------hhhhhcccCccccccCCC-C-----CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 312 ------WVFDFWNRGELLEARDPN-L-----GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 312 ------~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+................. . ...........+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000 0 00111123456889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.53 Aligned_cols=261 Identities=20% Similarity=0.336 Sum_probs=198.6
Q ss_pred CccchHHHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCC--cceEeeee
Q 036051 83 HRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR--HRNLVQLL 158 (420)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~ 158 (420)
..+.+..+....++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++.+++ ||||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 344555555667889999999999999999999864 778999998643 3445678899999999997 59999999
Q ss_pred eeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEE
Q 036051 159 GYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRL 238 (420)
Q Consensus 159 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl 238 (420)
+++...+..++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+ .+++||||||+||++++ +.+||
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 99999999999999 55889999998654 68899999999999999999999 89999999999999975 79999
Q ss_pred eeecCcccccCCCC-CcccccccCCcccccccccC-----------CCCCccchhhhhHHHHHHHhcCCccCCCCCCccc
Q 036051 239 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIERQGPEEN 306 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~ 306 (420)
+|||++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999986543322 12234568999999999865 4688899999999999999999999975432210
Q ss_pred chhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......... ......... ...+.+++.+||+.||.+|||+.|+++
T Consensus 248 -----~~~~~~~~~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 -----KLHAIIDPN-----HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -----HHHHHHCTT-----SCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHhcc-----cccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 011111100 111111111 245778888999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=336.04 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=154.8
Q ss_pred CCc-cceecccCceEEEEEEeC--CCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEEE
Q 036051 97 FRE-KELLGSGGFGRVYRGTLP--KSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVY 171 (420)
Q Consensus 97 ~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 171 (420)
|++ .++||+|+||+||+|++. .++..||||++...... ..+.+|+.++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 568999999999999975 45778999999754322 467899999999999999999999854 67899999
Q ss_pred eecCCCChhhhhccC-------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE----cCCCcEEEee
Q 036051 172 DYMPNGSLDKYLYNQ-------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL----DGELNGRLGD 240 (420)
Q Consensus 172 e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll----~~~~~~kl~D 240 (420)
||+. ++|.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9995 5888877532 12358999999999999999999999 999999999999999 6778999999
Q ss_pred ecCcccccCCCC--CcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 241 FGLARLYDHGTD--PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 241 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999987653221 223446789999999999774 589999999999999999999999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=334.61 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=191.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------eEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 168 (420)
.+|...+.||+|+||.||+|++..++. ||+|++...... ..+|+.+++.++||||+++++++...+ ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999977665 888877543221 236899999999999999999986543 388
Q ss_pred EEEeecCCCChhhhhc-cCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEEeeecCccc
Q 036051 169 LVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRLGDFGLARL 246 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg~~~~ 246 (420)
+||||++++.+..... ......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999997644333322 1112368999999999999999999999 9999999999999999 789999999999987
Q ss_pred ccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh--------hhc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF--------DFW 317 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~ 317 (420)
..... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+......... ...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64332 23345789999999998664 58999999999999999999999998755432211100000 000
Q ss_pred ccCccccccCCCCCC-----cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 NRGELLEARDPNLGT-----EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ........+.... .+.......+.+++.+||+.||.+|||+.|+++
T Consensus 270 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 N-PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp C-GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred C-hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 0000001111110 011122346889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=324.74 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=191.4
Q ss_pred HHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch------hHHHHHHHHHHHhccC----CcceEeeeeee
Q 036051 91 YIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------QGMKEFVAEIVSIGRL----RHRNLVQLLGY 160 (420)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~~ 160 (420)
....++|++.+.||+|+||.||+|++..++..||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999988899999999865432 1223456788888888 89999999999
Q ss_pred eeeCCeEEEEEee-cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEE
Q 036051 161 CRRKGELLLVYDY-MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRL 238 (420)
Q Consensus 161 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl 238 (420)
+...+..++|+|+ +.+++|.+++.... .+++..++.++.||+.||.|||+ .+++||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999997644 58999999999999999999999 8999999999999999 8899999
Q ss_pred eeecCcccccCCCCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc
Q 036051 239 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 239 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
+|||++...... ......|+..|+|||++.+..+ +.++||||||+++|||++|+.||...... . .
T Consensus 182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---~--- 247 (312)
T 2iwi_A 182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----L---E--- 247 (312)
T ss_dssp CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H---H---
T ss_pred EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-----h---h---
Confidence 999999876532 2334568999999999876665 45899999999999999999999642110 0 0
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
......... ...+.+++.+||+.||++|||+.|+++
T Consensus 248 --------~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 --------AELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------TCCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------hccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111122 234778889999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=326.93 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=199.0
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchh------HHHHHHHHHHHhccCC--cceEeeeeeeeee
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQ------GMKEFVAEIVSIGRLR--HRNLVQLLGYCRR 163 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 163 (420)
...++|++.+.||+|+||.||+|++..++..||||++...... ....+.+|+.++.+++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457789999999999999999999889999999998654211 1244667899999986 5999999999999
Q ss_pred CCeEEEEEeecCC-CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc-CCCcEEEeee
Q 036051 164 KGELLLVYDYMPN-GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD-GELNGRLGDF 241 (420)
Q Consensus 164 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Df 241 (420)
.+..++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+ .+++||||||+|||++ +++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999976 89999997643 68999999999999999999999 9999999999999999 7889999999
Q ss_pred cCcccccCCCCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC
Q 036051 242 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 242 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
|++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... . .+
T Consensus 195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~-----~~ 258 (320)
T 3a99_A 195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I-----RG 258 (320)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H-----HC
T ss_pred ccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------h-----cc
Confidence 999876432 2334568999999999876665 68899999999999999999999642110 0 00
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ......+ ...+.+++.+||+.||++|||+.|+++
T Consensus 259 ~------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 Q------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011122 234778888999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=317.47 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=179.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhH-HHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQG-MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|+..+.||+|+||.||+|.+..++..||||++.... ... .+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999998888999999986542 222 233444555677889999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccC-cEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
||+ ++.+..+.... ...+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55555555432 2368999999999999999999998 5 8999999999999999999999999999765432
Q ss_pred CCCcccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 251 TDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
. ......+|+.|+|||++. ...++.++||||||+++|||++|+.||......... ...... .
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~------~ 245 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ------E 245 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHH------S
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-----HHHHhc------c
Confidence 2 223456899999999984 456889999999999999999999999764332111 111110 0
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EPPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111110 012234778888999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.22 Aligned_cols=259 Identities=27% Similarity=0.335 Sum_probs=200.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeee------CCe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KGE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 166 (420)
.++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999888999999998764 44456779999999999999999999998765 677
Q ss_pred EEEEEeecCCCChhhhhccCC-CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc---EEEeeec
Q 036051 167 LLLVYDYMPNGSLDKYLYNQP-KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN---GRLGDFG 242 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg 242 (420)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 2358899999999999999999999 99999999999999997665 9999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhc-----
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFW----- 317 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 317 (420)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .|.....
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence 998765432 2334678999999999999999999999999999999999999997542111 1110000
Q ss_pred -------ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHH
Q 036051 318 -------NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362 (420)
Q Consensus 318 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 362 (420)
..+.....................+.+++.+||+.||.+|||+.|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 001110000111112334455677889999999999999999866
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.15 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=185.5
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEEeec
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
.|...+.||+|+||+||.+.. .++..||||++.... .+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345568899999999976544 457789999886543 24577899999876 8999999999999999999999999
Q ss_pred CCCChhhhhccCCCcc-----CcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-------------CcE
Q 036051 175 PNGSLDKYLYNQPKVT-----LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-------------LNG 236 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-------------~~~ 236 (420)
. |+|.+++....... .++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997654211 2344567899999999999999 999999999999999754 489
Q ss_pred EEeeecCcccccCCCCC---cccccccCCcccccccccC-------CCCCccchhhhhHHHHHHHhc-CCccCCCCCCcc
Q 036051 237 RLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVAC-GRRPIERQGPEE 305 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~ 305 (420)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 2234579999999999865 678999999999999999999 999996543322
Q ss_pred cchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ....... ..+.............+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~----~i~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S----NIIRGIF--------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----HHHHTCC--------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHhcCCC--------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 0011000 0011111123455677889999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=307.07 Aligned_cols=232 Identities=14% Similarity=0.122 Sum_probs=185.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+..+.+++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357899999999999999999998889999999997542 34457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++++|.+++... ....++..++.|++.||+|||+ .+|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999643 2445788899999999999999 999999999999999999999998543
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
|++ .++.++|||||||++|||++|+.||......+..... .... .+ .+..
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~------~~~~ 224 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AG------QPIE 224 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TS------CBCC
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-cc------CCCC
Confidence 333 3688999999999999999999999876543311000 0000 00 0000
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......+....+.+++.+||+.||.+| |+.|+++.|+...
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 001111223457889999999999999 9999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=306.48 Aligned_cols=231 Identities=19% Similarity=0.261 Sum_probs=180.1
Q ss_pred cCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHh-ccCCcceEeeeeeeeee----CCeEE
Q 036051 95 KGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSI-GRLRHRNLVQLLGYCRR----KGELL 168 (420)
Q Consensus 95 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~ 168 (420)
++|.+. +.||+|+||.||+|.+..++..||+|++... ..+.+|+..+ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7899999999999999888999999998643 3456788887 55689999999999877 67899
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~ 245 (420)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999999987765579999999999999999999999 99999999999999998 7889999999986
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
... +..++.++|||||||++|||++|+.||........... ... ....
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~------~~~~ 216 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKT------RIRM 216 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCC------SSCT
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHH------HHhh
Confidence 432 23467899999999999999999999976543221000 000 0000
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
................+.+++.+||+.||.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001110000122356788999999999999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=325.63 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=184.8
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 171 (420)
...+|...+.||+|+||+||.... .+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 345688889999999999654333 3567899999865432 2246799999998 7999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-----CCcEEEeeecCccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARL 246 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfg~~~~ 246 (420)
||+. |+|.+++..... .+.+..++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||++..
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9995 699999976543 45556678999999999999999 99999999999999953 34688999999987
Q ss_pred ccCCCC--CcccccccCCccccccccc---CCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccC
Q 036051 247 YDHGTD--PQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRG 320 (420)
Q Consensus 247 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 320 (420)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~- 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGA- 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTC-
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hhcc-
Confidence 653321 2334467999999999997 4567889999999999999999 899986543221100 0000
Q ss_pred ccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... ... .........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~----~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL----DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC----TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc----ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 000 011223445778999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.88 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=192.6
Q ss_pred hcCCCccceecccCceEEEEEEeCC-Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCe-----
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE----- 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 166 (420)
.++|++.+.||+|+||.||+|.+.. ++..||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999865 6788999988654 34455678999999999999999999999987665
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+ .+|+||||||+|||++.+ .+||+|||++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 58999999999999999999999 999999999999999986 899999999986
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... ....||+.|+|||++.+. ++.++|||||||++|||++|..||....... .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~ 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------------c
Confidence 5432 345799999999998765 4889999999999999999998876421110 0
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-HHHHHHHHh
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPS-MRQVVQILE 368 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~ 368 (420)
+ ...........+.+++.+||+.||.+||+ +.++.+.|.
T Consensus 285 -~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 -P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 01111123356888999999999999996 555555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=324.23 Aligned_cols=242 Identities=15% Similarity=0.117 Sum_probs=182.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCc-ceE---------------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRH-RNL--------------- 154 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni--------------- 154 (420)
+.+|...+.||+|+||.||+|++..+++.||||++.... ....+.|.+|+.++..++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777889999999999999998889999999987432 2225678999999999976 211
Q ss_pred eee------eeeeee-----CCeEEEEEeecCCCChhhhhc-----cCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcE
Q 036051 155 VQL------LGYCRR-----KGELLLVYDYMPNGSLDKYLY-----NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVV 218 (420)
Q Consensus 155 v~~------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 218 (420)
+.+ ..++.. ....+++|+++ +++|.+++. ......+++..++.++.||+.||+|||+ .+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 111 111111 12467777766 789999984 2333468899999999999999999999 999
Q ss_pred EecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccc----------cCCCCCccchhhhhHHHH
Q 036051 219 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT----------RTGKATTSADVFSFGAFL 288 (420)
Q Consensus 219 iH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~slGvvl 288 (420)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998764432 344567 999999999 556688999999999999
Q ss_pred HHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 289 LEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 289 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
|||++|+.||......+... ...... ..+ ...+.+++.+||+.||++|||+.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSE---------------WIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999997654332110 000000 111 245788888999999999999877753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=305.01 Aligned_cols=243 Identities=16% Similarity=0.157 Sum_probs=182.5
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccCC---------cceEe
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRLR---------HRNLV 155 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv 155 (420)
..++|++.+.||+|+||+||+|++ ++..||||++.... ....+.+.+|+.++++++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346788899999999999999998 56889999987542 222366788888888775 66665
Q ss_pred eeeee-----------------eee-------------CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHh
Q 036051 156 QLLGY-----------------CRR-------------KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205 (420)
Q Consensus 156 ~~~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~ 205 (420)
++.++ +.+ .+..++||||+++|++.+.+.. ..+++.++..++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 55554 333 6789999999999977776644 25899999999999999
Q ss_pred HhHHhh-hcccCcEEecccCCCCEEEcCCC--------------------cEEEeeecCcccccCCCCCcccccccCCcc
Q 036051 206 GLLYLH-EEWEQVVIHRDVKASNVLLDGEL--------------------NGRLGDFGLARLYDHGTDPQTTHVVGTLGY 264 (420)
Q Consensus 206 ~L~~LH-~~~~~~iiH~dlk~~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y 264 (420)
||+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 8 8999999999999999887 8999999999876432 34799999
Q ss_pred cccccccCCCCCccchhhhhHHH-HHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHH
Q 036051 265 LAPEHTRTGKATTSADVFSFGAF-LLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELIL 343 (420)
Q Consensus 265 ~aPE~~~~~~~~~~sDv~slGvv-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 343 (420)
+|||++.+.. +.++||||||++ .+++++|..||..... ........... ..................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQ---MTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHT---CCCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhh---hccCcccchhhhhhcCHHHH
Confidence 9999998766 899999998777 6678889998843100 00000000000 01111112233445677899
Q ss_pred HHhhcccccCCCCCCCHHHHH
Q 036051 344 KLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 344 ~l~~~cl~~dP~~RPt~~evl 364 (420)
+++.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=277.07 Aligned_cols=186 Identities=17% Similarity=0.074 Sum_probs=132.3
Q ss_pred ecccCceEEEEEEeCCCceeeeeeccccc----------chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEEE
Q 036051 103 LGSGGFGRVYRGTLPKSKIEIAVKKISHE----------SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 103 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.+.|+.|.+..++..-.+..+++|++... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45666666665554445667999988643 123356799999999999 7999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||++|++|.++|...+ .++.. +|+.||+.||+|+|+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999998765 45543 588999999999999 999999999999999999999999999998765432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 298 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~ 298 (420)
......+||+.|+|||++.+ .+..++|+|++|++++++.++..++
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 23445789999999999975 4677899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-28 Score=244.09 Aligned_cols=184 Identities=15% Similarity=0.148 Sum_probs=143.9
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccc--------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
...+.||+|+||.||+|... +..+++|+..... ....+.+.+|++++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999664 4568888653321 1123558999999999999999977777667778899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++++|.+++.. +..++.|++.||.|||+ .+|+||||||+|||++. ++||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999865 45889999999999999 99999999999999998 999999999987643
Q ss_pred CCCCc------ccccccCCcccccccccC--CCCCccchhhhhHHHHHHHhcCCccC
Q 036051 250 GTDPQ------TTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPI 298 (420)
Q Consensus 250 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el~tg~~p~ 298 (420)
..... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22111 235689999999999976 56788899999999888888777766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=204.83 Aligned_cols=151 Identities=15% Similarity=0.053 Sum_probs=121.7
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccch------------------hHHHHHHHHHHHhccCC
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------------------QGMKEFVAEIVSIGRLR 150 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~ 150 (420)
.+......|.+.+.||+|+||.||+|.+ .++..||+|++..... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444556677779999999999999999 7788999999864321 13456899999999998
Q ss_pred cceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 151 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+++||||||+|||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl 226 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV 226 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEE
Confidence 5 667775544 55699999999999998 422 2345799999999999998 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCCCcccccccCCccccccccc
Q 036051 231 DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 271 (420)
+ ++.+||+|||++.. +..+.|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999999863 34478888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7e-21 Score=175.31 Aligned_cols=138 Identities=17% Similarity=0.132 Sum_probs=106.8
Q ss_pred CCCccceecccCceEEEEEEeCCCcee--eeeecccccch------------------------hHHHHHHHHHHHhccC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIE--IAVKKISHESR------------------------QGMKEFVAEIVSIGRL 149 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l 149 (420)
-|.+.+.||+|+||.||+|.+..++.. ||||++..... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999998666778 99998643311 1123578899999999
Q ss_pred CcceE--eeeeeeeeeCCeEEEEEeecCC-C----ChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhh-hcccCcEEec
Q 036051 150 RHRNL--VQLLGYCRRKGELLLVYDYMPN-G----SLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH-EEWEQVVIHR 221 (420)
Q Consensus 150 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiH~ 221 (420)
+|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| + .+++||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 88754 333432 356899999942 4 55554322 235577889999999999999 8 999999
Q ss_pred ccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 222 DVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 222 dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-17 Score=159.91 Aligned_cols=140 Identities=11% Similarity=0.043 Sum_probs=98.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch--------------hHHHH--------HHHHHHHhccCCcc
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR--------------QGMKE--------FVAEIVSIGRLRHR 152 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~ 152 (420)
.-|++.+.||+|++|.||+|... +|..||||+++.... ..... ...|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34889999999999999999985 577899998643200 00111 22355555555443
Q ss_pred eEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC
Q 036051 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232 (420)
Q Consensus 153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~ 232 (420)
++....-+.. ...++||||+++++|..+... .....++.|++.+|.+||. .++|||||||.|||+++
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 3321111111 123799999999888765421 2345678999999999998 89999999999999987
Q ss_pred CC----------cEEEeeecCccccc
Q 036051 233 EL----------NGRLGDFGLARLYD 248 (420)
Q Consensus 233 ~~----------~~kl~Dfg~~~~~~ 248 (420)
++ .+.|+||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=118.23 Aligned_cols=143 Identities=15% Similarity=0.062 Sum_probs=110.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 172 (420)
-..|.....++.|+.+.||++... +..+++|+...........+.+|+..++.+. +..++++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 356777888888999999999864 4579999986532122235778898888884 6778889999998899999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc--------------------------------------
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW-------------------------------------- 214 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 214 (420)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999876421 1234477889999999999810
Q ss_pred ------------------cCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 215 ------------------EQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 215 ------------------~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=110.84 Aligned_cols=136 Identities=18% Similarity=0.142 Sum_probs=96.6
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcce--EeeeeeeeeeCCeEEEEEee
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~ 173 (420)
++....+.+.|..+.||++... ++..+++|+..... ...+..|+..++.+.+.+ +++++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecC-CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3443333345666999999764 45569999876541 234678888888875434 56688888887889999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc---------------------------------------
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW--------------------------------------- 214 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 214 (420)
++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 211 11 2356777888888888621
Q ss_pred ----------------cCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 215 ----------------EQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 215 ----------------~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.7e-10 Score=109.45 Aligned_cols=142 Identities=11% Similarity=0.172 Sum_probs=106.0
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeeccc--ccc-hhHHHHHHHHHHHhccCC--cceEeeeeeeeeeC---CeEEEE
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HES-RQGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRK---GELLLV 170 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 170 (420)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.++..+. +..+++++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 35779999999999998753 468888876 332 122346778998888886 45678888888776 458999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc------------------------------------
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW------------------------------------ 214 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------ 214 (420)
|||++|..+.+... ..++..++..++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999988854221 14677888899999999999999721
Q ss_pred -------------------cCcEEecccCCCCEEEcCCCc--EEEeeecCccc
Q 036051 215 -------------------EQVVIHRDVKASNVLLDGELN--GRLGDFGLARL 246 (420)
Q Consensus 215 -------------------~~~iiH~dlk~~NIll~~~~~--~kl~Dfg~~~~ 246 (420)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1.5e-10 Score=108.50 Aligned_cols=184 Identities=18% Similarity=0.187 Sum_probs=120.7
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-Ccce--EeeeeeeeeeCC---eEEEEEee
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRN--LVQLLGYCRRKG---ELLLVYDY 173 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~ 173 (420)
.+.++.|....||+.. ..+++|+.... .....+.+|...+..+ .+.. +++++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4669999999999864 24888886433 3346678899988777 3322 344555443333 45899999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhc----------------------------------------
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE---------------------------------------- 213 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 213 (420)
++|.+|.+.... .++..++..++.+++..|..||+.
T Consensus 98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999888754321 466677788888888888888851
Q ss_pred ---------------ccCcEEecccCCCCEEEcC--CCcEEEeeecCcccccCCCCCcccccccCCcc---cccccccC-
Q 036051 214 ---------------WEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY---LAPEHTRT- 272 (420)
Q Consensus 214 ---------------~~~~iiH~dlk~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 272 (420)
....++|+|+++.||++++ +..+.|+||+.+..-.... .......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHH
Confidence 0135899999999999998 4567899999886532210 00000111 12221100
Q ss_pred ----C---------CCCccchhhhhHHHHHHHhcCCccCC
Q 036051 273 ----G---------KATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 273 ----~---------~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
+ ......+.|++|.++|.+.+|..+|.
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 01123589999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1.6e-07 Score=86.14 Aligned_cols=136 Identities=19% Similarity=0.163 Sum_probs=96.5
Q ss_pred eecccCce-EEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEEeecCCCCh
Q 036051 102 LLGSGGFG-RVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSL 179 (420)
Q Consensus 102 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 179 (420)
.+..|..| .||+.....++..+++|+-... ....+..|...|+.+. +--++++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555555 6999888767777899986533 2356778888887773 33367788999999999999999999887
Q ss_pred hhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc---------------------------------------------
Q 036051 180 DKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW--------------------------------------------- 214 (420)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------- 214 (420)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7654321 1223345556666666666420
Q ss_pred ----------cCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 215 ----------EQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 215 ----------~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=7.2e-07 Score=83.48 Aligned_cols=136 Identities=19% Similarity=0.119 Sum_probs=92.6
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc---eEeeeeeeee-eCCeEEEEEeecC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---NLVQLLGYCR-RKGELLLVYDYMP 175 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~ 175 (420)
.+.++.|....||+. +..+++|+... ......+..|...|..+.+. .+++++.++. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 567889999999988 23588888532 23346788999999988642 3556666664 4456789999999
Q ss_pred CCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhc------------------------------------------
Q 036051 176 NGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE------------------------------------------ 213 (420)
Q Consensus 176 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 213 (420)
|.+|.+.... .++..+...++.+++..|..||+.
T Consensus 97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9888763211 233444445555555555555531
Q ss_pred ---------------ccCcEEecccCCCCEEEcC---CCc-EEEeeecCccc
Q 036051 214 ---------------WEQVVIHRDVKASNVLLDG---ELN-GRLGDFGLARL 246 (420)
Q Consensus 214 ---------------~~~~iiH~dlk~~NIll~~---~~~-~kl~Dfg~~~~ 246 (420)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.3e-06 Score=83.35 Aligned_cols=82 Identities=7% Similarity=-0.028 Sum_probs=54.8
Q ss_pred ccee-cccCceEEEEEEeC---C---Cceeeeeecccccc---hhHHHHHHHHHHHhccCC-c--ceEeeeeeeeeeC--
Q 036051 100 KELL-GSGGFGRVYRGTLP---K---SKIEIAVKKISHES---RQGMKEFVAEIVSIGRLR-H--RNLVQLLGYCRRK-- 164 (420)
Q Consensus 100 ~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~-- 164 (420)
.+.| +.|....+|+.... + ++..+++|+..... ......+..|+..+..+. + -.+++++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88989999998763 1 15568889765432 001134567777777774 2 3466778777655
Q ss_pred -CeEEEEEeecCCCChhh
Q 036051 165 -GELLLVYDYMPNGSLDK 181 (420)
Q Consensus 165 -~~~~lv~e~~~~g~L~~ 181 (420)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=4.7e-06 Score=80.81 Aligned_cols=76 Identities=9% Similarity=0.057 Sum_probs=47.4
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccch-------hHHHHHHHHHHHhccCCc--c-eEeeeeeeeeeCCeEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR-------QGMKEFVAEIVSIGRLRH--R-NLVQLLGYCRRKGELLL 169 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 169 (420)
.+.||.|..+.||++....++..++||....... .....+..|.+.+..+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999998755566799997543211 112345667777776631 3 34455544 3445689
Q ss_pred EEeecCCC
Q 036051 170 VYDYMPNG 177 (420)
Q Consensus 170 v~e~~~~g 177 (420)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.2e-05 Score=70.93 Aligned_cols=140 Identities=18% Similarity=0.251 Sum_probs=78.0
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-----CcceEeeee-e--eeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-----RHRNLVQLL-G--YCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~ 171 (420)
.+.|+.|..+.||+.... ++ .+++|+..... ..+..|...+..+ ..|.++... | +....+..++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET-TE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC-CC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778999999874 34 48899886532 2223344444433 234433311 1 223467789999
Q ss_pred eecCCCChhh--------------hhcc----C--CC------ccCcHHHHH----------------------------
Q 036051 172 DYMPNGSLDK--------------YLYN----Q--PK------VTLNWRQRY---------------------------- 197 (420)
Q Consensus 172 e~~~~g~L~~--------------~l~~----~--~~------~~l~~~~~~---------------------------- 197 (420)
+|++|..+.. .++. . +. ..-.|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9998865530 1111 0 00 001222110
Q ss_pred ---HHHHHhHhHhHHhhh----------cccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 198 ---GVIKGVALGLLYLHE----------EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 198 ---~i~~~ia~~L~~LH~----------~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 124789999999999999888889999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00022 Score=66.51 Aligned_cols=138 Identities=14% Similarity=0.096 Sum_probs=90.5
Q ss_pred ccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC---cceEeeeeeeeeeCCeEEEEEeecC
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLLVYDYMP 175 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 175 (420)
..+.|+.|....+|+.... +..+++|+.... ....+..|...|+.+. ...+++++.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567999999999999863 456889987543 2356778888888773 3567888888888888999999999
Q ss_pred CCChhh-----------hhccCCC--------------------ccCcHHHHH---HHHHH----------------hHh
Q 036051 176 NGSLDK-----------YLYNQPK--------------------VTLNWRQRY---GVIKG----------------VAL 205 (420)
Q Consensus 176 ~g~L~~-----------~l~~~~~--------------------~~l~~~~~~---~i~~~----------------ia~ 205 (420)
+..+.. .|+.... ..-+|...+ ++..+ +..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876531 1222110 012344332 11111 111
Q ss_pred H-hHHhhh-cccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 206 G-LLYLHE-EWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 206 ~-L~~LH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 1246799999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=71.60 Aligned_cols=77 Identities=14% Similarity=0.115 Sum_probs=47.5
Q ss_pred cCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCcccccc--cCCcccccccccCC---CCCccchhhhhHHHHH
Q 036051 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV--GTLGYLAPEHTRTG---KATTSADVFSFGAFLL 289 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~ 289 (420)
...++|+|+++.|||++.++ ++|+||+.+..-....+ ..... -...|.+|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 37899999999999999876 99999998864321110 00001 12345666654311 1223355667777888
Q ss_pred HHhcC
Q 036051 290 EVACG 294 (420)
Q Consensus 290 el~tg 294 (420)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=8.9e-05 Score=68.37 Aligned_cols=80 Identities=16% Similarity=0.184 Sum_probs=53.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-c--ceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-H--RNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~ 171 (420)
......+.+|.|..+.||+.+.. +|+.|++|+...........|..|...|+.|. . --+++++++. .-++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 34455678999999999999985 56679999876543332345678888887763 2 1234444432 237899
Q ss_pred eecCCCCh
Q 036051 172 DYMPNGSL 179 (420)
Q Consensus 172 e~~~~g~L 179 (420)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99977654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00018 Score=70.34 Aligned_cols=74 Identities=19% Similarity=0.234 Sum_probs=48.6
Q ss_pred cceecccCceEEEEEEeCC-------CceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 171 (420)
.+.|+.|-...+|+....+ .+..+++|+...... ...+..|..++..+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889999999998753 245688998844211 1345578888877743233 566665542 3899
Q ss_pred eecCCCCh
Q 036051 172 DYMPNGSL 179 (420)
Q Consensus 172 e~~~~g~L 179 (420)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99976454
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00033 Score=64.92 Aligned_cols=72 Identities=11% Similarity=0.075 Sum_probs=42.8
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeec-CCC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYM-PNG 177 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g 177 (420)
.+.|+.|....+|+. ..+++|+........ ....+|+..+..+...++ +++++++ .+.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 678999999999998 248888876432111 112356666655532112 4555543 33347899999 665
Q ss_pred Chh
Q 036051 178 SLD 180 (420)
Q Consensus 178 ~L~ 180 (420)
+|.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00063 Score=66.95 Aligned_cols=75 Identities=8% Similarity=0.034 Sum_probs=46.5
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEeecCCCC
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.+.|+.|-...+|+....+.+..+++|+........ -+-..|..++..+...++ +++++++. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 467888999999999985434678899875432111 111467777777753333 56777663 2 25999998755
Q ss_pred h
Q 036051 179 L 179 (420)
Q Consensus 179 L 179 (420)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0036 Score=58.23 Aligned_cols=141 Identities=15% Similarity=0.106 Sum_probs=75.6
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcce--Eeeeeee------eeeCCeEEEEEe
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGY------CRRKGELLLVYD 172 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 172 (420)
+.|+.|....+|+....+ + .+++|+...... ...+..|+..+..+...+ +++++.. ....+..+++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeCC-c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 457778889999998743 3 588998865211 123445666555553111 2333321 223466799999
Q ss_pred ecCCCChhhh--------------hccC----CCc------cCcHHHHHHHH------------HHhHhHhHHhhhc---
Q 036051 173 YMPNGSLDKY--------------LYNQ----PKV------TLNWRQRYGVI------------KGVALGLLYLHEE--- 213 (420)
Q Consensus 173 ~~~~g~L~~~--------------l~~~----~~~------~l~~~~~~~i~------------~~ia~~L~~LH~~--- 213 (420)
|++|..+... ++.. ... ...|...+.-. ..+...+..+...
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9988654220 1110 000 01122211100 1123344444421
Q ss_pred -ccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 214 -WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 214 -~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999987556899998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.001 Score=57.79 Aligned_cols=99 Identities=16% Similarity=0.063 Sum_probs=64.3
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCccc
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 256 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 256 (420)
-+|.+.|...+. ++++.++|.++.|.+.+|.-+-.. ..+ ..+=+.|..|++..+|+|...+ +.+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 478888876644 899999999999999998776210 011 1333456899999999988764 1110
Q ss_pred ccccCCcccccccccCCCCCccchhhhhHHHHHHHhc
Q 036051 257 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC 293 (420)
Q Consensus 257 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t 293 (420)
.....+.|||... ...+.+.-|||||+++|.-+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888763 345678899999999998653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0016 Score=61.18 Aligned_cols=32 Identities=38% Similarity=0.436 Sum_probs=27.7
Q ss_pred cCcEEecccCCCCEEEcCC----CcEEEeeecCccc
Q 036051 215 EQVVIHRDVKASNVLLDGE----LNGRLGDFGLARL 246 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~----~~~kl~Dfg~~~~ 246 (420)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3679999999999999874 6799999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.001 Score=63.82 Aligned_cols=141 Identities=21% Similarity=0.189 Sum_probs=81.7
Q ss_pred cceecccCceEEEEEEeCC-------CceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPK-------SKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (420)
.+.|..|-...+|+....+ ++..+++|+..... .....+.+|..+++.+. +.-.+++++++.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4567788889999998742 34578899864321 22345668888887773 2223566666654 2899
Q ss_pred eecCCCChhhh-----------------hccCC---CccC--cHHHHHHHHHHhHh-------------------HhHHh
Q 036051 172 DYMPNGSLDKY-----------------LYNQP---KVTL--NWRQRYGVIKGVAL-------------------GLLYL 210 (420)
Q Consensus 172 e~~~~g~L~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------~L~~L 210 (420)
||++|.+|..- |+... .... -|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99988665421 11110 0111 23444545444322 12333
Q ss_pred hh-----cccCcEEecccCCCCEEEcCC----CcEEEeeecCcc
Q 036051 211 HE-----EWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLAR 245 (420)
Q Consensus 211 H~-----~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfg~~~ 245 (420)
.. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 113568999999999999876 689999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0017 Score=62.02 Aligned_cols=75 Identities=11% Similarity=0.089 Sum_probs=42.4
Q ss_pred cceecccCceEEEEEEeCCC--------ceeeeeecccccchhHHHHHHHHHHHhccCCcce-EeeeeeeeeeCCeEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKS--------KIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLV 170 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 170 (420)
.+.++.|....+|+....++ +..+++|+........ .+...|...+..+...+ .+++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 45678888899999987431 2468889875432211 12346666666663222 34555443 2 2689
Q ss_pred EeecCCCCh
Q 036051 171 YDYMPNGSL 179 (420)
Q Consensus 171 ~e~~~~g~L 179 (420)
+||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0091 Score=55.65 Aligned_cols=141 Identities=15% Similarity=0.154 Sum_probs=76.8
Q ss_pred ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcc--eEeeeeee-----eeeCCeEEEEEee
Q 036051 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR--NLVQLLGY-----CRRKGELLLVYDY 173 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~ 173 (420)
..++ |....||+.... ++..+++|....... ....+..|...+..+... .+++++.. ....+..++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4577 888899988764 344689998863311 123455566666655321 13334432 2234567889999
Q ss_pred cCCCChhh----h----------hcc----CC---CccCcHHHH----HHHHH---------------HhHhHhHHhhh-
Q 036051 174 MPNGSLDK----Y----------LYN----QP---KVTLNWRQR----YGVIK---------------GVALGLLYLHE- 212 (420)
Q Consensus 174 ~~~g~L~~----~----------l~~----~~---~~~l~~~~~----~~i~~---------------~ia~~L~~LH~- 212 (420)
++|..+.. . ++. .. ....++... ..++. .+...+..+..
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98755421 0 110 00 011222111 00110 11111222221
Q ss_pred ---cccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 213 ---EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 213 ---~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1235689999999999999 4 899999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.014 Score=54.82 Aligned_cols=32 Identities=31% Similarity=0.376 Sum_probs=27.9
Q ss_pred cCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 215 ~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 36799999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.04 Score=53.42 Aligned_cols=75 Identities=8% Similarity=0.010 Sum_probs=46.0
Q ss_pred cceecccCceEEEEEEeCCC-------ceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKS-------KIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (420)
.+.+..|-...+|+...... +..+++|+........ -+..+|..+++.+. +.-.+++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 45688888899999987521 3568899875432111 12245666666663 22234555433 2 27899
Q ss_pred eecCCCCh
Q 036051 172 DYMPNGSL 179 (420)
Q Consensus 172 e~~~~g~L 179 (420)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.26 Score=42.67 Aligned_cols=116 Identities=7% Similarity=0.048 Sum_probs=80.4
Q ss_pred CcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 150 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
.||++++. .+....+.+.+.++.-+++.=+..++ .++...+++++.+|+....+++. -+|--|.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 68888766 45566666666666554332222232 56788999999999999877775 467789999999
Q ss_pred EcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCC
Q 036051 230 LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
++.++.+++.-.|+...+. |. ..+...=.-.+=+++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999888754322 11 11222223456678888999988885
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.84 E-value=0.15 Score=49.02 Aligned_cols=30 Identities=30% Similarity=0.396 Sum_probs=25.0
Q ss_pred cEEecccCCCCEEE------cCCCcEEEeeecCccc
Q 036051 217 VVIHRDVKASNVLL------DGELNGRLGDFGLARL 246 (420)
Q Consensus 217 ~iiH~dlk~~NIll------~~~~~~kl~Dfg~~~~ 246 (420)
.++|+|+.+.|||+ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4566799999988753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.71 E-value=0.045 Score=34.23 Aligned_cols=27 Identities=22% Similarity=0.448 Sum_probs=11.5
Q ss_pred EEehhHHH-HHHHHHHHHHHhhhheecc
Q 036051 41 TIGLPVIC-VSLILAAVSGVVYVIRRKR 67 (420)
Q Consensus 41 ~i~~~~~~-~~~~~~~~~~~~~~~~r~~ 67 (420)
.|+..+++ +++++++++.+++++|||+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 34444443 4443334444444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.20 E-value=0.044 Score=34.17 Aligned_cols=27 Identities=19% Similarity=0.116 Sum_probs=11.6
Q ss_pred EehhH-HHHHHHHHHHHHHhhhheeccc
Q 036051 42 IGLPV-ICVSLILAAVSGVVYVIRRKRK 68 (420)
Q Consensus 42 i~~~~-~~~~~~~~~~~~~~~~~~r~~~ 68 (420)
|+..+ +++++++++++.+++++|||++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 44434 3344444444444444444443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.47 Score=41.14 Aligned_cols=115 Identities=10% Similarity=-0.012 Sum_probs=78.4
Q ss_pred CcceEeeeeeeeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhH-HhhhcccCcEEecccCCCCE
Q 036051 150 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL-YLHEEWEQVVIHRDVKASNV 228 (420)
Q Consensus 150 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~iiH~dlk~~NI 228 (420)
.||++ -...-.+.+.+.+.++.-+++.=...++ .++...+++++.+|+.... +++. -+|--|.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 67777 3333466677777777664443333342 5778899999999999888 6665 56778999999
Q ss_pred EEcCCCcEEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCC
Q 036051 229 LLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIE 299 (420)
Q Consensus 229 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~ 299 (420)
++|.++.+++.-.|+-..+ +|.- .+..-=.-.+=+++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999988875432 2221 1111123356678888888887774
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.26 E-value=0.059 Score=33.53 Aligned_cols=25 Identities=20% Similarity=0.207 Sum_probs=8.9
Q ss_pred EehhHHHHHHHHHHHHHHhhhheec
Q 036051 42 IGLPVICVSLILAAVSGVVYVIRRK 66 (420)
Q Consensus 42 i~~~~~~~~~~~~~~~~~~~~~~r~ 66 (420)
|++.++++++++++.+.++++.|||
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHhheehh
Confidence 3333333333333333333333333
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.23 E-value=0.035 Score=54.58 Aligned_cols=62 Identities=10% Similarity=0.130 Sum_probs=18.4
Q ss_pred ccceecccCceEEEEEEeCCCceeeee------eccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee
Q 036051 99 EKELLGSGGFGRVYRGTLPKSKIEIAV------KKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR 163 (420)
Q Consensus 99 ~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 163 (420)
+.+.|| ||.||+|.+.....+||+ |..... ..+....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 999999999765568999 665432 22334568888888888999999999887543
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=90.46 E-value=0.11 Score=33.82 Aligned_cols=16 Identities=31% Similarity=0.655 Sum_probs=12.8
Q ss_pred ceeeEEeEEeeeCCCC
Q 036051 2 VSHYILGWSFKINGQA 17 (420)
Q Consensus 2 ~~~~~~~~~~~~~~~~ 17 (420)
+.|+|++|+|+.+++.
T Consensus 33 ~~h~IlsWsF~s~~~~ 48 (52)
T 2ltn_B 33 AAHEVLSWSFHSELSG 48 (52)
T ss_dssp CEEEEEEEEEEEEEC-
T ss_pred eeEEEEEeEEEeeccc
Confidence 5799999999987643
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=85.79 E-value=0.37 Score=29.07 Aligned_cols=25 Identities=12% Similarity=0.013 Sum_probs=10.7
Q ss_pred EEehhHHHHHHHHHHHHHHhhhhee
Q 036051 41 TIGLPVICVSLILAAVSGVVYVIRR 65 (420)
Q Consensus 41 ~i~~~~~~~~~~~~~~~~~~~~~~r 65 (420)
+.+++++.++.+++++...+|++||
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeeehHHHHHHHHHHHHHHHHeec
Confidence 3444444443333333334444444
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.75 E-value=0.62 Score=28.53 Aligned_cols=6 Identities=33% Similarity=0.955 Sum_probs=2.2
Q ss_pred hhheec
Q 036051 61 YVIRRK 66 (420)
Q Consensus 61 ~~~~r~ 66 (420)
++++||
T Consensus 34 ~~~~rR 39 (41)
T 2k9y_A 34 FFIHRR 39 (41)
T ss_dssp HSSSSS
T ss_pred eeEeee
Confidence 333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 420 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-69
Identities = 68/300 (22%), Positives = 130/300 (43%), Gaps = 35/300 (11%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR 133
+DWE+ G + +GSG FG VY+G + + + ++ +
Sbjct: 1 DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTP 45
Query: 134 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNW 193
Q ++ F E+ + + RH N++ +GY +L +V + SL +L+
Sbjct: 46 QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIET-KFEM 103
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
+ + + A G+ YLH + +IHRD+K++N+ L +L ++GDFGLA + +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160
Query: 254 -QTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL 309
Q + G++ ++APE R + +DV++FG L E+ G+ P +
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---- 216
Query: 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ RG P+L ++ + + + +L C RP Q++ +E
Sbjct: 217 --QIIFMVGRGY----LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-68
Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 35/295 (11%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR 133
++WE+ + + E LG+G FG V+ G ++AVK + +
Sbjct: 6 DEWEVPR--------------ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGS 49
Query: 134 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNW 193
F+AE + +L+H+ LV+L + + ++ +YM NGSL +L + L
Sbjct: 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTI 108
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
+ + +A G+ ++ E IHRD++A+N+L+ L+ ++ DFGLARL +
Sbjct: 109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313
+ + APE G T +DV+SFG L E+ R
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP--------------- 210
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ E+++ + E + +L LC P RP+ + +LE
Sbjct: 211 YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 1e-67
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 19/288 (6%)
Query: 82 PHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVA 141
P Y + K LG G +G VY G K + +AVK + ++ + ++EF+
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62
Query: 142 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIK 201
E + ++H NLVQLLG C R+ ++ ++M G+L YL + ++ +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 202 GVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 261
++ + YL + + IHRD+ A N L+ ++ DFGL+RL T
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321
+ + APE K + +DV++FG L E+A + + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ E + + E E + +L C +P+ RPS ++ Q E
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-66
Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 29/293 (9%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 159
+E +G G FG V+RG E+AVK S + AEI LRH N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64
Query: 160 YCRRKG----ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE-- 213
+ +L LV DY +GSL YL + + A GL +LH E
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 214 ---WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLAP 267
+ + HRD+K+ N+L+ + D GLA +D TD H VGT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 268 E------HTRTGKATTSADVFSFGAFLLEVACGRRPI----ERQGPEENLILVDWVFDFW 317
E + + ++ AD+++ G E+A + Q P +L+ D +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 318 NRGELLEARDPNLGTEYV-AEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + PN+ + E L ++ K+ C +++ AR + ++ + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-65
Identities = 72/295 (24%), Positives = 117/295 (39%), Gaps = 35/295 (11%)
Query: 74 EDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR 133
+ WE+ + R + LG G FG V+ GT + +A+K +
Sbjct: 10 DAWEIPR--------------ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGT 53
Query: 134 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNW 193
+ F+ E + +LRH LVQL + +V +YM GSL +L + L
Sbjct: 54 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
Q + +A G+ Y+ +HRD++A+N+L+ L ++ DFGLARL +
Sbjct: 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313
+ + APE G+ T +DV+SFG L E+ R
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP--------------- 214
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ E+L+ + E E + L C +P RP+ + LE
Sbjct: 215 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 3e-65
Identities = 75/308 (24%), Positives = 145/308 (47%), Gaps = 38/308 (12%)
Query: 85 FRYKDLYIATKGFREK---------ELLGSGGFGRVYRGTLP---KSKIEIAVKKI-SHE 131
F ++D A + F ++ +++G+G FG V G L K +I +A+K + S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 132 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTL 191
+ + ++F++E +G+ H N++ L G + ++++ ++M NGSLD +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 192 NWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251
Q G+++G+A G+ YL + +HRD+ A N+L++ L ++ DFGL+R + T
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 252 DPQTTH----VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIERQGPEEN 306
T + + APE + K T+++DV+S+G + E ++ G RP
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233
Query: 307 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366
+ +++ A + + + + +L L C D RP Q+V
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 367 LERDVALP 374
L++ + P
Sbjct: 287 LDKMIRNP 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-63
Identities = 64/273 (23%), Positives = 112/273 (41%), Gaps = 21/273 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ +GSG FG V+ G +K ++A+K I E ++F+ E + +L H LVQ
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L G C + + LV+++M +G L YL Q + G+ V G+ E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGM---AYLEEA 120
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
VIHRD+ A N L+ ++ DFG+ R +T + + +PE + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 277 TSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVA 336
+ +DV+SFG + EV + + + P L + +V
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLASTHVY 232
Query: 337 EELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + C P RP+ ++++ L
Sbjct: 233 Q-------IMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-63
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 23/273 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG+G FG V G + + ++A+K I E EF+ E + L H LVQ
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L G C ++ + ++ +YM NG L YL +Q + K V + YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 276
+HRD+ A N L++ + ++ DFGL+R + + + PE K +
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 277 TSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+ +D+++FG + E+ + G+ P ++ + E E L
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP----------------YERFTNSETAEHIAQGLRLYRP 223
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
E + + C H RP+ + ++ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-61
Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 28/288 (9%)
Query: 88 KDLYIATKGFREKEL-LGSGGFGRVYRGTLP--KSKIEIAVKKISHESRQG-MKEFVAEI 143
K L++ ++ LG G FG V +G K +I++A+K + + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 144 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGV 203
+ +L + +V+L+G C+ + L+LV + G L K+L + + + ++ V
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQV 118
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGT 261
++G+ YL E+ +HRD+ A NVLL ++ DFGL++ D +
Sbjct: 119 SMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIERQGPEENLILVDWVFDFWNRG 320
L + APE K ++ +DV+S+G + E + G++P ++ E V F +G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
+ +E EL L C RP V Q +
Sbjct: 229 KRMECPP------ECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-61
Identities = 66/302 (21%), Positives = 119/302 (39%), Gaps = 35/302 (11%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM-KEFVAEIVSIGRLR 150
+ F + LG+G G V++ + S + +A K I E + + + + E+ +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
+V G GE+ + ++M GSLD+ L + + + V V GL YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYL 120
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
E + ++HRDVK SN+L++ +L DFG++ D VGT Y++PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERL 175
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
+ + +D++S G L+E+A GR PI +E ++ + R P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 331 GTEYVAEELELILKLGLL---------------------------CSHSDPTARPSMRQV 363
+ + + L C +P R ++Q+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 364 VQ 365
+
Sbjct: 296 MV 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-61
Identities = 69/290 (23%), Positives = 137/290 (47%), Gaps = 26/290 (8%)
Query: 92 IATKGFREKELLGSGGFGRVYRGTLP----KSKIEIAVKKISHESRQGMK-EFVAEIVSI 146
I ++++G+G FG VY+G L K ++ +A+K + + + +F+ E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 147 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
G+ H N+++L G + ++++ +YM NG+LDK+ + + Q G+++G+A G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAG 122
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGY 264
+ YL +HRD+ A N+L++ L ++ DFGL+R+ + + T+ + +
Sbjct: 123 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324
APE K T+++DV+SFG + EV + + E+++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMK 224
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALP 374
A + + I +L + C + RP +V IL++ + P
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ + +G G FG V G +K+ AVK I +++ + F+AE + +LRH NLVQ
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 157 LLGYC-RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
LLG KG L +V +YM GSL YL ++ + L V + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 123
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+HRD+ A NVL+ + ++ DFGL + + + APE R K
Sbjct: 124 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKF 177
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+T +DV+SFG L E+ R + P ++++ + + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------RVEKGYKMDAPDGCP 226
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
E++ C H D RPS Q+ + LE
Sbjct: 227 PAVYEVMKN----CWHLDAAMRPSFLQLREQLEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-60
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 29/279 (10%)
Query: 100 KELLGSGGFGRVYRGTLPKS---KIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 155
E++G G FG VY GTL + KI AVK ++ + G + +F+ E + + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 156 QLLGYC-RRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LLG C R +G L+V YM +G L ++ T+ +G+ +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-----KFL 146
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG---TDPQTTHVVGTLGYLAPEHT 270
+ +HRD+ A N +LD + ++ DFGLAR + T + ++A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
+T K TT +DV+SFG L E+ P P ++ D LL P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL---QP-- 256
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
EY + L ++ L C H RPS ++V +
Sbjct: 257 --EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 6e-60
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG---MKEFVAEIVSIGRLR 150
K F + +G G FG VY ++ +A+KK+S+ +Q ++ + E+ + +LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
H N +Q G R+ LV +Y + D ++ L + V G GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH- 269
H +IHRDVKA N+LL +LGDFG A + VGT ++APE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVI 183
Query: 270 --TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
G+ DV+S G +E+A + P+ L + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNES 231
Query: 328 PNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
P L + + +E + C P RP+ +++
Sbjct: 232 PALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 7e-60
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 97 FREKELLGSGGFGRVYRGTLPKS--KIEIAVKKIS-HESRQGMKEFVAEIVSIGRL-RHR 152
+ ++++G G FG+V + + K +++ A+K++ + S+ ++F E+ + +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------------NQPKVTLNWRQRYG 198
N++ LLG C +G L L +Y P+G+L +L N TL+ +Q
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 258
VA G+ YL ++ IHRD+ A N+L+ ++ DFGL+R + + T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMG 186
Query: 259 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318
+ ++A E TT++DV+S+G L E+ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGMT 231
Query: 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
EL E E + + L C P RPS Q++ L R
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-59
Identities = 71/316 (22%), Positives = 130/316 (41%), Gaps = 42/316 (13%)
Query: 82 PHRFRYKDLY-IATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQG 135
P + Y + + LG+G FG+V T + + +AVK + +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 136 MKE-FVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ------- 186
+E ++E+ + L H N+V LLG C G L++ +Y G L +L +
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 187 ---------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237
++ L+ VA G+ +L + IHRD+ A N+LL +
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185
Query: 238 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR 296
+ DFGLAR + + + + ++APE T +DV+S+G FL E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 297 PIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA 356
P ++ ++++ L E+ E+ + C +DP
Sbjct: 246 SPYPGMPVDSKFY-----------KMIKEGFRMLSPEHAPAEM---YDIMKTCWDADPLK 291
Query: 357 RPSMRQVVQILERDVA 372
RP+ +Q+VQ++E+ ++
Sbjct: 292 RPTFKQIVQLIEKQIS 307
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNL 154
+ +G+G +GR + + K++ + S + V+E+ + L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 155 VQLLGYC--RRKGELLLVYDYMPNGSLDKYLYNQPK--VTLNWRQRYGVIKGVALGLLYL 210
V+ R L +V +Y G L + K L+ V+ + L L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 211 HE--EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
H + V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T VGT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPE 184
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328
+D++S G L E+ P +E G++ E +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIREGKFR 232
Query: 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ Y E E+I + + RPS+ ++++
Sbjct: 233 RIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-59
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG G FG+VY+ ++ + A K I +S + +++++ EI + H N+V+
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
LL + L ++ ++ G++D + + L Q V K L YLH+
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK-- 130
Query: 217 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-----HTR 271
+IHRD+KA N+L + + +L DFG++ T + +GT ++APE ++
Sbjct: 131 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
ADV+S G L+E+A P P V + E P+
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPS-- 239
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ + + + K C + AR + Q++Q
Sbjct: 240 -RWSSNFKDFLKK----CLEKNVDARWTTSQLLQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 4e-58
Identities = 69/313 (22%), Positives = 121/313 (38%), Gaps = 47/313 (15%)
Query: 86 RYKDLYIATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHESRQGM-KEF 139
+ L +G G FGRV++ P + +AVK + E+ M +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 140 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT--------- 190
E + + N+V+LLG C + L+++YM G L+++L + T
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 191 -------------LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR 237
L+ ++ + + VA G+ YL E +HRD+ N L+ + +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 238 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR 296
+ DFGL+R +Y + + ++ PE + TT +DV+++G L E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 297 PIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTA 356
E V + G +L + + L LC P
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 357 RPSMRQVVQILER 369
RPS + +IL+R
Sbjct: 286 RPSFCSIHRILQR 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNL 154
+ +G G F VY+G ++ +E+A ++ ++ + F E + L+H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 155 VQLLGYC----RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
V+ + K ++LV + M +G+L YL + + + + GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
H +IHRD+K N+ + G ++GD GLA L V+GT ++APE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEM 184
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
K S DV++FG +LE+A P + + P
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-----------VTSGVKPA 232
Query: 330 LGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
+ E+ E+I C + R S++ ++
Sbjct: 233 SFDKVAIPEVKEIIEG----CIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 28/272 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRN 153
F LG G FG VY +SK +A+K + E + E+ LRH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+++L GY + L+ +Y P G++ + L K + ++ I +A L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH-- 123
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+ VIHRD+K N+LL ++ DFG + H + T + GTL YL PE
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
D++S G E G+ P E +E + + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------------KRISRVEFTFPDF 226
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+LI + +P+ RP +R+V++
Sbjct: 227 VTEGARDLISR----LLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-57
Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 23/273 (8%)
Query: 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 153
K + E +G G G VY + E+A+++++ + + + + EI+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
+V L EL +V +Y+ GSL + + Q V + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN 135
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
VIHRD+K+ N+LL + + +L DFG + + +VGT ++APE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
D++S G +E+ G P + P L L+ E ++P E
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNP----E 240
Query: 334 YVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
++ + + + C D R S ++++Q
Sbjct: 241 KLSAIFRDFLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-57
Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 99 EKELLGSGGFGRVYRGTLPKSKI--EIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNL 154
E + LGSG FG V +G K+ +AVK + +E+ E +AE + +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+++G C + +LV + G L+KYL + + ++ V++G+ YL E
Sbjct: 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRT 272
+HRD+ A NVLL + ++ DFGL++ D TH + + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 273 GKATTSADVFSFGAFLLE-VACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
K ++ +DV+SFG + E + G++P E V +GE +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGCP----- 232
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
E+ L LC D RP V L
Sbjct: 233 -AGCPREM---YDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 22/272 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 155
+ + LG G +G V ++ +AVK + + E EI L H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ G+ R L +Y G L + + QR+ + G++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG- 123
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRTGK 274
+ HRD+K N+LLD N ++ DFGLA ++ + + + + GTL Y+APE + +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 275 -ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
DV+S G L + G P ++ W + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------WKEKKTYLNPWKKID-- 233
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ L L+ K +P+AR ++ + +
Sbjct: 234 --SAPLALLHK----ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-56
Identities = 73/318 (22%), Positives = 125/318 (39%), Gaps = 49/318 (15%)
Query: 82 PHRFRYKDLY-IATKGFREKELLGSGGFGRVYRGTLPKSK-----IEIAVKKISHESRQG 135
+ Y + + ++LGSG FG+V T I++AVK + ++
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 136 MKE-FVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKV---- 189
+E ++E+ + +L H N+V LLG C G + L+++Y G L YL ++ +
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 190 -----------------TLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG 232
L + VA G+ +L + +HRD+ A NVL+
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTH 199
Query: 233 ELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE- 290
++ DFGLAR + + + ++APE G T +DV+S+G L E
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 291 VACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCS 350
+ G P + N +L++ Y EE+ +I++ C
Sbjct: 260 FSLGVNPYPGIPVDANFY------------KLIQNGFKMDQPFYATEEIYIIMQ---SCW 304
Query: 351 HSDPTARPSMRQVVQILE 368
D RPS + L
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (468), Expect = 3e-55
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 21/271 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ E LG+G FG V+R T + A K + + EI ++ LRH LV
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
L E++++Y++M G L + + ++ ++ + ++ V GL ++HE
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 217 VVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+H D+K N++ + + L DFGL D + T GT + APE
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKP 201
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334
D++S G + G P + +E L V + ++ + +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISEDG 256
Query: 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ I K +DP R ++ Q ++
Sbjct: 257 K----DFIRK----LLLADPNTRMTIHQALE 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-55
Identities = 71/311 (22%), Positives = 131/311 (42%), Gaps = 39/311 (12%)
Query: 82 PHRFRYKDLY------IATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISH 130
P F D+Y +A + LG G FG VY G + + +A+K ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 131 E-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY----- 184
S + EF+ E + ++V+LLG + L++ + M G L YL
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 185 ---NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDF 241
N + + + +A G+ YL+ +HRD+ A N ++ + ++GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF 177
Query: 242 GLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIER 300
G+ R +Y+ + + + +++PE + G TT +DV+SFG L E+A +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 301 QGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSM 360
E V F G LL+ D +++ +L +C +P RPS
Sbjct: 238 GLSNE------QVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSF 282
Query: 361 RQVVQILERDV 371
+++ ++ ++
Sbjct: 283 LEIISSIKEEM 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 9e-55
Identities = 76/288 (26%), Positives = 114/288 (39%), Gaps = 29/288 (10%)
Query: 91 YIATKGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE---SRQGMKEFVAEIV 144
I K R E LG G FG V RG + +AVK + + + M +F+ E+
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 145 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGV 203
++ L HRNL++L G + +V + P GSL L +Q L RY V
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQV 120
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGT 261
A G+ YL + IHRD+ A N+LL ++GDFGL R D H
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 262 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321
+ APE +T + ++D + FG L E+ + P L + GE
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE 232
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
L E +++ + + C P RP+ + L
Sbjct: 233 RLPR------PEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-54
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 26/279 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKS----KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 151
F++ ++LGSG FG VY+G KI +A+K++ S + KE + E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 152 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLH 211
++ +LLG C + L+ MP G L Y+ + +A G+ YL
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 212 EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHT 270
+ ++HRD+ A NVL+ + ++ DFGLA+ L + + ++A E
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 271 RTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330
T +DV+S+G + E+ +D E+ +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGE 230
Query: 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
+ + + C D +RP R+++ +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-54
Identities = 59/299 (19%), Positives = 120/299 (40%), Gaps = 38/299 (12%)
Query: 75 DWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE 131
D+E+ R +G G FG V++G + + +A+K +
Sbjct: 1 DYEIQ--RERIELG------------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 46
Query: 132 SRQGMKE-FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVT 190
+ ++E F+ E +++ + H ++V+L+G + + ++ + G L +L + +
Sbjct: 47 TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY-S 104
Query: 191 LNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250
L+ ++ L YL + +HRD+ A NVL+ +LGDFGL+R +
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV 310
T + + + ++APE + T+++DV+ FG + E+ + ++I
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-- 219
Query: 311 DWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G + + L+ K C DP+ RP ++ L
Sbjct: 220 ---------GRIENGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-53
Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 42/301 (13%)
Query: 97 FREKELLGSGGFGRVYRGTL-------PKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGR 148
+ LG G FG+V P ++AVK + + + + + + ++E+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 149 L-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQ--------------PKVTLNW 193
+ +H+N++ LLG C + G L ++ +Y G+L +YL + P+ L+
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 194 RQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253
+ VA G+ YL + IHRD+ A NVL+ + ++ DFGLAR H
Sbjct: 135 KDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 254 QTTHVV-GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDW 312
+ T + ++APE T +DV+SFG L E+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------------- 237
Query: 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372
+ EL + + + + + C H+ P+ RP+ +Q+V+ L+R VA
Sbjct: 238 -YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 373 L 373
L
Sbjct: 297 L 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 4e-53
Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 22/300 (7%)
Query: 68 KFAEELEDWELDYGPHRFRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKK 127
+ + ED Y P K + + E LGSG FG V+R + K
Sbjct: 3 DYDKFYEDIWKKYVPQPVEVKQGSVYDY-YDILEELGSGAFGVVHRCVEKATGRVFVAKF 61
Query: 128 ISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQP 187
I+ EI + +L H L+ L K E++L+ +++ G L + +
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 188 KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLAR 245
++ + ++ GL ++HE ++H D+K N++ + + + DFGLA
Sbjct: 122 Y-KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
+ D T + APE D+++ G + G P + E
Sbjct: 178 KLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 306 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
L V E E ++ E + I +P R ++ ++
Sbjct: 236 TLQNV-----KRCDWEFDEDAFSSVSPEAK----DFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-51
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 32/279 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F+ ++LG G F V + E A+K + + E + RL H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
V+L + +L Y NG L KY+ + Y + L YLH +
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHGK 127
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHVVGTLGYLAPEHTRT 272
+IHRD+K N+LL+ +++ ++ DFG A++ + VGT Y++PE
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 273 GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA---RDPN 329
A S+D+++ G + ++ G P F N + + + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP----------------FRAGNEYLIFQKIIKLEYD 228
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
++ + +L+ K D T R ++
Sbjct: 229 FPEKFFPKARDLVEK----LLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 1e-50
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 18/270 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 155
+ +++LG+G F V +++ +A+K I+ ++ +G + EI + +++H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
L G L L+ + G L + + T R I V + YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLHDLGI 128
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 275
+ LD + + DFGL+++ D G+ + GT GY+APE
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPY 186
Query: 276 TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYV 335
+ + D +S G + CG P + + + E ++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFDSPYWDDISDSAK 241
Query: 336 AEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ I DP R + Q +Q
Sbjct: 242 ----DFIRH----LMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-50
Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 40/296 (13%)
Query: 97 FREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHESRQG-MKEFVAEIVSIGR-L 149
+ + LG G FG+V + +AVK + + + ++E+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 150 RHRNLVQLLGYCRRKGE-LLLVYDYMPNGSLDKYLYNQ--------------PKVTLNWR 194
H N+V LLG C + G L+++ ++ G+L YL ++ K L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 195 QRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 253
VA G+ +L IHRD+ A N+LL + ++ DFGLAR +Y
Sbjct: 135 HLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV 313
+ L ++APE T +DV+SFG L E+ P + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEF 246
Query: 314 FDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369
G + A D Y E+ + L C H +P+ RP+ ++V+ L
Sbjct: 247 CRRLKEGTRMRAPD------YTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-48
Identities = 55/280 (19%), Positives = 108/280 (38%), Gaps = 25/280 (8%)
Query: 88 KDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIG 147
K+LY + + E LG G FG V+R SK K + + EI +
Sbjct: 1 KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56
Query: 148 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGL 207
RHRN++ L EL+++++++ + + + N LN R+ + V L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEAL 115
Query: 208 LYLHEEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYL 265
+LH + H D++ N++ + + +FG AR G + + Y
Sbjct: 116 QFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYY 170
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325
APE + +T+ D++S G + + G P + ++ + + E
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT-- 221
Query: 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
D E E ++ + + + +R + + +Q
Sbjct: 222 FDEEAFKEISIEAMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGR-LRHR 152
F ++LG G FG+V+ K+ A+K + + ++ + E + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 153 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHE 212
L + + K L V +Y+ G L ++ + K L+ Y + LGL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFL-- 119
Query: 213 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 272
+ +++RD+K N+LLD + + ++ DFG+ + G T GT Y+APE
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 273 GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332
K S D +SFG L E+ G+ P Q EE + F+ R EA+D
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD----- 232
Query: 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
L++K +P R +R I +
Sbjct: 233 --------LLVK----LFVREPEKRLGVRG--DIRQ 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 8e-47
Identities = 62/273 (22%), Positives = 104/273 (38%), Gaps = 29/273 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLR--- 150
F ++G GGFG VY + A+K + + +QG + E + + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
+V + +L + D M G L +L + + Y + LGL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHM 123
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 270
H + V++RD+K +N+LLD + R+ D GLA + + VGT GY+APE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 177
Query: 271 RTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329
+ G A +SAD FS G L ++ G P + ++ +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVE 227
Query: 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQ 362
L + E L+ D R
Sbjct: 228 LPDSFSPELRSLLEG----LLQRDVNRRLGCLG 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 1e-46
Identities = 61/283 (21%), Positives = 105/283 (37%), Gaps = 28/283 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
+ E+LG GG V+ + ++AVK + + F E + L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 154 LVQLLGYCRRKGE----LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+V + + +V +Y+ +L ++ + + ++ VI L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAP 267
+ +IHRDVK +N+++ ++ DFG+AR + QT V+GT YL+P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
E R +DV+S G L EV G P P AR
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIPPSARH 238
Query: 328 PNLGTEYVAEELELILKLGLLCSHSDPTARP-SMRQVVQILER 369
L + ++LK +P R + ++ L R
Sbjct: 239 EGLSADLD----AVVLK----ALAKNPENRYQTAAEMRADLVR 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 6e-46
Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 36/285 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS---------HESRQGMKEFVAEIVSIG 147
+ KE+LG G V R + E AVK I E ++ + + E+ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 148 RLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
++ H N++QL LV+D M G L YL KVTL+ ++ +++ +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEV 122
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 266
+ LH+ ++HRD+K N+LLD ++N +L DFG + D G + V GT YLA
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLA 177
Query: 267 PEHTRTGKA------TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG 320
PE D++S G + + G P + L ++
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MSGNY 232
Query: 321 ELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ + +L+ + P R + + +
Sbjct: 233 QFGSPEWDDYSDTVK----DLVSR----FLVVQPQKRYTAEEALA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-44
Identities = 55/274 (20%), Positives = 110/274 (40%), Gaps = 27/274 (9%)
Query: 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLL 158
++LG G G+V + +++ + A+K + + E+ R + ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 159 GYCR----RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
+ LL+V + + G L + ++ R+ ++K + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 215 EQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 271
+ HRDVK N+L + +L DFG A+ T T Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 272 TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331
K S D++S G + + CG P R + + PN
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ISPGMKTRIRMGQYEFPNPE 240
Query: 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
V+EE++++++ ++PT R ++ + +
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-44
Identities = 58/291 (19%), Positives = 109/291 (37%), Gaps = 33/291 (11%)
Query: 85 FRYKDLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKI------SHESRQGMKE 138
FR +++ + E LGSG F V + + ++ A K I S ++
Sbjct: 3 FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 139 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYG 198
E+ + ++H N++ L K +++L+ + + G L +L + +T +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF- 118
Query: 199 VIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDPQ 254
+ L ++ + H D+K N++L + + DFGLA D G +
Sbjct: 119 ----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--E 172
Query: 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF 314
++ GT ++APE AD++S G + G P +E L V V
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231
Query: 315 DFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
E + N + I + DP R +++ +Q
Sbjct: 232 ----NYEFEDEYFSNTSALAK----DFIRR----LLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 8e-44
Identities = 56/269 (20%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F+ LG+G FGRV+ + A+K + E + ++ E + + + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
++++ G + ++ ++ DY+ G L L + + Y A L L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYL 120
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+ +I+RD+K N+LLD + ++ DFG A+ T + GT Y+APE T
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTK 176
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
S D +SFG + E+ G P + E + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------------EKILNAELRFPPF 223
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQ 362
+ + +L+ + D + R Q
Sbjct: 224 FNEDVKDLLSR----LITRDLSQRLGNLQ 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-42
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 27/290 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKS-KIEIAVKKISHESRQGMKE-----FVAEIVSIGRLR 150
+ +G G +G+V++ K+ +A+K++ ++ + VA + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 151 HRNLVQLLGYC-----RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVAL 205
H N+V+L C R+ +L LV++++ YL P+ + ++ +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLR 127
Query: 206 GLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 265
GL +LH V+HRD+K N+L+ +L DFGLAR+Y T VV TL Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 182
Query: 266 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV----------DWVFD 315
APE T D++S G E+ + + L + DW D
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ ++ ++V + EL L L C +P R S +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-42
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 23/282 (8%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE-----FVAEIVSIGRLRHRNLV 155
+ LG G F VY+ + +A+KKI R K+ + EI + L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
LL K + LV+D+M N +T + + Y + GL YLH+ W
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQHW- 120
Query: 216 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 274
++HRD+K +N+LLD +L DFGLA+ + TH V T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV----------DWVFDFWNRGELLE 324
D+++ G L E+ + + L + W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 325 ARDPNLGTEYVAEEL-ELILKLGLLCSHSDPTARPSMRQVVQ 365
P + ++ + +L L +P AR + Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 18/283 (6%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
F++ E +G G +G VY+ + +A+KKI E+ + EI + L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+LL + +L LV++++ + L K++ + + + GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
V+HRD+K N+L++ E +L DFGLAR + T VV
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 275 ATTSADVFSFGAFLLEVACGRRP------------IERQGPEENLILVDWVFDFWNRGEL 322
+T+ D++S G E+ R I R + ++ V +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 323 LEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
++ V E L H DP R S + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-42
Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 36/302 (11%)
Query: 90 LYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGM-KEFVAEIVSIGR 148
++ + +G G +G V +K+ +A+KKIS Q + + EI + R
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 149 LRHRNLVQLLGYCR----RKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVA 204
RH N++ + R + + + + ++ L K L Q L+ + +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQIL 119
Query: 205 LGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT--THVVGTL 262
GL Y+H V+HRD+K SN+LL+ + ++ DFGLAR+ D D T V T
Sbjct: 120 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 263 GYLAPEHTRTGKATT-SADVFSFGAFLLEVACGRRPIERQGPEENL-----ILVDWVFDF 316
Y APE K T S D++S G L E+ R + + L IL +
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 317 WNRGELLEARDPNLGTEYV-------------AEELELILKLGLLCSHSDPTARPSMRQV 363
N L+AR+ L + ++ L+L+ K +P R + Q
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK----MLTFNPHKRIEVEQA 292
Query: 364 VQ 365
+
Sbjct: 293 LA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 2e-42
Identities = 53/281 (18%), Positives = 101/281 (35%), Gaps = 24/281 (8%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+R +GSG FG +Y GT + E+A+K +++ + E ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 157 LLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQ 216
+ +C +G+ ++ + SL+ L+N + + + + + Y+H +
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 217 VVIHRDVKASNVLLDGELNGRL---GDFGLARLYDHGTDPQ------TTHVVGTLGYLAP 267
IHRDVK N L+ G L DFGLA+ Y Q ++ GT Y +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 268 EHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327
+ + D+ S G L+ G P + + + + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPI 237
Query: 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILE 368
L Y +E + C +P + Q+
Sbjct: 238 EVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLFR 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-42
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 28/289 (9%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ + +++G+G FG VY+ L S +A+KK+ + R E+ + +L H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 157 LLGYCRRKGE------LLLVYDYMPNGSLDKYL-YNQPKVTLNWRQRYGVIKGVALGLLY 209
L + GE L LV DY+P Y++ K TL + + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 210 LHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
+H + HRD+K N+LLD + +L DFG A+ G +P +++
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF------------DF 316
T+S DV+S G L E+ G+ + L+ + V
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 317 WNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+ + + + + + L PTAR + +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (368), Expect = 2e-41
Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 20/283 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
+ E +G G +G VY+ + A+KKI E + EI + L+H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+L K L+LV++++ + L + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
V+HRD+K N+L++ E ++ DFGLAR + T +V + K
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENL-----ILVDWVFDFWNRGELLEARDPN 329
+T+ D++S G E+ G + L IL W L DPN
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 330 LGTEYVAEELELILKLG-----LL--CSHSDPTARPSMRQVVQ 365
+ L LL DP R + +Q ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-41
Identities = 62/277 (22%), Positives = 98/277 (35%), Gaps = 28/277 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F +LLG G FG+V + A+K + E ++ + V E + RH
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
L L + L V +Y G L +L + T + Y A + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYL 121
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+ V++RD+K N++LD + + ++ DFGL + GT YLAPE
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333
+ D + G + E+ CGR P Q E EL+ +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------------ELILMEEIRFPRT 227
Query: 334 YVAEELELILKLGLLCSHSDPTARPSMRQ--VVQILE 368
E L+ DP R +++E
Sbjct: 228 LSPEAKSLLAG----LLKKDPKQRLGGGPSDAKEVME 260
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-41
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 34/298 (11%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNL 154
+ + +G G FG V++ K+ ++A+KK+ E+ + + EI + L+H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 155 VQLLGYC--------RRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALG 206
V L+ C R KG + LV+D+ + K TL+ +R + +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQML 126
Query: 207 LLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH---VVGTLG 263
L L+ ++HRD+KA+NVL+ + +L DFGLAR + + Q V TL
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 264 YLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENL-----ILVDWVFDFW 317
Y PE + D++ G + E+ ++ + L + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 318 NRGELLEARDPNLGTEYVAEELELILKLGLL----------CSHSDPTARPSMRQVVQ 365
+ E + + +++ LK + DP R +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-40
Identities = 61/279 (21%), Positives = 100/279 (35%), Gaps = 40/279 (14%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKE------FVAEIVSIGRLR 150
++ LLGSGGFG VY G + +A+K + + E E+V + ++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 151 --HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
+++LL + R +L+ + + L V +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 267
+ V+HRD+K N+L+D +L DFG L D T GT Y P
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPP 178
Query: 268 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326
E R + SA V+S G L ++ CG P F + E++ +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------FEHDEEIIRGQ 220
Query: 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365
+E LI C P+ RP+ ++
Sbjct: 221 -VFFRQRVSSECQHLIRW----CLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 3e-40
Identities = 48/309 (15%), Positives = 102/309 (33%), Gaps = 38/309 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LV 155
++ +G G FG ++ GT + ++A+K S + E + L +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64
Query: 156 QLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWE 215
+ + + +LV D + G + L + + + K + + +HE
Sbjct: 65 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119
Query: 216 QVVIHRDVKASNVLLDGELNG-----RLGDFGLARLYD------HGTDPQTTHVVGTLGY 264
+ +++RD+K N L+ + + DFG+ + Y H + ++ GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 265 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324
++ + + D+ + G + G P + N + + GE +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------GEKKQ 233
Query: 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALGLSAR 384
+ EE + + A P + + + L
Sbjct: 234 STPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK----------VLERL 280
Query: 385 GITYQEGFD 393
T E FD
Sbjct: 281 NTTEDENFD 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-39
Identities = 55/284 (19%), Positives = 108/284 (38%), Gaps = 20/284 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
+ + E +G G +G V++ ++ +A+K++ + + EI + L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 155 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW 214
V+L +L LV+++ + + + + + L L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCH 118
Query: 215 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 274
+ V+HRD+K N+L++ +L +FGLAR + + VV
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 275 ATTSADVFSFGAFLLEVACGRRPIERQGPEENLI------LVDWVFDFWNRGELLEARDP 328
+TS D++S G E+A RP+ ++ + L + W L P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 329 NLGTEYVAEELELILKLG-----LL--CSHSDPTARPSMRQVVQ 365
+ ++ KL LL +P R S + +Q
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-36
Identities = 62/291 (21%), Positives = 115/291 (39%), Gaps = 32/291 (10%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 154
+R+ + +GSG +G V ++ ++A+KK+ +S K E+ + +RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 155 VQLLGYCRRKG------ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
+ LL + LV +M G+ L K+ + Q + + GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFL--VYQMLKGLR 135
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
Y+H HRD+K N+ ++ + ++ DFGLAR D T +VV
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEV 189
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL-----ILVDWVFDFWNRGELL 323
+ T + D++S G + E+ G+ + + L + +F R +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 324 EARDPNLGT-EYVAEELELILK------LGLL--CSHSDPTARPSMRQVVQ 365
EA++ G E ++ IL + LL D R + + +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 1e-35
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 12/212 (5%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 153
F + LG+G FGRV +S A+K + + + ++ + E + +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 154 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE 213
LV+L + L +V +Y+ G + +L + + + L YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL 160
Query: 214 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 273
+I+RD+K N+L+D + ++ DFG A+ +T + GT LAPE +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSK 213
Query: 274 KATTSADVFSFGAFLLEVACGRRPIERQGPEE 305
+ D ++ G + E+A G P P +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 3e-34
Identities = 56/314 (17%), Positives = 112/314 (35%), Gaps = 42/314 (13%)
Query: 81 GPHRFRYKDLYIATKG---FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMK 137
+ Y+ + ++ LG G + V+ + ++ VK + + K
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---K 74
Query: 138 EFVAEIVSIGRLR-HRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYNQPKVTLNWR 194
+ EI + LR N++ L + LV++++ N + TL
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDY 129
Query: 195 QRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDP 253
+ + L Y H ++HRDVK NV++D E RL D+GLA Y G +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 254 QTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEE------- 305
V + + PE S D++S G L + + P
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 306 NLILVDWVFDFWNRGEL-LEARDPNLGTEYVAEELELILKLGLLCSHS------------ 352
++ + ++D+ ++ + L+ R ++ + + E + S
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 353 -DPTARPSMRQVVQ 365
D +R + R+ ++
Sbjct: 305 YDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 30/289 (10%)
Query: 92 IATKGFREKELLGSGGFGRVYRG---TLPKSKIEIAVKKISH----ESRQGMKEFVAEIV 144
+ + F ++LG+G +G+V+ + + A+K + + + + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 145 SIGRLRHR-NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGV 203
+ +R LV L + + +L L+ DY+ G L +L + + T + Q Y V
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----V 135
Query: 204 ALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 263
+L L + +I+RD+K N+LLD + L DFGL++ + + GT+
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 264 YLAPEHTRTGKA--TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321
Y+AP+ R G + + D +S G + E+ G P G + + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------SR 246
Query: 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQ--VVQILE 368
+ +P E A +LI + DP R +I E
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQR----LLMKDPKKRLGCGPRDADEIKE 291
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-33
Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 43/302 (14%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 154
++ + +GSG G V +A+KK+S +++ K E+V + + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 155 VQLLGYCRRKG------ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLL 208
+ LL + ++ LV + M + ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133
Query: 209 YLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 268
+LH +IHRD+K SN+++ + ++ DFGLAR GT T V T Y APE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 269 HTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENL-----ILVDWVFDFWNRGELL 323
+ D++S G + E+ + + + L +F + +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 324 EARDPNLGTEYVAEELELILKLGLLCSHS--------------------DPTARPSMRQV 363
+Y + L + S DP R S+
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 364 VQ 365
+Q
Sbjct: 309 LQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-31
Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 38/294 (12%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 154
++ +GSG +G V K+ + +AVKK+S +S K E+ + ++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 155 VQLLGYCRRKGEL-----LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLY 209
+ LL L + + ++ L+ + Q L +I + GL Y
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 136
Query: 210 LHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 269
+H +IHRD+K SN+ ++ + ++ DFGLAR D T +V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 270 TRTGKATTSADVFSFGAFLLEVACGRRP---------------IERQGPEENLILVDWVF 314
+ D++S G + E+ GR + E L +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 315 DFWNRGELLEARDPNLGTEYVA---EELELILKLGLLCSHSDPTARPSMRQVVQ 365
L + N ++ ++L+ K D R + Q +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK----MLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 7e-25
Identities = 44/238 (18%), Positives = 76/238 (31%), Gaps = 19/238 (7%)
Query: 97 FREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 156
+ LG G F V+ + +A+K + + + EI + R+ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 157 LLGYCRRKGELLLVY--DYMPNGSL------------DKYLYNQPKVTLNWRQRYGVIKG 202
LL + PNG + + + K
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 203 VALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHG-TDPQTTHVVG 260
+ LGL Y+H +IH D+K NVL++ L +A L + D T+ +
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 261 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318
T Y +PE AD++S + E+ G E D +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 3e-19
Identities = 30/159 (18%), Positives = 52/159 (32%), Gaps = 20/159 (12%)
Query: 101 ELLGSGGFGRVYRGTLPKSKIEIAVK----------KISHESRQGMKEFVAEIVSIGRLR 150
+L+G G V+ K E VK K+ + G F + R
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 151 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYL 210
R L +L G K VY + N L + + + + V+ + +
Sbjct: 65 FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 211 HEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249
+ ++H D+ NVL+ E + DF +
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 36.7 bits (84), Expect = 0.003
Identities = 10/33 (30%), Positives = 13/33 (39%), Gaps = 1/33 (3%)
Query: 3 SHYILGWSFKINGQAQELNLSQLPKLPRVGPKK 35
SH +L WSF N N+ L L +
Sbjct: 220 SHDVLSWSFASNLPHASSNIDPL-DLTSFVLHE 251
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.7 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-57 Score=420.79 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=217.5
Q ss_pred HHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 92 IATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
+..++|++.+.||+|+||+||+|++..+++.||||++..... ..++|.+|+.++++++||||++++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 345678889999999999999999988899999999875533 3467999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.......+++..++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999987666689999999999999999999999 999999999999999999999999999998765544
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
........|++.|+|||++.+..++.++|||||||++|||++|..|+........ +......+ ..+...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~-----~~~~~~ 238 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD-----YRMERP 238 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTT-----CCCCCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcC-----CCCCCC
Confidence 4444445689999999999999999999999999999999998777654333221 11111111 112222
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. ....+.+++.+||+.||++|||+.||++.|+...
T Consensus 239 ~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 239 EG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22 2345788999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-56 Score=417.92 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=199.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCce---eeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKI---EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
++|++.+.||+|+||+||+|+++.++. .||||++... .....+.|.+|+.+|++++||||++++|+|...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345667899999999999999865543 5899988654 445567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++..... .+++.+++.++.|||.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876533 68999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCC----cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 251 TDP----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 251 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ... +..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~----i~~~----- 249 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INA----IEQD----- 249 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HHTT-----
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC-----
Confidence 221 1223467899999999999999999999999999999998 8999976554321 111 1111
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
..+.. +.+....+.+++.+||+.||++|||+.||++.|++.+.
T Consensus 250 ~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 YRLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 12234557889999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=406.25 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=204.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999999899999999986543 23345689999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC-C
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-D 252 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 252 (420)
+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999997654 69999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred CcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ..+ .... .....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~----~~~~-----~~~~~- 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW----KEKK-----TYLNP- 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHH----HTTC-----TTSTT-
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHH----hcCC-----CCCCc-
Confidence 23445689999999999988776 678999999999999999999997654332110 000 0000 00000
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112244667888999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=406.65 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=203.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
.++|++.+.||+|+||+||+|++++ .||||++... .....+.|.+|+.++++++||||+++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4678899999999999999999743 4999998644 44556889999999999999999999998765 5689999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++..... .+++.++..++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999975533 69999999999999999999999 999999999999999999999999999998764432
Q ss_pred C-CcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 252 D-PQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 252 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... .....+. ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~----~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGY----LS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTS----CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCC----CC
Confidence 2 23345679999999999864 358999999999999999999999998655432211 1111111 11
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+.. .....+....+.+++.+||+.||++|||+.||++.|+...
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 1112223456888999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=408.14 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=210.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|+..+.||+|+||+||+|++..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999899999999987665445577999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++...... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999988764 58999999999999999999999 999999999999999999999999999998765432 23
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCcc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEY 334 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (420)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... ..+.. ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~------~~~~~--~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATN------GTPEL--QN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHH------CSCCC--SS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhC------CCCCC--CC
Confidence 445679999999999999999999999999999999999999997654332111 11000 01111 11
Q ss_pred cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 335 VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 335 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222345778889999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=407.33 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=197.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||+||+|++.+ +..||||++..... ..++|.+|++++++++||||++++|+|...+..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3578889999999999999999964 56799999975433 346799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|.+++.... ..+++..++.++.|||.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred cCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999987653 368999999999999999999999 99999999999999999999999999999876554444
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcC-CccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......||+.|+|||++.+..++.++|||||||++|||+|+ +.||......+ +...+ ..+ ..+..+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i----~~~-----~~~~~p~ 225 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI----STG-----FRLYKPR 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHH----HHT-----CCCCCCT
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHH----Hhc-----CCCCCcc
Confidence 44456789999999999999999999999999999999995 45554332221 11111 111 1111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
.. ...+.+++.+||+.||++|||+.||++.|++.
T Consensus 226 ~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LA----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 22 24577889999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=407.38 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=207.5
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||+||+|+++ ++..||||++..... ..+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 467888999999999999999986 456799999975433 34679999999999999999999998865 567999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|.+++.......+++.+++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999998876655569999999999999999999999 99999999999999999999999999999977654433
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......||+.|+|||++.+..++.++|||||||++|||+||..|+........ .. ..+..+ ..+..+..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~----~~i~~~-----~~~~~p~~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI----QNLERG-----YRMVRPDN 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTT-----CCCCCCTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHhc-----CCCCCccc
Confidence 44456789999999999988999999999999999999997665543332211 11 111111 11112222
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+ ...+.+++.+||+.||++||||.||++.|+.
T Consensus 235 ~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 C----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2 3457888999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=399.06 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=207.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999999999999999986432 233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997654 68999999999999999999999 99999999999999999999999999999765432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. ....+. .+..+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~------~~~~p 224 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRV------EFTFP 224 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTT------CCCCC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC------CCCCC
Confidence 334567999999999999999999999999999999999999999765433211 111111 11122
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
... ...+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 222 234678888999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=397.11 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=212.4
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|+..+.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++||||++++|+|.+.+..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 368899999999999999999995 677899999876533 346899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|..++..... .+++..+++++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred cCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999765533 68899999999999999999999 99999999999999999999999999999876554444
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+..+. .+..+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-------~~i~~~~-----~~~~p~ 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGL-----RLYRPH 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTTC-----CCCCCT
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-------HHHHhCC-----CCCCcc
Confidence 4445678999999999999999999999999999999998 89999876543311 1111111 111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
. ....+.+++.+||+.||++|||+.|+++.|..
T Consensus 225 ~----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 L----ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp T----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred c----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2 22457889999999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=406.07 Aligned_cols=261 Identities=26% Similarity=0.472 Sum_probs=203.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCc----eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSK----IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
.+.|+..++||+|+||+||+|.++.++ ..||||++... ......+|.+|+.++.+++||||++++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 456788899999999999999986543 46999998654 3444567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+.++++.+++..... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999998876543 69999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 249 HGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..|+........ +. ..+..+ .
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~----~~i~~~-----~ 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM----KAINDG-----F 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----HHHHTT-----C
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HH----HHHhcc-----C
Confidence 4322 122335689999999999999999999999999999999997666544332211 11 111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCCC
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVAL 373 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 373 (420)
.+.... +....+.+++.+||+.||++||||.||++.|++.+..
T Consensus 231 ~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 112222 2335578899999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=403.82 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=195.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee--CCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 170 (420)
++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|++++++++||||+++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788999999999999999999989999999998654 34445779999999999999999999998864 4568999
Q ss_pred EeecCCCChhhhhccC--CCccCcHHHHHHHHHHhHhHhHHhhhcc--cCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 171 YDYMPNGSLDKYLYNQ--PKVTLNWRQRYGVIKGVALGLLYLHEEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2236999999999999999999999821 13499999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+. ...+.++..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~---- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCC----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCC----
Confidence 654322 23456899999999999999999999999999999999999999976543321 111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+.....++ ..+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12222233 34778888999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=404.61 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=207.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+.|++.+.||+|+||+||+|++..++..||||++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999999999999999997766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
++|+|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999999976543 269999999999999999999999 999999999999999999999999999997543211 12
Q ss_pred ccccccCCccccccccc-----CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 255 TTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.....||+.|+|||++. +..|+.++|||||||++|||++|+.||....+.+... ... .+ ..+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~i~-~~-----~~~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------KIA-KS-----EPPT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHH-HS-----CCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH------HHH-cC-----CCCC
Confidence 23467999999999983 4568999999999999999999999998765433211 000 00 1111
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+ .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111222345778889999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=401.03 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=206.4
Q ss_pred hcCCCccce-ecccCceEEEEEEeCC--Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKEL-LGSGGFGRVYRGTLPK--SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|.+.+. ||+|+||+||+|.++. ++..||||++... .....+.|.+|++++++++||||++++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345566664 9999999999998753 4557999998754 34456789999999999999999999999865 46899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... ..+++.++..++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999986543 369999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccccc
Q 036051 250 GTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEAR 326 (420)
Q Consensus 250 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (420)
... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ...+..+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-------~~~i~~~~----- 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK----- 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTC-----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC-----
Confidence 322 12234568999999999998899999999999999999998 9999987554321 11111221
Q ss_pred CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 327 DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 327 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
.+..+.. ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 230 ~~~~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 RMECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1222222 23457789999999999999999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=393.46 Aligned_cols=245 Identities=24% Similarity=0.423 Sum_probs=198.1
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee----CCeEEEEE
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLVY 171 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 171 (420)
+..+.||+|+||+||+|++..++..||+|++... .....+.|.+|++++++++||||+++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5567899999999999999988999999988654 34445679999999999999999999999865 35689999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCc--EEecccCCCCEEEc-CCCcEEEeeecCccccc
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQV--VIHRDVKASNVLLD-GELNGRLGDFGLARLYD 248 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~dlk~~NIll~-~~~~~kl~Dfg~~~~~~ 248 (420)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999997654 68999999999999999999998 66 99999999999997 57899999999998643
Q ss_pred CCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......... ......+. .+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~-----~~ 231 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV-----KP 231 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC-----CC
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCC-----CC
Confidence 22 3345689999999999865 5999999999999999999999999754432211 11111110 00
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..+.......+.+++.+||++||++|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111112234778899999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=396.79 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEeC--CCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeecCC
Q 036051 101 ELLGSGGFGRVYRGTLP--KSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN 176 (420)
Q Consensus 101 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 176 (420)
+.||+|+||+||+|.+. +.++.||||++... +....+.|.+|+.++++++||||++++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 34578999998654 33345789999999999999999999999965 457899999999
Q ss_pred CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC--c
Q 036051 177 GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--Q 254 (420)
Q Consensus 177 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 254 (420)
|+|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998654 68999999999999999999999 99999999999999999999999999999876543322 2
Q ss_pred ccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 255 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ...+..+. .+..+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-------~~~i~~~~-----~~~~p~~ 234 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGE-----RMGCPAG 234 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTC-----CCCCCTT
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------HHHHHcCC-----CCCCCcc
Confidence 234578999999999999999999999999999999998 8999986543321 11111221 1122222
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
+ ...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 235 ~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 235 C----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp C----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred c----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2 3457788999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=406.34 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=208.2
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCc-----eeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSK-----IEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
..++|++.+.||+|+||+||+|++...+ ..||+|.+... .......|.+|+.++.++ +||||+++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3467889999999999999999985433 36999988654 333446789999999998 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCCC---------------------ccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccC
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPK---------------------VTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVK 224 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk 224 (420)
..++||||+++|+|.++|+.... ..+++..++.++.||+.||+|||+ ++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 99999999999999999975431 258999999999999999999999 999999999
Q ss_pred CCCEEEcCCCcEEEeeecCcccccCCCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCC
Q 036051 225 ASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQG 302 (420)
Q Consensus 225 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~ 302 (420)
|+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866543332 2334678999999999999999999999999999999998 899998655
Q ss_pred CcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 303 PEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
..+.. ......+ ..+..+.. ....+.+++.+||+.||++|||+.||++.|..
T Consensus 272 ~~~~~------~~~~~~~-----~~~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDANF------YKLIQNG-----FKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHHH------HHHHHTT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH------HHHHhcC-----CCCCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 43321 1111111 11112222 23457889999999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=407.98 Aligned_cols=204 Identities=28% Similarity=0.403 Sum_probs=181.3
Q ss_pred HhcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|+.+|++++||||++++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999999999999999998754 3334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .++|+||||||+|||+++++.+||+|||+|......
T Consensus 84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997654 68999999999999999999997 148999999999999999999999999999865432
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGP 303 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~ 303 (420)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 22346899999999999999999999999999999999999999976554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-53 Score=402.49 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=211.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999899999999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--CCCcEEEeeecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
++|+|.+++..... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++......
T Consensus 106 ~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 106 SGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999865433 69999999999999999999999 9999999999999996 4578999999999876543
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+... .. ... ......
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i-~~~------~~~~~~ 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------NV-KSC------DWNMDD 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHT------CCCSCC
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH------HH-HhC------CCCCCc
Confidence 23445689999999999999999999999999999999999999997654332111 00 000 111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112223457788899999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=396.17 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=205.3
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999999889999999986532 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987654 68999999999999999999999 999999999999999999999999999998765432
Q ss_pred -CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 252 -DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 252 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .....+ ....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~------~~~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKL------EYDF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTT------CCCC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcC------CCCC
Confidence 22334567999999999999999999999999999999999999999865432211 111111 1112
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
+..++ ..+.+++.+||+.||++|||+.|+++
T Consensus 230 p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 22222 34778899999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=400.75 Aligned_cols=246 Identities=29% Similarity=0.416 Sum_probs=203.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
..|+..+.||+|+||+||+|++..++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999999999999999998654 2344567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|..++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999987766543 68999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcccccccCCcccccccccC---CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......+.. .... ....+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~------~~~~~ 232 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA------QNESP 232 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH------HSCCC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH------hCCCC
Confidence 234579999999999854 46899999999999999999999999765432211 1111 11111
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
..... .....+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 11234778888999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=396.53 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=202.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEee
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 173 (420)
.++|++.+.||+|+||+||+|+++++ ..||||++..... ..+.|.+|+.++++++||||++++++|.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 36788999999999999999999755 5699999965533 34679999999999999999999999855 567999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 253 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 253 (420)
+++|+|..++.......++|.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999999876544469999999999999999999999 99999999999999999999999999999876544444
Q ss_pred cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCCc
Q 036051 254 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGTE 333 (420)
Q Consensus 254 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (420)
......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ....+. .+ ..+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~----~~-----~~~~~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE----RG-----YRMPCPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH----TT-----CCCCCCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hc-----CCCCCCcc
Confidence 44556789999999999999999999999999999999997766654433221 111111 11 11112222
Q ss_pred ccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 334 YVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 334 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
....+.+++.+||+.||++|||+.+|+++|+...
T Consensus 239 ----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 ----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2345778899999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-53 Score=399.35 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=192.3
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc-hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
.+.|++.+.||+|+||+||+|+++.+++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356889999999999999999999889999999987543 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc---CCCcEEEeeecCcccccC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDH 249 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~~ 249 (420)
|+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997654 69999999999999999999999 9999999999999994 578999999999986543
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPN 329 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (420)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+ ..+. ..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i----~~~~------~~ 227 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQI----LKAE------YE 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHH----HTTC------CC
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHH----hccC------CC
Confidence 22 234567999999999999999999999999999999999999999765432211 100 0111 11
Q ss_pred CCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 330 LGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 330 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
............+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111122345778899999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-52 Score=400.35 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=210.8
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|++.+.||+|+||+||+|++..+++.||||++..........+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999998899999999997765555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc--CCCcEEEeeecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
++|+|.+++.... ..+++.+++.|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999998876543 369999999999999999999999 9999999999999998 6789999999999876543
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... ....+ ......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------~i~~~------~~~~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-------NVKRC------DWEFDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHC------CCCCCS
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhC------CCCCCc
Confidence 23445689999999999999999999999999999999999999997654332110 00011 111111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222345778999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-53 Score=397.36 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=213.2
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCC-----Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeee
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 162 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 162 (420)
+++...++|++.+.||+|+||+||+|++++ ++..||||++... .....++|.+|+.++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999999753 4578999999765 3344577999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChhhhhccCC----------------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEe
Q 036051 163 RKGELLLVYDYMPNGSLDKYLYNQP----------------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIH 220 (420)
Q Consensus 163 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH 220 (420)
..+..+++|||+++|+|.+++.... ...+++..++.|+.|++.||+|||+ ++++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 9999999999999999999986432 1248899999999999999999999 99999
Q ss_pred cccCCCCEEEcCCCcEEEeeecCcccccCCC-CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCC-ccC
Q 036051 221 RDVKASNVLLDGELNGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-RPI 298 (420)
Q Consensus 221 ~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~-~p~ 298 (420)
|||||+|||+|.++.+||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654322 22333457889999999999999999999999999999999986 567
Q ss_pred CCCCCcccchhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 299 ERQGPEENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
......+.. ..+.++.. +..+... ...+.+++.+||+.||++||||.||+++|++++
T Consensus 244 ~~~~~~e~~-------~~v~~~~~-----~~~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVI-------YYVRDGNI-----LACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHH-------HHHHTTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHH-------HHHHcCCC-----CCCCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 655443311 11112211 1122222 345788999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=390.75 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=208.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccc------hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.|.+|+.++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367899999999999999999999899999999986431 12357799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC----cEEEeeecC
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL 243 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfg~ 243 (420)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997654 69999999999999999999999 9999999999999998776 499999999
Q ss_pred cccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 244 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 244 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+... ....+
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~--- 231 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAV--- 231 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHTT---
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH-------HHHhc---
Confidence 98765332 3344678999999999999999999999999999999999999998654332110 00010
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
...............+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111122345778999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=389.54 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=198.1
Q ss_pred hcCCCccceecccCceEEEEEEeCCC---ceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS---KIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.++|++.+.||+|+||+||+|++..+ +..||||++... .....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46788899999999999999998543 356899988654 3444577999999999999999999999986 467899
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999876553 368999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCC
Q 036051 250 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDP 328 (420)
Q Consensus 250 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (420)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||......+.. ..+.++. .+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~-------~~i~~~~-----~~ 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGE-----RL 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC-----CC
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC-----CC
Confidence 44444555678999999999999999999999999999999988 88999776544311 1111111 11
Q ss_pred CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 329 NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 329 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..... ....+.+++.+||+.||++|||+.||++.|+..
T Consensus 229 ~~~~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 PMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12222 234578889999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=387.10 Aligned_cols=250 Identities=32% Similarity=0.449 Sum_probs=198.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeee-CCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 172 (420)
.++|+..+.||+|+||.||+|+++ +..||||+++... ..+.|.+|++++++++||||++++|+|.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 356778899999999999999994 5679999997543 33679999999999999999999998854 467899999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+++|+|.++|.......+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC---
Confidence 9999999999976554568999999999999999999999 9999999999999999999999999999986543
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......+|..|+|||++.+..++.++|||||||++|||+| |+.||......+ +..++ .++ ..+...
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~-----~~~~~~ 222 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG-----YKMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTT-----CCCCCC
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC-----CCCCCC
Confidence 2233467899999999998999999999999999999998 677776544332 11111 111 122222
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
... ...+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 223 ~~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 222 24577889999999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=391.15 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=209.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 170 (420)
-++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35789999999999999999999999999999998754 233457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999998654 68899999999999999999999 99999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+.. ..... .....
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~------~~~~~ 224 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILM------EEIRF 224 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHH------CCCCC
T ss_pred -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-------HHHhc------CCCCC
Confidence 22344578999999999999999999999999999999999999999875543211 11111 11222
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
+..++. .+.+++.+||+.||.+||+ +.|+++
T Consensus 225 p~~~s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTLSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCH----HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 233333 4677888999999999995 778875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-51 Score=385.87 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=206.2
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999999988999999998654 2233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 9999999999988765 57888999999999999999999 9999999999999999999999999999987643
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .....+ ....+
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~------~~~~p 221 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNA------ELRFP 221 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHC------CCCCC
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-------HHHHcC------CCCCC
Confidence 233468999999999999999999999999999999999999999765433211 111111 11122
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
...+ ..+.+++.+||+.||.+|| |+.|+++
T Consensus 222 ~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2222 3467888889999999996 8999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=393.73 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=202.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCce----eeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKI----EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 169 (420)
.+|++.++||+|+||+||+|++..+++ .||+|++... .....++|.+|+.++++++||||++++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468899999999999999999876664 5888887644 334467899999999999999999999999865 5678
Q ss_pred EEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccC
Q 036051 170 VYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 249 (420)
Q Consensus 170 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 249 (420)
++||+.+|+|.+++.... ..+++..++.++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 889999999999887653 379999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCC-cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 250 GTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 250 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+.. ..+..+ ..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-------~~i~~~-----~~ 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKG-----ER 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-------HHHHHT-----CC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcC-----CC
Confidence 3322 2334568999999999999999999999999999999998 78888765543311 111111 11
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+..+.. ....+.+++.+||+.||.+|||+.||++.|++..
T Consensus 232 ~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111122 2345788999999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=382.67 Aligned_cols=270 Identities=27% Similarity=0.323 Sum_probs=204.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----eEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 170 (420)
++|.+.+.||+|+||+||+|++ ++..||||++...... ...+..|+..+.+++||||++++++|.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 5677789999999999999998 4678999998654332 223345666777889999999999997653 68999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcc-----cCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEW-----EQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
|||+++|+|.++|+.. .++|.+++.++.|+|.||+|||+.. .++|+||||||+|||+++++.+||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999865 5899999999999999999999631 3699999999999999999999999999998
Q ss_pred cccCCCC---CcccccccCCcccccccccCCC------CCccchhhhhHHHHHHHhcCCccCCCCCCcccch----hhhh
Q 036051 246 LYDHGTD---PQTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACGRRPIERQGPEENLI----LVDW 312 (420)
Q Consensus 246 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~----~~~~ 312 (420)
....... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7654332 1234567999999999987543 5779999999999999999998886544322111 0001
Q ss_pred hhhhcccCccccccCCCCCCcc-cHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 313 VFDFWNRGELLEARDPNLGTEY-VAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..............+|.+...+ ..+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111112222334443332 345667799999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=383.82 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=197.8
Q ss_pred hcCCCccceecccCceEEEEEEeCC---Cceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK---SKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||+||+|++.. ....||||++... .....++|.+|+.++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3568889999999999999998643 2357999998754 33445789999999999999999999999976 467
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccc
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 247 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 247 (420)
++||||+++|+|.+++..... .+++..++.++.|||.||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 899999999999998875433 69999999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCCC--cccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 248 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 248 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...+..+.. ......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~i~~~~---- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG---- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HHHHhCC----
Confidence 543322 2233567889999999999999999999999999999998 89999765543311 1111111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
..+.....+ ...+.+++.+||+.||++|||+.||+++|++
T Consensus 232 -~~~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -ERLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111111222 2457789999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-51 Score=380.28 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=202.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----e
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----E 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 166 (420)
.++|++.+.||+|+||+||+|++..+++.||||++... +......|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999999989999999998654 3344567999999999999999999999887643 4
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.|+||||+++++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999887654 68999999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCC--CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 247 YDHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 247 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....+.+. ..........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~-- 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI-- 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC--
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC--
Confidence 533222 234456899999999999999999999999999999999999999976543321 1111111111
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCC-CHHHHHHHHhc
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARP-SMRQVVQILER 369 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~ 369 (420)
.......+....+.+++.+||+.||.+|| |+.++++.|.+
T Consensus 233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111112234577888899999999999 89999888865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-51 Score=376.99 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=206.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---------hhHHHHHHHHHHHhccCC-cceEeeeeeeeeeC
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---------RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK 164 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 164 (420)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999998899999999986532 122346889999999997 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCc
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 244 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~ 244 (420)
+..|+||||+++|+|.++|..+. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 68999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCccccccccc------CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTR------TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWN 318 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 318 (420)
+...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||......+.. ....
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i~ 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIM 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHHH
Confidence 8765432 334568999999999884 345788999999999999999999999865533211 1111
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.+. ..............+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 01111111223345778899999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=387.57 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=204.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCce--eeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 170 (420)
++|++.+.||+|+||+||+|++++++. .||||++... .....+.|.+|+++|.++ +||||++++++|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999977665 4778887543 334456799999999998 799999999999999999999
Q ss_pred EeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcE
Q 036051 171 YDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNG 236 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~ 236 (420)
|||+++|+|.++|+... ...+++.+++.++.|||.||.|||+ ++++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 2468999999999999999999999 999999999999999999999
Q ss_pred EEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCc-cCCCCCCcccchhhhhhhh
Q 036051 237 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR-PIERQGPEENLILVDWVFD 315 (420)
Q Consensus 237 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~ 315 (420)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||...+..+ +.+.
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~--- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK--- 238 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH---
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHH---
Confidence 999999998654322 2234568999999999999999999999999999999999765 565443322 1111
Q ss_pred hcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 316 FWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+.++ ..+...... ...+.+++.+||+.||++||||.||++.|++.+
T Consensus 239 -i~~~-----~~~~~~~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 -LPQG-----YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -GGGT-----CCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHhc-----CCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 122222222 345778889999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=384.22 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=201.9
Q ss_pred cCCCcc-ceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccC-CcceEeeeeeeeee----CCeEE
Q 036051 95 KGFREK-ELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR----KGELL 168 (420)
Q Consensus 95 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~ 168 (420)
++|.+. +.||+|+||+||+|++..+++.||||++... ..+.+|+.++.++ +||||+++++++.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 578776 4699999999999999888999999998643 4467899887654 89999999999865 46789
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC---CCcEEEeeecCcc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR 245 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg~~~ 245 (420)
+|||||+||+|.++|...+...+++.++..++.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999987655579999999999999999999999 99999999999999985 4579999999998
Q ss_pred cccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccc
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEA 325 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (420)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+........ .+.... ..
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i------~~ 231 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRI------RM 231 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC------CS
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHH------hc
Confidence 765432 3345689999999999999999999999999999999999999997654432110 000000 00
Q ss_pred cCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 326 RDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 326 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.....+..........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111222233456888999999999999999999988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-50 Score=383.89 Aligned_cols=245 Identities=22% Similarity=0.269 Sum_probs=206.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc---chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 171 (420)
++|++.+.||+|+||.||+|+++.+++.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999999989999999998643 2233467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 251 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 251 (420)
||+.+|+|..++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 9999999999997654 68999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 252 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 252 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....... .....+ .+...
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~------~~~~p 258 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSG------KVRFP 258 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------CCCCC
T ss_pred --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-------HHHhcC------CCCCC
Confidence 233468999999999999999999999999999999999999999765432211 111111 11122
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCC-----CHHHHHH
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARP-----SMRQVVQ 365 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 365 (420)
..++ ..+.+++.+||+.||.+|+ |+.|+++
T Consensus 259 ~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2223 3477888899999999994 8999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=381.34 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=202.2
Q ss_pred cceecccCceEEEEEEeCCCc---eeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeee-CCeEEEEEeec
Q 036051 100 KELLGSGGFGRVYRGTLPKSK---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYDYM 174 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 174 (420)
.++||+|+||+||+|++..++ ..||||++... .....++|.+|++++++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 36899998753 55556889999999999999999999999875 56899999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC--
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-- 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 252 (420)
++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999876543 67889999999999999999999 9999999999999999999999999999987654322
Q ss_pred -CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCC
Q 036051 253 -PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLG 331 (420)
Q Consensus 253 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (420)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ...++ ..+. .+..+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~-----~~~~p 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGR-----RLLQP 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC-----CCCCC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC-----CCCCc
Confidence 223345789999999999999999999999999999999998888765432211 11111 1111 11111
Q ss_pred CcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 332 TEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 332 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
.. ....+.+++.+||+.||++||||.||++.|++..
T Consensus 257 ~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 257 EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12 2345778999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=384.73 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=207.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
++|++.+.||+|+||+||+|++..+++.||||++...... ...+.+|+++|++++||||+++++++.+.+.+|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 5788999999999999999999999999999999765433 356889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC--CcEEEeeecCcccccCCCC
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE--LNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfg~~~~~~~~~~ 252 (420)
++|+|.+++...+ ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||++......
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999997653 368999999999999999999999 999999999999999854 58999999999875432
Q ss_pred CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCCCC
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNLGT 332 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (420)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .... .+ ......
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~------~~i~-~~------~~~~~~ 224 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIM-NA------EYTFDE 224 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH-HT------CCCCCH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hC------CCCCCh
Confidence 2344567899999999999999999999999999999999999999765543211 0000 00 011111
Q ss_pred cccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 333 EYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 333 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112345788999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-50 Score=385.74 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=201.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHH---HHHHHHhccCCcceEeeeeeeeeeCCeEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEF---VAEIVSIGRLRHRNLVQLLGYCRRKGELL 168 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 168 (420)
++|++.+.||+|+||.||+|++..+++.||||++.... ......+ ..|+.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999999899999999986431 1112223 34577888889999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
+||||+++|+|.++|.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 68899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccC
Q 036051 249 HGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARD 327 (420)
Q Consensus 249 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (420)
.. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+...+. ... ....
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~------~~~~ 225 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTMA 225 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHS------SSCC
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhc------ccCC
Confidence 43 2344679999999999864 56899999999999999999999999875543321111 000 0111
Q ss_pred CCCCCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 328 PNLGTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 328 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
+.....++ ..+.+++.+||+.||.+||| +.|+++
T Consensus 226 ~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 12222233 34778888999999999999 688865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=382.96 Aligned_cols=259 Identities=28% Similarity=0.458 Sum_probs=207.7
Q ss_pred hcCCCccceecccCceEEEEEEeCCC-------ceeeeeecccccc-hhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS-------KIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK 164 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 164 (420)
.++|++.+.||+|+||.||+|++... +..||||++.... .....++.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46788899999999999999987443 3479999997653 34457889999999888 899999999999999
Q ss_pred CeEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEE
Q 036051 165 GELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLL 230 (420)
Q Consensus 165 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll 230 (420)
+..++||||+++|+|.++|.... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 2358999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhc-CCccCCCCCCcccch
Q 036051 231 DGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIERQGPEENLI 308 (420)
Q Consensus 231 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~t-g~~p~~~~~~~~~~~ 308 (420)
+.++.+||+|||++........ .......+|+.|+|||++.++.++.++|||||||++|||++ |..||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999987654432 23445678999999999999999999999999999999998 688886554332
Q ss_pred hhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 309 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+...+..+ ..+.....+ ...+.+++.+||+.||.+|||+.||++.|++.+
T Consensus 246 ----~~~~i~~~-----~~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 ----LFKLLKEG-----HRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----HHHHHHTT-----CCCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHcC-----CCCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11222221 112222222 245788999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=384.13 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=199.2
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----Cceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeC-C
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK-G 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 165 (420)
.++|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|...+.++ +|+||+.+++++... +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4678899999999999999999743 3467999998754 344456788888888877 689999999987654 5
Q ss_pred eEEEEEeecCCCChhhhhccCC--------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP--------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD 231 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~ 231 (420)
..++||||+++|+|.++|+... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 7899999999999999997542 2358999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCC-ccCCCCCCcccchh
Q 036051 232 GELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-RPIERQGPEENLIL 309 (420)
Q Consensus 232 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~-~p~~~~~~~~~~~~ 309 (420)
+++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+||. .||......+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999986544332 2334567999999999999999999999999999999999875 57765443321
Q ss_pred hhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCC
Q 036051 310 VDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDV 371 (420)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 371 (420)
+......+ ..+...... ...+.+++.+||+.||++|||+.|+++.|++.+
T Consensus 246 ---~~~~~~~~-----~~~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 246 ---FCRRLKEG-----TRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp ---HHHHHHHT-----CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHhcC-----CCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111 112222222 234778899999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=380.61 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=204.5
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc---hhHHHHHHHHHHHhc-cCCcceEeeeeeeeeeCCeEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES---RQGMKEFVAEIVSIG-RLRHRNLVQLLGYCRRKGELLLV 170 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 170 (420)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999999999999999996532 233456677777665 68999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCC
Q 036051 171 YDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 171 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 250 (420)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++++||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 58899999999999999999999 99999999999999999999999999999865433
Q ss_pred CCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccccccCCCC
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLEARDPNL 330 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (420)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.. .... ...+..
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~------~~~~~~ 222 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIR------MDNPFY 222 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHH------HCCCCC
T ss_pred -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHH------cCCCCC
Confidence 22344568999999999999999999999999999999999999999865543211 1111 112222
Q ss_pred CCcccHHHHHHHHHHhhcccccCCCCCCCHH-HHH
Q 036051 331 GTEYVAEELELILKLGLLCSHSDPTARPSMR-QVV 364 (420)
Q Consensus 331 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 364 (420)
+...+ ..+.+++.+||+.||.+|||+. |++
T Consensus 223 p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CccCC----HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 22222 3477888899999999999995 675
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=382.62 Aligned_cols=260 Identities=24% Similarity=0.430 Sum_probs=210.9
Q ss_pred hcCCCccceecccCceEEEEEEeCC-----Cceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPK-----SKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 167 (420)
.++|++.+.||+|+||+||+|.+.. .+..||||++... .......|.+|++++++++||||++++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4678889999999999999998842 3567999999754 444456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccC--------CCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 168 LLVYDYMPNGSLDKYLYNQ--------PKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
++||||+++|+|.+++... ....+++..+..++.|+|.||.|||+ .+|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999998643 12357899999999999999999999 899999999999999999999999
Q ss_pred eecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCC-ccCCCCCCcccchhhhhhhhhc
Q 036051 240 DFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-RPIERQGPEENLILVDWVFDFW 317 (420)
Q Consensus 240 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~ 317 (420)
|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+.. ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-------~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------HHH
Confidence 9999986644322 2233457899999999999999999999999999999999985 666554332211 111
Q ss_pred ccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcCCC
Q 036051 318 NRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERDVA 372 (420)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 372 (420)
.++.. +.....+ ...+.+++.+||+.||++|||+.+|++.|++.+.
T Consensus 249 ~~~~~-----~~~p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGL-----LDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCC-----CCCcccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 1111222 3458889999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=380.87 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=210.2
Q ss_pred HhcCCCccceecccCceEEEEEEeC-----CCceeeeeeccccc-chhHHHHHHHHHHHhccC-CcceEeeeeeeeeeCC
Q 036051 93 ATKGFREKELLGSGGFGRVYRGTLP-----KSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG 165 (420)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 165 (420)
..++|++.+.||+|+||.||+|++. .++..||||++... .......|.+|+.+++++ +||||++++++|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3568888999999999999999863 45678999999764 334456799999999998 7999999999999999
Q ss_pred eEEEEEeecCCCChhhhhccCC----------------CccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEE
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQP----------------KVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVL 229 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIl 229 (420)
..++||||+++|+|.++++... ...+++..+..++.||+.||+|||+ ++++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 9999999999999999987542 2358999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeeecCcccccCCCC-CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcC-CccCCCCCCcccc
Q 036051 230 LDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIERQGPEENL 307 (420)
Q Consensus 230 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg-~~p~~~~~~~~~~ 307 (420)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||......+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654332 233446789999999999999999999999999999999995 5555444432211
Q ss_pred hhhhhhhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 308 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
...+..+ ..+..... ....+.+|+.+||+.||.+|||+.||+++|++.
T Consensus 258 ------~~~i~~~-----~~~~~~~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 ------YKMIKEG-----FRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ------HHHHHHT-----CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHhcC-----CCCCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 11222122 234578899999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=375.85 Aligned_cols=260 Identities=25% Similarity=0.271 Sum_probs=196.5
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccchhH-----HHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEeec
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQG-----MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 174 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 174 (420)
+++||+|+||+||+|++..+++.||||++....... .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999999889999999986542221 245889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCCCc
Q 036051 175 PNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 254 (420)
Q Consensus 175 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 254 (420)
.++++..++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 888777666543 368889999999999999999999 9999999999999999999999999999986654322 2
Q ss_pred ccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc------ccccc-
Q 036051 255 TTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE------LLEAR- 326 (420)
Q Consensus 255 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 326 (420)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......-......... .....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 334679999999999865 4679999999999999999999999976554332111000000000000 00000
Q ss_pred CCCCCCc----ccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 327 DPNLGTE----YVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 327 ~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 00112345788999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=371.50 Aligned_cols=267 Identities=25% Similarity=0.336 Sum_probs=202.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999999889999999986542 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+.+ ++..++.......+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9954 55555554444579999999999999999999999 999999999999999999999999999998664322
Q ss_pred CcccccccCCcccccccccCCC-CCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh--------hhhhhhcc-cCcc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV--------DWVFDFWN-RGEL 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~-~~~~ 322 (420)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+..... +..+.... ....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2344467999999999876655 578999999999999999999999765432211100 00000000 0000
Q ss_pred ccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 323 LEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 323 ~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
............ .......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000000 01112457788999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=365.14 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=196.1
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccch------hHHHHHHHHHHHhccCC--cceEeeeeeeeeeCCe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESR------QGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGE 166 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 166 (420)
++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 578999999999999999999998999999998864311 11234678999999986 8999999999999999
Q ss_pred EEEEEeecCC-CChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCC-CcEEEeeecCc
Q 036051 167 LLLVYDYMPN-GSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLA 244 (420)
Q Consensus 167 ~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfg~~ 244 (420)
.++||||+.+ +++.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 57778876543 68999999999999999999999 999999999999999854 79999999999
Q ss_pred ccccCCCCCcccccccCCcccccccccCCCC-CccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCccc
Q 036051 245 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELL 323 (420)
Q Consensus 245 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (420)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . . .+
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i--~--------~~--- 219 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---I--I--------RG--- 219 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---H--H--------HC---
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---H--h--------hc---
Confidence 865432 3345679999999999977665 6779999999999999999999964211 0 0 00
Q ss_pred cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 324 EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......++ ..+.+++.+||+.||++|||+.|+++
T Consensus 220 ---~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112222 34778888999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=368.80 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=196.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCC-ceeeeeecccccch--hHHHHHHHHHHHhccC---CcceEeeeeeeeee----
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKS-KIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRR---- 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 163 (420)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998644 67799999865321 1123455677666655 89999999998853
Q ss_pred -CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeec
Q 036051 164 -KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFG 242 (420)
Q Consensus 164 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 242 (420)
....++++||++++++....... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 35789999999877665444333 3468999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhh----------h
Q 036051 243 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVD----------W 312 (420)
Q Consensus 243 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~----------~ 312 (420)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+.+.....- |
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98754322 23445689999999999999999999999999999999999999998665433211110 0
Q ss_pred hhhhcccCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 313 VFDFWNRGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
-....................+.......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000000000001111122345678889999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-48 Score=363.27 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=198.9
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccc--hhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57889999999999999999996 66789999986542 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
|+.++.+..+..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CCSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 998777776665443 69999999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhh-----h----hcccCcc
Q 036051 253 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVF-----D----FWNRGEL 322 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~-----~----~~~~~~~ 322 (420)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+......... . .......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 22344568999999999865 456899999999999999999999997654332111000000 0 0000000
Q ss_pred c---cccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 323 L---EARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 323 ~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. ....+.............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000001111122345778899999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=359.59 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee--------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-------- 163 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 163 (420)
-++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|+.+|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36789999999999999999999889999999998654 22334678899999999999999999998754
Q ss_pred CCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecC
Q 036051 164 KGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 243 (420)
Q Consensus 164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~ 243 (420)
.+..++||||+.++.+........ .++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 346899999998777665544333 68889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCC---CcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhccc
Q 036051 244 ARLYDHGTD---PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNR 319 (420)
Q Consensus 244 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 319 (420)
+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 976543221 122335799999999998765 6899999999999999999999999765443322111111100000
Q ss_pred C--------ccccccCCC-CCCcccHHH------HHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 320 G--------ELLEARDPN-LGTEYVAEE------LELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 320 ~--------~~~~~~~~~-~~~~~~~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
. ......... .......+. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 000000000 001111111 2346689999999999999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=363.12 Aligned_cols=267 Identities=24% Similarity=0.270 Sum_probs=198.2
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc-chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC----eEE
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELL 168 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 168 (420)
+++|++.+.||+|+||+||+|++..+++.||||++... .....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35689999999999999999999889999999998754 3444577899999999999999999999986643 234
Q ss_pred EEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccccc
Q 036051 169 LVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 248 (420)
Q Consensus 169 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 248 (420)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 455666799999999765 58999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC--CcccccccCCccccccccc-CCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccC-----
Q 036051 249 HGTD--PQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRG----- 320 (420)
Q Consensus 249 ~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 320 (420)
.... .......||+.|+|||++. +..++.++||||+||++|||++|+.||......+...............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3221 2234567999999999984 4567899999999999999999999997654332111110000000000
Q ss_pred -----ccccccCCCCC-Ccc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHHH
Q 036051 321 -----ELLEARDPNLG-TEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQI 366 (420)
Q Consensus 321 -----~~~~~~~~~~~-~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 366 (420)
.......+... ..+ .......+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 000 01112357789999999999999999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=362.41 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=195.8
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCC------
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ 165 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 165 (420)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+|++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36788999999999999999999988999999999754 3344567899999999999999999999987654
Q ss_pred eEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 166 ELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 166 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.+++||||+ +.+|..+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 67888877654 59999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhh
Q 036051 246 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDF 316 (420)
Q Consensus 246 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~ 316 (420)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............... ...
T Consensus 170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 7543 2345679999999999865 45789999999999999999999999765433221110000 000
Q ss_pred cccC---cccccc---CCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 317 WNRG---ELLEAR---DPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 317 ~~~~---~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... ...... ...............+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000000 000000111112234678899999999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=348.94 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=204.4
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeCCeEEEEEe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 172 (420)
++|++.+.||+|+||+||+|++..+++.||||+++.. .......+.+|+.++++++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4789999999999999999999999999999998644 33446788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCcccccCCCC
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 252 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 252 (420)
++.+++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988876654 67899999999999999999999 9999999999999999999999999999987654322
Q ss_pred CcccccccCCcccccccccCCC-CCccchhhhhHHHHHHHhcCCccCCCCCCcccch-hhhhhhh------------hcc
Q 036051 253 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIERQGPEENLI-LVDWVFD------------FWN 318 (420)
Q Consensus 253 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~------------~~~ 318 (420)
......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.......... ....... ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 233345788899999987654 6899999999999999999999975443322110 0000000 000
Q ss_pred cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.......................+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000001111222345778889999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-46 Score=350.14 Aligned_cols=259 Identities=17% Similarity=0.186 Sum_probs=197.7
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceE-eeeeeeeeeCCeEEEEEee
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDY 173 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 173 (420)
++|++.+.||+|+||+||+|++..+++.||||++...... .++..|++++++++|+|+ +.+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4689999999999999999999888999999987654322 457889999999987665 4555666788899999999
Q ss_pred cCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEc---CCCcEEEeeecCcccccCC
Q 036051 174 MPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHG 250 (420)
Q Consensus 174 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfg~~~~~~~~ 250 (420)
+ +++|...+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++.....
T Consensus 85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 667777665443 268999999999999999999999 9999999999999986 3557999999999876543
Q ss_pred CC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 251 TD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 251 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----- 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----- 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-----
Confidence 21 2234567999999999999999999999999999999999999999776544322111100000000
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhc
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILER 369 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 369 (420)
...+.... .....+.+++..||+.||++||++.++.+.|+.
T Consensus 235 ~~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000001 122457788889999999999999999888875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=359.81 Aligned_cols=261 Identities=24% Similarity=0.284 Sum_probs=193.4
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCcceEeeeeeeeeeC------CeEEE
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GELLL 169 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 169 (420)
+|+..++||+|+||+||+|++..+++.||||++..... .+.+|+.+|++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57778999999999999999999999999999865432 234799999999999999999988543 35799
Q ss_pred EEeecCCCChhhhhc-cCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccc
Q 036051 170 VYDYMPNGSLDKYLY-NQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLY 247 (420)
Q Consensus 170 v~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~ 247 (420)
||||++++.+..+.. ......+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997654443332 1223479999999999999999999999 9999999999999999775 8999999999876
Q ss_pred cCCCCCcccccccCCcccccccccC-CCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhhhhhc
Q 036051 248 DHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWVFDFW 317 (420)
Q Consensus 248 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~~~~~ 317 (420)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... ++.....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 5432 2334679999999998765 57899999999999999999999999765533221110 0000000
Q ss_pred c---cCccccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 N---RGELLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
. .......................+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000000000011122345778889999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=358.86 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=202.5
Q ss_pred cCCCccceecccCceEEEEEEe---CCCceeeeeeccccc----chhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCe
Q 036051 95 KGFREKELLGSGGFGRVYRGTL---PKSKIEIAVKKISHE----SRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGE 166 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 166 (420)
++|++.+.||+|+||+||+|+. +.+++.||||++... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 345788999998643 12234567899999999966 899999999999999
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.++++||+.+|+|.+++.... .+++.....++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999997665 56788999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCcccccccccCC--CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCcccc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGELLE 324 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (420)
+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+..... .....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~------- 249 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL------- 249 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH-------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc-------
Confidence 654444445567899999999998654 4688999999999999999999999876554322111 00000
Q ss_pred ccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCC-----HHHHHH
Q 036051 325 ARDPNLGTEYVAEELELILKLGLLCSHSDPTARPS-----MRQVVQ 365 (420)
Q Consensus 325 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 365 (420)
...+..... ....+.+++.+||++||++||| +.|+++
T Consensus 250 ~~~~~~~~~----~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCCCCccc----CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011112122 2345778888999999999994 788875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-45 Score=344.57 Aligned_cols=261 Identities=17% Similarity=0.211 Sum_probs=206.0
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc-ceEeeeeeeeeeCCeEEEEEe
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYD 172 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 172 (420)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|++.+..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4679999999999999999999998899999998855432 2346778888888865 899999999999999999999
Q ss_pred ecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcC-----CCcEEEeeecCcccc
Q 036051 173 YMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARLY 247 (420)
Q Consensus 173 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfg~~~~~ 247 (420)
|+ +++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+
T Consensus 82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 7899998876543 68999999999999999999999 99999999999999974 568999999999876
Q ss_pred cCCCC------CcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhhhhhcccCc
Q 036051 248 DHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWVFDFWNRGE 321 (420)
Q Consensus 248 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 321 (420)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 53321 123346799999999999999999999999999999999999999986655432221111111100000
Q ss_pred cccccCCCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhcC
Q 036051 322 LLEARDPNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQILERD 370 (420)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 370 (420)
..+ +...+ +..+.+++..|++.+|++||++..+.+.|+..
T Consensus 237 ~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 237 LRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 000 01111 23477788889999999999999988887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=349.67 Aligned_cols=258 Identities=21% Similarity=0.242 Sum_probs=197.6
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeee--CCeEEEEE
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR--KGELLLVY 171 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 171 (420)
++|++.+.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999999899999999987543 356789999999995 9999999999874 45699999
Q ss_pred eecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCC-cEEEeeecCcccccCC
Q 036051 172 DYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG 250 (420)
Q Consensus 172 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfg~~~~~~~~ 250 (420)
||+.+++|..+.+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++......
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987642 58999999999999999999999 9999999999999998655 6999999999876543
Q ss_pred CCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchh-----------hhhhhhhcc
Q 036051 251 TDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLIL-----------VDWVFDFWN 318 (420)
Q Consensus 251 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~~~ 318 (420)
. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........... .++......
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 33456789999999998765 479999999999999999999999976543221100 000000000
Q ss_pred cC--ccccccCC--------CCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 319 RG--ELLEARDP--------NLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 319 ~~--~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.. ........ .............+.+|+.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000 0000011112245778899999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=351.10 Aligned_cols=261 Identities=22% Similarity=0.237 Sum_probs=192.0
Q ss_pred cCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeee------CCe
Q 036051 95 KGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KGE 166 (420)
Q Consensus 95 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 166 (420)
++|++.+.||+|+||+||+|++..+++.||||++... +......+.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999999989999999998654 34445678999999999999999999999853 368
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
+|+||||+.++ +.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 99999999655 4444432 58899999999999999999999 9999999999999999999999999999886
Q ss_pred ccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhh---------hhh----
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLILV---------DWV---- 313 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~---------~~~---- 313 (420)
.... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.+........ ++.
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5432 2334557899999999999999999999999999999999999999765432211000 000
Q ss_pred ---hhhcccC------ccccccC---CCCCCcccHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 314 ---FDFWNRG------ELLEARD---PNLGTEYVAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 314 ---~~~~~~~------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
....... ....... ..............+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0000000 01111122334567889999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=350.54 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=195.9
Q ss_pred hcCCCccceecccCceEEEEEEeCCCceeeeeeccccc--chhHHHHHHHHHHHhccCCcceEeeeeeeeeeC-----Ce
Q 036051 94 TKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE 166 (420)
Q Consensus 94 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 166 (420)
.++|++.+.||+|+||+||+|++..+++.||||++... +....+.+.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999999989999999999754 334456789999999999999999999988643 34
Q ss_pred EEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEeeecCccc
Q 036051 167 LLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 246 (420)
Q Consensus 167 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~~ 246 (420)
.+++++|+.+|+|.+++..+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 46677788899999999654 59999999999999999999999 9999999999999999999999999999875
Q ss_pred ccCCCCCcccccccCCcccccccccCC-CCCccchhhhhHHHHHHHhcCCccCCCCCCcccchhhhhh--------hhhc
Q 036051 247 YDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIERQGPEENLILVDWV--------FDFW 317 (420)
Q Consensus 247 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~ 317 (420)
... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+........... ....
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 432 33446789999999987664 5688999999999999999999999765432211100000 0000
Q ss_pred ccCc---cccccCCCCCCcc---cHHHHHHHHHHhhcccccCCCCCCCHHHHHH
Q 036051 318 NRGE---LLEARDPNLGTEY---VAEELELILKLGLLCSHSDPTARPSMRQVVQ 365 (420)
Q Consensus 318 ~~~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 365 (420)
.... ............+ .......+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 0000000000000 0011244678899999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-39 Score=313.64 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=191.0
Q ss_pred CCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-----------cceEeeeeeeeeeC
Q 036051 96 GFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----------HRNLVQLLGYCRRK 164 (420)
Q Consensus 96 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~ 164 (420)
+|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 48999999999999999999998999999999975532 2356778888887775 57899999887643
Q ss_pred --CeEEEEEeecCCCC-hhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCc------
Q 036051 165 --GELLLVYDYMPNGS-LDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELN------ 235 (420)
Q Consensus 165 --~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~------ 235 (420)
...+++++++..+. ............+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 56667777665543 3333334444578899999999999999999997 378999999999999986543
Q ss_pred EEEeeecCcccccCCCCCcccccccCCcccccccccCCCCCccchhhhhHHHHHHHhcCCccCCCCCCcccch----hhh
Q 036051 236 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIERQGPEENLI----LVD 311 (420)
Q Consensus 236 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el~tg~~p~~~~~~~~~~~----~~~ 311 (420)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.......... +..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999765432 234579999999999999999999999999999999999999997544321110 000
Q ss_pred hh-----------------hhhcccCccccccCCCC----------CCcccHHHHHHHHHHhhcccccCCCCCCCHHHHH
Q 036051 312 WV-----------------FDFWNRGELLEARDPNL----------GTEYVAEELELILKLGLLCSHSDPTARPSMRQVV 364 (420)
Q Consensus 312 ~~-----------------~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 364 (420)
.+ ................. ...........+.+++.+||+.||.+|||+.|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00 00000000000000000 1123455667899999999999999999999998
Q ss_pred H
Q 036051 365 Q 365 (420)
Q Consensus 365 ~ 365 (420)
+
T Consensus 327 ~ 327 (362)
T d1q8ya_ 327 N 327 (362)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.8e-24 Score=186.82 Aligned_cols=162 Identities=14% Similarity=0.070 Sum_probs=118.4
Q ss_pred CccceecccCceEEEEEEeCCCceeeeeecccccc------------------hhHHHHHHHHHHHhccCCcceEeeeee
Q 036051 98 REKELLGSGGFGRVYRGTLPKSKIEIAVKKISHES------------------RQGMKEFVAEIVSIGRLRHRNLVQLLG 159 (420)
Q Consensus 98 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~~~~ 159 (420)
.+.+.||+|+||+||+|++. +++.||||++.... ......+..|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999985 57789999864321 011234556888899999999988876
Q ss_pred eeeeCCeEEEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhcccCcEEecccCCCCEEEcCCCcEEEe
Q 036051 160 YCRRKGELLLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEEWEQVVIHRDVKASNVLLDGELNGRLG 239 (420)
Q Consensus 160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 239 (420)
+.. .+++|||+++..+.. ++......++.|++.+|+|||+ .+|+||||||+|||++++ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 532 379999998765543 3344567889999999999999 999999999999999965 59999
Q ss_pred eecCcccccCCCCCcccccccCCcccc------cccccCCCCCccchhhhhHHH
Q 036051 240 DFGLARLYDHGTDPQTTHVVGTLGYLA------PEHTRTGKATTSADVFSFGAF 287 (420)
Q Consensus 240 Dfg~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDv~slGvv 287 (420)
|||.+......... .|.. .+.+ .+.|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99999765432111 1111 1111 3567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=5.1e-08 Score=86.73 Aligned_cols=148 Identities=15% Similarity=0.080 Sum_probs=97.0
Q ss_pred HHHHHhcCCCccceecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeE
Q 036051 89 DLYIATKGFREKELLGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGEL 167 (420)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 167 (420)
++...-..|+..+..+.+..+.||+... ++..+++|+...........+.+|...+..+. +--+++++.+..+++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4444455666655544555578999875 34457888876554333345667777766653 33356778888888999
Q ss_pred EEEEeecCCCChhhhhccCCCccCcHHHHHHHHHHhHhHhHHhhhc----------------------------------
Q 036051 168 LLVYDYMPNGSLDKYLYNQPKVTLNWRQRYGVIKGVALGLLYLHEE---------------------------------- 213 (420)
Q Consensus 168 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------- 213 (420)
++||++++|.++.+..... .....++.+++..+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998876544221 11223344455555555531
Q ss_pred ----------------------ccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 214 ----------------------WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 214 ----------------------~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
....++|+|+.|.||++++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=8.7e-06 Score=71.35 Aligned_cols=76 Identities=17% Similarity=0.125 Sum_probs=51.3
Q ss_pred eecccCc-eEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC--cceEeeeeeeeeeCCeEEEEEeecCCCC
Q 036051 102 LLGSGGF-GRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 102 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~ 178 (420)
.+..|.. +.||+.... ++..+++|....... ..+..|...++.+. .-.+++++.+..+.+..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 4455553 679999874 455588887654432 23456666666553 2336677888888888999999998876
Q ss_pred hhh
Q 036051 179 LDK 181 (420)
Q Consensus 179 L~~ 181 (420)
+.+
T Consensus 93 ~~~ 95 (255)
T d1nd4a_ 93 LLS 95 (255)
T ss_dssp TTT
T ss_pred ccc
Confidence 644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.70 E-value=4.8e-05 Score=71.23 Aligned_cols=78 Identities=9% Similarity=0.040 Sum_probs=45.9
Q ss_pred cceecccCceEEEEEEeCCCceeeeeecccccc-------hhHHHHHHHHHHHhccCC---cceEeeeeeeeeeCCeEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKSKIEIAVKKISHES-------RQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLL 169 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 169 (420)
.+.||.|....||+....+++..++||.-.... .........|...|..+. ...+++++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 456899999999999987777778998543210 001122345666665442 23455666553 445588
Q ss_pred EEeecCCCCh
Q 036051 170 VYDYMPNGSL 179 (420)
Q Consensus 170 v~e~~~~g~L 179 (420)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.00082 Score=62.58 Aligned_cols=75 Identities=16% Similarity=0.155 Sum_probs=48.7
Q ss_pred cceecccCceEEEEEEeCCC-------ceeeeeecccccchhHHHHHHHHHHHhccCC-cceEeeeeeeeeeCCeEEEEE
Q 036051 100 KELLGSGGFGRVYRGTLPKS-------KIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY 171 (420)
Q Consensus 100 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 171 (420)
.+.|+.|-.-.+|+...... ...|.+++..... . .....+|..+++.+. +.-.+++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 45788899999999987432 3457777765322 1 234457887777774 3334567777643 6799
Q ss_pred eecCCCChh
Q 036051 172 DYMPNGSLD 180 (420)
Q Consensus 172 e~~~~g~L~ 180 (420)
||+++..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0016 Score=58.70 Aligned_cols=69 Identities=16% Similarity=0.080 Sum_probs=42.9
Q ss_pred ceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCCc-----ceEeeee--eeeeeCCeEEEEEeecCCCC
Q 036051 108 FGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-----RNLVQLL--GYCRRKGELLLVYDYMPNGS 178 (420)
Q Consensus 108 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~~~--~~~~~~~~~~lv~e~~~~g~ 178 (420)
.-.||+++.. +|..+++|+..... ...+++..|...+..|.. +..+..- ......+..+.++++++|..
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4589999984 56679999986542 223556677777766632 2222211 12345667899999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0015 Score=58.52 Aligned_cols=157 Identities=13% Similarity=0.018 Sum_probs=80.5
Q ss_pred cchHHHHHHhcCCCccce-----ecccCceEEEEEEeCCCceeeeeecccccchhHHHHHHHHHHHhccCC-----cceE
Q 036051 85 FRYKDLYIATKGFREKEL-----LGSGGFGRVYRGTLPKSKIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----HRNL 154 (420)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni 154 (420)
.+.+|+.....+|.+.+. |..|---+.|+.+..+ + .+++|++...... +++..|+..+..+. .|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCCH--HHHHHHHHHHHhhhhcccccccc
Confidence 355667666777876543 4466667889998743 4 4899998653211 23334555555543 2322
Q ss_pred eeeee---eeeeCCeEEEEEeecCCCChhhhh--------------c----cC--C--CccC-----------------c
Q 036051 155 VQLLG---YCRRKGELLLVYDYMPNGSLDKYL--------------Y----NQ--P--KVTL-----------------N 192 (420)
Q Consensus 155 v~~~~---~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~--~--~~~l-----------------~ 192 (420)
+...+ +....+....++.+..+......- + .. . .... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 22211 123345567777777654332110 0 00 0 0000 0
Q ss_pred HHHHHHHHHHhHhHhHHhh-hcccCcEEecccCCCCEEEcCCCcEEEeeecCcc
Q 036051 193 WRQRYGVIKGVALGLLYLH-EEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 245 (420)
Q Consensus 193 ~~~~~~i~~~ia~~L~~LH-~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg~~~ 245 (420)
.......+..+...+.-.+ .....++||+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011111222222222222 1234689999999999999988777899999875
|